Cloning	O
and	O
characterization	O
of	O
the	O
mouse	B-PRGE
Mcoln1	E-PRGE
gene	S-SO
reveals	O
an	O
alternatively	B-SO
spliced	I-SO
transcript	E-SO
not	O
seen	O
in	O
humans	S-LIVB

Abstract	O

Background	O

Mucolipidosis	O
type	O
IV	O
(	O
MLIV	O
)	O
is	O
an	O
autosomal	S-GO
recessive	O
lysosomal	S-GO
storage	O
disorder	O
characterized	O
by	O
severe	O
neurologic	O
and	O
ophthalmologic	O
abnormalities	O
.	O

Recently	O
the	O
MLIV	S-PRGE
gene	S-SO
,	O
MCOLN1	S-PRGE
,	O
has	O
been	O
identified	O
as	O
a	O
new	O
member	O
of	O
the	O
transient	O
receptor	O
potential	O
(	O
TRP	O
)	O
cation	S-CHEBI
channel	O
superfamily	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
the	O
mouse	S-LIVB
homologue	S-SO
,	O
Mcoln1	S-PRGE
,	O
and	O
report	O
a	O
novel	O
splice	B-SO
variant	E-SO
that	O
is	O
not	O
seen	O
in	O
humans	S-LIVB
.	O

Results	O

The	O
human	S-LIVB
and	O
mouse	S-LIVB
genes	S-SO
display	O
a	O
high	O
degree	B-SO
of	I-SO
synteny	E-SO
.	O

Mcoln1	S-PRGE
shows	O
91	O
%	O
amino	B-CHEBI
acid	E-CHEBI
and	O
86	O
%	O
nucleotide	S-CHEBI
identity	O
to	O
MCOLN1	S-PRGE
.	O

Also	O
,	O
Mcoln1	S-PRGE
maps	O
to	O
chromosome	S-GO
8	O
and	O
contains	O
an	O
open	B-SO
reading	I-SO
frame	E-SO
of	O
580	O
amino	B-CHEBI
acids	E-CHEBI
,	O
with	O
a	O
transcript	S-SO
length	O
of	O
approximately	O
2	O
kb	O
encoded	O
by	O
14	O
exons	S-SO
,	O
similar	O
to	O
its	O
human	S-LIVB
counterpart	S-SO
.	O

The	O
transcript	S-SO
that	O
results	O
from	O
murine	S-LIVB
specific	O
alternative	O
splicing	O
encodes	O
a	O
611	O
amino	B-CHEBI
acid	E-CHEBI
protein	S-CHEBI
that	O
differs	O
at	O
the	O
c	B-SO
-	I-SO
terminus	E-SO
.	O

Conclusions	O

Mcoln1	S-PRGE
is	O
highly	O
similar	O
to	O
MCOLN1	S-PRGE
,	O
especially	O
in	O
the	O
transmembrane	S-GO
domains	S-SO
and	O
ion	S-CHEBI
pore	O
region	S-SO
.	O

Also	O
,	O
the	O
late	B-GO
endosomal	E-GO
/	O
lysosomal	S-GO
targeting	O
signal	S-SO
is	O
conserved	S-SO
,	O
supporting	O
the	O
hypothesis	O
that	O
the	O
protein	S-CHEBI
is	O
localized	O
to	O
these	O
vesicle	B-GO
membranes	E-GO
.	O

To	O
date	O
,	O
there	O
are	O
very	O
few	O
reports	O
describing	O
species	O
-	O
specific	O
splice	B-SO
variants	E-SO
.	O

While	O
identification	O
of	O
Mcoln1	S-PRGE
is	O
crucial	O
to	O
the	O
development	O
of	O
mouse	S-LIVB
models	O
for	O
MLIV	O
,	O
the	O
fact	O
that	O
there	O
are	O
two	O
transcripts	S-SO
in	O
mice	S-LIVB
suggests	O
an	O
additional	O
or	O
alternate	O
function	O
of	O
the	O
gene	S-SO
that	O
may	O
complicate	O
phenotypic	O
assessment	O
.	O

Background	O

Mucolipidosis	O
type	O
IV	O
(	O
MLIV	O
;	O
MIM	O
252650	O
)	O
is	O
an	O
autosomal	S-GO
recessive	O
lysosomal	S-GO
storage	O
disorder	O
that	O
is	O
characterized	O
by	O
corneal	O
clouding	O
,	O
delayed	O
psychomotor	O
development	O
,	O
and	O
mental	O
retardation	O
that	O
usually	O
presents	O
during	O
the	O
first	O
year	O
of	O
life	O
[	O
1	O
]	O
.	O

Another	O
interesting	O
clinical	O
characteristic	O
is	O
that	O
patients	O
are	O
constitutively	O
achlorhydric	O
with	O
associated	O
hypergastremia	O
[	O
2	O
]	O
.	O

Patients	O
with	O
MLIV	O
do	O
not	O
show	O
mucopolysaccharide	S-CHEBI
excretion	O
,	O
skeletal	O
changes	O
,	O
or	O
organomegaly	O
like	O
the	O
other	O
mucolipidoses	O
.	O

Abnormal	O
lysosomal	S-GO
storage	O
bodies	O
and	O
large	O
vacuoles	S-GO
have	O
been	O
found	O
in	O
skin	O
and	O
conjuctival	O
biopsies	O
using	O
electron	O
-	O
microscopy	O
and	O
,	O
prior	O
to	O
gene	S-SO
identification	O
,	O
served	O
as	O
the	O
only	O
means	O
of	O
diagnosis	O
[	O
3	O
-	O
5	O
]	O
.	O

A	O
recent	O
report	O
estimates	O
that	O
the	O
carrier	O
frequency	O
of	O
MLIV	O
in	O
the	O
Ashkenazi	O
Jewish	O
population	O
is	O
1	O
in	O
100	O
,	O
and	O
mutations	S-SO
have	O
been	O
reported	O
in	O
Jewish	O
and	O
non	O
-	O
Jewish	O
families	O
[	O
6	O
-	O
9	O
]	O
.	O

The	O
human	S-LIVB
gene	S-SO
MCOLN1	S-PRGE
(	O
GenBank	O
#	O
AF287270	O
)	O
maps	O
to	O
chromosome	S-GO
19p13	O
.	O
2	O
-	O
13	O
.	O
3	O
and	O
encodes	O
a	O
novel	O
protein	S-CHEBI
that	O
is	O
a	O
member	O
of	O
the	O
transient	O
receptor	O
potential	O
(	O
TRP	O
)	O
cation	S-CHEBI
channel	O
gene	S-SO
superfamily	O
[	O
7	O
-	O
10	O
]	O
.	O

Protein	S-CHEBI
trafficking	O
studies	O
suggest	O
that	O
MLIV	O
is	O
the	O
result	O
of	O
a	O
defect	O
in	O
the	O
late	O
endocytic	O
pathway	O
,	O
contrary	O
to	O
the	O
other	O
mucolipidoses	O
which	O
are	O
typically	O
caused	O
by	O
defective	O
lysosomal	S-GO
hydrolases	O
[	O
11	O
,	O
12	O
]	O
.	O

Recent	O
work	O
in	O
Caenorhabditis	B-LIVB
elegans	E-LIVB
supports	O
this	O
hypothesis	O
.	O

Loss	O
of	O
function	O
mutants	S-SO
of	O
the	O
MCOLN1	S-PRGE
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
homologue	S-SO
,	O
cup	B-PRGE
-	I-PRGE
5	E-PRGE
,	O
result	O
in	O
an	O
increased	O
rate	O
of	O
endocytosis	O
,	O
accumulation	O
of	O
large	O
vacuoles	S-GO
,	O
and	O
a	O
decreased	O
rate	O
of	O
endocytosed	O
protein	S-CHEBI
breakdown	O
;	O
while	O
over	O
-	O
expression	O
of	O
this	O
gene	S-SO
reverses	O
the	O
phenotype	O
[	O
13	O
]	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
mouse	S-LIVB
homologue	S-SO
of	O
MCOLN1	S-PRGE
is	O
crucial	O
for	O
the	O
development	O
of	O
mouse	S-LIVB
models	O
of	O
MLIV	O
to	O
further	O
study	O
this	O
disorder	O
.	O

Results	O
and	O
discussion	O

Cloning	O
and	O
mapping	O
of	O
the	O
mouse	S-LIVB
homologue	S-SO
Mcoln1	S-PRGE

In	O
order	O
to	O
clone	O
the	O
mouse	S-LIVB
homologue	S-SO
of	O
MCOLN1	S-PRGE
,	O
the	O
human	S-LIVB
amino	B-SO
acid	I-SO
sequence	E-SO
was	O
compared	O
to	O
the	O
high	O
throughput	O
genomic	B-SO
sequence	E-SO
(	O
HTGS	O
)	O
database	O
using	O
TBLASTN	O
,	O
which	O
identified	O
the	O
mouse	S-LIVB
BAC	S-SO
clone	S-SO
RPCI	O
-	O
23	O
_	O
387H4	O
(	O
GB	O
No	O
.	O
AC079544	O
.	O
1	O
)	O
.	O

Correspondence	O
with	O
the	O
Joint	O
Genome	S-SO
Institute	O
and	O
the	O
Lawrence	O
Livermore	O
National	O
Laboratory	O
(	O
LLNL	O
)	O
Human	S-LIVB
Genome	S-SO
Center	O
confirmed	O
the	O
location	S-SO
of	O
this	O
BAC	S-SO
to	O
mouse	S-LIVB
chromosome	S-GO
8	O
and	O
allowed	O
us	O
to	O
construct	O
a	O
physical	B-SO
map	E-SO
of	O
this	O
region	S-SO
[	O
14	O
]	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
BAC	B-SO
sequence	E-SO
was	O
then	O
compared	O
to	O
the	O
mouse	S-LIVB
EST	S-SO
database	O
using	O
BLASTN	O
,	O
and	O
multiple	O
ESTs	S-SO
and	O
their	O
corresponding	O
I	O
.	O
M	O
.	O
A	O
.	O
G	O
.	O
E	O
.	O
clones	S-SO
were	O
identified	O
.	O

Figure	O
1	O

Physical	B-SO
and	I-SO
transcript	I-SO
map	E-SO
of	O
the	O
Mcoln1	S-PRGE
gene	S-SO
region	S-SO
.	O

(	O
A	O
)	O
Physical	B-SO
map	E-SO
showing	O
a	O
590	O
kb	O
segment	B-SO
of	I-SO
mouse	I-SO
chromosome	E-SO
8	O
syntenous	S-SO
to	O
human	S-LIVB
chromosome	S-GO
19	O
,	O
anchored	O
by	O
the	O
genes	S-SO
Insr	S-PRGE
and	O
Nte	S-PRGE
.	O

The	O
region	S-SO
is	O
covered	O
by	O
three	O
BACs	S-SO
:	O
RPCI	O
-	O
23	O
_	O
334D24	O
(	O
AC087153	O
)	O
,	O
RPCI	O
-	O
23	O
_	O
312B8	O
(	O
AC087150	O
)	O
,	O
and	O
RPCI	O
-	O
23	O
_	O
387H4	O
(	O
AC079544	O
)	O
.	O

(	O
B	O
)	O
The	O
transcript	S-SO
map	O
of	O
Mcoln1	S-PRGE
shows	O
14	O
exons	S-SO
,	O
and	O
the	O
locations	S-SO
of	O
the	O
probes	S-SO
used	O
in	O
this	O
study	O
are	O
illustrated	O
.	O

The	O
map	O
also	O
shows	O
the	O
expanded	O
exon	S-SO
13	O
in	O
the	O
alternatively	B-SO
spliced	I-SO
transcript	E-SO
(	O
hashed	O
box	O
)	O
.	O

UniGene	O
cluster	O
Mm	O
.	O
39099	O
is	O
the	O
homologue	S-SO
of	O
the	O
human	S-LIVB
zinc	S-CHEBI
finger	O
gene	S-SO
(	O
AC001252	O
)	O
.	O

It	O
should	O
be	O
noted	O
that	O
the	O
scale	O
of	O
the	O
transcript	S-SO
map	O
is	O
in	O
reference	O
to	O
the	O
201	O
kb	O
scale	O
of	O
BAC	S-SO
RPCI	O
-	O
23	O
_	O
387H4	O
.	O

Three	O
clones	S-SO
(	O
ID	O
Nos	O
.	O
604971	O
,	O
1228665	O
,	O
1247566	O
)	O
from	O
the	O
UniGene	O
cluster	O
Mm	O
.	O

8356	O
were	O
obtained	O
,	O
sequenced	O
,	O
and	O
assembled	O
into	O
a	O
2	O
kb	O
transcript	S-SO
with	O
an	O
open	B-SO
reading	I-SO
frame	E-SO
of	O
580	O
amino	B-CHEBI
acids	E-CHEBI
designated	O
Mcoln1	S-PRGE
(	O
GB	O
No	O
.	O
AF302010	O
)	O
.	O

Comparison	O
of	O
the	O
cDNA	B-SO
sequence	E-SO
to	O
the	O
BAC	S-SO
clone	S-SO
showed	O
that	O
the	O
gene	S-SO
consists	O
of	O
14	O
exons	S-SO
.	O

We	O
then	O
created	O
a	O
transcript	S-SO
map	O
of	O
the	O
Mcoln1	S-PRGE
region	B-SO
of	I-SO
mouse	I-SO
chromosome	E-SO
8	O
(	O
Fig	O
.	O
1B	O
)	O
,	O
noting	O
the	O
presence	O
of	O
the	O
UniGene	O
Cluster	O
Mm	O
.	O

39099	O
,	O
a	O
homologue	S-SO
of	O
the	O
human	S-LIVB
zinc	S-CHEBI
finger	O
gene	S-SO
(	O
GB	O
No	O
.	O
AC001252	O
)	O
that	O
terminates	O
approximately	O
1	O
.	O
8	O
kb	O
before	O
the	O
start	O
of	O
Mcoln1	S-PRGE
;	O
and	O
Nte	S-PRGE
,	O
the	O
mouse	S-LIVB
homologue	S-SO
of	O
the	O
human	B-PRGE
neuropathy	I-PRGE
target	I-PRGE
esterase	I-PRGE
gene	I-PRGE
(	I-PRGE
NTE	E-PRGE
)	O
beginning	O
130	O
base	B-SO
pairs	E-SO
after	O
the	O
polyadenylation	B-SO
signal	E-SO
for	O
Mcoln1	S-PRGE
.	O

The	O
transcript	S-SO
map	O
of	O
the	O
region	S-SO
surrounding	O
Mcoln1	S-PRGE
is	O
similar	O
to	O
the	O
corresponding	O
region	S-SO
of	O
the	O
homologous	B-SO
human	I-SO
MCOLN1	I-SO
region	E-SO
[	O
15	O
]	O
,	O
and	O
the	O
presence	O
of	O
the	O
zinc	S-CHEBI
finger	O
gene	S-SO
and	O
Nte	S-PRGE
confirms	O
and	O
extends	O
the	O
region	B-SO
of	I-SO
synteny	E-SO
between	O
human	S-LIVB
chromosome	S-GO
19	O
and	O
mouse	S-LIVB
chromosome	S-GO
8	O
.	O

Characterization	O
of	O
Mcoln1	S-PRGE

Comparison	O
of	O
the	O
mouse	S-LIVB
and	O
human	S-LIVB
peptide	B-SO
sequences	E-SO
showed	O
91	O
%	O
identity	O
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
homologue	S-SO
cup	B-PRGE
-	I-PRGE
5	E-PRGE
shows	O
34	O
%	O
identity	O
with	O
Mcoln1	S-PRGE
and	O
BLASTP	O
analysis	O
of	O
Mcoln1	S-PRGE
identified	O
a	O
putative	O
Drosophila	B-LIVB
melanogaster	E-LIVB
homologue	S-SO
that	O
shows	O
38	O
%	O
identity	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Interestingly	O
,	O
two	O
MCOLN1	S-PRGE
amino	B-CHEBI
acid	E-CHEBI
substitutions	S-SO
that	O
result	O
in	O
MLIV	O
occur	O
at	O
conserved	S-SO
amino	B-CHEBI
acids	E-CHEBI
.	O

TMPred	O
analysis	O
predicts	O
a	O
protein	S-CHEBI
structure	O
that	O
is	O
nearly	O
identical	O
to	O
MCOLN1	S-PRGE
,	O
containing	O
6	O
transmembrane	S-GO
domains	S-SO
with	O
the	O
N	B-SO
-	I-SO
and	I-SO
C	I-SO
-	I-SO
termini	E-SO
residing	O
in	O
the	O
cytoplasm	S-GO
(	O
Fig	O
.	O
2	O
)	O
[	O
9	O
]	O
.	O

Figure	O
2	O

Peptide	B-SO
sequence	E-SO
comparison	O
of	O
Mcoln1	S-PRGE
to	O
human	S-LIVB
,	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
,	O
and	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
(	O
cup	B-PRGE
-	I-PRGE
5	E-PRGE
)	O
homologues	S-SO
.	O

Blue	O
lines	O
indicate	O
transmembrane	S-GO
domains	S-SO
,	O
the	O
red	O
box	O
surrounds	O
the	O
putative	O
channel	O
pore	O
,	O
the	O
orange	O
box	O
surrounds	O
the	O
putative	O
late	B-GO
endosomal	E-GO
/	O
lysosomal	S-GO
targeting	O
signal	S-SO
.	O

Expression	O
analysis	O
of	O
Mcoln1	S-PRGE

Mouse	S-LIVB
adult	O
multiple	O
tissue	O
and	O
embryonic	O
Northern	O
blots	O
were	O
hybridized	O
using	O
a	O
probe	S-SO
generated	O
from	O
mouse	S-LIVB
exon	S-SO
2	O
(	O
probe	S-SO
1	O
,	O
Fig	O
.	O
1B	O
)	O
,	O
yielding	O
a	O
band	O
of	O
approximately	O
2	O
.	O
4	O
kb	O
(	O
isoform	S-SO
1	O
)	O
,	O
as	O
expected	O
,	O
and	O
a	O
less	O
abundant	O
and	O
unexpected	O
4	O
.	O
4	O
kb	O
band	O
(	O
isoform	S-SO
2	O
)	O
(	O
Figs	O
.	O
3A	O
&	O
3B	O
)	O
.	O

The	O
2	O
.	O
4	O
kb	O
band	O
shows	O
ubiquitous	O
but	O
variable	O
expression	O
,	O
with	O
the	O
highest	O
expression	O
in	O
brain	O
,	O
liver	O
and	O
kidney	O
.	O

The	O
fetal	O
tissue	O
blot	O
shows	O
decreasing	O
levels	O
of	O
the	O
2	O
.	O
4	O
kb	O
message	S-SO
with	O
increasing	O
gestational	O
age	O
.	O

Since	O
the	O
human	B-PRGE
MCOLN1	E-PRGE
gene	S-SO
encodes	O
a	O
single	O
transcript	S-SO
[	O
7	O
-	O
9	O
]	O
,	O
we	O
carried	O
out	O
additional	O
hybridizations	O
with	O
probes	S-SO
generated	O
from	O
various	O
regions	B-SO
of	I-SO
the	I-SO
coding	I-SO
sequence	I-SO
and	I-SO
3	I-SO
'	I-SO
UTR	E-SO
,	O
and	O
all	O
probes	S-SO
identified	O
the	O
same	O
two	O
transcripts	S-SO
in	O
the	O
mouse	S-LIVB
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
verify	O
the	O
presence	O
of	O
a	O
single	O
mouse	S-LIVB
locus	S-SO
,	O
we	O
hybridized	O
a	O
mouse	S-LIVB
Southern	O
blot	O
with	O
the	O
exon	S-SO
2	O
probe	S-SO
.	O

Four	O
different	O
restriction	O
enzymes	S-SO
were	O
used	O
,	O
and	O
only	O
the	O
expected	O
size	O
bands	O
for	O
the	O
chromosome	B-SO
8	I-SO
locus	E-SO
were	O
detected	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
3	O

Northern	O
analysis	O
of	O
Mcoln1	S-PRGE
.	O

(	O
A	O
)	O
Mouse	S-LIVB
fetal	O
tissue	O
Northern	O
and	O
(	O
B	O
)	O
mouse	S-LIVB
multiple	O
tissue	O
Northern	O
blots	O
(	O
Clontech	O
)	O
hybridized	O
with	O
a	O
probe	S-SO
generated	O
from	O
exon	S-SO
2	O
(	O
probe	S-SO
1	O
,	O
Fig	O
.	O
1B	O
)	O
.	O

(	O
C	O
)	O
Hybridization	O
of	O
the	O
multiple	O
tissue	O
blot	O
with	O
a	O
probe	S-SO
from	O
the	O
alternatively	O
spliced	O
segment	B-SO
of	I-SO
exon	E-SO
13	O
(	O
probe	S-SO
2	O
,	O
Fig	O
.	O
1B	O
)	O
.	O

beta	B-PRGE
-	I-PRGE
Actin	E-PRGE
control	O
hybridization	O
is	O
shown	O
below	O
each	O
blot	O
.	O

Characterization	O
of	O
the	O
Mcoln1	S-PRGE
alternative	B-SO
splice	I-SO
variant	E-SO

In	O
order	O
to	O
determine	O
the	O
coding	B-SO
sequence	E-SO
for	O
the	O
larger	O
transcript	S-SO
,	O
we	O
searched	O
the	O
mouse	S-LIVB
EST	S-SO
database	O
using	O
each	O
intron	S-SO
as	O
well	O
as	O
the	O
genomic	B-SO
sequence	E-SO
flanking	O
the	O
Mcoln1	S-PRGE
gene	S-SO
.	O

Two	O
ESTs	S-SO
were	O
identified	O
that	O
contained	O
sequence	S-SO
from	O
intron	S-SO
12	O
(	O
GB	O
No	O
.	O
AI430291	O
and	O
AA874645	O
)	O
,	O
and	O
the	O
corresponding	O
clones	S-SO
were	O
sequenced	O
.	O

Clone	S-SO
408619	O
(	O
ESTs	S-SO
:	O
GB	O
No	O
.	O
AI430291	O
,	O
AI429558	O
)	O
begins	O
approximately	O
1	O
.	O
1	O
kb	O
before	O
exon	S-SO
13	O
and	O
continues	O
through	O
the	O
exon	S-SO
and	O
splices	O
correctly	O
to	O
exon	S-SO
14	O
.	O

Clone	S-SO
1281641	O
(	O
EST	S-SO
:	O
GB	O
No	O
.	O
AA874645	O
)	O
begins	O
175	O
bp	S-SO
before	O
exon	S-SO
13	O
and	O
also	O
splices	O
correctly	O
to	O
exon	S-SO
14	O
.	O

A	O
mouse	S-LIVB
multiple	O
tissue	O
Northern	O
was	O
hybridized	O
using	O
a	O
probe	S-SO
generated	O
from	O
the	O
putative	O
intron	B-SO
sequence	E-SO
in	O
clone	S-SO
408619	O
(	O
Probe	S-SO
2	O
,	O
Fig	O
.	O
1B	O
)	O
,	O
which	O
detected	O
only	O
the	O
4	O
.	O
4	O
kb	O
band	O
(	O
Fig	O
.	O
3C	O
)	O
.	O

In	O
order	O
to	O
determine	O
the	O
sequence	S-SO
of	O
the	O
entire	O
transcript	S-SO
,	O
RT	O
-	O
PCR	O
using	O
primers	S-SO
in	O
exons	S-SO
10	O
and	O
11	O
paired	O
with	O
a	O
primer	S-SO
in	O
intron	S-SO
12	O
was	O
performed	O
using	O
BALB	O
/	O
c	O
mouse	S-LIVB
brain	O
total	O
RNA	S-SO
and	O
the	O
resulting	O
products	S-SO
sequenced	O
.	O

These	O
products	S-SO
show	O
that	O
the	O
larger	O
transcript	S-SO
is	O
due	O
to	O
an	O
alternative	O
splice	O
event	O
that	O
results	O
in	O
an	O
expanded	O
exon	S-SO
13	O
.	O

Specifically	O
,	O
exon	S-SO
12	O
splices	O
at	O
bp	S-SO
436	O
of	O
intron	S-SO
12	O
,	O
creating	O
a	O
large	O
1614	O
bp	S-SO
exon	S-SO
13	O
that	O
splices	O
correctly	O
to	O
exon	S-SO
14	O
.	O

The	O
open	B-SO
reading	I-SO
frame	E-SO
of	O
this	O
alternatively	B-SO
spliced	I-SO
transcript	E-SO
is	O
611	O
amino	B-CHEBI
acids	E-CHEBI
,	O
28	O
amino	B-CHEBI
acids	E-CHEBI
longer	O
than	O
the	O
message	S-SO
encoded	O
by	O
the	O
2	O
.	O
4	O
kb	O
transcript	S-SO
.	O

TMPred	O
analysis	O
predicts	O
that	O
isoform	S-SO
2	O
encodes	O
a	O
protein	S-CHEBI
identical	O
in	O
structure	O
to	O
Mcoln1	S-PRGE
,	O
possessing	O
6	O
transmembrane	S-GO
domains	S-SO
and	O
a	O
channel	O
pore	O
,	O
however	O
the	O
protein	S-CHEBI
sequences	S-SO
diverge	O
at	O
amino	B-CHEBI
acid	E-CHEBI
526	O
.	O

The	O
55	O
amino	B-CHEBI
acid	E-CHEBI
C	B-SO
-	I-SO
terminal	I-SO
cytoplasmic	I-SO
tail	E-SO
encoded	O
by	O
the	O
2	O
.	O
4	O
kb	O
transcript	S-SO
is	O
completely	O
different	O
from	O
the	O
86	O
amino	B-SO
acid	I-SO
tail	E-SO
encoded	O
by	O
the	O
murine	S-LIVB
specific	O
4	O
.	O
4	O
kb	O
transcript	S-SO
(	O
Fig	O
.	O
4	O
)	O
.	O

Clontech	O
Mouse	S-LIVB
RNA	S-SO
Master	O
Blots	O
were	O
hybridized	O
with	O
the	O
exon	S-SO
2	O
and	O
intron	S-SO
12	O
probes	S-SO
mentioned	O
above	O
in	O
an	O
attempt	O
to	O
determine	O
if	O
these	O
two	O
transcripts	S-SO
showed	O
differences	O
in	O
expression	O
patterns	O
,	O
however	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
22	O
tissues	O
represented	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
4	O

Peptide	B-SO
sequence	E-SO
comparison	O
of	O
the	O
two	O
alternatively	B-SO
spliced	I-SO
Mcoln1	I-SO
isoforms	E-SO
.	O

The	O
green	O
box	O
surrounds	O
the	O
divergent	O
c	B-SO
-	I-SO
terminal	I-SO
cytoplasmic	I-SO
tails	E-SO
.	O

The	O
blue	O
lines	O
indicate	O
the	O
transmembrane	S-GO
domains	S-SO
.	O

Next	O
,	O
we	O
directly	O
compared	O
the	O
nucleotide	B-SO
and	I-SO
amino	I-SO
acid	I-SO
sequence	E-SO
of	O
the	O
alternatively	B-SO
spliced	I-SO
mouse	I-SO
transcript	E-SO
to	O
the	O
entire	O
human	B-PRGE
MCOLN1	E-PRGE
genomic	B-SO
sequence	E-SO
and	O
found	O
no	O
significant	O
similarity	O
.	O

As	O
mentioned	O
previously	O
,	O
Northern	O
blots	O
performed	O
with	O
human	B-PRGE
MCOLN1	E-PRGE
probes	S-SO
show	O
only	O
one	O
2	O
.	O
4	O
kb	O
transcript	S-SO
.	O

In	O
addition	O
,	O
we	O
hybridized	O
a	O
human	S-LIVB
multiple	O
tissue	O
Northern	O
and	O
human	S-LIVB
Southern	O
with	O
a	O
probe	S-SO
in	O
human	S-LIVB
intron	S-SO
12	O
that	O
is	O
adjacent	S-SO
to	O
exon	S-SO
13	O
.	O

The	O
probe	S-SO
was	O
located	O
in	O
the	O
region	S-SO
syntenic	S-SO
to	O
that	O
which	O
encodes	O
the	O
alternate	B-SO
mouse	I-SO
transcript	E-SO
.	O

Only	O
the	O
expected	O
bands	O
were	O
detected	O
on	O
the	O
Southern	O
and	O
no	O
bands	O
were	O
detected	O
on	O
the	O
Northern	O
,	O
confirming	O
that	O
this	O
alternative	B-SO
transcript	E-SO
is	O
specific	O
to	O
murine	B-PRGE
Mcoln1	E-PRGE
.	O

Recent	O
BLASTP	O
analysis	O
of	O
the	O
alternate	B-SO
Mcoln1	I-SO
transcript	E-SO
yields	O
a	O
match	S-SO
to	O
a	O
putative	O
145	O
amino	B-CHEBI
acid	E-CHEBI
anonymous	O
protein	S-CHEBI
(	O
GB	O
No	O
.	O
BAB25862	O
)	O
predicted	S-SO
from	O
a	O
RIKEN	O
clone	S-SO
.	O

It	O
is	O
obvious	O
from	O
our	O
results	O
,	O
however	O
,	O
that	O
the	O
identification	O
of	O
this	O
sequence	S-SO
as	O
a	O
full	O
-	O
length	O
protein	S-CHEBI
is	O
incorrect	O
since	O
probes	S-SO
unique	O
to	O
the	O
clone	S-SO
,	O
as	O
well	O
as	O
probes	S-SO
containing	O
the	O
Mcoln1	S-PRGE
coding	B-SO
sequence	E-SO
,	O
identify	O
the	O
same	O
transcripts	S-SO
.	O

Conclusions	O

Comparison	O
of	O
Mcoln1	S-PRGE
isoform	S-SO
1	O
to	O
its	O
human	S-LIVB
homologue	S-SO
shows	O
striking	O
similarity	O
at	O
both	O
the	O
amino	B-CHEBI
acid	E-CHEBI
and	O
nucleotide	S-CHEBI
level	O
.	O

All	O
six	O
of	O
the	O
transmembrane	S-GO
domains	S-SO
,	O
as	O
well	O
as	O
the	O
putative	O
cation	S-CHEBI
channel	O
are	O
highly	O
conserved	S-SO
.	O

The	O
putative	O
di	O
-	O
leucine	S-CHEBI
(	O
L	S-CHEBI
-	O
L	S-CHEBI
-	O
X	S-CHEBI
-	O
X	S-CHEBI
)	O
motif	O
at	O
the	O
C	B-SO
-	I-SO
terminus	E-SO
,	O
which	O
may	O
act	O
as	O
a	O
late	B-GO
endosomal	E-GO
/	O
lysosomal	S-GO
targeting	O
signal	S-SO
,	O
is	O
also	O
conserved	S-SO
[	O
9	O
]	O
.	O

This	O
speculation	O
is	O
supported	O
by	O
work	O
with	O
cup	B-PRGE
-	I-PRGE
5	E-PRGE
[	O
13	O
]	O
,	O
the	O
c	B-LIVB
.	I-LIVB
elegans	E-LIVB
homologue	S-SO
of	O
MCOLN1	S-PRGE
,	O
since	O
cellular	S-CL
localization	O
studies	O
suggest	O
that	O
the	O
protein	S-CHEBI
is	O
found	O
in	O
the	O
late	B-GO
endosomes	E-GO
and	O
/	O
or	O
lysosomes	S-GO
.	O

The	O
mouse	B-PRGE
Mcoln1	E-PRGE
gene	S-SO
has	O
two	O
alternatively	B-SO
spliced	I-SO
isoforms	E-SO
,	O
with	O
isoform	S-SO
2	O
having	O
a	O
different	O
c	B-SO
-	I-SO
terminal	I-SO
cytoplasmic	I-SO
tail	E-SO
.	O

The	O
unique	O
86	O
amino	B-CHEBI
acid	E-CHEBI
c	B-SO
-	I-SO
terminal	I-SO
tail	E-SO
lacks	O
the	O
lysosomal	S-GO
targeting	O
signal	S-SO
and	O
does	O
not	O
contain	O
any	O
conserved	S-SO
domains	S-SO
when	O
compared	O
against	O
the	O
current	O
profile	O
databases	O
.	O

We	O
speculate	O
that	O
this	O
protein	S-CHEBI
may	O
have	O
similar	O
channel	O
function	O
but	O
an	O
alternate	O
subcellular	O
localization	O
,	O
but	O
this	O
must	O
be	O
proven	O
once	O
isoform	S-SO
-	O
specific	O
antibodies	S-GO
are	O
raised	O
.	O

However	O
,	O
our	O
results	O
suggest	O
that	O
phenotypic	O
assessment	O
of	O
Mcoln1	S-PRGE
knock	O
-	O
out	O
mice	S-LIVB
may	O
be	O
complicated	O
and	O
that	O
care	O
must	O
be	O
taken	O
when	O
interpreting	O
data	O
on	O
mouse	S-LIVB
gene	S-SO
expression	O
and	O
phenotype	O
.	O

Interestingly	O
,	O
the	O
second	O
Mcoln1	S-PRGE
isoform	S-SO
is	O
not	O
seen	O
in	O
humans	S-LIVB
and	O
the	O
sequence	S-SO
of	O
the	O
alternatively	O
spliced	O
region	S-SO
is	O
not	O
conserved	S-SO
between	O
man	S-LIVB
and	O
mouse	S-LIVB
.	O

To	O
date	O
,	O
very	O
few	O
genes	S-SO
have	O
been	O
reported	O
that	O
show	O
species	O
specific	O
alternative	B-SO
splice	I-SO
variants	E-SO
.	O

MOG	S-PRGE
,	O
myelin	B-PRGE
/	I-PRGE
oligodendrocyte	I-PRGE
glycoprotein	E-PRGE
,	O
has	O
many	O
different	B-SO
splice	I-SO
variants	E-SO
in	O
humans	S-LIVB
that	O
are	O
not	O
found	O
in	O
mice	S-LIVB
[	O
17	O
]	O
.	O

ATP11B	S-PRGE
,	O
a	O
P	O
-	O
type	O
ATPase	O
,	O
has	O
a	O
rabbit	S-LIVB
-	O
specific	O
splice	B-SO
variant	E-SO
that	O
deletes	S-SO
a	O
transmembrane	S-GO
domain	S-SO
and	O
therefore	O
likely	O
alters	O
the	O
putative	O
function	O
of	O
the	O
protein	S-CHEBI
[	O
18	O
]	O
.	O

Sequencing	O
of	O
the	O
human	S-LIVB
genome	S-SO
has	O
led	O
to	O
estimates	O
of	O
approximately	O
32	O
,	O
000	O
genes	S-SO
,	O
a	O
total	O
surprise	O
given	O
the	O
previous	O
significantly	O
higher	O
estimates	O
that	O
were	O
based	O
on	O
the	O
number	O
of	O
expressed	B-SO
sequence	I-SO
tags	E-SO
(	O
ESTs	S-SO
)	O
in	O
the	O
public	O
databases	O
.	O

This	O
apparent	O
disparity	O
suggests	O
a	O
major	O
role	O
for	O
alternative	O
splicing	O
in	O
creating	O
genetic	S-SO
complexity	O
,	O
and	O
has	O
brought	O
the	O
study	O
of	O
splicing	O
regulation	O
to	O
the	O
forefront	O
of	O
molecular	O
genetics	O
.	O

It	O
is	O
likely	O
that	O
an	O
abundance	O
of	O
species	O
-	O
specific	O
splice	B-SO
variants	E-SO
will	O
be	O
identified	O
as	O
the	O
characterization	O
of	O
alternatively	B-SO
spliced	I-SO
transcripts	E-SO
progresses	O
.	O

Materials	O
and	O
methods	O

Bioinformatics	O

We	O
conducted	O
database	O
searches	O
using	O
BLAST	O
and	O
Draft	O
Human	S-LIVB
Genome	S-SO
Browser	O
.	O

Sequences	S-SO
from	O
UniGene	O
were	O
used	O
to	O
confirm	O
the	O
Mcoln1	S-PRGE
sequence	S-SO
.	O

We	O
performed	O
motif	O
searches	O
using	O
ProfileScan	O
and	O
TMPred	O
and	O
alignment	O
of	O
protein	S-CHEBI
sequences	S-SO
using	O
Pileup	O
(	O
GCG	O
)	O
and	O
Boxshade	O
.	O

DNA	S-SO
Sequencing	O

I	O
.	O
M	O
.	O
A	O
.	O
G	O
.	O
E	O
.	O

Clones	S-SO
were	O
purchased	O
from	O
Research	O
Genetics	O
(	O
Huntsville	O
,	O
AL	O
)	O
.	O

Sequencing	O
was	O
performed	O
using	O
the	O
AmpliCycle	O
sequencing	O
kit	O
from	O
Applied	O
Biosystems	O
(	O
Foster	O
City	O
,	O
CA	O
)	O
on	O
a	O
Genomyx	O
LR	O
programmable	O
DNA	S-SO
sequencer	O
.	O

RT	O
-	O
PCR	O
Reaction	O

BALB	O
/	O
c	O
mouse	S-LIVB
brain	O
total	O
RNA	S-SO
was	O
purchased	O
from	O
Clontech	O
Laboratories	O
(	O
Palo	O
Alto	O
,	O
CA	O
)	O
and	O
made	O
to	O
a	O
1	O
mu	O
g	O
/	O
ml	O
concentration	O
.	O

This	O
RNA	S-SO
was	O
used	O
as	O
a	O
template	O
to	O
create	O
cDNA	S-SO
via	O
RT	O
-	O
PCR	O
using	O
random	S-SO
hexamers	O
and	O
oligo	S-SO
dT	O
primer	S-SO
.	O

The	O
RT	O
product	S-SO
was	O
used	O
to	O
confirm	O
the	O
alternatively	B-SO
spliced	I-SO
form	E-SO
using	O
primers	S-SO
:	O
5	O
'	O
-	O
CATCTACCTGGGCTATTGC	O
-	O
3	O
'	O
(	O
forward	S-SO
)	O
and	O
5	O
'	O
-	O
GCTCTCAGGTGGTGGACAC	O
-	O
3	O
'	O
(	O
reverse	S-SO
)	O
in	O
a	O
PCR	O
reaction	O
with	O
an	O
annealing	O
temperature	O
of	O
61	O
degrees	O
C	O
.	O

Southern	O
Blot	O
Analysis	O

Total	O
mouse	S-LIVB
genomic	B-SO
DNA	E-SO
was	O
digested	O
using	O
EcoRI	O
,	O
BamHI	O
,	O
PstI	O
,	O
and	O
XbaI	O
.	O

The	O
digests	O
were	O
electrophoresed	O
on	O
a	O
1	O
%	O
agarose	S-CHEBI
gel	O
at	O
60V	O
overnight	O
and	O
were	O
transferred	O
onto	O
a	O
Hybond	O
N	O
+	O
membrane	O
from	O
Amersham	O
Pharmacia	O
Biotech	O
(	O
Piscataway	O
,	O
NJ	O
)	O
.	O

A	O
32P	S-CHEBI
-	O
dATP	S-CHEBI
labeled	O
PCR	O
fragment	B-SO
of	I-SO
the	I-SO
Mcoln1	I-SO
coding	I-SO
region	E-SO
corresponding	O
to	O
exon	S-SO
2	O
was	O
used	O
as	O
a	O
probe	S-SO
(	O
primers	S-SO
5	O
'	O
-	O
CCCCACAGAAGAGGAAGAC	O
-	O
3	O
'	O
(	O
forward	S-SO
)	O
and	O
5	O
'	O
-	O
AGATCTTGACCACCTGCAG	O
-	O
3	O
'	O
(	O
reverse	S-SO
)	O
with	O
an	O
annealing	O
temperature	O
of	O
59	O
degrees	O
C	O
)	O
.	O

Hybridization	O
and	O
washes	O
were	O
carried	O
out	O
in	O
standard	O
conditions	O
[	O
16	O
]	O
.	O

Northern	O
Blot	O
Analysis	O

Mouse	S-LIVB
embryo	O
multiple	O
-	O
tissue	O
northern	O
blot	O
and	O
mouse	S-LIVB
adult	O
multiple	O
-	O
tissue	O
northern	O
blot	O
filters	O
were	O
purchased	O
from	O
Clontech	O
Laboratories	O
(	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

The	O
filters	O
were	O
hybridized	O
with	O
the	O
32P	S-CHEBI
-	O
dATP	S-CHEBI
labeled	O
DNA	S-SO
fragment	B-SO
of	I-SO
Mcoln1	I-SO
coding	I-SO
region	E-SO
corresponding	O
to	O
exon	S-SO
2	O
(	O
see	O
above	O
)	O
.	O

For	O
the	O
alternative	O
transcript	S-SO
,	O
a	O
probe	S-SO
was	O
generated	O
in	O
the	O
region	S-SO
between	O
exons	S-SO
12	O
and	O
13	O
with	O
primers	S-SO
5	O
'	O
-	O
GTGTCCACCACCTGAGAG	O
-	O
3	O
'	O
(	O
forward	S-SO
)	O
and	O
5	O
'	O
-	O
GAAGTAGCATTCCTGCAGGC	O
-	O
3	O
'	O
(	O
reverse	S-SO
)	O
with	O
an	O
annealing	O
temperature	O
of	O
62	O
degrees	O
C	O
.	O

The	O
filters	O
were	O
then	O
hybridized	O
with	O
beta	B-PRGE
-	I-PRGE
actin	E-PRGE
probes	S-SO
.	O

Hybridizations	O
and	O
washes	O
were	O
carried	O
out	O
in	O
standard	O
conditions	O
,	O
with	O
the	O
stripping	O
of	O
previously	O
bound	O
probes	S-SO
in	O
between	O
[	O
16	O
]	O
.	O

Acknowledgements	O

This	O
work	O
was	O
supported	O
by	O
grant	O
NS39995	O
.	O

Dorsoventral	O
Patterning	O
of	O
the	O
Mouse	S-LIVB
Coat	O
by	O
Tbx15	S-PRGE

Abstract	O

Many	O
members	O
of	O
the	O
animal	S-LIVB
kingdom	O
display	O
coat	O
or	O
skin	O
color	O
differences	O
along	O
their	O
dorsoventral	O
axis	O
.	O

To	O
determine	O
the	O
mechanisms	O
that	O
control	O
regional	O
differences	O
in	O
pigmentation	O
,	O
we	O
have	O
studied	O
how	O
a	O
classical	O
mouse	S-LIVB
mutation	S-SO
,	O
droopy	O
ear	O
(	O
deH	O
)	O
,	O
affects	O
dorsoventral	O
skin	O
characteristics	O
,	O
especially	O
those	O
under	O
control	O
of	O
the	O
Agouti	S-PRGE
gene	S-SO
.	O

Mice	S-LIVB
carrying	O
the	O
Agouti	S-PRGE
allele	S-SO
black	O
-	O
and	O
-	O
tan	O
(	O
at	O
)	O
normally	O
have	O
a	O
sharp	O
boundary	O
between	O
dorsal	O
black	O
hair	O
and	O
yellow	O
ventral	O
hair	O
;	O
the	O
deH	O
mutation	S-SO
raises	O
the	O
pigmentation	O
boundary	O
,	O
producing	O
an	O
apparent	O
dorsal	O
-	O
to	O
-	O
ventral	O
transformation	O
.	O

We	O
identify	O
a	O
216	O
kb	O
deletion	S-SO
in	O
deH	O
that	O
removes	S-SO
all	O
but	O
the	O
first	O
exon	O
of	O
the	O
Tbx15	S-PRGE
gene	S-SO
,	O
whose	O
embryonic	O
expression	O
in	O
developing	O
mesenchyme	O
correlates	O
with	O
pigmentary	S-CHEBI
and	O
skeletal	O
malformations	O
observed	O
in	O
deH	O
/	O
deH	O
animals	S-LIVB
.	O

Construction	O
of	O
a	O
targeted	O
allele	S-SO
of	O
Tbx15	S-PRGE
confirmed	O
that	O
the	O
deH	O
phenotype	O
was	O
caused	O
by	O
Tbx15	S-PRGE
loss	O
of	O
function	O
.	O

Early	O
embryonic	O
expression	O
of	O
Tbx15	S-PRGE
in	O
dorsal	O
mesenchyme	O
is	O
complementary	O
to	O
Agouti	S-PRGE
expression	O
in	O
ventral	O
mesenchyme	O
;	O
in	O
the	O
absence	O
of	O
Tbx15	S-PRGE
,	O
expression	O
of	O
Agouti	S-PRGE
in	O
both	O
embryos	O
and	O
postnatal	O
animals	S-LIVB
is	O
displaced	O
dorsally	O
.	O

Transplantation	O
experiments	O
demonstrate	O
that	O
positional	O
identity	O
of	O
the	O
skin	O
with	O
regard	O
to	O
dorsoventral	O
pigmentation	O
differences	O
is	O
acquired	O
by	O
E12	O
.	O
5	O
,	O
which	O
is	O
shortly	O
after	O
early	O
embryonic	O
expression	O
of	O
Tbx15	S-PRGE
.	O

Fate	O
-	O
mapping	O
studies	O
show	O
that	O
the	O
dorsoventral	O
pigmentation	O
boundary	O
is	O
not	O
in	O
register	O
with	O
a	O
previously	O
identified	O
dermal	O
cell	S-CL
lineage	O
boundary	O
,	O
but	O
rather	O
with	O
the	O
limb	O
dorsoventral	O
boundary	O
.	O

Embryonic	O
expression	O
of	O
Tbx15	S-PRGE
in	O
dorsolateral	O
mesenchyme	O
provides	O
an	O
instructional	O
cue	O
required	O
to	O
establish	O
the	O
future	O
positional	O
identity	O
of	O
dorsal	O
dermis	O
.	O

These	O
findings	O
represent	O
a	O
novel	O
role	O
for	O
T	O
-	O
box	O
gene	S-SO
action	O
in	O
embryonic	O
development	O
,	O
identify	O
a	O
previously	O
unappreciated	O
aspect	O
of	O
dorsoventral	O
patterning	O
that	O
is	O
widely	O
represented	O
in	O
furred	O
mammals	S-LIVB
,	O
and	O
provide	O
insight	O
into	O
the	O
mechanisms	O
that	O
underlie	O
region	O
-	O
specific	O
differences	O
in	O
body	O
morphology	O
.	O

Introduction	O

A	O
fundamental	O
question	O
in	O
developmental	O
biology	O
is	O
how	O
adjacent	O
regions	O
of	O
the	O
vertebrate	S-LIVB
body	O
acquire	O
differences	O
in	O
their	O
appearance	O
or	O
morphology	O
.	O

Mechanisms	O
that	O
establish	O
the	O
general	O
body	O
plan	O
make	O
use	O
of	O
a	O
relatively	O
small	O
number	O
of	O
signaling	O
pathways	O
shared	O
among	O
all	O
animals	S-LIVB
(	O
reviewed	O
in	O
Pires	O
-	O
daSilva	O
and	O
Sommer	O
2003	O
)	O
,	O
but	O
the	O
extent	O
to	O
which	O
these	O
pathways	O
control	O
finer	O
differences	O
between	O
body	O
regions	O
is	O
not	O
clear	O
.	O

Among	O
vertebrates	S-LIVB
,	O
differences	O
in	O
the	O
shape	O
or	O
number	O
of	O
skeletal	O
elements	O
,	O
altered	O
morphology	O
of	O
epidermal	O
appendages	O
,	O
and	O
variation	O
in	O
pigment	S-CHEBI
distribution	O
combine	O
to	O
produce	O
the	O
majority	O
of	O
what	O
distinguishes	O
one	O
animal	S-LIVB
from	O
another	O
.	O

Among	O
these	O
,	O
pigment	S-CHEBI
patterns	O
are	O
an	O
excellent	O
system	O
to	O
investigate	O
how	O
morphological	O
differences	O
arise	O
,	O
both	O
for	O
different	O
regions	O
of	O
the	O
body	O
within	O
a	O
species	O
and	O
for	O
different	O
animals	S-LIVB
from	O
closely	O
related	O
species	O
.	O

In	O
natural	O
environments	O
,	O
color	O
variation	O
is	O
a	O
nearly	O
universal	O
mechanism	O
for	O
recognition	O
,	O
camouflage	O
,	O
or	O
both	O
;	O
consequently	O
,	O
a	O
large	O
number	O
of	O
pigment	S-CHEBI
patterns	O
have	O
been	O
characterized	O
from	O
an	O
evolutionary	O
and	O
ecological	O
perspective	O
(	O
Boughman	O
2001	O
;	O
Jiggins	O
et	O
al	O
.	O
2001	O
)	O
.	O

In	O
the	O
laboratory	O
,	O
color	O
variation	O
has	O
been	O
the	O
subject	O
of	O
vertebrate	S-LIVB
genetics	O
for	O
more	O
than	O
a	O
century	O
(	O
Searle	O
1968	O
;	O
Silvers	O
1979	O
)	O
,	O
and	O
many	O
pigmentary	S-CHEBI
components	O
have	O
been	O
identified	O
whose	O
actions	O
are	O
understood	O
in	O
a	O
cellular	S-CL
or	O
organ	O
-	O
based	O
context	O
(	O
reviewed	O
in	O
Bennett	O
and	O
Lamoreux	O
2003	O
)	O
.	O

Several	O
mechanisms	O
may	O
contribute	O
to	O
regional	O
differences	O
in	O
vertebrate	S-LIVB
pigmentation	O
.	O

In	O
the	O
embryo	O
,	O
alterations	O
in	O
the	O
determination	O
or	O
migration	O
of	O
melanoblasts	S-CL
from	O
the	O
neural	O
crest	O
affect	O
the	O
number	O
or	O
distribution	O
of	O
pigment	B-CL
cells	E-CL
in	O
the	O
skin	O
(	O
reviewed	O
in	O
Reedy	O
et	O
al	O
.	O
1998	O
)	O
.	O

Within	O
hair	O
follicles	O
,	O
paracrine	O
signals	O
control	O
the	O
type	O
of	O
pigment	S-CHEBI
made	O
in	O
specific	O
regions	O
of	O
the	O
body	O
or	O
at	O
specific	O
times	O
during	O
the	O
hair	O
cycle	O
(	O
reviewed	O
in	O
Furumura	O
et	O
al	O
.	O
1996	O
;	O
Barsh	O
et	O
al	O
.	O
2000	O
)	O
.	O

Finally	O
,	O
movement	O
of	O
pigment	B-GO
granules	E-GO
within	O
melanocytes	S-CL
or	O
from	O
melanocytes	S-CL
to	O
keratinocytes	S-CL
makes	O
use	O
of	O
cellular	S-CL
machinery	O
that	O
is	O
shared	O
by	O
a	O
variety	O
of	O
cell	S-CL
types	O
,	O
but	O
that	O
can	O
vary	O
in	O
different	O
regions	O
of	O
the	O
body	O
(	O
reviewed	O
in	O
Marks	O
and	O
Seabra	O
2001	O
)	O
.	O

However	O
,	O
for	O
all	O
of	O
these	O
mechanisms	O
--	O
white	O
spotting	O
,	O
pigment	S-CHEBI
-	O
type	O
switching	O
,	O
and	O
melanosome	S-GO
biogenesis	O
--	O
more	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
molecular	S-CHEBI
components	O
than	O
their	O
spatial	O
and	O
temporal	O
control	O
.	O

One	O
of	O
the	O
most	O
obvious	O
aspects	O
of	O
regional	O
color	O
variation	O
in	O
vertebrates	S-LIVB
is	O
a	O
dark	O
dorsal	O
surface	O
juxtaposed	O
to	O
a	O
light	O
ventral	O
surface	O
,	O
apparent	O
in	O
the	O
color	O
of	O
skin	O
,	O
scales	O
,	O
feathers	O
,	O
or	O
hair	O
,	O
in	O
which	O
the	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
compartments	O
is	O
often	O
sharp	O
and	O
lies	O
in	O
register	O
with	O
the	O
limbs	O
.	O

In	O
rodents	S-LIVB
and	O
probably	O
other	O
mammals	S-LIVB
,	O
this	O
dorsoventral	O
difference	O
in	O
hair	O
color	O
is	O
brought	O
about	O
by	O
differences	O
in	O
pigment	S-CHEBI
type	O
as	O
determined	O
by	O
allelic	S-SO
variation	O
of	O
the	O
Agouti	S-PRGE
gene	S-SO
(	O
Bultman	O
et	O
al	O
.	O
1992	O
;	O
Miller	O
et	O
al	O
.	O
1993	O
)	O
.	O

Secreted	O
by	O
dermal	B-CL
papilla	I-CL
cells	E-CL
within	O
each	O
hair	O
follicle	O
(	O
Millar	O
et	O
al	O
.	O
1995	O
)	O
,	O
Agouti	S-PRGE
protein	S-CHEBI
causes	O
melanocytes	S-CL
in	O
that	O
follicle	O
to	O
switch	O
from	O
the	O
production	O
of	O
brown	O
/	O
black	O
eumelanin	S-CHEBI
to	O
red	O
/	O
yellow	O
pheomelanin	O
.	O

Agouti	S-PRGE
protein	S-CHEBI
has	O
a	O
short	O
radius	O
of	O
action	O
(	O
Silvers	O
and	O
Russel	O
1955	O
)	O
and	O
can	O
be	O
switched	O
on	O
and	O
off	O
during	O
a	O
single	O
hair	O
cycle	O
(	O
Bultman	O
et	O
al	O
.	O
1992	O
,	O
1994	O
;	O
Miller	O
et	O
al	O
.	O
1993	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
;	O
thus	O
,	O
its	O
regulated	O
expression	O
is	O
thought	O
to	O
be	O
responsible	O
for	O
the	O
cream	O
-	O
colored	O
or	O
yellow	O
ventral	O
surface	O
of	O
mice	S-LIVB
carrying	O
the	O
black	O
-	O
and	O
-	O
tan	O
(	O
at	O
)	O
allele	S-SO
and	O
for	O
the	O
yellow	O
markings	O
around	O
the	O
feet	O
,	O
ears	O
,	O
or	O
head	O
,	O
i	O
.	O
e	O
.	O
,	O
tan	O
points	O
or	O
head	O
spots	O
,	O
of	O
certain	O
dog	S-LIVB
breeds	O
.	O

In	O
laboratory	O
mice	S-LIVB
,	O
previous	O
studies	O
from	O
our	O
group	O
and	O
others	O
identified	O
two	O
predominant	O
Agouti	S-PRGE
mRNA	S-CHEBI
isoforms	S-SO
that	O
differ	O
by	O
virtue	O
of	O
their	O
transcriptional	B-SO
initiation	I-SO
site	E-SO
and	O
5	B-SO
'	I-SO
untranslated	I-SO
exons	E-SO
.	O

A	O
"	O
hair	O
cycle	O
-	O
specific	O
"	O
transcript	S-SO
is	O
expressed	O
in	O
both	O
dorsal	O
and	O
ventral	O
skin	O
for	O
2	O
-	O
3	O
days	O
during	O
early	O
hair	O
growth	O
,	O
while	O
a	O
"	O
ventral	O
-	O
specific	O
"	O
transcript	S-SO
is	O
expressed	O
throughout	O
the	O
entire	O
period	O
of	O
active	O
hair	O
growth	O
,	O
but	O
only	O
in	O
ventral	O
skin	O
(	O
Bultman	O
et	O
al	O
.	O
1994	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
.	O

Animals	S-LIVB
carrying	O
the	O
at	O
allele	S-SO
express	O
only	O
the	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
transcript	S-SO
(	O
Bultman	O
et	O
al	O
.	O
1994	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
and	O
have	O
black	O
dorsal	O
hairs	O
and	O
cream	O
-	O
colored	O
to	O
yellow	O
ventral	O
hairs	O
,	O
with	O
a	O
sharp	O
boundary	O
at	O
the	O
level	O
of	O
the	O
limb	O
-	O
body	O
wall	O
articulations	O
and	O
in	O
the	O
middle	O
of	O
the	O
whisker	O
pad	O
.	O

Ventral	O
-	O
specific	O
Agouti	S-PRGE
isoforms	S-SO
are	O
also	O
expressed	O
in	O
developing	O
skin	O
from	O
embryonic	O
day	O
10	O
.	O
5	O
(	O
E10	O
.	O
5	O
)	O
and	O
beyond	O
and	O
may	O
play	O
a	O
role	O
in	O
pigment	B-CL
cell	E-CL
differentiation	O
(	O
Millar	O
et	O
al	O
.	O
1995	O
)	O
.	O

Thus	O
,	O
regulatory	B-SO
elements	E-SO
for	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
isoforms	S-SO
are	O
responsive	O
to	O
dorsoventral	O
positional	O
cues	O
established	O
in	O
the	O
embryo	O
and	O
whose	O
effects	O
persist	O
after	O
birth	O
.	O

The	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
color	O
compartments	O
in	O
at	O
/	O
at	O
mice	S-LIVB
bears	O
superficial	O
resemblance	O
to	O
dorsoventral	O
boundaries	O
apparent	O
for	O
many	O
other	O
mammals	S-LIVB
,	O
but	O
morphogenetic	O
differences	O
between	O
dorsal	O
and	O
ventral	O
skin	O
seem	O
likely	O
to	O
include	O
more	O
elements	O
than	O
the	O
type	O
of	O
pigment	S-CHEBI
made	O
by	O
hair	O
follicle	O
melanocytes	S-CL
.	O

In	O
particular	O
,	O
dermis	O
of	O
the	O
flank	O
has	O
at	O
least	O
two	O
distinct	O
origins	O
:	O
dermatomal	O
derivatives	O
of	O
somites	O
and	O
loose	O
mesenchyme	O
derived	O
from	O
the	O
lateral	O
plate	O
mesoderm	O
(	O
Mauger	O
1972	O
;	O
Christ	O
et	O
al	O
.	O
1983	O
;	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
;	O
these	O
lineages	O
are	O
established	O
early	O
in	O
development	O
and	O
could	O
,	O
in	O
principle	O
,	O
set	O
up	O
compartments	O
whose	O
identity	O
contributes	O
to	O
dorsoventral	O
differences	O
in	O
adult	O
skin	O
.	O

To	O
better	O
understand	O
the	O
mechanisms	O
that	O
give	O
rise	O
to	O
differences	O
between	O
dorsal	O
and	O
ventral	O
skin	O
and	O
to	O
the	O
boundary	O
between	O
them	O
,	O
we	O
have	O
determined	O
how	O
several	O
morphologic	O
characteristics	O
vary	O
along	O
the	O
dorsoventral	O
axis	O
of	O
the	O
mouse	S-LIVB
and	O
how	O
these	O
characteristics	O
correspond	O
to	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
expression	O
and	O
the	O
lineage	O
boundary	O
that	O
distinguishes	O
somite	O
from	O
lateral	O
plate	O
derivatives	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
apparent	O
uniformity	O
of	O
the	O
dorsoventral	O
boundary	O
represents	O
the	O
sum	O
of	O
independent	O
mechanisms	O
that	O
affect	O
melanocyte	S-CL
density	O
and	O
/	O
or	O
differentiation	O
,	O
pigment	S-CHEBI
-	O
type	O
synthesis	O
,	O
and	O
hair	O
length	O
;	O
surprisingly	O
,	O
none	O
of	O
these	O
coincide	O
with	O
the	O
somite	O
-	O
lateral	O
plate	O
lineage	O
boundary	O
.	O

We	O
also	O
make	O
use	O
of	O
a	O
classical	O
mouse	S-LIVB
mutation	S-SO
,	O
droopy	O
ear	O
(	O
Curry	O
1959	O
)	O
,	O
that	O
produces	O
a	O
dorsal	O
-	O
to	O
-	O
ventral	O
transformation	O
of	O
flank	O
coat	O
color	O
by	O
allowing	O
expansion	O
of	O
the	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
transcript	S-SO
.	O

By	O
positional	S-SO
cloning	O
and	O
gene	S-SO
targeting	O
,	O
we	O
identify	O
an	O
allele	S-SO
of	O
droopy	B-PRGE
ear	E-PRGE
,	O
deH	O
,	O
as	O
a	O
loss	O
of	O
function	O
for	O
Tbx15	S-PRGE
,	O
which	O
encodes	O
a	O
T	O
-	O
box	O
transcription	O
factor	O
expressed	O
in	O
a	O
dynamic	O
and	O
spatially	O
restricted	O
manner	O
in	O
the	O
developing	O
skin	O
and	O
musculoskeletal	O
system	O
.	O

Embryonic	O
expression	O
and	O
transplantation	O
studies	O
suggest	O
that	O
Tbx15	S-PRGE
is	O
required	O
to	O
establish	O
certain	O
characteristics	O
of	O
dorsal	O
patterning	O
in	O
mesenchymal	B-CL
cells	E-CL
of	O
the	O
developing	O
flank	O
.	O

These	O
results	O
identify	O
a	O
previously	O
unappreciated	O
aspect	O
of	O
dorsoventral	O
patterning	O
that	O
is	O
widely	O
represented	O
in	O
furred	O
mammals	S-LIVB
and	O
provide	O
insight	O
into	O
the	O
mechanisms	O
that	O
underlie	O
region	O
-	O
specific	O
differences	O
in	O
body	O
morphology	O
.	O

Results	O

Morphological	O
Components	O
of	O
Dorsoventral	O
Skin	O
Differences	O

Besides	O
the	O
obvious	O
change	O
in	O
hair	O
color	O
that	O
frequently	O
distinguishes	O
dorsal	O
from	O
ventral	O
skin	O
,	O
casual	O
observation	O
suggests	O
there	O
are	O
additional	O
differences	O
in	O
hair	O
length	O
,	O
distribution	O
of	O
hair	O
type	O
,	O
and	O
skin	O
thickness	O
.	O

Furthermore	O
,	O
dorsoventral	O
differences	O
in	O
pigmentation	O
can	O
represent	O
differences	O
in	O
the	O
number	O
and	O
/	O
or	O
differentiated	O
state	O
of	O
pigment	B-CL
cells	E-CL
,	O
as	O
well	O
as	O
the	O
type	O
of	O
pigment	S-CHEBI
synthesized	O
in	O
response	O
to	O
expression	O
of	O
Agouti	S-PRGE
.	O

In	O
particular	O
,	O
ventral	O
hair	O
of	O
at	O
/	O
at	O
animals	S-LIVB
can	O
vary	O
from	O
cream	O
-	O
colored	O
to	O
reddish	O
-	O
yellow	O
depending	O
on	O
age	O
,	O
strain	O
background	O
,	O
and	O
position	O
along	O
the	O
dorsoventral	O
axis	O
.	O

To	O
evaluate	O
the	O
relationship	O
among	O
these	O
components	O
,	O
we	O
compared	O
their	O
features	O
among	O
mice	S-LIVB
of	O
different	O
Agouti	S-PRGE
genotypes	S-SO
.	O

Semiquantitative	O
measurements	O
of	O
hair	O
length	O
plotted	O
as	O
a	O
function	O
of	O
dorsoventral	O
position	O
reveal	O
that	O
the	O
apparent	O
sharp	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
pigment	S-CHEBI
compartments	O
in	O
at	O
/	O
at	O
mice	S-LIVB
coincides	O
with	O
a	O
more	O
gradual	O
change	O
in	O
both	O
hair	O
color	O
and	O
hair	O
length	O
(	O
Figure	O
1A	O
-	O
1D	O
)	O
.	O

Within	O
the	O
region	O
of	O
transition	O
from	O
dorsum	O
to	O
ventrum	O
(	O
Figure	O
1B	O
)	O
,	O
flank	O
hairs	O
from	O
at	O
/	O
at	O
mice	S-LIVB
become	O
progressively	O
shorter	O
and	O
exhibit	O
increasing	O
amounts	O
of	O
pheomelanin	O
deposition	O
progressing	O
from	O
the	O
tip	O
to	O
the	O
base	O
of	O
the	O
hair	O
.	O

However	O
,	O
the	O
region	O
of	O
transition	O
for	O
hair	O
length	O
is	O
considerably	O
broader	O
than	O
that	O
for	O
pigmentation	O
and	O
independent	O
of	O
Agouti	S-PRGE
genotype	S-SO
.	O

Although	O
hair	O
-	O
cycle	O
timing	O
varies	O
along	O
the	O
rostrocaudal	O
axis	O
,	O
measurements	O
of	O
absolute	O
hair	O
length	O
for	O
mice	S-LIVB
matched	O
for	O
age	O
and	O
rostrocaudal	O
level	O
are	O
remarkably	O
similar	O
(	O
Figure	O
1D	O
)	O
.	O

Furthermore	O
,	O
measurements	O
of	O
relative	O
hair	O
length	O
for	O
animals	S-LIVB
of	O
different	O
age	O
,	O
size	O
,	O
and	O
Agouti	S-PRGE
genotype	S-SO
also	O
are	O
very	O
similar	O
when	O
normalized	O
to	O
body	O
circumference	O
(	O
Figure	O
1C	O
)	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
indicate	O
that	O
variation	O
of	O
hair	O
length	O
along	O
the	O
dorsoventral	O
axis	O
is	O
stereotyped	O
and	O
maintained	O
through	O
multiple	O
hair	O
cycles	O
,	O
with	O
a	O
transition	O
in	O
hair	O
length	O
that	O
is	O
gradual	O
and	O
encompasses	O
the	O
pigment	S-CHEBI
-	O
type	O
transition	O
in	O
at	O
/	O
at	O
mice	S-LIVB
.	O

Dorsal	O
and	O
ventral	O
skin	O
develop	O
at	O
different	O
rates	O
.	O

Transverse	O
sections	O
of	O
skin	O
at	O
postnatal	O
day	O
4	O
.	O
5	O
(	O
P4	O
.	O
5	O
)	O
exhibit	O
dorsal	O
hair	O
follicles	O
that	O
are	O
noticeably	O
more	O
developed	O
than	O
ventral	O
hair	O
follicles	O
,	O
along	O
with	O
a	O
gradual	O
dorsoventral	O
decrease	O
in	O
dermal	O
thickness	O
(	O
Figure	O
1F	O
)	O
.	O

However	O
,	O
differences	O
in	O
skin	O
thickness	O
disappear	O
by	O
3	O
-	O
4	O
wk	O
of	O
age	O
(	O
Forsthoefel	O
et	O
al	O
.	O
1966	O
)	O
,	O
and	O
,	O
overall	O
,	O
the	O
proportion	O
of	O
different	O
hair	O
types	O
is	O
also	O
similar	O
in	O
dorsa	O
and	O
ventra	O
of	O
adult	O
mice	S-LIVB
.	O

In	O
age	O
-	O
matched	O
inbred	O
mice	S-LIVB
,	O
we	O
observed	O
a	O
small	O
decrease	O
in	O
the	O
ratio	O
of	O
undercoat	O
hairs	O
(	O
zigzags	O
)	O
to	O
overcoat	O
hairs	O
(	O
auchenes	O
,	O
awls	O
,	O
and	O
guard	O
hairs	O
)	O
in	O
dorsum	O
compared	O
to	O
ventrum	O
(	O
Figure	O
1E	O
)	O
,	O
but	O
there	O
was	O
no	O
consistent	O
difference	O
in	O
hair	O
-	O
type	O
distribution	O
for	O
outbred	O
mice	S-LIVB
(	O
data	O
not	O
shown	O
)	O
.	O

Differences	O
between	O
dorsal	O
and	O
ventral	O
pigmentation	O
of	O
at	O
/	O
at	O
mice	S-LIVB
are	O
usually	O
attributed	O
to	O
pigment	S-CHEBI
-	O
type	O
differences	O
caused	O
by	O
ventral	O
-	O
specific	O
expression	O
of	O
Agouti	S-PRGE
,	O
but	O
animals	S-LIVB
homozygous	O
for	O
a	O
null	O
allele	S-SO
of	O
Agouti	S-PRGE
,	O
extreme	O
nonagouti	O
(	O
ae	O
)	O
,	O
have	O
ventral	O
hairs	O
that	O
contain	O
less	O
melanin	S-CHEBI
than	O
dorsal	O
hairs	O
,	O
giving	O
a	O
slightly	O
paler	O
appearance	O
to	O
the	O
ventral	O
coat	O
(	O
Figure	O
1G	O
)	O
.	O

Using	O
DOPA	S-CHEBI
staining	O
as	O
an	O
indicator	O
of	O
tyrosinase	S-PRGE
activity	O
,	O
we	O
observed	O
a	O
gradual	O
dorsoventral	O
transition	O
in	O
isolated	O
dermis	O
preparations	O
from	O
P4	O
.	O
5	O
ae	O
/	O
ae	O
mice	S-LIVB
(	O
Figure	O
1G	O
)	O
.	O

By	O
contrast	O
,	O
skin	O
from	O
at	O
/	O
at	O
mice	S-LIVB
reveal	O
an	O
abrupt	O
dorsoventral	O
transition	O
of	O
DOPA	S-CHEBI
staining	O
,	O
which	O
probably	O
reflects	O
the	O
additive	O
effects	O
of	O
reduced	O
melanin	S-CHEBI
content	O
(	O
as	O
in	O
ae	O
/	O
ae	O
mice	S-LIVB
)	O
and	O
downregulation	O
of	O
tyrosinase	S-PRGE
activity	O
induced	O
by	O
Agouti	S-PRGE
.	O

Melanin	S-CHEBI
content	O
of	O
individual	O
hairs	O
is	O
likely	O
to	O
be	O
influenced	O
both	O
by	O
the	O
number	O
of	O
pigment	B-CL
cells	E-CL
and	O
their	O
follicular	O
environment	O
.	O

Regardless	O
,	O
dorsoventral	O
differences	O
in	O
hair	O
pigment	S-CHEBI
content	O
of	O
ae	O
/	O
ae	O
mice	S-LIVB
persist	O
throughout	O
multiple	O
hair	O
cycles	O
into	O
adulthood	O
,	O
similar	O
to	O
hair	O
length	O
(	O
but	O
unlike	O
skin	O
thickness	O
)	O
.	O

Thus	O
,	O
at	O
least	O
three	O
characteristics	O
distinguish	O
dorsal	O
from	O
ventral	O
skin	O
:	O
differences	O
in	O
pigment	S-CHEBI
-	O
type	O
synthesis	O
(	O
depending	O
on	O
Agouti	S-PRGE
genotype	S-SO
)	O
,	O
differences	O
in	O
hair	O
length	O
,	O
and	O
differences	O
in	O
melanin	S-CHEBI
content	O
.	O

Ventralization	O
of	O
Skin	O
Morphology	O
by	O
the	O
droopy	B-PRGE
ear	E-PRGE
Mutation	S-SO

Named	O
after	O
its	O
effects	O
on	O
craniofacial	O
morphology	O
,	O
droopy	O
ear	O
is	O
a	O
recessive	O
mutation	S-SO
on	O
mouse	S-LIVB
Chromosome	S-GO
3	O
;	O
the	O
original	O
allele	S-SO
described	O
more	O
than	O
40	O
years	O
ago	O
by	O
Curry	O
(	O
1959	O
)	O
is	O
extinct	O
,	O
but	O
a	O
spontaneous	O
remutation	O
that	O
occurred	O
in	O
Harwell	O
,	O
deH	O
,	O
is	O
available	O
through	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
.	O

External	O
craniofacial	O
malformations	O
are	O
the	O
most	O
obvious	O
characteristic	O
of	O
deH	O
/	O
deH	O
animals	S-LIVB
,	O
including	O
widely	O
spaced	O
eyes	O
,	O
small	O
palpebral	O
fissures	O
,	O
a	O
broad	O
nasal	O
area	O
,	O
and	O
a	O
shortened	O
skull	O
held	O
in	O
an	O
elevated	O
position	O
,	O
which	O
presumably	O
causes	O
or	O
contributes	O
to	O
the	O
abnormal	O
position	O
of	O
the	O
ears	O
.	O

We	O
became	O
interested	O
in	O
droopy	B-PRGE
ear	E-PRGE
because	O
the	O
original	O
allele	S-SO
was	O
described	O
to	O
affect	O
pigment	S-CHEBI
pattern	O
in	O
a	O
way	O
that	O
suggests	O
a	O
possible	O
dorsal	O
to	O
ventral	O
transformation	O
:	O
"	O
On	O
a	O
genetic	S-SO
background	O
(	O
at	O
and	O
AW	O
)	O
which	O
causes	O
the	O
belly	O
hair	O
to	O
be	O
lighter	O
than	O
the	O
back	O
hair	O
,	O
the	O
belly	O
hair	O
comes	O
up	O
farther	O
round	O
the	O
sides	O
of	O
the	O
body	O
and	O
face	O
"	O
(	O
Curry	O
1959	O
)	O
.	O

An	O
abnormal	O
dorsoventral	O
pigment	S-CHEBI
pattern	O
is	O
readily	O
apparent	O
in	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
mice	S-LIVB
,	O
but	O
comparison	O
to	O
nonmutant	O
animals	S-LIVB
is	O
more	O
accurately	O
described	O
in	O
terms	O
of	O
ventral	O
,	O
lateral	O
,	O
and	O
dorsal	O
regions	O
(	O
Figures	O
1G	O
and	O
2A	O
)	O
.	O

The	O
ventral	O
region	O
has	O
short	O
hairs	O
with	O
a	O
gray	O
base	O
and	O
cream	O
-	O
colored	O
tip	O
whose	O
boundary	O
coincides	O
with	O
the	O
limb	O
-	O
body	O
wall	O
junction	O
;	O
both	O
the	O
appearance	O
of	O
this	O
region	O
and	O
position	O
of	O
the	O
boundary	O
are	O
approximately	O
similar	O
in	O
at	O
/	O
at	O
compared	O
to	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
mice	S-LIVB
.	O

The	O
lateral	O
region	O
contains	O
yellow	O
hairs	O
of	O
progressively	O
increasing	O
length	O
;	O
in	O
at	O
/	O
at	O
mice	S-LIVB
,	O
the	O
lateral	O
region	O
appears	O
as	O
a	O
thin	O
yellow	O
stripe	O
along	O
the	O
flank	O
,	O
but	O
in	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
mice	S-LIVB
,	O
the	O
lateral	O
region	O
is	O
considerably	O
expanded	O
with	O
a	O
diffuse	O
boundary	O
along	O
the	O
dorsal	O
flank	O
,	O
and	O
a	O
dorsal	O
eumelanic	S-CHEBI
region	O
whose	O
size	O
is	O
correspondingly	O
reduced	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
.	O

Total	O
body	O
size	O
is	O
smaller	O
in	O
mutant	S-SO
compared	O
to	O
nonmutant	O
animals	S-LIVB
,	O
but	O
the	O
proportion	O
of	O
body	O
circumference	O
occupied	O
by	O
the	O
lateral	O
region	O
in	O
mutant	S-SO
animals	S-LIVB
is	O
increased	O
about	O
2	O
-	O
fold	O
,	O
from	O
11	O
.	O
9	O
%	O
to	O
22	O
.	O
2	O
%	O
(	O
Figure	O
2C	O
)	O
.	O

The	O
proportion	O
of	O
the	O
ventral	O
cream	O
-	O
colored	O
region	O
is	O
also	O
expanded	O
a	O
small	O
amount	O
,	O
47	O
.	O
9	O
%	O
in	O
mutant	S-SO
compared	O
to	O
37	O
.	O
8	O
%	O
in	O
nonmutant	O
animals	S-LIVB
,	O
but	O
expansion	O
of	O
the	O
lateral	O
region	O
,	O
which	O
occurs	O
at	O
all	O
levels	O
of	O
the	O
body	O
,	O
including	O
the	O
limbs	O
and	O
the	O
cranium	O
(	O
but	O
not	O
the	O
whisker	O
pad	O
)	O
,	O
is	O
the	O
major	O
feature	O
responsible	O
for	O
the	O
ventralized	O
appearance	O
caused	O
by	O
deH	O
.	O

To	O
investigate	O
whether	O
deH	O
affects	O
other	O
dorsoventral	O
skin	O
characteristics	O
besides	O
pigment	S-CHEBI
-	O
type	O
switching	O
,	O
we	O
examined	O
its	O
effects	O
on	O
hair	O
length	O
and	O
pigmentation	O
in	O
an	O
ae	O
/	O
ae	O
background	O
.	O

Overall	O
,	O
deH	O
causes	O
a	O
small	O
but	O
consistent	O
reduction	O
in	O
hair	O
length	O
in	O
both	O
dorsum	O
and	O
ventrum	O
;	O
when	O
mutant	S-SO
and	O
nonmutant	O
animals	S-LIVB
are	O
normalized	O
for	O
body	O
circumference	O
,	O
reduced	O
hair	O
length	O
is	O
most	O
apparent	O
in	O
the	O
lateral	O
region	O
(	O
Figure	O
2E	O
)	O
.	O

Adult	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
animals	S-LIVB
exhibit	O
body	O
-	O
size	O
reduction	O
and	O
skeletal	O
abnormalities	O
,	O
but	O
display	O
no	O
coat	O
-	O
color	O
phenotype	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
ae	O
/	O
ae	O
and	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
neonates	O
are	O
clearly	O
distinguishable	O
in	O
the	O
first	O
few	O
days	O
after	O
birth	O
,	O
when	O
a	O
dorsoventral	O
gradient	O
of	O
melanogenic	O
activity	O
is	O
apparent	O
under	O
the	O
skin	O
(	O
Figure	O
2D	O
)	O
.	O

At	O
this	O
stage	O
,	O
melanoblast	S-CL
migration	O
from	O
the	O
neural	O
crest	O
is	O
mostly	O
complete	O
,	O
but	O
there	O
is	O
a	O
dorsoventral	O
gradient	O
in	O
melanocyte	S-CL
differentiation	O
and	O
pigment	S-CHEBI
synthesis	O
.	O

The	O
skin	O
of	O
ae	O
/	O
ae	O
neonates	O
appears	O
uniformly	O
dark	O
over	O
the	O
entire	O
dorsum	O
,	O
but	O
in	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
neonates	O
,	O
the	O
area	O
of	O
dark	O
skin	O
is	O
more	O
restricted	O
,	O
particularly	O
above	O
the	O
limbs	O
,	O
and	O
resembles	O
the	O
pattern	O
of	O
dorsal	O
eumelanin	S-CHEBI
in	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
adult	O
animals	S-LIVB
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggest	O
that	O
deH	O
interferes	O
with	O
the	O
establishment	O
of	O
dorsoventral	O
patterning	O
during	O
skin	O
development	O
by	O
causing	O
dorsal	O
expansion	O
of	O
a	O
lateral	O
region	O
that	O
is	O
normally	O
3	O
-	O
5	O
mm	O
in	O
width	O
.	O

This	O
same	O
region	O
may	O
serve	O
as	O
a	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
skin	O
by	O
inhibiting	O
melanocyte	S-CL
differentiation	O
,	O
by	O
promoting	O
pheomelanin	O
synthesis	O
,	O
and	O
by	O
supporting	O
a	O
progressive	O
increase	O
in	O
hair	O
growth	O
from	O
ventrum	O
to	O
dorsum	O
.	O

As	O
described	O
below	O
,	O
the	O
gene	S-SO
defective	O
in	O
deH	O
,	O
Tbx15	S-PRGE
,	O
is	O
normally	O
expressed	O
in	O
the	O
dorsal	O
region	O
and	O
therefore	O
is	O
likely	O
to	O
play	O
a	O
role	O
in	O
establishing	O
the	O
size	O
and	O
dorsal	O
extent	O
of	O
the	O
lateral	O
region	O
.	O

Positional	S-SO
Cloning	O
of	O
deH	O

As	O
a	O
visible	O
marker	O
,	O
early	O
linkage	O
studies	O
with	O
the	O
original	O
droopy	B-PRGE
ear	E-PRGE
allele	S-SO
or	O
the	O
deH	O
allele	S-SO
identified	O
a	O
map	S-SO
position	S-SO
in	O
the	O
middle	O
of	O
Chromosome	S-GO
3	O
,	O
distal	O
to	O
matted	S-PRGE
and	O
proximal	O
to	O
Varitint	B-PRGE
-	I-PRGE
waddler	E-PRGE
(	O
Carter	O
and	O
Falconer	O
1951	O
;	O
Curry	O
1959	O
;	O
Lane	O
and	O
Eicher	O
1979	O
;	O
Holmes	O
et	O
al	O
.	O
1981	O
)	O
.	O

We	O
used	O
an	O
F2	O
intercross	O
with	O
CAST	O
/	O
Ei	O
mice	S-LIVB
to	O
localize	O
deH	O
to	O
a	O
0	O
.	O
1	O
cM	O
interval	S-SO
between	O
D3Mit213	O
and	O
16	O
.	O
MMHAP32FLF1	O
,	O
which	O
was	O
refined	O
by	O
development	O
of	O
a	O
bacterial	B-SO
artificial	I-SO
chromosome	E-SO
(	O
BAC	S-SO
)	O
contig	S-SO
and	O
additional	O
markers	O
to	O
a	O
1	O
.	O
4	O
Mb	O
region	S-SO
that	O
contained	O
eight	O
genes	S-SO
,	O
including	O
Tbx15	S-PRGE
(	O
Figure	O
3A	O
)	O
.	O

We	O
considered	O
Tbx15	S-PRGE
as	O
an	O
excellent	O
candidate	O
for	O
the	O
skeletal	O
abnormalities	O
caused	O
by	O
deH	O
,	O
based	O
on	O
studies	O
by	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
,	O
who	O
described	O
its	O
embryonic	O
expression	O
in	O
the	O
craniofacial	O
region	O
and	O
developing	O
limbs	O
.	O

Using	O
sequence	S-SO
information	O
from	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
and	O
the	O
partially	B-SO
completed	E-SO
mouse	S-LIVB
genome	B-SO
sequence	E-SO
,	O
we	O
found	O
that	O
portions	B-SO
of	I-SO
several	I-SO
Tbx15	I-SO
exons	E-SO
could	O
not	O
be	O
amplified	O
from	O
deH	O
/	O
deH	O
genomic	B-SO
DNA	E-SO
.	O

The	O
same	O
gene	S-SO
was	O
initially	O
referred	O
to	O
as	O
Tbx8	S-PRGE
(	O
Wattler	O
et	O
al	O
.	O
1998	O
)	O
and	O
then	O
later	O
renamed	O
Tbx14	S-PRGE
,	O
but	O
is	O
currently	O
referred	O
to	O
in	O
several	O
vertebrate	S-LIVB
genomes	S-SO
as	O
Tbx15	S-PRGE
(	O
Agulnik	O
et	O
al	O
.	O
1998	O
;	O
Begemann	O
et	O
al	O
.	O
2002	O
)	O
.	O

By	O
comparing	O
the	O
sequence	S-SO
of	O
a	O
1	O
.	O
3	O
kb	O
junction	S-SO
fragment	S-SO
amplified	O
from	O
deH	O
/	O
deH	O
genomic	B-SO
DNA	E-SO
to	O
publicly	O
available	O
mouse	S-LIVB
genome	B-SO
sequence	E-SO
,	O
we	O
identified	O
a	O
216	O
kb	O
deletion	S-SO
that	O
extends	O
from	O
Tbx15	S-PRGE
intron	S-SO
1	O
to	O
148	O
kb	O
downstream	O
of	O
the	O
polyadenylation	B-SO
sequence	E-SO
in	O
a	O
region	S-SO
annotated	O
as	O
a	O
mannose	B-PRGE
-	I-PRGE
6	I-PRGE
-	I-PRGE
phosphate	I-PRGE
receptor	E-PRGE
pseudogene	S-SO
,	O
M6pr	S-PRGE
-	O
ps	S-SO
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

(	O
Ludwig	O
et	O
al	O
.	O
1992	O
)	O
.	O

By	O
Northern	O
blot	O
analysis	O
,	O
we	O
identified	O
a	O
fusion	S-SO
transcript	S-SO
produced	O
from	O
the	O
deH	O
chromosome	S-GO
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
the	O
deletion	S-SO
removes	S-SO
534	O
of	O
the	O
602	O
amino	B-CHEBI
acids	E-CHEBI
encoded	O
by	O
Tbx15	S-PRGE
(	O
including	O
the	O
T	O
-	O
box	O
DNA	S-SO
-	O
binding	O
domain	S-SO
)	O
,	O
deH	O
/	O
+	S-SO
animals	S-LIVB
are	O
grossly	O
normal	O
,	O
and	O
the	O
phenotype	O
of	O
deH	O
/	O
deH	O
animals	S-LIVB
is	O
identical	O
to	O
that	O
described	O
for	O
the	O
original	O
allele	S-SO
.	O

In	O
addition	O
,	O
other	O
than	O
M6pr	S-PRGE
-	O
ps	S-SO
,	O
no	O
other	O
genes	S-SO
or	O
transcripts	S-SO
have	O
been	O
annotated	O
to	O
the	O
216	O
kb	O
deletion	S-SO
.	O

While	O
the	O
positional	S-SO
cloning	O
work	O
was	O
underway	O
,	O
one	O
of	O
us	O
(	O
A	O
.	O
Russ	O
)	O
generated	O
an	O
independent	O
mutation	S-SO
of	O
Tbx15	S-PRGE
by	O
gene	S-SO
targeting	O
in	O
embryonic	O
stem	B-CL
cells	E-CL
.	O

The	O
targeted	O
allele	S-SO
,	O
Tbx15LacZ	O
,	O
carries	O
an	O
IRES	S-SO
-	O
LacZ	O
-	O
neo	O
cDNA	S-SO
cassette	S-SO
that	O
disrupts	O
the	O
open	B-SO
reading	I-SO
frame	E-SO
at	O
codon	S-SO
154	O
early	O
in	O
the	O
T	O
-	O
box	O
domain	S-SO
(	O
Figure	O
3D	O
)	O
.	O

Animals	S-LIVB
heterozygous	O
for	O
the	O
targeted	O
allele	S-SO
are	O
completely	O
normal	O
with	O
regard	O
to	O
size	O
,	O
skeletal	O
morphology	O
,	O
and	O
hair	O
-	O
color	O
distribution	O
,	O
but	O
Tbx15LacZ	O
/	O
Tbx15LacZ	O
homozygotes	O
were	O
noted	O
to	O
exhibit	O
reduced	O
body	O
size	O
and	O
an	O
abnormal	O
craniofacial	O
appearance	O
identical	O
to	O
that	O
caused	O
by	O
deH	O
.	O

We	O
generated	O
Tbx15LacZ	O
/	O
deH	O
compound	O
heterozygotes	O
;	O
on	O
an	O
Aw	O
/	O
at	O
background	O
,	O
these	O
animals	S-LIVB
exhibited	O
the	O
same	O
abnormal	O
restriction	O
of	O
dorsal	O
pigmentation	O
at	O
P3	O
.	O
5	O
and	O
expanded	O
yellow	O
flank	O
area	O
as	O
described	O
above	O
for	O
deH	O
/	O
deH	O
animals	S-LIVB
(	O
see	O
Figure	O
2	O
)	O
.	O

These	O
observations	O
demonstrate	O
that	O
the	O
pigmentary	S-CHEBI
and	O
craniofacial	O
characteristics	O
of	O
deH	O
are	O
caused	O
by	O
loss	O
of	O
function	O
for	O
Tbx15	S-PRGE
.	O

Expression	O
of	O
Tbx15	S-PRGE
and	O
Agouti	S-PRGE

Previous	O
studies	O
by	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
using	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
described	O
expression	O
of	O
Tbx15	S-PRGE
as	O
first	O
detectable	O
at	O
E9	O
.	O
5	O
in	O
the	O
limb	O
buds	O
,	O
progressing	O
to	O
the	O
branchial	O
arches	O
,	O
flanks	O
,	O
and	O
craniofacial	O
regions	O
through	O
E12	O
.	O
5	O
.	O

To	O
investigate	O
this	O
pattern	O
in	O
more	O
detail	O
,	O
we	O
hybridized	O
a	O
Tbx15	S-PRGE
mRNA	S-CHEBI
probe	S-SO
to	O
a	O
series	O
of	O
transverse	O
sections	O
at	O
E12	O
.	O
5	O
and	O
observed	O
expression	O
in	O
multiple	O
mesenchymal	O
tissues	O
of	O
the	O
head	O
,	O
trunk	O
,	O
and	O
developing	O
limbs	O
(	O
Figure	O
4A	O
)	O
,	O
much	O
of	O
which	O
is	O
consistent	O
with	O
the	O
skull	O
,	O
cervical	O
vertebrae	O
,	O
and	O
limb	O
malformations	O
reported	O
for	O
mice	S-LIVB
carrying	O
the	O
original	O
droopy	B-PRGE
ear	E-PRGE
allele	S-SO
.	O

We	O
were	O
particularly	O
interested	O
in	O
determining	O
the	O
exact	O
nature	O
of	O
the	O
embryonic	O
flank	O
expression	O
relative	O
to	O
the	O
ventralized	O
phenotype	O
of	O
adult	O
deH	O
/	O
deH	O
mice	S-LIVB
.	O

Transverse	O
abdominal	O
sections	O
from	O
different	O
times	O
during	O
development	O
reveal	O
a	O
dorsolateral	O
band	O
of	O
expression	O
in	O
the	O
superficial	O
mesenchyme	O
at	O
E11	O
.	O
5	O
that	O
broadens	O
both	O
dorsally	O
and	O
ventrally	O
over	O
the	O
next	O
several	O
days	O
(	O
Figure	O
4B	O
)	O
.	O

By	O
E13	O
.	O
5	O
,	O
the	O
developing	O
dermis	O
has	O
become	O
separated	O
from	O
the	O
loose	O
mesenchyme	O
by	O
a	O
subcutaneous	O
muscle	O
layer	O
;	O
Tbx15	S-PRGE
is	O
expressed	O
in	O
all	O
of	O
these	O
layers	O
as	O
well	O
as	O
the	O
underlying	O
abdominal	O
muscles	O
.	O

In	O
P3	O
.	O
5	O
skin	O
,	O
Tbx15	S-PRGE
is	O
expressed	O
in	O
both	O
dorsal	O
and	O
ventral	O
skin	O
,	O
most	O
strongly	O
in	O
the	O
condensed	O
upper	O
dermis	O
and	O
developing	O
dermal	O
sheaths	O
of	O
hair	O
follicles	O
;	O
faint	O
expression	O
can	O
also	O
be	O
detected	O
in	O
rare	O
dermal	B-CL
papillae	I-CL
cells	E-CL
(	O
Figure	O
4B	O
)	O
.	O

Although	O
the	O
effects	O
of	O
Agouti	S-PRGE
on	O
pigment	S-CHEBI
-	O
type	O
switching	O
occur	O
during	O
postnatal	O
hair	O
growth	O
,	O
the	O
ventral	O
-	O
specific	O
isoform	S-SO
of	O
Agouti	S-PRGE
is	O
expressed	O
in	O
developing	O
skin	O
beginning	O
at	O
E11	O
.	O
5	O
.	O

We	O
compared	O
adjacent	O
sections	O
hybridized	O
with	O
probes	S-SO
for	O
Tbx15	S-PRGE
and	O
Agouti	S-PRGE
and	O
observed	O
complementary	O
patterns	O
at	O
E12	O
.	O
5	O
,	O
with	O
expression	O
of	O
Agouti	S-PRGE
in	O
ventral	O
skin	O
and	O
expression	O
of	O
Tbx15	S-PRGE
in	O
dorsal	O
skin	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

The	O
junction	O
between	O
expression	O
domains	O
is	O
indistinct	O
,	O
and	O
by	O
E14	O
.	O
5	O
,	O
Tbx15	S-PRGE
expression	O
extends	O
ventrally	O
and	O
overlaps	O
extensively	O
with	O
Agouti	S-PRGE
expression	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
.	O

We	O
also	O
examined	O
the	O
effect	O
of	O
deH	O
on	O
expression	O
of	O
Agouti	S-PRGE
and	O
found	O
no	O
difference	O
between	O
mutant	S-SO
and	O
nonmutant	O
at	O
E12	O
.	O
5	O
or	O
E13	O
.	O
5	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
at	O
E14	O
.	O
5	O
,	O
the	O
normal	O
ventral	O
-	O
to	O
-	O
dorsal	O
gradient	O
of	O
Agouti	S-PRGE
expression	O
appeared	O
to	O
extend	O
more	O
dorsally	O
in	O
deH	O
/	O
deH	O
embryos	O
(	O
Figure	O
6A	O
)	O
.	O

In	O
P4	O
.	O
5	O
skin	O
,	O
expression	O
of	O
Agouti	S-PRGE
is	O
also	O
extended	O
dorsally	O
in	O
deH	O
/	O
deH	O
animals	S-LIVB
and	O
is	O
most	O
apparent	O
in	O
the	O
midflank	O
region	O
within	O
the	O
upper	O
dermis	O
and	O
dermal	B-CL
papillae	I-CL
cells	E-CL
(	O
Figure	O
6B	O
)	O
.	O

Thus	O
,	O
while	O
the	O
pigmentation	O
phenotype	O
of	O
deH	O
/	O
deH	O
mice	S-LIVB
can	O
be	O
explained	O
,	O
not	O
surprisingly	O
,	O
by	O
dorsal	O
extension	O
of	O
Agouti	S-PRGE
expression	O
after	O
birth	O
,	O
patterned	O
expression	O
of	O
Tbx15	S-PRGE
and	O
Agouti	S-PRGE
are	O
apparent	O
some	O
10	O
days	O
earlier	O
,	O
between	O
E12	O
.	O
5	O
and	O
E13	O
.	O
5	O
,	O
and	O
the	O
effects	O
of	O
Tbx15	S-PRGE
deficiency	O
on	O
expression	O
of	O
Agouti	S-PRGE
can	O
be	O
detected	O
by	O
E14	O
.	O
5	O
.	O

Relationship	O
of	O
Embryonic	O
Tbx15	S-PRGE
Expression	O
to	O
Dorsal	O
and	O
Ventral	O
Pigmentation	O
Domains	O

The	O
observations	O
described	O
above	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
transient	O
expression	O
of	O
Tbx15	S-PRGE
in	O
the	O
embryonic	O
dorsal	O
flank	O
is	O
required	O
to	O
establish	O
positional	O
identity	O
of	O
the	O
future	O
dermis	O
,	O
at	O
least	O
with	O
respect	O
to	O
pigment	S-CHEBI
-	O
type	O
synthesis	O
caused	O
by	O
the	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
isoform	S-SO
.	O

To	O
further	O
investigate	O
this	O
hypothesis	O
,	O
we	O
carried	O
out	O
transplantation	O
experiments	O
in	O
which	O
pieces	O
of	O
embryonic	O
skin	O
were	O
isolated	O
from	O
different	O
dorsoventral	O
positions	O
.	O

We	O
evaluated	O
the	O
embryonic	O
skin	O
fragments	O
for	O
their	O
potential	O
to	O
give	O
rise	O
to	O
different	O
hair	O
colors	O
and	O
for	O
their	O
expression	O
of	O
Tbx15	S-PRGE
and	O
Agouti	S-PRGE
.	O

Previous	O
studies	O
by	O
Silvers	O
and	O
colleagues	O
(	O
Poole	O
and	O
Silvers	O
1976	O
)	O
showed	O
that	O
dorsal	O
and	O
ventral	O
skin	O
isolated	O
from	O
at	O
/	O
at	O
embryos	O
gives	O
rise	O
to	O
black	O
and	O
yellow	O
hair	O
,	O
respectively	O
,	O
when	O
transplanted	O
into	O
testis	O
and	O
allowed	O
to	O
develop	O
for	O
several	O
weeks	O
.	O

Furthermore	O
,	O
dermal	O
-	O
epidermal	O
recombination	O
experiments	O
carried	O
out	O
at	O
E14	O
.	O
5	O
demonstrated	O
that	O
positional	O
identity	O
is	O
carried	O
by	O
the	O
embryonic	O
dermis	O
.	O

In	O
a	O
variation	O
on	O
this	O
experiment	O
,	O
we	O
divided	O
embryonic	O
skin	O
from	O
at	O
/	O
a	O
embryos	O
into	O
dorsal	O
,	O
flank	O
,	O
and	O
ventral	O
pieces	O
and	O
analyzed	O
the	O
different	O
pieces	O
for	O
their	O
ability	O
to	O
give	O
rise	O
to	O
black	O
or	O
yellow	O
hair	O
after	O
testis	O
transplantation	O
,	O
and	O
,	O
in	O
parallel	O
,	O
for	O
gene	S-SO
expression	O
using	O
in	O
situ	O
hybridization	O
.	O

For	O
the	O
purposes	O
of	O
a	O
reproducible	O
morphologic	O
boundary	O
,	O
we	O
divided	O
flank	O
from	O
ventral	O
skin	O
based	O
on	O
a	O
change	O
in	O
skin	O
thickness	O
and	O
divided	O
dorsal	O
from	O
flank	O
skin	O
at	O
the	O
level	O
of	O
an	O
ectodermal	O
notch	O
that	O
lies	O
at	O
the	O
same	O
level	O
as	O
the	O
ventral	O
extent	O
of	O
the	O
myotome	O
(	O
Figure	O
7	O
)	O
(	O
Huang	O
and	O
Christ	O
2000	O
;	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Sudo	O
et	O
al	O
.	O
2001	O
;	O
Burke	O
and	O
Nowicki	O
2003	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
.	O

We	O
found	O
that	O
E12	O
.	O
5	O
is	O
the	O
earliest	O
time	O
at	O
which	O
embryonic	O
ventral	O
skin	O
is	O
able	O
to	O
produce	O
hair	O
when	O
transplanted	O
to	O
the	O
testis	O
.	O

Of	O
the	O
grafts	O
that	O
produced	O
hair	O
,	O
ventral	O
skin	O
gave	O
rise	O
to	O
yellow	O
hair	O
(	O
n	O
=	O
3	O
)	O
,	O
and	O
dorsal	O
skin	O
gave	O
rise	O
to	O
black	O
hair	O
(	O
n	O
=	O
4	O
)	O
.	O

Transplantation	O
of	O
flank	O
skin	O
gave	O
rise	O
to	O
a	O
patch	O
of	O
yellow	O
hair	O
juxtaposed	O
against	O
a	O
patch	O
of	O
black	O
hair	O
in	O
85	O
%	O
of	O
the	O
successful	O
grafts	O
(	O
n	O
=	O
13	O
)	O
;	O
the	O
remaining	O
two	O
flank	O
grafts	O
produced	O
solely	O
black	O
or	O
yellow	O
hair	O
.	O

In	O
no	O
case	O
did	O
we	O
observe	O
intermingling	O
of	O
black	O
and	O
yellow	O
hairs	O
.	O

As	O
predicted	O
from	O
the	O
experiments	O
using	O
tissue	O
sections	O
(	O
see	O
Figures	O
5	O
and	O
6	O
)	O
,	O
dorsal	O
pieces	O
expressed	O
Tbx15	S-PRGE
but	O
not	O
Agouti	S-PRGE
,	O
while	O
flank	O
pieces	O
expressed	O
both	O
genes	S-SO
(	O
see	O
Figure	O
7	O
)	O
.	O

Thus	O
,	O
dorsoventral	O
identity	O
for	O
adult	O
pigmentation	O
is	O
established	O
by	O
the	O
time	O
when	O
patterned	O
expression	O
becomes	O
apparent	O
for	O
Tbx15	S-PRGE
and	O
Agouti	S-PRGE
(	O
E11	O
.	O
5	O
-	O
E12	O
.	O
5	O
)	O
;	O
furthermore	O
,	O
positional	O
identity	O
is	O
maintained	O
throughout	O
later	O
stages	O
of	O
skin	O
development	O
,	O
even	O
though	O
expression	O
of	O
Tbx15	S-PRGE
broadens	O
to	O
include	O
ventral	O
as	O
well	O
as	O
dorsal	O
skin	O
.	O

Relationship	O
of	O
the	O
Dorsoventral	O
Pigment	S-CHEBI
Boundary	O
to	O
Lineage	O
Compartments	O
and	O
the	O
Lateral	O
Somitic	O
Frontier	O

The	O
ectodermal	O
notch	O
that	O
we	O
used	O
to	O
mark	O
the	O
boundary	O
between	O
embryonic	O
dorsum	O
and	O
embryonic	O
flank	O
is	O
a	O
characteristic	O
feature	O
in	O
vertebrate	S-LIVB
embryos	O
.	O

In	O
cell	S-CL
lineage	O
studies	O
carried	O
out	O
in	O
the	O
chick	O
system	O
,	O
the	O
notch	O
serves	O
as	O
a	O
landmark	O
for	O
the	O
boundary	O
between	O
dermis	O
derived	O
from	O
somitic	O
mesoderm	O
and	O
dermis	O
derived	O
from	O
lateral	O
plate	O
mesoderm	O
and	O
has	O
been	O
termed	O
the	O
"	O
lateral	O
somitic	O
frontier	O
"	O
(	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Sudo	O
et	O
al	O
.	O
2001	O
;	O
Burke	O
and	O
Nowicki	O
2003	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
.	O

Although	O
fate	O
-	O
mapping	O
studies	O
have	O
not	O
been	O
carried	O
out	O
in	O
mammalian	S-LIVB
embryos	O
,	O
somite	O
-	O
and	O
lateral	O
plate	O
-	O
derived	O
mesoderm	O
could	O
give	O
rise	O
to	O
precursors	O
for	O
dermis	O
dorsal	O
and	O
ventral	O
to	O
the	O
limb	O
-	O
body	O
wall	O
junction	O
,	O
respectively	O
.	O

However	O
,	O
this	O
notion	O
conflicts	O
with	O
our	O
observation	O
that	O
the	O
future	O
pigmentation	O
boundary	O
lies	O
ventral	O
to	O
the	O
ectodermal	O
notch	O
(	O
see	O
Figure	O
7	O
)	O
.	O

To	O
examine	O
directly	O
the	O
relationship	O
between	O
the	O
pigmentation	O
boundary	O
and	O
dermis	O
derived	O
from	O
lateral	O
plate	O
mesoderm	O
,	O
we	O
made	O
use	O
of	O
a	O
Cre	O
transgene	S-SO
driven	O
by	O
the	O
Hoxb6	S-PRGE
promoter	S-SO
that	O
was	O
developed	O
by	O
Kuehn	O
and	O
colleagues	O
(	O
Lowe	O
et	O
al	O
.	O
2000	O
)	O
.	O

As	O
described	O
by	O
Lowe	O
et	O
al	O
.	O

(	O
2000	O
)	O
,	O
midgestation	O
embryos	O
carrying	O
both	O
the	O
Hoxb6	S-PRGE
-	O
Cre	O
transgene	S-SO
and	O
the	O
R26R	O
lacZ	O
reporter	O
gene	S-SO
(	O
Soriano	O
1999	O
)	O
exhibit	O
X	O
-	O
Gal	O
staining	O
in	O
lateral	O
plate	O
mesoderm	O
but	O
not	O
somite	O
-	O
derived	O
mesoderm	O
of	O
the	O
trunk	O
.	O

In	O
whole	O
-	O
mount	O
skin	O
preparations	O
from	O
P1	O
.	O
5	O
or	O
P4	O
.	O
5	O
neonatal	O
animals	S-LIVB
,	O
we	O
observed	O
a	O
ventral	O
band	O
of	O
dark	O
X	O
-	O
Gal	O
staining	O
corresponding	O
to	O
lateral	O
plate	O
-	O
derived	O
dermis	O
,	O
which	O
represents	O
63	O
%	O
of	O
the	O
total	O
circumference	O
(	O
Figure	O
8A	O
)	O
.	O

However	O
,	O
in	O
parallel	O
preparations	O
from	O
at	O
/	O
at	O
mice	S-LIVB
,	O
the	O
ventral	O
pheomelanin	O
domain	O
represents	O
47	O
%	O
of	O
the	O
total	O
skin	O
circumference	O
;	O
therefore	O
,	O
the	O
proportions	O
of	O
total	O
skin	O
circumference	O
occupied	O
by	O
dorsal	O
eumelanin	S-CHEBI
and	O
somite	O
-	O
derived	O
dermis	O
are	O
53	O
%	O
and	O
37	O
%	O
,	O
respectively	O
(	O
Figure	O
8B	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
pigmentation	O
boundary	O
is	O
clearly	O
distinct	O
from	O
,	O
and	O
more	O
ventral	O
to	O
,	O
the	O
boundary	O
between	O
lateral	O
plate	O
-	O
and	O
somite	O
-	O
derived	O
dermis	O
.	O

Because	O
the	O
pigmentation	O
boundary	O
lies	O
in	O
register	O
with	O
the	O
limb	O
-	O
body	O
wall	O
junction	O
(	O
see	O
Figure	O
2	O
)	O
,	O
we	O
wondered	O
whether	O
mechanisms	O
used	O
for	O
dorsoventral	O
limb	O
patterning	O
might	O
be	O
related	O
to	O
those	O
used	O
to	O
establish	O
the	O
pigmentation	O
boundary	O
.	O

In	O
the	O
developing	O
limb	O
,	O
Engrailed1	S-PRGE
(	O
En1	S-PRGE
)	O
,	O
Wnt7a	S-PRGE
,	O
and	O
Lmx1b	S-PRGE
are	O
part	O
of	O
a	O
network	O
whose	O
restricted	O
domains	O
of	O
expression	O
help	O
to	O
establish	O
dorsoventral	O
identity	O
(	O
reviewed	O
in	O
Niswander	O
2003	O
)	O
.	O

En1	S-PRGE
is	O
transiently	O
expressed	O
in	O
the	O
developing	O
flank	O
;	O
at	O
E11	O
.	O
5	O
,	O
transverse	O
abdominal	O
sections	O
reveal	O
domains	O
in	O
the	O
neural	O
tube	O
,	O
somite	O
-	O
derived	O
mesenchyme	O
,	O
and	O
the	O
ventral	O
body	O
wall	O
(	O
Figure	O
8C	O
)	O
.	O

An	O
adjacent	O
section	O
hybridized	O
with	O
Tbx15	S-PRGE
reveals	O
a	O
complementary	O
pattern	O
in	O
the	O
flank	O
,	O
which	O
provides	O
additional	O
evidence	O
for	O
developmental	O
mechanisms	O
that	O
establish	O
a	O
pigmentation	O
boundary	O
entirely	O
within	O
lateral	O
plate	O
mesoderm	O
and	O
independent	O
of	O
lineage	O
restrictions	O
imposed	O
by	O
the	O
lateral	O
somitic	O
frontier	O
.	O

Discussion	O

Several	O
mutations	S-SO
and	O
genes	S-SO
have	O
been	O
identified	O
that	O
affect	O
the	O
pattern	O
of	O
hair	O
follicle	O
development	O
,	O
but	O
Tbx15	S-PRGE
is	O
the	O
only	O
gene	S-SO
of	O
which	O
we	O
are	O
aware	O
that	O
affects	O
the	O
pattern	O
of	O
hair	O
pigmentation	O
in	O
different	O
body	O
regions	O
.	O

Ventral	O
areas	O
that	O
normally	O
produce	O
yellow	O
hair	O
in	O
the	O
trunk	O
,	O
limbs	O
,	O
and	O
craniofacial	O
regions	O
are	O
expanded	O
in	O
deH	O
/	O
deH	O
mice	S-LIVB
and	O
,	O
in	O
the	O
trunk	O
at	O
least	O
,	O
represent	O
inappropriate	O
dorsal	O
expression	O
of	O
an	O
Agouti	S-PRGE
mRNA	S-CHEBI
isoform	S-SO
that	O
is	O
normally	O
restricted	O
to	O
ventral	O
skin	O
.	O

The	O
deH	O
allele	S-SO
is	O
caused	O
by	O
a	O
large	O
deletion	S-SO
that	O
removes	S-SO
most	O
of	O
the	O
Tbx15	S-PRGE
coding	B-SO
sequence	E-SO
,	O
but	O
the	O
pleiotropic	O
phenotype	O
is	O
caused	O
by	O
a	O
simple	O
loss	O
of	O
function	O
for	O
Tbx15	S-PRGE
rather	O
than	O
a	O
dominant	O
-	O
negative	O
or	O
contiguous	O
gene	S-SO
effect	O
.	O

In	O
particular	O
,	O
there	O
is	O
no	O
heterozygous	O
phenotype	O
,	O
no	O
other	O
genes	S-SO
lie	O
within	O
or	O
close	O
to	O
the	O
deletion	B-SO
breakpoints	E-SO
,	O
and	O
the	O
expression	O
pattern	O
of	O
Tbx15	S-PRGE
is	O
consistent	O
with	O
the	O
spectrum	O
of	O
phenotypic	O
abnormalities	O
in	O
both	O
the	O
original	O
de	S-PRGE
allele	S-SO
and	O
the	O
deH	O
allele	S-SO
.	O

Finally	O
,	O
a	O
Tbx15	S-PRGE
targeted	O
allele	S-SO
has	O
the	O
same	O
phenotype	O
as	O
deH	O
.	O

Our	O
results	O
suggest	O
that	O
patterned	O
expression	O
of	O
Tbx15	S-PRGE
provides	O
an	O
instructional	O
cue	O
required	O
to	O
establish	O
the	O
future	O
identity	O
of	O
dorsal	O
dermis	O
with	O
regard	O
to	O
pigmentary	S-CHEBI
and	O
hair	O
length	O
patterning	O
.	O

The	O
ventral	O
edge	O
of	O
Tbx15	S-PRGE
expression	O
in	O
the	O
developing	O
flank	O
does	O
not	O
correspond	O
to	O
a	O
known	O
lineage	O
compartment	O
,	O
but	O
,	O
like	O
limb	O
development	O
,	O
occurs	O
within	O
lateral	O
plate	O
mesoderm	O
.	O

These	O
findings	O
represent	O
a	O
novel	O
role	O
for	O
T	O
-	O
box	O
gene	S-SO
action	O
in	O
embryonic	O
development	O
and	O
provide	O
evidence	O
for	O
a	O
previously	O
unappreciated	O
complexity	O
to	O
acquisition	O
of	O
dorsoventral	O
positional	O
identity	O
in	O
mammalian	S-LIVB
skin	O
.	O

Distinct	O
Morphologic	O
Regions	O
Represent	O
the	O
Sum	O
of	O
Different	O
Gradients	O

The	O
visual	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
skin	O
in	O
at	O
/	O
at	O
mice	S-LIVB
is	O
reminiscent	O
of	O
other	O
systems	O
in	O
which	O
adjacent	O
compartments	O
enforce	O
a	O
binary	O
choice	O
between	O
alternative	O
patterns	O
of	O
gene	S-SO
expression	O
and	O
cell	S-CL
fate	O
(	O
reviewed	O
in	O
Dahmann	O
and	O
Basler	O
1999	O
)	O
.	O

However	O
,	O
Agouti	S-PRGE
mRNA	S-CHEBI
in	O
both	O
embryonic	O
and	O
postnatal	O
skin	O
is	O
distributed	O
along	O
a	O
gradient	O
whose	O
dorsal	O
boundary	O
is	O
indistinct	O
and	O
overlaps	O
with	O
two	O
additional	O
gradients	O
recognized	O
by	O
their	O
effects	O
on	O
hair	O
length	O
and	O
histochemical	O
staining	O
for	O
melanocytes	S-CL
.	O

The	O
three	O
gradients	O
are	O
close	O
but	O
not	O
congruent	O
,	O
and	O
it	O
is	O
their	O
proximity	O
that	O
gives	O
rise	O
to	O
the	O
superficial	O
distinction	O
between	O
dorsal	O
and	O
ventral	O
skin	O
of	O
at	O
/	O
at	O
mice	S-LIVB
.	O

Indeed	O
,	O
slight	O
differences	O
between	O
the	O
regions	O
of	O
transition	O
for	O
pigment	S-CHEBI
-	O
type	O
switching	O
and	O
pigment	S-CHEBI
content	O
give	O
rise	O
to	O
a	O
subtle	O
yellow	O
stripe	O
along	O
the	O
flank	O
(	O
see	O
Figures	O
1	O
,	O
2	O
,	O
and	O
9A	O
)	O
.	O

Levels	O
of	O
Agouti	S-PRGE
mRNA	S-CHEBI
remain	O
high	O
throughout	O
the	O
entire	O
ventrum	O
,	O
but	O
hair	O
pigment	S-CHEBI
content	O
is	O
reduced	O
,	O
giving	O
rise	O
to	O
a	O
cream	O
-	O
colored	O
region	O
in	O
the	O
ventrum	O
that	O
,	O
depending	O
on	O
age	O
and	O
genetic	S-SO
backgrounds	O
,	O
may	O
appear	O
more	O
or	O
less	O
distinct	O
from	O
the	O
yellow	O
flank	O
stripe	O
.	O

Loss	O
of	O
Tbx15	S-PRGE
affects	O
dorsoventral	O
transitions	O
of	O
hair	O
length	O
,	O
pigment	S-CHEBI
content	O
,	O
and	O
expression	O
of	O
the	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
isoform	S-SO
;	O
however	O
,	O
the	O
former	O
two	O
effects	O
are	O
subtle	O
and	O
contribute	O
little	O
,	O
if	O
at	O
all	O
,	O
to	O
the	O
abnormal	O
pigmentation	O
of	O
adult	O
deH	O
/	O
deH	O
mice	S-LIVB
.	O

Thus	O
,	O
despite	O
the	O
abnormal	O
pattern	O
of	O
dark	O
skin	O
in	O
neonatal	O
deH	O
/	O
deH	O
mice	S-LIVB
(	O
e	O
.	O
g	O
.	O
,	O
Figure	O
2D	O
)	O
,	O
the	O
most	O
obvious	O
feature	O
in	O
adults	O
is	O
dorsal	O
displacement	O
of	O
the	O
"	O
boundary	O
"	O
between	O
black	O
and	O
yellow	O
hair	O
(	O
Figure	O
9A	O
)	O
.	O

Genetics	O
of	O
Tbx15	S-PRGE

Named	O
for	O
the	O
presence	O
of	O
a	O
DNA	S-SO
-	O
binding	O
domain	S-SO
first	O
identified	O
in	O
the	O
mouse	B-PRGE
Brachyury	E-PRGE
gene	S-SO
(	O
haploinsufficiency	O
causes	O
a	O
short	O
tail	O
)	O
,	O
T	O
box	O
-	O
containing	O
genes	S-SO
have	O
been	O
identified	O
as	O
developmental	O
regulators	O
in	O
a	O
wide	O
spectrum	O
of	O
tissues	O
and	O
multicellular	O
organisms	S-LIVB
(	O
reviewed	O
in	O
Papaioannou	O
2001	O
)	O
.	O

The	O
Tbx15	S-PRGE
subfamily	O
,	O
which	O
also	O
includes	O
Tbx18	S-PRGE
and	O
Tbx22	S-PRGE
,	O
is	O
likely	O
to	O
have	O
arisen	O
during	O
early	O
chordate	S-LIVB
evolution	O
since	O
there	O
is	O
a	O
single	O
gene	S-SO
in	O
amphioxus	S-LIVB
but	O
no	O
obvious	O
homolog	S-SO
in	O
the	O
fly	S-LIVB
genome	S-SO
(	O
Ruvinsky	O
et	O
al	O
.	O
2000	O
)	O
.	O

Consistent	O
with	O
this	O
relationship	O
,	O
the	O
three	O
genes	S-SO
are	O
expressed	O
in	O
partially	O
overlapping	O
patterns	O
that	O
include	O
anterior	O
somites	O
(	O
Tbx18	S-PRGE
and	O
Tbx22	S-PRGE
)	O
,	O
limb	O
mesenchyme	O
(	O
Tbx15	S-PRGE
and	O
Tbx18	S-PRGE
)	O
,	O
and	O
craniofacial	O
mesenchyme	O
(	O
all	O
three	O
genes	S-SO
,	O
Tbx15	S-PRGE
more	O
broadly	O
than	O
Tbx18	S-PRGE
or	O
Tbx22	S-PRGE
)	O
(	O
Agulnik	O
et	O
al	O
.	O
1998	O
;	O
Kraus	O
et	O
al	O
.	O
2001	O
;	O
Braybrook	O
et	O
al	O
.	O
2002	O
;	O
Bush	O
et	O
al	O
.	O
2002	O
;	O
Herr	O
et	O
al	O
.	O
2003	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
an	O
ancestral	O
gene	S-SO
for	O
Tbx15	S-PRGE
,	O
Tbx18	S-PRGE
,	O
and	O
Tbx22	S-PRGE
may	O
have	O
been	O
important	O
for	O
craniofacial	O
development	O
in	O
cephalochordates	S-LIVB
,	O
with	O
acquisition	O
of	O
additional	O
expression	O
patterns	O
and	O
developmental	O
functions	O
in	O
the	O
limb	O
and	O
the	O
trunk	O
during	O
early	O
vertebrate	S-LIVB
evolution	O
.	O

Expression	O
of	O
Tbx18	S-PRGE
and	O
Tbx22	S-PRGE
has	O
not	O
been	O
reported	O
in	O
embryonic	O
flank	O
mesenchyme	O
,	O
which	O
suggests	O
that	O
Tbx15	S-PRGE
is	O
the	O
only	O
family	O
member	O
involved	O
in	O
establishing	O
the	O
dorsoventral	O
identity	O
of	O
the	O
trunk	O
.	O

However	O
,	O
it	O
would	O
not	O
be	O
surprising	O
to	O
find	O
some	O
degree	O
of	O
functional	O
redundancy	O
in	O
animals	S-LIVB
mutated	S-SO
for	O
two	O
or	O
three	O
of	O
the	O
subfamily	O
members	O
in	O
other	O
body	O
regions	O
,	O
particularly	O
the	O
limbs	O
and	O
the	O
head	O
.	O

For	O
example	O
,	O
mutations	S-SO
in	O
Tbx22	S-PRGE
cause	O
the	O
human	S-LIVB
syndrome	O
X	S-GO
-	O
linked	O
cleft	O
palate	O
and	O
ankyloglossia	O
(	O
Braybrook	O
et	O
al	O
.	O
2001	O
)	O
.	O

Despite	O
high	O
levels	O
of	O
Tbx22	S-PRGE
expression	O
in	O
periocular	O
embryonic	O
mesenchyme	O
(	O
Braybrook	O
et	O
al	O
.	O
2002	O
;	O
Bush	O
et	O
al	O
.	O
2002	O
;	O
Herr	O
et	O
al	O
.	O
2003	O
)	O
,	O
the	O
condition	O
does	O
not	O
affect	O
the	O
eye	O
,	O
perhaps	O
because	O
residual	O
activity	O
is	O
provided	O
by	O
Tbx15	S-PRGE
in	O
the	O
same	O
region	O
.	O

In	O
an	O
initial	O
description	O
of	O
the	O
expression	O
and	O
map	S-SO
location	S-SO
of	O
mouse	B-PRGE
Tbx15	E-PRGE
,	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
suggested	O
human	B-PRGE
Tbx15	E-PRGE
that	O
lies	O
on	O
Chromosome	S-GO
1p11	O
.	O
1	O
as	O
a	O
candidate	O
for	O
acromegaloid	O
facial	O
appearance	O
(	O
AFA	O
)	O
syndrome	O
,	O
for	O
which	O
there	O
is	O
a	O
weak	O
positive	O
LOD	O
score	O
to	O
Chromosome	S-GO
1p	O
(	O
Hughes	O
et	O
al	O
.	O
1985	O
)	O
.	O

Originally	O
described	O
as	O
a	O
rare	O
autosomal	S-GO
-	O
dominant	O
syndrome	O
with	O
progressive	O
facial	O
coarsening	O
,	O
overgrowth	O
of	O
the	O
intraoral	O
mucosa	O
,	O
and	O
large	O
,	O
doughy	O
hands	O
,	O
more	O
recent	O
case	O
reports	O
describe	O
macrosomia	O
,	O
macrocephaly	O
,	O
or	O
both	O
and	O
generalized	O
hypertrichosis	O
with	O
progressive	O
coarsening	O
(	O
Dallapiccola	O
et	O
al	O
.	O
1992	O
;	O
Irvine	O
et	O
al	O
.	O
1996	O
;	O
da	O
Silva	O
et	O
al	O
.	O
1998	O
;	O
Zelante	O
et	O
al	O
.	O
2000	O
)	O
.	O

The	O
deH	O
phenotype	O
exhibits	O
little	O
overlap	O
with	O
these	O
features	O
;	O
instead	O
,	O
we	O
suggest	O
a	O
more	O
likely	O
candidate	O
for	O
mutations	S-SO
of	O
human	B-PRGE
TBX15	E-PRGE
would	O
be	O
frontofacionasal	O
syndrome	O
,	O
an	O
unmapped	O
autosomal	S-GO
recessive	O
condition	O
characterized	O
by	O
brachycephaly	O
,	O
blepharophimosis	O
,	O
and	O
midface	O
hypoplasia	O
(	O
Reardon	O
et	O
al	O
.	O
1994	O
)	O
.	O

Two	O
of	O
us	O
(	O
S	O
.	O
Kuijper	O
and	O
F	O
.	O
Meijlink	O
)	O
became	O
interested	O
in	O
the	O
deH	O
mutation	S-SO
because	O
of	O
its	O
effects	O
on	O
skeletal	O
development	O
(	O
Curry	O
1959	O
)	O
and	O
the	O
possibility	O
that	O
the	O
aristaless	O
-	O
related	O
gene	S-SO
Alx3	S-PRGE
might	O
be	O
allelic	S-SO
with	O
droopy	B-PRGE
ear	E-PRGE
(	O
ten	O
Berge	O
et	O
al	O
.	O
1998	O
)	O
.	O

In	O
spite	O
of	O
similarities	O
between	O
skeletal	O
phenotypes	O
of	O
deH	O
and	O
Alx3	S-PRGE
or	O
Alx4	S-PRGE
mutants	S-SO
,	O
subsequent	O
experiments	O
(	O
unpublished	O
data	O
)	O
excluded	O
allelism	O
of	O
Alx3	S-PRGE
and	O
deH	O
,	O
and	O
a	O
full	O
description	O
of	O
the	O
Tbx15	S-PRGE
skeletal	O
phenotype	O
will	O
be	O
published	O
elsewhere	O
.	O

Developmental	O
Mechanism	O
of	O
Tbx15	S-PRGE
Expression	O
and	O
Action	O
in	O
the	O
Skin	O

Our	O
attention	O
to	O
the	O
role	O
of	O
Tbx15	S-PRGE
in	O
pigment	S-CHEBI
patterning	O
was	O
motivated	O
by	O
the	O
effects	O
of	O
Agouti	S-PRGE
in	O
postnatal	O
animals	S-LIVB
.	O

However	O
,	O
Agouti	S-PRGE
is	O
also	O
expressed	O
in	O
the	O
embryo	O
,	O
where	O
it	O
provides	O
a	O
convenient	O
marker	O
of	O
ventral	O
dermis	O
identity	O
.	O

Because	O
an	O
expanded	O
domain	O
of	O
embryonic	O
Agouti	S-PRGE
expression	O
in	O
deH	O
/	O
deH	O
animals	S-LIVB
is	O
detectable	O
by	O
E14	O
.	O
5	O
,	O
the	O
effects	O
of	O
Tbx15	S-PRGE
on	O
dorsoventral	O
patterning	O
must	O
occur	O
prior	O
to	O
this	O
time	O
.	O

Among	O
other	O
T	O
-	O
box	O
genes	S-SO
whose	O
developmental	O
actions	O
are	O
at	O
least	O
partially	O
understood	O
,	O
two	O
general	O
themes	O
have	O
emerged	O
,	O
one	O
focused	O
on	O
the	O
ability	O
to	O
specify	O
alternative	O
fates	O
for	O
an	O
undifferentiated	O
group	O
of	O
precursor	O
cells	S-CL
and	O
another	O
focused	O
on	O
the	O
ability	O
to	O
support	O
proliferative	O
expansion	O
of	O
a	O
cell	S-CL
population	O
whose	O
fate	O
is	O
already	O
determined	O
(	O
reviewed	O
in	O
Tada	O
and	O
Smith	O
2001	O
)	O
.	O

Either	O
mechanism	O
may	O
apply	O
to	O
the	O
apparent	O
dorsal	O
-	O
to	O
-	O
ventral	O
transformation	O
in	O
deH	O
/	O
deH	O
mice	S-LIVB
.	O

For	O
example	O
,	O
while	O
the	O
expanded	O
domain	O
of	O
Agouti	S-PRGE
expression	O
in	O
postnatal	O
deH	O
/	O
deH	O
animals	S-LIVB
can	O
be	O
traced	O
to	O
events	O
that	O
occur	O
between	O
E11	O
.	O
5	O
and	O
E13	O
.	O
5	O
,	O
the	O
underlying	O
cause	O
may	O
be	O
that	O
embryonic	O
cells	S-CL
in	O
dorsolateral	O
mesenchyme	O
acquire	O
a	O
ventral	O
rather	O
than	O
dorsal	O
identity	O
or	O
that	O
those	O
cells	S-CL
fail	O
to	O
proliferate	O
normally	O
,	O
followed	O
by	O
compensatory	O
expansion	O
of	O
ventral	O
cells	S-CL
.	O

Cell	S-CL
lineage	O
studies	O
should	O
provide	O
a	O
definitive	O
answer	O
,	O
but	O
we	O
favor	O
the	O
latter	O
hypothesis	O
,	O
because	O
measurements	O
of	O
dorsoventral	O
regions	O
according	O
to	O
hair	O
color	O
in	O
deH	O
/	O
deH	O
mice	S-LIVB
revealed	O
a	O
small	O
increase	O
of	O
the	O
cream	O
-	O
colored	O
ventral	O
region	O
in	O
addition	O
to	O
the	O
approximate	O
doubling	O
of	O
the	O
yellow	O
flank	O
region	O
(	O
see	O
Figure	O
2	O
)	O
.	O

In	O
embryonic	O
mesenchyme	O
,	O
expression	O
of	O
Tbx15	S-PRGE
and	O
Agouti	S-PRGE
are	O
complementary	O
,	O
and	O
it	O
is	O
possible	O
that	O
Tbx15	S-PRGE
acts	O
directly	O
to	O
inhibit	O
Agouti	S-PRGE
transcription	O
in	O
dorsolateral	O
mesenchyme	O
.	O

However	O
,	O
the	O
ability	O
of	O
Tbx15	S-PRGE
to	O
suppress	O
expression	O
of	O
the	O
ventral	O
-	O
specific	O
Agouti	S-PRGE
isoform	S-SO
in	O
postnatal	O
mice	S-LIVB
is	O
likely	O
to	O
be	O
indirect	O
,	O
since	O
postnatal	O
expression	O
of	O
Tbx15	S-PRGE
occurs	O
broadly	O
along	O
the	O
dorsoventral	O
axis	O
and	O
overlaps	O
extensively	O
with	O
that	O
of	O
Agouti	S-PRGE
.	O

In	O
either	O
case	O
,	O
the	O
targets	O
of	O
Tbx15	S-PRGE
action	O
in	O
the	O
skin	O
include	O
genes	S-SO
in	O
addition	O
to	O
Agouti	S-PRGE
,	O
since	O
hair	O
length	O
and	O
melanocyte	S-CL
distribution	O
exhibit	O
a	O
demonstrable	O
,	O
albeit	O
subtle	O
,	O
alteration	O
in	O
animals	S-LIVB
that	O
carry	O
a	O
null	O
Agouti	S-PRGE
allele	S-SO
.	O

One	O
potential	O
target	O
is	O
Alx4	S-PRGE
,	O
which	O
,	O
like	O
Agouti	S-PRGE
,	O
is	O
expressed	O
in	O
ventral	O
embryonic	O
mesenchyme	O
,	O
and	O
,	O
when	O
mutated	S-SO
,	O
affects	O
hair	O
-	O
follicle	O
as	O
well	O
as	O
limb	O
and	O
craniofacial	O
development	O
(	O
Qu	O
et	O
al	O
.	O
1997	O
,	O
1998	O
;	O
Wu	O
et	O
al	O
.	O
2000	O
;	O
Wuyts	O
et	O
al	O
.	O
2000	O
;	O
Mavrogiannis	O
et	O
al	O
.	O
2001	O
)	O
.	O

However	O
,	O
expression	O
of	O
ventral	O
markers	O
such	O
as	O
Alx4	S-PRGE
,	O
as	O
well	O
as	O
Alx3	S-PRGE
and	O
Msx2	S-PRGE
,	O
appears	O
to	O
be	O
unaffected	O
at	O
E11	O
.	O
5	O
in	O
deH	O
/	O
deH	O
embryos	O
(	O
data	O
not	O
shown	O
)	O
.	O

Differences	O
and	O
Similarities	O
to	O
Dorsoventral	O
Limb	O
Patterning	O

Loss	O
of	O
Tbx15	S-PRGE
also	O
affects	O
regional	O
distribution	O
of	O
hair	O
color	O
in	O
the	O
limbs	O
,	O
with	O
areas	O
that	O
would	O
normally	O
produce	O
black	O
hair	O
giving	O
rise	O
to	O
yellow	O
hair	O
instead	O
.	O

However	O
,	O
neither	O
normal	O
patterns	O
of	O
pigment	S-CHEBI
-	O
type	O
synthesis	O
in	O
the	O
limb	O
nor	O
their	O
disruption	O
in	O
deH	O
/	O
deH	O
mice	S-LIVB
correspond	O
to	O
obvious	O
developmental	O
compartments	O
.	O

Furthermore	O
,	O
losses	O
of	O
function	O
for	O
En1	S-PRGE
or	O
Wnt7a	S-PRGE
,	O
which	O
cause	O
a	O
partial	O
transformation	O
of	O
the	O
distal	O
limb	O
from	O
dorsum	O
to	O
ventrum	O
(	O
Loomis	O
et	O
al	O
.	O
1996	O
)	O
or	O
ventrum	O
to	O
dorsum	O
(	O
Parr	O
and	O
McMahon	O
1995	O
)	O
,	O
respectively	O
,	O
have	O
no	O
effect	O
on	O
regional	O
patterns	O
of	O
Agouti	S-PRGE
expression	O
or	O
distribution	O
of	O
hair	O
-	O
color	O
regions	O
(	O
Y	O
.	O
Chen	O
,	O
unpublished	O
data	O
)	O
.	O

(	O
Ectopic	O
pigmentation	O
of	O
the	O
ventral	O
footpads	O
that	O
develops	O
in	O
En1	S-PRGE
mutant	S-SO
mice	S-LIVB
is	O
unrelated	O
to	O
pigment	S-CHEBI
-	O
type	O
synthesis	O
and	O
instead	O
likely	O
reflects	O
a	O
requirement	O
for	O
En1	S-PRGE
,	O
independent	O
of	O
Wnt7a	S-PRGE
,	O
to	O
repress	O
migration	O
or	O
proliferation	O
(	O
or	O
both	O
)	O
of	O
pigment	B-CL
cells	E-CL
in	O
ventral	O
epidermis	O
[	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
]	O
.	O
)	O

These	O
considerations	O
notwithstanding	O
,	O
control	O
of	O
dorsoventral	O
trunk	O
pattern	O
by	O
Tbx15	S-PRGE
shares	O
certain	O
features	O
with	O
control	O
of	O
dorsoventral	O
limb	O
patterning	O
by	O
Lmx1b	S-PRGE
,	O
a	O
LIM	O
domain	S-SO
transcription	O
factor	O
that	O
acts	O
downstream	O
of	O
Wnt7a	S-PRGE
and	O
En1	S-PRGE
(	O
Riddle	O
et	O
al	O
.	O
1995	O
;	O
Vogel	O
et	O
al	O
.	O
1995	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Logan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
;	O
Chen	O
and	O
Johnson	O
2002	O
)	O
.	O

Both	O
Tbx15	S-PRGE
and	O
Lmx1b	S-PRGE
act	O
autonomously	O
in	O
mesenchymal	B-CL
cells	E-CL
to	O
promote	O
a	O
dorsal	O
identity	O
,	O
yet	O
have	O
expression	O
domains	O
that	O
do	O
not	O
correspond	O
to	O
cell	S-CL
lineage	O
compartments	O
in	O
the	O
flank	O
(	O
Tbx15	S-PRGE
)	O
or	O
the	O
limb	O
(	O
Lmx1b	S-PRGE
)	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
)	O
.	O

In	O
the	O
case	O
of	O
Lmx1b	S-PRGE
,	O
its	O
expression	O
in	O
the	O
distal	O
limb	O
depends	O
on	O
Wnt7a	S-PRGE
produced	O
in	O
the	O
overlying	O
dorsal	O
ectoderm	O
(	O
Riddle	O
et	O
al	O
.	O
1995	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
)	O
.	O

Wnt7a	S-PRGE
,	O
in	O
turn	O
,	O
is	O
restricted	O
to	O
dorsal	O
ectoderm	O
by	O
En1	S-PRGE
in	O
the	O
ventral	O
ectoderm	O
(	O
Loomis	O
et	O
al	O
.	O
1996	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Logan	O
et	O
al	O
.	O
1997	O
)	O
,	O
whose	O
expression	O
marks	O
a	O
lineage	O
boundary	O
coincident	O
with	O
the	O
dorsoventral	O
midline	O
of	O
the	O
apical	O
ectodermal	O
ridge	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
;	O
Kimmel	O
et	O
al	O
.	O
2000	O
)	O
.	O

As	O
described	O
above	O
,	O
En1	S-PRGE
or	O
Wnt7a	S-PRGE
mutations	S-SO
have	O
not	O
been	O
reported	O
to	O
affect	O
patterns	O
of	O
hair	O
-	O
color	O
distribution	O
(	O
C	O
.	O
Loomis	O
,	O
personal	O
communication	O
;	O
Parr	O
and	O
McMahon	O
1995	O
;	O
Loomis	O
et	O
al	O
.	O
1996	O
)	O
.	O

However	O
,	O
the	O
essential	O
theme	O
that	O
ectodermal	O
lineage	O
compartments	O
control	O
the	O
fate	O
of	O
underlying	O
mesenchyme	O
in	O
developing	O
limbs	O
may	O
apply	O
to	O
the	O
trunk	O
as	O
well	O
as	O
the	O
limb	O
.	O

The	O
mammary	O
glands	O
also	O
develop	O
at	O
a	O
stereotyped	O
dorsoventral	O
position	O
and	O
depend	O
on	O
epithelial	O
-	O
mesenchymal	O
interactions	O
.	O

However	O
,	O
the	O
number	O
and	O
apparent	O
position	O
of	O
the	O
mammary	O
glands	O
are	O
normal	O
in	O
deH	O
/	O
deH	O
animals	S-LIVB
,	O
indicating	O
the	O
existence	O
of	O
additional	O
mechanisms	O
that	O
control	O
dorsoventral	O
patterning	O
in	O
the	O
trunk	O
as	O
well	O
as	O
in	O
the	O
limbs	O
.	O

These	O
ideas	O
are	O
summarized	O
in	O
the	O
model	O
shown	O
in	O
Figure	O
9B	O
.	O

We	O
speculate	O
that	O
a	O
diffusible	O
signal	O
from	O
dorsal	O
trunk	O
ectoderm	O
,	O
at	O
or	O
prior	O
to	O
E11	O
.	O
5	O
,	O
promotes	O
expression	O
of	O
Tbx15	S-PRGE
in	O
dorsal	O
trunk	O
mesenchyme	O
,	O
which	O
then	O
establishes	O
dorsal	O
positional	O
identity	O
of	O
those	O
cells	S-CL
as	O
manifested	O
by	O
differences	O
in	O
Agouti	S-PRGE
expression	O
,	O
pigment	B-CL
-	I-CL
cell	E-CL
development	O
,	O
and	O
hair	O
growth	O
.	O

Because	O
the	O
ventral	O
limit	O
of	O
Tbx15	S-PRGE
expression	O
corresponds	O
to	O
the	O
dorsal	O
limit	O
of	O
En1	S-PRGE
expression	O
and	O
because	O
the	O
normal	O
position	O
of	O
the	O
pigmentation	O
boundary	O
lies	O
approximately	O
in	O
register	O
with	O
the	O
limb	O
-	O
bud	O
outgrowths	O
,	O
we	O
depict	O
the	O
position	O
of	O
a	O
putative	O
dorsoventral	O
boundary	O
in	O
trunk	O
ectoderm	O
as	O
coincident	O
with	O
the	O
limb	O
dorsoventral	O
boundary	O
.	O

This	O
model	O
is	O
consistent	O
with	O
studies	O
in	O
the	O
chick	O
,	O
where	O
distinct	O
dorsal	O
and	O
ventral	O
lineage	O
compartments	O
exist	O
for	O
ectoderm	O
in	O
both	O
the	O
limb	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
;	O
Kimmel	O
et	O
al	O
.	O
2000	O
)	O
and	O
interlimb	O
regions	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
)	O
,	O
but	O
not	O
for	O
limb	O
mesoderm	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
)	O
.	O

In	O
fact	O
,	O
the	O
same	O
mechanism	O
that	O
determines	O
dorsoventral	O
position	O
of	O
the	O
limbs	O
and	O
the	O
apical	O
ectodermal	O
ridge	O
may	O
also	O
act	O
on	O
expression	O
of	O
Tbx15	S-PRGE
in	O
the	O
trunk	O
,	O
since	O
ectopic	O
limbs	O
induced	O
in	O
the	O
interlimb	O
region	O
by	O
application	O
of	O
FGF	O
beads	O
develop	O
along	O
a	O
single	O
line	O
that	O
is	O
coincident	O
with	O
normal	O
limb	O
buds	O
(	O
and	O
the	O
future	O
pigmentation	O
boundary	O
)	O
(	O
Cohn	O
et	O
al	O
.	O
1995	O
;	O
Crossley	O
et	O
al	O
.	O
1996	O
;	O
Vogel	O
et	O
al	O
.	O
1996	O
;	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
)	O
.	O

Our	O
model	O
predicts	O
that	O
ectopic	O
expression	O
of	O
Tbx15	S-PRGE
in	O
ventral	O
mesenchyme	O
should	O
give	O
rise	O
to	O
a	O
dorsalized	O
pigmentation	O
phenotype	O
and	O
could	O
be	O
tested	O
with	O
gain	O
-	O
of	O
-	O
function	O
approaches	O
.	O

However	O
,	O
Tbx15	S-PRGE
expression	O
is	O
very	O
dynamic	O
and	O
is	O
restricted	O
to	O
dorsal	O
mesoderm	O
only	O
from	O
E11	O
.	O
5	O
to	O
E13	O
.	O
5	O
.	O

It	O
is	O
possible	O
that	O
Tbx15	S-PRGE
influences	O
skin	O
patterning	O
in	O
a	O
very	O
narrow	O
window	O
of	O
development	O
;	O
alternatively	O
,	O
establishment	O
of	O
dorsal	O
identity	O
by	O
Tbx15	S-PRGE
may	O
require	O
another	O
as	O
-	O
yet	O
-	O
unidentified	O
factor	O
that	O
is	O
only	O
present	O
in	O
the	O
mesenchyme	O
underlying	O
dorsal	O
ectoderm	O
.	O

Pigmentation	O
Patterns	O
and	O
Tbx15	S-PRGE
in	O
Other	O
Mammals	S-LIVB

The	O
lateral	O
somitic	O
frontier	O
,	O
defined	O
as	O
the	O
lineage	O
boundary	O
between	O
somite	O
-	O
derived	O
versus	O
lateral	O
plate	O
-	O
derived	O
mesoderm	O
,	O
is	O
established	O
during	O
somitogenesis	O
early	O
in	O
development	O
(	O
Mauger	O
1972	O
;	O
Christ	O
et	O
al	O
.	O
1983	O
;	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
,	O
but	O
remains	O
distinct	O
in	O
postnatal	O
animals	S-LIVB
despite	O
the	O
potential	O
for	O
extensive	O
cell	S-CL
mixing	O
(	O
see	O
Figure	O
8	O
)	O
.	O

However	O
,	O
our	O
transplantation	O
and	O
fate	O
-	O
mapping	O
studies	O
demonstrate	O
that	O
the	O
lateral	O
somitic	O
frontier	O
lies	O
dorsal	O
to	O
the	O
pigmentation	O
boundary	O
and	O
does	O
not	O
obviously	O
correlate	O
with	O
a	O
difference	O
in	O
skin	O
morphology	O
.	O

An	O
additional	O
dorsoventral	O
domain	O
that	O
is	O
not	O
externally	O
apparent	O
has	O
emerged	O
from	O
studies	O
of	O
Msx1	S-PRGE
,	O
whose	O
expression	O
marks	O
a	O
subgroup	O
of	O
somite	O
-	O
derived	O
mesenchymal	B-CL
cells	E-CL
that	O
contribute	O
to	O
dermis	O
in	O
a	O
narrow	O
stripe	O
along	O
the	O
paraspinal	O
region	O
(	O
Houzelstein	O
et	O
al	O
.	O
2000	O
)	O
.	O

Thus	O
,	O
there	O
exist	O
at	O
least	O
three	O
distinct	O
boundaries	O
in	O
postnatal	O
mammalian	S-LIVB
skin	O
that	O
are	O
parallel	O
to	O
the	O
sagittal	O
plane	O
,	O
marked	O
by	O
differences	O
in	O
pigment	S-CHEBI
-	O
type	O
synthesis	O
,	O
differences	O
in	O
cell	S-CL
lineage	O
,	O
and	O
differences	O
in	O
expression	O
of	O
Msx1	S-PRGE
.	O

In	O
rodents	S-LIVB
,	O
only	O
the	O
pigmentation	O
boundary	O
is	O
evident	O
externally	O
,	O
but	O
many	O
mammals	S-LIVB
have	O
more	O
complicated	O
patterns	O
of	O
hair	O
type	O
,	O
length	O
,	O
and	O
/	O
or	O
color	O
that	O
vary	O
along	O
the	O
dorsoventral	O
axis	O
.	O

Raccoons	S-LIVB
,	O
squirrels	O
,	O
skunks	S-LIVB
,	O
and	O
many	O
different	O
ungulates	O
exhibit	O
lateral	O
stripes	O
whose	O
developmental	O
origins	O
have	O
not	O
been	O
investigated	O
,	O
but	O
may	O
correspond	O
to	O
the	O
lateral	O
somitic	O
frontier	O
,	O
the	O
paraspinal	O
Msx1	S-PRGE
compartment	O
,	O
or	O
an	O
interaction	O
between	O
these	O
domains	O
.	O

The	O
effect	O
of	O
Tbx15	S-PRGE
on	O
pigmentation	O
in	O
laboratory	O
mice	S-LIVB
is	O
reminiscent	O
of	O
coat	O
-	O
color	O
patterns	O
in	O
both	O
selected	O
and	O
natural	O
populations	O
of	O
other	O
mammals	S-LIVB
.	O

Saddle	O
markings	O
are	O
common	O
in	O
some	O
dog	S-LIVB
breeds	O
,	O
such	O
as	O
German	O
shepherds	O
,	O
and	O
in	O
certain	O
populations	O
of	O
Peromyscus	B-LIVB
polionotus	E-LIVB
,	O
in	O
which	O
a	O
dorsal	O
extension	O
of	O
ventral	O
depigmentation	O
provides	O
an	O
adaptive	O
advantage	O
to	O
subspecies	O
that	O
live	O
on	O
white	O
sand	O
reefs	O
(	O
Blair	O
1951	O
;	O
Kaufman	O
1974	O
;	O
Belk	O
and	O
Smith	O
1996	O
)	O
.	O

Neither	O
German	O
shepherds	O
nor	O
deer	B-LIVB
mice	E-LIVB
have	O
craniofacial	O
characteristics	O
similar	O
to	O
the	O
deH	O
mutation	S-SO
,	O
but	O
the	O
pigmentation	O
patterns	O
in	O
these	O
animals	S-LIVB
could	O
represent	O
alterations	O
in	O
the	O
regulation	O
or	O
action	O
of	O
Tbx15	S-PRGE
activity	O
.	O

From	O
the	O
opposite	O
perspective	O
,	O
the	O
effects	O
of	O
Tbx15	S-PRGE
on	O
coat	O
color	O
are	O
only	O
apparent	O
in	O
certain	O
genetic	S-SO
backgrounds	O
and	O
may	O
not	O
be	O
evident	O
at	O
all	O
in	O
mammals	S-LIVB
that	O
lack	O
dorsoventral	O
pigmentation	O
patterns	O
.	O

Studying	O
the	O
sequence	S-SO
and	O
expression	O
of	O
Tbx15	S-PRGE
in	O
other	O
vertebrates	S-LIVB
may	O
provide	O
additional	O
insight	O
into	O
patterns	O
that	O
affect	O
the	O
skeleton	O
as	O
well	O
as	O
the	O
pigmentary	S-CHEBI
system	O
.	O

Materials	O
and	O
Methods	O

Mice	S-LIVB

All	O
mice	S-LIVB
were	O
obtained	O
originally	O
from	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
,	O
except	O
the	O
BA	O
strain	O
(	O
Stanford	O
Veterinary	O
Services	O
Center	O
,	O
Stanford	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
Hoxb6	S-PRGE
-	O
Cre	O
transgenic	S-SO
mice	S-LIVB
(	O
kindly	O
provided	O
by	O
M	O
.	O
Kuehn	O
of	O
the	O
National	O
Institutes	O
of	O
Health	O
,	O
Bethesda	O
,	O
Maryland	O
,	O
United	O
States	O
)	O
,	O
mice	S-LIVB
carrying	O
the	O
R26R	O
lacZ	O
reporter	O
allele	S-SO
(	O
kindly	O
provided	O
by	O
P	O
.	O
Soriano	O
,	O
Fred	O
Hutchinson	O
Cancer	O
Research	O
Center	O
,	O
Seattle	O
,	O
Washington	O
,	O
United	O
States	O
)	O
,	O
and	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
ae	O
/	O
ae	O
mice	S-LIVB
(	O
kindly	O
provided	O
by	O
L	O
.	O
Siracusa	O
,	O
Jefferson	O
Medical	O
College	O
,	O
Philadelphia	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
.	O

The	O
deH	O
mutation	S-SO
arose	O
in	O
the	O
1960s	O
in	O
Harwell	O
,	O
probably	O
on	O
the	O
BN	O
strain	O
background	O
(	O
C	O
.	O
Beechey	O
,	O
personal	O
communication	O
)	O
.	O

We	O
obtained	O
deH	O
on	O
a	O
B6	O
/	O
EiC3H	O
background	O
,	O
introduced	S-SO
the	O
at	O
allele	S-SO
from	O
the	O
BTBR	O
strain	O
,	O
and	O
have	O
maintained	O
the	O
line	O
as	O
a	O
mixed	O
deH	O
/	O
+	S-SO
x	O
deH	O
/	O
+	S-SO
intercross	O
stock	O
with	O
periodic	O
outcrossing	O
to	O
BTBR	O
or	O
B6	O
.	O

For	O
timed	O
matings	O
,	O
the	O
morning	O
of	O
the	O
plug	O
was	O
considered	O
E0	O
.	O
5	O
.	O

Postnatally	O
,	O
the	O
day	O
of	O
birth	O
was	O
considered	O
to	O
be	O
P0	O
.	O
5	O
.	O

Phenotypic	O
analysis	O

For	O
measurements	O
of	O
hair	O
length	O
and	O
color	O
,	O
the	O
entire	O
interlimb	O
region	O
of	O
skin	O
was	O
first	O
dissected	O
with	O
a	O
single	O
incision	O
at	O
the	O
dorsal	O
midline	O
and	O
preserved	O
with	O
powdered	O
sodium	B-CHEBI
bicarbonate	E-CHEBI
.	O

Slices	O
2	O
-	O
2	O
.	O
5	O
mm	O
in	O
width	O
were	O
then	O
prepared	O
parallel	O
to	O
the	O
dorsoventral	O
axis	O
,	O
hair	O
length	O
boundaries	O
determined	O
from	O
electronic	O
images	O
with	O
Adobe	O
Photoshop	O
(	O
San	O
Jose	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
and	O
measurements	O
obtained	O
using	O
ImageJ	O
(	O
National	O
Institutes	O
of	O
Health	O
)	O
.	O

This	O
approach	O
samples	O
awls	O
and	O
auchenes	O
,	O
because	O
they	O
are	O
much	O
thicker	O
and	O
therefore	O
visually	O
more	O
predominant	O
than	O
zigzag	O
underhairs	O
.	O

To	O
assess	O
dorsoventral	O
variation	O
in	O
hair	O
-	O
type	O
distribution	O
,	O
several	O
hundred	O
hairs	O
were	O
plucked	O
from	O
the	O
middorsum	O
or	O
midventrum	O
of	O
8	O
-	O
wk	O
-	O
old	O
male	O
BA	O
strain	O
animals	S-LIVB
,	O
then	O
sorted	O
and	O
categorized	O
using	O
a	O
dissection	O
microscope	O
.	O

No	O
attempt	O
was	O
made	O
to	O
distinguish	O
between	O
awls	O
and	O
auchenes	O
.	O

For	O
skin	O
histology	O
,	O
12	O
mu	O
m	O
sections	O
from	O
paraffin	O
-	O
embedded	O
tissue	O
were	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

For	O
DOPA	S-CHEBI
staining	O
,	O
the	O
dermis	O
and	O
epidermis	O
were	O
split	O
after	O
3	O
h	O
of	O
incubation	O
in	O
2	O
M	O
sodium	S-CHEBI
bromide	S-CHEBI
at	O
37	O
degrees	O
C	O
(	O
this	O
preparation	O
causes	O
most	O
hair	O
follicles	O
to	O
remain	O
with	O
the	O
dermis	O
)	O
,	O
individually	O
fixed	O
for	O
1	O
h	O
,	O
then	O
rinsed	O
and	O
stained	O
with	O
0	O
.	O
1	O
%	O
L	B-CHEBI
-	I-CHEBI
DOPA	E-CHEBI
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
,	O
0	O
.	O
1	O
M	O
sodium	B-CHEBI
phosphate	E-CHEBI
buffer	O
(	O
pH	O
6	O
.	O
8	O
)	O
for	O
5	O
h	O
at	O
37	O
degrees	O
C	O
in	O
the	O
dark	O
,	O
changing	O
the	O
staining	O
solution	O
after	O
1	O
h	O
.	O

The	O
samples	O
were	O
then	O
fixed	O
overnight	O
,	O
dehydrated	O
,	O
and	O
mounted	O
.	O

This	O
method	O
is	O
sufficient	O
to	O
stain	O
interfollicular	O
melanocytes	S-CL
without	O
creating	O
a	O
high	O
background	O
.	O

The	O
fixative	O
used	O
was	O
always	O
4	O
%	O
paraformaldehyde	O
.	O

Positional	S-SO
cloning	O

A	O
high	O
-	O
resolution	O
map	S-SO
for	O
deH	O
was	O
generated	O
from	O
an	O
intersubspecific	O
intercross	O
between	O
deH	O
/	O
deH	O
and	O
CAST	O
/	O
Ei	O
mice	S-LIVB
.	O

We	O
initially	O
localized	O
deH	O
to	O
a	O
1	O
cM	O
interval	S-SO
between	O
D3Mit233	O
and	O
D3Mit11	O
.	O

F2	O
animals	S-LIVB
carrying	O
recombinant	O
chromosomes	S-GO
between	O
these	O
markers	O
whose	O
genotype	S-SO
at	O
de	S-PRGE
was	O
indeterminate	O
(	O
deH	O
/	O
+	S-SO
or	O
+	S-SO
/	O
+	S-SO
)	O
were	O
progeny	O
-	O
tested	O
by	O
crossing	O
to	O
deH	O
/	O
deH	O
animals	S-LIVB
.	O

Further	O
genetic	S-SO
mapping	O
established	O
a	O
minimal	O
region	S-SO
of	O
0	O
.	O
1	O
cM	O
between	O
D3Mit213	O
and	O
16	O
.	O
MMHAP32FLF1	O
;	O
these	O
markers	O
were	O
used	O
to	O
initiate	O
construction	O
of	O
a	O
physical	B-SO
map	E-SO
with	O
BAC	S-SO
genomic	B-SO
clones	E-SO
(	O
Research	O
Genetics	O
,	O
Huntsville	O
,	O
Alabama	O
,	O
United	O
States	O
,	O
and	O
Genome	S-SO
Systems	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

End	B-SO
sequence	I-SO
from	I-SO
those	I-SO
BACs	E-SO
was	O
used	O
to	O
develop	O
SSCP	O
markers	O
M1	O
to	O
M3	O
,	O
as	O
depicted	O
in	O
Figure	O
3	O
,	O
and	O
to	O
establish	O
a	O
minimal	O
physical	O
interval	S-SO
of	O
1	O
.	O
4	O
Mb	O
.	O

Primer	S-SO
pairs	O
used	O
were	O
TTCCCTCCAATAAGTTCTGGGTACC	O
and	O
AAGCTTGCTGCTCTGGATTCCATTTGTAG	O
for	O
M1	O
,	O
CCTTCATTTTTTTTTCAAGTAAAA	O
and	O
AAGCTTGGCTTAGTCCCAGTGGC	O
for	O
M2	O
,	O
CCTCCAGGAAGATCTACTAGGCAC	O
and	O
ATGGAAAAAAAAAAGTAAGATTGAAAG	O
for	O
M3	O
,	O
and	O
TGGTTATCGATCTGTGGACCATTC	O
and	O
AAGTGAGAGAGCAGGATGGACCAC	O
for	O
M4	O
(	O
the	O
M4	O
marker	O
represents	O
STS	S-SO
16	O
.	O
MMHAP32FLF1	O
)	O
.	O

Genomic	B-SO
sequence	E-SO
and	O
annotations	O
were	O
obtained	O
from	O
the	O
UCSC	O
Genome	S-SO
Browser	O
February	O
2003	O
assembly	S-SO
version	S-SO
mm3	O
(	O
http	O
:	O
/	O
/	O
genome	S-SO
.	O
ucsc	O
.	O
edu	O
)	O
;	O
the	O
1	O
.	O
4	O
Mb	O
interval	S-SO
between	O
M1	O
and	O
M4	O
contains	O
eight	O
genes	S-SO
:	O
four	O
hydroxysteroid	S-CHEBI
dehydrogenase	O
isomerases	O
,	O
Hsd3b3	S-PRGE
,	O
Hsd3b2	S-PRGE
,	O
Hsd3b6	S-PRGE
,	O
and	O
Hsd3b1	S-PRGE
;	O
an	O
hydroacid	S-CHEBI
oxidase	O
,	O
Hao3	S-PRGE
;	O
a	O
tryptophanyl	B-CHEBI
-	I-CHEBI
tRNA	E-CHEBI
synthetase	O
,	O
Wars2	S-PRGE
;	O
a	O
T	O
-	O
box	O
gene	S-SO
,	O
Tbx15	S-PRGE
;	O
and	O
a	O
novel	O
gene	S-SO
,	O
4931427F14Rik	S-PRGE
.	O

In	O
the	O
genome	B-SO
sequence	E-SO
,	O
M1	O
primers	S-SO
correspond	O
to	O
AGGCCTCCAATAAGTTCTGGGTACC	O
and	O
AAGCTTGCTCTCTGGATTCCATTTGTAG	O
,	O
the	O
M2	O
reverse	B-SO
primer	E-SO
corresponds	O
to	O
AAGCTTGGCTTTAGTCCCAGTGGGC	O
,	O
and	O
the	O
M3	O
primers	S-SO
correspond	O
to	O
CCTCCAGGAAGAATCTACTAGGCAC	O
and	O
AATGAAAAAAAAAAAAGTAAGATTGAAAG	O
.	O

Minor	O
differences	O
among	O
the	O
sequences	S-SO
of	O
the	O
primers	S-SO
we	O
obtained	O
from	O
the	O
BAC	B-SO
ends	E-SO
and	O
the	O
public	O
genome	B-SO
sequence	E-SO
may	O
represent	O
strain	O
differences	O
or	O
sequencing	O
errors	O
on	O
the	O
BAC	S-SO
DNA	S-SO
.	O

A	O
multiplex	O
genotyping	O
assay	O
was	O
developed	O
to	O
genotype	O
for	O
the	O
deH	O
deletion	S-SO
using	O
primers	S-SO
GGAGCAGATCCAATTGCTTT	O
,	O
TCCATAGCCCATCTTCACAA	O
,	O
and	O
CATGTCCACTTCTGCTTCCA	O
.	O

This	O
PCR	O
assay	O
produces	O
a	O
392	O
bp	S-SO
product	S-SO
from	O
the	O
deH	O
chromosome	S-GO
and	O
a	O
595	O
bp	S-SO
product	S-SO
from	O
the	O
nonmutant	O
chromosome	S-GO
.	O

Gene	S-SO
targeting	O

A	O
targeted	O
allele	S-SO
of	O
Tbx15	S-PRGE
was	O
constructed	O
using	O
the	O
same	O
approach	O
described	O
in	O
Russ	O
et	O
al	O
.	O

(	O
2000	O
)	O
.	O

In	O
brief	O
,	O
an	O
IRES	S-SO
-	O
LacZ	O
-	O
neo	O
cassette	S-SO
with	O
5	O
'	O
and	O
3	O
'	O
homology	O
arms	O
of	O
3	O
.	O
5	O
kb	O
and	O
1	O
.	O
8	O
kb	O
was	O
inserted	S-SO
into	O
a	O
unique	O
BamHI	O
site	S-SO
that	O
lies	O
479	O
nucleotides	S-CHEBI
downstream	O
of	O
the	O
transcriptional	O
initiation	O
site	S-SO
(	O
relative	O
to	O
the	O
mRNA	B-CHEBI
sequence	E-CHEBI
)	O
in	O
exon	S-SO
3	O
.	O

Positive	O
ES	O
clones	S-SO
were	O
injected	O
into	O
B6	O
blastocysts	O
,	O
and	O
chimeric	O
founders	O
crossed	O
to	O
either	O
B6	O
mice	S-LIVB
or	O
to	O
deH	O
/	O
+	S-SO
animals	S-LIVB
.	O

In	O
situ	O
hybridization	O

In	O
situ	O
hybridization	O
was	O
carried	O
out	O
on	O
12	O
-	O
mu	O
m	O
paraffin	O
sections	O
using	O
digoxigenin	S-CHEBI
-	O
labeled	O
RNA	S-SO
probes	S-SO
(	O
Roche	O
Diagnostics	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
according	O
to	O
standard	O
protocols	O
(	O
Wilkinson	O
and	O
Nieto	O
1993	O
)	O
.	O

Embryos	O
and	O
postnatal	O
skin	O
samples	O
were	O
obtained	O
from	O
intercrosses	O
of	O
deH	O
/	O
+	S-SO
mice	S-LIVB
.	O

Embryos	O
E13	O
.	O
5	O
or	O
younger	O
were	O
fixed	O
for	O
24	O
h	O
;	O
those	O
older	O
than	O
E13	O
.	O
5	O
and	O
postnatal	O
skin	O
were	O
fixed	O
for	O
36	O
-	O
48	O
h	O
prior	O
to	O
embedding	O
.	O

The	O
Tbx15	S-PRGE
probe	S-SO
was	O
generated	O
by	O
RT	O
-	O
PCR	O
using	O
primers	S-SO
GGCGGCTAAAATGAGTGAAC	O
and	O
TGCCTGCTTTGGTGATGAT	O
(	O
corresponds	O
to	O
exons	S-SO
1	O
and	O
2	O
)	O
,	O
and	O
the	O
En1	S-PRGE
probe	S-SO
was	O
generated	O
by	O
PCR	O
from	O
genomic	B-SO
DNA	E-SO
using	O
primers	S-SO
ACGCACCAGGAAGCTAAAGA	O
and	O
AGCAACGAAAACGAAACTGG	O
(	O
located	O
in	O
the	O
last	O
exon	S-SO
)	O
.	O

The	O
Agouti	S-PRGE
probe	S-SO
corresponds	O
to	O
the	O
protein	S-CHEBI
-	O
coding	B-SO
sequence	E-SO
.	O

Embryonic	O
skin	O
transplantation	O

(	O
BTBR	O
-	O
at	O
/	O
at	O
x	O
B6	O
-	O
a	O
/	O
a	O
)	O
F1	O
embryos	O
at	O
E12	O
.	O
5	O
were	O
dissected	O
in	O
sterile	O
Tyrode	O
'	O
s	O
solution	O
,	O
and	O
embryonic	O
skin	O
was	O
divided	O
into	O
dorsal	O
,	O
flank	O
,	O
and	O
ventral	O
pieces	O
,	O
each	O
1	O
-	O
2	O
mm2	O
in	O
size	O
,	O
as	O
shown	O
in	O
Figure	O
7	O
.	O

Skin	O
fragments	O
were	O
grafted	O
to	O
the	O
testes	O
of	O
congenic	O
animals	S-LIVB
as	O
follows	O
.	O

After	O
anesthetization	O
with	O
2	O
.	O
5	O
%	O
Avertin	O
,	O
a	O
1	O
.	O
5	O
-	O
cm	O
incision	O
in	O
the	O
skin	O
and	O
body	O
wall	O
was	O
made	O
at	O
a	O
point	O
level	O
with	O
the	O
top	O
of	O
the	O
limbs	O
.	O

The	O
fat	O
pads	O
were	O
pulled	O
out	O
and	O
laid	O
on	O
the	O
outside	O
of	O
the	O
body	O
,	O
exposing	O
the	O
testes	O
.	O

Forceps	O
were	O
used	O
to	O
introduce	O
a	O
small	O
hole	O
in	O
the	O
testis	O
capsule	O
through	O
which	O
a	O
piece	O
of	O
dissected	O
embryonic	O
skin	O
was	O
inserted	O
,	O
the	O
testes	O
were	O
then	O
replaced	O
into	O
the	O
abdominal	O
cavity	O
,	O
and	O
the	O
wound	O
was	O
closed	O
in	O
both	O
the	O
body	O
wall	O
and	O
the	O
skin	O
.	O

After	O
21	O
days	O
,	O
mice	S-LIVB
that	O
received	O
grafts	O
were	O
sacrificed	O
and	O
the	O
resulting	O
hair	O
was	O
dissected	O
from	O
the	O
testes	O
and	O
examined	O
.	O

Fate	O
-	O
mapping	O
the	O
lateral	O
somitic	O
frontier	O

The	O
Hoxb6	S-PRGE
-	O
Cre	O
transgene	S-SO
described	O
by	O
Kuehn	O
and	O
colleagues	O
(	O
Lowe	O
et	O
al	O
.	O
2000	O
)	O
is	O
expressed	O
in	O
the	O
lateral	O
plate	O
but	O
not	O
the	O
somitic	O
mesoderm	O
of	O
the	O
trunk	O
,	O
beginning	O
at	O
E9	O
.	O
5	O
.	O

Animals	S-LIVB
doubly	O
heterozygous	O
for	O
this	O
transgene	S-SO
and	O
the	O
R26R	O
reporter	O
gene	S-SO
were	O
used	O
as	O
a	O
source	O
of	O
whole	O
skin	O
at	O
P1	O
.	O
5	O
or	O
P4	O
.	O
5	O
.	O

Skin	O
sections	O
parallel	O
to	O
the	O
dorsoventral	O
axis	O
were	O
prepared	O
with	O
a	O
single	O
incision	O
along	O
the	O
ventral	O
midline	O
and	O
stained	O
for	O
beta	O
-	O
galactosidase	O
activity	O
using	O
standard	O
protocols	O
at	O
room	O
temperature	O
.	O

The	O
P1	O
.	O
5	O
sample	O
was	O
stained	O
overnight	O
and	O
the	O
P4	O
.	O
5	O
samples	O
were	O
stained	O
for	O
5	O
.	O
5	O
h	O
.	O

Similar	O
nonstained	O
skin	O
sections	O
were	O
prepared	O
from	O
animals	S-LIVB
carrying	O
the	O
at	O
allele	S-SO
.	O

Images	O
of	O
the	O
different	O
skin	O
fragments	O
were	O
aligned	O
and	O
scaled	O
,	O
and	O
the	O
relative	O
position	O
of	O
the	O
somite	O
-	O
lateral	O
plate	O
and	O
the	O
pigmentation	O
boundaries	O
were	O
measured	O
using	O
ImageJ	O
.	O

Supporting	O
Information	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
/	O
index	O
.	O
html	O
)	O
accession	O
numbers	O
discussed	O
in	O
this	O
paper	O
are	O
for	O
4931427F14Rik	S-PRGE
(	O
AK016477	O
)	O
,	O
Agouti	S-PRGE
gene	S-SO
(	O
L06451	O
)	O
,	O
Alx3	S-PRGE
(	O
U96109	O
)	O
,	O
Alx4	S-PRGE
(	O
AF001465	O
)	O
,	O
En1	S-PRGE
(	O
L12703	O
)	O
,	O
M6pr	S-PRGE
-	O
ps	O
(	O
X64069	O
)	O
,	O
Tbx14	S-PRGE
(	O
AF013282	O
)	O
,	O
Tbx15	S-PRGE
(	O
AF041822	O
)	O
,	O
Tbx18	S-PRGE
(	O
AF306666	O
)	O
,	O
and	O
Tbx22	S-PRGE
(	O
NM	O
_	O
145224	O
)	O
.	O

The	O
OMIM	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
omim	O
/	O
)	O
accession	O
numbers	O
discussed	O
in	O
this	O
paper	O
are	O
for	O
acromegaloid	O
facial	O
appearance	O
(	O
MIM	O
102150	O
)	O
,	O
frontofacionasal	O
syndrome	O
(	O
MIM	O
229400	O
)	O
and	O
human	S-LIVB
syndrome	O
X	S-GO
-	O
linked	O
cleft	O
palate	O
and	O
ankyloglossia	O
(	O
MIM	O
303400	O
)	O
.	O

Acknowledgements	O

We	O
thank	O
Colin	O
Beechey	O
and	O
Bruce	O
Cattanach	O
for	O
providing	O
information	O
about	O
the	O
origin	O
of	O
deH	O
,	O
Cindy	O
Loomis	O
for	O
communicating	O
unpublished	O
results	O
,	O
and	O
Michael	O
Kuehn	O
for	O
providing	O
Hoxb6	S-PRGE
-	O
Cre	O
transgenic	S-SO
mice	S-LIVB
.	O

We	O
are	O
especially	O
grateful	O
to	O
Hirotake	O
Ono	O
for	O
discussion	O
,	O
to	O
Hermie	O
Manuel	O
and	O
to	O
Carla	O
Kroon	O
-	O
Veenboer	O
for	O
technical	O
help	O
,	O
and	O
to	O
David	O
Kingsley	O
for	O
first	O
drawing	O
our	O
attention	O
to	O
the	O
effects	O
of	O
droopy	B-PRGE
ear	E-PRGE
on	O
pigmentation	O
.	O

SIC	O
is	O
supported	O
by	O
a	O
grant	O
from	O
The	O
Donald	O
E	O
.	O
and	O
Delia	O
B	O
.	O
Baxter	O
Foundation	O
.	O

GSB	O
is	O
an	O
associate	O
investigator	O
of	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
.	O

Abbreviations	O

ae	O
-	O
extreme	O
nonagouti	O
allele	S-SO

AFA	O
-	O
acromegaloid	O
facial	O
appearance	O

at	O
-	O
black	O
-	O
and	O
-	O
tan	O
allele	S-SO

AW	O
-	O
white	O
-	O
bellied	O
Agouti	S-PRGE
allele	S-SO

B6	O
-	O
C57BL	O
/	O
6J	O
mice	S-LIVB

BAC	S-SO
-	O
bacterial	B-SO
artificial	I-SO
chromosome	E-SO

deH	O
-	O
droopy	B-PRGE
ear	E-PRGE
allele	S-SO
that	O
arose	O
in	O
Harwell	O

E10	O
.	O
5	O
-	O
embryonic	O
day	O
10	O
.	O
5	O

En1	S-PRGE
-	O
Engrailed1	S-PRGE

M6pr	S-PRGE
-	O
ps	S-SO
-	O
mannose	B-PRGE
-	I-PRGE
6	I-PRGE
-	I-PRGE
phosphate	I-PRGE
receptor	E-PRGE
pseudogene	S-SO

P4	O
.	O
5	O
-	O
postnatal	O
day	O
4	O
.	O
5	O

Tbx15	S-PRGE
-	O
T	B-PRGE
-	I-PRGE
box	I-PRGE
gene	I-PRGE
15	E-PRGE

Figures	O
and	O
Tables	O

Figure	O
1	O

Dorsoventral	O
Skin	O
Characteristics	O

(	O
A	O
)	O
Skin	O
slices	O
from	O
animals	S-LIVB
of	O
different	O
age	O
and	O
genotype	S-SO
demonstrate	O
similar	O
patterns	O
of	O
hair	O
-	O
length	O
variation	O
along	O
the	O
dorsoventral	O
axis	O
(	O
scale	O
bar	O
=	O
1	O
cm	O
)	O
.	O

(	O
B	O
)	O
Enlarged	O
area	O
from	O
(	O
A	O
)	O
,	O
demonstrating	O
the	O
transition	O
in	O
hair	O
length	O
and	O
color	O
in	O
at	O
/	O
at	O
mice	S-LIVB
(	O
scale	O
bar	O
=	O
0	O
.	O
375	O
cm	O
)	O
.	O

(	O
C	O
)	O
Proportional	O
hair	O
length	O
for	O
(	O
A	O
)	O
plotted	O
as	O
a	O
function	O
of	O
relative	O
position	O
along	O
the	O
dorsoventral	O
axis	O
.	O

(	O
D	O
)	O
Hair	O
length	O
plotted	O
as	O
a	O
function	O
of	O
absolute	O
position	O
along	O
the	O
dorsoventral	O
axis	O
for	O
8	O
-	O
wk	O
-	O
old	O
BA	O
strain	O
mice	S-LIVB
.	O

(	O
E	O
)	O
Proportion	O
of	O
zigzag	O
hairs	O
(	O
+/-	O
SEM	O
)	O
differs	O
slightly	O
between	O
dorsum	O
and	O
ventrum	O
of	O
inbred	O
mice	S-LIVB
(	O
p	O
<	O
0	O
.	O
0001	O
,	O
chi	O
2	O
test	O
,	O
n	O
=	O
1	O
,	O
958	O
,	O
1	O
,	O
477	O
,	O
1	O
,	O
579	O
,	O
1	O
,	O
502	O
)	O
.	O

(	O
F	O
)	O
Differences	O
in	O
dorsal	O
and	O
ventral	O
skin	O
development	O
at	O
P4	O
.	O
5	O
(	O
scale	O
bar	O
=	O
1	O
mm	O
,	O
upper	O
;	O
200	O
mu	O
m	O
,	O
lower	O
)	O
.	O

(	O
G	O
)	O
Differences	O
in	O
hair	O
melanin	S-CHEBI
content	O
and	O
DOPA	S-CHEBI
staining	O
for	O
dorsum	O
(	O
d	O
)	O
,	O
flank	O
(	O
f	O
)	O
,	O
and	O
ventrum	O
(	O
v	O
)	O
in	O
ae	O
/	O
ae	O
and	O
at	O
/	O
at	O
mice	S-LIVB
.	O

The	O
upper	O
panel	O
also	O
demonstrates	O
a	O
cream	O
-	O
colored	O
appearance	O
of	O
the	O
at	O
/	O
at	O
ventrum	O
.	O

The	O
middle	O
panel	O
shows	O
representative	O
awls	O
(	O
scale	O
bar	O
=	O
100	O
mu	O
m	O
)	O
.	O

The	O
lower	O
panel	O
shows	O
DOPA	S-CHEBI
-	O
stained	O
dermis	O
(	O
scale	O
bar	O
=	O
200	O
mu	O
m	O
)	O
.	O

Figure	O
2	O

The	O
deH	O
Pigmentation	O
Phenotype	O

(	O
A	O
)	O
10	O
-	O
wk	O
-	O
old	O
deH	O
/	O
deH	O
and	O
nonmutant	O
animals	S-LIVB
on	O
a	O
at	O
background	O
.	O

A	O
thin	O
stripe	O
of	O
yellow	O
hair	O
normally	O
separates	O
the	O
dorsal	O
black	O
hairs	O
from	O
the	O
ventral	O
cream	O
hairs	O
.	O

In	O
deH	O
,	O
the	O
yellow	O
stripe	O
is	O
extended	O
dorsally	O
,	O
and	O
the	O
boundary	O
between	O
the	O
yellow	O
and	O
the	O
black	O
hairs	O
is	O
fuzzier	O
.	O

(	O
B	O
)	O
Skin	O
slices	O
taken	O
from	O
1	O
.	O
5	O
-	O
mo	O
-	O
old	O
deH	O
/	O
deH	O
and	O
nonmutant	O
littermates	O
(	O
scale	O
bar	O
=	O
0	O
.	O
5	O
cm	O
)	O
.	O

(	O
C	O
)	O
Proportion	O
of	O
total	O
skin	O
area	O
as	O
determined	O
by	O
observation	O
of	O
pelts	O
taken	O
from	O
the	O
interlimb	O
region	O
.	O

The	O
proportion	O
occupied	O
by	O
the	O
yellow	O
lateral	O
compartment	O
(	O
+/-	O
SEM	O
)	O
differs	O
between	O
mutant	S-SO
and	O
nonmutant	O
littermate	O
flanks	O
(	O
p	O
<	O
0	O
.	O
0005	O
,	O
paired	O
t	O
-	O
test	O
,	O
n	O
=	O
6	O
pairs	O
)	O
.	O

There	O
is	O
also	O
(	O
data	O
not	O
shown	O
)	O
a	O
small	O
increase	O
in	O
the	O
proportion	O
of	O
total	O
skin	O
area	O
occupied	O
by	O
the	O
ventral	O
cream	O
-	O
colored	O
compartment	O
,	O
47	O
.	O
9	O
%	O
in	O
mutant	S-SO
compared	O
to	O
37	O
.	O
8	O
%	O
in	O
nonmutant	O
(	O
p	O
<	O
0	O
.	O
005	O
,	O
paired	O
t	O
-	O
test	O
,	O
n	O
=	O
6	O
pairs	O
)	O
.	O

(	O
D	O
)	O
On	O
an	O
ae	O
/	O
ae	O
background	O
,	O
the	O
extent	O
of	O
dorsal	O
skin	O
pigmentation	O
is	O
reduced	O
in	O
deH	O
/	O
deH	O
neonates	O
(	O
P3	O
.	O
5	O
)	O
.	O

(	O
E	O
)	O
Hair	O
length	O
in	O
a	O
representative	O
pair	O
of	O
1	O
.	O
5	O
-	O
mo	O
-	O
old	O
deH	O
/	O
deH	O
and	O
nonmutant	O
littermates	O
,	O
averaged	O
over	O
three	O
skin	O
slices	O
at	O
different	O
rostrocaudal	O
levels	O
,	O
and	O
plotted	O
as	O
a	O
function	O
of	O
the	O
absolute	O
distance	O
from	O
middorsum	O
or	O
the	O
percentage	O
of	O
total	O
slice	O
length	O
.	O

Figure	O
3	O

Molecular	S-CHEBI
Genetics	O
of	O
deH	O
and	O
Tbx15	S-PRGE

(	O
A	O
)	O
Genetic	S-SO
and	O
physical	B-SO
map	E-SO
,	O
as	O
described	O
in	O
the	O
text	O
.	O

Markers	O
M1	O
to	O
M3	O
are	O
SSCP	O
markers	O
generated	O
from	O
a	O
BAC	S-SO
contig	S-SO
of	O
the	O
region	S-SO
;	O
marker	O
M4	O
is	O
STS	S-SO
16	O
.	O
MMHAP32FLF1	O
and	O
was	O
also	O
used	O
as	O
an	O
SSCP	O
marker	O
.	O

M2	O
and	O
M3	O
,	O
which	O
flank	S-SO
the	O
Tbx15	S-PRGE
and	O
M6pr	S-PRGE
-	O
ps	S-SO
on	O
the	O
UCSC	O
genome	S-SO
browser	O
map	S-SO
and	O
lie	O
634	O
kb	O
apart	O
,	O
were	O
nonrecombinant	O
with	O
deH	O
in	O
2340	O
meioses	O
.	O

(	O
B	O
)	O
The	O
deH	O
mutation	S-SO
is	O
a	O
deletion	S-SO
that	O
starts	O
in	O
Tbx15	S-PRGE
intron	S-SO
1	O
and	O
ends	O
in	O
the	O
M6pr	S-PRGE
-	O
ps	S-SO
.	O

(	O
C	O
)	O
Sequence	S-SO
of	O
deletion	B-SO
breakpoints	E-SO
.	O

(	O
D	O
)	O
Diagram	O
of	O
Tbx15LacZ	O
allele	S-SO
constructed	O
by	O
gene	S-SO
targeting	O
.	O

As	O
described	O
in	O
the	O
text	O
,	O
this	O
allele	S-SO
is	O
predicted	O
to	O
give	O
rise	O
to	O
a	O
protein	S-CHEBI
truncated	O
after	O
approximately	O
154	O
codons	S-SO
and	O
is	O
lacking	O
critical	O
residues	S-CHEBI
of	O
the	O
T	O
box	O
.	O

Heterozygotes	O
for	O
the	O
targeted	O
allele	S-SO
exhibit	O
normal	O
size	O
,	O
morphology	O
,	O
and	O
hair	O
-	O
color	O
patterns	O
,	O
but	O
homozygotes	O
and	O
Tbx15LacZ	O
/	O
deH	O
compound	O
heterozygotes	O
are	O
identical	O
to	O
deH	O
homozygotes	O
.	O

Figure	O
4	O

Developmental	O
Expression	O
of	O
Tbx15	S-PRGE

(	O
A	O
)	O
At	O
E12	O
.	O
5	O
,	O
transverse	O
sections	O
at	O
different	O
levels	O
show	O
expression	O
in	O
head	O
mesenchyme	O
(	O
a	O
and	O
b	O
)	O
;	O
myotome	O
,	O
occipital	O
,	O
and	O
periocular	O
mesenchyme	O
(	O
b	O
)	O
;	O
palatal	O
shelf	O
,	O
cervical	O
sclerotome	O
,	O
and	O
nasal	O
cartilage	O
(	O
c	O
)	O
;	O
maxillary	O
and	O
mandibular	O
processes	O
(	O
d	O
)	O
;	O
limbs	O
(	O
e	O
)	O
;	O
and	O
myotome	O
and	O
lateral	O
mesenchyme	O
(	O
e	O
and	O
f	O
)	O
(	O
scale	O
bars	O
=	O
500	O
mu	O
m	O
)	O
.	O

(	O
B	O
)	O
Transverse	O
sections	O
through	O
the	O
flank	O
at	O
different	O
times	O
show	O
expression	O
in	O
lateral	O
mesenchyme	O
(	O
E11	O
.	O
5	O
)	O
,	O
expanding	O
dorsally	O
at	O
E12	O
.	O
5	O
,	O
and	O
both	O
ventrally	O
and	O
dorsally	O
at	O
E13	O
.	O
5	O
,	O
detectable	O
in	O
loose	O
mesenchyme	O
underlying	O
the	O
dermis	O
and	O
the	O
abdominal	O
and	O
subcutaneous	O
muscles	O
(	O
scale	O
bar	O
=	O
500	O
mu	O
m	O
)	O
.	O

At	O
P3	O
.	O
5	O
,	O
Tbx15	S-PRGE
is	O
expressed	O
in	O
the	O
entire	O
dermis	O
and	O
is	O
most	O
strongly	O
expressed	O
in	O
dermal	O
sheaths	O
(	O
scale	O
bar	O
=	O
200	O
mu	O
m	O
)	O
.	O

Figure	O
5	O

Embryonic	O
Expression	O
of	O
Tbx15	S-PRGE
Compared	O
to	O
Agouti	S-PRGE
in	O
at	O
/	O
at	O
Mice	S-LIVB

(	O
A	O
and	O
C	O
)	O
Tbx15	S-PRGE
.	O

(	O
B	O
and	O
D	O
)	O
Agouti	S-PRGE
.	O

At	O
E12	O
.	O
5	O
,	O
expression	O
of	O
Tbx15	S-PRGE
in	O
dorsal	O
skin	O
is	O
approximately	O
complementary	O
to	O
that	O
of	O
Agouti	S-PRGE
in	O
ventral	O
skin	O
.	O

At	O
E14	O
.	O
5	O
,	O
the	O
levels	O
of	O
expression	O
for	O
both	O
genes	S-SO
are	O
lower	O
,	O
but	O
Tbx15	S-PRGE
expression	O
has	O
expanded	O
ventrally	O
and	O
overlaps	O
extensively	O
with	O
that	O
of	O
Agouti	S-PRGE
.	O

In	O
all	O
four	O
panels	O
,	O
arrows	O
mark	O
the	O
approximate	O
ventral	O
limit	O
of	O
Tbx15	S-PRGE
and	O
the	O
approximate	O
dorsal	O
limit	O
of	O
Agouti	S-PRGE
(	O
scale	O
bars	O
=	O
500	O
mu	O
m	O
)	O
.	O

Figure	O
6	O

Effect	O
of	O
deH	O
on	O
Agouti	S-PRGE
Expression	O

Comparable	O
sections	O
from	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
and	O
at	O
/	O
at	O
;	O
+	S-SO
/	O
+	S-SO
littermates	O
.	O

(	O
A	O
)	O
At	O
E14	O
.	O
5	O
,	O
deH	O
/	O
deH	O
embryos	O
have	O
a	O
smaller	O
body	O
cavity	O
and	O
loose	O
skin	O
within	O
which	O
Agouti	S-PRGE
expression	O
appears	O
to	O
be	O
shifted	O
dorsally	O
,	O
as	O
marked	O
by	O
arrows	O
(	O
scale	O
bars	O
=	O
500	O
mu	O
m	O
)	O
.	O

(	O
B	O
)	O
At	O
P4	O
.	O
5	O
,	O
Agouti	S-PRGE
expression	O
in	O
both	O
dorsal	O
and	O
ventral	O
skin	O
is	O
similar	O
in	O
deH	O
/	O
deH	O
compared	O
to	O
nonmutant	O
,	O
but	O
in	O
the	O
midflank	O
region	O
,	O
there	O
is	O
increased	O
Agouti	S-PRGE
expression	O
in	O
deH	O
/	O
deH	O
,	O
especially	O
in	O
the	O
upper	O
dermis	O
(	O
scale	O
bars	O
=	O
200	O
mu	O
m	O
)	O
.	O

Sections	O
shown	O
are	O
representative	O
of	O
two	O
mutant	S-SO
and	O
two	O
nonmutant	O
samples	O
examined	O
at	O
each	O
time	O
.	O

Figure	O
7	O

Embryonic	O
Establishment	O
of	O
Dorsoventral	O
Skin	O
Patterning	O

Pieces	O
of	O
skin	O
from	O
dorsal	O
,	O
flank	O
,	O
and	O
ventral	O
regions	O
of	O
at	O
/	O
a	O
E12	O
.	O
5	O
embryos	O
were	O
transplanted	O
into	O
the	O
testes	O
of	O
congenic	O
animals	S-LIVB
as	O
described	O
in	O
the	O
text	O
.	O

Hair	O
color	O
of	O
the	O
grafts	O
was	O
examined	O
3	O
wk	O
later	O
.	O

Grafts	O
of	O
ventral	O
embryonic	O
skin	O
(	O
n	O
=	O
3	O
)	O
produced	O
yellow	O
hairs	O
,	O
dorsal	O
embryonic	O
skin	O
(	O
n	O
=	O
4	O
)	O
produced	O
black	O
hairs	O
,	O
and	O
flank	O
embryonic	O
skin	O
produced	O
mostly	O
(	O
13	O
out	O
of	O
15	O
)	O
black	O
and	O
yellow	O
hairs	O
in	O
distinct	O
regions	O
as	O
shown	O
.	O

In	O
parallel	O
,	O
in	O
situ	O
hybridization	O
studies	O
revealed	O
that	O
the	O
embryonic	O
flank	O
contains	O
the	O
boundary	O
of	O
expression	O
between	O
Agouti	S-PRGE
and	O
Tbx15	S-PRGE
(	O
scale	O
bars	O
=	O
1	O
mm	O
for	O
hairs	O
and	O
200	O
mu	O
m	O
for	O
in	O
situ	O
hybridization	O
results	O
)	O
.	O

Figure	O
8	O

Comparison	O
of	O
the	O
Dorsoventral	O
at	O
/	O
at	O
Pigmentation	O
Boundary	O
to	O
the	O
Lateral	O
Somitic	O
Frontier	O

(	O
A	O
)	O
Dorsoventral	O
slices	O
of	O
skin	O
from	O
at	O
the	O
midtrunk	O
region	O
prepared	O
such	O
that	O
the	O
dorsal	O
midline	O
lies	O
in	O
the	O
center	O
of	O
the	O
slice	O
.	O

Sections	O
were	O
taken	O
at	O
P1	O
.	O
5	O
(	O
a	O
)	O
or	O
P4	O
.	O
5	O
(	O
b	O
-	O
e	O
)	O
from	O
at	O
/	O
at	O
or	O
R26R	O
/	O
+	S-SO
;	O
Tg	S-SO
.	O
Hoxb6	S-PRGE
-	O
Cre	O
/	O
+	S-SO
mice	S-LIVB
(	O
the	O
latter	O
were	O
stained	O
with	O
X	O
-	O
Gal	O
)	O
,	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

For	O
purposes	O
of	O
comparison	O
,	O
images	O
were	O
proportionally	O
scaled	O
.	O

The	O
boundary	O
of	O
X	O
-	O
Gal	O
staining	O
marks	O
dermis	O
derived	O
from	O
lateral	O
plate	O
versus	O
dermis	O
derived	O
from	O
mesoderm	O
(	O
the	O
lateral	O
somitic	O
frontier	O
)	O
and	O
lies	O
more	O
dorsal	O
than	O
the	O
at	O
/	O
at	O
pigmentation	O
boundary	O
.	O

(	O
B	O
)	O
Quantitation	O
of	O
mean	O
(	O
+/-	O
SEM	O
)	O
dorsal	O
pigmentation	O
area	O
(	O
n	O
=	O
5	O
)	O
and	O
somite	O
-	O
derived	O
dermis	O
area	O
(	O
n	O
=	O
3	O
)	O
shows	O
a	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
005	O
,	O
t	O
-	O
test	O
)	O
.	O

(	O
C	O
)	O
RNA	S-SO
in	O
situ	O
hybridization	O
showing	O
that	O
Tbx15	S-PRGE
expression	O
at	O
E11	O
.	O
5	O
is	O
complementary	O
to	O
En1	S-PRGE
expression	O
on	O
the	O
flank	O
(	O
scale	O
bars	O
=	O
200	O
mu	O
m	O
)	O
.	O

The	O
arrow	O
indicates	O
the	O
boundary	O
between	O
the	O
expression	O
domains	O
of	O
the	O
two	O
genes	S-SO
.	O

Figure	O
9	O

Model	O
for	O
Acquisition	O
of	O
Dorsoventral	O
Patterning	O
in	O
the	O
Trunk	O
and	O
the	O
Role	O
of	O
Tbx15	S-PRGE

(	O
A	O
)	O
A	O
tricolor	O
pigmentation	O
pattern	O
is	O
generated	O
by	O
the	O
combination	O
of	O
distinct	O
mechanisms	O
that	O
affect	O
distribution	O
of	O
Agouti	S-PRGE
mRNA	S-CHEBI
and	O
histochemical	O
staining	O
for	O
melanocytes	S-CL
;	O
effects	O
of	O
the	O
latter	O
mechanism	O
by	O
itself	O
are	O
evident	O
in	O
ae	O
/	O
ae	O
mice	S-LIVB
(	O
see	O
Figure	O
1	O
)	O
.	O

In	O
at	O
/	O
at	O
mice	S-LIVB
,	O
reduced	O
hair	O
melanocyte	S-CL
activity	O
and	O
high	O
levels	O
of	O
Agouti	S-PRGE
mRNA	S-CHEBI
in	O
the	O
ventrum	O
lead	O
to	O
a	O
cream	O
color	O
;	O
as	O
melanocyte	S-CL
activity	O
gradually	O
increases	O
towards	O
the	O
dorsum	O
,	O
a	O
lateral	O
stripe	O
is	O
apparent	O
on	O
the	O
flank	O
.	O

The	O
distributions	O
of	O
Agouti	S-PRGE
mRNA	S-CHEBI
and	O
histochemical	O
staining	O
for	O
melanocytes	S-CL
are	O
both	O
affected	O
by	O
Tbx15	S-PRGE
and	O
are	O
externally	O
evident	O
by	O
a	O
widening	O
of	O
the	O
lateral	O
stripe	O
and	O
an	O
increased	O
proportion	O
of	O
total	O
skin	O
occupied	O
by	O
the	O
cream	O
-	O
colored	O
area	O
.	O

(	O
B	O
)	O
The	O
lateral	O
yellow	O
stripe	O
in	O
at	O
/	O
at	O
mice	S-LIVB
lies	O
at	O
the	O
same	O
level	O
as	O
the	O
limb	O
dorsoventral	O
boundary	O
.	O

As	O
described	O
in	O
the	O
text	O
,	O
we	O
propose	O
that	O
distinct	O
dorsoventral	O
compartments	O
in	O
ectoderm	O
of	O
the	O
trunk	O
provide	O
an	O
instructional	O
cue	O
to	O
the	O
mesoderm	O
,	O
leading	O
to	O
expression	O
of	O
Tbx15	S-PRGE
in	O
dorsal	O
trunk	O
mesenchyme	O
and	O
acquisition	O
of	O
dorsal	O
dermis	O
character	O
.	O

In	O
the	O
absence	O
of	O
Tbx15	S-PRGE
,	O
dorsal	O
mesenchyme	O
assumes	O
ventral	O
characteristics	O
instead	O
.	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

SIC	O
and	O
GSB	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

SIC	O
,	O
CDVR	O
,	O
CC	O
,	O
AR	O
,	O
and	O
SK	O
performed	O
the	O
experiments	O
.	O

SIC	O
,	O
CDVR	O
,	O
CC	O
,	O
SK	O
,	O
and	O
FM	O
analyzed	O
the	O
data	O
.	O

YC	O
and	O
AR	O
contributed	O
reagents	S-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

SIC	O
and	O
GSB	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
Brigid	O
L	O
.	O

M	O
.	O

Hogan	O
,	O
Duke	O
University	O
Medical	O
Center	O

Late	O
gestational	O
lung	O
hypoplasia	O
in	O
a	O
mouse	S-LIVB
model	O
of	O
the	O
Smith	O
-	O
Lemli	O
-	O
Opitz	O
syndrome	O

Abstract	O

Background	O

Normal	O
post	O
-	O
squalene	S-CHEBI
cholesterol	S-CHEBI
biosynthesis	O
is	O
important	O
for	O
mammalian	S-LIVB
embryonic	O
development	O
.	O

Neonatal	O
mice	S-LIVB
lacking	O
functional	O
dehydrocholesterol	B-PRGE
Delta	I-PRGE
7	I-PRGE
-	I-PRGE
reductase	E-PRGE
(	O
Dhcr7	S-PRGE
)	O
,	O
a	O
model	O
for	O
the	O
human	S-LIVB
disease	O
of	O
Smith	O
-	O
Lemli	O
-	O
Opitz	O
syndrome	O
,	O
die	O
within	O
24	O
hours	O
of	O
birth	O
.	O

Although	O
they	O
have	O
a	O
number	O
of	O
biochemical	O
and	O
structural	O
abnormalities	O
,	O
one	O
cause	O
of	O
death	O
is	O
from	O
apparent	O
respiratory	O
failure	O
due	O
to	O
developmental	O
pulmonary	O
abnormalities	O
.	O

Results	O

In	O
this	O
study	O
,	O
we	O
characterized	O
further	O
the	O
role	O
of	O
cholesterol	S-CHEBI
deficiency	O
in	O
lung	O
development	O
of	O
these	O
mice	S-LIVB
.	O

Significant	O
growth	O
retardation	O
,	O
beginning	O
at	O
E14	O
.	O
5	O
~	O
E16	O
.	O
5	O
,	O
was	O
observed	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Normal	O
lobation	O
but	O
smaller	O
lungs	O
with	O
a	O
significant	O
decrease	O
in	O
lung	O
-	O
to	O
-	O
body	O
weight	O
ratio	O
was	O
noted	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
,	O
compared	O
to	O
controls	O
.	O

Lung	O
branching	O
morphogenesis	O
was	O
comparable	O
between	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
controls	O
at	O
early	O
stages	O
,	O
but	O
delayed	O
saccular	O
development	O
was	O
visible	O
in	O
all	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
from	O
E17	O
.	O
5	O
onwards	O
.	O

Impaired	O
pre	O
-	O
alveolar	O
development	O
of	O
varying	O
severity	O
,	O
inhibited	O
cell	S-CL
proliferation	O
,	O
delayed	O
differentiation	O
of	O
type	O
I	O
alveolar	O
epithelial	B-CL
cells	E-CL
(	O
AECs	O
)	O
and	O
delayed	O
vascular	O
development	O
were	O
all	O
evident	O
in	O
knockout	O
lungs	O
.	O

Differentiation	O
of	O
type	O
II	O
AECs	O
was	O
apparently	O
normal	O
as	O
judged	O
by	O
surfactant	S-CHEBI
protein	S-CHEBI
(	O
SP	O
)	O
mRNAs	S-CHEBI
and	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
immunostaining	O
.	O

A	O
significant	O
amount	O
of	O
cholesterol	S-CHEBI
was	O
detectable	O
in	O
knockout	O
lungs	O
,	O
implicating	O
some	O
maternal	O
transfer	O
of	O
cholesterol	S-CHEBI
.	O

No	O
significant	O
differences	O
of	O
the	O
spatial	O
-	O
temporal	O
localization	O
of	O
sonic	B-PRGE
hedgehog	E-PRGE
(	O
Shh	S-PRGE
)	O
or	O
its	O
downstream	O
targets	O
by	O
immunohistochemistry	O
were	O
detected	O
between	O
knockout	O
and	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
and	O
Shh	S-PRGE
autoprocessing	O
occurred	O
normally	O
in	O
tissues	O
from	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Conclusion	O

Our	O
data	O
indicated	O
that	O
cholesterol	S-CHEBI
deficiency	O
caused	O
by	O
Dhcr7	S-PRGE
null	O
was	O
associated	O
with	O
a	O
distinct	O
lung	O
saccular	O
hypoplasia	O
,	O
characterized	O
by	O
failure	O
to	O
terminally	O
differentiate	O
alveolar	O
sacs	O
,	O
a	O
delayed	O
differentiation	O
of	O
type	O
I	O
AECs	O
and	O
an	O
immature	O
vascular	O
network	O
at	O
late	O
gestational	O
stages	O
.	O

The	O
molecular	S-CHEBI
mechanism	O
of	O
impaired	O
lung	O
development	O
associated	O
with	O
sterol	S-CHEBI
deficiency	O
by	O
Dhcr7	S-PRGE
loss	O
is	O
still	O
unknown	O
,	O
but	O
these	O
results	O
do	O
not	O
support	O
the	O
involvement	O
of	O
dysregulated	O
Shh	S-PRGE
-	O
Patched	O
-	O
Gli	O
pathway	O
in	O
causing	O
this	O
defect	O
.	O

Background	O

Cholesterol	S-CHEBI
is	O
a	O
necessary	O
membrane	S-GO
constituent	O
of	O
all	O
mammalian	S-LIVB
,	O
reptile	S-LIVB
and	O
avian	S-LIVB
cells	S-CL
,	O
as	O
well	O
as	O
a	O
few	O
other	O
organisms	S-LIVB
,	O
but	O
not	O
all	O
eukaryotic	B-LIVB
organisms	E-LIVB
.	O

In	O
the	O
latter	O
cases	O
,	O
such	O
as	O
plants	S-LIVB
and	O
fungi	S-LIVB
,	O
cholesterol	S-CHEBI
-	O
like	O
sterols	S-CHEBI
(	O
phytosterols	S-CHEBI
,	O
ergosterol	S-CHEBI
etc	O
.	O
)	O
seem	O
to	O
substitute	O
for	O
cholesterol	S-CHEBI
.	O

The	O
precise	O
need	O
for	O
sterols	S-CHEBI
in	O
biological	B-GO
membranes	E-GO
still	O
remains	O
poorly	O
defined	O
,	O
though	O
its	O
link	O
with	O
microdomains	O
(	O
variously	O
termed	O
rafts	O
,	O
caveoli	S-GO
etc	O
.	O
)	O
may	O
be	O
part	O
of	O
the	O
answer	O
[	O
1	O
]	O
.	O

Although	O
the	O
accumulation	O
of	O
cholesterol	S-CHEBI
in	O
atherosclerotic	O
plaques	O
has	O
led	O
to	O
the	O
concept	O
that	O
'	O
too	O
much	O
'	O
cholesterol	S-CHEBI
may	O
be	O
deleterious	O
,	O
too	O
little	O
cholesterol	S-CHEBI
has	O
now	O
been	O
proven	O
pathophysiological	O
for	O
abnormal	O
embryonic	O
development	O
.	O

Smith	O
-	O
Lemli	O
-	O
Opitz	O
syndrome	O
(	O
SLOS	O
,	O
MIM	O
270400	O
)	O
,	O
a	O
relative	O
common	O
dysmorphology	O
disorder	O
,	O
is	O
caused	O
by	O
mutations	S-SO
in	O
DHCR7	S-PRGE
[	O
2	O
-	O
5	O
]	O
,	O
which	O
encodes	O
for	O
7	B-PRGE
-	I-PRGE
dehydrocholesterol	I-PRGE
Delta	I-PRGE
7	I-PRGE
-	I-PRGE
reductase	E-PRGE
and	O
catalyzes	O
a	O
final	O
step	O
of	O
cholesterol	S-CHEBI
biosynthesis	O
.	O

Recognition	O
of	O
other	O
dysmorphology	O
syndromes	O
caused	O
by	O
defects	O
in	O
the	O
post	O
-	O
squalene	S-CHEBI
cholesterol	S-CHEBI
biosynthesis	O
pathway	O
,	O
such	O
as	O
desmosterolosis	O
,	O
lathosterolosis	O
,	O
X	S-GO
-	O
linked	O
chondrodysplasia	O
punctanta	O
and	O
CHILD	O
syndrome	O
[	O
6	O
-	O
15	O
]	O
,	O
has	O
strengthened	O
this	O
concept	O
.	O

Genetic	S-SO
disruption	O
of	O
the	O
Dhcr7	S-PRGE
results	O
in	O
neonatal	O
lethality	O
[	O
16	O
]	O
.	O

Neonatal	O
mice	S-LIVB
homozygous	O
for	O
the	O
Dhcr7	S-PRGE
gene	S-SO
disruption	O
are	O
deficient	O
in	O
cholesterol	S-CHEBI
and	O
have	O
increased	O
accumulation	O
of	O
the	O
cholesterol	S-CHEBI
precursor	O
7	O
-	O
dehydrocholesterol	O
(	O
7DHC	O
)	O
.	O

Although	O
no	O
embryonic	O
lethality	O
was	O
noted	O
,	O
these	O
knockout	O
pups	O
exhibited	O
a	O
number	O
of	O
developmental	O
abnormalities	O
and	O
died	O
within	O
24	O
h	O
after	O
birth	O
.	O

A	O
similar	O
mouse	S-LIVB
SLOS	O
model	O
,	O
generated	O
by	O
replacing	S-SO
exons	S-SO
3	O
,	O
4	O
and	O
part	B-SO
of	I-SO
exon	E-SO
5	O
of	O
the	O
murine	B-PRGE
Dhcr7	E-PRGE
gene	S-SO
,	O
with	O
similar	O
biochemical	O
and	O
structural	O
defects	O
and	O
a	O
100	O
%	O
neonatal	O
lethality	O
,	O
has	O
also	O
been	O
reported	O
[	O
17	O
]	O
.	O

Poor	O
lung	O
development	O
or	O
diffuse	O
lung	O
alveolar	O
atelectasis	O
with	O
cyanotic	O
and	O
lethargic	O
breathing	O
are	O
consistent	O
between	O
both	O
Dhcr7	S-PRGE
null	O
models	O
[	O
16	O
,	O
17	O
]	O
,	O
and	O
therefore	O
is	O
the	O
likely	O
reason	O
for	O
the	O
respiratory	O
insufficiency	O
and	O
subsequent	O
death	O
of	O
Dhcr7	S-PRGE
-	O
/	O
-	O
pups	O
.	O

These	O
Dhcr7	S-PRGE
knockout	O
mice	S-LIVB
are	O
models	O
for	O
human	S-LIVB
SLOS	O
,	O
especially	O
the	O
more	O
severely	O
affected	O
patients	O
,	O
since	O
early	O
postnatal	O
lethality	O
with	O
respiratory	O
failure	O
has	O
been	O
reported	O
in	O
severe	O
SLOS	O
cases	O
[	O
4	O
,	O
5	O
]	O
.	O

Developmental	O
lung	O
abnormalities	O
are	O
also	O
relatively	O
common	O
in	O
SLOS	O
patients	O
,	O
including	O
pulmonary	O
hypoplasia	O
,	O
abnormal	O
pulmonary	O
lobation	O
and	O
pulmonary	O
arteries	O
,	O
anomalies	O
of	O
laryngeal	O
and	O
tracheal	O
development	O
[	O
18	O
]	O
.	O

Mammalian	S-LIVB
lung	O
is	O
unique	O
in	O
that	O
it	O
is	O
fully	O
developed	O
,	O
but	O
does	O
not	O
function	O
for	O
gas	O
exchange	O
until	O
at	O
the	O
moment	O
of	O
birth	O
;	O
the	O
majority	O
of	O
structural	O
development	O
and	O
maturation	O
takes	O
place	O
in	O
utero	O
.	O

Lung	O
development	O
is	O
a	O
complex	O
process	O
that	O
involves	O
branching	O
morphogenesis	O
of	O
epithelium	O
,	O
interstitial	O
development	O
including	O
vasculogenesis	O
,	O
cellular	S-CL
differentiation	O
,	O
biochemical	O
maturation	O
and	O
physical	O
growth	O
.	O

Four	O
stages	O
of	O
mouse	S-LIVB
lung	O
development	O
have	O
been	O
described	O
,	O
based	O
upon	O
the	O
histological	O
appearances	O
of	O
lung	O
;	O
pseudoglandular	O
,	O
canalicular	O
,	O
terminal	O
saccular	O
and	O
alveolar	O
stages	O
[	O
19	O
]	O
.	O

Impaired	O
hedgehog	O
function	O
has	O
been	O
proposed	O
as	O
a	O
mechanism	O
underlying	O
malformations	O
found	O
in	O
SLOS	O
.	O

Hedgehog	O
family	O
members	O
play	O
diverse	O
roles	O
in	O
embryonic	O
development	O
,	O
and	O
cholesterol	S-CHEBI
is	O
necessary	O
for	O
maturation	O
of	O
these	O
morphogens	O
[	O
20	O
-	O
23	O
]	O
.	O

The	O
sonic	B-PRGE
hedgehog	E-PRGE
(	O
Shh	S-PRGE
)	O
signaling	O
cascade	O
has	O
been	O
shown	O
to	O
play	O
a	O
central	O
role	O
in	O
lung	O
development	O
[	O
24	O
-	O
26	O
]	O
.	O

Loss	O
of	O
Shh	S-PRGE
function	O
resulted	O
in	O
severe	O
lung	O
defects	O
associated	O
with	O
loss	O
of	O
branching	O
morphogenesis	O
,	O
but	O
preserved	O
proximal	O
-	O
to	O
-	O
distal	O
differentiation	O
of	O
lung	O
epithelium	O
[	O
24	O
]	O
.	O

Overexpression	O
of	O
Shh	S-PRGE
in	O
the	O
distal	O
lung	O
epithelium	O
resulted	O
in	O
the	O
absence	O
of	O
functional	O
alveoli	O
and	O
an	O
increase	O
in	O
interstitial	O
tissue	O
caused	O
by	O
an	O
increased	O
proliferation	O
of	O
both	O
epithelial	B-CL
and	I-CL
mesenchyme	I-CL
cells	E-CL
[	O
26	O
]	O
.	O

Mice	S-LIVB
with	O
Shh	S-PRGE
overexpression	O
died	O
less	O
than	O
24	O
h	O
after	O
birth	O
,	O
probably	O
owing	O
to	O
respiratory	O
failure	O
.	O

It	O
has	O
been	O
reported	O
that	O
inhibition	O
of	O
cholesterol	S-CHEBI
biosynthesis	O
by	O
chemical	B-CHEBI
inhibitors	E-CHEBI
of	O
Dhcr7	S-PRGE
also	O
led	O
to	O
a	O
disturbance	O
of	O
the	O
Shh	S-PRGE
signaling	O
with	O
abnormal	O
embryogenesis	O
[	O
27	O
,	O
28	O
]	O
,	O
and	O
severe	O
sterol	S-CHEBI
deprivation	O
can	O
indeed	O
inhibit	O
the	O
processing	O
of	O
transfected	O
Shh	S-PRGE
in	O
cultured	O
mammalian	S-LIVB
cells	S-CL
[	O
29	O
]	O
.	O

In	O
the	O
present	O
studies	O
,	O
we	O
characterized	O
lung	O
development	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
from	O
E10	O
.	O
5	O
to	O
birth	O
.	O

Our	O
results	O
showed	O
that	O
cholesterol	S-CHEBI
deficiency	O
,	O
caused	O
by	O
loss	O
of	O
Dhcr7	S-PRGE
activity	O
,	O
did	O
not	O
alter	O
lung	O
branching	O
morphogenesis	O
(	O
early	O
gestational	O
stages	O
,	O
E9	O
.	O
5	O
to	O
E14	O
.	O
5	O
)	O
.	O

However	O
,	O
lung	O
saccular	O
development	O
was	O
impaired	O
,	O
with	O
arrested	O
or	O
partially	O
developed	O
epithelial	O
tubules	O
and	O
delayed	O
vascular	O
development	O
.	O

Differentiation	O
of	O
type	O
II	O
alveolar	O
epithelial	B-CL
cells	E-CL
(	O
AECs	O
)	O
appeared	O
normal	O
but	O
differentiation	O
of	O
type	O
I	O
AECs	O
was	O
severely	O
impaired	O
.	O

Therefore	O
,	O
cholesterol	S-CHEBI
deficiency	O
resulted	O
in	O
a	O
distinct	O
late	O
gestational	O
lung	O
hypoplasia	O
,	O
characterized	O
by	O
impaired	O
sacculation	O
with	O
delayed	O
type	O
I	O
AECs	O
differentiation	O
and	O
immature	O
vascular	O
development	O
.	O

However	O
,	O
this	O
study	O
does	O
not	O
support	O
the	O
concept	O
that	O
the	O
perturbation	O
of	O
Shh	S-PRGE
-	O
Patched	O
-	O
Gli	O
pathway	O
was	O
involved	O
in	O
the	O
pathogenesis	O
of	O
developmental	O
lung	O
hypoplasia	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Patterns	O
of	O
expression	O
of	O
Shh	S-PRGE
signaling	O
cascade	O
members	O
were	O
not	O
altered	O
,	O
and	O
processing	O
of	O
Shh	S-PRGE
appeared	O
normal	O
.	O

Results	O

Body	O
growth	O
retardation	O
at	O
late	O
gestation	O
stage	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O

Dhcr7	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
were	O
born	O
in	O
the	O
expected	O
Mendelian	O
ratios	O
from	O
heterozygous	O
parents	O
,	O
but	O
all	O
of	O
these	O
pups	O
died	O
within	O
24	O
h	O
and	O
most	O
within	O
14	O
h	O
of	O
birth	O
[	O
16	O
]	O
.	O

At	O
birth	O
,	O
they	O
were	O
clearly	O
smaller	O
than	O
wild	B-SO
-	I-SO
type	E-SO
or	O
heterozygous	O
littermates	O
.	O

An	O
experienced	O
investigator	O
can	O
pick	O
out	O
knockout	O
pups	O
based	O
on	O
this	O
along	O
with	O
presence	O
of	O
hypoxia	O
and	O
their	O
lack	O
of	O
spontaneous	O
movement	O
.	O

The	O
breathing	O
frequency	O
in	O
P0	O
Dhcr7	S-PRGE
-	O
/	O
-	O
pups	O
was	O
markedly	O
slower	O
than	O
control	O
littermates	O
(	O
34	O
+/-	O
7	O
breaths	O
/	O
min	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
,	O
n	O
=	O
10	O
vs	O
.	O
92	O
+/-	O
16	O
breaths	O
/	O
min	O
in	O
controls	O
,	O
n	O
=	O
32	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
breathing	O
was	O
observed	O
to	O
be	O
more	O
irregular	O
and	O
shallow	O
,	O
with	O
long	O
periods	O
of	O
apnea	O
.	O

To	O
determine	O
the	O
gestational	O
stage	O
at	O
which	O
growth	O
of	O
the	O
knockout	O
embryos	O
was	O
affected	O
,	O
embryos	O
were	O
harvested	O
at	O
various	O
stages	O
of	O
gestation	O
and	O
their	O
body	O
lengths	O
compared	O
between	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
controls	O
.	O

A	O
linear	O
increase	O
in	O
body	O
length	O
from	O
E9	O
.	O
5	O
to	O
E19	O
.	O
5	O
in	O
control	O
embryos	O
was	O
observed	O
(	O
Fig	O
.	O
1	O
)	O
.	O

No	O
significant	O
differences	O
in	O
body	O
length	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
heterozygous	O
embryos	O
were	O
noted	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
,	O
knockout	O
embryos	O
showed	O
comparable	O
body	O
length	O
growth	O
until	O
E14	O
.	O
5	O
~	O
E16	O
.	O
5	O
,	O
then	O
began	O
to	O
show	O
a	O
slower	O
increase	O
in	O
length	O
,	O
such	O
that	O
by	O
E17	O
.	O
5	O
,	O
this	O
was	O
statistically	O
significant	O
(	O
18	O
.	O
87	O
+/-	O
1	O
.	O
29	O
mm	O
in	O
controls	O
,	O
n	O
=	O
15	O
compared	O
to	O
16	O
.	O
69	O
+/-	O
1	O
.	O
05	O
mm	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
,	O
n	O
=	O
7	O
,	O
p	O
<	O
0	O
.	O
05	O
,	O
Fig	O
.	O
1	O
)	O
.	O

Figure	O
1	O

Body	O
length	O
growth	O
curves	O
.	O

Body	O
length	O
growth	O
vs	O
.	O
gestational	O
days	O
is	O
as	O
shown	O
.	O

Control	O
embryos	O
(	O
filled	O
triangles	O
,	O
wild	B-SO
-	I-SO
type	E-SO
and	O
heterozygous	O
embryos	O
were	O
pooled	O
together	O
as	O
there	O
were	O
no	O
differences	O
between	O
these	O
two	O
groups	O
)	O
and	O
knockout	O
embryos	O
(	O
filled	O
circles	O
)	O
were	O
as	O
shown	O
.	O

The	O
growth	O
curve	O
showed	O
a	O
linear	O
increase	O
from	O
E9	O
.	O
5	O
to	O
E19	O
.	O
5	O
in	O
controls	O
,	O
but	O
deviated	O
at	O
~	O
E14	O
.	O
5	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Body	O
lengths	O
at	O
E17	O
.	O
5	O
(	O
18	O
.	O
87	O
+/-	O
1	O
.	O
29	O
mm	O
in	O
controls	O
,	O
n	O
=	O
15	O
vs	O
.	O
16	O
.	O
69	O
+/-	O
1	O
.	O
05	O
mm	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
,	O
n	O
=	O
7	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
E18	O
.	O
5	O
(	O
21	O
.	O
35	O
+/-	O
1	O
.	O
05	O
mm	O
in	O
controls	O
,	O
n	O
=	O
15	O
vs	O
.	O
19	O
.	O
38	O
+/-	O
0	O
.	O
9	O
mm	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
,	O
n	O
=	O
5	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
E19	O
.	O
5	O
(	O
23	O
.	O
4	O
+/-	O
0	O
.	O
97	O
mm	O
in	O
controls	O
,	O
n	O
=	O
13	O
vs	O
.	O
20	O
.	O
3	O
+/-	O
0	O
.	O
44	O
mm	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
,	O
n	O
=	O
4	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
were	O
significantly	O
decreased	O
,	O
compared	O
to	O
those	O
in	O
controls	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
+/-	O
s	O
.	O
d	O
.	O

Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
at	O
late	O
stages	O
displayed	O
pulmonary	O
hypoplasia	O
with	O
delayed	O
saccular	O
development	O

Wet	O
lung	O
weights	O
,	O
as	O
well	O
as	O
lung	O
to	O
body	O
weight	O
ratios	O
were	O
significantly	O
lower	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
at	O
E18	O
.	O
5	O
compared	O
to	O
those	O
in	O
wild	B-SO
-	I-SO
type	E-SO
but	O
not	O
at	O
E13	O
.	O
5	O
(	O
Table	O
1	O
)	O
.	O

Both	O
body	O
and	O
lung	O
weights	O
were	O
reduced	O
,	O
but	O
lungs	O
seemed	O
to	O
be	O
more	O
affected	O
.	O

A	O
representative	O
figure	O
of	O
embryos	O
at	O
E10	O
.	O
5	O
and	O
of	O
the	O
pups	O
at	O
birth	O
was	O
shown	O
in	O
Fig	O
.	O

2A	O
and	O
2B	O
.	O

Table	O
1	O

Whole	O
body	O
and	O
lung	O
weights	O
of	O
mouse	S-LIVB
embryos	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
compared	O
to	O
Dhcr7	S-PRGE
+	S-SO
/	O
+	S-SO
.	O

BW	O
,	O
body	O
weight	O
;	O
LW	O
,	O
lung	O
weight	O
.	O

Figure	O
2	O

Embryonic	O
size	O
,	O
lung	O
morphology	O
and	O
histology	O
at	O
various	O
stages	O
of	O
development	O
.	O

Panel	O
A	O
shows	O
the	O
size	O
and	O
general	O
morphology	O
of	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
Dhcr7	S-PRGE
-	O
/	O
-	O
(	O
-	O
/	O
-	O
)	O
embryos	O
at	O
E10	O
.	O
5	O
,	O
without	O
significant	O
difference	O
.	O

At	O
P0	O
,	O
the	O
knockout	O
pups	O
were	O
significantly	O
smaller	O
and	O
appeared	O
hypoxic	O
(	O
panel	O
B	O
)	O
.	O

Panel	O
C	O
shows	O
dorsal	O
views	O
of	O
lungs	O
from	O
knockout	O
and	O
wild	B-SO
-	I-SO
type	E-SO
at	O
E13	O
.	O
5	O
and	O
panel	O
D	O
those	O
at	O
P0	O
.	O

Cross	O
-	O
sectional	O
examination	O
at	O
the	O
cardiopulmonary	O
level	O
at	O
E	O
20	O
.	O
5	O
(	O
prior	O
to	O
birth	O
)	O
showed	O
normal	O
lobar	O
septation	O
,	O
but	O
lungs	O
from	O
knockout	O
animals	S-LIVB
were	O
smaller	O
in	O
size	O
and	O
had	O
less	O
distal	O
sac	O
space	O
(	O
cf	O
.	O
panels	O
E	O
and	O
F	O
)	O
.	O

Original	O
magnification	O
:	O
Panels	O
A	O
and	O
C	O
,	O
2X	O
;	O
panels	O
B	O
and	O
D	O
,	O
0	O
.	O
7X	O
;	O
E	O
and	O
F	O
,	O
2X	O
.	O

Labels	O
:	O
r	O
,	O
right	O
;	O
l	O
,	O
left	O
;	O
b	O
,	O
bronchial	O
;	O
br	O
,	O
bronchiole	O
;	O
e	O
,	O
esophagus	O
;	O
pa	O
,	O
pulmonary	O
artery	O
;	O
ra	O
,	O
right	O
atrium	O
;	O
la	O
,	O
left	O
atrium	O
;	O
rv	O
,	O
right	O
ventricle	O
;	O
lv	O
,	O
left	O
ventricle	O
.	O

We	O
examined	O
the	O
lungs	O
for	O
any	O
gross	O
morphological	O
abnormalities	O
.	O

The	O
overall	O
organogenesis	O
of	O
lungs	O
was	O
preserved	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
pups	O
;	O
four	O
right	O
lung	O
lobes	O
and	O
a	O
single	O
left	O
lobe	O
flanking	O
the	O
heart	O
were	O
easily	O
seen	O
on	O
external	O
examination	O
at	O
birth	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

Examination	O
for	O
lobation	O
at	O
E13	O
.	O
5	O
also	O
showed	O
comparable	O
gross	O
anatomy	O
(	O
Fig	O
.	O
2C	O
)	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
embryos	O
.	O

Histological	O
analyses	O
of	O
the	O
cardiopulmonary	O
structures	O
at	O
E20	O
.	O
5	O
,	O
taken	O
just	O
before	O
birth	O
to	O
avoid	O
artifacts	O
from	O
lack	O
of	O
lung	O
inflation	O
,	O
also	O
confirmed	O
normal	O
gross	O
anatomic	O
development	O
(	O
Fig	O
.	O
2E	O
and	O
2F	O
)	O
.	O

Additionally	O
,	O
no	O
cardiac	O
defects	O
were	O
identified	O
and	O
this	O
was	O
confirmed	O
by	O
more	O
detailed	O
histological	O
analyses	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
despite	O
the	O
obvious	O
hypoxia	O
frequently	O
observed	O
at	O
birth	O
of	O
the	O
knockout	O
pups	O
,	O
major	O
cardiac	O
structural	O
abnormalities	O
were	O
not	O
observed	O
to	O
account	O
for	O
this	O
phenotype	O
.	O

No	O
distinguishable	O
morphological	O
differences	O
were	O
discernable	O
between	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
at	O
E10	O
.	O
5	O
,	O
E13	O
.	O
5	O
,	O
E14	O
.	O
5	O
and	O
E16	O
.	O
5	O
at	O
low	O
(	O
10X	O
)	O
or	O
high	O
(	O
40X	O
)	O
magnifications	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
a	O
-	O
h	O
,	O
data	O
for	O
E10	O
.	O
5	O
and	O
E13	O
.	O
5	O
not	O
shown	O
)	O
.	O

However	O
,	O
from	O
E17	O
.	O
5	O
onwards	O
,	O
lungs	O
from	O
knockout	O
embryos	O
appeared	O
to	O
have	O
less	O
saccular	O
space	O
and	O
relatively	O
more	O
mesenchyme	O
compared	O
to	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
I	O
-	O
x	O
)	O
.	O

Lungs	O
from	O
control	O
animals	S-LIVB
showed	O
normal	O
progression	O
with	O
formation	O
of	O
sac	O
-	O
like	O
structures	O
,	O
the	O
precursors	O
of	O
the	O
alveoli	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
i	O
,	O
m	O
,	O
q	O
and	O
u	O
)	O
.	O

In	O
lungs	O
from	O
knockout	O
embryos	O
,	O
expansion	O
of	O
epithelial	O
tubules	O
occurred	O
but	O
was	O
significantly	O
delayed	O
(	O
Fig	O
.	O
3	O
,	O
cf	O
.	O
panel	O
A	O
:	O
j	O
,	O
n	O
,	O
r	O
,	O
v	O
with	O
i	O
,	O
m	O
,	O
q	O
and	O
u	O
)	O
.	O

Morphometric	O
measurements	O
of	O
lung	O
sections	O
at	O
E17	O
.	O
5	O
,	O
E18	O
.	O
5	O
,	O
E20	O
.	O
5	O
and	O
in	O
lungs	O
from	O
neonates	O
showed	O
that	O
the	O
proportion	O
of	O
terminal	O
sac	O
space	O
area	O
was	O
significantly	O
decreased	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
,	O
compared	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
B	O
)	O
.	O

Interstitial	O
mesenchyme	O
appeared	O
thicker	O
and	O
the	O
lungs	O
had	O
less	O
septation	O
compared	O
to	O
control	O
lungs	O
.	O

This	O
'	O
thickening	O
'	O
of	O
the	O
alveoli	O
may	O
explain	O
the	O
hypoxia	O
frequently	O
seen	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
pups	O
at	O
birth	O
.	O

Figure	O
3	O

Histological	O
analyses	O
of	O
lungs	O
at	O
various	O
embryonic	O
stages	O
.	O

Panel	O
A	O
indicates	O
lung	O
sections	O
stained	O
with	O
H	O
and	O
E	O
,	O
and	O
taken	O
at	O
various	O
gestational	O
stages	O
as	O
indicated	O
.	O

The	O
first	O
two	O
columns	O
are	O
at	O
lower	O
magnification	O
(	O
10X	O
)	O
and	O
the	O
last	O
two	O
columns	O
at	O
higher	O
magnification	O
(	O
40X	O
)	O
.	O

The	O
first	O
and	O
third	O
columns	O
are	O
representative	O
sections	O
from	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
embryos	O
and	O
the	O
second	O
and	O
fourth	O
columns	O
from	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

No	O
differences	O
were	O
visible	O
at	O
E14	O
.	O
5	O
or	O
E16	O
.	O
5	O
(	O
panel	O
A	O
,	O
a	O
-	O
h	O
)	O
.	O

Significant	O
differences	O
were	O
visible	O
from	O
E17	O
.	O
5	O
onwards	O
(	O
panel	O
A	O
,	O
i	O
-	O
x	O
)	O
.	O

Distal	O
tubules	O
showed	O
dilation	O
and	O
mesenchyme	O
thinning	O
,	O
with	O
progression	O
of	O
septation	O
in	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
(	O
panel	O
A	O
,	O
i	O
,	O
m	O
and	O
q	O
)	O
,	O
whereas	O
the	O
knockout	O
lungs	O
showed	O
less	O
saccular	O
structures	O
and	O
more	O
mesenchyme	O
(	O
panel	O
A	O
,	O
j	O
,	O
n	O
and	O
r	O
)	O
.	O

At	O
higher	O
magnifications	O
of	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
(	O
panel	O
A	O
,	O
k	O
,	O
o	O
and	O
s	O
)	O
,	O
developing	O
pre	O
-	O
alveoli	O
and	O
thinning	O
mesenchyme	O
(	O
arrowheads	O
)	O
were	O
seen	O
but	O
sections	O
from	O
knockout	O
embryos	O
showed	O
a	O
delay	O
in	O
this	O
sequence	O
of	O
development	O
(	O
panel	O
A	O
,	O
l	O
,	O
p	O
and	O
t	O
)	O
.	O

At	O
birth	O
,	O
lungs	O
from	O
knockout	O
pups	O
showed	O
deficient	O
septation	O
and	O
thick	O
-	O
walled	O
mesenchyme	O
(	O
panel	O
A	O
,	O
x	O
,	O
arrowheads	O
)	O
.	O

Labels	O
:	O
de	O
,	O
distal	O
epithelium	O
;	O
m	O
,	O
mesenchyme	O
;	O
PA	O
,	O
pulmonary	O
artery	O
;	O
a	O
,	O
pre	O
-	O
alveoli	O
;	O
b	O
,	O
bronchi	O
.	O

Panel	O
B	O
shows	O
the	O
morphometric	O
analyses	O
of	O
lung	O
terminal	O
sac	O
spaces	O
in	O
lungs	O
at	O
various	O
gestational	O
stages	O
.	O

A	O
significant	O
reduction	O
in	O
the	O
terminal	O
sac	O
space	O
was	O
noted	O
from	O
E17	O
.	O
5	O
onwards	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
+/-	O
s	O
.	O
d	O
.	O

Attenuated	O
cell	S-CL
proliferation	O
in	O
late	O
gestational	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O

Does	O
the	O
loss	O
of	O
normal	O
cholesterol	S-CHEBI
biosynthesis	O
lead	O
to	O
abnormalities	O
of	O
cell	S-CL
proliferation	O
/	O
division	O
or	O
cell	S-CL
death	O
?	O

Cell	S-CL
proliferation	O
was	O
examined	O
by	O
immunostaining	O
for	O
PCNA	S-PRGE
and	O
also	O
by	O
BrdU	O
incorporation	S-SO
.	O

Both	O
PCNA	S-PRGE
and	O
BrdU	O
staining	O
of	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
lungs	O
at	O
early	O
gestational	O
stages	O
(	O
E13	O
.	O
5	O
and	O
E14	O
.	O
5	O
)	O
showed	O
comparable	O
patterns	O
(	O
Fig	O
.	O
4	O
,	O
panels	O
A	O
-	O
D	O
)	O
.	O

However	O
,	O
a	O
clear	O
reduction	O
of	O
PCNA	S-PRGE
and	O
BrdU	O
labeling	O
was	O
visualized	O
in	O
distal	O
lungs	O
of	O
knockout	O
embryos	O
at	O
late	O
gestational	O
stages	O
(	O
E18	O
.	O
5	O
and	O
E20	O
.	O
5	O
,	O
Fig	O
.	O
4	O
,	O
panels	O
E	O
-	O
H	O
)	O
.	O

Attenuated	O
PCNA	S-PRGE
labeling	O
was	O
also	O
noted	O
in	O
knockout	O
hearts	O
at	O
term	O
(	O
Fig	O
.	O
4	O
,	O
cf	O
.	O
panels	O
I	O
and	O
J	O
)	O
.	O

When	O
lungs	O
were	O
stained	O
for	O
pHH3	O
,	O
a	O
marker	O
of	O
active	O
cell	S-CL
division	O
,	O
a	O
clear	O
reduction	O
of	O
pHH3	O
expression	O
in	O
the	O
epithelium	O
of	O
knockout	O
lung	O
was	O
observed	O
at	O
E20	O
.	O
5	O
but	O
not	O
at	O
E14	O
.	O
5	O
(	O
Fig	O
.	O
4	O
,	O
panels	O
K	O
,	O
L	O
,	O
O	O
and	O
P	O
)	O
.	O

In	O
contrast	O
,	O
using	O
the	O
TUNEL	O
assay	O
,	O
no	O
apparent	O
differences	O
in	O
cell	S-CL
apoptosis	O
rates	O
were	O
observed	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
lungs	O
at	O
E18	O
.	O
5	O
(	O
Fig	O
.	O
4	O
,	O
cf	O
.	O
panels	O
M	O
and	O
N	O
)	O
.	O

Thus	O
,	O
at	O
the	O
late	O
gestational	O
stages	O
,	O
cell	S-CL
proliferation	O
/	O
division	O
was	O
impaired	O
in	O
knockout	O
embryos	O
with	O
no	O
increase	O
in	O
cell	S-CL
death	O
rates	O
.	O

Figure	O
4	O

Analyses	O
of	O
cell	S-CL
proliferation	O
,	O
cell	S-CL
division	O
and	O
cell	S-CL
death	O
.	O

Cell	S-CL
proliferation	O
(	O
PCNA	S-PRGE
:	O
panels	O
A	O
,	O
B	O
,	O
E	O
and	O
F	O
;	O
BrdU	O
:	O
panels	O
C	O
,	O
D	O
,	O
G	O
and	O
H	O
)	O
,	O
cell	S-CL
division	O
(	O
pHH3	O
:	O
panels	O
K	O
,	O
L	O
,	O
O	O
and	O
P	O
)	O
and	O
cell	S-CL
death	O
(	O
TUNEL	O
:	O
panels	O
M	O
and	O
N	O
)	O
were	O
analyzed	O
by	O
immunostaining	O
on	O
lung	O
sections	O
at	O
early	O
and	O
late	O
gestational	O
stages	O
.	O

Both	O
PCNA	S-PRGE
and	O
BrdU	O
labeled	O
cells	B-CL
in	I-CL
both	I-CL
epithelial	I-CL
and	I-CL
mesenchymal	I-CL
regions	E-CL
were	O
comparable	O
at	O
early	O
stages	O
(	O
E14	O
.	O
5	O
for	O
PCNA	S-PRGE
and	O
E13	O
.	O
5	O
for	O
BrdU	O
)	O
between	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
lungs	O
.	O

Positively	O
stained	O
cells	S-CL
in	O
distal	O
lungs	O
at	O
late	O
stage	O
(	O
E20	O
.	O
5	O
for	O
PCNA	S-PRGE
and	O
E18	O
.	O
5	O
for	O
BrdU	O
)	O
from	O
knockout	O
lungs	O
were	O
markedly	O
reduced	O
,	O
compared	O
with	O
wild	B-SO
-	I-SO
type	E-SO
.	O

PCNA	S-PRGE
labeling	O
of	O
cardiac	O
muscle	O
was	O
also	O
attenuated	O
in	O
knockout	O
embryos	O
at	O
E20	O
.	O
5	O
(	O
cf	O
.	O
panels	O
I	O
and	O
J	O
)	O
.	O

No	O
apparent	O
differences	O
in	O
TUNEL	O
immunostaining	O
were	O
observed	O
in	O
lung	O
sections	O
at	O
E18	O
.	O
5	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
.	O

The	O
pHH3	O
immunostaining	O
was	O
comparable	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
lungs	O
at	O
E14	O
.	O
5	O
,	O
and	O
the	O
lungs	O
from	O
wild	B-SO
-	I-SO
type	E-SO
at	O
E20	O
.	O
5	O
showed	O
a	O
high	O
index	O
of	O
positive	O
cells	S-CL
,	O
whereas	O
lungs	O
from	O
knockout	O
showed	O
a	O
apparent	O
reduced	O
staining	O
pattern	O
.	O

Note	O
the	O
dividing	O
cells	S-CL
are	O
mainly	O
epithelial	O
.	O

Original	O
magnification	O
:	O
A	O
-	O
D	O
and	O
G	O
-	O
N	O
are	O
20X	O
;	O
E	O
,	O
F	O
,	O
O	O
and	O
P	O
are	O
40X	O
.	O

Sterol	S-CHEBI
content	O
of	O
developing	O
lungs	O
in	O
Dhcr7	S-PRGE
deficient	O
mice	O

Markedly	O
elevated	O
7	O
-	O
DHC	O
/	O
8	O
-	O
DHC	O
levels	O
and	O
reduced	O
body	O
cholesterol	S-CHEBI
levels	O
have	O
been	O
reported	O
previously	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
P0	O
mice	S-LIVB
[	O
16	O
,	O
17	O
]	O
.	O

A	O
significant	O
amount	O
of	O
cholesterol	S-CHEBI
was	O
detectable	O
in	O
lungs	O
of	O
Dhcr7	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
,	O
comprising	O
~	O
60	O
%	O
and	O
~	O
30	O
%	O
of	O
total	O
tissue	O
sterols	S-CHEBI
at	O
E13	O
.	O
5	O
and	O
neonate	O
,	O
respectively	O
.	O

In	O
contrast	O
to	O
the	O
doubling	O
of	O
cholesterol	S-CHEBI
in	O
the	O
lungs	O
of	O
wild	B-SO
type	E-SO
embryos	O
(	O
1	O
.	O
82	O
mg	O
/	O
g	O
tissue	O
at	O
E13	O
.	O
5	O
to	O
3	O
.	O
55	O
mg	O
/	O
g	O
tissue	O
at	O
P0	O
)	O
,	O
cholesterol	S-CHEBI
content	O
in	O
the	O
lungs	O
of	O
Dhcr7	S-PRGE
null	O
embryos	O
remained	O
at	O
almost	O
constant	O
low	O
levels	O
between	O
E13	O
.	O
5	O
and	O
P0	O
gestational	O
stages	O
(	O
Fig	O
.	O
5	O
)	O
.	O

There	O
was	O
a	O
progressive	O
increase	O
in	O
7	O
-	O
DHC	O
and	O
8	O
-	O
DHC	O
;	O
the	O
latter	O
is	O
generated	O
as	O
a	O
spontaneous	O
isomerization	O
from	O
the	O
former	O
.	O

Total	O
sterols	S-CHEBI
at	O
birth	O
were	O
reduced	O
in	O
lungs	O
of	O
the	O
Dhcr7	S-PRGE
null	O
mice	S-LIVB
,	O
but	O
were	O
only	O
lower	O
by	O
~	O
30	O
%	O
(	O
Fig	O
.	O
5	O
,	O
see	O
values	O
for	O
P0	O
mice	S-LIVB
)	O
.	O

Figure	O
5	O

Sterol	S-CHEBI
analyses	O
of	O
embryonic	O
lungs	O
.	O

Sterol	S-CHEBI
contents	O
,	O
including	O
cholesterol	S-CHEBI
(	O
black	O
bars	O
)	O
and	O
7DHC	O
/	O
8DHC	O
(	O
white	O
bars	O
)	O
,	O
were	O
quantitated	O
by	O
GC	O
-	O
MS	O
in	O
the	O
lungs	O
from	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
+/-	O
s	O
.	O
d	O
and	O
the	O
number	O
of	O
lungs	O
analyzed	O
is	O
as	O
indicated	O
.	O

Total	O
sterols	S-CHEBI
were	O
lower	O
at	O
all	O
stages	O
in	O
knockout	O
lungs	O
,	O
with	O
almost	O
no	O
increase	O
in	O
cholesterol	S-CHEBI
content	O
with	O
time	O
(	O
black	O
bars	O
)	O
,	O
but	O
there	O
was	O
a	O
progressive	O
increment	O
in	O
the	O
precursor	O
sterols	S-CHEBI
,	O
7DHC	O
/	O
8DHC	O
(	O
open	O
bars	O
)	O
,	O
with	O
increasing	O
gestation	O
.	O

Cholesterol	S-CHEBI
is	O
absolutely	O
required	O
for	O
steroid	B-CHEBI
hormone	E-CHEBI
synthesis	O
by	O
the	O
adrenal	O
glands	O
.	O

Adrenal	O
insufficiency	O
,	O
as	O
has	O
been	O
reported	O
in	O
some	O
severe	O
cases	O
of	O
SLOS	O
patients	O
,	O
could	O
be	O
responsible	O
for	O
the	O
lung	O
hypoplasia	O
and	O
perinatal	O
lethality	O
[	O
30	O
]	O
.	O

Steroids	S-CHEBI
,	O
but	O
particularly	O
corticosteroids	S-CHEBI
,	O
are	O
necessary	O
for	O
lung	O
maturation	O
,	O
especially	O
the	O
synthesis	O
and	O
secretion	O
of	O
surfactant	S-CHEBI
components	O
[	O
31	O
]	O
.	O

We	O
determined	O
plasma	O
corticosterone	S-CHEBI
levels	O
in	O
P0	O
mice	S-LIVB
within	O
12	O
h	O
of	O
birth	O
.	O

Wild	B-SO
type	E-SO
P0	O
mice	S-LIVB
had	O
corticosterone	S-CHEBI
levels	O
of	O
158	O
+/-	O
50	O
ng	O
/	O
ml	O
(	O
n	O
=	O
11	O
)	O
,	O
compared	O
with	O
225	O
+/-	O
50	O
ng	O
/	O
ml	O
(	O
n	O
=	O
7	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
P0	O
mice	S-LIVB
.	O

Thus	O
,	O
the	O
corticosterone	S-CHEBI
levels	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
were	O
not	O
decreased	O
,	O
but	O
increased	O
by	O
~	O
40	O
%	O
.	O

However	O
,	O
since	O
these	O
P0	O
mice	S-LIVB
were	O
dying	O
,	O
perhaps	O
this	O
increase	O
was	O
sub	O
-	O
optimal	O
given	O
the	O
stress	O
.	O

Nevertheless	O
,	O
an	O
absolute	O
lack	O
of	O
corticosterone	S-CHEBI
was	O
not	O
present	O
in	O
these	O
knockout	O
pups	O
.	O

To	O
further	O
rule	O
out	O
any	O
effects	O
of	O
corticosterone	S-CHEBI
deficiency	O
on	O
lung	O
immaturity	O
,	O
we	O
examined	O
lungs	O
for	O
surfactant	S-CHEBI
protein	S-CHEBI
expression	O
.	O

Surfactant	B-PRGE
protein	I-PRGE
C	E-PRGE
,	O
as	O
determined	O
by	O
IHC	O
,	O
was	O
comparable	O
in	O
lung	O
sections	O
from	O
wild	B-SO
-	I-SO
type	E-SO
or	O
Dhcr7	S-PRGE
null	O
embryos	O
at	O
either	O
E18	O
.	O
5	O
or	O
at	O
E20	O
.	O
5	O
gestational	O
ages	O
(	O
Fig	O
.	O
6	O
,	O
panel	O
A	O
)	O
.	O

Northern	O
analyses	O
for	O
SP	B-PRGE
-	I-PRGE
A	E-PRGE
,	O
SP	B-PRGE
-	I-PRGE
B	E-PRGE
,	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
or	O
SP	B-PRGE
-	I-PRGE
D	E-PRGE
showed	O
no	O
significantly	O
differences	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
Dhcr7	S-PRGE
null	O
mice	S-LIVB
at	O
term	O
(	O
Fig	O
.	O
6	O
,	O
panel	O
B	O
)	O
.	O

Thus	O
,	O
surfactant	S-CHEBI
protein	S-CHEBI
expression	O
was	O
not	O
altered	O
by	O
Dhcr7	S-PRGE
deficiency	O
.	O

Figure	O
6	O

Surfactant	S-CHEBI
protein	S-CHEBI
expression	O
in	O
lungs	O
.	O

Panel	O
A	O
shows	O
the	O
immunostaining	O
patterns	O
for	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
in	O
lungs	O
at	O
E18	O
.	O
5	O
and	O
E20	O
.	O
5	O
from	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

No	O
significant	O
differences	O
in	O
the	O
patterns	O
of	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
staining	O
were	O
evident	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
lungs	O
(	O
panel	O
A	O
,	O
a	O
-	O
d	O
)	O
.	O

Note	O
that	O
the	O
underdeveloped	O
epithelial	O
tubules	O
in	O
knockout	O
lungs	O
also	O
expressed	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
(	O
panel	O
A	O
,	O
b	O
and	O
d	O
,	O
arrowheads	O
)	O
,	O
indicating	O
normal	O
type	O
II	O
AECs	O
differentiation	O
.	O

Original	O
magnification	O
:	O
10X	O
.	O

Panel	O
B	O
,	O
left	O
-	O
hand	O
panel	O
,	O
shows	O
a	O
representative	O
result	O
from	O
Northern	O
analyses	O
of	O
total	O
RNA	S-SO
from	O
wild	B-SO
-	I-SO
type	E-SO
,	O
heterozygous	O
and	O
knockout	O
P0	O
lungs	O
for	O
SP	B-PRGE
-	I-PRGE
A	E-PRGE
,	O
SP	B-PRGE
-	I-PRGE
B	E-PRGE
,	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
and	O
SP	B-PRGE
-	I-PRGE
D	E-PRGE
expression	O
.	O

Densitometry	O
analyses	O
showed	O
the	O
relative	O
expression	O
(	O
n	O
=	O
3	O
,	O
mean	O
+/-	O
s	O
.	O
d	O
.	O
)	O
of	O
these	O
surfactant	S-CHEBI
protein	S-CHEBI
mRNAs	S-CHEBI
were	O
not	O
significantly	O
different	O
between	O
these	O
three	O
genotypes	S-SO
.	O

Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
showed	O
abnormal	O
differentiation	O
of	O
type	O
I	O
alveolar	O
epithelial	B-CL
cells	E-CL
(	O
AECs	O
)	O

At	O
E20	O
.	O
5	O
,	O
the	O
distal	O
lung	O
of	O
wild	B-SO
type	E-SO
embryos	O
consisted	O
of	O
saccular	O
structures	O
lined	O
by	O
flat	O
type	O
I	O
AECs	O
,	O
and	O
by	O
cuboidal	O
surfactant	S-CHEBI
-	O
producing	O
type	O
II	O
AECs	O
(	O
Fig	O
.	O
7A	O
)	O
.	O

In	O
contrast	O
,	O
the	O
formation	O
of	O
these	O
typical	O
saccules	O
was	O
impaired	O
in	O
Dhcr7	S-PRGE
deficient	O
lungs	O
.	O

Instead	O
,	O
these	O
saccular	O
structures	O
were	O
lined	O
by	O
a	O
low	O
columnar	O
epithelium	O
that	O
lacked	O
flattened	O
type	O
I	O
-	O
like	O
cells	S-CL
with	O
the	O
presence	O
of	O
many	O
undeveloped	O
or	O
arrested	O
epithelial	O
tubules	O
(	O
Fig	O
.	O
7B	O
)	O
.	O

Consistent	O
with	O
disruption	O
of	O
type	O
I	O
AECs	O
differentiation	O
was	O
the	O
dramatic	O
reduction	O
of	O
expression	O
of	O
T1	B-PRGE
alpha	E-PRGE
,	O
an	O
apical	B-GO
membrane	E-GO
protein	S-CHEBI
marker	O
of	O
lung	O
type	O
I	O
AECs	O
(	O
Fig	O
.	O
7	O
,	O
cf	O
.	O
panels	O
C	O
and	O
D	O
)	O
.	O

Decreased	O
immunostaining	O
for	O
AQP5	S-PRGE
,	O
another	O
type	O
I	O
AEC	O
marker	O
,	O
was	O
also	O
noted	O
in	O
Dhcr7	S-PRGE
deficient	O
lungs	O
at	O
E20	O
.	O
5	O
,	O
compared	O
to	O
control	O
lungs	O
(	O
Fig	O
.	O
7	O
,	O
cf	O
.	O
panels	O
E	O
and	O
F	O
)	O
.	O

Megalin	S-PRGE
,	O
a	O
low	B-PRGE
density	I-PRGE
lipoprotein	I-PRGE
receptor	E-PRGE
(	O
LDLR	S-PRGE
)	O
gene	S-SO
family	O
member	O
,	O
is	O
expressed	O
by	O
embryonic	O
epithelial	B-CL
cells	E-CL
and	O
can	O
function	O
as	O
an	O
endocytic	O
Shh	S-PRGE
receptor	O
[	O
32	O
]	O
.	O

Megalin	S-PRGE
was	O
highly	O
expressed	O
on	O
the	O
distal	O
epithelium	O
at	O
E20	O
.	O
5	O
from	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
,	O
as	O
well	O
as	O
type	O
I	O
AECs	O
lining	O
the	O
developed	O
saccules	O
(	O
Fig	O
.	O
7G	O
)	O
.	O

In	O
contrast	O
,	O
though	O
megalin	S-PRGE
staining	O
was	O
detected	O
in	O
developing	O
saccules	O
in	O
knockout	O
embryonic	O
lungs	O
,	O
its	O
expression	O
was	O
confined	O
to	O
undifferentiated	O
cuboidal	O
cells	S-CL
(	O
Fig	O
.	O
7H	O
)	O
,	O
further	O
indicating	O
a	O
delay	O
in	O
type	O
I	O
AECs	O
differentiation	O
in	O
the	O
knockout	O
lungs	O
.	O

Figure	O
7	O

Characterization	O
of	O
type	O
I	O
AECs	O
differentiation	O
.	O

The	O
normal	O
distal	O
saccules	O
of	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
at	O
near	O
term	O
(	O
E20	O
.	O
5	O
)	O
showed	O
typical	O
type	O
I	O
(	O
t1	O
)	O
and	O
type	O
II	O
(	O
t2	O
)	O
epithelial	B-CL
cells	E-CL
(	O
panel	O
A	O
,	O
arrowheads	O
)	O
,	O
but	O
knockout	O
(	O
-	O
/	O
-	O
)	O
littermate	O
lungs	O
showed	O
less	O
developed	O
saccules	O
lined	O
by	O
columnar	O
epithelial	B-CL
cells	E-CL
(	O
panel	O
B	O
,	O
black	O
arrowheads	O
)	O
,	O
with	O
partially	O
arrested	O
tubules	O
in	O
the	O
distal	O
lung	O
(	O
panel	O
B	O
,	O
green	O
arrowheads	O
)	O
.	O

Immunostaining	O
for	O
type	O
I	O
cell	S-CL
markers	O
T1	B-PRGE
alpha	E-PRGE
and	O
AQP5	S-PRGE
demonstrated	O
an	O
intense	O
staining	O
in	O
flat	O
epithelial	B-CL
cells	I-CL
in	I-CL
wild	I-CL
-	I-CL
type	I-CL
lungs	E-CL
at	O
E20	O
.	O
5	O
(	O
panels	O
C	O
and	O
E	O
,	O
arrowheads	O
)	O
.	O

In	O
contrast	O
,	O
in	O
knockout	O
littermate	O
lungs	O
,	O
T1	B-PRGE
alpha	E-PRGE
and	O
AQP5	S-PRGE
staining	O
was	O
dramatically	O
decreased	O
(	O
panels	O
D	O
and	O
F	O
,	O
arrowheads	O
)	O
.	O

Megalin	S-PRGE
expression	O
(	O
Meg	S-PRGE
)	O
was	O
detected	O
in	O
the	O
airway	O
epithelial	B-CL
cells	E-CL
,	O
but	O
not	O
in	O
proximal	O
bronchiole	O
epithelial	B-CL
cells	I-CL
(	I-CL
data	I-CL
not	I-CL
shown	I-CL
)	I-CL
in	I-CL
the	I-CL
lungs	E-CL
from	O
both	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
at	O
E20	O
.	O
5	O
.	O

The	O
elongated	O
megalin	S-PRGE
-	O
positive	O
epithelial	B-CL
cells	E-CL
,	O
lining	O
the	O
normally	O
developed	O
sacculi	O
,	O
were	O
readily	O
evident	O
in	O
many	O
areas	O
of	O
the	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
.	O

In	O
contrast	O
,	O
the	O
terminal	O
epithelial	B-CL
cells	E-CL
positively	O
stained	O
by	O
megalin	S-PRGE
antibodies	S-GO
in	O
knockout	O
lungs	O
were	O
comprised	O
mainly	O
of	O
undifferentiated	O
cuboidal	O
cells	S-CL
(	O
compare	O
the	O
arrowheads	O
in	O
G	O
and	O
H	O
)	O
.	O

Original	O
magnification	O
:	O
A	O
,	O
B	O
,	O
G	O
and	O
H	O
are	O
60X	O
,	O
C	O
-	O
F	O
are	O
40X	O
.	O

Delayed	O
vascular	O
development	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O

There	O
is	O
a	O
close	O
relationship	O
between	O
blood	O
vessel	O
development	O
and	O
lung	O
structural	O
development	O
.	O

At	O
later	O
lung	O
developmental	O
stages	O
,	O
timed	O
capillary	O
bed	O
development	O
is	O
essential	O
for	O
the	O
formation	O
of	O
mature	O
alveolar	O
gas	O
-	O
exchange	O
,	O
with	O
a	O
loss	O
of	O
mesenchyme	O
separating	O
the	O
capillary	O
beds	O
and	O
the	O
AECs	O
[	O
19	O
]	O
.	O

In	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
at	O
late	O
gestational	O
stages	O
,	O
the	O
relative	O
abundance	O
of	O
mesenchyme	O
was	O
consistent	O
with	O
the	O
general	O
arrest	O
in	O
sacculation	O
.	O

To	O
investigate	O
whether	O
the	O
delayed	O
lung	O
sacculation	O
also	O
involved	O
abnormal	O
blood	O
vessel	O
development	O
,	O
immunostaining	O
for	O
the	O
alpha	O
-	O
isoform	S-SO
of	O
caveolin	B-PRGE
-	I-PRGE
1	E-PRGE
(	O
cav	O
-	O
1	O
alpha	O
)	O
and	O
platelet	B-PRGE
endothelial	I-PRGE
cell	I-PRGE
adhesion	I-PRGE
molecular	E-PRGE
(	O
PECAM	B-PRGE
-	I-PRGE
1	E-PRGE
)	O
were	O
performed	O
on	O
sections	O
from	O
wild	B-SO
-	I-SO
type	E-SO
and	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
.	O

In	O
the	O
developing	O
lung	O
,	O
cav	O
-	O
1	O
alpha	O
is	O
expressed	O
strictly	O
in	O
the	O
endothelium	O
of	O
developing	O
capillary	O
and	O
blood	O
vessels	O
.	O

Cav	O
-	O
1	O
alpha	O
is	O
present	O
in	O
the	O
terminally	O
differentiated	O
type	O
I	O
AECs	O
,	O
but	O
is	O
not	O
detectable	O
in	O
its	O
progenitors	O
or	O
type	O
II	O
AECs	O
[	O
33	O
]	O
.	O

At	O
E14	O
.	O
5	O
,	O
both	O
the	O
epithelium	O
and	O
mesenchyme	O
were	O
negative	O
for	O
cav	O
-	O
1	O
alpha	O
staining	O
,	O
and	O
cav	O
-	O
1	O
alpha	O
was	O
detected	O
in	O
the	O
developing	O
blood	O
vessels	O
and	O
capillaries	O
,	O
with	O
no	O
differences	O
observed	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
(	O
Fig	O
.	O
8	O
,	O
panels	O
A	O
and	O
B	O
)	O
.	O

Cav	O
-	O
1	O
alpha	O
immunostaining	O
demonstrated	O
that	O
the	O
vascular	O
development	O
proceeded	O
rapidly	O
during	O
saccular	O
stages	O
in	O
normal	O
lungs	O
(	O
E17	O
.	O
5	O
and	O
E20	O
.	O
5	O
)	O
.	O

In	O
near	O
-	O
term	O
normal	O
lungs	O
(	O
E20	O
.	O
5	O
)	O
,	O
an	O
extensive	O
vascular	O
network	O
,	O
associated	O
with	O
markedly	O
thinned	O
septation	O
walls	O
of	O
well	O
-	O
developed	O
alveoli	O
and	O
close	O
apposition	O
to	O
flat	O
type	O
I	O
AECs	O
,	O
was	O
observed	O
(	O
Fig	O
.	O
8	O
,	O
panels	O
C	O
and	O
E	O
)	O
.	O

In	O
contrast	O
,	O
the	O
cav	O
-	O
1	O
alpha	O
patterns	O
in	O
lungs	O
from	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
revealed	O
a	O
relatively	O
undeveloped	O
pulmonary	O
capillary	O
bed	O
(	O
Fig	O
.	O
8	O
,	O
panels	O
D	O
and	O
F	O
)	O
.	O

At	O
E20	O
.	O
5	O
,	O
cav	O
-	O
1	O
alpha	O
stained	O
cells	S-CL
in	O
knockout	O
lungs	O
were	O
embedded	O
in	O
a	O
relatively	O
thick	O
mesenchyme	O
surrounding	O
undeveloped	O
epithelial	O
tubules	O
,	O
and	O
these	O
epithelial	B-CL
cells	E-CL
remained	O
cuboidal	O
,	O
instead	O
of	O
flattening	O
out	O
(	O
Fig	O
.	O
8	O
,	O
panel	O
F	O
)	O
.	O

PECAM	B-PRGE
-	I-PRGE
1	E-PRGE
staining	O
at	O
E20	O
.	O
5	O
confirmed	O
the	O
delayed	O
lung	O
vascular	O
development	O
at	O
these	O
late	O
gestational	O
stages	O
in	O
Dhcr7	S-PRGE
deficient	O
embryos	O
(	O
Fig	O
.	O
8	O
,	O
cf	O
.	O
panels	O
G	O
and	O
H	O
)	O
.	O

Figure	O
8	O

Immunostaining	O
patterns	O
for	O
caveolin	O
-	O
1	O
alpha	O
and	O
PECAM	B-PRGE
-	I-PRGE
1	E-PRGE
in	O
lung	O
sections	O
.	O

Cav	O
-	O
1	O
alpha	O
staining	O
was	O
compared	O
at	O
E14	O
.	O
5	O
,	O
E17	O
.	O
5	O
and	O
E20	O
.	O
5	O
stages	O
of	O
development	O
.	O

Both	O
the	O
epithelium	O
and	O
mesenchyme	O
were	O
negative	O
for	O
cav	O
-	O
1	O
alpha	O
at	O
E14	O
.	O
5	O
.	O

Developing	O
blood	O
vessels	O
(	O
red	O
arrowheads	O
)	O
and	O
capillaries	O
(	O
arrows	O
)	O
(	O
panels	O
A	O
and	O
B	O
)	O
were	O
stained	O
positively	O
for	O
cav	O
-	O
1	O
alpha	O
,	O
but	O
the	O
staining	O
patterns	O
between	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
lungs	O
were	O
not	O
altered	O
.	O

Cav	O
-	O
1	O
alpha	O
was	O
also	O
detected	O
at	O
the	O
proximal	O
bronchiole	O
sub	O
-	O
epithelial	O
matrices	O
(	O
panels	O
A	O
-	O
D	O
,	O
black	O
arrowheads	O
)	O
.	O

At	O
E17	O
.	O
5	O
,	O
the	O
airway	O
epithelium	O
,	O
negative	O
for	O
cav	O
-	O
1	O
alpha	O
staining	O
,	O
was	O
surrounded	O
by	O
rings	O
of	O
cav	O
-	O
1	O
alpha	O
positively	O
stained	O
capillary	O
networks	O
(	O
panels	O
C	O
and	O
D	O
,	O
arrows	O
)	O
.	O

Cav	O
-	O
1	O
alpha	O
expression	O
patterns	O
in	O
lungs	O
from	O
knockout	O
embryos	O
at	O
E17	O
.	O
5	O
were	O
similar	O
to	O
wild	B-SO
-	I-SO
type	E-SO
embryos	O
,	O
but	O
relative	O
less	O
capillary	O
bed	O
was	O
noted	O
in	O
knockout	O
lungs	O
(	O
cf	O
.	O
panels	O
C	O
and	O
D	O
)	O
.	O

At	O
E20	O
.	O
5	O
of	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
,	O
both	O
cav	O
-	O
1	O
alpha	O
and	O
PECAM	B-PRGE
-	I-PRGE
1	E-PRGE
staining	O
demonstrated	O
an	O
extensive	O
vascular	O
network	O
in	O
the	O
well	O
developed	O
saccules	O
,	O
with	O
staining	O
observed	O
in	O
close	O
proximity	O
to	O
flat	O
epithelial	B-CL
cells	E-CL
lining	O
the	O
air	O
spaces	O
(	O
panels	O
E	O
and	O
G	O
,	O
arrows	O
)	O
.	O

However	O
,	O
delayed	O
vascular	O
development	O
was	O
observed	O
in	O
knockout	O
lungs	O
,	O
showing	O
capillaries	O
(	O
panels	O
F	O
and	O
H	O
,	O
arrows	O
)	O
of	O
the	O
knockout	O
lungs	O
at	O
E20	O
.	O
5	O
were	O
embedded	O
in	O
a	O
relatively	O
thick	O
mesenchyme	O
around	O
the	O
undeveloped	O
epithelial	O
tubules	O
in	O
which	O
the	O
epithelial	B-CL
cells	E-CL
were	O
remained	O
cuboidal	O
(	O
arrowheads	O
)	O
.	O

Original	O
magnification	O
:	O
A	O
-	O
D	O
are	O
20X	O
;	O
E	O
-	O
H	O
are	O
40X	O
.	O

Is	O
the	O
pattern	O
of	O
sonic	B-PRGE
hedgehog	E-PRGE
expression	O
or	O
signaling	O
altered	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
?	O

Shh	S-PRGE
is	O
critical	O
for	O
normal	O
embryonic	O
development	O
and	O
its	O
autoprocessing	O
,	O
resulting	O
in	O
a	O
cholesterol	B-CHEBI
molecule	E-CHEBI
covalently	O
attached	O
at	O
its	O
C	B-SO
-	I-SO
terminus	E-SO
,	O
is	O
a	O
necessary	O
step	O
for	O
its	O
regulated	O
signaling	O
function	O
[	O
23	O
,	O
34	O
]	O
.	O

Thus	O
,	O
disruption	O
of	O
cholesterol	S-CHEBI
biosynthesis	O
could	O
conceivably	O
disrupt	O
its	O
pattern	O
of	O
distribution	O
and	O
thus	O
affect	O
normal	O
development	O
.	O

To	O
determine	O
whether	O
aberrant	O
expression	O
of	O
Shh	S-PRGE
contributed	O
to	O
the	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lung	O
phenotype	O
,	O
distribution	O
of	O
Shh	S-PRGE
in	O
the	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
was	O
assessed	O
from	O
E10	O
.	O
5	O
to	O
P0	O
by	O
IHC	O
using	O
Shh	S-PRGE
-	O
N	S-CHEBI
peptide	S-SO
antibody	S-GO
.	O

At	O
E10	O
.	O
5	O
,	O
the	O
distribution	O
of	O
Shh	S-PRGE
was	O
detected	O
in	O
the	O
epithelial	B-CL
cells	E-CL
of	O
lung	O
buds	O
(	O
Fig	O
.	O
9	O
,	O
left	O
panel	O
:	O
C	O
and	O
D	O
)	O
,	O
as	O
well	O
as	O
in	O
the	O
more	O
typical	O
Shh	S-PRGE
-	O
expressing	O
locations	O
,	O
such	O
as	O
the	O
floor	O
plate	O
,	O
notochord	O
and	O
mid	O
gut	O
(	O
Fig	O
.	O
9	O
,	O
left	O
panel	O
:	O
A	O
-	O
D	O
)	O
.	O

Importantly	O
,	O
no	O
differences	O
between	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
control	O
embryos	O
were	O
noted	O
.	O

Likewise	O
,	O
examination	O
of	O
lung	O
sections	O
from	O
increasing	O
gestational	O
ages	O
through	O
to	O
birth	O
showed	O
no	O
significant	O
differences	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
Dhcr7	S-PRGE
deficient	O
tissues	O
.	O

The	O
patterns	O
of	O
staining	O
observed	O
were	O
comparable	O
to	O
those	O
previously	O
reported	O
for	O
Shh	S-PRGE
in	O
mouse	S-LIVB
lungs	O
[	O
25	O
]	O
.	O

Figure	O
9	O

Shh	S-PRGE
and	O
Ptch	O
expression	O
patterns	O
at	O
different	O
gestational	O
stages	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
.	O

Left	O
panel	O
shows	O
the	O
Shh	S-PRGE
immunostaining	O
patterns	O
using	O
an	O
antibody	S-GO
to	O
Shh	S-PRGE
N	S-CHEBI
-	O
peptide	S-SO
at	O
various	O
gestational	O
stages	O
as	O
indicated	O
by	O
the	O
legend	O
on	O
the	O
y	O
-	O
axis	O
.	O

There	O
were	O
no	O
significant	O
differences	O
noted	O
at	O
any	O
of	O
the	O
stages	O
examined	O
between	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

At	O
E10	O
.	O
5	O
,	O
Shh	S-PRGE
was	O
detected	O
in	O
the	O
floor	O
plate	O
(	O
fp	O
)	O
,	O
notochord	O
(	O
nc	O
)	O
(	O
A	O
and	O
B	O
)	O
,	O
mid	O
-	O
gut	O
(	O
mg	O
)	O
and	O
the	O
epithelial	O
buds	O
of	O
lungs	O
(	O
lb	O
)	O
(	O
C	O
and	O
D	O
)	O
.	O

Shh	S-PRGE
staining	O
was	O
restricted	O
to	O
epithelial	B-CL
cells	E-CL
in	O
the	O
distal	O
region	O
of	O
the	O
primordial	O
tubes	O
of	O
lungs	O
at	O
E13	O
.	O
5	O
and	O
E15	O
.	O
5	O
.	O

Note	O
that	O
proximal	O
epithelial	B-CL
cells	E-CL
of	O
primordial	O
tubes	O
were	O
not	O
immunostained	O
for	O
Shh	S-PRGE
(	O
E	O
and	O
F	O
,	O
arrows	O
)	O
.	O

Shh	S-PRGE
was	O
detected	O
in	O
the	O
lung	B-CL
epithelial	I-CL
cells	E-CL
on	O
E18	O
.	O
5	O
,	O
and	O
mainly	O
in	O
the	O
conducting	O
airways	O
in	O
the	O
neonates	O
.	O

Original	O
magnifications	O
:	O
A	O
~	O
H	O
,	O
K	O
and	O
L	O
are	O
10X	O
,	O
I	O
and	O
J	O
are	O
20X	O
.	O

Right	O
panel	O
shows	O
the	O
patterns	O
of	O
Ptch	O
IHC	O
at	O
various	O
gestational	O
stages	O
.	O

Immunostaining	O
of	O
Ptch	O
from	O
E13	O
.	O
5	O
to	O
P	O
0	O
confirmed	O
concordance	O
with	O
Shh	S-PRGE
expression	O
and	O
was	O
not	O
significantly	O
different	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
embryos	O
.	O

Note	O
that	O
the	O
proximal	O
epithelial	B-CL
cells	E-CL
of	O
primordial	O
tubes	O
were	O
also	O
not	O
immunostained	O
for	O
Ptch	O
at	O
E13	O
.	O
5	O
lungs	O
(	O
arrows	O
)	O
.	O

Original	O
magnifications	O
:	O
A	O
~	O
F	O
,	O
I	O
and	O
J	O
are	O
10X	O
.	O

G	O
and	O
H	O
are	O
20X	O
.	O

To	O
further	O
investigate	O
Shh	S-PRGE
signaling	O
in	O
these	O
embryos	O
,	O
we	O
examined	O
the	O
patterns	O
of	O
expression	O
of	O
Patched	O
(	O
Ptch	O
)	O
,	O
a	O
cognate	O
receptor	O
for	O
Shh	S-PRGE
and	O
one	O
whose	O
expression	O
is	O
also	O
regulated	O
by	O
Shh	S-PRGE
signaling	O
.	O

The	O
patterns	O
of	O
Ptch	O
in	O
lung	O
sections	O
from	O
various	O
gestational	O
stages	O
were	O
also	O
indistinguishable	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
embryos	O
(	O
Fig	O
.	O
9	O
,	O
right	O
panels	O
)	O
.	O

The	O
expression	O
of	O
Ptch	O
was	O
in	O
concordance	O
with	O
that	O
of	O
Shh	S-PRGE
(	O
Fig	O
9	O
,	O
left	O
and	O
right	O
panels	O
)	O
,	O
showing	O
lung	B-CL
epithelial	I-CL
cell	E-CL
expression	O
.	O

Downstream	O
of	O
the	O
Shh	S-PRGE
-	O
Ptch	O
signaling	O
cascade	O
are	O
proteins	S-CHEBI
such	O
as	O
smoothened	S-PRGE
(	O
Smo	S-PRGE
)	O
,	O
and	O
Gli	O
proteins	S-CHEBI
,	O
key	O
regulators	O
of	O
target	O
-	O
gene	S-SO
expression	O
in	O
response	O
to	O
Shh	S-PRGE
signaling	O
.	O

No	O
differences	O
in	O
expression	O
patterns	O
for	O
Smo	S-PRGE
(	O
Fig	O
.	O
10	O
,	O
upper	O
panels	O
)	O
,	O
Gli1	S-PRGE
(	O
Fig	O
.	O
10	O
,	O
middle	O
panels	O
)	O
or	O
Gli3	S-PRGE
(	O
Fig	O
.	O
10	O
,	O
bottom	O
panels	O
)	O
were	O
noted	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
knockout	O
lungs	O
at	O
E13	O
.	O
5	O
,	O
E15	O
.	O
5	O
and	O
E17	O
.	O
5	O
gestational	O
days	O
.	O

Figure	O
10	O

Comparisons	O
of	O
Smo	S-PRGE
,	O
Gli1	S-PRGE
and	O
Gli3	S-PRGE
expression	O
in	O
lung	O
sections	O
.	O

Smoothened	S-PRGE
(	O
Smo	S-PRGE
,	O
upper	O
panel	O
)	O
,	O
Gli1	S-PRGE
(	O
middle	O
panel	O
)	O
and	O
Gli3	S-PRGE
(	O
bottom	O
panel	O
)	O
showed	O
a	O
pattern	O
of	O
distribution	O
similar	O
to	O
that	O
seen	O
with	O
Shh	S-PRGE
and	O
Ptch	O
(	O
compare	O
to	O
Fig	O
.	O
7	O
)	O
.	O

No	O
differences	O
between	O
wild	B-SO
-	I-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
were	O
evident	O
.	O

Original	O
magnifications	O
:	O
20X	O
.	O

Shh	S-PRGE
protein	S-CHEBI
processing	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O

Since	O
Shh	S-PRGE
expression	O
,	O
as	O
well	O
as	O
some	O
of	O
the	O
Shh	S-PRGE
signaling	O
components	O
appeared	O
to	O
be	O
normal	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
,	O
endogenous	O
autoprocessing	O
of	O
Shh	S-PRGE
to	O
generate	O
a	O
cholesterol	S-CHEBI
-	O
modified	O
N	B-SO
-	I-SO
terminal	E-SO
fragment	S-SO
of	O
Shh	S-PRGE
(	O
Shh	S-PRGE
-	O
Np	O
)	O
was	O
evaluated	O
.	O

COS	O
-	O
1	O
cells	S-CL
,	O
transfected	O
with	O
full	O
length	O
Shh	S-PRGE
cDNA	S-SO
(	O
capable	O
of	O
endogenous	O
autocleavage	O
)	O
or	O
a	O
truncated	O
Shh	S-PRGE
cDNA	S-SO
(	O
Shh	S-PRGE
-	O
N	S-CHEBI
,	O
expression	O
of	O
the	O
shorter	O
form	S-SO
constitutively	O
)	O
were	O
used	O
as	O
controls	O
(	O
Fig	O
.	O
11	O
,	O
tracks	O
1	O
and	O
2	O
)	O
.	O

Transfection	O
of	O
the	O
full	O
-	O
length	O
cDNA	S-SO
for	O
Shh	S-PRGE
led	O
to	O
the	O
detection	O
of	O
an	O
~	O
20	O
kD	O
protein	S-CHEBI
that	O
corresponds	O
with	O
the	O
cleaved	O
and	O
tailed	O
Shh	S-PRGE
(	O
Fig	O
.	O
11	O
,	O
track	O
1	O
)	O
,	O
as	O
previously	O
described	O
[	O
35	O
]	O
.	O

Transfection	O
of	O
COS	O
cells	S-CL
with	O
the	O
constitutive	O
truncated	O
Shh	S-PRGE
-	O
N	S-CHEBI
cDNA	S-SO
led	O
to	O
two	O
slower	O
migrating	O
bands	O
that	O
correspond	O
to	O
truncated	O
Shh	S-PRGE
,	O
but	O
which	O
are	O
thought	O
to	O
be	O
generated	O
by	O
differences	O
in	O
lipid	S-CHEBI
modifications	O
,	O
as	O
previously	O
demonstrated	O
[	O
35	O
]	O
.	O

In	O
tissue	O
lysates	O
from	O
wild	B-SO
-	I-SO
type	E-SO
,	O
Dhcr7	S-PRGE
+	S-SO
/	O
-	O
and	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
at	O
E11	O
.	O
5	O
,	O
a	O
band	O
running	O
at	O
the	O
same	O
position	O
as	O
Shh	S-PRGE
-	O
Np	O
(	O
autocleaved	O
and	O
tailed	O
)	O
was	O
detected	O
in	O
all	O
of	O
the	O
lysates	O
.	O

There	O
were	O
no	O
distinguishable	O
differences	O
between	O
Dhcr7	S-PRGE
-	O
/	O
-	O
and	O
the	O
wild	B-SO
-	I-SO
type	E-SO
samples	O
,	O
suggesting	O
that	O
Shh	S-PRGE
autoprocessing	O
occurred	O
normally	O
,	O
despite	O
an	O
absolute	O
deficiency	O
of	O
cholesterol	S-CHEBI
in	O
knockout	O
embryos	O
.	O

More	O
importantly	O
,	O
no	O
band	O
corresponding	O
to	O
a	O
full	B-PRGE
-	I-PRGE
length	I-PRGE
Shh	E-PRGE
(	O
~	O
45	O
kD	O
)	O
was	O
present	O
in	O
the	O
lung	O
lysates	O
from	O
the	O
knockout	O
embryos	O
,	O
suggesting	O
that	O
processing	O
of	O
Shh	S-PRGE
was	O
not	O
impaired	O
.	O

Figure	O
11	O

Shh	S-PRGE
protein	S-CHEBI
autoprocessing	O
in	O
mouse	S-LIVB
embryos	O
.	O

Western	O
blotting	O
of	O
lysates	O
from	O
wild	B-SO
-	I-SO
type	E-SO
(	O
track	O
3	O
)	O
,	O
heterozygous	O
(	O
track	O
4	O
)	O
and	O
knockout	O
(	O
track	O
5	O
)	O
embryos	O
at	O
E11	O
.	O
5	O
,	O
or	O
COS1	O
cells	S-CL
transfected	O
with	O
Shh	S-PRGE
(	O
track	O
1	O
)	O
or	O
Shh	S-PRGE
-	O
N	S-CHEBI
(	O
track	O
2	O
)	O
were	O
probed	O
with	O
anti	O
-	O
Shh	S-PRGE
-	O
N19	O
antibodies	S-GO
.	O

20	O
mu	O
g	O
of	O
lysate	O
proteins	S-CHEBI
from	O
Shh	S-PRGE
transfected	O
COS1	O
cells	S-CL
and	O
75	O
mu	O
g	O
from	O
embryos	O
was	O
loaded	O
.	O

Both	O
unprocessed	O
(	O
Shh	S-PRGE
,	O
upper	O
arrow	O
~	O
45	O
kDa	O
,	O
faint	O
signal	O
)	O
and	O
processed	O
(	O
Shh	S-PRGE
-	O
Np	O
,	O
lowest	O
arrow	O
,	O
strong	O
signal	O
,	O
track	O
1	O
)	O
forms	S-SO
of	O
Shh	S-PRGE
were	O
detected	O
from	O
Shh	S-PRGE
transfected	O
COS1	O
cells	S-CL
.	O

The	O
two	O
slower	O
migrating	O
bands	O
in	O
Shh	S-PRGE
-	O
N	S-CHEBI
transfected	O
COS1	O
cells	S-CL
(	O
track	O
2	O
)	O
represented	O
Shh	S-PRGE
-	O
N	S-CHEBI
proteins	S-CHEBI
with	O
different	O
lipid	S-CHEBI
modifications	O
at	O
its	O
N	B-SO
terminus	E-SO
.	O

A	O
major	O
band	O
running	O
at	O
the	O
same	O
position	O
as	O
processed	O
Shh	S-PRGE
was	O
detected	O
in	O
lysates	O
from	O
all	O
the	O
embryos	O
(	O
tracks	O
3	O
-	O
5	O
)	O
.	O

Importantly	O
,	O
no	O
significant	O
amounts	O
of	O
unprocessed	O
or	O
aberrantly	O
migrating	O
Shh	S-PRGE
proteins	S-CHEBI
were	O
detected	O
in	O
lysates	O
from	O
knockout	O
embryos	O
at	O
this	O
stage	O
.	O

Discussion	O

The	O
elucidation	O
that	O
SLOS	O
is	O
caused	O
by	O
a	O
defect	O
in	O
an	O
enzyme	S-SO
necessary	O
for	O
cholesterol	S-CHEBI
biosynthesis	O
has	O
improved	O
our	O
understanding	O
of	O
embryonic	O
development	O
.	O

This	O
discovery	O
has	O
led	O
to	O
the	O
identification	O
of	O
other	O
disorders	O
of	O
embryonic	O
development	O
caused	O
by	O
mutations	S-SO
in	O
genes	S-SO
encoding	O
other	O
enzymes	S-SO
in	O
the	O
post	O
-	O
squalene	S-CHEBI
steps	O
of	O
cholesterol	S-CHEBI
biosynthesis	O
.	O

Although	O
these	O
genetic	S-SO
studies	O
now	O
implicate	O
the	O
need	O
for	O
normal	O
cholesterol	S-CHEBI
synthesis	O
,	O
the	O
mechanistic	O
role	O
(	O
s	O
)	O
of	O
cholesterol	S-CHEBI
in	O
normal	O
embryonic	O
development	O
remains	O
to	O
be	O
clarified	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
report	O
the	O
characterization	O
of	O
lung	O
development	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Although	O
cardiac	O
abnormalities	O
are	O
common	O
in	O
human	S-LIVB
SLOS	O
[	O
36	O
]	O
,	O
no	O
structural	O
abnormalities	O
of	O
the	O
heart	O
or	O
the	O
great	O
vessels	O
were	O
observed	O
in	O
the	O
Dhcr7	S-PRGE
-	O
/	O
-	O
pups	O
.	O

Lung	O
development	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
at	O
the	O
early	O
stages	O
,	O
from	O
lung	O
bud	O
formation	O
to	O
canalicular	O
stage	O
,	O
was	O
morphologically	O
similar	O
to	O
controls	O
.	O

Instead	O
,	O
a	O
distinct	O
lung	O
hypoplasia	O
at	O
the	O
saccular	O
stage	O
,	O
characterized	O
by	O
arrested	O
or	O
partially	O
developed	O
distal	O
epithelial	O
tubules	O
,	O
reduced	O
terminal	O
sac	O
space	O
,	O
delayed	O
type	O
I	O
AECs	O
differentiation	O
and	O
delayed	O
vascular	O
development	O
,	O
was	O
consistently	O
observed	O
at	O
late	O
gestational	O
stages	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

At	O
late	O
stages	O
of	O
normal	O
fetal	O
development	O
,	O
the	O
mammalian	S-LIVB
alveolar	O
epithelium	O
undergoes	O
an	O
abrupt	O
differentiation	O
as	O
a	O
part	O
of	O
the	O
preparation	O
of	O
the	O
lungs	O
for	O
the	O
postnatal	O
demands	O
of	O
gas	O
exchange	O
[	O
37	O
]	O
.	O

Both	O
type	O
II	O
AECs	O
,	O
producing	O
pulmonary	O
surfactants	S-CHEBI
,	O
and	O
type	O
I	O
AECs	O
,	O
lining	O
the	O
expanded	O
alveoli	O
,	O
are	O
important	O
for	O
alveolar	O
maturation	O
.	O

In	O
addition	O
,	O
the	O
vascular	O
development	O
of	O
alveoli	O
is	O
also	O
essential	O
for	O
normal	O
lung	O
morphogenesis	O
at	O
late	O
gestational	O
stages	O
[	O
19	O
]	O
.	O

We	O
show	O
here	O
that	O
the	O
differentiation	O
of	O
type	O
I	O
AECs	O
but	O
not	O
type	O
II	O
AECs	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
was	O
blocked	O
or	O
delayed	O
,	O
as	O
indicated	O
by	O
fewer	O
flattened	O
type	O
I	O
cells	S-CL
and	O
by	O
reduced	O
expression	O
of	O
markers	O
of	O
type	O
I	O
AECs	O
,	O
T1	B-PRGE
alpha	E-PRGE
and	O
AQP5	S-PRGE
.	O

Delayed	O
vascular	O
development	O
was	O
also	O
involved	O
in	O
the	O
delayed	O
sacculation	O
of	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
.	O

Additionally	O
,	O
the	O
mesenchyme	O
separating	O
the	O
AECs	O
from	O
the	O
vascular	O
beds	O
remained	O
thickened	O
.	O

In	O
support	O
of	O
normal	O
differentiation	O
of	O
type	O
II	O
AECs	O
,	O
no	O
alteration	O
in	O
the	O
gene	S-SO
expression	O
patterns	O
for	O
surfactant	B-PRGE
proteins	I-PRGE
A	I-PRGE
,	I-PRGE
B	I-PRGE
,	I-PRGE
C	I-PRGE
or	I-PRGE
D	E-PRGE
was	O
noted	O
,	O
nor	O
was	O
the	O
pattern	O
of	O
distribution	O
of	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
altered	O
in	O
lungs	O
from	O
knockout	O
embryos	O
.	O

Thus	O
,	O
impaired	O
gas	O
exchange	O
,	O
as	O
opposed	O
to	O
poor	O
inflation	O
and	O
alveolar	O
tension	O
,	O
may	O
be	O
the	O
cause	O
of	O
respiratory	O
failure	O
in	O
these	O
pups	O
.	O

Loss	O
of	O
functional	O
Dhcr7	S-PRGE
led	O
to	O
a	O
retardation	O
of	O
embryonic	O
growth	O
from	O
E14	O
.	O
5	O
~	O
E16	O
.	O
5	O
onwards	O
.	O

By	O
this	O
stage	O
,	O
cholesterol	S-CHEBI
levels	O
were	O
already	O
lower	O
and	O
its	O
immediate	O
precursor	O
,	O
7	O
-	O
DHC	O
,	O
elevated	O
in	O
the	O
lungs	O
(	O
this	O
study	O
)	O
as	O
well	O
as	O
in	O
the	O
whole	O
body	O
[	O
16	O
,	O
17	O
]	O
.	O

Intrauterine	O
growth	O
retardation	O
(	O
IUGR	O
)	O
followed	O
by	O
postnatal	O
failure	O
to	O
thrive	O
is	O
a	O
universally	O
observed	O
phenotype	O
in	O
SLOS	O
patients	O
[	O
2	O
,	O
18	O
]	O
.	O

We	O
showed	O
here	O
that	O
body	O
length	O
was	O
significantly	O
reduced	O
at	O
later	O
stages	O
of	O
gestation	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
animals	S-LIVB
,	O
compared	O
to	O
controls	O
.	O

Whole	O
body	O
weights	O
and	O
fresh	O
lung	O
weights	O
(	O
as	O
well	O
as	O
brain	O
,	O
heart	O
and	O
kidney	O
,	O
data	O
not	O
shown	O
)	O
at	O
late	O
gestational	O
stages	O
were	O
also	O
lower	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Interestingly	O
,	O
the	O
lower	O
lung	O
/	O
body	O
ratios	O
at	O
E18	O
.	O
5	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
compared	O
to	O
wild	B-SO
-	I-SO
type	E-SO
suggested	O
a	O
disproportionate	O
inhibition	O
of	O
lung	O
growth	O
than	O
other	O
organs	O
.	O

Cell	S-CL
proliferation	O
and	O
division	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
lungs	O
were	O
markedly	O
arrested	O
without	O
apparent	O
increase	O
in	O
cell	S-CL
apoptosis	O
.	O

Therefore	O
,	O
it	O
appears	O
that	O
growth	O
retardation	O
caused	O
by	O
cholesterol	S-CHEBI
deficiency	O
was	O
primarily	O
because	O
of	O
an	O
inhibition	O
of	O
cell	S-CL
growth	O
and	O
proliferation	O
,	O
rather	O
than	O
an	O
increase	O
in	O
cell	S-CL
death	O
.	O

Cholesterol	S-CHEBI
is	O
present	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
,	O
as	O
it	O
is	O
in	O
Sc5d	S-PRGE
-	O
/	O
-	O
(	O
lathosterolosis	O
)	O
and	O
Dhcr24	S-PRGE
-	O
/	O
-	O
(	O
desmosterolosis	O
)	O
embryos	O
[	O
15	O
,	O
38	O
]	O
.	O

Total	O
sterols	S-CHEBI
and	O
cholesterol	S-CHEBI
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryonic	O
lungs	O
(	O
as	O
well	O
as	O
in	O
brain	O
and	O
liver	O
,	O
data	O
not	O
shown	O
)	O
were	O
reduced	O
and	O
7DHC	O
/	O
8DHC	O
elevated	O
,	O
but	O
a	O
significant	O
amount	O
of	O
cholesterol	S-CHEBI
was	O
detectable	O
,	O
comprising	O
~	O
60	O
%	O
and	O
~	O
30	O
%	O
of	O
total	O
tissue	O
sterols	S-CHEBI
at	O
E13	O
.	O
5	O
and	O
neonate	O
,	O
respectively	O
.	O

Fetal	O
cholesterol	S-CHEBI
can	O
either	O
be	O
synthesized	O
endogenously	O
in	O
fetal	O
tissues	O
or	O
accrued	O
from	O
extra	O
-	O
embryonic	O
tissues	O
such	O
as	O
maternal	O
serum	O
,	O
placenta	O
,	O
and	O
yolk	O
sac	O
[	O
39	O
]	O
.	O

Since	O
these	O
mice	S-LIVB
theoretically	O
can	O
not	O
synthesize	O
cholesterol	S-CHEBI
,	O
any	O
accumulation	O
of	O
cholesterol	S-CHEBI
must	O
be	O
derived	O
from	O
the	O
maternal	O
sources	O
.	O

Interestingly	O
,	O
Dhcr24	S-PRGE
null	O
mice	S-LIVB
are	O
viable	O
but	O
contained	O
almost	O
no	O
cholesterol	S-CHEBI
in	O
plasma	O
and	O
tissues	O
at	O
3	O
-	O
months	O
,	O
whereas	O
cholesterol	S-CHEBI
content	O
in	O
Dhcr24	S-PRGE
null	O
embryo	O
tissues	O
accounts	O
for	O
~	O
60	O
%	O
at	O
E11	O
.	O
5	O
and	O
~	O
30	O
%	O
at	O
E17	O
.	O
5	O
,	O
of	O
total	O
tissue	O
sterols	S-CHEBI
[	O
38	O
]	O
.	O

These	O
results	O
,	O
as	O
well	O
as	O
this	O
study	O
,	O
suggest	O
that	O
a	O
considerable	O
amount	O
of	O
maternal	O
cholesterol	S-CHEBI
can	O
be	O
transferred	O
to	O
the	O
murine	S-LIVB
fetus	O
.	O

One	O
explanation	O
of	O
why	O
the	O
Dhcr24	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
are	O
developmentally	O
normal	O
but	O
Dhcr7	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
are	O
affected	O
may	O
be	O
because	O
desmosterol	S-CHEBI
can	O
functionally	O
substitute	O
for	O
cholesterol	S-CHEBI
,	O
whereas	O
the	O
other	O
cholesterol	S-CHEBI
precursors	O
can	O
not	O
.	O

Although	O
a	O
mechanistic	O
understanding	O
of	O
why	O
a	O
deficiency	O
in	O
cholesterol	S-CHEBI
biosynthesis	O
leads	O
to	O
abnormal	O
embryonic	O
development	O
is	O
lacking	O
,	O
a	O
frequently	O
advanced	O
explanation	O
has	O
been	O
that	O
Shh	S-PRGE
signaling	O
,	O
involved	O
in	O
early	O
developmental	O
patterning	O
,	O
may	O
be	O
disrupted	O
.	O

In	O
the	O
developing	O
lung	O
primordium	O
,	O
Shh	S-PRGE
is	O
expressed	O
initially	O
at	O
E9	O
and	O
promotes	O
branching	O
morphogenesis	O
,	O
which	O
is	O
impaired	O
in	O
Shh	S-PRGE
knockout	O
mice	S-LIVB
[	O
24	O
]	O
,	O
suggesting	O
that	O
Shh	S-PRGE
,	O
secreted	O
by	O
the	O
epithelium	O
,	O
is	O
critical	O
for	O
branching	O
morphogenesis	O
.	O

In	O
this	O
study	O
,	O
the	O
lack	O
of	O
evidence	O
of	O
abnormal	O
lung	O
branching	O
morphogenesis	O
in	O
the	O
early	O
stages	O
,	O
but	O
a	O
consistent	O
delayed	O
maturation	O
of	O
the	O
gas	O
-	O
exchange	O
region	O
of	O
the	O
lung	O
in	O
the	O
saccular	O
period	O
of	O
development	O
of	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
was	O
observed	O
,	O
suggesting	O
early	O
Shh	S-PRGE
signaling	O
was	O
normal	O
.	O

Shh	S-PRGE
protein	S-CHEBI
expression	O
and	O
autoprocessing	O
at	O
E11	O
.	O
5	O
was	O
indistinguishable	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
.	O

Additionally	O
,	O
although	O
these	O
experiments	O
were	O
not	O
quantitative	O
,	O
the	O
abundance	O
of	O
Shh	S-PRGE
appeared	O
unchanged	O
between	O
these	O
genotypes	S-SO
.	O

Thus	O
,	O
it	O
is	O
possible	O
that	O
the	O
cholesterol	S-CHEBI
levels	O
(	O
roughly	O
50	O
%	O
of	O
normal	O
levels	O
)	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
were	O
enough	O
for	O
completion	O
of	O
Shh	S-PRGE
autoprocessing	O
or	O
7DHC	O
accumulated	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryonic	O
tissues	O
can	O
also	O
participate	O
efficiently	O
as	O
a	O
sterol	S-CHEBI
adduct	O
in	O
the	O
Shh	S-PRGE
processing	O
reaction	O
[	O
20	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
also	O
examined	O
the	O
Shh	S-PRGE
signaling	O
pathway	O
by	O
immunohistochemistry	O
of	O
known	O
key	O
components	O
of	O
this	O
pathway	O
,	O
such	O
as	O
patched	O
,	O
smoothened	S-PRGE
and	O
Gli	O
proteins	S-CHEBI
.	O

Shh	S-PRGE
signaling	O
leads	O
to	O
the	O
activation	O
of	O
transcription	O
and	O
increased	O
protein	S-CHEBI
levels	O
of	O
these	O
components	O
[	O
40	O
-	O
42	O
]	O
.	O

If	O
Shh	S-PRGE
signaling	O
were	O
defective	O
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
,	O
these	O
could	O
have	O
resulted	O
in	O
abnormalities	O
of	O
the	O
staining	O
patterns	O
of	O
these	O
components	O
,	O
but	O
no	O
such	O
disturbance	O
was	O
detected	O
.	O

Indeed	O
,	O
the	O
patterns	O
of	O
protein	S-CHEBI
expression	O
seemed	O
comparable	O
and	O
indistinguishable	O
from	O
wild	B-SO
-	I-SO
type	E-SO
embryos	O
at	O
all	O
stages	O
of	O
lung	O
development	O
examined	O
.	O

In	O
a	O
recent	O
in	O
vitro	O
study	O
[	O
43	O
]	O
,	O
mouse	S-LIVB
embryonic	O
fibroblasts	S-CL
(	O
MEFs	O
)	O
from	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryos	O
,	O
grown	O
in	O
lipid	O
-	O
depleted	O
culture	O
and	O
transiently	O
treated	O
with	O
cyclodextrin	S-CHEBI
,	O
showed	O
no	O
affect	O
on	O
Shh	S-PRGE
processing	O
.	O

However	O
,	O
a	O
deficiency	O
in	O
their	O
ability	O
to	O
respond	O
to	O
Shh	S-PRGE
activation	O
,	O
as	O
judged	O
by	O
reporter	O
gene	S-SO
expression	O
,	O
was	O
demonstrable	O
.	O

In	O
contrast	O
,	O
when	O
CHO	O
cells	S-CL
,	O
that	O
stably	O
expressed	O
Shh	S-PRGE
,	O
were	O
subjected	O
to	O
sterol	S-CHEBI
deprivation	O
,	O
an	O
arrest	O
of	O
Shh	S-PRGE
autoprocessing	O
was	O
clearly	O
demonstrable	O
[	O
29	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
did	O
not	O
detect	O
unprocessed	O
Shh	S-PRGE
in	O
Dhcr7	S-PRGE
-	O
/	O
-	O
embryonic	O
tissues	O
at	O
E11	O
.	O
5	O
.	O

Subtle	O
differences	O
in	O
Shh	S-PRGE
signal	O
transduction	O
can	O
not	O
be	O
excluded	O
by	O
the	O
present	O
study	O
.	O

However	O
,	O
we	O
favor	O
a	O
model	O
whereby	O
the	O
loss	O
of	O
normal	O
cholesterol	S-CHEBI
biosynthesis	O
is	O
important	O
,	O
not	O
so	O
much	O
for	O
Shh	S-PRGE
autocleavage	O
,	O
as	O
for	O
the	O
loss	O
of	O
the	O
correct	O
plasma	B-GO
membrane	E-GO
milieu	O
.	O

Since	O
the	O
loss	O
of	O
cholesterol	S-CHEBI
content	O
in	O
the	O
plasma	B-GO
membrane	E-GO
(	O
and	O
perhaps	O
any	O
membrane	S-GO
)	O
is	O
likely	O
to	O
alter	O
the	O
function	O
of	O
receptors	O
more	O
sensitive	O
to	O
this	O
,	O
loss	O
of	O
normal	O
cholesterol	S-CHEBI
synthesis	O
may	O
cause	O
a	O
loss	O
of	O
signal	O
transduction	O
of	O
a	O
host	O
of	O
such	O
pathways	O
.	O

Thus	O
,	O
this	O
effect	O
may	O
not	O
be	O
limited	O
to	O
the	O
Shh	S-PRGE
pathway	O
and	O
other	O
targets	O
may	O
be	O
more	O
important	O
.	O

This	O
hypothesis	O
is	O
amenable	O
to	O
testing	O
in	O
the	O
Dhcr7	S-PRGE
null	O
mice	S-LIVB
.	O

Conclusion	O

Cholesterol	S-CHEBI
deficiency	O
caused	O
by	O
Dhcr7	S-PRGE
deficiency	O
in	O
mice	S-LIVB
resulted	O
in	O
,	O
along	O
with	O
IUGR	O
,	O
a	O
distinct	O
lung	O
saccular	O
hypoplasia	O
with	O
impaired	O
differentiation	O
of	O
type	O
I	O
but	O
not	O
type	O
II	O
AECs	O
and	O
delayed	O
associated	O
vascular	O
development	O
.	O

Loss	O
of	O
the	O
correct	O
amounts	O
of	O
cholesterol	S-CHEBI
in	O
the	O
membranes	S-GO
may	O
perturb	O
those	O
receptors	O
that	O
depend	O
upon	O
cholesterol	S-CHEBI
for	O
efficient	O
signal	O
transduction	O
.	O

Further	O
investigation	O
of	O
which	O
transcriptional	O
and	O
signal	O
transduction	O
pathways	O
are	O
more	O
significantly	O
affected	O
by	O
the	O
loss	O
of	O
Dhcr7	S-PRGE
will	O
be	O
critical	O
to	O
elucidate	O
the	O
mechanism	O
of	O
lung	O
hypoplasia	O
of	O
this	O
model	O
,	O
as	O
well	O
as	O
the	O
role	O
of	O
cholesterol	S-CHEBI
in	O
embryonic	O
development	O
.	O

Methods	O

Animals	S-LIVB

All	O
mice	S-LIVB
were	O
housed	O
in	O
an	O
animal	S-LIVB
facility	O
at	O
22	O
degrees	O
C	O
with	O
a	O
12	O
h	O
light	O
~	O
12	O
h	O
dark	O
cycle	O
and	O
all	O
protocols	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	S-LIVB
Welfare	O
Committee	O
.	O

Dhcr7	S-PRGE
heterozygous	O
animals	S-LIVB
used	O
in	O
this	O
study	O
have	O
been	O
backcrossed	O
onto	O
a	O
C57BL	O
/	O
6J	O
background	O
for	O
11	O
successive	O
generations	O
.	O

The	O
presence	O
of	O
vaginal	O
plugs	O
was	O
considered	O
as	O
embryonic	O
day	O
(	O
E	O
)	O
0	O
.	O
5	O
.	O

Timed	O
pregnant	O
females	O
were	O
sacrificed	O
,	O
embryos	O
dissected	O
from	O
the	O
uteri	O
and	O
placed	O
in	O
1X	O
PBS	O
.	O

Crown	O
-	O
rump	O
lengths	O
of	O
the	O
embryos	O
were	O
measured	O
by	O
use	O
of	O
an	O
electronic	O
digital	O
caliper	O
and	O
embryos	O
weighed	O
,	O
after	O
blotting	O
off	O
excess	O
fluid	O
.	O

Each	O
lung	O
was	O
removed	O
intact	O
from	O
the	O
thoracic	O
cavity	O
,	O
blotted	O
free	O
of	O
excess	O
fluid	O
,	O
and	O
weighed	O
.	O

Mice	S-LIVB
were	O
classified	O
as	O
P0	O
when	O
birth	O
was	O
witnessed	O
and	O
their	O
breathing	O
activities	O
visualized	O
under	O
a	O
dissecting	O
microscope	O
.	O

Digital	O
images	O
of	O
embryos	O
or	O
lungs	O
were	O
captured	O
using	O
a	O
Zeiss	O
-	O
1000	O
dissecting	O
microscope	O
.	O

Genotyping	O
was	O
performed	O
by	O
PCR	O
,	O
as	O
described	O
previously	O
[	O
16	O
]	O
.	O

And	O
in	O
selective	O
cases	O
,	O
Southern	O
blotting	O
was	O
performed	O
for	O
confirmation	O
of	O
Dhcr7	S-PRGE
genotype	S-SO
.	O

Biochemical	O
measurements	O

Tissue	O
sterol	S-CHEBI
compositions	O
were	O
analyzed	O
by	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
(	O
GC	O
-	O
MS	O
)	O
as	O
described	O
previously	O
[	O
2	O
,	O
44	O
]	O
.	O

Serum	O
corticosterone	S-CHEBI
levels	O
were	O
measured	O
by	O
radioimmunoassay	O
(	O
RIA	O
)	O
on	O
the	O
blood	O
obtained	O
from	O
decapitated	O
neonates	O
by	O
a	O
commercial	O
source	O
(	O
DRTC	O
hormone	S-CHEBI
Assay	O
Core	O
Lab	O
,	O
Vanderbilt	O
University	O
,	O
TN	O
)	O
.	O

Histology	O
and	O
Immunohistochemistry	O

Thoracic	O
parts	O
from	O
embryos	O
or	O
P0	O
mice	S-LIVB
were	O
fixed	O
in	O
either	O
Amsterdam	O
'	O
s	O
fixative	O
(	O
methanol	S-CHEBI
:	O
acetone	S-CHEBI
:	O
acetic	B-CHEBI
acid	E-CHEBI
:	O
water	S-CHEBI
,	O
35	O
:	O
35	O
:	O
5	O
:	O
25	O
v	O
/	O
v	O
)	O
or	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
.	O

Tissues	O
were	O
fixed	O
overnight	O
at	O
room	O
temperature	O
(	O
RT	O
)	O
,	O
rinsed	O
in	O
PBS	O
,	O
dehydrated	O
in	O
a	O
graded	O
ethanol	S-CHEBI
series	O
,	O
cleared	O
in	O
toluene	S-CHEBI
and	O
embedded	O
in	O
paraffin	O
.	O

Five	O
mu	O
m	O
sections	O
were	O
mounted	O
on	O
Superfrost	O
-	O
Plus	O
slides	O
(	O
VWR	O
,	O
West	O
Chester	O
,	O
PA	O
)	O
for	O
histological	O
or	O
immunohistochemistry	O
(	O
IHC	O
)	O
analyses	O
.	O

IHC	O
was	O
performed	O
using	O
an	O
indirect	O
method	O
.	O

After	O
deparaffination	O
in	O
xylene	S-CHEBI
and	O
rehydration	O
through	O
a	O
graded	O
series	O
of	O
ethanol	S-CHEBI
,	O
sections	O
were	O
heated	O
at	O
95	O
degrees	O
C	O
in	O
10	O
mM	O
sodium	S-CHEBI
citrate	S-CHEBI
(	O
pH	O
6	O
.	O
0	O
)	O
for	O
an	O
initial	O
15	O
min	O
and	O
for	O
three	O
successive	O
5	O
-	O
min	O
periods	O
[	O
25	O
]	O
.	O

After	O
cooling	O
,	O
the	O
sections	O
were	O
treated	O
with	O
hydrogen	B-CHEBI
peroxide	E-CHEBI
(	O
3	O
%	O
v	O
/	O
v	O
in	O
PBS	O
,	O
pH7	O
.	O
4	O
)	O
for	O
10	O
min	O
and	O
rinsed	O
in	O
the	O
PBS	O
.	O

Sections	O
were	O
blocked	O
with	O
5	O
%	O
normal	O
serum	O
for	O
2	O
h	O
,	O
washed	O
in	O
PBS	O
and	O
incubated	O
with	O
antibodies	S-GO
against	O
Shh	S-PRGE
-	O
N19	O
(	O
1	O
:	O
100	O
)	O
,	O
Patched	O
(	O
1	O
:	O
100	O
)	O
,	O
Smo	S-PRGE
-	O
N19	O
(	O
1	O
:	O
100	O
)	O
,	O
Gli1	S-PRGE
(	O
1	O
:	O
100	O
)	O
,	O
Gli3	S-PRGE
-	O
N19	O
(	O
1	O
:	O
100	O
)	O
,	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
C19	O
(	O
1	O
:	O
200	O
)	O
,	O
caveolin	O
1	O
alpha	O
-	O
N20	O
(	O
1	O
:	O
200	O
)	O
,	O
aquaporin	B-PRGE
5	E-PRGE
(	O
AQP5	S-PRGE
,	O
1	O
:	O
200	O
)	O
,	O
megalin	S-PRGE
(	O
1	O
:	O
200	O
)	O
,	O
PECAM	B-PRGE
-	I-PRGE
1	E-PRGE
(	O
1	O
:	O
200	O
)	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
CA	O
)	O
or	O
T1	B-PRGE
alpha	E-PRGE
(	O
mAB	O
8	O
.	O
1	O
.	O
1	O
,	O
1	O
:	O
1000	O
dilution	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
)	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
a	O
humidified	O
chamber	O
.	O

The	O
sections	O
were	O
washed	O
in	O
PBS	O
,	O
incubated	O
with	O
biotinylated	O
secondary	O
antibodies	S-GO
(	O
1	O
:	O
1000	O
~	O
1	O
:	O
5000	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
in	O
PBS	O
for	O
2	O
h	O
at	O
RT	O
,	O
incubated	O
with	O
HRP	O
-	O
streptavidin	O
complex	O
for	O
30	O
min	O
,	O
rinsed	O
in	O
PBS	O
and	O
visualized	O
using	O
a	O
Metal	S-CHEBI
Enhanced	O
Diaminobenzidine	O
(	O
DAB	O
)	O
Substrate	O
Kit	O
(	O
Pierce	O
,	O
Rockford	O
,	O
IL	O
)	O
.	O

Digital	O
images	O
were	O
collected	O
using	O
a	O
Polaroid	O
Digital	O
Microscope	O
Camera	O
mounted	O
on	O
an	O
Olympus	O
BX40	O
microscope	O
.	O

Lung	O
morphometry	O

Terminal	O
saccular	O
space	O
areas	O
were	O
measured	O
using	O
NIH	O
Image	O
software	O
(	O
NIH	O
,	O
Bethesda	O
,	O
MD	O
)	O
as	O
previously	O
described	O
[	O
45	O
]	O
.	O

Multiple	O
measurements	O
were	O
performed	O
on	O
randomly	O
selected	O
0	O
.	O
04	O
-	O
mm2	O
fields	O
located	O
in	O
the	O
distal	O
part	O
of	O
the	O
lung	O
sections	O
.	O

The	O
proportion	O
of	O
lung	O
comprising	O
terminal	O
saccular	O
spaces	O
was	O
calculated	O
as	O
a	O
percentage	O
of	O
the	O
total	O
examined	O
area	O
of	O
the	O
lung	O
section	O
.	O

Three	O
animals	S-LIVB
per	O
genotype	S-SO
were	O
examined	O
.	O

Assessment	O
of	O
cell	S-CL
proliferation	O
/	O
Division	O
/	O
death	O

Changes	O
in	O
cell	S-CL
proliferation	O
and	O
division	O
were	O
assessed	O
by	O
proliferating	B-PRGE
cell	I-PRGE
nuclear	I-PRGE
antigen	E-PRGE
(	O
PCNA	S-PRGE
)	O
IHC	O
,	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
incorporation	S-SO
and	O
phosphorylated	O
histone	S-CHEBI
H3	O
(	O
pHH3	O
)	O
IHC	O
.	O

The	O
PCNA	S-PRGE
(	O
1	O
:	O
2000	O
)	O
and	O
pHH3	O
-	O
Ser28	O
(	O
1	O
:	O
200	O
)	O
antibodies	S-GO
were	O
obtained	O
from	O
Santa	O
Cruz	O
Biotechnology	O
.	O

For	O
BrdU	O
incorporation	S-SO
,	O
timed	O
pregnant	O
mice	S-LIVB
at	O
E18	O
.	O
5	O
were	O
injected	O
intra	O
-	O
peritoneally	O
with	O
100	O
mu	O
g	O
/	O
gm	O
body	O
weight	O
of	O
BrdU	O
(	O
Sigma	O
,	O
St	O
Louis	O
,	O
MO	O
)	O
2	O
h	O
prior	O
to	O
sacrifice	O
,	O
embryos	O
dissected	O
from	O
uteri	O
and	O
processed	O
as	O
described	O
above	O
.	O

Sections	O
were	O
stained	O
with	O
a	O
monoclonal	O
anti	O
-	O
BrdU	O
antibody	S-GO
(	O
1	O
:	O
100	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
)	O
and	O
visualized	O
with	O
a	O
Cy2	O
-	O
conjugated	O
rabbit	S-LIVB
anti	O
-	O
mouse	S-LIVB
antibody	S-GO
using	O
a	O
laser	O
-	O
scanning	O
confocal	O
microscope	O
.	O

Cell	S-CL
death	O
was	O
investigated	O
by	O
terminal	B-PRGE
deoxynucleotidyltransferase	E-PRGE
-	O
mediated	O
dUTP	S-CHEBI
nick	O
-	O
end	O
labeling	O
(	O
TUNEL	O
)	O
using	O
the	O
Fluorescein	O
In	O
Situ	O
Cell	S-CL
Death	O
Detection	O
Kit	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
IN	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Western	O
blotting	O

Sample	O
preparation	O
and	O
western	O
blotting	O
was	O
performed	O
according	O
to	O
Kawakami	O
et	O
al	O
with	O
some	O
minor	O
modifications	O
[	O
35	O
]	O
.	O

Briefly	O
,	O
3	O
embryos	O
from	O
each	O
genotype	S-SO
were	O
pooled	O
,	O
homogenized	O
in	O
ice	O
cold	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	S-CHEBI
-	O
pH8	O
.	O
0	O
,	O
150	O
mM	O
NaCl	S-CHEBI
,	O
2	O
mM	O
EDTA	S-CHEBI
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
0	O
.	O
5	O
mM	O
DTT	S-CHEBI
,	O
1	O
mM	O
PMSF	S-CHEBI
and	O
2	O
mu	O
g	O
/	O
ml	O
each	O
of	O
aprotinin	O
,	O
leupeptin	O
and	O
pepstatin	O
A	O
)	O
with	O
a	O
tissue	O
homogenizer	O
(	O
PRO	O
Scientific	O
Inc	O
.	O
,	O
Oxford	O
,	O
CT	O
)	O
using	O
three	O
pulses	O
of	O
10	O
seconds	O
each	O
and	O
then	O
subjected	O
to	O
Dounce	O
homogenizer	O
by	O
10	O
strokes	O
.	O

The	O
homogenates	O
were	O
centrifuged	O
at	O
10	O
,	O
000	O
g	O
for	O
30	O
minutes	O
at	O
4	O
degrees	O
C	O
,	O
supernatants	O
collected	O
,	O
protein	S-CHEBI
concentration	O
determined	O
and	O
used	O
for	O
western	O
blotting	O
.	O

COS1	O
cells	S-CL
were	O
transfected	O
using	O
Superfect	O
transfection	O
reagent	S-CHEBI
(	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
)	O
with	O
expression	O
constructs	S-SO
encoding	O
either	O
the	O
full	B-PRGE
-	I-PRGE
length	I-PRGE
Shh	E-PRGE
or	O
the	O
N	B-SO
-	I-SO
terminal	E-SO
fragment	S-SO
of	O
Shh	S-PRGE
without	O
post	O
-	O
translational	O
modifications	S-SO
(	O
constructs	S-SO
kindly	O
provided	O
by	O
Dr	O
.	O
Pao	O
-	O
Tien	O
Chuang	O
,	O
Cardiovascular	O
Research	O
Institute	O
,	O
University	O
of	O
California	O
,	O
San	O
Francisco	O
,	O
CA	O
)	O
,	O
harvested	O
3	O
days	O
after	O
transfection	O
and	O
protein	S-CHEBI
extracts	O
prepared	O
as	O
described	O
above	O
.	O

Protein	S-CHEBI
concentration	O
was	O
determined	O
using	O
Bio	O
-	O
Rad	O
protein	S-CHEBI
assay	O
kit	O
(	O
BioRad	O
,	O
Hercules	O
,	O
CA	O
)	O
and	O
20	O
mu	O
g	O
(	O
COS1	O
cells	S-CL
)	O
and	O
75	O
mu	O
g	O
(	O
embryos	O
)	O
of	O
lysates	O
separated	O
by	O
15	O
%	O
SDS	S-CHEBI
-	O
PAGE	O
,	O
transferred	O
onto	O
nitrocellulose	O
membrane	O
,	O
incubated	O
with	O
primary	O
antibody	S-GO
(	O
Shh	S-PRGE
-	O
N19	O
,	O
1	O
:	O
100	O
)	O
for	O
2	O
hours	O
,	O
followed	O
by	O
donkey	S-LIVB
anti	O
-	O
goat	O
HRP	O
second	O
antibody	S-GO
(	O
1	O
:	O
1000	O
)	O
and	O
visualized	O
by	O
chemiluminescent	O
detection	O
according	O
to	O
manufacturer	O
'	O
s	O
protocols	O
(	O
Perkin	O
-	O
Elmer	O
Life	O
Sciences	O
,	O
Boston	O
MA	O
)	O
.	O

Northern	O
blotting	O

Northern	O
blotting	O
was	O
performed	O
as	O
previously	O
described	O
[	O
46	O
]	O
,	O
using	O
total	O
RNA	S-SO
(	O
20	O
mu	O
g	O
)	O
from	O
P0	O
mice	S-LIVB
lungs	O
.	O

The	O
cDNA	S-SO
probes	S-SO
for	O
SP	B-PRGE
-	I-PRGE
A	E-PRGE
,	O
SP	B-PRGE
-	I-PRGE
B	E-PRGE
and	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
were	O
kindly	O
provided	O
by	O
Dr	O
.	O
Jeffery	O
Whitsett	O
(	O
Division	O
of	O
Pulmonary	O
Biology	O
,	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
,	O
Cincinnati	O
,	O
Ohio	O
)	O
.	O

A	O
cDNA	S-SO
probe	S-SO
for	O
SP	B-PRGE
-	I-PRGE
D	E-PRGE
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
,	O
using	O
murine	S-LIVB
SP	B-PRGE
-	I-PRGE
D	E-PRGE
cDNA	S-SO
specific	O
primers	S-SO
(	O
sense	O
5	O
'	O
-	O
TGCCTGGTCGTGATGGACG	O
-	O
3	O
'	O
,	O
and	O
antisense	S-SO
5	O
'	O
-	O
AGCACTGTCTGGAAGCCCGC	O
-	O
3	O
'	O
)	O
and	O
confirmed	O
by	O
sequencing	O
.	O

Author	O
'	O
s	O
contributions	O

HY	O
designed	O
the	O
experiments	O
.	O

HY	O
,	O
ALP	O
and	O
JLC	O
performed	O
experiments	O
.	O

GST	O
analyzed	O
tissue	O
sterols	S-CHEBI
by	O
GC	O
-	O
MS	O
and	O
JO	O
performed	O
lung	O
morphometric	O
analyses	O
.	O

HY	O
,	O
AW	O
and	O
SBP	O
analyzed	O
the	O
data	O
.	O

HY	O
and	O
SBP	O
prepared	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
Jeffery	O
Whitsett	O
for	O
providing	O
cDNA	S-SO
probes	S-SO
for	O
SP	B-PRGE
-	I-PRGE
A	E-PRGE
,	O
SP	B-PRGE
-	I-PRGE
B	E-PRGE
and	O
SP	B-PRGE
-	I-PRGE
C	E-PRGE
and	O
Pao	O
-	O
Tien	O
Chuang	O
for	O
the	O
Shh	S-PRGE
and	O
Shh	S-PRGE
-	O
N	S-CHEBI
plasmids	S-SO
.	O

This	O
research	O
was	O
supported	O
by	O
a	O
Beginning	O
Grant	O
-	O
in	O
-	O
Aid	O
0160349U	O
from	O
the	O
American	O
Heart	O
Association	O
,	O
Mid	O
-	O
Atlantic	O
Consortium	O
(	O
HY	O
)	O
;	O
NIH	O
PO1	O
HL52813	O
and	O
NIH	O
PO1	O
HD39946	O
(	O
AW	O
)	O
and	O
NIH	O
HL68660	O
(	O
SBP	O
)	O
.	O

Dopamine	B-PRGE
D2	I-PRGE
receptors	E-PRGE
mediate	O
two	O
-	O
odor	O
discrimination	O
and	O
reversal	O
learning	O
in	O
C57BL	O
/	O
6	O
mice	S-LIVB

Abstract	O

Background	O

Dopamine	S-CHEBI
modulation	O
of	O
neuronal	S-CL
signaling	O
in	O
the	O
frontal	O
cortex	O
,	O
midbrain	O
,	O
and	O
striatum	O
is	O
essential	O
for	O
processing	O
and	O
integrating	O
diverse	O
external	O
sensory	O
stimuli	O
and	O
attaching	O
salience	O
to	O
environmental	O
cues	O
that	O
signal	O
causal	O
relationships	O
,	O
thereby	O
guiding	O
goal	O
-	O
directed	O
,	O
adaptable	O
behaviors	O
.	O

At	O
the	O
cellular	S-CL
level	O
,	O
dopamine	S-CHEBI
signaling	O
is	O
mediated	O
through	O
D1	B-PRGE
-	I-PRGE
like	I-PRGE
or	I-PRGE
D2	I-PRGE
-	I-PRGE
like	I-PRGE
receptors	E-PRGE
.	O

Although	O
a	O
role	O
for	O
D1	B-PRGE
-	I-PRGE
like	I-PRGE
receptors	E-PRGE
in	O
a	O
variety	O
of	O
goal	O
-	O
directed	O
behaviors	O
has	O
been	O
identified	O
,	O
an	O
explicit	O
involvement	O
of	O
D2	B-PRGE
receptors	E-PRGE
has	O
not	O
been	O
clearly	O
established	O
.	O

To	O
determine	O
whether	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
-	O
mediated	O
signaling	O
contributes	O
to	O
associative	O
and	O
reversal	O
learning	O
,	O
we	O
compared	O
C57Bl	O
/	O
6J	O
mice	S-LIVB
that	O
completely	O
lack	O
functional	O
dopamine	B-PRGE
D2	I-PRGE
receptors	E-PRGE
to	O
wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
with	O
respect	O
to	O
their	O
ability	O
to	O
attach	O
appropriate	O
salience	O
to	O
external	O
stimuli	O
(	O
stimulus	O
discrimination	O
)	O
and	O
disengage	O
from	O
inappropriate	O
behavioral	O
strategies	O
when	O
reinforcement	O
contingencies	O
change	O
(	O
e	O
.	O
g	O
.	O
reversal	O
learning	O
)	O
.	O

Results	O

Mildly	O
food	S-CHEBI
-	O
deprived	O
female	O
wild	B-SO
-	I-SO
type	E-SO
and	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
deficient	O
mice	S-LIVB
rapidly	O
learned	O
to	O
retrieve	O
and	O
consume	O
visible	O
food	S-CHEBI
reinforcers	O
from	O
a	O
small	O
plastic	O
dish	O
.	O

Furthermore	O
,	O
both	O
genotypes	S-SO
readily	O
learned	O
to	O
dig	O
through	O
the	O
same	O
dish	O
filled	O
with	O
sterile	O
sand	O
in	O
order	O
to	O
locate	O
a	O
buried	O
food	S-CHEBI
pellet	O
.	O

However	O
,	O
the	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
deficient	O
mice	S-LIVB
required	O
significantly	O
more	O
trials	O
than	O
wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
to	O
discriminate	O
between	O
two	O
dishes	O
,	O
each	O
filled	O
with	O
a	O
different	O
scented	O
sand	O
,	O
and	O
to	O
associate	O
one	O
of	O
the	O
two	O
odors	O
with	O
the	O
presence	O
of	O
a	O
reinforcer	O
(	O
food	S-CHEBI
)	O
.	O

In	O
addition	O
,	O
the	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
deficient	O
mice	S-LIVB
repeatedly	O
fail	O
to	O
alter	O
their	O
response	O
patterns	O
during	O
reversal	O
trials	O
where	O
the	O
reinforcement	O
rules	O
were	O
inverted	O
.	O

Conclusions	O

Inbred	O
C57Bl	O
/	O
6J	O
mice	S-LIVB
that	O
develop	O
in	O
the	O
complete	O
absence	O
of	O
functional	O
dopamine	B-PRGE
D2	I-PRGE
receptors	E-PRGE
are	O
capable	O
of	O
olfaction	O
but	O
display	O
an	O
impaired	O
ability	O
to	O
acquire	O
odor	O
-	O
driven	O
reinforcement	O
contingencies	O
.	O

Furthermore	O
,	O
the	O
ability	O
of	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
deficient	O
mice	S-LIVB
to	O
adjust	O
their	O
responding	O
to	O
a	O
previously	O
reinforced	O
stimulus	O
when	O
unexpected	O
outcomes	O
are	O
encountered	O
is	O
significantly	O
impaired	O
.	O

These	O
findings	O
suggest	O
that	O
signaling	O
mediated	O
by	O
the	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
is	O
important	O
for	O
regulating	O
associative	O
and	O
reversal	O
learning	O
and	O
may	O
have	O
implications	O
for	O
the	O
treatment	O
of	O
human	S-LIVB
attention	O
disorders	O
.	O

Background	O

Reinforcement	O
-	O
mediated	O
associative	O
learning	O
,	O
or	O
the	O
ability	O
to	O
ascribe	O
deterministic	O
relationships	O
between	O
environmental	O
stimuli	O
that	O
signal	O
the	O
probability	O
of	O
receiving	O
a	O
primary	O
reinforcer	O
(	O
e	O
.	O
g	O
.	O
food	S-CHEBI
)	O
,	O
has	O
been	O
divided	O
into	O
3	O
components	O
or	O
stages	O
[	O
1	O
]	O
.	O

The	O
first	O
,	O
unlearned	O
stage	O
is	O
the	O
organism	S-LIVB
'	O
s	O
experience	O
with	O
a	O
primary	O
reinforcer	O
that	O
elicits	O
some	O
unlearned	O
/	O
innate	O
physiological	O
response	O
(	O
e	O
.	O
g	O
.	O
palatability	O
of	O
a	O
food	S-CHEBI
or	O
satiety	O
)	O
.	O

The	O
second	O
phase	O
involves	O
the	O
attachment	O
of	O
salience	O
to	O
external	O
stimuli	O
(	O
discriminative	O
stimuli	O
)	O
that	O
signal	O
whether	O
the	O
delivery	O
of	O
a	O
primary	O
reinforcer	O
will	O
or	O
will	O
not	O
occur	O
based	O
on	O
some	O
emitted	O
behavior	O
(	O
e	O
.	O
g	O
.	O
a	O
rodent	S-LIVB
lever	O
presses	O
for	O
food	S-CHEBI
pellets	O
only	O
when	O
a	O
stimulus	O
light	O
is	O
illuminated	O
in	O
an	O
operant	O
chamber	O
)	O
.	O

Finally	O
,	O
there	O
is	O
the	O
maintenance	O
of	O
associative	O
learning	O
relationships	O
over	O
time	O
(	O
a	O
stimulus	O
light	O
always	O
signifies	O
a	O
food	S-CHEBI
pellet	O
is	O
available	O
subsequent	O
to	O
a	O
lever	O
press	O
)	O
[	O
see	O
refs	O
.	O
[	O
1	O
,	O
2	O
]	O
for	O
review	O
]	O
.	O

Berridge	O
and	O
Robinson	O
[	O
1	O
]	O
have	O
proposed	O
that	O
dopamine	S-CHEBI
plays	O
a	O
pivotal	O
role	O
in	O
the	O
second	O
phase	O
of	O
reinforcement	O
-	O
mediated	O
associative	O
learning	O
by	O
molding	O
the	O
"	O
incentive	O
salience	O
"	O
or	O
learned	O
motivational	O
properties	O
of	O
conditioned	O
stimuli	O
.	O

In	O
support	O
of	O
this	O
view	O
are	O
several	O
studies	O
demonstrating	O
that	O
the	O
disruption	O
of	O
dopamine	S-CHEBI
signaling	O
via	O
acute	O
blockade	O
of	O
dopamine	S-CHEBI
receptors	O
with	O
dopamine	B-CHEBI
receptor	I-CHEBI
antagonists	E-CHEBI
[	O
3	O
-	O
9	O
]	O
or	O
6	O
-	O
OHDA	O
lesions	O
[	O
1	O
,	O
10	O
,	O
11	O
]	O
do	O
not	O
disrupt	O
phase	O
1	O
,	O
the	O
palatability	O
or	O
primary	O
reinforcing	O
characteristics	O
of	O
a	O
natural	O
reinforcer	O
(	O
e	O
.	O
g	O
.	O
palatability	O
)	O
but	O
disrupt	O
phase	O
2	O
,	O
the	O
formation	O
of	O
incentive	O
salience	O
.	O

Dopamine	S-CHEBI
signaling	O
is	O
mediated	O
at	O
the	O
cellular	S-CL
level	O
by	O
two	O
major	O
subclasses	O
of	O
G	O
-	O
protein	O
coupled	O
receptors	O
that	O
are	O
referred	O
to	O
as	O
D	B-PRGE
-	I-PRGE
1	I-PRGE
like	E-PRGE
(	O
D1aR	S-PRGE
,	O
D1b	S-PRGE
/	O
5R	O
)	O
or	O
D	B-PRGE
-	I-PRGE
2	I-PRGE
like	E-PRGE
(	O
D2R	S-PRGE
,	O
D3R	S-PRGE
,	O
D4R	S-PRGE
)	O
[	O
12	O
,	O
13	O
]	O
.	O

Although	O
individual	O
genes	S-SO
code	O
for	O
each	O
dopamine	S-CHEBI
receptor	O
subtype	O
,	O
there	O
is	O
considerable	O
pharmacological	O
overlap	O
between	O
D1	B-PRGE
-	I-PRGE
like	I-PRGE
and	I-PRGE
D2	I-PRGE
-	I-PRGE
like	I-PRGE
receptors	E-PRGE
.	O

Several	O
studies	O
have	O
used	O
pharmacological	O
manipulations	O
to	O
investigate	O
the	O
contribution	O
of	O
dopamine	S-CHEBI
receptor	O
subtypes	O
in	O
various	O
stages	O
of	O
associative	O
learning	O
[	O
1	O
,	O
2	O
,	O
14	O
]	O
.	O

Currently	O
it	O
is	O
held	O
that	O
excitatory	O
dopamine	B-PRGE
D1Rs	E-PRGE
mediate	O
the	O
acquisition	O
and	O
expression	O
of	O
several	O
conditioned	O
behaviors	O
involving	O
food	S-CHEBI
reinforcers	O
[	O
e	O
.	O
g	O
.	O
[	O
6	O
,	O
7	O
]	O
]	O
as	O
well	O
as	O
responding	O
for	O
conditioned	O
cues	O
predictive	O
of	O
cocaine	S-CHEBI
delivery	O
[	O
9	O
]	O
-	O
consistent	O
with	O
the	O
interpretation	O
that	O
D1R	S-PRGE
mediated	O
signaling	O
might	O
modulate	O
the	O
maintenance	O
of	O
stimulus	O
-	O
response	O
outcomes	O
.	O

Despite	O
a	O
growing	O
literature	O
demonstrating	O
disrupted	O
associative	O
learning	O
following	O
acute	O
manipulations	O
of	O
dopamine	B-PRGE
D1R	E-PRGE
signaling	O
during	O
acquisition	O
of	O
associative	O
learning	O
tasks	O
with	O
food	S-CHEBI
[	O
e	O
.	O
g	O
.	O
[	O
6	O
,	O
7	O
]	O
]	O
,	O
the	O
actual	O
contribution	O
of	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
on	O
acquisition	O
and	O
maintenance	O
of	O
associative	O
learning	O
in	O
rodents	S-LIVB
is	O
unresolved	O
.	O

While	O
D2R	S-PRGE
antagonists	S-CHEBI
have	O
been	O
used	O
in	O
the	O
context	O
of	O
rodent	S-LIVB
associative	O
learning	O
paradigms	O
,	O
their	O
lack	O
of	O
receptor	O
subtype	O
specificity	O
[	O
13	O
]	O
and	O
motor	O
-	O
disrupting	O
effects	O
[	O
6	O
,	O
8	O
]	O
have	O
prevented	O
a	O
rigorous	O
examination	O
of	O
the	O
actual	O
role	O
this	O
dopamine	S-CHEBI
receptor	O
subtype	O
plays	O
in	O
associative	O
and	O
reversal	O
learning	O
in	O
the	O
context	O
of	O
an	O
operant	O
behavior	O
.	O

Past	O
experiments	O
seeking	O
to	O
explore	O
the	O
possible	O
involvement	O
of	O
dopamine	B-PRGE
D2Rs	E-PRGE
in	O
associative	O
learning	O
have	O
utilized	O
low	O
to	O
moderate	O
doses	O
of	O
drugs	S-CHEBI
[	O
2	O
,	O
5	O
,	O
6	O
]	O
and	O
site	O
-	O
specific	O
administration	O
[	O
7	O
,	O
9	O
]	O
in	O
order	O
to	O
avoid	O
the	O
confounding	O
effect	O
that	O
locomotor	O
disruption	O
associated	O
with	O
acute	O
D2R	S-PRGE
blockade	O
can	O
have	O
on	O
learning	O
performance	O
in	O
rodents	S-LIVB
.	O

Besides	O
their	O
lack	O
of	O
receptor	O
subtype	O
specificity	O
,	O
an	O
acute	O
exposure	O
to	O
commercially	O
available	O
D2	B-PRGE
receptor	E-PRGE
antagonists	S-CHEBI
fails	O
to	O
completely	O
block	O
signaling	O
mediated	O
solely	O
by	O
D2Rs	S-PRGE
.	O

Moreover	O
,	O
acute	O
dosing	O
does	O
not	O
recapitulate	O
the	O
marked	O
learning	O
deficits	O
produced	O
in	O
rodents	S-LIVB
[	O
15	O
,	O
16	O
]	O
by	O
chronic	O
exposure	O
to	O
dopamine	B-CHEBI
D2R	I-CHEBI
antagonists	E-CHEBI
[	O
6	O
,	O
7	O
]	O
.	O

The	O
influence	O
of	O
dopamine	B-PRGE
D2R	E-PRGE
-	O
mediated	O
signaling	O
on	O
reversal	O
learning	O
is	O
also	O
poorly	O
understood	O
.	O

Reversal	O
learning	O
can	O
be	O
conceptualized	O
as	O
the	O
ability	O
to	O
recognize	O
an	O
unexpected	O
consequence	O
to	O
a	O
previously	O
established	O
associative	O
learning	O
rule	O
and	O
then	O
alter	O
response	O
strategies	O
accordingly	O
[	O
17	O
,	O
18	O
]	O
.	O

Reversal	O
learning	O
in	O
rodents	S-LIVB
can	O
serve	O
as	O
an	O
index	O
of	O
learning	O
adaptability	O
and	O
alertness	O
that	O
correlates	O
with	O
human	S-LIVB
attentional	O
-	O
shift	O
paradigms	O
[	O
17	O
,	O
18	O
]	O
.	O

Additionally	O
,	O
a	O
previous	O
report	O
demonstrated	O
that	O
excitotoxic	O
lesions	O
of	O
terminal	S-GO
field	O
targets	O
of	O
mesocortical	O
dopamine	S-CHEBI
have	O
been	O
shown	O
to	O
disrupt	O
reversal	O
learning	O
[	O
19	O
]	O
.	O

Administration	O
of	O
the	O
D2R	S-PRGE
/	O
D3R	S-PRGE
antagonist	S-CHEBI
,	O
sulpiride	O
,	O
impairs	O
spatial	O
reversal	O
leaning	O
in	O
mice	S-LIVB
[	O
20	O
]	O
and	O
has	O
also	O
been	O
shown	O
to	O
impair	O
attention	O
and	O
the	O
cognitive	O
performances	O
of	O
healthy	O
human	S-LIVB
volunteers	O
[	O
21	O
]	O
.	O

Moreover	O
an	O
inverse	O
relationship	O
between	O
lower	O
dopamine	B-PRGE
D2R	E-PRGE
levels	O
and	O
compulsive	O
behavior	O
in	O
human	S-LIVB
subjects	O
has	O
been	O
reported	O
[	O
22	O
]	O
.	O

Taken	O
together	O
these	O
findings	O
suggest	O
that	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
could	O
play	O
a	O
critical	O
role	O
in	O
reversal	O
learning	O
but	O
are	O
insufficient	O
to	O
prove	O
it	O
.	O

In	O
an	O
effort	O
to	O
establish	O
the	O
contribution	O
of	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
-	O
mediated	O
signaling	O
to	O
associative	O
and	O
non	O
-	O
spatial	O
reversal	O
learning	O
in	O
adult	O
mice	S-LIVB
,	O
we	O
compared	O
mice	S-LIVB
[	O
23	O
]	O
that	O
had	O
developed	O
in	O
the	O
complete	O
absence	O
of	O
all	O
functional	O
dopamine	B-PRGE
D2	I-PRGE
receptors	E-PRGE
(	O
D2R	S-PRGE
-	O
/	O
-	O
)	O
to	O
wild	B-SO
-	I-SO
type	E-SO
littermates	O
(	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
)	O
in	O
a	O
go	O
/	O
no	O
-	O
go	O
operant	O
learning	O
procedure	O
that	O
measures	O
primary	O
reinforcement	O
,	O
sensory	O
processing	O
,	O
and	O
reversal	O
learning	O
[	O
17	O
-	O
19	O
]	O
.	O

Here	O
we	O
report	O
that	O
dopamine	B-PRGE
D2R	E-PRGE
-	O
mediated	O
signaling	O
must	O
be	O
intact	O
if	O
a	O
mouse	S-LIVB
is	O
to	O
efficiently	O
learn	O
to	O
associate	O
a	O
food	S-CHEBI
reinforcer	O
with	O
a	O
specific	O
odor	O
and	O
then	O
adaptively	O
disengage	O
inappropriate	O
behavioral	O
strategies	O
following	O
the	O
reversal	O
of	O
reinforcement	O
contingencies	O
.	O

Results	O

Both	O
wild	B-SO
-	I-SO
type	E-SO
and	O
D2R	S-PRGE
deficient	O
mice	S-LIVB
learn	O
operant	O
behaviors	O
equally	O
well	O

Mildly	O
food	S-CHEBI
-	O
deprived	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
and	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
readily	O
learned	O
to	O
locate	O
and	O
consume	O
food	S-CHEBI
pellets	O
during	O
both	O
training	O
sessions	O
.	O

Figure	O
1	O
depicts	O
the	O
latency	O
for	O
both	O
genotypes	S-SO
to	O
ambulate	O
to	O
a	O
dish	O
to	O
retrieve	O
an	O
unhidden	O
food	S-CHEBI
pellet	O
.	O

There	O
were	O
no	O
differences	O
between	O
genotypes	S-SO
to	O
retrieve	O
the	O
reinforcers	O
(	O
F1	O
,	O
59	O
=	O
0	O
.	O
2	O
,	O
p	O
>	O
0	O
.	O
65	O
)	O
,	O
and	O
both	O
groups	O
significantly	O
decreased	O
the	O
amount	O
of	O
time	O
necessary	O
to	O
perform	O
this	O
task	O
along	O
successive	O
trials	O
(	O
F4	O
,	O
59	O
=	O
5	O
.	O
74	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figure	O
2	O
depicts	O
the	O
latency	O
to	O
dig	O
for	O
the	O
food	S-CHEBI
pellet	O
buried	O
in	O
a	O
single	O
dish	O
filled	O
with	O
unscented	O
sand	O
.	O

No	O
genotype	S-SO
differences	O
were	O
found	O
in	O
the	O
ability	O
to	O
dig	O
through	O
unscented	O
sand	O
for	O
a	O
hidden	O
food	S-CHEBI
pellet	O
(	O
F1	O
,	O
128	O
=	O
1	O
.	O
26	O
,	O
p	O
>	O
0	O
.	O
27	O
)	O
.	O

Wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
outperform	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
in	O
an	O
odor	O
-	O
driven	O
,	O
stimulus	O
-	O
discrimination	O
,	O
operant	O
task	O

To	O
master	O
the	O
odor	O
-	O
driven	O
stimulus	O
discrimination	O
task	O
,	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
required	O
significantly	O
more	O
trials	O
(	O
Fig	O
.	O
3A	O
:	O
t	O
(	O
14	O
)	O
=	O
2	O
.	O
20	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
committed	O
more	O
errors	O
(	O
Fig	O
.	O
3B	O
:	O
t	O
(	O
14	O
)	O
=	O
2	O
.	O
92	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
than	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
to	O
learn	O
to	O
associate	O
a	O
specific	O
odor	O
with	O
the	O
presence	O
or	O
absence	O
of	O
the	O
food	S-CHEBI
reinforcer	O
.	O

However	O
,	O
both	O
genotypes	S-SO
did	O
learn	O
the	O
task	O
and	O
eventually	O
maintained	O
accurate	O
discrimination	O
for	O
a	O
minimum	O
of	O
8	O
correct	O
responses	O
out	O
of	O
10	O
trials	O
.	O

Mice	S-LIVB
lacking	O
dopamine	B-PRGE
D2	I-PRGE
receptors	E-PRGE
engage	O
in	O
unreinforced	O
behavior	O
in	O
a	O
perseverative	O
manner	O
following	O
reversal	O
of	O
reinforcement	O
contingencies	O

D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
repeatedly	O
failed	O
to	O
inhibit	O
previously	O
established	O
learning	O
contingencies	O
during	O
reversal	O
trials	O
(	O
Fig	O
.	O
4A	O
:	O
t	O
(	O
14	O
)	O
=	O
3	O
.	O
54	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
committed	O
significantly	O
more	O
reversal	O
errors	O
than	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
Fig	O
.	O
4B	O
:	O
t	O
(	O
14	O
)	O
=	O
3	O
.	O
18	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Categorical	O
division	O
of	O
reversal	O
errors	O
(	O
Ferry	O
et	O
al	O
.	O
,	O
2000	O
)	O
-	O
digging	O
in	O
the	O
dish	O
that	O
did	O
not	O
contain	O
the	O
food	S-CHEBI
pellet	O
(	O
S	O
-	O
)	O
(	O
error	O
of	O
commission	O
;	O
Fig	O
.	O
5A	O
)	O
versus	O
failing	O
to	O
respond	O
within	O
3	O
-	O
min	O
of	O
presentation	O
(	O
error	O
of	O
omission	O
;	O
Fig	O
.	O
5B	O
)	O
revealed	O
that	O
both	O
genotypes	S-SO
chiefly	O
committed	O
errors	O
of	O
commission	O
versus	O
errors	O
of	O
omission	O
(	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
,	O
U	O
=	O
0	O
.	O
00	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
U	O
=	O
9	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
committed	O
more	O
commission	O
errors	O
than	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
U	O
=	O
5	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
there	O
were	O
no	O
differences	O
between	O
D2R	S-PRGE
-	O
/	O
-	O
and	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
in	O
omission	O
errors	O
(	O
U	O
=	O
27	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
65	O
)	O
.	O

Moreover	O
,	O
the	O
number	O
of	O
commission	O
errors	O
committed	O
during	O
the	O
first	O
reversal	O
session	O
(	O
an	O
index	O
of	O
stimulus	O
bound	O
perseveration	O
,	O
where	O
all	O
animals	S-LIVB
are	O
responding	O
to	O
the	O
reversed	O
contingencies	O
for	O
the	O
first	O
time	O
;	O
Fig	O
.	O
6	O
)	O
indicated	O
a	O
deficit	O
in	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
compared	O
to	O
the	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
U	O
=	O
8	O
.	O
5	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Finally	O
,	O
in	O
an	O
attempt	O
to	O
assess	O
whether	O
perseveration	O
occurred	O
across	O
multiple	O
reversal	O
sessions	O
(	O
Fig	O
.	O
7	O
)	O
,	O
we	O
analyzed	O
the	O
number	O
of	O
commission	O
errors	O
emitted	O
before	O
relearning	O
the	O
reinforcement	O
contingencies	O
during	O
the	O
reversal	O
sessions	O
.	O

The	O
data	O
depicted	O
were	O
collected	O
from	O
subjects	O
that	O
had	O
not	O
achieved	O
the	O
80	O
%	O
performance	O
criterion	O
.	O

Therefore	O
,	O
the	O
number	O
of	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
represented	O
in	O
session	O
#	O
1	O
is	O
8	O
,	O
in	O
session	O
#	O
2	O
n	O
=	O
8	O
,	O
session	O
#	O
3	O
n	O
=	O
6	O
(	O
2	O
mice	S-LIVB
met	O
our	O
criterion	O
)	O
,	O
in	O
session	O
#	O
4	O
n	O
=	O
5	O
(	O
three	O
met	O
the	O
criterion	O
)	O
.	O

Following	O
session	O
5	O
,	O
the	O
remaining	O
5	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
had	O
met	O
criteria	O
.	O

For	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
,	O
each	O
point	O
on	O
the	O
graph	O
represents	O
8	O
subjects	O
.	O

None	O
of	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
achieved	O
the	O
criterion	O
of	O
80	O
%	O
accuracy	O
by	O
session	O
5	O
.	O

For	O
the	O
overall	O
2	O
-	O
way	O
ANOVA	O
,	O
there	O
was	O
a	O
significant	O
difference	O
between	O
genotypes	S-SO
for	O
the	O
number	O
of	O
perseverative	O
errors	O
(	O
F1	O
,	O
51	O
=	O
16	O
.	O
61	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
determine	O
the	O
contribution	O
of	O
dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
-	O
mediated	O
signaling	O
to	O
the	O
various	O
stages	O
of	O
associative	O
and	O
reversal	O
learning	O
.	O

D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
demonstrated	O
that	O
they	O
were	O
capable	O
of	O
learning	O
to	O
locate	O
and	O
consume	O
food	S-CHEBI
pellets	O
,	O
indicating	O
that	O
their	O
locomotor	O
behavior	O
was	O
not	O
detectably	O
disrupted	O
and	O
their	O
primary	O
motivation	O
to	O
obtain	O
a	O
natural	O
reinforcer	O
(	O
food	S-CHEBI
pellet	O
)	O
was	O
undisturbed	O
.	O

Rather	O
,	O
the	O
impaired	O
ability	O
of	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
to	O
assign	O
appropriate	O
discriminative	O
stimulus	O
relationships	O
in	O
an	O
operant	O
discrimination	O
task	O
argues	O
that	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
contributes	O
to	O
the	O
neuronal	S-CL
processes	O
involved	O
in	O
attaching	O
salience	O
to	O
environmental	O
stimuli	O
.	O

The	O
deficient	O
capacity	O
of	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
to	O
disengage	O
inappropriate	O
decision	O
strategies	O
strongly	O
argues	O
that	O
mesolimbic	O
dopamine	S-CHEBI
signaling	O
,	O
mediated	O
by	O
dopamine	B-PRGE
D2Rs	E-PRGE
is	O
essential	O
for	O
efficient	O
reversal	O
learning	O
to	O
occur	O
.	O

Mice	S-LIVB
with	O
or	O
without	O
intact	O
dopamine	B-PRGE
D2R	E-PRGE
-	O
mediated	O
signaling	O
displayed	O
similar	O
decreases	O
in	O
latencies	O
to	O
retrieve	O
unhidden	O
food	S-CHEBI
pellets	O
(	O
Fig	O
.	O
1	O
)	O
and	O
learned	O
to	O
dig	O
for	O
food	S-CHEBI
buried	O
in	O
unscented	O
sand	O
(	O
Fig	O
.	O
2	O
)	O
.	O

These	O
findings	O
are	O
in	O
complete	O
agreement	O
with	O
earlier	O
studies	O
that	O
utilized	O
rats	S-LIVB
and	O
fairly	O
selective	O
D2R	S-PRGE
antagonists	S-CHEBI
[	O
3	O
-	O
8	O
]	O
,	O
as	O
well	O
as	O
even	O
very	O
extensive	O
6	O
-	O
OHDA	O
lesions	O
[	O
1	O
,	O
10	O
,	O
11	O
]	O
in	O
associative	O
and	O
operant	O
learning	O
paradigms	O
.	O

Our	O
results	O
add	O
to	O
a	O
growing	O
literature	O
demonstrating	O
a	O
negligible	O
role	O
of	O
dopamine	S-CHEBI
,	O
and	O
now	O
,	O
specifically	O
,	O
D2Rs	S-PRGE
in	O
the	O
unconditioned	O
or	O
hedonic	O
value	O
of	O
natural	O
(	O
food	S-CHEBI
)	O
reinforcers	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
comparatively	O
poor	O
skill	O
of	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
during	O
discrimination	O
trials	O
suggests	O
a	O
role	O
for	O
D2Rs	S-PRGE
in	O
acquisition	O
of	O
appropriate	O
S	O
+	O
/	O
S	O
-	O
relationships	O
in	O
operant	O
associative	O
learning	O
.	O

Several	O
studies	O
have	O
demonstrated	O
that	O
both	O
the	O
acquisition	O
[	O
6	O
,	O
7	O
]	O
and	O
expression	O
[	O
9	O
]	O
of	O
associative	O
learning	O
are	O
mediated	O
by	O
dopamine	B-PRGE
D1Rs	E-PRGE
.	O

Most	O
literature	O
reviews	O
identify	O
dopamine	B-PRGE
D1Rs	E-PRGE
with	O
dopamine	S-CHEBI
-	O
mediated	O
learning	O
and	O
D2Rs	S-PRGE
with	O
motor	O
related	O
behaviors	O
[	O
e	O
.	O
g	O
.	O
[	O
24	O
]	O
]	O
.	O

Moreover	O
,	O
it	O
has	O
been	O
reported	O
that	O
acute	O
administration	O
of	O
the	O
dopamine	B-CHEBI
D2	I-CHEBI
/	I-CHEBI
3	I-CHEBI
antagonist	E-CHEBI
,	O
raclopride	O
,	O
actually	O
improves	O
acquisition	O
of	O
food	S-CHEBI
-	O
motivated	O
associative	O
learning	O
[	O
6	O
]	O
.	O

However	O
,	O
only	O
acute	O
administrations	O
of	O
antagonists	S-CHEBI
were	O
given	O
,	O
and	O
learning	O
was	O
not	O
measured	O
during	O
complete	O
D1R	S-PRGE
or	O
D2R	S-PRGE
blockade	O
[	O
6	O
]	O
.	O

Significantly	O
,	O
the	O
reports	O
cited	O
above	O
failed	O
to	O
address	O
the	O
technical	O
limitations	O
of	O
the	O
approach	O
:	O
i	O
.	O
e	O
.	O
that	O
the	O
antagonists	S-CHEBI
used	O
lack	O
adequate	O
subtype	O
specificity	O
and	O
only	O
partially	O
blocked	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
thus	O
making	O
it	O
impossible	O
to	O
rigorously	O
assess	O
the	O
role	O
of	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
in	O
associative	O
and	O
reversal	O
learning	O
.	O

Additionally	O
,	O
none	O
of	O
these	O
studies	O
addressed	O
the	O
observation	O
that	O
the	O
effects	O
of	O
D2R	S-PRGE
antagonists	S-CHEBI
on	O
locomotion	O
and	O
learning	O
depend	O
on	O
whether	O
exposure	O
is	O
chronic	O
or	O
acute	O
[	O
e	O
.	O
g	O
.	O
[	O
15	O
,	O
16	O
]	O
]	O
.	O

That	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
orchestrates	O
just	O
motor	O
components	O
of	O
learning	O
is	O
a	O
conclusion	O
that	O
is	O
potentially	O
biased	O
due	O
to	O
the	O
practice	O
of	O
avoiding	O
doses	O
of	O
drugs	S-CHEBI
that	O
induce	O
catalepsy	O
(	O
and	O
therefore	O
measuring	O
only	O
partial	O
blockade	O
of	O
dopamine	B-PRGE
D2Rs	E-PRGE
)	O
and	O
single	O
administrations	O
[	O
e	O
.	O
g	O
.	O
[	O
3	O
]	O
]	O
.	O

Quite	O
possibly	O
,	O
the	O
functional	O
role	O
of	O
D2Rs	S-PRGE
in	O
associative	O
learning	O
might	O
be	O
masked	O
because	O
of	O
this	O
concern	O
about	O
locomotor	O
disruption	O
[	O
2	O
,	O
6	O
,	O
8	O
]	O
.	O

Doses	O
of	O
raclopride	O
as	O
low	O
as	O
0	O
.	O
5	O
mg	O
/	O
kg	O
significantly	O
disrupt	O
motor	O
behavior	O
[	O
25	O
]	O
,	O
although	O
this	O
peripheral	O
dose	O
is	O
consistently	O
used	O
in	O
learning	O
paradigms	O
[	O
e	O
.	O
g	O
.	O
[	O
6	O
]	O
]	O
.	O

One	O
might	O
then	O
ask	O
:	O
"	O
How	O
then	O
could	O
the	O
role	O
of	O
D2Rs	S-PRGE
in	O
associative	O
learning	O
be	O
dissociated	O
from	O
motor	O
behavior	O
?	O
"	O
Seminal	O
experiments	O
[	O
26	O
-	O
28	O
]	O
have	O
clearly	O
demonstrated	O
that	O
repeated	O
administration	O
of	O
catalepsy	O
-	O
inducing	O
doses	O
of	O
D2R	S-PRGE
antagonists	S-CHEBI
in	O
rodents	S-LIVB
actually	O
leads	O
to	O
a	O
striking	O
behavioral	O
tolerance	O
to	O
catalepsy	O
.	O

These	O
doses	O
have	O
been	O
shown	O
to	O
occupy	O
well	O
over	O
80	O
%	O
of	O
available	O
D2Rs	S-PRGE
[	O
29	O
]	O
.	O

Future	O
experiments	O
measuring	O
acquisition	O
of	O
associative	O
learning	O
in	O
rodents	S-LIVB
that	O
received	O
chronic	O
administration	O
of	O
D2R	S-PRGE
antagonists	S-CHEBI
and	O
demonstrated	O
behavioral	O
tolerance	O
to	O
their	O
motor	O
disrupting	O
effects	O
would	O
be	O
a	O
logical	O
test	O
of	O
this	O
hypothesis	O
.	O

However	O
,	O
the	O
realization	O
that	O
multiple	O
dopamine	S-CHEBI
receptor	O
subtypes	O
would	O
be	O
concurrently	O
targeted	O
with	O
the	O
presently	O
commercially	O
available	O
antagonists	S-CHEBI
,	O
such	O
as	O
D2Rs	S-PRGE
,	O
D3Rs	S-PRGE
,	O
and	O
D4Rs	S-PRGE
would	O
have	O
to	O
be	O
rectified	O
.	O

We	O
would	O
argue	O
that	O
the	O
most	O
parsimonious	O
approach	O
at	O
this	O
time	O
is	O
to	O
utilize	O
mice	S-LIVB
that	O
have	O
been	O
genetically	S-SO
altered	S-SO
such	O
that	O
they	O
are	O
lacking	O
one	O
or	O
both	O
functional	O
alleles	S-SO
of	O
the	O
specific	O
receptor	O
of	O
interest	O
.	O

While	O
they	O
do	O
have	O
their	O
limitations	O
(	O
e	O
.	O
g	O
.	O
developmental	O
compensation	O
and	O
strain	O
effects	O
in	O
mouse	S-LIVB
lines	O
not	O
backcrossed	O
adequately	O
to	O
a	O
parental	O
strain	O
for	O
a	O
minimum	O
of	O
10	O
generations	O
)	O
,	O
use	O
of	O
our	O
inbred	O
(	O
N20	O
generation	O
)	O
animals	S-LIVB
in	O
the	O
present	O
study	O
(	O
where	O
no	O
differences	O
in	O
locomotor	O
behavior	O
were	O
detected	O
between	O
D2R	S-PRGE
-	O
/	O
-	O
and	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
;	O
Figs	O
.	O
1	O
&	O
2	O
)	O
revealed	O
a	O
previously	O
unappreciated	O
role	O
of	O
D2R	S-PRGE
-	O
mediated	O
signaling	O
in	O
associative	O
learning	O
and	O
attention	O
that	O
could	O
not	O
be	O
measured	O
with	O
the	O
currently	O
available	O
,	O
acutely	O
administered	O
D2R	S-PRGE
antagonists	S-CHEBI
.	O

A	O
cursory	O
analysis	O
of	O
our	O
data	O
might	O
suggest	O
to	O
some	O
that	O
the	O
genetic	S-SO
manipulation	O
of	O
the	O
drd2	S-PRGE
locus	S-SO
conferred	O
a	O
gross	O
olfactory	O
impairment	O
to	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
.	O

Rather	O
,	O
we	O
argue	O
that	O
this	O
is	O
not	O
likely	O
because	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
did	O
learn	O
to	O
retrieve	O
the	O
food	S-CHEBI
pellets	O
from	O
the	O
dishes	O
and	O
eventually	O
learned	O
to	O
accurately	O
discriminate	O
odors	O
.	O

Recent	O
electrophysiological	O
data	O
demonstrate	O
that	O
dopamine	B-PRGE
D2R	I-PRGE
'	I-PRGE
s	E-PRGE
are	O
located	O
on	O
glutamatergic	S-CHEBI
terminal	O
axons	S-GO
of	O
olfactory	O
nerves	O
and	O
depress	O
excitatory	O
input	O
of	O
the	O
olfactory	O
nerve	O
to	O
the	O
mitral	O
cells	S-CL
of	O
the	O
olfactory	O
bulb	O
[	O
30	O
,	O
31	O
]	O
.	O

Consequently	O
,	O
our	O
data	O
,	O
and	O
data	O
from	O
other	O
studies	O
,	O
suggest	O
that	O
the	O
complete	O
lack	O
of	O
D2Rs	S-PRGE
in	O
the	O
olfactory	O
bulb	O
does	O
not	O
prevent	O
transduction	O
of	O
olfactory	O
stimuli	O
;	O
rather	O
it	O
affects	O
the	O
ability	O
to	O
habituate	O
,	O
or	O
tune	O
,	O
olfactory	O
nerve	O
activity	O
associated	O
with	O
repeatedly	O
encountered	O
concentrations	O
of	O
chemical	S-CHEBI
stimuli	O
[	O
32	O
]	O
.	O

The	O
performance	O
of	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
during	O
reversal	O
learning	O
is	O
deficient	O
revealing	O
a	O
role	O
for	O
dopamine	B-PRGE
D2R	E-PRGE
-	O
mediated	O
signaling	O
in	O
tasks	O
requiring	O
behavioral	O
flexibility	O

Perseverative	O
behavioral	O
patterns	O
characterized	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
relative	O
to	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
during	O
reversal	O
learning	O
sessions	O
(	O
Figure	O
4	O
)	O
,	O
manifested	O
during	O
early	O
reversal	O
trials	O
(	O
Figure	O
6	O
)	O
and	O
persisted	O
across	O
several	O
sessions	O
(	O
Figure	O
7	O
)	O
.	O

These	O
findings	O
are	O
significant	O
because	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
respond	O
to	O
food	S-CHEBI
reinforcers	O
and	O
ultimately	O
form	O
and	O
maintain	O
odor	O
-	O
driven	O
S	O
+	O
/	O
S	O
-	O
relationships	O
(	O
a	O
putative	O
D1R	S-PRGE
-	O
mediated	O
behavior	O
[	O
6	O
]	O
)	O
just	O
as	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
both	O
groups	O
achieved	O
>=	O
80	O
%	O
discrimination	O
accuracy	O
,	O
the	O
dopamine	B-PRGE
D1Rs	E-PRGE
in	O
our	O
mice	S-LIVB
were	O
not	O
targeted	O
)	O
.	O

A	O
future	O
extension	O
of	O
this	O
study	O
would	O
be	O
to	O
test	O
performance	O
over	O
a	O
fixed	O
number	O
of	O
trials	O
and	O
determine	O
patterns	O
of	O
error	O
rates	O
during	O
acquisition	O
of	O
the	O
discrimination	O
and	O
reversal	O
learning	O
tasks	O
.	O

This	O
manipulation	O
would	O
control	O
the	O
number	O
of	O
errors	O
based	O
on	O
trials	O
performed	O
to	O
determine	O
if	O
the	O
apparent	O
difference	O
in	O
absolute	O
number	O
of	O
errors	O
demonstrated	O
by	O
the	O
mutant	S-SO
mice	S-LIVB
(	O
the	O
putative	O
performance	O
deficit	O
)	O
is	O
simply	O
a	O
reflection	O
of	O
extra	O
trials	O
.	O

Nonetheless	O
,	O
the	O
inability	O
of	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
to	O
disengage	O
from	O
previously	O
established	O
S	O
+	O
/	O
S	O
-	O
contingencies	O
(	O
responding	O
to	O
a	O
discriminative	O
stimulus	O
;	O
Fig	O
.	O
4	O
)	O
strongly	O
argues	O
that	O
mesolimbic	O
dopamine	S-CHEBI
,	O
and	O
in	O
particular	O
dopamine	B-PRGE
D2R	E-PRGE
-	O
mediated	O
signaling	O
,	O
modulates	O
the	O
process	O
of	O
alerting	O
the	O
subject	O
that	O
familiar	O
contingencies	O
are	O
now	O
associated	O
unexpected	O
consequences	O
.	O

Schultz	O
and	O
colleagues	O
have	O
demonstrated	O
that	O
dopamine	B-CL
cells	E-CL
display	O
consistent	O
tonic	O
firing	O
patterns	O
during	O
maintenance	O
of	O
associative	O
learning	O
tasks	O
[	O
33	O
]	O
.	O

However	O
,	O
phasic	O
burst	O
activity	O
of	O
dopaminergic	B-CL
cells	E-CL
occurs	O
when	O
discrepancies	O
between	O
predicted	O
and	O
actual	O
reinforcement	O
contingencies	O
transpire	O
[	O
14	O
]	O
.	O

This	O
robust	O
increase	O
of	O
dopaminergic	B-CL
cell	E-CL
activation	O
in	O
response	O
to	O
unpredicted	O
outcomes	O
has	O
been	O
referred	O
to	O
as	O
an	O
"	O
error	O
"	O
signal	O
[	O
14	O
]	O
.	O

To	O
date	O
,	O
the	O
molecular	S-CHEBI
basis	O
of	O
this	O
error	O
signal	O
has	O
not	O
been	O
identified	O
.	O

The	O
inability	O
of	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
to	O
desist	O
responding	O
to	O
a	O
previously	O
reinforced	O
stimulus	O
suggests	O
that	O
the	O
dopamine	B-PRGE
D2R	E-PRGE
might	O
in	O
fact	O
be	O
the	O
focal	O
point	O
of	O
this	O
error	O
-	O
signaling	O
cascade	O
.	O

Electrophysiological	O
data	O
further	O
support	O
the	O
hypothesis	O
that	O
signaling	O
mediated	O
by	O
dopamine	B-PRGE
D2Rs	E-PRGE
tunes	O
D1R	S-PRGE
-	O
mediated	O
mesocorticolimbic	O
output	O
.	O

Calabresi	O
et	O
al	O
.	O

[	O
34	O
]	O
demonstrated	O
that	O
tetanic	O
stimulation	O
of	O
dorsal	O
striatum	O
slices	O
prepared	O
from	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
is	O
associated	O
with	O
enhanced	O
EPSP	O
and	O
as	O
a	O
result	O
increased	O
striatal	O
synaptic	S-GO
efficacy	O
.	O

In	O
contrast	O
,	O
stimulation	O
of	O
dorsal	O
striatum	O
slices	O
from	O
wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
resulted	O
in	O
IPSP	O
activity	O
,	O
long	O
-	O
term	O
depression	O
,	O
and	O
decreased	O
neuronal	S-CL
activity	O
of	O
striatal	O
efferents	O
[	O
34	O
]	O
.	O

Carlsson	O
and	O
colleagues	O
[	O
35	O
]	O
have	O
speculated	O
that	O
dopamine	B-PRGE
D2R	E-PRGE
stimulation	O
in	O
the	O
striatum	O
serves	O
to	O
"	O
brake	O
"	O
or	O
diminish	O
excitatory	O
corticostriatal	O
signaling	O
and	O
plasticity	O
.	O

Indeed	O
,	O
perseverative	O
behavior	O
is	O
associated	O
with	O
over	O
activity	O
of	O
the	O
dorsal	O
striatum	O
in	O
rodents	S-LIVB
[	O
36	O
]	O
and	O
over	O
activity	O
of	O
the	O
caudate	O
in	O
patients	O
with	O
ADHD	O
[	O
37	O
]	O
and	O
a	O
strong	O
inverse	O
correlation	O
of	O
D2R	S-PRGE
binding	O
with	O
compulsive	O
behavior	O
has	O
been	O
reported	O
[	O
22	O
]	O
.	O

Importantly	O
,	O
our	O
data	O
indicate	O
that	O
the	O
poor	O
performances	O
displayed	O
by	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
are	O
manifestations	O
of	O
reversal	O
learning	O
deficits	O
and	O
not	O
gross	O
motivational	O
or	O
sensory	O
impairments	O
.	O

We	O
therefore	O
argue	O
that	O
D2Rs	S-PRGE
participate	O
in	O
signaling	O
or	O
alerting	O
the	O
organism	S-LIVB
of	O
learning	O
contingency	O
changes	O
during	O
reversal	O
learning	O
and	O
sculpt	O
ongoing	O
goal	O
-	O
directed	O
behavior	O
.	O

Conclusions	O

This	O
study	O
demonstrates	O
that	O
signaling	O
by	O
dopamine	B-PRGE
D2Rs	E-PRGE
does	O
not	O
mediate	O
the	O
hedonic	O
value	O
of	O
reinforcers	O
,	O
supporting	O
and	O
refining	O
earlier	O
findings	O
[	O
1	O
,	O
2	O
]	O
.	O

However	O
,	O
mice	S-LIVB
completely	O
deficient	O
in	O
D2Rs	S-PRGE
demonstrated	O
disrupted	O
acquisition	O
of	O
discriminative	O
stimulus	O
relationships	O
and	O
an	O
impaired	O
ability	O
to	O
recognize	O
changes	O
in	O
behavioral	O
determinants	O
.	O

Therefore	O
,	O
we	O
suggest	O
that	O
during	O
associative	O
learning	O
or	O
when	O
unexpected	O
reinforcement	O
outcomes	O
are	O
modified	O
(	O
reversal	O
learning	O
)	O
dopamine	S-CHEBI
-	O
driven	O
reinforcement	O
impulses	O
involve	O
signaling	O
mediated	O
by	O
dopamine	B-PRGE
D2Rs	E-PRGE
.	O

In	O
the	O
course	O
of	O
associative	O
learning	O
,	O
striatal	O
synapses	S-GO
[	O
38	O
]	O
receive	O
experience	O
-	O
driven	O
gain	O
[	O
7	O
]	O
,	O
thus	O
permitting	O
newly	O
established	O
reinforcement	O
-	O
mediated	O
signals	O
to	O
traverse	O
ascending	O
efferents	O
en	O
route	O
to	O
the	O
frontal	O
cortex	O
,	O
completing	O
a	O
functional	O
limbic	O
/	O
motor	O
circuit	O
[	O
39	O
-	O
41	O
]	O
.	O

Possibly	O
,	O
the	O
lack	O
of	O
dopamine	B-PRGE
D2R	E-PRGE
-	O
mediated	O
signaling	O
prevents	O
refinement	O
of	O
the	O
corticostriatal	O
reinforcement	O
circuits	O
in	O
the	O
brains	O
of	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
,	O
thus	O
impairing	O
their	O
ability	O
to	O
form	O
S	O
+	O
/	O
S	O
-	O
contingencies	O
and	O
disengage	O
inappropriate	O
dopamine	B-PRGE
D1R	E-PRGE
-	O
mediated	O
associative	O
responding	O
when	O
unexpected	O
consequences	O
to	O
goal	O
-	O
directed	O
behaviors	O
happened	O
.	O

Consequently	O
,	O
we	O
are	O
compelled	O
to	O
conclude	O
that	O
the	O
perseverative	O
performance	O
deficits	O
demonstrated	O
by	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
in	O
the	O
tasks	O
used	O
in	O
the	O
present	O
study	O
reveal	O
a	O
previously	O
unreported	O
role	O
for	O
D2Rs	S-PRGE
in	O
associative	O
and	O
reversal	O
learning	O
.	O

Methods	O

Subjects	O

The	O
sixteen	O
,	O
8	O
-	O
10	O
week	O
old	O
,	O
25	O
-	O
30	O
g	O
mice	S-LIVB
(	O
8	O
per	O
genotype	S-SO
)	O
used	O
in	O
this	O
study	O
were	O
the	O
congenic	O
offspring	O
of	O
breeders	O
that	O
were	O
descendants	O
of	O
the	O
original	O
F2	O
hybrid	O
(	O
129	O
/	O
Sv	O
x	O
C57BL	O
/	O
6J	O
;	O
Kelly	O
et	O
al	O
.	O
,	O
1997	O
)	O
that	O
was	O
backcrossed	O
to	O
inbred	O
C57Bl	O
/	O
6J	O
stock	O
(	O
Jackson	O
Laboratories	O
,	O
ME	O
)	O
.	O

This	O
breeding	O
strategy	O
was	O
repeated	O
for	O
20	O
successive	O
generations	O
with	O
the	O
gender	O
of	O
the	O
donor	O
/	O
mutant	S-SO
alternating	O
with	O
each	O
generation	O
.	O

All	O
experimental	O
subjects	O
were	O
genotyped	O
by	O
PCR	O
as	O
previously	O
described	O
[	O
23	O
]	O
.	O

All	O
testing	O
occured	O
randomly	O
across	O
estrous	O
cycles	O
.	O

The	O
Department	O
of	O
Comparative	O
Medicine	O
at	O
Oregon	O
Health	O
and	O
Science	O
University	O
approved	O
all	O
protocols	O
,	O
and	O
all	O
animals	S-LIVB
were	O
maintained	O
in	O
accordance	O
to	O
National	O
Institutes	O
of	O
Health	O
'	O
s	O
Guide	O
for	O
the	O
Care	O
and	O
Use	O
of	O
Laboratory	O
Animals	S-LIVB
.	O

Experimental	O
procedures	O

Odor	O
discrimination	O
training	O
and	O
testing	O

A	O
2	O
-	O
odor	O
discrimination	O
paradigm	O
was	O
chosen	O
because	O
it	O
permits	O
a	O
measure	O
of	O
attentional	O
focus	O
in	O
goal	O
-	O
directed	O
behavior	O
.	O

Odor	O
discrimination	O
was	O
chosen	O
as	O
the	O
particular	O
task	O
because	O
it	O
is	O
a	O
highly	O
robust	O
behavior	O
in	O
rodents	S-LIVB
[	O
18	O
]	O
.	O

To	O
minimize	O
experimental	O
error	O
,	O
the	O
experimenter	O
was	O
blind	O
to	O
genotype	S-SO
during	O
testing	O
.	O

Mice	S-LIVB
were	O
mildly	O
food	S-CHEBI
deprived	O
to	O
approximately	O
85	O
%	O
ad	O
libitum	O
weight	O
.	O

Dopamine	B-PRGE
D2R	I-PRGE
-	I-PRGE
/	I-PRGE
-	I-PRGE
and	I-PRGE
D2R	E-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
n	O
=	O
8	O
per	O
group	O
)	O
were	O
initially	O
trained	O
to	O
ambulate	O
the	O
length	O
of	O
a	O
polyvinyl	O
mouse	S-LIVB
cage	O
(	O
30	O
-	O
cm	O
)	O
to	O
retrieve	O
~	O
30	O
-	O
mg	O
of	O
Pico	O
(R)	O
fat	O
supplemented	O
rodent	S-LIVB
food	S-CHEBI
located	O
in	O
a	O
small	O
plastic	O
cup	O
(	O
3	O
-	O
cm	O
)	O
attached	O
to	O
the	O
floor	O
of	O
the	O
testing	O
apparatus	O
with	O
Velcro	O
.	O

Each	O
subject	O
received	O
five	O
trials	O
,	O
and	O
the	O
latency	O
to	O
locate	O
and	O
start	O
to	O
consume	O
the	O
food	S-CHEBI
pellet	O
was	O
recorded	O
manually	O
with	O
a	O
standard	O
hand	O
-	O
held	O
stopwatch	O
.	O

Twenty	O
-	O
four	O
hours	O
later	O
subjects	O
were	O
trained	O
to	O
ambulate	O
towards	O
and	O
dig	O
through	O
the	O
same	O
3	O
-	O
cm	O
dish	O
filled	O
with	O
sterile	O
sand	O
to	O
locate	O
a	O
food	S-CHEBI
pellet	O
buried	O
underneath	O
the	O
sand	O
.	O

Subjects	O
received	O
10	O
trials	O
.	O

If	O
a	O
mouse	S-LIVB
failed	O
to	O
locate	O
a	O
food	S-CHEBI
pellet	O
within	O
10	O
-	O
min	O
of	O
the	O
first	O
trial	O
,	O
an	O
additional	O
food	S-CHEBI
pellet	O
was	O
dropped	O
on	O
top	O
of	O
the	O
dish	O
.	O

This	O
manipulation	O
usually	O
ensured	O
that	O
a	O
subject	O
would	O
dig	O
through	O
the	O
sand	O
to	O
locate	O
the	O
original	O
pellet	O
and	O
learn	O
this	O
task	O
.	O

The	O
next	O
day	O
,	O
mice	S-LIVB
were	O
presented	O
to	O
the	O
testing	O
apparatus	O
that	O
now	O
contained	O
2	O
dishes	O
,	O
each	O
filled	O
with	O
different	O
scented	O
sand	O
.	O

One	O
odor	O
signaled	O
that	O
a	O
food	S-CHEBI
reinforcer	O
was	O
buried	O
in	O
that	O
particular	O
dish	O
(	O
S	O
+	O
)	O
while	O
the	O
other	O
odor	O
signaled	O
that	O
no	O
reinforcer	O
was	O
contained	O
within	O
that	O
particular	O
dish	O
(	O
S	O
-	O
)	O
.	O

The	O
sand	O
was	O
scented	O
by	O
adding	O
0	O
.	O
80	O
grams	O
of	O
either	O
cinnamon	O
or	O
dill	S-LIVB
weed	O
to	O
98	O
.	O
8	O
grams	O
of	O
autoclaved	O
playground	O
sand	O
purchased	O
from	O
a	O
local	O
farm	O
and	O
garden	O
store	O
.	O

Finally	O
,	O
0	O
.	O
40	O
grams	O
of	O
finely	O
ground	O
food	S-CHEBI
was	O
mixed	O
with	O
the	O
scented	O
sand	O
in	O
order	O
to	O
mask	O
any	O
odor	O
emitted	O
by	O
the	O
food	S-CHEBI
reinforcer	O
in	O
the	O
S	O
+	O
dish	O
.	O

This	O
final	O
mixture	O
did	O
not	O
appear	O
to	O
be	O
palatable	O
to	O
the	O
subjects	O
.	O

A	O
trial	O
terminated	O
when	O
the	O
mouse	S-LIVB
:	O
dug	O
in	O
the	O
correct	O
dish	O
and	O
consumed	O
the	O
hidden	O
pellet	O
,	O
or	O
began	O
to	O
dig	O
in	O
the	O
incorrect	O
dish	O
.	O

Digging	O
was	O
considered	O
the	O
actual	O
physical	O
displacement	O
of	O
sand	O
with	O
the	O
forepaws	O
and	O
/	O
or	O
snout	O
.	O

Placing	O
forelimbs	O
on	O
either	O
of	O
the	O
dishes	O
and	O
sniffing	O
was	O
not	O
considered	O
digging	O
and	O
was	O
not	O
penalized	O
or	O
scored	O
.	O

Each	O
completed	O
trial	O
was	O
separated	O
by	O
a	O
20	O
-	O
sec	O
inter	O
-	O
trial	O
-	O
interval	O
(	O
ITI	O
)	O
.	O

Preliminary	O
experiments	O
demonstrated	O
that	O
an	O
extended	O
time	O
-	O
out	O
period	O
following	O
an	O
incorrect	O
response	O
was	O
not	O
required	O
to	O
ensure	O
goal	O
-	O
directed	O
behavior	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
or	O
mutant	S-SO
mice	S-LIVB
for	O
this	O
particular	O
task	O
(	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
the	O
20	O
-	O
sec	O
ITI	O
was	O
used	O
to	O
separate	O
all	O
trials	O
(	O
successful	O
and	O
unsuccessful	O
)	O
.	O

The	O
S	O
+	O
and	O
S	O
-	O
scents	O
were	O
counterbalanced	O
across	O
subjects	O
in	O
order	O
to	O
control	O
for	O
potential	O
scent	O
bias	O
(	O
pilot	O
data	O
suggest	O
there	O
are	O
no	O
biases	O
,	O
data	O
not	O
shown	O
)	O
.	O

Following	O
accurate	O
discrimination	O
,	O
defined	O
as	O
8	O
correct	O
retrievals	O
across	O
10	O
consecutive	O
trials	O
,	O
reversal	O
trials	O
began	O
.	O

Reversal	O
learning	O
measurement	O

We	O
next	O
investigated	O
the	O
contribution	O
of	O
dopamine	B-PRGE
D2Rs	E-PRGE
to	O
reversal	O
learning	O
behavior	O
by	O
inverting	O
the	O
reinforcement	O
contingencies	O
-	O
now	O
the	O
former	O
S	O
+	O
signaled	O
no	O
reinforcer	O
and	O
the	O
previous	O
S	O
-	O
now	O
indicated	O
reinforcement	O
availability	O
.	O

This	O
manipulation	O
permits	O
an	O
evaluation	O
of	O
the	O
ability	O
to	O
inhibit	O
responses	O
to	O
previously	O
reinforced	O
discriminative	O
stimuli	O
[	O
18	O
]	O
.	O

The	O
number	O
of	O
trials	O
necessary	O
to	O
establish	O
8	O
out	O
of	O
10	O
accurate	O
responses	O
was	O
our	O
definition	O
of	O
successful	O
reversal	O
learning	O
.	O

Data	O
analysis	O

The	O
latency	O
to	O
retrieve	O
a	O
pellet	O
from	O
an	O
empty	O
dish	O
,	O
the	O
latency	O
to	O
dig	O
through	O
a	O
dish	O
filled	O
with	O
unscented	O
sand	O
,	O
and	O
the	O
number	O
of	O
errors	O
of	O
commission	O
committed	O
across	O
the	O
reversal	O
sessions	O
were	O
analyzed	O
with	O
2	O
-	O
way	O
analyses	O
of	O
variance	O
(	O
genotype	S-SO
x	O
trials	O
)	O
.	O

The	O
number	O
of	O
trials	O
necessary	O
to	O
attain	O
criterion	O
performance	O
in	O
odor	O
discrimination	O
(	O
8	O
correct	O
responses	O
across	O
10	O
consecutive	O
trials	O
)	O
and	O
errors	O
committed	O
while	O
learning	O
the	O
discrimination	O
tasks	O
were	O
separated	O
as	O
individual	O
testing	O
phases	O
(	O
e	O
.	O
g	O
.	O
odor	O
discrimination	O
and	O
reversal	O
learning	O
)	O
and	O
analyzed	O
separately	O
with	O
unpaired	O
2	O
-	O
tailed	O
t	O
-	O
tests	O
.	O

Significance	O
was	O
established	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Errors	O
committed	O
during	O
reversal	O
trials	O
were	O
further	O
categorically	O
separated	O
as	O
errors	O
of	O
commission	O
(	O
failing	O
to	O
withhold	O
responding	O
to	O
S	O
-	O
)	O
and	O
errors	O
of	O
omission	O
(	O
failing	O
to	O
dig	O
in	O
either	O
dish	O
after	O
3	O
-	O
min	O
had	O
expired	O
)	O
.	O

Categorical	O
errors	O
and	O
number	O
of	O
commission	O
errors	O
committed	O
during	O
the	O
first	O
reversal	O
learning	O
session	O
were	O
analyzed	O
between	O
groups	O
with	O
nonparametric	O
Mann	O
-	O
Whitney	O
U	O
tests	O
.	O

Authors	O
'	O
contributions	O

PJK	O
designed	O
and	O
ran	O
all	O
of	O
the	O
experiments	O
,	O
analyzed	O
the	O
data	O
,	O
and	O
co	O
-	O
wrote	O
the	O
manuscript	O
.	O

DKG	O
oversaw	O
and	O
facilitated	O
the	O
experiments	O
and	O
co	O
-	O
wrote	O
the	O
manuscript	O
.	O

Acknowledgements	O

This	O
study	O
was	O
supported	O
by	O
grants	O
DA07262	O
(	O
PJK	O
)	O
,	O
DA12062	O
(	O
DKG	O
)	O
,	O
and	O
MH067497	O
(	O
DKG	O
)	O
.	O

We	O
thank	O
Katherine	O
M	O
.	O
Suchland	O
for	O
her	O
excellent	O
technical	O
assistance	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Mice	S-LIVB
lacking	O
dopamine	B-PRGE
D2	I-PRGE
receptors	E-PRGE
acquire	O
a	O
goal	O
-	O
directed	O
behavior	O
similar	O
to	O
wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
.	O

Both	O
genotypes	S-SO
readily	O
learned	O
to	O
retrieve	O
food	S-CHEBI
pellets	O
from	O
a	O
small	O
dish	O
and	O
significantly	O
decreased	O
their	O
latencies	O
to	O
perform	O
this	O
task	O
across	O
trials	O
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figure	O
2	O

Wild	B-SO
-	I-SO
type	E-SO
and	O
D2R	S-PRGE
-	O
deficient	O
mice	S-LIVB
perform	O
the	O
digging	O
task	O
equally	O
well	O
.	O

No	O
differences	O
in	O
responding	O
as	O
a	O
function	O
of	O
genotype	S-SO
were	O
found	O
,	O
and	O
similar	O
latencies	O
to	O
retrieve	O
the	O
reinforcer	O
were	O
seen	O
.	O

These	O
response	O
patterns	O
suggest	O
that	O
the	O
training	O
from	O
the	O
previous	O
day	O
influenced	O
behavior	O
,	O
demonstrating	O
that	O
both	O
genotypes	S-SO
are	O
capable	O
of	O
learning	O
and	O
retaining	O
goal	O
-	O
directed	O
behaviors	O
.	O

Figure	O
3	O

Dopamine	B-PRGE
D2	I-PRGE
receptor	E-PRGE
-	O
mediated	O
signaling	O
contributes	O
to	O
the	O
acquisition	O
of	O
odor	O
discrimination	O
/	O
associative	O
learning	O
.	O

Wild	B-SO
-	I-SO
type	E-SO
(	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
)	O
mice	S-LIVB
outperformed	O
(	O
mean	O
+	O
standard	O
error	O
)	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
during	O
acquisition	O
of	O
(	O
A	O
)	O
odor	O
discrimination	O
(	O
*	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
(	O
B	O
)	O
committed	O
significantly	O
fewer	O
discrimination	O
errors	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
during	O
the	O
discrimination	O
task	O
.	O

Figure	O
4	O

D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
perseverate	O
in	O
unreinforced	O
behavior	O
during	O
reversal	O
learning	O
trials	O
.	O

The	O
number	O
of	O
necessary	O
trials	O
(	O
mean	O
+	O
standard	O
error	O
)	O
to	O
(	O
A	O
)	O
demonstrate	O
reversal	O
learning	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
and	O
(	O
B	O
)	O
reversal	O
errors	O
committed	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
by	O
D2R	S-PRGE
-	O
/	O
-	O
and	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
.	O

Figure	O
5	O

Reversal	O
learning	O
measures	O
reveal	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
emit	O
significantly	O
more	O
errors	O
of	O
commission	O
but	O
not	O
errors	O
of	O
omission	O
than	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
.	O

Response	O
patterns	O
(	O
mean	O
+	O
standard	O
error	O
)	O
by	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
are	O
more	O
suggestive	O
of	O
stimulus	O
bound	O
perseveration	O
and	O
not	O
extinction	O
.	O

D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
committed	O
significantly	O
more	O
errors	O
of	O
commission	O
(	O
A	O
)	O
than	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
but	O
no	O
differences	O
in	O
errors	O
of	O
omission	O
(	O
B	O
)	O
were	O
observed	O
between	O
genotypes	S-SO
(	O
p	O
>	O
0	O
.	O
6	O
)	O
.	O

Figure	O
6	O

Mice	S-LIVB
lacking	O
functional	O
D2Rs	S-PRGE
display	O
an	O
inability	O
to	O
withhold	O
inappropriate	O
responses	O
.	O

Response	O
patterns	O
during	O
first	O
10	O
reversal	O
trials	O
reveal	O
deficits	O
in	O
mice	S-LIVB
lacking	O
D2Rs	S-PRGE
.	O

When	O
the	O
mice	S-LIVB
encountered	O
the	O
inverted	O
reinforcement	O
contingencies	O
during	O
the	O
first	O
reversal	O
learning	O
session	O
,	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
demonstrated	O
an	O
almost	O
complete	O
inability	O
to	O
inhibit	O
responding	O
to	O
previously	O
reinforced	O
stimuli	O
compared	O
to	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figure	O
7	O

D2R	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
commit	O
significantly	O
more	O
perseverative	O
errors	O
across	O
reversal	O
sessions	O
than	O
wild	B-SO
-	I-SO
type	E-SO
mice	S-LIVB
.	O

An	O
analysis	O
of	O
the	O
time	O
course	O
of	O
responding	O
for	O
errors	O
of	O
commission	O
across	O
the	O
first	O
four	O
reversal	O
sessions	O
revealed	O
that	O
the	O
D2R	S-PRGE
-	O
/	O
-	O
committed	O
several	O
more	O
errors	O
of	O
commission	O
than	O
the	O
D2R	S-PRGE
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Structure	O
-	O
function	O
evolution	O
of	O
the	O
Transforming	O
acidic	S-CHEBI
coiled	B-SO
coil	E-SO
genes	S-SO
revealed	O
by	O
analysis	O
of	O
phylogenetically	O
diverse	O
organisms	S-LIVB

Abstract	O

Background	O

Examination	O
of	O
ancient	O
gene	S-SO
families	O
can	O
provide	O
an	O
insight	O
into	O
how	O
the	O
evolution	O
of	O
gene	S-SO
structure	O
can	O
relate	O
to	O
function	O
.	O

Functional	O
homologs	S-SO
of	O
the	O
evolutionarily	B-SO
conserved	E-SO
transforming	O
acidic	S-CHEBI
coiled	B-SO
coil	E-SO
(	O
TACC	O
)	O
gene	S-SO
family	O
are	O
present	O
in	O
organisms	S-LIVB
from	O
yeast	S-LIVB
to	O
man	S-LIVB
.	O

However	O
,	O
correlations	O
between	O
functional	O
interactions	O
and	O
the	O
evolution	O
of	O
these	O
proteins	S-CHEBI
have	O
yet	O
to	O
be	O
determined	O
.	O

Results	O

We	O
have	O
performed	O
an	O
extensive	O
database	O
analysis	O
to	O
determine	O
the	O
genomic	B-SO
and	I-SO
cDNA	I-SO
sequences	E-SO
of	O
the	O
TACCs	O
from	O
phylogenetically	O
diverse	O
organisms	S-LIVB
.	O

This	O
analysis	O
has	O
determined	O
the	O
phylogenetic	O
relationship	O
of	O
the	O
TACC	O
proteins	S-CHEBI
to	O
other	O
coiled	B-SO
coil	E-SO
proteins	S-CHEBI
,	O
the	O
resolution	O
of	O
the	O
placement	O
of	O
the	O
rabbit	S-LIVB
TACC4	O
as	O
the	O
orthologue	S-SO
of	O
human	B-PRGE
TACC3	E-PRGE
,	O
and	O
RHAMM	S-PRGE
as	O
a	O
distinct	O
family	O
of	O
coiled	B-SO
coil	E-SO
proteins	S-CHEBI
.	O

We	O
have	O
also	O
extended	O
the	O
analysis	O
of	O
the	O
TACCs	O
to	O
the	O
interaction	O
databases	O
of	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
and	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
to	O
identify	O
potentially	O
novel	O
TACC	O
interactions	O
.	O

The	O
validity	O
of	O
this	O
modeling	O
was	O
confirmed	O
independently	O
by	O
the	O
demonstration	O
of	O
direct	O
binding	O
of	O
human	B-PRGE
TACC2	E-PRGE
to	O
the	O
nuclear	S-GO
hormone	S-CHEBI
receptor	O
RXR	B-PRGE
beta	E-PRGE
.	O

Conclusion	O

The	O
data	O
so	O
far	O
suggest	O
that	O
the	O
ancestral	O
TACC	O
protein	S-CHEBI
played	O
a	O
role	O
in	O
centrosomal	S-GO
/	O
mitotic	O
spindle	S-GO
dynamics	O
.	O

TACC	O
proteins	S-CHEBI
were	O
then	O
recruited	O
to	O
complexes	S-GO
involved	O
in	O
protein	S-CHEBI
translation	O
,	O
RNA	S-SO
processing	O
and	O
transcription	O
by	O
interactions	O
with	O
specific	O
bridging	O
proteins	S-CHEBI
.	O

However	O
,	O
during	O
evolution	O
,	O
the	O
TACC	O
proteins	S-CHEBI
have	O
now	O
acquired	O
the	O
ability	O
to	O
directly	O
interact	O
with	O
components	O
of	O
these	O
complexes	S-GO
(	O
such	O
as	O
the	O
LSm	O
proteins	S-CHEBI
,	O
nuclear	S-GO
hormone	S-CHEBI
receptors	O
,	O
GAS41	S-PRGE
,	O
and	O
transcription	O
factors	O
)	O
.	O

This	O
suggests	O
that	O
the	O
function	O
of	O
the	O
TACC	O
proteins	S-CHEBI
may	O
have	O
evolved	O
from	O
performing	O
assembly	O
or	O
coordination	O
functions	O
in	O
the	O
centrosome	S-GO
to	O
include	O
a	O
more	O
intimate	O
role	O
in	O
the	O
functional	O
evolution	O
of	O
chromatin	S-GO
remodeling	O
,	O
transcriptional	O
and	O
posttranscriptional	O
complexes	S-GO
in	O
the	O
cell	S-CL
.	O

Background	O

The	O
evolution	O
of	O
complex	O
organisms	S-LIVB
has	O
been	O
associated	O
with	O
the	O
generation	O
of	O
gene	S-SO
families	O
by	O
the	O
continual	O
duplication	S-SO
of	O
an	O
initial	O
relatively	O
small	O
set	O
of	O
ancestral	O
genes	S-SO
.	O

Through	O
this	O
process	O
,	O
followed	O
by	O
subsequent	O
mutation	S-SO
,	O
reduplication	O
and	O
exon	S-SO
shuffling	O
between	O
gene	S-SO
families	O
,	O
genes	S-SO
have	O
evolved	O
both	O
discrete	O
,	O
and	O
partially	O
redundant	O
functions	O
with	O
their	O
related	O
family	O
members	O
.	O

With	O
the	O
completion	O
of	O
the	O
genome	S-SO
sequencing	O
projects	O
of	O
human	S-LIVB
,	O
mouse	S-LIVB
,	O
rat	S-LIVB
,	O
fruit	B-LIVB
fly	E-LIVB
and	O
nematodes	S-LIVB
,	O
we	O
are	O
now	O
in	O
a	O
position	O
to	O
ask	O
fundamental	O
questions	O
in	O
regard	O
to	O
how	O
genes	S-SO
interact	O
in	O
the	O
context	O
of	O
the	O
whole	O
organism	S-LIVB
.	O

Thus	O
,	O
with	O
the	O
appropriate	O
application	O
of	O
bioinformatics	O
,	O
it	O
is	O
now	O
possible	O
to	O
trace	O
the	O
lineage	O
of	O
particular	O
genes	S-SO
and	O
gene	S-SO
families	O
,	O
with	O
related	O
gene	S-SO
families	O
in	O
other	O
organisms	S-LIVB
.	O

Furthermore	O
,	O
with	O
the	O
growing	O
amount	O
of	O
large	O
-	O
scale	O
proteomic	O
and	O
genomic	S-SO
data	O
becoming	O
publicly	O
available	O
,	O
this	O
analysis	O
can	O
now	O
be	O
extended	O
to	O
reveal	O
the	O
complex	O
interplay	O
between	O
evolution	O
of	O
gene	S-SO
structure	O
and	O
protein	S-CHEBI
function	O
.	O

The	O
first	O
Transforming	O
acidic	S-CHEBI
coiled	B-SO
coil	E-SO
gene	S-SO
,	O
TACC1	S-PRGE
,	O
was	O
identified	O
during	O
the	O
development	O
of	O
an	O
expression	O
map	O
of	O
the	O
proximal	O
short	O
arm	B-SO
of	I-SO
human	I-SO
chromosome	E-SO
8	O
[	O
1	O
]	O
.	O

Two	O
additional	O
TACC	O
family	O
members	O
were	O
subsequently	O
identified	O
and	O
mapped	O
to	O
paralogous	B-SO
chromosomal	I-SO
regions	E-SO
on	O
human	S-LIVB
chromosomes	S-GO
4p16	O
and	O
10q26	O
,	O
physically	O
close	O
to	O
members	O
of	O
the	O
FGFR	S-PRGE
gene	S-SO
family	O
[	O
1	O
-	O
3	O
]	O
.	O

This	O
mapping	O
data	O
,	O
together	O
with	O
identification	O
of	O
a	O
single	O
TACC	O
gene	S-SO
in	O
the	O
protostomes	S-LIVB
Caenorhabitis	B-LIVB
elegans	E-LIVB
,	O
and	O
Drosophila	B-LIVB
melanogaster	E-LIVB
[	O
4	O
-	O
6	O
]	O
,	O
led	O
to	O
the	O
speculation	O
that	O
the	O
ancestral	O
FGFR	S-PRGE
and	O
TACC	O
genes	S-SO
were	O
located	O
physically	O
close	O
to	O
each	O
other	O
.	O

Thus	O
,	O
during	O
the	O
evolution	O
of	O
vertebrates	S-LIVB
,	O
subsequent	O
successive	O
duplications	S-SO
of	O
the	O
ancestral	O
gene	B-SO
cluster	E-SO
have	O
given	O
rise	O
to	O
three	O
TACC	O
family	O
members	O
located	O
close	O
to	O
FGFR	S-PRGE
genes	S-SO
in	O
humans	S-LIVB
.	O

In	O
accordance	O
with	O
the	O
proposed	O
quadruplication	O
of	O
the	O
vertebrate	S-LIVB
genome	S-SO
during	O
evolution	O
,	O
there	O
is	O
a	O
fourth	O
FGFR	S-PRGE
family	O
member	O
in	O
vertebrates	S-LIVB
,	O
raising	O
the	O
question	O
of	O
whether	O
a	O
fourth	O
TACC	O
gene	S-SO
is	O
associated	O
with	O
FGFR4	S-PRGE
in	O
vertebrate	S-LIVB
genomes	S-SO
.	O

To	O
date	O
,	O
only	O
three	O
active	O
TACC	O
genes	S-SO
have	O
been	O
cloned	O
in	O
humans	S-LIVB
[	O
1	O
-	O
3	O
]	O
,	O
one	O
in	O
each	O
of	O
mouse	S-LIVB
[	O
7	O
]	O
,	O
Xenopus	B-LIVB
laevis	E-LIVB
[	O
8	O
]	O
,	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
[	O
4	O
]	O
,	O
and	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
[	O
5	O
,	O
6	O
]	O
.	O

Although	O
two	O
additional	O
new	O
candidate	O
TACC	O
family	O
members	O
,	O
Oryctolagus	B-LIVB
cuniculus	E-LIVB
TACC4	O
[	O
9	O
]	O
and	O
human	B-PRGE
RHAMM	E-PRGE
[	O
10	O
]	O
have	O
been	O
proposed	O
,	O
their	O
true	O
identity	O
and	O
placement	O
in	O
the	O
evolution	O
of	O
the	O
TACC	O
family	O
is	O
under	O
debate	O
.	O

Thus	O
,	O
the	O
identification	O
and	O
functional	O
characterization	O
of	O
new	O
members	O
of	O
the	O
TACC	O
family	O
in	O
other	O
organisms	S-LIVB
,	O
alternatively	B-SO
spliced	I-SO
isoforms	E-SO
of	O
each	O
TACC	O
and	O
comparison	O
of	O
the	O
phylogenetic	O
relationship	O
of	O
these	O
genes	S-SO
relative	O
to	O
other	O
members	O
of	O
the	O
coiled	B-SO
coil	E-SO
superfamily	O
will	O
resolve	O
this	O
issue	O
and	O
provide	O
clues	O
to	O
the	O
evolution	O
of	O
TACC	O
function	O
.	O

Results	O
and	O
Discussion	O

In	O
silico	O
identification	O
of	O
TACC	O
family	O
members	O
from	O
vertebrate	S-LIVB
and	O
invertebrate	O
lineages	O

Sequence	S-SO
similarity	O
searches	O
of	O
the	O
publicly	O
available	O
genome	S-SO
databases	O
with	O
the	O
BLAST	O
and	O
TBLAST	O
programs	O
were	O
performed	O
to	O
identify	O
TACC	O
and	O
RHAMM	S-PRGE
orthologues	S-SO
,	O
and	O
other	O
members	O
of	O
the	O
coiled	B-SO
coil	E-SO
superfamily	O
in	O
a	O
diverse	O
set	O
of	O
species	O
(	O
Fig	O
.	O
1	O
)	O
.	O

This	O
identified	O
the	O
complete	O
sequence	S-SO
of	O
the	O
TACC	O
genes	S-SO
in	O
representatives	O
of	O
five	O
major	O
phylogenetically	O
distinct	O
clades	O
.	O

Where	O
possible	O
,	O
the	O
construction	O
of	O
the	O
TACC	O
sequences	S-SO
from	O
these	O
organisms	S-LIVB
was	O
also	O
confirmed	O
by	O
the	O
analysis	O
of	O
the	O
cDNA	S-SO
databases	O
.	O

Several	O
partial	S-SO
sequences	S-SO
in	O
other	O
vertebrate	S-LIVB
species	O
,	O
the	O
echinodermate	S-LIVB
Strongylocentrotus	B-LIVB
purpuratus	E-LIVB
and	O
the	O
protostome	S-LIVB
insect	S-LIVB
Anopheles	B-LIVB
gambiae	E-LIVB
were	O
also	O
identified	O
,	O
suggesting	O
an	O
ancient	O
conservation	S-SO
of	O
the	O
TACC	O
genes	S-SO
in	O
metazoan	S-LIVB
lineages	O
.	O

However	O
,	O
due	O
to	O
the	O
relative	O
infancy	O
of	O
the	O
cDNA	S-SO
/	O
genome	S-SO
projects	O
for	O
these	O
latter	O
organisms	S-LIVB
,	O
complete	O
characterization	O
of	O
these	O
TACC	O
genes	S-SO
could	O
not	O
be	O
undertaken	O
.	O

No	O
conclusion	O
could	O
be	O
made	O
about	O
the	O
existence	O
of	O
TACC	O
-	O
like	O
sequence	S-SO
in	O
non	O
-	O
bilaterian	S-LIVB
metazoans	S-LIVB
,	O
such	O
as	O
Cnidaria	S-LIVB
or	O
Porifera	S-LIVB
,	O
due	O
to	O
the	O
paucity	O
of	O
sequence	S-SO
information	O
for	O
these	O
organisms	S-LIVB
,	O
and	O
additional	O
definitive	O
sequences	S-SO
with	O
a	O
defined	O
TACC	O
domain	S-SO
could	O
not	O
be	O
found	O
in	O
other	O
non	O
-	O
metazoan	S-LIVB
organisms	S-LIVB
.	O

Figure	O
1	O

Phylogenetic	O
analysis	O
of	O
the	O
TACC	O
family	O
members	O
compared	O
to	O
other	O
coiled	B-SO
coil	E-SO
proteins	S-CHEBI
.	O

The	O
phylogenetic	O
tree	O
was	O
constructed	O
as	O
described	O
in	O
the	O
Methods	O
section	O
.	O

The	O
TACC	O
family	O
defines	O
a	O
separate	O
subfamily	O
of	O
coiled	B-SO
coil	E-SO
containing	O
proteins	S-CHEBI
,	O
distinct	O
from	O
other	O
coiled	B-SO
coil	E-SO
families	O
such	O
as	O
the	O
keratins	O
,	O
RHAMM	S-PRGE
and	O
tropomyosins	O
.	O

Note	O
that	O
the	O
RHAMM	S-PRGE
proteins	S-CHEBI
form	O
a	O
separate	O
branch	O
more	O
closely	O
related	O
to	O
the	O
tropomyosins	O
and	O
kinesin	O
like	O
proteins	S-CHEBI
(	O
KLP	O
)	O
,	O
than	O
the	O
TACC	O
proteins	S-CHEBI
.	O

At	O
the	O
base	O
of	O
the	O
chordate	S-LIVB
branch	O
of	O
life	O
,	O
a	O
single	O
TACC	O
gene	S-SO
was	O
identified	O
in	O
the	O
genome	S-SO
of	O
the	O
urochordate	S-LIVB
Ciona	B-LIVB
intestinalis	E-LIVB
[	O
11	O
]	O
,	O
and	O
a	O
partial	S-SO
TACC	O
sequence	S-SO
from	O
an	O
analysis	O
of	O
the	O
Halocynthia	B-LIVB
rortezi	E-LIVB
EST	S-SO
database	O
[	O
12	O
]	O
.	O

This	O
confirms	O
the	O
original	O
assumption	O
that	O
a	O
single	O
TACC	O
gene	S-SO
was	O
present	O
in	O
the	O
chordate	S-LIVB
ancestor	O
.	O

The	O
next	O
major	O
event	O
in	O
the	O
evolution	O
of	O
the	O
chordate	S-LIVB
genome	S-SO
has	O
been	O
suggested	O
to	O
have	O
occurred	O
687	O
+/-	O
155	O
.	O
7	O
million	O
years	O
ago	O
(	O
MYA	O
)	O
,	O
with	O
the	O
first	O
duplication	S-SO
of	O
the	O
chordate	S-LIVB
genome	S-SO
,	O
and	O
a	O
second	O
duplication	S-SO
occurring	O
shortly	O
thereafter	O
.	O

Thus	O
,	O
if	O
the	O
TACC	O
genes	S-SO
were	O
duplicated	O
at	O
both	O
events	O
,	O
we	O
would	O
expect	O
to	O
identify	O
four	O
TACC	O
genes	S-SO
in	O
the	O
most	O
"	O
primitive	O
"	O
compact	O
vertebrate	S-LIVB
genome	S-SO
sequenced	O
to	O
date	O
,	O
the	O
pufferfish	S-LIVB
Takifugu	B-LIVB
rubripes	E-LIVB
,	O
with	O
three	O
genes	S-SO
corresponding	O
to	O
the	O
human	B-PRGE
TACC1	E-PRGE
-	O
3	O
,	O
and	O
,	O
in	O
keeping	O
with	O
the	O
proposed	O
model	O
for	O
genomic	S-SO
duplication	S-SO
of	O
the	O
chromosomal	B-SO
loci	E-SO
for	O
the	O
TACC	O
genes	S-SO
(	O
discussed	O
below	O
)	O
,	O
a	O
possible	O
fourth	O
gene	S-SO
deriving	O
from	O
the	O
TACC3	S-PRGE
ancestor	O
.	O

Indeed	O
,	O
four	O
TACC	O
genes	S-SO
were	O
identified	O
in	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
.	O

Of	O
these	O
,	O
two	O
genes	S-SO
corresponded	O
to	O
the	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
orthologues	S-SO
of	O
human	B-PRGE
TACC2	I-PRGE
and	I-PRGE
TACC3	E-PRGE
.	O

However	O
,	O
the	O
other	O
two	O
genes	S-SO
,	O
trTACC1A	S-PRGE
and	O
trTACC1B	S-PRGE
are	O
clearly	O
most	O
related	O
to	O
TACC1	S-PRGE
(	O
Fig	O
.	O
1	O
)	O
.	O

Although	O
trTACC1A	S-PRGE
is	O
highly	O
homologous	S-SO
to	O
trTACC1B	S-PRGE
,	O
the	O
latter	O
encodes	O
a	O
significantly	O
smaller	O
predicted	S-SO
protein	S-CHEBI
.	O

The	O
trTACC1B	S-PRGE
gene	S-SO
is	O
encoded	O
by	O
15	O
exons	S-SO
over	O
approximately	O
7	O
kb	O
of	O
the	O
Takifugu	S-LIVB
Scaffold	S-SO
191	O
(	O
see	O
below	O
)	O
.	O

A	O
search	O
of	O
this	O
region	S-SO
using	O
the	O
trTACC1A	S-PRGE
sequence	S-SO
and	O
gene	S-SO
prediction	O
software	O
has	O
so	O
far	O
failed	O
to	O
identify	O
additional	O
exons	S-SO
of	O
trTACC1B	S-PRGE
.	O

However	O
,	O
given	O
the	O
intron	S-SO
/	O
exon	S-SO
structure	O
of	O
this	O
apparently	O
complete	O
gene	S-SO
,	O
it	O
appears	O
likely	O
that	O
trTACC1B	S-PRGE
is	O
active	O
in	O
the	O
pufferfish	S-LIVB
,	O
and	O
presumably	O
fulfils	O
either	O
a	O
temporal	O
-	O
spatial	O
specific	O
function	O
within	O
the	O
organism	S-LIVB
,	O
or	O
a	O
distinct	O
function	O
from	O
the	O
larger	O
trTACC1A	S-PRGE
product	O
within	O
the	O
cell	S-CL
.	O

Thus	O
,	O
based	O
upon	O
the	O
surrounding	O
chromosomal	B-SO
loci	E-SO
(	O
see	O
below	O
)	O
,	O
the	O
trTACC1A	S-PRGE
and	O
trTACC1B	S-PRGE
genes	S-SO
appear	O
to	O
have	O
arisen	O
from	O
the	O
duplication	S-SO
of	O
the	O
chromosomal	B-SO
segment	E-SO
containing	O
the	O
teleost	S-LIVB
TACC1	S-PRGE
ancestor	O
,	O
during	O
the	O
additional	O
partial	O
genomic	S-SO
duplication	S-SO
that	O
occurred	O
in	O
the	O
teleost	S-LIVB
lineage	O
.	O

Therefore	O
,	O
this	O
analysis	O
of	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
does	O
not	O
support	O
the	O
hypothesis	O
that	O
the	O
region	S-SO
surrounding	O
the	O
TACC3	S-PRGE
ancestor	O
was	O
included	O
in	O
the	O
second	O
round	O
of	O
vertebrate	S-LIVB
genomic	S-SO
duplication	S-SO
.	O

Examination	O
of	O
higher	O
vertebrates	S-LIVB
led	O
to	O
the	O
identification	O
of	O
splice	B-SO
variants	E-SO
of	O
TACC1	S-PRGE
and	O
TACC2	S-PRGE
in	O
Mus	B-LIVB
musculus	E-LIVB
,	O
and	O
the	O
assembly	O
of	O
the	O
previously	O
unidentified	O
orthologues	S-SO
of	O
TACC1	S-PRGE
-	O
3	O
from	O
Rattus	B-LIVB
norvegus	E-LIVB
.	O

In	O
addition	O
,	O
the	O
TACC1X	O
sequence	S-SO
was	O
found	O
on	O
mouse	S-LIVB
chromosome	B-GO
X	E-GO
.	O

This	O
gene	S-SO
is	O
clearly	O
related	O
to	O
the	O
mouse	B-PRGE
TACC1	E-PRGE
,	O
however	O
,	O
further	O
examination	O
revealed	O
a	O
mouse	S-LIVB
B1	O
repeat	S-SO
distributed	O
over	O
the	O
length	O
of	O
the	O
proposed	O
intron	S-SO
.	O

In	O
addition	O
,	O
no	O
expression	O
of	O
TACC1X	O
was	O
detected	O
in	O
mouse	S-LIVB
RNA	S-SO
by	O
rt	O
-	O
PCR	O
analysis	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
this	O
sequence	S-SO
is	O
a	O
processed	B-SO
pseudogene	E-SO
.	O

Similarly	O
,	O
TACC1	S-PRGE
pseudogenes	S-SO
also	O
exist	O
spread	O
over	O
22	O
kb	O
of	O
the	O
centromeric	B-GO
region	I-GO
of	I-GO
human	I-GO
chromosome	E-GO
10	O
and	O
,	O
in	O
8q21	O
,	O
a	O
shorter	O
region	S-SO
86	O
%	O
identical	O
to	O
the	O
final	O
359	O
bp	S-SO
of	O
the	O
TACC1	S-PRGE
3	B-SO
'	I-SO
untranslated	I-SO
region	E-SO
.	O

No	O
pseudogenes	S-SO
corresponding	O
to	O
TACC2	S-PRGE
or	O
TACC3	S-PRGE
were	O
identified	O
in	O
any	O
mammalian	S-LIVB
species	O
.	O

Characterization	O
of	O
vertebrate	S-LIVB
TACC3	S-PRGE
orthologues	S-SO

Based	O
upon	O
current	O
functional	O
analysis	O
,	O
the	O
characterization	O
of	O
TACC3	S-PRGE
orthologues	S-SO
is	O
likely	O
to	O
be	O
pivotal	O
to	O
understanding	O
the	O
sequence	S-SO
and	O
functional	O
evolution	O
of	O
the	O
TACC	O
gene	S-SO
family	O
.	O

As	O
indicated	O
below	O
,	O
the	O
chromosomal	B-SO
region	E-SO
containing	O
the	O
TACC	O
gene	S-SO
precursors	O
was	O
duplicated	O
twice	O
during	O
vertebrate	S-LIVB
evolution	O
.	O

Although	O
the	O
analysis	O
of	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
,	O
rodents	S-LIVB
and	O
humans	S-LIVB
so	O
far	O
suggests	O
that	O
the	O
vertebrate	S-LIVB
TACC3	S-PRGE
precursor	O
was	O
not	O
included	O
in	O
the	O
second	O
round	O
of	O
genomic	S-SO
duplication	S-SO
,	O
it	O
could	O
not	O
be	O
excluded	O
that	O
a	O
TACC4	O
gene	S-SO
may	O
have	O
been	O
lost	S-SO
during	O
the	O
evolution	O
of	O
these	O
lineages	O
.	O

The	O
cloning	O
of	O
a	O
new	O
member	O
of	O
the	O
TACC	O
family	O
in	O
Oryctolagus	B-LIVB
cuniculus	E-LIVB
has	O
added	O
to	O
this	O
controversy	O
[	O
9	O
]	O
.	O

Designated	O
TACC4	O
,	O
the	O
1	O
.	O
5	O
kb	O
cDNA	S-SO
was	O
highly	O
related	O
,	O
but	O
proposed	O
to	O
be	O
distinct	O
from	O
TACC3	S-PRGE
.	O

However	O
,	O
Northern	O
blot	O
data	O
suggested	O
that	O
this	O
gene	S-SO
produces	O
a	O
single	O
2	O
.	O
3	O
kb	O
transcript	S-SO
[	O
9	O
]	O
,	O
indicating	O
that	O
the	O
cloned	O
cDNA	S-SO
was	O
incomplete	S-SO
.	O

The	O
degree	O
of	O
similarity	O
to	O
the	O
published	O
sequence	S-SO
of	O
human	B-PRGE
and	I-PRGE
mouse	I-PRGE
TACC3	E-PRGE
suggested	O
to	O
us	O
that	O
TACC4	O
actually	O
represents	O
a	O
partial	S-SO
rabbit	B-PRGE
TACC3	E-PRGE
cDNA	S-SO
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
set	O
out	O
to	O
clone	O
the	O
complete	O
rabbit	B-PRGE
TACC3	E-PRGE
sequence	S-SO
,	O
based	O
upon	O
the	O
known	S-SO
features	S-SO
of	O
human	B-PRGE
and	I-PRGE
mouse	I-PRGE
TACC3	E-PRGE
.	O

We	O
have	O
previously	O
noted	O
that	O
the	O
N	B-SO
-	I-SO
terminal	I-SO
and	I-SO
C	I-SO
-	I-SO
terminal	I-SO
regions	E-SO
of	O
the	O
human	B-PRGE
and	I-PRGE
mouse	I-PRGE
TACC3	E-PRGE
proteins	S-CHEBI
are	O
highly	O
conserved	S-SO
(	O
[	O
2	O
]	O
,	O
see	O
below	O
)	O
.	O

Therefore	O
,	O
based	O
upon	O
the	O
sequence	S-SO
identity	O
between	O
these	O
genes	S-SO
,	O
we	O
designed	O
a	O
consensus	S-SO
oligonucleotide	S-SO
primer	S-SO
,	O
T3con2	O
,	O
that	O
would	O
be	O
suitable	O
for	O
the	O
identification	O
of	O
the	O
region	S-SO
containing	O
the	O
initiator	O
methionine	S-CHEBI
of	O
the	O
TACC3	S-PRGE
cDNAs	S-SO
from	O
primates	S-LIVB
and	O
rodents	S-LIVB
.	O

Using	O
this	O
primer	S-SO
,	O
in	O
combination	O
with	O
the	O
TACC4	O
-	O
specific	O
RACE	O
primer	S-SO
(	O
RACE2	O
)	O
,	O
initially	O
used	O
by	O
Steadman	O
et	O
al	O
[	O
9	O
]	O
,	O
we	O
isolated	O
a	O
1	O
.	O
5	O
kb	O
PCR	B-SO
product	E-SO
from	O
rabbit	S-LIVB
brain	O
cDNA	S-SO
by	O
rt	O
-	O
PCR	O
.	O

In	O
combination	O
with	O
3	O
'	O
RACE	O
,	O
this	O
generated	O
a	O
consensus	S-SO
cDNA	S-SO
of	O
2283	O
bp	S-SO
which	O
corresponds	O
to	O
the	O
transcript	S-SO
size	O
of	O
2	O
.	O
3	O
kb	O
detected	O
by	O
the	O
"	O
TACC4	O
"	O
sequence	S-SO
reported	O
in	O
Figure	O
4	O
of	O
Steadman	O
et	O
al	O
[	O
9	O
]	O
.	O

Thus	O
,	O
while	O
it	O
remains	O
possible	O
that	O
the	O
"	O
TACC4	O
"	O
sequence	S-SO
is	O
an	O
alternative	B-SO
splice	I-SO
product	E-SO
,	O
or	O
is	O
the	O
product	O
of	O
reduplication	O
of	O
the	O
TACC3	S-PRGE
gene	S-SO
(	O
events	O
that	O
would	O
be	O
specific	O
to	O
the	O
rabbit	S-LIVB
)	O
,	O
the	O
only	O
transcript	S-SO
detected	O
in	O
rabbit	S-LIVB
RNA	S-SO
corresponds	O
to	O
the	O
predicted	S-SO
transcript	S-SO
size	O
of	O
the	O
TACC3	S-PRGE
sequence	S-SO
that	O
we	O
have	O
identified	O
here	O
.	O

Furthermore	O
,	O
the	O
string	B-SO
of	I-SO
nucleotides	E-SO
found	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
"	O
TACC4	O
"	O
sequence	S-SO
is	O
also	O
found	O
at	O
the	O
5	O
'	O
ends	O
of	O
a	O
number	O
of	O
cDNA	B-SO
sequences	E-SO
(	O
e	O
.	O
g	O
.	O
U82468	O
,	O
NM	O
_	O
023500	O
)	O
,	O
that	O
were	O
isolated	O
by	O
5	O
'	O
RACE	O
,	O
suggesting	O
that	O
they	O
may	O
correspond	O
to	O
an	O
artefact	O
of	O
the	O
5	O
'	O
RACE	O
methodology	O
used	O
in	O
their	O
construction	O
.	O

The	O
rabbit	S-LIVB
"	O
TACC4	O
"	O
and	O
the	O
rabbit	B-PRGE
TACC3	E-PRGE
sequence	S-SO
that	O
we	O
have	O
isolated	O
are	O
also	O
found	O
on	O
the	O
same	O
branch	O
of	O
the	O
TACC	O
phylogenetic	O
tree	O
with	O
the	O
other	O
TACC3	S-PRGE
orthologues	S-SO
,	O
including	O
maskin	B-PRGE
(	I-PRGE
Xenopus	I-PRGE
laevis	I-PRGE
)	E-PRGE
,	O
and	O
the	O
newly	O
identified	O
TACC3	S-PRGE
sequences	S-SO
in	O
Rattus	B-LIVB
norvegus	E-LIVB
,	O
Gallus	B-LIVB
gallus	E-LIVB
,	O
Silurana	B-LIVB
tropicalis	E-LIVB
,	O
Danio	B-LIVB
rerio	E-LIVB
and	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
,	O
reported	O
in	O
this	O
manuscript	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Thus	O
,	O
it	O
is	O
not	O
in	O
a	O
separate	O
branch	O
that	O
may	O
be	O
expected	O
if	O
the	O
sequence	S-SO
was	O
a	O
distinct	O
TACC	O
family	O
member	O
.	O

Placement	O
of	O
the	O
RHAMM	S-PRGE
gene	S-SO
in	O
the	O
phylogeny	O
of	O
the	O
coiled	B-SO
coil	E-SO
gene	S-SO
family	O

Human	B-PRGE
RHAMM	E-PRGE
has	O
also	O
been	O
proposed	O
to	O
be	O
the	O
missing	O
fourth	O
member	O
of	O
the	O
TACC	O
family	O
[	O
10	O
]	O
.	O

Evidence	O
used	O
in	O
support	O
of	O
this	O
claim	O
included	O
its	O
chromosomal	B-SO
location	E-SO
on	O
5q32	O
in	O
humans	S-LIVB
(	O
discussed	O
below	O
)	O
,	O
its	O
sequence	S-SO
similarity	O
in	O
its	O
coiled	B-SO
coil	E-SO
domain	S-SO
to	O
the	O
TACC	O
domain	S-SO
and	O
the	O
subcellular	O
localization	O
of	O
the	O
RHAMM	S-PRGE
protein	S-CHEBI
in	O
the	O
centrosome	S-GO
.	O

However	O
,	O
if	O
RHAMM	S-PRGE
were	O
a	O
bona	O
fide	O
TACC	O
family	O
member	O
,	O
then	O
we	O
would	O
predict	O
its	O
evolution	O
would	O
be	O
similar	O
to	O
those	O
of	O
other	O
TACC	O
family	O
members	O
,	O
and	O
fit	O
with	O
the	O
proposed	O
evolution	O
of	O
the	O
vertebrate	S-LIVB
genome	S-SO
.	O

Thus	O
,	O
we	O
set	O
out	O
to	O
identify	O
RHAMM	S-PRGE
orthologues	S-SO
and	O
related	O
genes	S-SO
in	O
metazoans	S-LIVB
,	O
so	O
that	O
a	O
more	O
complete	O
phylogeny	O
of	O
the	O
coiled	B-SO
coil	E-SO
super	O
family	O
could	O
be	O
generated	O
.	O

We	O
identified	O
a	O
single	O
RHAMM	S-PRGE
gene	S-SO
in	O
all	O
deuterostomes	S-LIVB
for	O
which	O
cDNA	B-SO
and	I-SO
/	I-SO
or	I-SO
genomic	I-SO
sequence	E-SO
was	O
available	O
,	O
including	O
C	B-LIVB
.	I-LIVB
intestinalis	E-LIVB
.	O

No	O
RHAMM	S-PRGE
gene	S-SO
was	O
identified	O
in	O
insects	S-LIVB
or	O
nematodes	S-LIVB
.	O

This	O
indicates	O
that	O
the	O
RHAMM	S-PRGE
/	O
TACC	O
genes	S-SO
diverged	O
after	O
the	O
protostome	S-LIVB
/	O
deuterostome	S-LIVB
split	O
833	O
-	O
933	O
MYA	O
,	O
but	O
prior	O
to	O
the	O
echinodermata	S-LIVB
/	O
urochordate	S-LIVB
divergence	O
(	O
>	O
750	O
MYA	O
)	O
.	O

Significantly	O
,	O
sequence	S-SO
and	O
phylogenetic	O
analysis	O
of	O
coiled	B-SO
coil	E-SO
proteins	S-CHEBI
(	O
Fig	O
.	O
1	O
)	O
clearly	O
shows	O
that	O
RHAMM	S-PRGE
does	O
not	O
contain	O
a	O
TACC	O
domain	S-SO
and	O
instead	O
forms	O
a	O
distinct	O
family	O
of	O
proteins	S-CHEBI
in	O
the	O
coiled	B-SO
coil	E-SO
superfamily	O
,	O
and	O
is	O
not	O
a	O
direct	O
descendant	O
of	O
the	O
ancestral	O
TACC	O
gene	S-SO
.	O

Evolution	O
of	O
the	O
chromosomal	B-SO
segments	E-SO
containing	O
the	O
TACC	O
genes	S-SO

The	O
phylogenetic	O
tree	O
of	O
the	O
FGFR	S-PRGE
genes	S-SO
closely	O
resembles	O
that	O
of	O
the	O
vertebrate	S-LIVB
TACC1	S-PRGE
-	O
3	O
genes	S-SO
.	O

Recently	O
,	O
detailed	O
analyses	O
of	O
the	O
chromosomal	B-SO
regions	E-SO
containing	O
the	O
FGFR	S-PRGE
gene	S-SO
family	O
in	O
humans	S-LIVB
,	O
mouse	S-LIVB
and	O
the	O
arthopod	S-LIVB
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
have	O
revealed	O
the	O
conservation	S-SO
of	O
paralogous	B-SO
chromosomal	I-SO
segments	E-SO
between	O
these	O
organisms	S-LIVB
(	O
Fig	O
.	O
2	O
,	O
[	O
13	O
]	O
,	O
Table	O
1	O
[	O
see	O
Additional	O
file	O
1	O
]	O
)	O
.	O

This	O
has	O
provided	O
further	O
support	O
that	O
an	O
ancient	O
chromosomal	B-SO
segment	E-SO
was	O
duplicated	O
twice	O
during	O
vertebrate	S-LIVB
evolution	O
,	O
with	O
the	O
first	O
duplication	S-SO
that	O
gave	O
rise	O
to	O
the	O
human	S-LIVB
chromosome	S-GO
4p16	O
/	O
5q32	O
-	O
ter	O
and	O
human	S-LIVB
chromosome	S-GO
8p	O
/	O
10q23	O
-	O
ter	O
ancestors	O
occurring	O
in	O
the	O
early	O
stages	O
after	O
the	O
invertebrate	O
divergence	O
.	O

This	O
suggests	O
that	O
the	O
ancestral	O
FGFR	S-PRGE
-	O
TACC	O
gene	S-SO
pair	O
most	O
probably	O
arose	O
prior	O
to	O
the	O
initial	O
duplication	S-SO
and	O
subsequent	O
divergence	O
of	O
these	O
paralogous	B-SO
chromosomal	I-SO
segments	E-SO
,	O
estimated	O
to	O
have	O
occurred	O
687	O
+/-	O
155	O
.	O
7	O
MYA	O
.	O

This	O
has	O
raised	O
the	O
suggestion	O
that	O
a	O
fourth	O
TACC	O
gene	S-SO
in	O
vertebrates	S-LIVB
would	O
reside	O
in	O
the	O
same	O
chromosomal	B-SO
region	E-SO
as	O
FGFR4	S-PRGE
.	O

Indeed	O
this	O
hypothesis	O
has	O
been	O
used	O
in	O
support	O
for	O
the	O
RHAMM	S-PRGE
gene	S-SO
as	O
a	O
member	O
of	O
the	O
TACC	O
family	O
[	O
10	O
]	O
.	O

Human	B-PRGE
RHAMM	E-PRGE
maps	O
to	O
chromosome	S-GO
5q32	O
in	O
a	O
region	S-SO
bounded	O
by	O
GPX3	S-PRGE
and	O
NKX2E	S-PRGE
.	O

These	O
loci	S-SO
separate	O
two	O
clusters	B-SO
of	I-SO
genes	E-SO
on	O
human	S-LIVB
chromosome	S-GO
5	O
that	O
are	O
paralogous	S-SO
with	O
4p16	O
.	O

Interestingly	O
,	O
these	O
three	O
clusters	S-SO
are	O
located	O
on	O
different	O
chromosomes	S-GO
in	O
mouse	S-LIVB
and	O
rat	S-LIVB
(	O
Fig	O
.	O
2	O
)	O
,	O
further	O
suggesting	O
that	O
this	O
cluster	B-SO
of	I-SO
genes	E-SO
was	O
transposed	O
into	O
this	O
region	S-SO
after	O
the	O
primate	S-LIVB
/	O
rodent	S-LIVB
divergence	O
.	O

Figure	O
2	O

Linear	O
organization	O
of	O
gene	B-SO
clusters	E-SO
centering	O
upon	O
the	O
chromosomal	B-SO
loci	E-SO
of	O
the	O
FGFR	S-PRGE
genes	S-SO
in	O
humans	S-LIVB
.	O

Paralogous	S-SO
genes	S-SO
present	O
in	O
at	O
least	O
two	O
of	O
the	O
four	O
loci	S-SO
are	O
shown	O
,	O
with	O
the	O
exception	O
of	O
the	O
region	S-SO
between	O
GPX3	S-PRGE
and	O
NKX2E	S-PRGE
on	O
chromosome	S-GO
5	O
,	O
which	O
appears	O
to	O
represent	O
a	O
series	O
of	O
intervening	O
genes	S-SO
inserted	S-SO
after	O
duplication	S-SO
of	O
the	O
4p16	O
/	O
5q32	O
-	O
35	O
clusters	S-SO
,	O
and	O
genes	S-SO
mentioned	O
in	O
Fig	O
.	O

3	O
.	O

Corresponding	O
syntenic	B-SO
mouse	I-SO
chromosomal	I-SO
regions	E-SO
(	O
mm	O
*	O
)	O
are	O
indicated	O
.	O

Takifugu	B-LIVB
rubripes	E-LIVB
scaffolds	S-SO
are	O
shown	O
(	O
TR	O
*	O
)	O
that	O
contain	O
more	O
than	O
one	O
homologous	S-SO
gene	S-SO
from	O
these	O
clusters	S-SO
.	O

Further	O
details	O
on	O
the	O
location	S-SO
of	O
paralogous	S-SO
genes	S-SO
can	O
be	O
found	O
in	O
[	O
see	O
Additional	O
file	O
1	O
]	O
.	O

Because	O
the	O
conservation	S-SO
of	O
gene	S-SO
order	O
can	O
also	O
provide	O
clues	O
to	O
the	O
evolution	O
of	O
gene	S-SO
regulation	O
,	O
we	O
next	O
attempted	O
to	O
trace	O
the	O
evolution	O
of	O
these	O
paralogous	B-SO
segments	E-SO
by	O
examining	O
the	O
genome	S-SO
of	O
the	O
tunicate	S-LIVB
C	B-LIVB
.	I-LIVB
intestinalis	E-LIVB
[	O
11	O
]	O
and	O
the	O
most	O
"	O
primitive	O
"	O
compact	O
vertebrate	S-LIVB
genome	S-SO
sequenced	O
to	O
date	O
,	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
[	O
14	O
]	O
.	O

Although	O
not	O
fully	O
assembled	O
,	O
examination	O
of	O
the	O
genome	S-SO
of	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
confirmed	O
the	O
presence	O
of	O
chromosomal	B-SO
segments	E-SO
paralogous	S-SO
to	O
those	O
found	O
in	O
higher	O
vertebrates	S-LIVB
(	O
Fig	O
.	O
2	O
)	O
.	O

For	O
instance	O
,	O
the	O
orthologues	S-SO
of	O
GPRK2L	S-PRGE
and	O
RGS12	S-PRGE
are	O
found	O
on	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
scaffold	S-SO
290	O
(	O
emb	O
|	O
CAAB01000290	O
.	O
1	O
)	O
,	O
and	O
within	O
300	O
kb	O
of	O
each	O
other	O
in	O
human	S-LIVB
4p16	O
.	O

The	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
orthologues	S-SO
of	O
FGFR3	S-PRGE
,	O
LETM1	O
and	O
WHSC1	O
are	O
located	O
on	O
the	O
same	O
166	O
kb	O
genomic	S-SO
scaffold	S-SO
251	O
(	O
emb	O
|	O
CAAB01000166	O
.	O
1	O
)	O
.	O

Significantly	O
,	O
the	O
three	O
human	S-LIVB
orthologues	S-SO
of	O
these	O
genes	S-SO
are	O
also	O
located	O
within	O
300	O
kb	O
of	O
each	O
other	O
on	O
4p16	O
.	O

Furthermore	O
,	O
TACC3	S-PRGE
and	O
FGFRL	S-PRGE
map	O
to	O
the	O
overlapping	S-SO
scaffolds	S-SO
1184	O
/	O
4669	O
(	O
emb	O
|	O
CAAB01004668	O
)	O
.	O

Similarly	O
,	O
elements	O
of	O
these	O
gene	B-SO
clusters	E-SO
,	O
extending	O
from	O
HMP19	S-PRGE
to	O
GPRK6	S-PRGE
in	O
human	S-LIVB
chromosome	S-GO
5q34	O
-	O
ter	O
are	O
also	O
found	O
in	O
the	O
pufferfish	S-LIVB
,	O
with	O
the	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
orthologues	S-SO
of	O
NSD1	S-PRGE
,	O
FGFR4	S-PRGE
and	O
a	O
RAB	O
-	O
like	O
gene	S-SO
mapping	O
on	O
scaffold	S-SO
407	O
(	O
emb	O
|	O
CAAB01000407	O
)	O
.	O

However	O
,	O
there	O
is	O
no	O
evidence	O
for	O
a	O
gene	S-SO
corresponding	O
to	O
a	O
TACC4	O
gene	S-SO
in	O
any	O
of	O
these	O
clusters	S-SO
.	O

As	O
noted	O
above	O
,	O
phylogenetic	O
analysis	O
of	O
the	O
TACC	O
sequences	S-SO
indicate	O
that	O
there	O
are	O
two	O
TACC1	S-PRGE
related	O
genes	S-SO
in	O
the	O
pufferfish	S-LIVB
.	O

trTACC1B	S-PRGE
is	O
located	O
on	O
the	O
180	O
kb	O
scaffold	S-SO
191	O
(	O
emb	O
|	O
CAAB01000191	O
.	O
1	O
)	O
,	O
which	O
also	O
contains	O
the	O
orthologues	S-SO
of	O
several	O
genes	S-SO
located	O
in	O
human	S-LIVB
chromosome	S-GO
8p21	O
-	O
11	O
.	O

Thus	O
,	O
this	O
scaffold	S-SO
represents	O
the	O
more	O
"	O
developed	O
"	O
TACC1	S-PRGE
chromosomal	B-SO
segment	E-SO
that	O
is	O
evident	O
in	O
higher	O
vertebrates	S-LIVB
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
trTACC1A	S-PRGE
gene	S-SO
is	O
located	O
in	O
the	O
396	O
kb	O
scaffold	S-SO
12	O
(	O
emb	O
|	O
CAAB010012	O
.	O
1	O
)	O
.	O

This	O
scaffold	S-SO
also	O
contains	O
the	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
orthologues	S-SO
of	O
MSX1	S-PRGE
,	O
STX18	S-PRGE
,	O
D4S234E	S-PRGE
and	O
the	O
predicted	B-SO
gene	E-SO
LOC118711	S-PRGE
,	O
in	O
addition	O
to	O
sequences	B-SO
with	I-SO
homology	E-SO
to	O
LOXL	S-PRGE
,	O
EVC	S-PRGE
,	O
LOC159291	S-PRGE
,	O
and	O
the	O
LDB	O
family	O
.	O

Thus	O
,	O
scaffold	S-SO
12	O
contains	O
genes	S-SO
found	O
in	O
the	O
regions	B-SO
of	I-SO
human	I-SO
chromosome	E-SO
4	O
and	O
10	O
that	O
also	O
contain	O
the	O
loci	S-SO
for	O
TACC3	S-PRGE
and	O
TACC2	S-PRGE
,	O
respectively	O
,	O
and	O
may	O
therefore	O
more	O
closely	O
resemble	O
the	O
genomic	S-SO
organization	O
resulting	O
from	O
the	O
initial	O
duplication	S-SO
of	O
the	O
ancestral	O
paralogous	B-SO
chromosomal	I-SO
segment	E-SO
.	O

Conserved	S-SO
paralogous	S-SO
clusters	S-SO
may	O
result	O
from	O
the	O
initial	O
clustering	B-SO
of	I-SO
the	I-SO
genes	E-SO
in	O
a	O
relatively	O
small	O
ancestral	O
genomic	S-SO
contig	S-SO
.	O

Some	O
evidence	O
for	O
the	O
existence	O
of	O
"	O
protoclusters	O
"	O
that	O
could	O
correspond	O
to	O
the	O
paralogous	B-SO
chromosomal	I-SO
segments	E-SO
noted	O
in	O
higher	O
vertebrates	S-LIVB
is	O
present	O
in	O
the	O
genome	S-SO
of	O
the	O
urochordate	S-LIVB
C	B-LIVB
.	I-LIVB
intestinalis	E-LIVB
[	O
11	O
]	O
.	O

For	O
instance	O
,	O
the	O
orthologues	S-SO
of	O
FGFR	S-PRGE
,	O
and	O
WHSC1	O
,	O
carboxypeptidase	B-PRGE
Z	E-PRGE
and	O
FLJ25359	O
cluster	S-SO
within	O
an	O
85	O
kb	O
region	S-SO
of	O
the	O
C	B-LIVB
.	I-LIVB
intestinalis	E-LIVB
genome	S-SO
and	O
the	O
human	S-LIVB
orthologues	S-SO
are	O
still	O
maintained	O
in	O
paralogous	B-SO
segments	E-SO
of	O
4p16	O
,	O
8p	O
and	O
10q	O
(	O
Fig	O
.	O
3	O
,	O
[	O
see	O
Additional	O
file	O
1	O
]	O
)	O
.	O

However	O
,	O
it	O
should	O
be	O
noted	O
that	O
no	O
clusters	B-SO
of	I-SO
genes	E-SO
from	O
the	O
vertebrate	S-LIVB
paralogous	B-SO
segments	E-SO
are	O
locate	O
close	O
to	O
the	O
TACC	O
or	O
RHAMM	B-PRGE
genes	I-PRGE
of	I-PRGE
C	I-PRGE
.	I-PRGE
intestinalis	E-PRGE
,	O
indicating	O
that	O
the	O
formation	O
of	O
the	O
much	O
larger	O
paralogous	B-SO
segments	E-SO
encompassing	O
the	O
FGFR	S-PRGE
-	O
TACC	O
genes	S-SO
formed	O
later	O
in	O
evolutionary	O
time	O
,	O
or	O
conversely	O
have	O
been	O
subject	O
to	O
extensive	O
rearrangement	O
in	O
tunicates	S-LIVB
.	O

In	O
combination	O
with	O
the	O
examination	O
of	O
the	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
genome	S-SO
,	O
this	O
also	O
provides	O
additional	O
evidence	O
that	O
either	O
the	O
second	O
round	O
of	O
duplication	S-SO
of	O
the	O
chromosomal	B-SO
segment	E-SO
that	O
contained	O
the	O
FGFR3	S-PRGE
/	O
4	O
ancestor	O
did	O
not	O
include	O
a	O
TACC	O
gene	S-SO
,	O
or	O
that	O
such	O
a	O
gene	S-SO
was	O
lost	O
very	O
early	O
in	O
vertebrate	S-LIVB
evolution	O
,	O
prior	O
to	O
the	O
divergence	O
of	O
the	O
Gnanthostome	S-LIVB
lineages	O
.	O

However	O
,	O
the	O
final	O
resolution	O
of	O
the	O
initial	O
evolution	O
of	O
these	O
paralogous	B-SO
segment	E-SO
will	O
await	O
the	O
sequencing	O
of	O
the	O
amphioxus	S-LIVB
and	O
lamprey	S-LIVB
genomes	S-SO
,	O
which	O
only	O
have	O
one	O
FGFR	S-PRGE
gene	S-SO
,	O
and	O
therefore	O
should	O
only	O
contain	O
one	O
copy	O
of	O
the	O
other	O
corresponding	O
genes	S-SO
in	O
this	O
conserved	B-SO
segment	E-SO
.	O

Figure	O
3	O

Formation	O
of	O
protoclusters	O
in	O
Takifugu	B-LIVB
rubripes	E-LIVB
and	O
Ciona	B-LIVB
intestinalis	E-LIVB
:	O
(	O
A	O
)	O
:	O
Structure	O
of	O
the	O
genomic	S-SO
scaffolds	S-SO
containing	O
the	O
Takifugu	B-PRGE
rubripes	I-PRGE
trTACC1A	I-PRGE
and	I-PRGE
trTACC1B	E-PRGE
genes	S-SO
.	O

Scaffold	S-SO
12	O
,	O
the	O
site	S-SO
for	O
the	O
trTACC1A	S-PRGE
gene	S-SO
contains	O
genes	S-SO
found	O
with	O
either	O
homologues	S-SO
or	O
orthologues	S-SO
on	O
the	O
distal	O
long	O
arm	B-SO
of	I-SO
human	I-SO
chromosome	E-SO
10	O
and	O
4p16	O
.	O

This	O
scaffold	S-SO
,	O
therefore	O
,	O
has	O
some	O
of	O
the	O
characteristics	O
of	O
the	O
predicted	S-SO
immediate	O
ancestor	O
of	O
the	O
TACC1	S-PRGE
/	O
TACC2	S-PRGE
chromosomal	B-SO
segment	E-SO
.	O

trTACC1B	S-PRGE
is	O
found	O
on	O
scaffold	S-SO
191	O
,	O
which	O
contains	O
orthologues	S-SO
of	O
genes	S-SO
found	O
in	O
the	O
proximal	O
short	O
arm	B-SO
of	I-SO
human	I-SO
chromosome	E-SO
8	O
.	O

(	O
B	O
)	O
:	O
Ciona	B-LIVB
intestinalis	E-LIVB
clusters	S-SO
containing	O
genes	S-SO
found	O
in	O
paralogous	B-SO
segments	E-SO
on	O
human	S-LIVB
8	O
,	O
4p16	O
,	O
10q	O
and	O
5q	O
.	O

Figure	O
4	O

Genomic	S-SO
structure	O
of	O
the	O
TACC	O
genes	S-SO
.	O

Conserved	B-SO
regions	E-SO
known	O
to	O
bind	O
protein	S-CHEBI
factors	O
in	O
all	O
human	S-LIVB
TACC	O
proteins	S-CHEBI
are	O
shown	O
.	O

The	O
SDP	O
repeat	S-SO
of	O
human	B-PRGE
TACC1	E-PRGE
-	O
3	O
is	O
known	O
to	O
bind	O
GAS41	S-PRGE
(	O
[	O
3	O
,	O
15	O
]	O
and	O
data	O
not	O
shown	O
)	O
.	O

The	O
TACC	O
domain	S-SO
binds	O
ch	B-PRGE
-	I-PRGE
TOG	E-PRGE
and	O
members	O
of	O
the	O
Aurora	O
kinases	O
in	O
all	O
species	O
examined	O
to	O
date	O
.	O

This	O
motif	O
is	O
characteristically	O
encoded	O
by	O
the	O
3	O
'	O
exons	S-SO
of	O
the	O
TACC	O
genes	S-SO
.	O

The	O
size	O
of	O
the	O
largest	O
isoform	S-SO
for	O
each	O
gene	S-SO
is	O
shown	O
.	O

Comparative	O
genomic	S-SO
structure	O
of	O
the	O
TACC	O
family	O

The	O
genomic	B-SO
DNA	I-SO
sequences	E-SO
corresponding	O
to	O
the	O
orthologous	S-SO
TACC	O
genes	S-SO
of	O
human	S-LIVB
,	O
mouse	S-LIVB
,	O
rat	S-LIVB
,	O
pufferfish	S-LIVB
,	O
C	B-LIVB
.	I-LIVB
intestinalis	E-LIVB
,	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
and	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
were	O
extracted	O
and	O
analyzed	O
by	O
Genescan	O
and	O
BLAST	O
to	O
determine	O
the	O
genomic	S-SO
structure	O
of	O
each	O
TACC	O
gene	S-SO
.	O

In	O
some	O
cases	O
,	O
for	O
rat	S-LIVB
and	O
pufferfish	S-LIVB
,	O
exons	S-SO
were	O
added	S-SO
or	O
modified	S-SO
based	O
on	O
the	O
best	O
similarity	O
of	O
translated	O
peptides	S-SO
to	O
the	O
corresponding	O
mouse	S-LIVB
and	O
human	S-LIVB
proteins	S-CHEBI
.	O

For	O
regions	S-SO
with	O
low	O
sequence	S-SO
similarity	O
in	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
,	O
genomic	B-SO
sequences	E-SO
from	O
the	O
fresh	O
water	O
pufferfish	S-LIVB
,	O
Tetraodon	B-LIVB
nigroviridis	E-LIVB
were	O
used	O
as	O
additional	O
means	O
to	O
verify	O
the	O
predicted	S-SO
exons	S-SO
.	O

The	O
general	O
structure	O
of	O
the	O
TACC	O
genes	S-SO
and	O
proteins	S-CHEBI
is	O
depicted	O
in	O
Fig	O
.	O

4	O
.	O

The	O
main	O
conserved	S-SO
feature	S-SO
of	O
the	O
TACC	O
family	O
,	O
the	O
TACC	O
domain	S-SO
,	O
is	O
located	O
at	O
the	O
carboxy	B-SO
terminus	E-SO
of	O
the	O
protein	S-CHEBI
.	O

In	O
the	O
case	O
of	O
the	O
C	B-PRGE
.	I-PRGE
elegans	I-PRGE
TAC	E-PRGE
protein	S-CHEBI
,	O
this	O
structure	O
comprises	O
the	O
majority	O
of	O
the	O
protein	S-CHEBI
and	O
is	O
encoded	O
by	O
two	O
of	O
the	O
three	O
exons	S-SO
of	O
the	O
gene	S-SO
.	O

In	O
the	O
higher	O
organisms	S-LIVB
,	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
,	O
and	O
the	O
deuterostomes	S-LIVB
C	B-LIVB
.	I-LIVB
intestinalis	E-LIVB
to	O
human	S-LIVB
,	O
this	O
feature	S-SO
is	O
also	O
encoded	O
by	O
the	O
final	O
exons	S-SO
of	O
the	O
gene	S-SO
(	O
five	O
in	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
,	O
seven	O
in	O
the	O
deuterostome	S-LIVB
genes	S-SO
)	O
.	O

Outside	O
of	O
the	O
TACC	O
domain	S-SO
,	O
however	O
,	O
TACC	O
family	O
members	O
show	O
relatively	O
little	O
homology	S-SO
.	O

It	O
is	O
interesting	O
that	O
each	O
TACC	O
gene	S-SO
contains	O
one	O
large	O
exon	S-SO
,	O
which	O
shows	O
considerable	O
variability	O
between	O
TACC	O
orthologues	S-SO
,	O
and	O
constitutes	O
the	O
main	O
difference	O
between	O
the	O
TACC3	S-PRGE
genes	S-SO
in	O
the	O
vertebrates	S-LIVB
(	O
see	O
below	O
)	O
.	O

In	O
deuterostomes	S-LIVB
,	O
this	O
exon	S-SO
contains	O
the	O
SDP	O
repeat	S-SO
(	O
or	O
in	O
the	O
case	O
of	O
the	O
murine	S-LIVB
TACC3	B-PRGE
'	I-PRGE
s	E-PRGE
,	O
a	O
rodent	S-LIVB
-	O
specific	O
24	O
amino	B-CHEBI
acid	E-CHEBI
repeat	S-SO
)	O
,	O
which	O
is	O
responsible	O
for	O
the	O
binding	O
of	O
the	O
SWI	B-GO
/	I-GO
SNF	I-GO
chromatin	I-GO
remodeling	I-GO
complex	E-GO
component	O
GAS41	S-PRGE
[	O
15	O
,	O
16	O
]	O
.	O

Of	O
the	O
vertebrate	S-LIVB
TACC	O
proteins	S-CHEBI
,	O
the	O
TACC3	S-PRGE
orthologues	S-SO
show	O
the	O
greatest	O
variability	O
in	O
size	O
and	O
sequence	S-SO
,	O
ranging	O
in	O
size	O
from	O
599	O
amino	B-CHEBI
acids	E-CHEBI
for	O
the	O
rat	B-PRGE
TACC3	E-PRGE
protein	S-CHEBI
,	O
to	O
942	O
amino	B-CHEBI
acids	E-CHEBI
in	O
the	O
Danio	B-LIVB
rerio	E-LIVB
protein	S-CHEBI
.	O

The	O
reasons	O
for	O
these	O
differences	O
are	O
apparent	O
from	O
the	O
genomic	S-SO
structure	O
of	O
the	O
TACC3	S-PRGE
orthologues	S-SO
.	O

TACC3	S-PRGE
can	O
be	O
divided	O
into	O
three	O
sections	O
:	O
a	O
conserved	B-SO
N	I-SO
-	I-SO
terminal	I-SO
region	E-SO
(	O
CNTR	O
)	O
of	O
108	O
amino	B-CHEBI
acids	E-CHEBI
,	O
encoded	O
by	O
exons	S-SO
2	O
and	O
3	O
in	O
each	O
vertebrate	S-LIVB
TACC3	S-PRGE
gene	S-SO
,	O
the	O
conserved	S-SO
TACC	O
domain	S-SO
distributed	O
over	O
the	O
final	O
seven	O
exons	S-SO
,	O
and	O
a	O
highly	O
variable	O
central	O
region	S-SO
.	O

The	O
lack	O
of	O
conservation	S-SO
in	O
both	O
size	O
and	O
sequence	S-SO
of	O
the	O
central	O
portion	S-SO
of	O
the	O
TACC3	S-PRGE
proteins	S-CHEBI
of	O
human	S-LIVB
and	O
mouse	S-LIVB
has	O
been	O
previously	O
noted	O
,	O
and	O
accounts	O
for	O
the	O
major	O
difference	O
between	O
these	O
two	O
orthologues	S-SO
[	O
2	O
]	O
.	O

The	O
majority	O
of	O
this	O
central	O
portion	S-SO
,	O
which	O
contains	O
the	O
SDP	O
repeat	B-SO
motifs	E-SO
,	O
is	O
encoded	O
by	O
one	O
exon	S-SO
in	O
human	S-LIVB
and	O
the	O
pufferfish	S-LIVB
(	O
emb	O
|	O
CAAB01001184	O
)	O
.	O

In	O
rodents	S-LIVB
,	O
however	O
,	O
this	O
region	S-SO
is	O
almost	O
entirely	O
composed	O
of	O
seven	O
24	O
amino	B-CHEBI
acid	E-CHEBI
repeats	S-SO
,	O
which	O
are	O
located	O
in	O
a	O
single	O
exon	S-SO
of	O
the	O
mouse	B-PRGE
and	I-PRGE
rat	I-PRGE
TACC3	E-PRGE
genes	S-SO
.	O

It	O
has	O
been	O
previously	O
reported	O
that	O
there	O
are	O
four	O
mouse	B-PRGE
TACC3	E-PRGE
splice	B-SO
variants	E-SO
that	O
differ	O
in	O
the	O
number	O
of	O
these	O
repeats	S-SO
[	O
2	O
,	O
7	O
,	O
17	O
]	O
.	O

As	O
these	O
repeats	S-SO
are	O
present	O
in	O
a	O
single	O
exon	S-SO
,	O
it	O
appears	O
likely	O
that	O
these	O
different	O
sequences	S-SO
may	O
be	O
the	O
result	O
of	O
the	O
DNA	S-SO
polymerases	O
used	O
in	O
the	O
cDNA	S-SO
synthesis	O
and	O
/	O
or	O
PCR	O
reaction	O
stuttering	O
through	O
the	O
repeat	B-SO
motif	E-SO
.	O

The	O
correct	O
sequence	S-SO
,	O
reported	O
by	O
Sadek	O
et	O
al	O
[	O
7	O
]	O
,	O
is	O
the	O
one	O
used	O
throughout	O
the	O
entirety	O
of	O
this	O
manuscript	O
.	O

These	O
repeats	S-SO
are	O
not	O
evident	O
in	O
the	O
rabbit	S-LIVB
protein	S-CHEBI
,	O
or	O
any	O
other	O
TACC	O
protein	S-CHEBI
,	O
and	O
may	O
indicate	O
that	O
the	O
rodent	S-LIVB
TACC3	S-PRGE
has	O
evolved	O
distinct	O
functions	O
,	O
as	O
has	O
already	O
been	O
noted	O
for	O
the	O
amphibian	S-LIVB
Xenopus	S-LIVB
TACC3	S-PRGE
,	O
maskin	S-PRGE
[	O
8	O
]	O
.	O

Alternative	O
splicing	O
in	O
vertebrate	S-LIVB
TACC	O
genes	S-SO

Whereas	O
exon	S-SO
shuffling	O
can	O
drive	O
the	O
functional	O
diversification	O
of	O
gene	S-SO
families	O
over	O
evolutionary	O
time	O
,	O
the	O
temporal	O
and	O
/	O
or	O
tissue	O
specific	O
alternative	O
splicing	O
of	O
a	O
gene	S-SO
can	O
give	O
rise	O
to	O
functional	O
diversification	O
of	O
a	O
single	O
gene	S-SO
during	O
the	O
development	O
of	O
an	O
organism	S-LIVB
.	O

Although	O
no	O
alternative	O
splicing	O
of	O
TACC3	S-PRGE
has	O
been	O
clearly	O
documented	O
,	O
both	O
temporal	O
and	O
tissue	O
specific	O
splicing	O
is	O
observed	O
in	O
the	O
TACC1	S-PRGE
and	O
TACC2	S-PRGE
genes	S-SO
.	O

In	O
the	O
case	O
of	O
TACC2	S-PRGE
,	O
an	O
additional	O
large	O
(	O
5	O
kb	O
)	O
exon	S-SO
accounts	O
for	O
the	O
main	O
difference	O
between	O
the	O
major	O
splice	B-SO
variants	E-SO
of	O
the	O
vertebrate	S-LIVB
TACC2	S-PRGE
genes	S-SO
[	O
3	O
]	O
.	O

The	O
alternative	O
splicing	O
of	O
this	O
exon	S-SO
suggests	O
a	O
major	O
functional	O
difference	O
between	O
the	O
two	O
TACC2	S-PRGE
isoforms	S-SO
,	O
TACC2s	O
and	O
TACC2l	O
[	O
3	O
]	O
,	O
as	O
well	O
as	O
a	O
significant	O
difference	O
between	O
TACC2	S-PRGE
and	O
its	O
closest	O
TACC	O
family	O
relative	O
,	O
TACC1	S-PRGE
.	O

However	O
,	O
the	O
function	O
of	O
this	O
region	S-SO
of	O
the	O
TACC2l	O
isoform	S-SO
is	O
current	O
unknown	O
.	O

Alternative	O
splicing	O
,	O
together	O
with	O
differential	O
promoter	S-SO
usage	O
has	O
already	O
been	O
noted	O
for	O
the	O
human	B-PRGE
TACC1	E-PRGE
gene	S-SO
[	O
18	O
,	O
19	O
]	O
.	O

In	O
addition	O
,	O
as	O
shown	O
in	O
Fig	O
.	O

5	O
,	O
we	O
have	O
identified	O
additional	O
TACC1	S-PRGE
isoforms	S-SO
that	O
result	O
from	O
alternative	O
splicing	O
of	O
exons	S-SO
1b	O
-	O
4a	O
.	O

The	O
functions	O
of	O
these	O
different	B-SO
isoforms	E-SO
are	O
unknown	O
,	O
however	O
the	O
region	S-SO
deleted	S-SO
from	O
the	O
shorter	O
variants	S-SO
can	O
include	O
the	O
binding	B-SO
site	E-SO
for	O
LSm7	S-PRGE
[	O
20	O
]	O
(	O
variants	S-SO
C	O
,	O
D	O
,	O
F	O
-	O
I	O
)	O
,	O
and	O
/	O
or	O
the	O
nuclear	S-GO
localization	O
signals	S-SO
and	O
binding	B-SO
site	E-SO
for	O
GAS41	S-PRGE
[	O
15	O
]	O
and	O
PCTAIRE2BP	S-PRGE
[	O
20	O
]	O
(	O
isoforms	S-SO
B	O
-	O
D	O
,	O
S	O
)	O
.	O

One	O
of	O
these	O
isoforms	S-SO
,	O
TACC1S	O
is	O
localized	O
exclusively	O
to	O
the	O
cytoplasm	S-GO
[	O
19	O
]	O
,	O
suggesting	O
that	O
the	O
shorter	O
isoforms	S-SO
would	O
not	O
be	O
able	O
to	O
interact	O
with	O
elements	O
of	O
the	O
chomatin	S-GO
remodeling	O
and	O
/	O
or	O
RNA	S-SO
processing	O
machinery	O
in	O
the	O
nucleus	S-GO
.	O

Thus	O
,	O
changes	O
in	O
the	O
complement	O
of	O
TACC1	S-PRGE
isoforms	S-SO
in	O
the	O
cell	S-CL
may	O
result	O
in	O
alterations	O
in	O
cellular	S-CL
RNA	S-SO
metabolism	O
at	O
multiple	O
levels	O
,	O
and	O
may	O
account	O
for	O
the	O
observation	O
that	O
TACC1D	O
and	O
TACC1F	O
isoforms	S-SO
are	O
associated	O
with	O
tumorigenic	O
changes	O
in	O
gastric	O
mucosa	O
[	O
18	O
]	O
.	O

Figure	O
5	O

Alternative	O
splicing	O
of	O
the	O
human	B-PRGE
TACC1	E-PRGE
gene	S-SO
.	O

(	O
A	O
)	O
:	O
Seven	O
splice	B-SO
variants	E-SO
have	O
been	O
identified	O
for	O
human	B-PRGE
TACC1	E-PRGE
(	O
A	O
-	O
F	O
and	O
S	O
)	O
.	O

We	O
have	O
also	O
identified	O
additional	O
splice	B-SO
variants	E-SO
(	O
G	O
-	O
I	O
)	O
from	O
database	O
analysis	O
and	O
rt	O
-	O
PCR	O
analysis	O
of	O
human	S-LIVB
brain	O
RNA	S-SO
.	O

(	O
B	O
)	O
:	O
Alternative	O
splicing	O
of	O
TACC1	S-PRGE
in	O
the	O
human	S-LIVB
brain	O
.	O

rt	O
-	O
PCR	O
analysis	O
confirms	O
splicing	O
of	O
the	O
untranslated	B-SO
exon	E-SO
1a	O
to	O
exon	S-SO
1	O
,	O
with	O
retention	O
of	O
the	O
originally	O
defined	O
start	O
methionine	S-CHEBI
(	O
GB	O
:	O
NP	O
_	O
006274	O
)	O
(	O
Variant	S-SO
A	O
*	O
,	O
lanes	O
1	O
and	O
3	O
)	O
.	O

Exon	S-SO
1a	O
also	O
splices	O
to	O
exon	S-SO
2	O
,	O
removing	S-SO
the	O
L	B-PRGE
-	I-PRGE
Sm7	E-PRGE
binding	O
motif	O
(	O
variant	S-SO
I	O
,	O
lanes	O
3	O
,	O
12	O
and	O
13	O
)	O
.	O

Variants	S-SO
that	O
functionally	O
delete	S-SO
exons	S-SO
2	O
and	O
/	O
or	O
3	O
,	O
such	O
as	O
variant	S-SO
C	O
(	O
lane	O
15	O
)	O
also	O
remove	S-SO
the	O
predicted	S-SO
nuclear	S-GO
localization	O
signals	S-SO
,	O
and	O
the	O
binding	O
domains	S-SO
for	O
GAS41	S-PRGE
and	O
PCTAIRE2BP	S-PRGE
.	O

These	O
variants	S-SO
would	O
retain	O
the	O
TACC	O
domain	S-SO
,	O
and	O
therefore	O
the	O
potential	O
to	O
bind	O
to	O
ch	B-PRGE
-	I-PRGE
TOG	E-PRGE
and	O
Aurora	B-PRGE
A	I-PRGE
kinase	E-PRGE
in	O
the	O
centrosome	S-GO
.	O

Lane	O
1	O
:	O
EF	O
/	O
X1R	O
,	O
Lane	O
2	O
:	O
EF	O
/	O
BX647R	O
,	O
Lane	O
3	O
:	O
EF	O
/	O
6SPR	O
,	O
Lane	O
4	O
:	O
EF	O
/	O
1DR	O
,	O
Lane	O
5	O
,	O
EF	O
/	O
128R	O
,	O
Lane	O
6	O
X3F	O
/	O
X1R	O
,	O
Lane	O
7	O
:	O
X3F	O
/	O
BX647R	O
,	O
Lane	O
8	O
:	O
X3F	O
/	O
6SPR	O
,	O
Lane	O
9	O
:	O
X3F	O
/	O
1DR	O
,	O
Lane	O
10	O
,	O
X3F	O
/	O
128R	O
,	O
Lane	O
11	O
:	O
1DF	O
/	O
X1R	O
,	O
Lane	O
12	O
:	O
1DF	O
/	O
BX647R	O
,	O
Lane	O
13	O
:	O
1DF	O
/	O
6SPR	O
,	O
Lane	O
14	O
:	O
1DF	O
/	O
1DR	O
,	O
Lane	O
15	O
:	O
1DF	O
/	O
128R	O
,	O
Lane	O
16	O
:	O
Biorad	O
1	O
kb	O
+	O
Size	O
ladder	O
.	O

In	O
silico	O
modeling	O
of	O
the	O
evolution	O
of	O
TACC	O
protein	S-CHEBI
function	O

The	O
protein	S-CHEBI
and	O
genomic	S-SO
structure	O
of	O
the	O
present	O
day	O
TACC	O
family	O
members	O
suggests	O
that	O
the	O
function	O
of	O
the	O
ancestral	O
TACC	O
protein	S-CHEBI
was	O
mediated	O
solely	O
through	O
the	O
interactions	O
of	O
the	O
conserved	S-SO
TACC	O
domain	S-SO
.	O

Using	O
an	O
in	O
silico	O
protein	S-CHEBI
-	O
protein	S-CHEBI
interaction	O
model	O
based	O
upon	O
known	O
mitotic	O
spindle	S-GO
and	O
centrosomal	S-GO
components	O
,	O
we	O
have	O
previously	O
predicted	O
a	O
number	O
of	O
additional	O
interactions	O
that	O
could	O
be	O
conserved	O
between	O
a	O
functional	O
TACC	O
homologue	S-SO
in	O
yeast	S-LIVB
,	O
spc	B-PRGE
-	I-PRGE
72	E-PRGE
,	O
and	O
one	O
or	O
more	O
human	S-LIVB
TACC	O
proteins	S-CHEBI
[	O
21	O
]	O
.	O

Thus	O
,	O
it	O
is	O
known	O
that	O
all	O
the	O
TACC	O
proteins	S-CHEBI
examined	O
to	O
date	O
interact	O
,	O
via	O
the	O
TACC	O
domain	S-SO
,	O
with	O
the	O
microtubule	S-GO
/	O
centrosomal	S-GO
proteins	S-CHEBI
of	O
the	O
stu2	S-PRGE
/	O
msps	S-PRGE
/	O
ch	B-PRGE
-	I-PRGE
TOG	E-PRGE
family	O
[	O
5	O
,	O
6	O
,	O
22	O
-	O
24	O
]	O
,	O
and	O
with	O
the	O
Aurora	O
kinases	O
[	O
20	O
,	O
21	O
,	O
25	O
]	O
.	O

These	O
interactions	O
are	O
required	O
for	O
the	O
accumulation	O
of	O
the	O
D	O
-	O
TACC	O
,	O
spc72	O
,	O
ceTAC1	O
and	O
TACC3	S-PRGE
proteins	S-CHEBI
to	O
the	O
centrosome	S-GO
[	O
5	O
,	O
6	O
,	O
22	O
-	O
24	O
]	O
.	O

Hence	O
,	O
this	O
functional	O
interaction	O
with	O
the	O
centrosome	S-GO
and	O
mitotic	O
spindle	S-GO
is	O
likely	O
to	O
represent	O
the	O
ancient	O
,	O
conserved	O
function	O
of	O
the	O
TACC	O
family	O
.	O

However	O
,	O
it	O
is	O
apparent	O
that	O
the	O
human	S-LIVB
TACC	O
proteins	S-CHEBI
also	O
differ	O
in	O
their	O
ability	O
to	O
interact	O
with	O
the	O
Aurora	O
kinases	O
.	O

For	O
instance	O
,	O
TACC1	S-PRGE
and	O
TACC3	S-PRGE
interact	O
with	O
Aurora	B-PRGE
A	I-PRGE
kinase	E-PRGE
,	O
whereas	O
TACC2	S-PRGE
interacts	O
with	O
Aurora	B-PRGE
C	I-PRGE
kinase	E-PRGE
[	O
21	O
]	O
,	O
suggesting	O
a	O
degree	O
of	O
functional	O
specialization	O
in	O
the	O
derivatives	O
of	O
the	O
ancestral	O
chordate	S-LIVB
TACC	O
,	O
after	O
the	O
radiation	O
of	O
the	O
vertebrate	S-LIVB
TACC	O
genes	S-SO
.	O

The	O
localization	O
of	O
the	O
vertebrate	S-LIVB
TACC	O
proteins	S-CHEBI
in	O
the	O
interphase	O
nucleus	S-GO
[	O
15	O
,	O
26	O
,	O
27	O
]	O
suggests	O
that	O
they	O
have	O
additional	O
functions	O
outside	O
their	O
ancient	O
role	O
in	O
the	O
centrosome	S-GO
and	O
microtubule	S-GO
dynamics	O
.	O

Thus	O
,	O
it	O
seems	O
likely	O
that	O
TACC	O
family	O
members	O
in	O
protostomes	S-LIVB
and	O
deuterostomes	S-LIVB
have	O
integrated	O
new	O
unique	O
functions	O
as	O
the	O
evolving	O
TACC	O
genes	S-SO
acquired	O
additional	O
exons	S-SO
.	O

The	O
results	O
of	O
the	O
pilot	O
large	O
-	O
scale	O
proteomic	O
analysis	O
in	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
and	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
provide	O
further	O
suggestive	O
evidence	O
to	O
this	O
functional	O
evolution	O
.	O

Yeast	S-LIVB
two	O
hybrid	O
analysis	O
indicates	O
that	O
ceTAC	S-PRGE
directly	O
binds	O
to	O
C	B-PRGE
.	I-PRGE
elegans	I-PRGE
lin15A	I-PRGE
,	I-PRGE
lin36	I-PRGE
and	I-PRGE
lin37	E-PRGE
[	O
28	O
]	O
.	O

These	O
proteins	S-CHEBI
bridge	O
ceTAC	S-PRGE
to	O
other	O
elements	O
of	O
the	O
cytoskeleton	S-GO
and	O
microtubule	S-GO
network	O
,	O
as	O
well	O
as	O
to	O
components	O
of	O
the	O
ribosome	S-GO
,	O
the	O
histone	S-CHEBI
deacetylase	O
chromatin	S-GO
remodeling	O
machinery	O
such	O
as	O
egr	B-PRGE
-	I-PRGE
1	E-PRGE
and	O
lin	B-PRGE
-	I-PRGE
53	E-PRGE
(	O
the	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
homologues	S-SO
of	O
the	O
human	B-PRGE
MTA	I-PRGE
-	I-PRGE
1	I-PRGE
and	I-PRGE
RbAP48	E-PRGE
)	O
,	O
and	O
to	O
transcription	O
factors	O
such	O
as	O
the	O
PAL1	S-PRGE
homeobox	O
and	O
the	O
nuclear	S-GO
hormone	S-CHEBI
receptor	O
nhr	B-PRGE
-	I-PRGE
86	E-PRGE
[	O
28	O
]	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Similarly	O
,	O
large	O
scale	O
proteomics	O
[	O
29	O
]	O
has	O
shown	O
that	O
Drosophila	B-PRGE
TACC	E-PRGE
interacts	O
with	O
two	O
proteins	S-CHEBI
,	O
the	O
RNA	S-SO
binding	O
protein	S-CHEBI
TBPH	S-PRGE
and	O
CG14540	S-PRGE
(	O
Fig	O
.	O
6B	O
)	O
,	O
and	O
thus	O
indirectly	O
with	O
the	O
Drosophila	S-LIVB
SWI	B-GO
/	I-GO
SNF	I-GO
chromatin	I-GO
remodeling	I-GO
complex	E-GO
and	O
DNA	S-SO
damage	O
repair	O
machinery	O
.	O

Significantly	O
,	O
the	O
ceTAC	S-PRGE
protein	S-CHEBI
has	O
also	O
recently	O
been	O
implicated	O
in	O
DNA	S-SO
repair	O
through	O
its	O
direct	O
interaction	O
with	O
the	O
C	B-PRGE
.	I-PRGE
elegans	I-PRGE
BARD1	E-PRGE
orthologue	S-SO
[	O
30	O
]	O
.	O

It	O
should	O
be	O
noted	O
that	O
a	O
number	O
of	O
interactions	O
with	O
the	O
TACC	O
proteins	S-CHEBI
from	O
these	O
organisms	S-LIVB
have	O
probably	O
been	O
missed	O
by	O
these	O
large	O
scale	O
methods	O
,	O
including	O
the	O
well	O
documented	O
direct	O
interactions	O
with	O
the	O
aurora	O
kinases	O
and	O
the	O
stu2	S-PRGE
/	O
msps	S-PRGE
/	O
ch	B-PRGE
-	I-PRGE
TOG	E-PRGE
family	O
.	O

Figure	O
6	O

Functional	O
evolution	O
of	O
the	O
TACC	O
proteins	S-CHEBI
modeled	O
in	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
and	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
.	O

(	O
A	O
)	O
.	O

C	B-LIVB
.	I-LIVB
elegans	E-LIVB
interaction	O
map	O
shows	O
empirically	O
defined	O
interactions	O
of	O
ceTAC	S-PRGE
,	O
and	O
extrapolated	O
interactions	O
defined	O
by	O
[	O
28	O
]	O
.	O

(	O
B	O
)	O
:	O
Using	O
the	O
BIND	O
database	O
[	O
29	O
]	O
,	O
DTACC	S-PRGE
directly	O
binds	O
to	O
TBPH	S-PRGE
and	O
CG14540	S-PRGE
,	O
and	O
thus	O
indirectly	O
to	O
chromatin	B-GO
remodeling	I-GO
complexes	E-GO
(	O
SWI	B-GO
/	I-GO
SNF	E-GO
and	O
histone	S-CHEBI
acetyltransferases	O
)	O
,	O
DNA	S-SO
damage	O
repair	O
machinery	O
(	O
via	O
RAD23	S-PRGE
)	O
,	O
and	O
RNA	S-SO
splicing	O
,	O
transport	O
and	O
translational	O
machinery	O
.	O

(	O
C	O
)	O
:	O
Predicted	O
interaction	O
map	O
for	O
vertebrate	S-LIVB
TACCs	O
,	O
based	O
upon	O
ceTAC	S-PRGE
,	O
suggests	O
an	O
indirect	O
interaction	O
with	O
the	O
nuclear	S-GO
hormone	S-CHEBI
receptor	O
RXR	B-PRGE
beta	E-PRGE
.	O

It	O
is	O
also	O
of	O
interest	O
that	O
this	O
predicts	O
a	O
functional	O
interaction	O
with	O
the	O
LDB	O
family	O
,	O
members	O
of	O
which	O
are	O
also	O
found	O
in	O
TACC	O
containing	O
paralogous	B-SO
segments	E-SO
noted	O
in	O
Figs	O
2	O
,	O
3	O
and	O
Additional	O
file	O
1	O
.	O

(	O
D	O
)	O
:	O
Predicted	O
TACC	O
interaction	O
map	O
based	O
upon	O
DTACC	S-PRGE
.	O

(	O
E	O
)	O
:	O
Vertebrate	S-LIVB
TACC	O
interactions	O
identified	O
to	O
date	O
.	O

?	O
denotes	O
uncertainty	O
over	O
the	O
identity	O
of	O
a	O
functional	O
vertebrate	S-LIVB
homologue	S-SO
.	O

In	O
C	O
,	O
D	O
and	O
E	O
,	O
'	O
*	O
'	O
denotes	O
one	O
or	O
more	O
members	O
of	O
the	O
TACC	O
or	O
Aurora	O
kinase	O
family	O
.	O

Because	O
of	O
the	O
evolutionary	B-SO
conservation	E-SO
of	O
the	O
TACC	O
domain	S-SO
,	O
we	O
would	O
predict	O
that	O
some	O
of	O
the	O
functional	O
interactions	O
seen	O
in	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
and	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
would	O
be	O
observed	O
in	O
higher	O
animals	S-LIVB
.	O

Phylogenetic	O
profiling	O
from	O
these	O
interaction	O
maps	O
suggests	O
two	O
similar	O
sets	O
of	O
predicted	O
interactions	O
for	O
vertebrate	S-LIVB
TACCs	O
(	O
Fig	O
.	O
6C	O
and	O
6D	O
)	O
.	O

Strikingly	O
,	O
however	O
,	O
the	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
specific	O
proteins	S-CHEBI
lin15A	S-PRGE
,	O
lin36	S-PRGE
and	O
lin37	S-PRGE
do	O
not	O
have	O
readily	O
discernible	O
homologues	S-SO
in	O
vertebrates	S-LIVB
or	O
Drosophila	S-LIVB
,	O
although	O
the	O
presence	O
of	O
a	O
zinc	S-CHEBI
finger	O
domain	S-SO
in	O
lin36	S-PRGE
may	O
suggest	O
that	O
this	O
protein	S-CHEBI
is	O
involved	O
directly	O
in	O
transcription	O
or	O
perform	O
an	O
adaptor	O
role	O
similar	O
to	O
LIM	O
containing	O
proteins	S-CHEBI
.	O

For	O
the	O
DTACC	S-PRGE
interacting	O
proteins	S-CHEBI
,	O
TBPH	S-PRGE
corresponds	O
to	O
TDP43	S-PRGE
,	O
a	O
protein	S-CHEBI
implicated	O
in	O
transcriptional	O
regulation	O
and	O
splicing	O
[	O
31	O
,	O
32	O
]	O
.	O

However	O
,	O
the	O
assignment	O
of	O
the	O
human	S-LIVB
homologue	S-SO
of	O
CG14540	S-PRGE
is	O
less	O
clear	O
,	O
with	O
the	O
closest	O
matches	S-SO
in	O
the	O
human	S-LIVB
databases	O
corresponding	O
to	O
glutamine	S-CHEBI
rich	O
transcription	O
factors	O
such	O
as	O
CREB	S-PRGE
and	O
the	O
G	S-CHEBI
-	O
box	O
binding	O
factor	O
.	O

Comparison	O
of	O
modeled	O
with	O
experimentally	O
defined	O
interactions	O
of	O
the	O
vertebrate	S-LIVB
TACC	O
proteins	S-CHEBI

The	O
interaction	O
data	O
for	O
the	O
vertebrate	S-LIVB
TACCs	O
is	O
relatively	O
limited	O
;	O
however	O
,	O
interaction	O
networks	O
are	O
now	O
beginning	O
to	O
emerge	O
.	O

The	O
results	O
of	O
our	O
functional	O
analysis	O
,	O
as	O
well	O
as	O
other	O
published	O
data	O
clearly	O
indicate	O
that	O
the	O
vertebrate	S-LIVB
TACCs	O
interact	O
with	O
proteins	S-CHEBI
that	O
can	O
be	O
divided	O
into	O
two	O
broad	O
categories	O
:	O
1	O
)	O
proteins	S-CHEBI
with	O
roles	O
in	O
centrosome	S-GO
/	O
mitotic	O
spindle	S-GO
dynamics	O
,	O
and	O
2	O
)	O
proteins	S-CHEBI
involved	O
in	O
gene	S-SO
regulation	O
,	O
either	O
at	O
the	O
level	O
of	O
transcription	O
,	O
or	O
subsequent	O
RNA	S-SO
processing	O
and	O
translation	O
[	O
3	O
,	O
5	O
-	O
7	O
,	O
15	O
,	O
19	O
-	O
21	O
,	O
24	O
,	O
25	O
,	O
33	O
,	O
34	O
]	O
.	O

Many	O
of	O
these	O
proteins	S-CHEBI
do	O
not	O
appear	O
to	O
interact	O
directly	O
with	O
the	O
protostome	O
TACCs	O
,	O
but	O
would	O
be	O
expected	O
to	O
be	O
in	O
the	O
same	O
protein	B-GO
complex	E-GO
(	O
Fig	O
.	O
6C	O
,	O
6D	O
)	O
.	O

Significant	O
analysis	O
of	O
the	O
association	O
of	O
the	O
TACCs	O
with	O
the	O
centrosome	S-GO
and	O
the	O
dynamics	O
of	O
mitotic	O
spindle	S-GO
assembly	O
from	O
yeast	S-LIVB
to	O
humans	O
has	O
been	O
published	O
[	O
5	O
,	O
6	O
,	O
21	O
-	O
24	O
]	O
.	O

From	O
this	O
analysis	O
,	O
it	O
seems	O
likely	O
that	O
the	O
vertebrate	S-LIVB
TACC3	S-PRGE
protein	S-CHEBI
has	O
retained	O
this	O
direct	O
ancestral	O
function	O
,	O
based	O
upon	O
its	O
location	O
in	O
these	O
structures	O
during	O
mitosis	O
[	O
27	O
]	O
,	O
its	O
strong	O
interaction	O
with	O
Aurora	B-PRGE
Kinase	I-PRGE
A	E-PRGE
,	O
and	O
the	O
observation	O
that	O
it	O
is	O
the	O
only	O
human	S-LIVB
TACC	O
protein	S-CHEBI
phosphorylated	O
by	O
this	O
enzyme	S-SO
[	O
21	O
]	O
.	O

However	O
,	O
the	O
variability	O
of	O
the	O
central	O
domain	S-SO
of	O
the	O
vertebrate	S-LIVB
orthologues	S-SO
,	O
suggests	O
that	O
TACC3	S-PRGE
may	O
also	O
have	O
acquired	O
additional	O
,	O
and	O
in	O
some	O
instances	O
,	O
species	O
-	O
specific	O
functions	O
.	O

For	O
instance	O
,	O
in	O
X	B-LIVB
.	I-LIVB
laevis	E-LIVB
,	O
the	O
maskin	S-PRGE
protein	S-CHEBI
has	O
acquired	O
a	O
binding	B-SO
site	I-SO
for	I-SO
the	I-SO
eIF4E	I-SO
protein	E-SO
,	O
and	O
thus	O
a	O
function	O
in	O
the	O
coordinated	O
control	O
of	O
polyadenylation	O
and	O
translation	O
in	O
the	O
Xenopus	S-LIVB
oocyte	S-CL
[	O
8	O
,	O
35	O
]	O
.	O

A	O
recent	O
study	O
has	O
suggested	O
that	O
this	O
function	O
may	O
be	O
unique	O
to	O
maskin	S-PRGE
:	O
although	O
it	O
is	O
unclear	O
whether	O
the	O
other	O
vertebrate	S-LIVB
TACC3	S-PRGE
proteins	S-CHEBI
interact	O
with	O
the	O
eIF4E	S-PRGE
/	O
CPEB	O
complex	S-GO
,	O
the	O
human	S-LIVB
TACC1A	O
isoform	S-SO
is	O
unable	O
to	O
interact	O
with	O
the	O
eIF4E	S-PRGE
/	O
CPEB	S-PRGE
complex	S-GO
.	O

Instead	O
,	O
some	O
TACC1	S-PRGE
isoforms	S-SO
have	O
evolved	O
a	O
related	O
,	O
but	O
distinct	O
function	O
by	O
directly	O
interacting	O
with	O
elements	O
of	O
the	O
RNA	S-SO
splicing	O
and	O
transport	O
machinery	O
[	O
19	O
]	O
.	O

To	O
further	O
characterize	O
the	O
evolving	O
functions	O
of	O
the	O
TACC	O
proteins	S-CHEBI
,	O
we	O
have	O
used	O
an	O
unbiased	O
yeast	S-LIVB
two	O
hybrid	O
screening	O
method	O
to	O
identify	O
proteins	S-CHEBI
that	O
bind	O
to	O
the	O
human	S-LIVB
TACC	O
proteins	S-CHEBI
[	O
3	O
,	O
34	O
]	O
.	O

In	O
a	O
screen	O
of	O
a	O
MATCHMAKER	O
fetal	O
brain	O
library	O
(	O
BD	O
Biosciences	O
Clontech	O
)	O
,	O
in	O
addition	O
to	O
isolating	O
the	O
histone	S-CHEBI
acetyltransferase	O
hGCN5L2	S-PRGE
[	O
34	O
]	O
,	O
we	O
also	O
identified	O
the	O
beta	O
3	O
isoform	S-SO
of	O
retinoid	B-PRGE
-	I-PRGE
X	I-PRGE
receptor	I-PRGE
beta	E-PRGE
as	O
a	O
protein	S-CHEBI
that	O
interacts	O
with	O
the	O
TACC	O
domain	S-SO
of	O
TACC2	S-PRGE
.	O

As	O
shown	O
in	O
Fig	O
.	O

7	O
,	O
this	O
interaction	O
is	O
confirmed	O
in	O
vitro	O
by	O
GST	S-PRGE
-	O
pull	O
down	O
analysis	O
.	O

Significantly	O
,	O
RXR	B-PRGE
beta	E-PRGE
is	O
a	O
close	O
family	O
relative	O
of	O
the	O
nuclear	S-GO
hormone	S-CHEBI
receptor	O
,	O
nhr	B-PRGE
-	I-PRGE
86	E-PRGE
,	O
from	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
,	O
which	O
interacts	O
with	O
the	O
ceTAC	S-PRGE
binding	O
protein	S-CHEBI
lin36	S-PRGE
(	O
Fig	O
.	O
6A	O
)	O
.	O

This	O
suggests	O
that	O
while	O
protostome	S-LIVB
TACCs	O
may	O
require	O
additional	O
protein	S-CHEBI
factors	O
to	O
interact	O
with	O
such	O
components	O
,	O
the	O
TACCs	O
in	O
higher	O
organisms	S-LIVB
may	O
have	O
evolved	O
the	O
ability	O
to	O
directly	O
interact	O
with	O
some	O
of	O
the	O
proteins	S-CHEBI
in	O
the	O
predicted	O
interaction	O
map	O
(	O
Fig	O
.	O
6E	O
)	O
.	O

Indeed	O
,	O
this	O
appears	O
to	O
be	O
directly	O
linked	O
to	O
the	O
acquisition	O
of	O
new	O
domains	S-SO
and	O
duplication	S-SO
of	O
the	O
chordate	S-LIVB
TACC	O
precursor	O
.	O

In	O
fact	O
,	O
the	O
first	O
identified	O
function	O
of	O
a	O
vertebrate	S-LIVB
TACC	O
protein	S-CHEBI
was	O
as	O
a	O
transcriptional	O
coactivator	O
acting	O
through	O
a	O
direct	O
interaction	O
with	O
the	O
ARNT	B-PRGE
transcription	I-PRGE
factor	E-PRGE
[	O
7	O
]	O
.	O

It	O
is	O
also	O
intriguing	O
that	O
the	O
deuterostome	S-LIVB
specific	O
SDP	O
repeat	S-SO
interacts	O
with	O
GAS41	S-PRGE
,	O
a	O
component	O
/	O
accessory	O
factor	O
of	O
the	O
human	S-LIVB
SWI	B-GO
/	I-GO
SNF	I-GO
chromatin	I-GO
remodeling	I-GO
complex	E-GO
[	O
3	O
,	O
15	O
]	O
.	O

Although	O
there	O
is	O
a	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
homologue	S-SO
of	O
GAS41	S-PRGE
,	O
dmGAS41	S-PRGE
,	O
the	O
large	O
scale	O
proteomic	O
interaction	O
database	O
does	O
not	O
indicate	O
a	O
direct	O
interaction	O
of	O
dmGAS41	S-PRGE
with	O
DTACC	S-PRGE
.	O

This	O
may	O
be	O
due	O
to	O
the	O
lack	O
of	O
the	O
SDP	O
repeat	B-SO
region	E-SO
in	O
the	O
Drosophila	B-PRGE
TACC	E-PRGE
protein	S-CHEBI
.	O

This	O
further	O
suggests	O
that	O
the	O
vertebrate	S-LIVB
TACCs	O
have	O
gained	O
the	O
specific	O
ability	O
to	O
direct	O
interact	O
with	O
transcriptional	B-GO
regulatory	I-GO
complexes	E-GO
,	O
and	O
that	O
bridging	O
protein	B-CHEBI
(	I-CHEBI
s	I-CHEBI
)	E-CHEBI
are	O
no	O
longer	O
required	O
.	O

Thus	O
,	O
where	O
the	O
ceTAC	S-PRGE
protein	S-CHEBI
is	O
only	O
composed	O
of	O
the	O
TACC	O
domain	S-SO
,	O
the	O
significantly	O
larger	O
TACC	O
family	O
members	O
in	O
higher	O
protostomes	S-LIVB
and	O
deuterostomes	S-LIVB
may	O
have	O
integrated	O
one	O
or	O
more	O
functions	O
of	O
the	O
bridging	O
protein	S-CHEBI
(	O
in	O
this	O
case	O
lin15A	S-PRGE
,	O
lin36	S-PRGE
or	O
lin37	S-PRGE
)	O
.	O

This	O
may	O
also	O
explain	O
the	O
absence	O
of	O
lin15A	S-PRGE
,	O
lin36	S-PRGE
and	O
lin37	S-PRGE
homologues	S-SO
in	O
higher	O
organisms	S-LIVB
,	O
as	O
they	O
were	O
no	O
longer	O
under	O
selective	O
evolutionary	O
pressure	O
to	O
remain	O
within	O
the	O
complex	S-GO
,	O
and	O
thus	O
lost	O
in	O
the	O
evolving	O
genome	S-SO
.	O

Figure	O
7	O

In	O
vitro	O
interaction	O
of	O
RXR	O
beta	O
3	O
and	O
TACC2s	S-PRGE
.	O

Top	O
panel	O
:	O
Autoradiograph	O
of	O
12	O
%	O
SDS	S-CHEBI
polyacrylamide	O
gel	O
with	O
in	O
vitro	O
translated	O
RXR	O
beta	O
3	O
construct	S-SO
pulled	O
down	O
with	O
GST	S-PRGE
-	O
TACC2	S-PRGE
(	O
Lane	O
1	O
)	O
or	O
GST	S-PRGE
(	O
Lane	O
2	O
)	O
;	O
Lane	O
3	O
:	O
5	O
%	O
input	O
of	O
in	O
vitro	O
translated	O
RXR	B-PRGE
-	I-PRGE
beta	E-PRGE
protein	S-CHEBI
.	O

Bottom	O
two	O
panels	O
represent	O
Coomassie	O
blue	O
stained	O
gels	O
of	O
pull	O
down	O
experiment	O
showing	O
loading	O
of	O
GST	S-PRGE
-	O
TACC2	S-PRGE
and	O
GST	S-PRGE
.	O

Conclusion	O

Proposed	O
functional	O
evolution	O
of	O
the	O
TACC	O
family	O

Examination	O
of	O
the	O
evolution	O
of	O
ancient	O
gene	S-SO
families	O
provides	O
an	O
insight	O
into	O
how	O
gene	S-SO
structure	O
relates	O
to	O
function	O
.	O

We	O
have	O
presented	O
above	O
,	O
a	O
detailed	O
examination	O
of	O
one	O
such	O
gene	S-SO
family	O
.	O

The	O
data	O
so	O
far	O
suggest	O
that	O
the	O
functional	O
TACC	O
homologue	S-SO
in	O
yeast	S-LIVB
(	O
spc72	S-PRGE
)	O
has	O
a	O
specific	O
role	O
in	O
centrosomal	S-GO
/	O
mitotic	O
spindle	S-GO
dynamics	O
[	O
21	O
,	O
22	O
]	O
.	O

This	O
ancient	O
TACC	O
function	O
is	O
conserved	O
throughout	O
evolution	O
in	O
both	O
protostomes	S-LIVB
and	O
deuterostomes	S-LIVB
.	O

In	O
addition	O
,	O
the	O
TACC	O
proteins	S-CHEBI
of	O
lower	O
organisms	S-LIVB
appear	O
to	O
interact	O
with	O
bridging	O
proteins	S-CHEBI
that	O
are	O
components	O
of	O
several	O
different	O
protein	B-GO
complexes	E-GO
involved	O
in	O
DNA	S-SO
damage	O
repair	O
,	O
protein	S-CHEBI
translation	O
,	O
RNA	S-SO
processing	O
and	O
transcription	O
.	O

However	O
,	O
over	O
the	O
process	O
of	O
evolutionary	O
time	O
,	O
with	O
the	O
acquisition	O
of	O
new	O
domains	S-SO
and	O
duplication	S-SO
of	O
the	O
chordate	S-LIVB
TACC	O
precursor	O
,	O
the	O
chordate	S-LIVB
TACC	O
proteins	S-CHEBI
have	O
acquired	O
the	O
ability	O
to	O
directly	O
interact	O
with	O
some	O
of	O
the	O
other	O
components	O
of	O
these	O
complexes	S-GO
(	O
such	O
as	O
the	O
LSm	O
proteins	S-CHEBI
,	O
nuclear	S-GO
hormone	S-CHEBI
receptors	O
,	O
GAS41	S-PRGE
,	O
accessory	O
proteins	S-CHEBI
and	O
transcription	O
factors	O
)	O
,	O
and	O
thus	O
evolved	O
additional	O
functions	O
within	O
these	O
complexes	S-GO
.	O

Indeed	O
,	O
the	O
first	O
assigned	O
function	O
of	O
a	O
vertebrate	S-LIVB
TACC	O
protein	S-CHEBI
,	O
mouse	B-PRGE
TACC3	E-PRGE
,	O
was	O
as	O
a	O
transcriptional	O
coactivator	O
of	O
the	O
ARNT	S-PRGE
mediated	O
transcriptional	O
response	O
to	O
hypoxia	O
and	O
polyaromatic	B-CHEBI
hydrocarbons	E-CHEBI
[	O
7	O
]	O
.	O

Mouse	B-PRGE
TACC3	E-PRGE
has	O
also	O
been	O
reported	O
to	O
interact	O
with	O
the	O
transcription	O
factor	O
STAT5	S-PRGE
[	O
33	O
]	O
.	O

Recently	O
,	O
we	O
have	O
demonstrated	O
that	O
TACC2	S-PRGE
and	O
TACC3	S-PRGE
can	O
bind	O
to	O
nuclear	S-GO
histone	S-CHEBI
acetyltransferases	O
[	O
34	O
]	O
,	O
further	O
confirming	O
a	O
more	O
direct	O
role	O
for	O
the	O
TACC	O
proteins	S-CHEBI
in	O
transcriptional	O
and	O
chromatin	S-GO
remodeling	O
events	O
.	O

Interestingly	O
although	O
all	O
human	S-LIVB
TACC	O
proteins	S-CHEBI
can	O
directly	O
interact	O
with	O
the	O
histone	S-CHEBI
acetyltransferase	O
pCAF	S-PRGE
in	O
vitro	O
,	O
the	O
TACC1	S-PRGE
isoforms	S-SO
expressed	O
in	O
human	S-LIVB
breast	O
cancer	O
cells	S-CL
do	O
not	O
interact	O
with	O
this	O
histone	S-CHEBI
acetylase	O
[	O
34	O
]	O
.	O

This	O
may	O
be	O
attributable	O
to	O
the	O
proposed	O
function	O
of	O
the	O
Exon	S-SO
1	O
containing	O
TACC1	S-PRGE
variants	S-SO
in	O
RNA	S-SO
processing	O
,	O
via	O
the	O
interaction	O
with	O
LSm	B-PRGE
-	I-PRGE
7	E-PRGE
and	O
SmG	S-PRGE
[	O
19	O
]	O
.	O

Thus	O
,	O
alternative	O
splicing	O
of	O
the	O
TACC1	S-PRGE
gene	S-SO
adds	O
further	O
diversity	O
to	O
TACC1	S-PRGE
function	O
,	O
as	O
the	O
deletion	S-SO
of	O
specific	O
exons	S-SO
and	O
their	O
associated	O
binding	O
domains	S-SO
will	O
change	O
the	O
potential	O
protein	B-GO
complexes	E-GO
with	O
which	O
they	O
can	O
associate	O
,	O
either	O
directly	O
,	O
or	O
by	O
redirecting	O
the	O
splice	B-SO
variants	E-SO
to	O
different	O
subcellular	O
compartments	O
.	O

With	O
the	O
duplication	S-SO
of	O
the	O
TACC1	S-PRGE
/	O
TACC2	S-PRGE
ancestor	O
,	O
it	O
is	O
apparent	O
that	O
an	O
even	O
greater	O
functional	O
diversity	O
may	O
have	O
been	O
introduced	O
into	O
the	O
TACC	O
family	O
.	O

The	O
TACC2	S-PRGE
protein	S-CHEBI
retains	O
the	O
ability	O
of	O
TACC3	S-PRGE
to	O
interact	O
with	O
GAS41	S-PRGE
,	O
INI1	S-PRGE
,	O
histone	S-CHEBI
acetyltransferases	O
and	O
transcription	O
factors	O
(	O
in	O
this	O
case	O
,	O
RXR	B-PRGE
beta	E-PRGE
)	O
(	O
Fig	O
.	O
7	O
)	O
[	O
3	O
,	O
34	O
]	O
.	O

However	O
,	O
the	O
tissue	O
specific	O
splicing	O
of	O
the	O
5	O
kb	O
exon	S-SO
in	O
the	O
TACC2l	O
isoform	S-SO
[	O
3	O
]	O
indicates	O
that	O
this	O
protein	S-CHEBI
has	O
several	O
temporal	O
and	O
tissue	O
specific	O
functions	O
yet	O
to	O
be	O
identified	O
.	O

Methods	O

Compilation	O
and	O
assembly	O
of	O
previously	O
uncharacterized	O
TACC	O
cDNAs	S-SO
and	O
genes	S-SO

Corresponding	O
orthologous	B-SO
sequences	E-SO
for	O
TACC	O
,	O
RHAMM	S-PRGE
,	O
KLP	O
,	O
KIF	O
,	O
TPM	O
and	O
keratins	O
families	O
were	O
identified	O
initially	O
using	O
the	O
TBLASTN	O
program	O
[	O
36	O
]	O
to	O
search	O
the	O
published	O
genomic	S-SO
and	O
cDNA	S-SO
databases	O
.	O

For	O
Takifugu	B-LIVB
rubripes	E-LIVB
,	O
gene	S-SO
predictions	O
were	O
produced	O
by	O
the	O
Ensembl	O
automated	O
pipeline	O
[	O
37	O
]	O
and	O
the	O
JGI	O
blast	O
server	O
.	O

DNA	B-SO
sequences	E-SO
covering	O
the	O
homology	B-SO
regions	E-SO
were	O
extracted	O
and	O
analyzed	O
by	O
Genscan	O
to	O
obtain	O
potential	O
exons	S-SO
.	O

In	O
some	O
cases	O
,	O
exons	S-SO
were	O
added	S-SO
or	O
modified	S-SO
based	O
on	O
the	O
best	O
similarity	O
of	O
translated	O
peptides	S-SO
to	O
the	O
corresponding	O
mouse	S-LIVB
and	O
human	S-LIVB
proteins	S-CHEBI
.	O

For	O
regions	S-SO
with	O
low	O
sequence	S-SO
similarity	O
,	O
genomic	B-SO
sequences	E-SO
from	O
the	O
fresh	O
water	O
pufferfish	S-LIVB
,	O
Tetraodon	B-LIVB
nigroviridis	E-LIVB
were	O
used	O
as	O
additional	O
means	O
to	O
verify	O
the	O
predicted	S-SO
exons	S-SO
.	O

Due	O
to	O
the	O
variability	O
of	O
the	O
central	O
region	S-SO
of	O
vertebrate	S-LIVB
TACC3	S-PRGE
cDNAs	S-SO
(	O
see	O
text	O
)	O
,	O
to	O
further	O
confirm	O
prediction	O
of	O
the	O
Takifugu	B-PRGE
rubripes	I-PRGE
TACC3	E-PRGE
,	O
full	O
length	O
cDNAs	S-SO
corresponding	O
to	O
the	O
Danio	B-PRGE
rerio	I-PRGE
TACC3	E-PRGE
(	O
IMAGE	O
clones	S-SO
2639991	O
,	O
2640369	O
and	O
3724452	O
)	O
were	O
also	O
obtained	O
from	O
A	O
.	O
T	O
.	O
C	O
.	O
C	O
.	O
and	O
fully	O
sequenced	O
.	O

Potential	O
paralogous	B-SO
chromosomal	I-SO
segments	E-SO
and	O
scaffold	S-SO
were	O
identified	O
by	O
searching	O
the	O
public	O
databases	O
deposited	O
at	O
NCBI	O
and	O
at	O
the	O
Human	S-LIVB
Genome	S-SO
Mapping	O
Project	O
,	O
Cambridge	O
UK	O
.	O

Cloning	O
of	O
vertebrate	S-LIVB
TACC	O
cDNAs	S-SO

The	O
rabbit	B-PRGE
TACC3	E-PRGE
was	O
cloned	O
by	O
rt	O
-	O
PCR	O
using	O
the	O
"	O
TACC4	O
"	O
specific	O
primer	S-SO
T4RACE2	O
[	O
9	O
]	O
(	O
5	O
'	O
-	O
cccgaactgctccaggtaatcgatctc	O
-	O
3	O
'	O
)	O
and	O
a	O
consensus	S-SO
primer	S-SO
,	O
T3con2	O
,	O
designed	S-SO
to	O
the	O
region	S-SO
encompassing	O
the	O
vertebrate	S-LIVB
TACC3	S-PRGE
initiator	O
methionine	S-CHEBI
(	O
5	O
'	O
-	O
tatgagtctgcaggtcttaaacgac	O
-	O
3	O
'	O
)	O
.	O

For	O
cloning	O
the	O
mouse	S-LIVB
Tacc1X	O
cDNA	S-SO
,	O
the	O
primers	S-SO
used	O
were	O
based	O
upon	O
the	O
genomic	B-SO
sequence	E-SO
reported	O
,	O
and	O
the	O
sequence	S-SO
of	O
the	O
IMAGE	O
cDNA	B-SO
clone	E-SO
4933429K08	O
:	O
T1XF	O
(	O
5	O
'	O
-	O
ccatgttcagtcattggcaggtc	O
-	O
3	O
'	O
)	O
,	O
T1XF2	O
(	O
5	O
'	O
-	O
ctgcagaaccaacagttcaag	O
-	O
3	O
'	O
)	O
,	O
T1XR1	O
(	O
5	O
'	O
-	O
agatctgtgacatcacagctc	O
-	O
3	O
'	O
)	O
,	O
T1XR2	O
(	O
5	O
'	O
-	O
ctcgagtcagttagtcttatccagctt	O
-	O
3	O
'	O
)	O
,	O
BB617F	O
(	O
5	O
'	O
-	O
accaccaacttgagtacctg	O
-	O
3	O
'	O
)	O
and	O
BB617R	O
(	O
5	O
'	O
-	O
gtatcttgaactgttggttctg	O
-	O
3	O
'	O
)	O
.	O

For	O
analysis	O
of	O
TACC1	S-PRGE
splice	B-SO
variants	E-SO
,	O
the	O
forward	B-SO
primers	E-SO
used	O
were	O
located	O
in	O
exon	S-SO
1b	O
:	O
EF	O
(	O
5	O
'	O
-	O
gagagatgcgaaatcagcg	O
-	O
3	O
'	O
)	O
,	O
Exon	S-SO
1d	O
:	O
X3F	O
(	O
5	O
'	O
-	O
agtcaaagaaggcatctgcag	O
-	O
3	O
'	O
)	O
,	O
Exon	S-SO
1a	O
:	O
1DF	O
(	O
5	O
'	O
-	O
ccaagttctgcgccatggg	O
-	O
3	O
'	O
)	O
.	O

The	O
reverse	B-SO
primers	E-SO
used	O
were	O
:	O
Exon	S-SO
1	O
:	O
X1R	O
(	O
5	O
'	O
-	O
ggatttggtctcggcttgcgaatc	O
-	O
3	O
'	O
)	O
,	O
Exon	S-SO
2	O
:	O
BX647R	O
(	O
5	O
'	O
-	O
cttgtgattcttggcttttgg	O
-	O
3	O
'	O
)	O
,	O
Exon	S-SO
3	O
:	O
6SPR	O
(	O
5	O
'	O
-	O
gtcatcgcctcgtcctggagggc	O
-	O
3	O
'	O
)	O
,	O
Exon	S-SO
4a	O
:	O
1DR	O
(	O
5	O
'	O
-	O
aatttcacttgttcagtagtc	O
-	O
3	O
'	O
)	O
,	O
Exon	S-SO
5	O
:	O
128R	O
(	O
5	O
'	O
-	O
cctgcttctgaggatgaaaacgc	O
-	O
3	O
'	O
)	O
.	O

Rabbit	S-LIVB
brain	O
poly	B-SO
A	I-SO
+	E-SO
mRNA	S-CHEBI
,	O
mouse	S-LIVB
testis	O
and	O
human	S-LIVB
brain	O
total	O
RNA	S-SO
were	O
obtained	O
from	O
BD	O
Bioscience	O
Clontech	O
(	O
Palo	O
Alto	O
,	O
CA	O
,	O
U	O
.	O
S	O
.	O
A	O
.	O
)	O
.	O

Reverse	O
transcription	O
and	O
PCR	O
was	O
performed	O
as	O
previously	O
described	O
,	O
using	O
either	O
1	O
mu	O
g	O
of	O
total	O
RNA	S-SO
or	O
50	O
ng	O
of	O
poly	B-SO
A	I-SO
+	E-SO
mRNA	S-CHEBI
as	O
template	O
for	O
first	O
strand	S-SO
cDNA	S-SO
synthesis	O
.	O

PCR	B-SO
products	E-SO
were	O
cloned	O
into	O
pCR2	O
.	O
1	O
(	O
Invitrogen	O
,	O
Carlsbad	O
CA	O
,	O
U	O
.	O
S	O
.	O
A	O
.	O
)	O
and	O
transformed	O
into	O
Inv	O
alpha	O
F	O
'	O
competent	O
cells	S-CL
.	O

Plasmid	S-SO
inserts	S-SO
were	O
sequenced	O
by	O
the	O
Roswell	O
Park	O
Cancer	O
Institute	O
Biopolymer	O
Core	O
Facility	O
.	O

Deposition	O
of	O
nucleotide	B-SO
sequences	E-SO

Sequences	S-SO
from	O
this	O
article	O
have	O
been	O
deposited	O
in	O
the	O
GenBank	O
database	O
with	O
the	O
following	O
accession	O
numbers	O
:	O
Homo	B-PRGE
sapiens	I-PRGE
TACC1	E-PRGE
short	O
isoform	S-SO
S	O
(	O
AY177411	O
)	O
,	O
Mus	B-PRGE
musculus	I-PRGE
TACC1	E-PRGE
short	O
isoform	S-SO
S	O
(	O
AY177412	O
)	O
,	O
Mus	B-PRGE
musculus	I-PRGE
TACC1	E-PRGE
long	O
isoform	S-SO
A	O
(	O
AY177413	O
)	O
,	O
Mus	B-LIVB
musculus	E-LIVB
TACC2s	O
(	O
AY177410	O
)	O
,	O
Oryctolagus	B-PRGE
cuniculus	I-PRGE
TACC3	E-PRGE
(	O
AY161270	O
)	O
,	O
Danio	B-PRGE
rerio	I-PRGE
TACC3	E-PRGE
(	O
AY170618	O
)	O
.	O

Annotations	O
submitted	O
to	O
the	O
Third	O
party	O
annotation	O
database	O
at	O
NCBI	O
are	O
as	O
follows	O
:	O
Rattus	B-PRGE
norvegus	I-PRGE
TACC1	E-PRGE
long	O
isoform	S-SO
A	O
(	O
BK001653	O
)	O
,	O
Takifugu	B-PRGE
rubripes	I-PRGE
TACC1A	E-PRGE
(	O
BK000666	O
/	O
BK000667	O
)	O
,	O
Takifugu	B-PRGE
rubripes	I-PRGE
TACC1B	E-PRGE
(	O
BK000664	O
)	O
,	O
Mus	B-LIVB
musculus	E-LIVB
TACC2l	O
(	O
BK001495	O
)	O
,	O
Rattus	B-LIVB
norvegus	E-LIVB
TACC2l	O
(	O
BK001658	O
)	O
,	O
Rattus	B-LIVB
norvegus	E-LIVB
TACC2s	O
(	O
BK001657	O
)	O
,	O
Takifugu	B-LIVB
rubripes	E-LIVB
TACC2l	O
(	O
BK000690	O
)	O
,	O
Rattus	B-PRGE
norvegus	I-PRGE
TACC3	E-PRGE
(	O
BK001491	O
)	O
,	O
Gallus	B-PRGE
gallus	I-PRGE
TACC3	E-PRGE
(	O
BK001482	O
)	O
,	O
Silurana	B-PRGE
tropicalis	I-PRGE
TACC3	E-PRGE
(	O
BK001481	O
)	O
,	O
Takifugu	B-PRGE
rubripes	I-PRGE
TACC3	E-PRGE
(	O
BK000649	O
)	O
,	O
Takifugu	B-PRGE
rubripes	I-PRGE
RHAMM	E-PRGE
(	O
BK000676	O
)	O
,	O
Ciona	B-PRGE
intestinalis	I-PRGE
RHAMM	E-PRGE
(	O
BK001479	O
)	O
,	O
Takifugu	B-PRGE
rubripes	I-PRGE
Keratin	E-PRGE
(	O
BK000677	O
)	O
,	O
Takifugu	B-PRGE
rubripes	I-PRGE
TPM1	E-PRGE
(	O
BAC10576	O
)	O
,	O
Ciona	B-PRGE
intestinalis	I-PRGE
Kif3b	E-PRGE
(	O
BK001492	O
)	O
,	O
Ciona	B-PRGE
intestinalis	I-PRGE
klp2	E-PRGE
(	O
BK001493	O
)	O
.	O

Phylogenetic	O
analysis	O

In	O
order	O
to	O
examine	O
evolutionary	O
relationships	O
of	O
proteins	S-CHEBI
containing	O
coiled	B-SO
coil	E-SO
domains	S-SO
,	O
protein	S-CHEBI
sequences	S-SO
representing	O
the	O
major	O
members	O
of	O
this	O
super	O
family	O
,	O
including	O
TACC	O
,	O
RHAMM	S-PRGE
,	O
KLP	O
,	O
keratin	O
and	O
tropomyosin	O
from	O
available	O
vertebrates	S-LIVB
and	O
their	O
recognizable	O
orthologues	S-SO
from	O
the	O
urochordate	S-LIVB
Ciona	B-LIVB
intestinalis	E-LIVB
,	O
Drosophila	B-LIVB
melanogaster	E-LIVB
,	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
and	O
Saccharomyces	B-LIVB
cerevisiae	E-LIVB
were	O
either	O
directly	O
retrieved	O
from	O
NCBI	O
sequence	S-SO
databases	O
,	O
newly	O
predicted	O
or	O
isolated	O
(	O
see	O
above	O
)	O
.	O

Species	O
abbreviations	O
are	O
as	O
follows	O
:	O
hs	S-LIVB
(	O
Homo	B-LIVB
sapiens	E-LIVB
)	O
,	O
mm	S-LIVB
(	O
Mus	B-LIVB
musculus	E-LIVB
)	O
,	O
rn	S-LIVB
(	O
Rattus	B-LIVB
norvegus	E-LIVB
)	O
,	O
oc	S-LIVB
(	O
Oryctolagus	B-LIVB
cuniculus	E-LIVB
)	O
,	O
gg	S-LIVB
(	O
Gallus	B-LIVB
gallus	E-LIVB
)	O
,	O
xl	S-LIVB
(	O
Xenopus	B-LIVB
laevis	E-LIVB
)	O
,	O
st	S-LIVB
(	O
Silurana	B-LIVB
tropicalis	E-LIVB
)	O
,	O
tr	S-LIVB
(	O
Takifugu	B-LIVB
rubripes	E-LIVB
)	O
,	O
dr	S-LIVB
(	O
Danio	B-LIVB
rerio	E-LIVB
)	O
,	O
ci	S-LIVB
(	O
Ciona	B-LIVB
intestinalis	E-LIVB
)	O
,	O
dm	S-LIVB
(	O
D	B-LIVB
.	I-LIVB
melanogaster	E-LIVB
)	O
,	O
ce	S-LIVB
(	O
C	B-LIVB
.	I-LIVB
elegans	E-LIVB
)	O
,	O
sc	S-LIVB
(	O
Saccharomyces	B-LIVB
cerevisiae	E-LIVB
)	O
.	O

The	O
sequences	S-SO
identified	O
above	O
and	O
the	O
following	O
protein	S-CHEBI
or	O
predicted	S-SO
translations	O
were	O
used	O
for	O
phylogenetic	O
analysis	O
:	O
hsTACC1A	O
(	O
NP	O
_	O
006274	O
)	O
,	O
hsTACC2l	O
(	O
AAO62630	O
)	O
hsTACC2s	O
(	O
AAO62629	O
)	O
,	O
hsTACC3	S-PRGE
(	O
NP	O
_	O
006333	O
)	O
,	O
mmTACC3	S-PRGE
(	O
Q9JJ11	O
)	O
,	O
xlMaskin	S-PRGE
(	O
Q9PTG8	O
)	O
,	O
dmTACC	S-PRGE
(	O
AAF52099	O
)	O
,	O
ceTAC1	S-PRGE
(	O
NP	O
_	O
497059	O
)	O
,	O
scSPC72	S-PRGE
(	O
NP	O
_	O
009352	O
)	O
,	O
hsRHAMM	S-PRGE
(	O
NP	O
_	O
036616	O
)	O
,	O
mmRHAMM	S-PRGE
(	O
NP	O
_	O
038580	O
)	O
,	O
rnRHAMM	S-PRGE
(	O
NP	O
_	O
037096	O
)	O
,	O
drRHAMM	S-PRGE
(	O
AAQ97980	O
)	O
,	O
hsKeratin	S-PRGE
(	O
CAB76828	O
)	O
,	O
mmKeratin	O
(	O
A61368	O
)	O
,	O
rnKeratin	O
(	O
XP	O
_	O
235679	O
)	O
,	O
hsTPM1	S-PRGE
(	O
NP	O
_	O
000357	O
)	O
,	O
mmTPM1	S-PRGE
(	O
NP	O
_	O
077745	O
)	O
,	O
rnTPM1	S-PRGE
(	O
NP	O
_	O
62004	O
,	O
drTPM1	S-PRGE
(	O
NP	O
_	O
571180	O
)	O
dmTPM1	S-PRGE
(	O
P06754	O
)	O
,	O
ceTPM	S-PRGE
(	O
NP	O
_	O
493540	O
)	O
scTPM1	S-PRGE
(	O
P17536	O
)	O
,	O
hsKLP2	S-PRGE
(	O
BAB03309	O
)	O
,	O
rnKIF15	S-PRGE
(	O
AAP44513	O
)	O
,	O
xlKLP2	S-PRGE
(	O
CAA08879	O
)	O
,	O
dmKLP2	S-PRGE
(	O
NP	O
_	O
476818	O
)	O
,	O
ceKLP18	S-PRGE
(	O
AA034669	O
)	O
,	O
hsKIF3A	S-PRGE
(	O
Q9Y496	O
)	O
,	O
mmKIF3A	S-PRGE
(	O
NP	O
_	O
032469	O
)	O
,	O
rnKIF3A	S-PRGE
(	O
XP	O
_	O
340797	O
)	O
,	O
xlKIF3A	S-PRGE
(	O
CAA08879	O
)	O
,	O
ceKLP11	S-PRGE
(	O
NP	O
_	O
741473	O
)	O
,	O
ciKIF3	O
(	O
ci0100148992	O
)	O
,	O
hsKIF3B	S-PRGE
(	O
NP	O
_	O
004789	O
)	O
,	O
mmKIF3B	S-PRGE
(	O
NP	O
_	O
004789	O
)	O
,	O
rnKIF3B	S-PRGE
(	O
XP	O
_	O
215883	O
)	O
,	O
dmKIF3B	S-PRGE
(	O
NP	O
_	O
524029	O
)	O
,	O
hsKIF3C	S-PRGE
(	O
NP	O
_	O
002245	O
)	O
,	O
mmKIF3C	S-PRGE
(	O
NP	O
_	O
032471	O
)	O
,	O
rnKIF3C	S-PRGE
(	O
NP	O
_	O
445938	O
)	O
,	O
dmKIF3C	S-PRGE
(	O
NP	O
_	O
651939	O
)	O
.	O

These	O
protein	S-CHEBI
sequences	S-SO
were	O
initially	O
aligned	O
with	O
CLUSTAL	O
X	O
[	O
38	O
]	O
.	O

Minor	O
adjustments	O
to	O
certain	O
regions	S-SO
of	O
the	O
alignment	O
for	O
optimization	O
purposes	O
were	O
made	O
based	O
on	O
pairwise	O
alignments	O
,	O
the	O
output	O
saved	O
in	O
PHYLIP	O
format	O
,	O
after	O
which	O
,	O
the	O
distances	O
between	O
proteins	S-CHEBI
were	O
calculated	O
using	O
Poisson	O
correction	O
and	O
the	O
Unrooted	O
trees	O
were	O
inferred	O
with	O
the	O
NJ	O
method	O
and	O
then	O
displayed	O
using	O
TreeView	O
[	O
39	O
]	O
.	O

Bootstrap	O
values	O
above	O
700	O
for	O
1000	O
trials	O
are	O
shown	O
at	O
the	O
node	O
.	O

To	O
validate	O
the	O
tree	O
,	O
the	O
same	O
sequence	S-SO
set	O
was	O
analyzed	O
with	O
tools	O
in	O
the	O
PHYLIP	O
package	O
[	O
40	O
]	O
,	O
using	O
PRODIST	O
followed	O
by	O
FITCH	O
or	O
NEIGNBOR	O
and	O
tree	O
displaying	O
using	O
TreeView	O
.	O

This	O
additional	O
method	O
produced	O
trees	O
with	O
essentially	O
the	O
same	O
topology	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
vitro	O
interaction	O
of	O
TACC2	S-PRGE
and	O
RXR	O
beta	O
3	O

The	O
TACC2	S-PRGE
cDNA	S-SO
was	O
cloned	O
into	O
GST	S-PRGE
fusion	S-SO
vector	S-SO
pGEX5X2	O
(	O
Amersham	O
Biosciences	O
,	O
Piscataway	O
,	O
NJ	O
,	O
USA	O
)	O
.	O

GST	S-PRGE
and	O
GST	S-PRGE
-	O
TACC2	S-PRGE
proteins	S-CHEBI
were	O
expressed	O
in	O
E	B-LIVB
.	I-LIVB
coli	E-LIVB
BL21	O
(	O
DE3	O
)	O
plys	O
"	O
S	O
"	O
with	O
1	O
mM	O
IPTG	O
at	O
37	O
degrees	O
C	O
shaker	O
for	O
2	O
hrs	O
.	O

Cells	S-CL
(	O
50	O
ml	O
)	O
were	O
harvested	O
and	O
resuspended	O
in	O
5	O
ml	O
of	O
20	O
mM	O
Tris	S-CHEBI
-	O
HCl	S-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	S-CHEBI
,	O
1	O
mM	O
EDTA	S-CHEBI
pH8	O
.	O
0	O
,	O
Protease	B-CHEBI
inhibitor	E-CHEBI
set	O
III	O
(	O
Calbiochem	O
)	O
.	O

The	O
cells	S-CL
were	O
lysed	O
by	O
sonication	O
and	O
lysate	O
cleared	O
by	O
centrifugation	O
at	O
7500	O
rpm	O
at	O
4	O
degrees	O
C	O
for	O
15	O
min	O
.	O

The	O
cleared	O
lysate	O
was	O
immobilized	O
on	O
glutathione	S-CHEBI
sepharose	O
beads	O
in	O
3	O
ml	O
of	O
20	O
mM	O
Tris	S-CHEBI
-	O
HCl	S-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	S-CHEBI
,	O
1	O
mM	O
EDTA	S-CHEBI
pH8	O
.	O
0	O
)	O
.	O

RXR	O
beta	O
3	O
cDNA	S-SO
was	O
cloned	O
into	O
pET	O
28C	O
(	O
+	O
)	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
and	O
protein	S-CHEBI
synthesized	O
by	O
TNT	O
quick	O
coupled	O
transcription	O
/	O
translation	O
system	O
kit	O
(	O
Promega	O
)	O
and	O
radiolabeled	O
with	O
35S	S-CHEBI
methionine	S-CHEBI
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
.	O

100	O
mu	O
l	O
of	O
in	O
vitro	O
translated	O
RXR	O
beta	O
3	O
protein	S-CHEBI
in	O
1	O
ml	O
of	O
20	O
mM	O
Tris	S-CHEBI
-	O
HCl	S-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	S-CHEBI
,	O
1	O
mM	O
EDTA	S-CHEBI
pH8	O
.	O
0	O
was	O
incubated	O
at	O
4	O
degrees	O
C	O
with	O
immobilized	O
GST	S-PRGE
-	O
TACC2	S-PRGE
or	O
GST	S-PRGE
for	O
90	O
min	O
.	O

Unbound	O
RXR	O
beta	O
3	O
was	O
removed	O
by	O
washing	O
three	O
times	O
with	O
20	O
mM	O
Tris	S-CHEBI
-	O
HCl	S-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	S-CHEBI
,	O
1	O
mM	O
EDTA	S-CHEBI
pH8	O
.	O
0	O
.	O

Bound	O
proteins	S-CHEBI
were	O
eluted	O
from	O
the	O
beads	O
at	O
room	O
temperature	O
for	O
10	O
min	O
in	O
elution	O
buffer	O
(	O
100	O
mM	O
Tris	S-CHEBI
HCl	S-CHEBI
,	O
pH8	O
.	O
0	O
,	O
20	O
mM	O
reduced	O
glutathione	S-CHEBI
)	O
.	O

The	O
proteins	S-CHEBI
were	O
analyzed	O
on	O
12	O
%	O
SDS	S-CHEBI
polyacrylamide	O
gels	O
.	O

Coomassie	O
blue	O
staining	O
verified	O
equal	O
loading	O
of	O
GST	S-PRGE
fusion	S-SO
protein	S-CHEBI
.	O

Dried	O
gels	O
were	O
autoradiographed	O
.	O

Authors	O
'	O
contributions	O

I	O
.	O
H	O
.	O
S	O
performed	O
most	O
of	O
the	O
sequence	S-SO
analysis	O
and	O
drafted	O
the	O
assembly	B-SO
of	I-SO
the	I-SO
TACC	I-SO
,	I-SO
KLP	I-SO
,	I-SO
KIF	I-SO
and	I-SO
RHAMM	I-SO
sequences	E-SO
.	O

I	O
.	O
H	O
.	O
S	O
.	O
performed	O
the	O
cDNA	S-SO
isolation	O
of	O
the	O
rabbit	B-PRGE
TACC3	E-PRGE
cDNA	S-SO
.	O

AK	O
identified	O
potential	O
TACC1	S-PRGE
splice	B-SO
variants	E-SO
,	O
and	O
the	O
interaction	O
between	O
RXR	O
beta	O
3	O
and	O
TACC2	S-PRGE
.	O

A	O
.	O
M	O
.	O
characterized	O
mouse	S-LIVB
TACC	O
orthologues	S-SO
.	O

P	O
.	O
L	O
.	O
performed	O
the	O
identification	O
and	O
assembly	O
of	O
T	B-LIVB
.	I-LIVB
rubripes	E-LIVB
gene	B-SO
sequences	E-SO
,	O
and	O
the	O
phylogenetic	O
analysis	O
.	O

I	O
.	O
H	O
.	O
S	O
.	O
conceived	O
and	O
designed	O
the	O
project	O
and	O
drafted	O
the	O
complete	O
manuscript	O
.	O

Supplementary	O
Material	O

Additional	O
file	O
1	O

Location	O
of	O
paralogous	S-SO
genes	S-SO
found	O
on	O
human	S-LIVB
4p16	O
,	O
5q31	O
-	O
ter	O
,	O
10q23	O
-	O
ter	O
,	O
8p	O
and	O
chromosome	S-GO
2	O
.	O

Positions	S-SO
of	O
genes	S-SO
are	O
given	O
in	O
Mb	O
from	O
the	O
telomere	S-SO
of	O
the	O
short	O
arm	B-SO
of	I-SO
the	I-SO
chromosome	E-SO
.	O

Blue	O
highlighted	O
genes	S-SO
(	O
five	O
copies	O
)	O
are	O
found	O
in	O
all	O
four	O
paralogous	B-SO
segments	E-SO
,	O
and	O
the	O
partially	O
duplicated	O
segment	B-SO
on	I-SO
chromosome	E-SO
2	O
.	O

Green	O
highlighted	O
genes	S-SO
are	O
found	O
in	O
either	O
all	O
four	O
paralogous	B-SO
segments	E-SO
,	O
or	O
three	O
of	O
the	O
segments	S-SO
and	O
the	O
partially	O
duplicated	O
region	B-SO
on	I-SO
chromosome	E-SO
2	O
.	O

Pink	O
highlighted	O
genes	S-SO
have	O
paralogues	S-SO
in	O
three	O
of	O
the	O
segments	S-SO
,	O
suggesting	O
either	O
loss	S-SO
of	O
the	O
fourth	O
copy	O
or	O
exclusion	O
of	O
one	O
paralogue	S-SO
from	O
the	O
second	O
round	O
of	O
duplication	S-SO
.	O

Black	O
highlighted	O
genes	S-SO
(	O
two	O
paralogues	S-SO
)	O
are	O
found	O
in	O
only	O
one	O
of	O
the	O
derivatives	O
of	O
the	O
second	O
round	O
of	O
genome	S-SO
duplication	S-SO
,	O
suggesting	O
complete	O
exclusion	O
of	O
both	O
copies	O
from	O
the	O
second	O
round	O
of	O
duplication	S-SO
.	O

Purple	O
highlighted	O
genes	S-SO
(	O
two	O
paralogues	S-SO
)	O
were	O
duplicated	O
at	O
the	O
second	O
round	O
of	O
genome	S-SO
duplication	S-SO
,	O
or	O
from	O
interchromosomal	O
recombination	O
between	O
paralogous	S-SO
clusters	S-SO
.	O

Click	O
here	O
for	O
file	O

Acknowledgements	O

We	O
wish	O
to	O
thank	O
Dr	O
.	O
Sei	O
-	O
ichi	O
Matsui	O
for	O
his	O
assistance	O
and	O
input	O
in	O
the	O
preparation	O
of	O
this	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
in	O
part	O
by	O
developmental	O
funds	O
support	O
from	O
the	O
Roswell	O
Park	O
Cancer	O
Institute	O
,	O
and	O
Core	O
grant	O
2P30CA016056	O
-	O
27	O
from	O
the	O
National	O
Cancer	O
Institute	O
.	O

Fog2	S-PRGE
Is	O
Required	O
for	O
Normal	O
Diaphragm	O
and	O
Lung	O
Development	O
in	O
Mice	S-LIVB
and	O
Humans	S-LIVB

Abstract	O

Congenital	O
diaphragmatic	O
hernia	O
and	O
other	O
congenital	O
diaphragmatic	O
defects	O
are	O
associated	O
with	O
significant	O
mortality	O
and	O
morbidity	O
in	O
neonates	O
;	O
however	O
,	O
the	O
molecular	S-CHEBI
basis	O
of	O
these	O
developmental	O
anomalies	O
is	O
unknown	O
.	O

In	O
an	O
analysis	O
of	O
E18	O
.	O
5	O
embryos	O
derived	O
from	O
mice	S-LIVB
treated	O
with	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	E-CHEBI
,	O
we	O
identified	O
a	O
mutation	S-SO
that	O
causes	O
pulmonary	O
hypoplasia	O
and	O
abnormal	O
diaphragmatic	O
development	O
.	O

Fog2	S-PRGE
(	O
Zfpm2	S-PRGE
)	O
maps	O
within	O
the	O
recombinant	O
interval	S-SO
carrying	O
the	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	E-CHEBI
-	O
induced	O
mutation	S-SO
,	O
and	O
DNA	S-SO
sequencing	O
of	O
Fog2	S-PRGE
identified	O
a	O
mutation	S-SO
in	O
a	O
splice	B-SO
donor	I-SO
site	E-SO
that	O
generates	O
an	O
abnormal	O
transcript	S-SO
encoding	O
a	O
truncated	O
protein	S-CHEBI
.	O

Human	S-LIVB
autopsy	O
cases	O
with	O
diaphragmatic	O
defect	O
and	O
pulmonary	O
hypoplasia	O
were	O
evaluated	O
for	O
mutations	S-SO
in	O
FOG2	S-PRGE
.	O

Sequence	S-SO
analysis	O
revealed	O
a	O
de	B-SO
novo	E-SO
mutation	S-SO
resulting	O
in	O
a	O
premature	O
stop	B-SO
codon	E-SO
in	O
a	O
child	O
who	O
died	O
on	O
the	O
first	O
day	O
of	O
life	O
secondary	O
to	O
severe	O
bilateral	O
pulmonary	O
hypoplasia	O
and	O
an	O
abnormally	O
muscularized	O
diaphragm	O
.	O

Using	O
a	O
phenotype	O
-	O
driven	O
approach	O
,	O
we	O
have	O
established	O
that	O
Fog2	S-PRGE
is	O
required	O
for	O
normal	O
diaphragm	O
and	O
lung	O
development	O
,	O
a	O
role	O
that	O
has	O
not	O
been	O
previously	O
appreciated	O
.	O

FOG2	S-PRGE
is	O
the	O
first	O
gene	S-SO
implicated	O
in	O
the	O
pathogenesis	O
of	O
nonsyndromic	O
human	S-LIVB
congenital	O
diaphragmatic	O
defects	O
,	O
and	O
its	O
necessity	O
for	O
pulmonary	O
development	O
validates	O
the	O
hypothesis	O
that	O
neonates	O
with	O
congenital	O
diaphragmatic	O
hernia	O
may	O
also	O
have	O
primary	O
pulmonary	O
developmental	O
abnormalities	O
.	O

Synopsis	O

Birth	O
defects	O
involving	O
the	O
diaphragm	O
are	O
as	O
common	O
and	O
as	O
serious	O
as	O
genetic	S-SO
disorders	O
such	O
as	O
cystic	O
fibrosis	O
,	O
yet	O
the	O
underlying	O
causes	O
of	O
these	O
defects	O
are	O
unknown	O
.	O

Most	O
babies	O
born	O
with	O
diaphragmatic	O
defects	O
have	O
very	O
small	O
lungs	O
,	O
and	O
many	O
die	O
in	O
the	O
newborn	O
period	O
with	O
severe	O
breathing	O
difficulties	O
.	O

It	O
is	O
unknown	O
whether	O
the	O
small	O
lungs	O
occur	O
because	O
these	O
children	O
have	O
a	O
diaphragmatic	O
defect	O
,	O
or	O
whether	O
some	O
patients	O
might	O
have	O
a	O
genetic	S-SO
abnormality	O
that	O
affects	O
the	O
development	O
of	O
both	O
the	O
lung	O
and	O
the	O
diaphragm	O
simultaneously	O
.	O

In	O
a	O
screen	O
of	O
fetal	O
mice	S-LIVB
carrying	O
chemically	S-CHEBI
induced	O
genetic	S-SO
mutations	S-SO
,	O
the	O
authors	O
found	O
that	O
a	O
mutation	S-SO
in	O
the	O
gene	S-SO
Fog2	S-PRGE
(	O
Friend	B-PRGE
of	I-PRGE
gata	I-PRGE
2	E-PRGE
)	O
,	O
causes	O
abnormal	O
diaphragm	O
development	O
and	O
small	O
lungs	O
.	O

The	O
lungs	O
have	O
a	O
primary	O
developmental	O
abnormality	O
that	O
includes	O
the	O
specific	O
loss	O
of	O
one	O
lung	O
lobe	O
.	O

Based	O
on	O
this	O
result	O
,	O
the	O
authors	O
studied	O
children	O
affected	O
with	O
diaphragmatic	O
abnormalities	O
,	O
and	O
identified	O
one	O
human	S-LIVB
baby	O
with	O
a	O
serious	O
mutation	S-SO
in	O
the	O
human	S-LIVB
gene	S-SO
FOG2	S-PRGE
who	O
died	O
at	O
five	O
hours	O
of	O
life	O
with	O
severe	O
breathing	O
difficulties	O
,	O
a	O
diaphragmatic	O
defect	O
,	O
and	O
small	O
lungs	O
.	O

The	O
authors	O
have	O
established	O
that	O
Fog2	S-PRGE
is	O
necessary	O
for	O
both	O
diaphragm	O
and	O
lung	O
development	O
in	O
mice	S-LIVB
and	O
in	O
humans	S-LIVB
.	O

This	O
is	O
the	O
first	O
known	O
cause	O
of	O
a	O
nonsyndromic	O
congenital	O
diaphragmatic	O
defect	O
and	O
establishes	O
that	O
some	O
patients	O
may	O
have	O
a	O
primary	O
developmental	O
abnormality	O
of	O
both	O
the	O
lung	O
and	O
the	O
diaphragm	O
.	O

Introduction	O

Congenital	O
diaphragmatic	O
defects	O
are	O
a	O
spectrum	O
of	O
relatively	O
common	O
birth	O
defects	O
.	O

The	O
Bochdalek	O
or	O
posterolateral	O
hernias	O
(	O
often	O
referred	O
to	O
as	O
congenital	O
diaphragmatic	O
hernia	O
[	O
CDH	O
]	O
)	O
occur	O
in	O
1	O
/	O
3	O
,	O
000	O
live	O
births	O
[	O
1	O
]	O
,	O
and	O
although	O
these	O
are	O
the	O
most	O
common	O
type	O
of	O
diaphragmatic	O
defect	O
presenting	O
at	O
birth	O
,	O
diaphragmatic	O
aplasia	O
and	O
diaphragmatic	O
muscularization	O
defects	O
(	O
eventrations	O
)	O
may	O
have	O
a	O
similar	O
clinical	O
presentation	O
.	O

Making	O
specific	O
anatomic	O
distinctions	O
among	O
these	O
types	O
of	O
defects	O
can	O
be	O
difficult	O
without	O
direct	O
gross	O
(	O
intraoperative	O
or	O
postmortem	O
)	O
examination	O
.	O

Pulmonary	O
hypoplasia	O
associated	O
with	O
these	O
diaphragmatic	O
defects	O
causes	O
severe	O
mortality	O
and	O
morbidity	O
.	O

The	O
pathogenesis	O
and	O
developmental	O
relationship	O
between	O
diaphragmatic	O
defects	O
and	O
pulmonary	O
hypoplasia	O
is	O
not	O
understood	O
.	O

Although	O
advances	O
in	O
the	O
medical	O
management	O
of	O
pulmonary	O
hypoplasia	O
may	O
have	O
decreased	O
the	O
mortality	O
associated	O
with	O
CDH	O
patients	O
who	O
survive	O
to	O
receive	O
care	O
at	O
high	O
-	O
volume	O
centers	O
[	O
2	O
,	O
3	O
]	O
,	O
the	O
population	O
-	O
based	O
mortality	O
has	O
been	O
reported	O
to	O
be	O
as	O
great	O
as	O
62	O
%	O
,	O
and	O
there	O
are	O
a	O
large	O
number	O
of	O
deaths	O
prior	O
to	O
birth	O
or	O
to	O
transfer	O
to	O
a	O
tertiary	O
care	O
facility	O
[	O
4	O
]	O
.	O

As	O
these	O
patients	O
commonly	O
present	O
with	O
severe	O
respiratory	O
failure	O
at	O
birth	O
,	O
therapy	O
has	O
been	O
centered	O
around	O
developing	O
better	O
methods	O
to	O
provide	O
ventilatory	O
support	O
while	O
not	O
producing	O
further	O
lung	O
injury	O
.	O

Extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
in	O
some	O
centers	O
to	O
provide	O
an	O
extended	O
period	O
of	O
cardiopulmonary	O
bypass	O
[	O
5	O
,	O
6	O
]	O
,	O
while	O
other	O
centers	O
have	O
success	O
using	O
other	O
ventilatory	O
support	O
techniques	O
[	O
7	O
]	O
.	O

The	O
morbidity	O
in	O
those	O
who	O
survive	O
is	O
high	O
,	O
and	O
many	O
patients	O
survive	O
with	O
chronic	O
respiratory	O
insufficiency	O
,	O
cognitive	O
and	O
neuromotor	O
deficits	O
,	O
and	O
hearing	O
loss	O
as	O
a	O
result	O
of	O
necessary	O
intensive	O
interventions	O
and	O
associated	O
structural	O
and	O
irreversible	O
developmental	O
abnormalities	O
[	O
8	O
-	O
11	O
]	O
.	O

To	O
date	O
,	O
there	O
have	O
been	O
no	O
specific	O
mutations	S-SO
found	O
to	O
be	O
associated	O
with	O
nonsyndromic	O
diaphragmatic	O
defects	O
and	O
pulmonary	O
hypoplasia	O
in	O
humans	S-LIVB
.	O

The	O
heritability	O
of	O
these	O
defects	O
is	O
unclear	O
,	O
as	O
the	O
high	O
morbidity	O
and	O
mortality	O
limit	O
the	O
collection	O
of	O
multigenerational	O
families	O
for	O
analysis	O
.	O

The	O
genetic	S-SO
etiologies	O
are	O
likely	O
to	O
be	O
complex	O
and	O
probably	O
arise	O
from	O
different	O
mutations	S-SO
in	O
various	O
parts	O
of	O
the	O
molecular	S-CHEBI
developmental	O
pathways	O
required	O
for	O
diaphragmatic	O
development	O
.	O

Indeed	O
,	O
there	O
are	O
numerous	O
reports	O
implicating	O
different	O
chromosomal	S-GO
abnormalities	O
in	O
the	O
pathogenesis	O
of	O
CDH	O
[	O
12	O
,	O
13	O
]	O
.	O

Given	O
the	O
difficulty	O
of	O
studying	O
lethal	O
developmental	O
abnormalities	O
in	O
humans	S-LIVB
,	O
it	O
is	O
of	O
great	O
potential	O
utility	O
to	O
develop	O
animal	S-LIVB
models	O
of	O
human	S-LIVB
birth	O
defects	O
,	O
as	O
the	O
specific	O
genetic	S-SO
abnormalities	O
found	O
in	O
animal	S-LIVB
models	O
can	O
then	O
be	O
investigated	O
in	O
human	S-LIVB
populations	O
.	O

We	O
screened	O
mice	S-LIVB
treated	O
with	O
the	O
chemical	B-CHEBI
mutagen	E-CHEBI
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	E-CHEBI
(	O
ENU	S-CHEBI
)	O
for	O
lines	O
with	O
developmental	O
defects	O
that	O
present	O
in	O
the	O
perinatal	O
period	O
[	O
14	O
]	O
.	O

From	O
this	O
screen	O
,	O
we	O
identified	O
a	O
line	O
of	O
mice	S-LIVB
carrying	O
a	O
recessive	O
mutation	S-SO
that	O
results	O
in	O
primary	O
pulmonary	O
hypoplasia	O
and	O
abnormal	O
diaphragmatic	O
and	O
cardiac	O
development	O
.	O

Positional	S-SO
cloning	O
analysis	O
identified	O
Fog2	S-PRGE
(	O
Zfpm2	S-PRGE
)	O
as	O
a	O
likely	O
candidate	O
,	O
and	O
DNA	S-SO
sequencing	O
revealed	O
a	O
mutation	S-SO
in	O
a	O
splice	B-SO
donor	I-SO
site	E-SO
that	O
generates	O
an	O
abnormal	O
transcript	S-SO
encoding	O
a	O
truncated	O
protein	S-CHEBI
.	O

This	O
result	O
suggested	O
that	O
we	O
examine	O
the	O
orthologous	S-SO
gene	S-SO
in	O
humans	S-LIVB
with	O
similar	O
developmental	O
defects	O
,	O
and	O
we	O
report	O
the	O
finding	O
of	O
a	O
de	B-SO
novo	E-SO
nonsense	O
mutation	S-SO
in	O
FOG2	S-PRGE
in	O
a	O
patient	O
who	O
died	O
at	O
birth	O
with	O
a	O
diaphragmatic	O
defect	O
and	O
severe	O
pulmonary	O
hypoplasia	O
.	O

This	O
is	O
the	O
first	O
reported	O
mutation	S-SO
associated	O
with	O
these	O
abnormalities	O
in	O
a	O
human	S-LIVB
.	O

We	O
present	O
additional	O
data	O
that	O
provide	O
direct	O
evidence	O
that	O
pulmonary	O
hypoplasia	O
may	O
be	O
a	O
primary	O
component	O
of	O
this	O
spectrum	O
of	O
disorders	O
.	O

Results	O

Identification	O
of	O
the	O
little	O
lung	O
Mutation	S-SO
in	O
Fog2	S-PRGE

We	O
screened	O
third	O
-	O
generation	O
progeny	O
of	O
ENU	S-CHEBI
-	O
mutagenized	O
mice	S-LIVB
at	O
embryonic	O
day	O
18	O
.	O
5	O
(	O
E18	O
.	O
5	O
)	O
for	O
abnormal	O
developmental	O
phenotypes	O
[	O
14	O
]	O
.	O

One	O
line	O
of	O
mice	S-LIVB
was	O
found	O
to	O
have	O
multiple	O
embryos	O
in	O
independent	O
litters	O
that	O
displayed	O
pulmonary	O
hypoplasia	O
and	O
a	O
thin	O
diaphragm	O
.	O

The	O
mutation	S-SO
,	O
which	O
we	O
called	O
little	O
lung	O
(	O
lil	O
)	O
,	O
was	O
mapped	O
to	O
Chromosome	S-GO
15	O
by	O
utilizing	O
a	O
strategy	O
of	O
interval	S-SO
haplotype	S-SO
analysis	O
(	O
data	O
not	O
shown	O
)	O
[	O
15	O
]	O
.	O

For	O
high	O
-	O
resolution	O
mapping	O
,	O
F2	O
progeny	O
from	O
two	O
crosses	O
were	O
analyzed	O
.	O

In	O
450	O
progeny	O
of	O
an	O
intercross	O
of	O
F1	O
(	O
A	O
/	O
J	O
x	O
FVB	O
/	O
N	O
)	O
lil	O
/	O
+	O
mice	S-LIVB
,	O
the	O
interval	S-SO
containing	O
the	O
mutation	S-SO
was	O
defined	O
by	O
19	O
recombinants	O
between	O
D15Mit220	O
and	O
D15Mit154	O
.	O

Because	O
of	O
the	O
lack	O
of	O
informative	O
markers	O
within	O
this	O
interval	S-SO
,	O
an	O
additional	O
39	O
F2	O
progeny	O
from	O
an	O
A	O
/	O
J	O
x	O
C57BL	O
/	O
6J	O
cross	O
were	O
tested	O
.	O

The	O
identification	O
of	O
two	O
recombinants	O
established	O
D15Mit85	O
as	O
the	O
proximal	O
and	O
D15Mit5	O
as	O
the	O
distal	O
flanking	O
markers	O
.	O

The	O
lil	O
phenotype	O
was	O
identified	O
at	O
E18	O
.	O
5	O
to	O
have	O
bilateral	O
pulmonary	O
hypoplasia	O
and	O
an	O
abnormal	O
diaphragm	O
.	O

Pulmonary	O
hypoplasia	O
was	O
apparent	O
in	O
all	O
mutant	S-SO
mice	S-LIVB
that	O
survived	O
to	O
birth	O
.	O

In	O
a	O
comparison	O
between	O
wild	B-SO
-	I-SO
type	E-SO
and	O
mutant	S-SO
mice	S-LIVB
found	O
dead	O
on	O
day	O
one	O
of	O
life	O
,	O
body	O
weights	O
were	O
not	O
different	O
;	O
however	O
,	O
the	O
lung	O
weights	O
were	O
significantly	O
lower	O
in	O
the	O
mutant	S-SO
mice	S-LIVB
.	O

The	O
average	O
mutant	S-SO
lung	O
weight	O
was	O
9	O
.	O
6	O
+/-	O
2	O
.	O
5	O
mg	O
while	O
the	O
average	O
wild	B-SO
-	I-SO
type	E-SO
lung	O
weight	O
was	O
26	O
.	O
4	O
+/-	O
4	O
.	O
6	O
mg	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

All	O
lungs	O
from	O
mutant	S-SO
mice	S-LIVB
were	O
lacking	O
an	O
accessory	O
lobe	O
on	O
the	O
right	O
side	O
and	O
had	O
underdevelopment	O
of	O
the	O
anterior	O
right	O
middle	O
lobe	O
(	O
Figure	O
1A	O
)	O
.	O

Diaphragms	O
from	O
mutant	S-SO
lil	O
mice	S-LIVB
were	O
intact	O
,	O
but	O
muscularization	O
was	O
absent	O
in	O
the	O
dorsal	O
regions	O
.	O

Myotubules	O
were	O
present	O
in	O
a	O
limited	O
and	O
abnormal	O
distribution	O
.	O

More	O
specifically	O
,	O
myotubules	O
normally	O
radiate	O
in	O
a	O
mediolateral	O
fashion	O
to	O
meet	O
the	O
lateral	O
body	O
walls	O
,	O
with	O
a	O
normal	O
paucity	O
of	O
muscle	O
fibers	O
in	O
the	O
central	O
tendonous	O
region	O
.	O

In	O
the	O
mutant	S-SO
diaphragm	O
,	O
myotubules	O
radiated	O
in	O
a	O
dorsal	O
-	O
ventral	O
orientation	O
,	O
and	O
muscle	O
tissue	O
did	O
not	O
meet	O
the	O
entire	O
surface	O
of	O
the	O
body	O
walls	O
(	O
Figure	O
1B	O
)	O
.	O

The	O
number	O
of	O
lil	O
mutant	S-SO
mice	S-LIVB
that	O
survived	O
to	O
birth	O
was	O
less	O
than	O
5	O
%	O
of	O
total	O
progeny	O
,	O
rather	O
than	O
the	O
25	O
%	O
expected	O
for	O
a	O
recessive	O
mutation	S-SO
.	O

We	O
evaluated	O
litters	O
at	O
different	O
embryonic	O
time	O
points	O
to	O
determine	O
whether	O
the	O
reduced	O
number	O
was	O
due	O
to	O
intra	O
-	O
uterine	O
demise	O
.	O

Litters	O
were	O
collected	O
at	O
E12	O
.	O
5	O
,	O
13	O
.	O
5	O
,	O
15	O
.	O
5	O
,	O
17	O
.	O
5	O
,	O
and	O
18	O
.	O
5	O
,	O
and	O
embryos	O
were	O
genotyped	O
and	O
evaluated	O
for	O
evidence	O
of	O
intra	O
-	O
uterine	O
demise	O
,	O
including	O
growth	O
retardation	O
,	O
pallor	O
,	O
and	O
tissue	O
friability	O
.	O
lil	O
embryos	O
had	O
a	O
progressively	O
higher	O
rate	O
of	O
demise	O
between	O
E13	O
.	O
5	O
and	O
E15	O
.	O
5	O
.	O

At	O
E12	O
.	O
5	O
,	O
20	O
out	O
of	O
87	O
(	O
23	O
%	O
)	O
were	O
homozygous	O
for	O
the	O
mutation	S-SO
,	O
and	O
all	O
of	O
these	O
appeared	O
viable	O
.	O

At	O
E13	O
.	O
5	O
,	O
13	O
of	O
49	O
(	O
27	O
%	O
)	O
were	O
mutant	S-SO
and	O
two	O
had	O
died	O
.	O

At	O
E15	O
.	O
5	O
,	O
22	O
out	O
of	O
91	O
(	O
24	O
%	O
)	O
were	O
mutant	S-SO
and	O
the	O
majority	O
of	O
mutant	S-SO
embryos	O
(	O
17	O
out	O
of	O
the	O
22	O
)	O
had	O
died	O
.	O

By	O
E18	O
.	O
5	O
,	O
nine	O
of	O
29	O
embryos	O
(	O
31	O
%	O
)	O
were	O
homozygous	O
for	O
the	O
mutation	S-SO
,	O
of	O
which	O
only	O
one	O
embryo	O
was	O
viable	O
.	O

Diaphragmatic	O
muscularization	O
was	O
abnormal	O
in	O
all	O
mutant	S-SO
mice	S-LIVB
examined	O
(	O
n	O
>	O
25	O
)	O
.	O

Pulmonary	O
hypoplasia	O
was	O
observed	O
in	O
100	O
%	O
of	O
mutants	S-SO
evaluated	O
for	O
that	O
phenotype	O
between	O
E11	O
.	O
5	O
and	O
birth	O
(	O
n	O
>	O
50	O
)	O
.	O

Examination	O
of	O
cardiac	O
morphology	O
showed	O
that	O
hearts	O
from	O
E15	O
.	O
5	O
lil	O
mutant	S-SO
mice	S-LIVB
had	O
a	O
variety	O
of	O
developmental	O
defects	O
,	O
including	O
enlarged	O
and	O
abnormally	O
developed	O
endocardial	O
cushions	O
,	O
a	O
double	O
-	O
outlet	O
right	O
ventricle	O
,	O
and	O
a	O
complete	O
atrioventricular	O
canal	O
.	O

The	O
myocardium	O
was	O
also	O
poorly	O
developed	O
,	O
with	O
thinning	O
of	O
the	O
outer	O
compact	O
layer	O
and	O
decreased	O
vascularity	O
.	O

The	O
cohort	O
of	O
mutant	S-SO
mice	S-LIVB
that	O
survived	O
to	O
birth	O
also	O
had	O
cardiac	O
malformations	O
including	O
atrioventricular	O
-	O
canal	O
-	O
type	O
ventricular	O
septal	O
defects	O
,	O
ostium	O
primum	O
atrial	O
septal	O
defects	O
,	O
and	O
enlarged	O
atria	O
(	O
data	O
not	O
shown	O
)	O
.	O

All	O
mutants	S-SO
specifically	O
evaluated	O
for	O
a	O
cardiac	O
phenotype	O
(	O
n	O
=	O
10	O
)	O
had	O
abnormal	O
cardiac	O
development	O
.	O

Examination	O
of	O
the	O
3	O
-	O
Mb	O
region	S-SO
between	O
D15Mit85	O
and	O
D15Mit5	O
in	O
DNA	B-SO
sequence	E-SO
databases	O
revealed	O
three	O
predicted	B-SO
genes	E-SO
and	O
four	O
known	S-SO
genes	S-SO
,	O
including	O
Fog2	S-PRGE
.	O

Targeted	O
mutations	S-SO
of	O
Fog2	S-PRGE
have	O
cardiac	O
defects	O
strikingly	O
similar	O
to	O
those	O
we	O
identified	O
in	O
lil	O
mutant	S-SO
mice	S-LIVB
,	O
including	O
atrioventricular	O
canal	O
defects	O
,	O
thinned	O
myocardium	O
,	O
and	O
absent	O
coronary	O
vasculature	O
[	O
16	O
]	O
.	O

RT	O
-	O
PCR	O
amplification	O
of	O
the	O
proximal	O
portion	S-SO
of	O
Fog2	S-PRGE
revealed	O
longer	O
transcripts	S-SO
in	O
the	O
lil	O
mutant	S-SO
than	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
embryos	O
(	O
Figure	O
2A	O
)	O
.	O

Sequencing	O
of	O
the	O
mutant	S-SO
transcript	S-SO
revealed	O
a	O
point	B-SO
mutation	I-SO
(	I-SO
from	I-SO
thymine	I-SO
to	I-SO
cytosine	E-SO
)	O
2	O
bp	S-SO
after	O
position	S-SO
301	O
,	O
which	O
is	O
in	O
the	O
splice	B-SO
donor	I-SO
site	E-SO
at	O
the	O
end	O
of	O
the	O
third	O
exon	S-SO
.	O

This	O
mutation	S-SO
causes	O
a	O
splicing	O
defect	O
that	O
results	O
in	O
the	O
insertion	S-SO
of	O
85	O
bp	S-SO
of	O
intronic	B-SO
sequence	E-SO
into	O
the	O
mutant	S-SO
transcript	S-SO
,	O
and	O
introduces	O
a	O
stop	B-SO
codon	E-SO
that	O
generates	O
a	O
severely	O
truncated	O
protein	B-CHEBI
product	E-CHEBI
(	O
Figure	O
2B	O
)	O
.	O

Heterozygous	O
lil	O
mutant	S-SO
mice	S-LIVB
were	O
crossed	O
with	O
a	O
Fog2	S-PRGE
+	O
/	O
-	O
(	O
null	O
allele	S-SO
)	O
mutant	S-SO
generated	O
by	O
gene	S-SO
targeting	O
[	O
16	O
]	O
.	O

Doubly	O
heterozygous	O
mice	S-LIVB
had	O
an	O
embryonic	O
lethal	O
phenotype	O
;	O
this	O
failure	O
to	O
complement	O
proves	O
that	O
lil	O
is	O
a	O
mutation	S-SO
in	O
Fog2	S-PRGE
.	O

The	O
variable	O
phenotype	O
of	O
lil	O
mice	S-LIVB
(	O
relative	O
to	O
that	O
found	O
for	O
the	O
Fog2	S-PRGE
null	O
mutant	S-SO
)	O
is	O
likely	O
due	O
to	O
the	O
generation	O
of	O
a	O
low	O
level	O
of	O
normal	O
transcript	S-SO
despite	O
the	O
presence	O
of	O
the	O
splice	B-SO
site	E-SO
mutation	S-SO
.	O

Lung	O
and	O
Diaphragm	O
Development	O
in	O
the	O
Fog2	S-PRGE
Mutant	S-SO
Mouse	S-LIVB

Experiments	O
were	O
conducted	O
to	O
evaluate	O
the	O
role	O
of	O
Fog2	S-PRGE
in	O
pulmonary	O
and	O
diaphragmatic	O
development	O
.	O

The	O
pulmonary	O
phenotype	O
is	O
characterized	O
by	O
diffuse	O
hypoplasia	O
and	O
specific	O
loss	O
of	O
the	O
accessory	O
lobe	O
and	O
a	O
portion	O
of	O
the	O
right	O
middle	O
lobe	O
.	O

It	O
is	O
well	O
established	O
that	O
abnormalities	O
in	O
either	O
diaphragmatic	O
development	O
or	O
fetal	O
breathing	O
can	O
result	O
in	O
a	O
secondary	O
pulmonary	O
hypoplasia	O
,	O
although	O
loss	O
of	O
normal	O
structure	O
has	O
never	O
been	O
documented	O
in	O
this	O
context	O
[	O
17	O
,	O
18	O
]	O
.	O

Fog2	S-PRGE
is	O
expressed	O
diffusely	O
in	O
the	O
pulmonary	O
mesenchyme	O
during	O
the	O
period	O
of	O
branching	O
morphogenesis	O
,	O
while	O
later	O
expression	O
is	O
restricted	O
to	O
the	O
smooth	O
muscles	O
of	O
airways	O
and	O
pulmonary	O
vessels	O
(	O
Figure	O
3	O
)	O
.	O

This	O
,	O
and	O
the	O
observation	O
that	O
lungs	O
appeared	O
small	O
on	O
transverse	O
sections	O
evaluated	O
prior	O
to	O
diaphragmatic	O
muscularization	O
or	O
function	O
,	O
suggests	O
that	O
the	O
pulmonary	O
hypoplasia	O
occurs	O
independently	O
of	O
the	O
diaphragmatic	O
defect	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
lungs	O
were	O
dissected	O
from	O
Fog2	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
and	O
littermate	O
controls	O
before	O
the	O
onset	O
of	O
fetal	O
diaphragmatic	O
motion	O
.	O

Fog2	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
were	O
used	O
for	O
this	O
experiment	O
,	O
as	O
we	O
wanted	O
to	O
avoid	O
potential	O
phenotypic	O
variance	O
from	O
the	O
lil	O
hypomorphic	O
mutation	S-SO
.	O

Lungs	O
dissected	O
at	O
E12	O
from	O
Fog2	S-PRGE
-	O
/	O
-	O
embryos	O
were	O
smaller	O
in	O
size	O
and	O
lacked	O
the	O
development	O
of	O
an	O
accessory	O
lobe	O
.	O

In	O
11	O
viable	O
Fog2	S-PRGE
-	O
/	O
-	O
lung	O
culture	O
explants	O
,	O
there	O
was	O
never	O
development	O
of	O
an	O
accessory	O
lobe	O
,	O
and	O
the	O
weights	O
of	O
mutant	S-SO
lungs	O
cultured	O
for	O
5	O
d	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
littermate	O
controls	O
(	O
Figure	O
4	O
)	O
.	O

These	O
data	O
demonstrate	O
that	O
the	O
pulmonary	O
hypoplasia	O
in	O
Fog2	S-PRGE
mutant	S-SO
mice	S-LIVB
is	O
a	O
primary	O
defect	O
.	O

Branching	O
in	O
the	O
unaffected	O
lobes	O
appeared	O
to	O
be	O
delayed	O
by	O
6	O
-	O
12	O
h	O
,	O
but	O
all	O
mutants	S-SO
developed	O
an	O
intricate	O
branching	O
pattern	O
in	O
the	O
unaffected	O
lobes	O
after	O
culture	O
for	O
5	O
d	O
.	O

Because	O
the	O
Fog2	S-PRGE
phenotype	O
is	O
striking	O
for	O
specific	O
lobar	O
loss	O
,	O
the	O
spatial	O
pattern	O
of	O
Fog2	S-PRGE
expression	O
was	O
evaluated	O
in	O
normal	O
embryos	O
during	O
the	O
period	O
of	O
early	O
lobar	O
establishment	O
to	O
determine	O
whether	O
Fog2	S-PRGE
expression	O
is	O
specifically	O
different	O
at	O
these	O
lobar	O
buds	O
.	O

Expression	O
was	O
evaluated	O
in	O
mice	S-LIVB
carrying	O
a	O
lacZ	O
gene	S-SO
incorporated	S-SO
into	O
the	O
Fog2	S-PRGE
locus	S-SO
(	O
S	O
.	O
Tevosian	O
,	O
unpublished	O
data	O
)	O
.	O

In	O
nine	O
mice	S-LIVB
examined	O
at	O
E11	O
.	O
5	O
,	O
all	O
lungs	O
showed	O
a	O
specific	O
enhancement	O
of	O
Fog2	S-PRGE
expression	O
in	O
the	O
mesenchyme	O
surrounding	O
the	O
accessory	O
bud	O
and	O
the	O
right	O
middle	O
lobe	O
bud	O
,	O
which	O
are	O
the	O
lobes	O
that	O
do	O
not	O
develop	O
normally	O
in	O
Fog2	S-PRGE
mutant	S-SO
mice	S-LIVB
(	O
Figure	O
5	O
)	O
.	O

By	O
E12	O
.	O
5	O
,	O
expression	O
was	O
diffuse	O
in	O
the	O
pulmonary	O
mesenchyme	O
,	O
as	O
was	O
seen	O
previously	O
with	O
in	O
situ	O
hybridization	O
on	O
tissue	O
sections	O
.	O

Diaphragms	O
from	O
Fog2	S-PRGE
lil	O
mice	S-LIVB
show	O
an	O
intact	O
membrane	O
with	O
a	O
defect	O
in	O
muscular	O
patterning	O
(	O
see	O
Figure	O
1B	O
)	O
.	O

The	O
membranous	O
portion	O
of	O
the	O
diaphragm	O
is	O
populated	O
by	O
a	O
migratory	O
population	O
of	O
muscle	B-CL
precursor	I-CL
cells	E-CL
,	O
much	O
like	O
the	O
limbs	O
[	O
19	O
,	O
20	O
]	O
.	O

Mice	S-LIVB
with	O
defects	O
in	O
genes	S-SO
known	O
to	O
be	O
important	O
for	O
the	O
control	O
of	O
this	O
process	O
have	O
intact	O
but	O
amuscular	O
diaphragms	O
[	O
17	O
,	O
21	O
,	O
22	O
]	O
.	O

Hepatocyte	B-PRGE
growth	I-PRGE
factor	E-PRGE
/	O
Scatter	B-PRGE
factor	E-PRGE
(	O
HGF	S-PRGE
)	O
is	O
one	O
potential	O
candidate	O
responsible	O
for	O
the	O
guidance	O
of	O
muscle	B-CL
precursors	E-CL
to	O
the	O
membranous	O
diaphragm	O
.	O

It	O
has	O
been	O
shown	O
that	O
HGF	S-PRGE
is	O
expressed	O
along	O
this	O
anatomic	O
pathway	O
[	O
23	O
]	O
,	O
and	O
mice	S-LIVB
with	O
absence	O
of	O
the	O
HGF	B-PRGE
receptor	E-PRGE
c	B-PRGE
-	I-PRGE
Met	E-PRGE
fail	O
to	O
form	O
muscularized	O
pleuroperitoneal	O
folds	O
(	O
PPFs	O
)	O
,	O
and	O
thus	O
have	O
amuscular	O
diaphragms	O
[	O
24	O
,	O
25	O
]	O
.	O

Fog2	S-PRGE
is	O
expressed	O
diffusely	O
in	O
the	O
early	O
amuscular	O
diaphragm	O
at	O
E11	O
.	O
5	O
as	O
well	O
as	O
in	O
the	O
later	O
muscularized	O
diaphragm	O
(	O
see	O
Figure	O
3C	O
and	O
3D	O
)	O
.	O

Pax3	S-PRGE
and	O
MyoD	S-PRGE
,	O
transcription	O
factors	O
required	O
for	O
appropriate	O
migration	O
and	O
determination	O
of	O
myogenic	B-CL
precursors	E-CL
,	O
were	O
detected	O
in	O
the	O
PPFs	O
of	O
Fog2	S-PRGE
lil	O
mice	S-LIVB
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
in	O
situ	O
expression	O
analysis	O
demonstrated	O
that	O
the	O
expression	O
of	O
HGF	S-PRGE
in	O
the	O
region	O
where	O
this	O
structure	O
meets	O
the	O
membranous	O
diaphragm	O
was	O
markedly	O
reduced	O
in	O
Fog2	S-PRGE
mutant	S-SO
mice	S-LIVB
(	O
Figure	O
6	O
)	O
.	O

We	O
hypothesize	O
that	O
Fog2	S-PRGE
is	O
required	O
(	O
either	O
directly	O
or	O
indirectly	O
)	O
for	O
the	O
induction	O
of	O
HGF	S-PRGE
in	O
the	O
developing	O
diaphragm	O
,	O
and	O
dysregulation	O
of	O
HGF	S-PRGE
patterning	O
along	O
the	O
path	O
of	O
muscle	B-CL
precursor	I-CL
cell	E-CL
migration	O
between	O
the	O
PPF	O
and	O
the	O
diaphragm	O
accounts	O
for	O
the	O
abnormal	O
phenotype	O
in	O
these	O
mice	S-LIVB
.	O

FOG2	S-PRGE
Mutation	S-SO
in	O
a	O
Patient	O
with	O
Diaphragm	O
and	O
Lung	O
Abnormalities	O

FOG2	S-PRGE
sequence	S-SO
analysis	O
was	O
performed	O
on	O
autopsy	O
tissue	O
from	O
30	O
of	O
32	O
deceased	O
children	O
with	O
an	O
anatomic	O
diagnosis	O
of	O
diaphragmatic	O
defect	O
evaluated	O
at	O
the	O
Children	O
'	O
s	O
Hospital	O
in	O
Boston	O
,	O
Massachusetts	O
,	O
between	O
1993	O
and	O
2003	O
.	O

Autopsy	O
reports	O
were	O
reviewed	O
to	O
determine	O
the	O
specific	O
diagnoses	O
.	O

Of	O
these	O
30	O
cases	O
,	O
17	O
(	O
57	O
%	O
)	O
had	O
Bochdalek	O
CDH	O
,	O
two	O
(	O
7	O
%	O
)	O
had	O
diaphragmatic	O
agenesis	O
,	O
seven	O
(	O
23	O
%	O
)	O
had	O
diaphragmatic	O
eventration	O
/	O
muscularization	O
defects	O
(	O
without	O
Bochdalek	O
CDH	O
)	O
,	O
and	O
four	O
(	O
13	O
%	O
)	O
had	O
Bochdalek	O
hernia	O
of	O
one	O
hemidiaphragm	O
and	O
eventration	O
of	O
the	O
other	O
.	O

Pulmonary	O
hypoplasia	O
was	O
assessed	O
using	O
lung	O
/	O
body	O
weight	O
ratio	O
and	O
radial	O
alveolar	O
counts	O
[	O
26	O
]	O
.	O

The	O
material	O
available	O
for	O
review	O
included	O
written	O
reports	O
and	O
histologic	O
slides	O
in	O
all	O
cases	O
and	O
gross	O
kodachromes	O
in	O
a	O
subset	O
of	O
cases	O
.	O

One	O
child	O
carried	O
a	O
highly	O
significant	O
FOG2	S-PRGE
sequence	B-SO
change	E-SO
.	O

The	O
patient	O
was	O
a	O
full	O
-	O
term	O
3	O
,	O
500	O
-	O
g	O
baby	O
girl	O
who	O
developed	O
severe	O
respiratory	O
failure	O
at	O
birth	O
and	O
died	O
after	O
5	O
h	O
of	O
resuscitation	O
.	O

Antemortem	O
radiographs	O
showed	O
opacified	O
lung	O
fields	O
and	O
possible	O
bowel	O
in	O
the	O
chest	O
.	O

The	O
patient	O
'	O
s	O
clinical	O
diagnosis	O
was	O
CDH	O
.	O

Review	O
of	O
autopsy	O
material	O
revealed	O
severe	O
bilateral	O
pulmonary	O
hypoplasia	O
(	O
combined	O
lung	O
weight	O
,	O
11	O
.	O
1	O
g	O
;	O
expected	O
for	O
body	O
length	O
/	O
weight	O
,	O
46	O
.	O
8	O
+/-	O
26	O
.	O
2	O
g	O
;	O
[	O
27	O
]	O
)	O
,	O
most	O
markedly	O
involving	O
the	O
left	O
lung	O
.	O

The	O
lung	O
/	O
body	O
weight	O
ratio	O
was	O
0	O
.	O
0037	O
(	O
expected	O
>	O
0	O
.	O
010	O
)	O
[	O
28	O
]	O
.	O

There	O
were	O
a	O
reduced	O
number	O
of	O
bronchial	O
generations	O
,	O
and	O
the	O
radial	O
alveolar	O
count	O
was	O
2	O
-	O
3	O
(	O
expected	O
=	O
5	O
)	O
[	O
29	O
]	O
.	O

There	O
were	O
incomplete	O
lung	O
fissures	O
bilaterally	O
.	O

A	O
deep	O
posterior	O
diaphragmatic	O
eventration	O
was	O
present	O
on	O
the	O
left	O
side	O
.	O

Additionally	O
,	O
two	O
muscularized	O
ligamentous	O
bands	O
resembling	O
diaphragmatic	O
remnants	O
encircled	O
the	O
left	O
lobe	O
of	O
the	O
liver	O
,	O
creating	O
an	O
abnormal	O
fissured	O
liver	O
contour	O
.	O

Away	O
from	O
the	O
eventration	O
,	O
the	O
diaphragm	O
appeared	O
well	O
muscularized	O
,	O
measuring	O
0	O
.	O
3	O
cm	O
in	O
thickness	O
.	O

A	O
complete	O
autopsy	O
revealed	O
no	O
other	O
malformations	O
;	O
the	O
heart	O
was	O
determined	O
to	O
be	O
grossly	O
normal	O
and	O
was	O
donated	O
for	O
valve	O
harvest	O
.	O

Sequence	S-SO
analysis	O
revealed	O
a	O
cytosine	S-CHEBI
to	O
thymine	S-CHEBI
heterozygous	O
change	S-SO
in	O
exon	S-SO
4	O
that	O
changes	S-SO
the	O
112th	O
amino	B-CHEBI
acid	E-CHEBI
from	O
arginine	S-CHEBI
to	O
a	O
stop	B-SO
codon	E-SO
.	O

This	O
mutation	S-SO
produces	O
a	O
severely	O
truncated	O
peptide	S-SO
that	O
does	O
not	O
contain	O
zinc	S-CHEBI
finger	O
domains	S-SO
(	O
Figure	O
7	O
)	O
.	O

This	O
base	S-SO
change	S-SO
was	O
not	O
present	O
in	O
the	O
analysis	O
of	O
DNA	S-SO
from	O
400	O
normal	O
adults	O
.	O

To	O
assess	O
the	O
likelihood	O
that	O
the	O
mutation	S-SO
was	O
causal	O
for	O
the	O
developmental	O
phenotype	O
,	O
we	O
examined	O
both	O
parents	O
.	O

Paternity	O
was	O
confirmed	O
,	O
and	O
sequence	S-SO
analysis	O
revealed	O
that	O
the	O
neither	O
parent	O
carried	O
this	O
mutation	S-SO
,	O
proving	O
that	O
the	O
patient	O
had	O
a	O
de	B-SO
novo	E-SO
mutation	S-SO
in	O
FOG2	S-PRGE
(	O
Figure	O
7	O
)	O
.	O

Discussion	O

Congenital	O
diaphragmatic	O
defects	O
are	O
a	O
heterogeneous	O
group	O
of	O
disorders	O
of	O
unknown	O
etiology	O
.	O

The	O
defects	O
that	O
present	O
in	O
the	O
pre	O
-	O
or	O
perinatal	O
period	O
include	O
Bochdalek	O
hernia	O
,	O
diaphragmatic	O
aplasia	O
,	O
and	O
various	O
degrees	O
of	O
muscularization	O
defects	O
or	O
eventrations	O
.	O

Different	O
types	O
of	O
defects	O
occur	O
in	O
the	O
same	O
patients	O
or	O
in	O
siblings	O
,	O
suggesting	O
these	O
represent	O
variable	O
expression	O
of	O
the	O
same	O
underlying	O
pathogenesis	O
[	O
30	O
,	O
31	O
]	O
.	O

Clinical	O
differentiation	O
between	O
these	O
defects	O
may	O
be	O
very	O
difficult	O
,	O
as	O
the	O
residual	O
membranous	O
diaphragm	O
of	O
a	O
muscularization	O
defect	O
is	O
thin	O
and	O
may	O
not	O
be	O
easily	O
visible	O
on	O
prenatal	O
ultrasound	O
or	O
postnatal	O
chest	O
radiographs	O
[	O
32	O
]	O
.	O

Although	O
diaphragmatic	O
muscularization	O
defects	O
were	O
historically	O
considered	O
to	O
be	O
predictive	O
of	O
a	O
good	O
outcome	O
,	O
there	O
have	O
been	O
inadequate	O
population	O
-	O
based	O
studies	O
that	O
include	O
fetal	O
or	O
neonatal	O
cases	O
and	O
autopsy	O
diagnoses	O
to	O
make	O
this	O
conclusion	O
definitive	O
.	O

In	O
fact	O
,	O
the	O
series	O
of	O
patients	O
we	O
report	O
here	O
and	O
the	O
published	O
literature	O
indicate	O
that	O
an	O
eventration	O
defect	O
may	O
be	O
associated	O
with	O
displacement	O
of	O
abdominal	O
contents	O
and	O
also	O
with	O
severe	O
pulmonary	O
hypoplasia	O
and	O
respiratory	O
insufficiency	O
[	O
33	O
,	O
34	O
]	O
.	O

Numerous	O
chromosome	S-GO
abnormalities	O
have	O
been	O
found	O
in	O
association	O
with	O
congenital	O
diaphragm	O
abnormalities	O
[	O
12	O
,	O
35	O
]	O
.	O

Human	B-PRGE
FOG2	E-PRGE
maps	O
to	O
Chromosome	S-GO
8q23	O
.	O
1	O
,	O
and	O
,	O
importantly	O
,	O
several	O
patients	O
with	O
diaphragm	O
defects	O
and	O
rearrangements	O
involving	O
this	O
locus	S-SO
have	O
been	O
reported	O
.	O

Specifically	O
,	O
there	O
are	O
three	O
unrelated	O
CDH	O
patients	O
with	O
cytogenetically	O
balanced	O
translocations	S-SO
at	O
or	O
near	O
the	O
FOG2	S-PRGE
locus	S-SO
[	O
36	O
,	O
37	O
]	O
.	O

Additionally	O
,	O
two	O
patients	O
with	O
deletions	S-SO
apparently	O
encompassing	O
the	O
FOG2	S-PRGE
locus	S-SO
have	O
died	O
from	O
multiple	O
congenital	O
anomalies	O
including	O
CDH	O
[	O
38	O
-	O
40	O
]	O
.	O

Inactivation	O
of	O
this	O
gene	S-SO
due	O
to	O
chromosomal	S-GO
rearrangement	O
or	O
deletion	S-SO
would	O
result	O
in	O
a	O
heterozygous	O
null	O
mutation	S-SO
similar	O
to	O
that	O
found	O
in	O
the	O
patient	O
we	O
report	O
.	O

Because	O
the	O
FOG2	S-PRGE
mutation	S-SO
we	O
report	O
is	O
de	B-SO
novo	E-SO
and	O
the	O
phenotypes	O
of	O
the	O
pulmonary	O
and	O
diaphragmatic	O
defects	O
are	O
similar	O
between	O
mouse	S-LIVB
and	O
human	S-LIVB
,	O
we	O
suggest	O
that	O
this	O
mutation	S-SO
in	O
FOG2	S-PRGE
is	O
the	O
first	O
reported	O
cause	O
of	O
a	O
human	S-LIVB
developmental	O
diaphragmatic	O
and	O
pulmonary	O
defect	O
.	O

In	O
contrast	O
to	O
the	O
affected	O
child	O
,	O
mice	S-LIVB
heterozygous	O
for	O
a	O
null	O
mutation	S-SO
of	O
Fog2	S-PRGE
appear	O
normal	O
.	O

However	O
,	O
there	O
is	O
ample	O
precedent	O
for	O
the	O
observation	O
that	O
haploinsufficiency	O
of	O
a	O
gene	S-SO
with	O
developmental	O
functions	O
is	O
much	O
less	O
well	O
tolerated	O
in	O
humans	S-LIVB
than	O
mice	S-LIVB
[	O
41	O
]	O
.	O

It	O
is	O
unclear	O
how	O
the	O
Fog2	S-PRGE
diaphragmatic	O
defect	O
relates	O
to	O
the	O
more	O
common	O
Bochdalek	O
CDH	O
,	O
as	O
the	O
pathogenic	O
mechanisms	O
for	O
both	O
are	O
largely	O
unknown	O
.	O

Muscle	B-CL
precursors	E-CL
destined	O
to	O
populate	O
the	O
diaphragm	O
migrate	O
from	O
the	O
lateral	O
dermomyotome	O
of	O
cervical	O
somites	O
.	O

Prior	O
to	O
migration	O
onto	O
the	O
diaphragm	O
,	O
they	O
populate	O
the	O
PPF	O
,	O
a	O
wedge	O
-	O
shaped	O
tissue	O
that	O
tapers	O
medially	O
from	O
the	O
lateral	O
body	O
wall	O
to	O
the	O
esophageal	O
mesentery	O
and	O
fuses	O
ventrally	O
with	O
the	O
septum	O
transversum	O
[	O
42	O
]	O
.	O

Muscle	B-CL
precursors	E-CL
reach	O
the	O
PPF	O
by	O
E11	O
,	O
where	O
they	O
proliferate	O
,	O
differentiate	O
,	O
and	O
then	O
migrate	O
toward	O
the	O
dorsolateral	O
costal	O
,	O
sternal	O
costal	O
,	O
and	O
crural	O
regions	O
of	O
the	O
developing	O
diaphragm	O
.	O

Thus	O
,	O
a	O
defect	O
in	O
PPF	O
formation	O
subsequently	O
results	O
in	O
the	O
abnormal	O
formation	O
of	O
the	O
diaphragm	O
[	O
43	O
]	O
.	O

We	O
have	O
shown	O
that	O
the	O
Fog2	S-PRGE
mutant	S-SO
does	O
have	O
an	O
abnormal	O
pattern	O
of	O
HGF	S-PRGE
expression	O
in	O
the	O
region	O
through	O
which	O
muscle	B-CL
precursor	I-CL
cells	E-CL
migrate	O
onto	O
the	O
developing	O
diaphragm	O
.	O

This	O
finding	O
may	O
account	O
for	O
the	O
abnormally	O
patterned	O
muscle	O
that	O
develops	O
in	O
the	O
Fog2	S-PRGE
mutant	S-SO
diaphragm	O
.	O

Although	O
Pax3	S-PRGE
and	O
MyoD	S-PRGE
expression	O
is	O
detected	O
in	O
the	O
PPF	O
,	O
a	O
detailed	O
analysis	O
of	O
transcription	O
factors	O
responsible	O
for	O
muscle	B-CL
precursor	I-CL
cell	E-CL
migration	O
and	O
differentiation	O
will	O
need	O
to	O
be	O
completed	O
both	O
in	O
the	O
PPF	O
and	O
along	O
the	O
pathway	O
of	O
muscle	B-CL
precursor	I-CL
cell	E-CL
migration	O
between	O
the	O
PPF	O
and	O
the	O
membranous	O
diaphragm	O
.	O

Fog2	S-PRGE
can	O
interact	O
with	O
any	O
of	O
the	O
Gata	O
factors	O
,	O
Gatas	B-PRGE
1	I-PRGE
-	I-PRGE
6	E-PRGE
,	O
as	O
well	O
as	O
other	O
transcription	O
factors	O
such	O
as	O
CoupTFII	S-PRGE
[	O
44	O
,	O
45	O
]	O
.	O

It	O
is	O
known	O
that	O
a	O
Fog2	S-PRGE
-	O
Gata4	S-PRGE
interaction	O
is	O
critical	O
for	O
normal	O
cardiac	O
and	O
gonadal	O
development	O
,	O
but	O
interacting	O
factors	O
in	O
the	O
lung	O
and	O
diaphragm	O
have	O
not	O
yet	O
been	O
determined	O
.	O

The	O
severity	O
of	O
pulmonary	O
hypoplasia	O
in	O
the	O
patient	O
we	O
report	O
was	O
out	O
of	O
proportion	O
to	O
that	O
of	O
the	O
diaphragm	O
defect	O
.	O

Pulmonary	O
hypoplasia	O
is	O
associated	O
with	O
abnormal	O
diaphragmatic	O
anatomy	O
or	O
function	O
,	O
and	O
is	O
known	O
to	O
occur	O
as	O
a	O
secondary	O
developmental	O
defect	O
in	O
models	O
of	O
diaphragmatic	O
dysfunction	O
such	O
as	O
complete	O
amuscularization	O
[	O
17	O
]	O
or	O
phrenic	O
nerve	O
disruption	O
[	O
46	O
]	O
.	O

It	O
occurs	O
in	O
a	O
surgical	O
model	O
of	O
CDH	O
in	O
which	O
a	O
hernia	O
is	O
physically	O
created	O
in	O
an	O
in	O
utero	O
lamb	S-LIVB
[	O
47	O
,	O
48	O
]	O
.	O

However	O
,	O
the	O
possibility	O
that	O
primary	O
pulmonary	O
developmental	O
abnormalities	O
occur	O
with	O
,	O
rather	O
than	O
secondary	O
to	O
,	O
diaphragmatic	O
defects	O
has	O
been	O
suggested	O
by	O
others	O
based	O
on	O
a	O
teratogenic	O
model	O
of	O
CDH	O
[	O
49	O
-	O
51	O
]	O
and	O
has	O
long	O
been	O
suspected	O
by	O
clinicians	O
who	O
care	O
for	O
these	O
patients	O
.	O

In	O
addition	O
,	O
the	O
high	O
incidence	O
of	O
lobar	O
abnormalities	O
associated	O
with	O
CDH	O
[	O
52	O
]	O
supports	O
the	O
possibility	O
that	O
this	O
disorder	O
can	O
be	O
associated	O
with	O
a	O
primary	O
developmental	O
pulmonary	O
abnormality	O
.	O

Our	O
analysis	O
of	O
mice	S-LIVB
carrying	O
mutations	S-SO
of	O
Fog2	S-PRGE
proves	O
that	O
there	O
is	O
a	O
primary	O
defect	O
in	O
lung	O
development	O
that	O
results	O
in	O
specific	O
loss	O
of	O
the	O
accessory	O
lobe	O
and	O
partial	O
loss	O
of	O
the	O
right	O
middle	O
lobe	O
.	O

The	O
specific	O
lobar	O
defects	O
prompted	O
us	O
to	O
evaluate	O
Fog2	S-PRGE
expression	O
at	O
the	O
time	O
of	O
early	O
lobar	O
budding	O
.	O

While	O
Fog2	S-PRGE
expression	O
is	O
diffuse	O
in	O
the	O
pulmonary	O
mesenchyme	O
after	O
lobar	O
structure	O
is	O
well	O
established	O
(	O
E12	O
.	O
5	O
)	O
,	O
it	O
is	O
more	O
focally	O
expressed	O
in	O
the	O
mesenchyme	O
surrounding	O
the	O
right	O
middle	O
lobe	O
and	O
accessory	O
buds	O
as	O
these	O
lobes	O
form	O
.	O

This	O
matches	O
the	O
phenotype	O
of	O
right	O
middle	O
lobe	O
and	O
accessory	O
lobe	O
loss	O
,	O
and	O
suggests	O
that	O
Fog2	S-PRGE
has	O
a	O
specific	O
patterning	O
role	O
in	O
establishment	O
of	O
these	O
lobes	O
.	O

It	O
is	O
less	O
clear	O
whether	O
loss	O
of	O
Fog2	S-PRGE
results	O
in	O
a	O
global	O
branching	O
defect	O
,	O
as	O
Fog2	S-PRGE
lungs	O
appear	O
to	O
have	O
a	O
slight	O
developmental	O
delay	O
,	O
which	O
could	O
result	O
from	O
many	O
causes	O
.	O

Cultured	O
Fog2	S-PRGE
lungs	O
do	O
develop	O
an	O
intricate	O
branching	O
pattern	O
in	O
the	O
unaffected	O
lobes	O
that	O
appears	O
similar	O
in	O
the	O
pattern	O
to	O
wild	B-SO
-	I-SO
type	E-SO
lungs	O
after	O
5	O
d	O
in	O
culture	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
a	O
mutation	S-SO
of	O
Fog2	S-PRGE
in	O
the	O
mouse	S-LIVB
causes	O
the	O
phenotype	O
of	O
abnormal	O
diaphragmatic	O
muscularization	O
and	O
primary	O
pulmonary	O
hypoplasia	O
.	O

We	O
furthermore	O
demonstrate	O
that	O
a	O
mutation	S-SO
in	O
this	O
gene	S-SO
is	O
associated	O
with	O
a	O
lethal	O
defect	O
in	O
lung	O
and	O
diaphragm	O
development	O
in	O
a	O
child	O
.	O

It	O
is	O
notable	O
that	O
,	O
despite	O
extensive	O
analysis	O
of	O
Fog2	S-PRGE
biology	O
and	O
the	O
generation	O
of	O
a	O
Fog2	S-PRGE
knock	O
-	O
out	O
mouse	S-LIVB
,	O
its	O
role	O
in	O
diaphragm	O
and	O
lung	O
development	O
was	O
previously	O
not	O
recognized	O
.	O

It	O
is	O
only	O
as	O
a	O
consequence	O
of	O
phenotype	O
-	O
driven	O
analyses	O
such	O
as	O
those	O
we	O
are	O
pursuing	O
that	O
one	O
has	O
the	O
opportunity	O
to	O
assay	O
all	O
of	O
the	O
potential	O
molecular	S-CHEBI
derangements	O
that	O
may	O
result	O
in	O
human	S-LIVB
disease	O
.	O

Materials	O
and	O
Methods	O

These	O
investigations	O
were	O
conducted	O
with	O
approval	O
of	O
the	O
institutional	O
review	O
board	O
for	O
Children	O
'	O
s	O
Hospital	O
,	O
Boston	O
,	O
and	O
Brigham	O
and	O
Women	O
'	O
s	O
Hospital	O
,	O
Boston	O
.	O

Animal	S-LIVB
use	O
was	O
approved	O
by	O
the	O
Center	O
for	O
Animal	S-LIVB
Resources	O
and	O
Comparative	O
Medicine	O
(	O
Harvard	O
Medical	O
School	O
)	O
.	O

Genetic	S-SO
mapping	O
of	O
the	O
mouse	S-LIVB
mutation	S-SO
lil	O
.	O

The	O
lil	O
mutation	S-SO
was	O
identified	O
as	O
described	O
in	O
results	O
.	O

Wild	B-SO
-	I-SO
type	E-SO
FVB	O
/	O
N	O
and	O
C57BL	O
/	O
6J	O
mice	S-LIVB
used	O
for	O
genetic	S-SO
crosses	O
were	O
obtained	O
from	O
the	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
.	O

Mice	S-LIVB
carrying	O
a	O
null	O
mutation	S-SO
of	O
Fog2	S-PRGE
generated	O
by	O
gene	S-SO
targeting	O
[	O
16	O
]	O
were	O
the	O
generous	O
gift	O
of	O
Dr	O
.	O
Stuart	O
Orkin	O
.	O

Developmental	O
analysis	O
of	O
mice	S-LIVB
.	O

Timed	O
pregnancies	O
were	O
set	O
up	O
for	O
collection	O
of	O
E11	O
.	O
5	O
-	O
E17	O
.	O
5	O
embryos	O
.	O

Embryos	O
were	O
fixed	O
,	O
dehydrated	O
,	O
and	O
embedded	O
in	O
paraffin	O
prior	O
to	O
sectioning	O
.	O

In	O
older	O
embryos	O
,	O
a	O
median	O
sternotomy	O
was	O
performed	O
under	O
microscopic	O
guidance	O
,	O
and	O
diaphragm	O
,	O
lungs	O
,	O
and	O
heart	O
were	O
examined	O
.	O

The	O
lungs	O
and	O
tracheobronchial	O
tree	O
were	O
removed	O
and	O
weighed	O
.	O

Whole	O
diaphragms	O
were	O
isolated	O
from	O
fixed	O
thoracic	O
tissue	O
from	O
E15	O
.	O
5	O
and	O
E17	O
.	O
5	O
embryos	O
.	O

For	O
lung	O
explant	O
culture	O
,	O
lungs	O
were	O
dissected	O
from	O
fresh	O
embryos	O
at	O
E11	O
.	O
5	O
and	O
E12	O
.	O
5	O
and	O
placed	O
on	O
porous	O
24	O
-	O
mm	O
(	O
0	O
.	O
4	O
-	O
mu	O
)	O
polyester	S-CHEBI
membranes	O
floated	O
in	O
wells	O
containing	O
2	O
ml	O
of	O
Dulbecco	O
'	O
s	O
modified	O
Eagle	O
'	O
s	O
medium	O
,	O
nutrient	S-CHEBI
mixture	O
F	O
-	O
12	O
(	O
11039	O
-	O
021	O
,	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
supplemented	O
with	O
10	O
%	O
fetal	O
bovine	S-LIVB
serum	O
,	O
0	O
.	O
3	O
mg	O
/	O
ml	O
L	B-CHEBI
-	I-CHEBI
glutamine	E-CHEBI
,	O
100	O
units	O
/	O
ml	O
penicillin	S-CHEBI
,	O
100	O
mcg	O
/	O
ml	O
streptomycin	S-CHEBI
,	O
and	O
0	O
.	O
25	O
mcg	O
/	O
ml	O
amphotericin	O
B	O
.	O

Lung	O
explants	O
were	O
cultured	O
at	O
37	O
degrees	O
C	O
in	O
95	O
%	O
air	O
/	O
5	O
%	O
CO2	S-CHEBI
for	O
up	O
to	O
5	O
d	O
.	O

They	O
were	O
photographed	O
daily	O
with	O
a	O
dissecting	O
microscope	O
(	O
MZ12	O
.	O
5	O
,	O
Leica	O
,	O
Wetzlar	O
,	O
Germany	O
)	O
equipped	O
with	O
a	O
Leica	O
DC500	O
digital	O
camera	O
.	O

Transgenic	S-SO
mice	S-LIVB
carrying	O
the	O
lacZ	O
gene	S-SO
driven	O
by	O
the	O
Fog2	S-PRGE
promoter	S-SO
have	O
been	O
developed	O
by	O
S	O
.	O

Tevosian	O
.	O

In	O
these	O
animals	S-LIVB
,	O
the	O
lacZ	O
gene	S-SO
is	O
incorporated	S-SO
(	O
"	O
knocked	O
-	O
in	O
"	O
)	O
into	O
the	O
Fog2	S-PRGE
locus	S-SO
to	O
allow	O
beta	O
-	O
galactosidase	O
expression	O
as	O
a	O
fusion	S-SO
protein	S-CHEBI
in	O
frame	S-SO
with	O
the	O
first	O
235	O
amino	B-CHEBI
acids	E-CHEBI
of	O
the	O
FOG2	S-PRGE
protein	S-CHEBI
.	O

The	O
Fog2	S-PRGE
-	O
lacZ	O
module	O
is	O
followed	O
by	O
an	O
ires	S-SO
-	O
eGFP	O
cassette	S-SO
.	O

This	O
creates	O
a	O
null	O
allele	S-SO
of	O
Fog2	S-PRGE
gene	S-SO
.	O

The	O
Fog2	S-PRGE
-	O
LacZ	O
-	O
eGFP	O
construct	S-SO
was	O
linearized	O
with	O
KspI	O
and	O
electroporated	O
into	O
the	O
CJ7	O
ES	O
cells	S-CL
.	O

The	O
correctly	O
targeted	O
clone	O
was	O
selected	O
by	O
the	O
Southern	O
blot	O
analysis	O
and	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
.	O

Fog2	S-PRGE
-	O
lacZ	O
-	O
eGFP	O
animals	S-LIVB
were	O
maintained	O
on	O
the	O
mixed	O
C57BL	O
/	O
6J	O
/	O
129	O
background	O
.	O

lacZ	O
Expression	O
in	O
whole	O
dissected	O
embryonic	O
lungs	O
was	O
analyzed	O
by	O
staining	O
for	O
beta	O
-	O
galactosidase	O
activity	O
with	O
X	O
-	O
gal	O
after	O
fixation	O
for	O
30	O
min	O
.	O

RT	O
-	O
PCR	O
and	O
sequence	S-SO
analysis	O
in	O
the	O
mouse	S-LIVB
.	O

RNA	S-SO
was	O
extracted	O
by	O
standard	O
techniques	O
from	O
thoracic	O
embryonic	O
tissue	O
.	O

RT	O
-	O
PCR	O
was	O
performed	O
using	O
six	O
primer	S-SO
sets	O
designed	S-SO
to	O
cover	O
the	O
Fog2	S-PRGE
gene	S-SO
.	O

RT	O
-	O
PCR	O
was	O
repeated	O
with	O
radiolabeled	S-CHEBI
primers	S-SO
to	O
amplify	O
an	O
abnormally	O
spliced	O
region	B-SO
of	I-SO
the	I-SO
gene	E-SO
(	O
Table	O
S1	O
)	O
,	O
and	O
the	O
product	S-SO
was	O
run	O
on	O
a	O
denaturing	O
sequencing	O
gel	O
according	O
to	O
standard	O
techniques	O
.	O

The	O
RT	O
-	O
PCR	B-SO
product	E-SO
was	O
cloned	O
into	O
pCR2	O
.	O
1	O
vector	S-SO
using	O
TOPO	O
TA	O
Cloning	O
Kit	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
sequenced	O
using	O
gene	S-SO
-	O
specific	O
primers	S-SO
.	O

Sequence	S-SO
analysis	O
was	O
done	O
using	O
Sequencher	O
4	O
.	O
1	O
(	O
Gene	S-SO
Codes	O
,	O
Ann	O
Arbor	O
,	O
Michigan	O
,	O
United	O
States	O
)	O
.	O

In	O
situ	O
hybridization	O
.	O

After	O
dehydration	O
and	O
embedding	O
in	O
paraffin	O
wax	O
,	O
10	O
-	O
mu	O
sections	O
were	O
subjected	O
to	O
radioactive	O
in	O
situ	O
hybridization	O
as	O
described	O
[	O
53	O
]	O
.	O

Probes	S-SO
labeled	O
with	O
35S	S-CHEBI
were	O
prepared	O
by	O
run	O
-	O
off	O
transcription	O
of	O
linearized	O
plasmid	S-SO
templates	O
and	O
hybridized	O
to	O
tissue	O
sections	O
.	O

Nuclei	S-GO
were	O
counterstained	O
with	O
Hoescht	O
33258	O
,	O
and	O
signal	O
was	O
imaged	O
using	O
fluorescent	O
and	O
darkfield	O
microscopy	O
.	O

Human	S-LIVB
DNA	B-SO
extraction	I-SO
and	I-SO
sequence	E-SO
analysis	O
.	O

DNA	S-SO
was	O
isolated	O
from	O
paraffin	O
blocks	O
by	O
phenol	S-CHEBI
-	O
chloroform	S-CHEBI
extraction	O
[	O
54	O
,	O
55	O
]	O
,	O
and	O
from	O
frozen	O
tissues	O
by	O
standard	O
techniques	O
.	O

Primers	S-SO
were	O
designed	O
to	O
amplify	O
FOG2	S-PRGE
coding	B-SO
exons	E-SO
plus	O
50	O
bp	S-SO
of	O
flanking	B-SO
upstream	I-SO
and	I-SO
downstream	I-SO
sequence	E-SO
.	O

PCR	O
amplification	O
and	O
sequencing	O
were	O
performed	O
by	O
standard	O
methods	O
.	O

Primer	B-SO
sequences	E-SO
used	O
are	O
listed	O
in	O
Table	O
S2	O
.	O

Sequence	S-SO
analysis	O
was	O
done	O
with	O
Sequencher	O
4	O
.	O
1	O
(	O
Gene	S-SO
Codes	O
)	O
.	O

DNA	S-SO
from	O
the	O
parents	O
of	O
one	O
autopsy	O
patient	O
was	O
extracted	O
from	O
fresh	O
blood	O
samples	O
.	O

A	O
second	O
set	O
of	O
blood	O
samples	O
was	O
sent	O
to	O
an	O
outside	O
CLIA	O
-	O
certified	O
laboratory	O
for	O
DNA	S-SO
extraction	O
,	O
PCR	O
,	O
sequencing	O
,	O
and	O
analysis	O
.	O

Paternity	O
testing	O
was	O
performed	O
by	O
the	O
outside	O
laboratory	O
using	O
a	O
standard	O
panel	O
of	O
markers	O
.	O

SNP	S-SO
genotyping	O
was	O
done	O
using	O
Harvard	O
Partners	O
Center	O
for	O
Genetics	O
and	O
Genomics	O
genotyping	O
core	O
facility	O
(	O
Cambridge	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Supporting	O
Information	O

Table	O
S1	O

Primers	S-SO
for	O
RT	O
-	O
PCR	O
(	O
Mouse	S-LIVB
)	O
:	O
Amplification	O
of	O
Abnormal	O
Transcript	S-SO
in	O
Fog2	S-PRGE
Mutant	S-SO
(	O
lil	O
)	O
Mice	S-LIVB

(	O
26	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S2	O

Human	S-LIVB
Primers	S-SO
for	O
Amplification	O
of	O
FOG2	S-PRGE
Coding	B-SO
Sequence	E-SO
from	O
Genomic	B-SO
DNA	E-SO

(	O
46	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

This	O
manuscript	O
is	O
dedicated	O
to	O
Baby	O
Lucy	O
and	O
her	O
parents	O
for	O
the	O
contribution	O
that	O
they	O
have	O
made	O
to	O
helping	O
us	O
to	O
understand	O
developmental	O
diaphragmatic	O
and	O
lung	O
defects	O
.	O

This	O
work	O
was	O
funded	O
by	O
National	O
Institute	O
of	O
Child	O
Health	O
and	O
Human	S-LIVB
Development	O
(	O
NIHCD	O
)	O
grant	O
HD36404	O
(	O
DRB	O
)	O
and	O
the	O
Hearst	O
Foundation	O
(	O
KGA	O
)	O
.	O

KGA	O
also	O
received	O
salary	O
support	O
from	O
NICHD	O
grant	O
T32HD040129	O
-	O
02	O
.	O

We	O
would	O
like	O
to	O
thank	O
Stuart	O
Orkin	O
,	O
M	O
.	O

D	O
.	O
,	O
for	O
the	O
generous	O
gift	O
of	O
his	O
Fog2	S-PRGE
-	O
/	O
-	O
mice	S-LIVB
.	O

We	O
would	O
also	O
like	O
to	O
thank	O
Raju	O
Kucherlapati	O
,	O
Ph	O
.	O

D	O
.	O
,	O
and	O
Birgit	O
Funke	O
,	O
Ph	O
.	O

D	O
.	O
,	O
for	O
providing	O
control	O
DNA	S-SO
samples	O
.	O

Abbreviations	O

CDH	O
-	O
congenital	O
diaphragmatic	O
hernia	O

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

ENU	S-CHEBI
-	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	E-CHEBI

HGF	S-PRGE
-	O
Hepatocyte	B-PRGE
growth	I-PRGE
factor	E-PRGE
/	O
Scatter	B-PRGE
factor	E-PRGE

lil	O
-	O
little	O
lung	O

PPF	O
-	O
pleuroperitoneal	O
fold	O

Figures	O

Figure	O
1	O

Abnormal	O
Pulmonary	O
and	O
Diaphragmatic	O
Development	O
in	O
the	O
lil	O
Mouse	S-LIVB

(	O
A	O
)	O
The	O
mutant	S-SO
hypoplastic	O
lung	O
(	O
right	O
)	O
lacks	O
the	O
development	O
of	O
the	O
accessory	O
lobe	O
and	O
the	O
anterior	O
portion	O
of	O
the	O
right	O
middle	O
lobe	O
(	O
marked	O
with	O
arrows	O
on	O
the	O
control	O
sample	O
on	O
the	O
left	O
)	O
.	O

(	O
B	O
)	O
Whole	O
diaphragms	O
show	O
a	O
lack	O
of	O
normal	O
muscularization	O
in	O
the	O
posterolateral	O
regions	O
and	O
the	O
peripheral	O
regions	O
of	O
the	O
mutant	S-SO
diaphragm	O
(	O
control	O
on	O
left	O
and	O
lil	O
diaphragm	O
on	O
the	O
right	O
)	O
.	O

Figure	O
2	O

The	O
ENU	S-CHEBI
-	O
Induced	O
lil	O
Mutation	S-SO
in	O
Fog2	S-PRGE
is	O
a	O
Splice	B-SO
Site	E-SO
Mutation	S-SO

(	O
A	O
)	O
RT	O
-	O
PCR	O
revealed	O
a	O
lengthened	O
transcript	S-SO
in	O
mice	S-LIVB
with	O
the	O
lil	O
phenotype	O
:	O
the	O
first	O
band	O
is	O
a	O
lil	O
mouse	S-LIVB
,	O
and	O
the	O
second	O
band	O
is	O
a	O
control	O
mouse	S-LIVB
.	O

(	O
B	O
)	O
Sequencing	O
Fog2	S-PRGE
revealed	O
a	O
splice	B-SO
site	E-SO
mutation	S-SO
that	O
causes	O
the	O
insertion	S-SO
of	O
85	O
bp	S-SO
of	O
intronic	B-SO
sequence	E-SO
in	O
the	O
mutant	S-SO
mouse	S-LIVB
.	O

This	O
results	O
in	O
a	O
premature	O
stop	B-SO
codon	E-SO
prior	O
to	O
zinc	S-CHEBI
finger	O
transcription	O
.	O

Figure	O
3	O

Fog2	S-PRGE
Is	O
Expressed	O
in	O
the	O
Developing	O
Lung	O
and	O
Diaphragm	O

Fog2	S-PRGE
is	O
expressed	O
in	O
the	O
diffuse	O
pulmonary	O
mesenchyme	O
at	O
E13	O
.	O
5	O
(	O
A	O
)	O
(	O
arrow	O
shows	O
mesenchyme	O
)	O
and	O
is	O
restricted	O
to	O
the	O
bronchial	O
and	O
vascular	O
smooth	O
muscle	O
(	O
sm	O
)	O
at	O
E16	O
.	O
5	O
(	O
B	O
)	O
.	O

Fog2	S-PRGE
is	O
expressed	O
diffusely	O
in	O
the	O
developing	O
diaphragm	O
(	O
Dia	O
)	O
both	O
prior	O
to	O
(	O
E11	O
.	O
5	O
)	O
(	O
C	O
)	O
and	O
after	O
muscularization	O
(	O
E13	O
.	O
5	O
)	O
(	O
D	O
)	O
.	O

Figure	O
4	O

Fog2	S-PRGE
Is	O
Necessary	O
for	O
Primary	O
Lung	O
Development	O

Fog2	S-PRGE
null	O
lungs	O
removed	O
prior	O
to	O
diaphragmatic	O
muscularization	O
and	O
grown	O
in	O
vitro	O
show	O
no	O
accessory	O
lobe	O
development	O
.	O

Accessory	O
lobe	O
is	O
labeled	O
with	O
black	O
arrow	O
in	O
control	O
littermate	O
lungs	O
.	O

Figure	O
5	O

Fog2	S-PRGE
Expression	O
in	O
Embryonic	O
Non	O
-	O
Mutant	S-SO
Lungs	O

In	O
embryonic	O
non	O
-	O
mutant	S-SO
lungs	O
,	O
Fog2	S-PRGE
is	O
most	O
highly	O
expressed	O
at	O
the	O
tips	O
of	O
the	O
accessory	O
(	O
single	O
arrows	O
)	O
and	O
right	O
middle	O
lobes	O
(	O
double	O
arrows	O
)	O
at	O
E11	O
.	O
25	O
(	O
A	O
)	O
and	O
E11	O
.	O
75	O
(	O
B	O
)	O
,	O
while	O
expression	O
is	O
diffuse	O
by	O
E12	O
.	O
75	O
(	O
C	O
)	O
.	O

Figure	O
6	O

HGF	S-PRGE
Patterning	O
Is	O
Abnormal	O
in	O
Fog2	S-PRGE
Null	O
Mice	S-LIVB

In	O
situ	O
hybridization	O
of	O
HGF	S-PRGE
in	O
E12	O
.	O
5	O
wild	B-SO
-	I-SO
type	E-SO
(	O
A	O
)	O
and	O
Fog2	S-PRGE
-	O
/	O
-	O
(	O
B	O
)	O
embryos	O
demonstrates	O
decreased	O
expression	O
in	O
the	O
region	O
where	O
the	O
PPF	O
meets	O
the	O
membranous	O
diaphragm	O
.	O

Li	O
,	O
liver	O
;	O
Lu	O
,	O
lung	O
.	O

Figure	O
7	O

FOG2	S-PRGE
Mutation	S-SO
in	O
a	O
Patient	O
with	O
Diaphragm	O
and	O
Lung	O
Abnormalities	O

Sequencing	O
revealed	O
a	O
de	B-SO
novo	E-SO
heterozygote	O
nonsense	O
mutation	S-SO
in	O
a	O
patient	O
who	O
died	O
at	O
birth	O
with	O
severe	O
pulmonary	O
hypoplasia	O
and	O
a	O
posterior	O
deep	O
diaphragmatic	O
eventration	O
.	O

She	O
was	O
clinically	O
diagnosed	O
with	O
CDH	O
.	O

This	O
nonsense	O
mutation	S-SO
occurs	O
prior	O
to	O
the	O
functional	O
zinc	S-CHEBI
finger	O
domains	S-SO
.	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

KGA	O
,	O
JJG	O
,	O
and	O
DRB	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

KGA	O
,	O
BJH	O
,	O
HH	O
,	O
SGT	O
,	O
LK	O
,	O
CR	O
,	O
RPB	O
,	O
and	O
JAE	O
performed	O
the	O
experiments	O
.	O

KGA	O
,	O
BJH	O
,	O
HH	O
,	O
LK	O
,	O
CR	O
,	O
JAE	O
,	O
JJG	O
,	O
and	O
DRB	O
analyzed	O
the	O
data	O
.	O

KGA	O
,	O
SOV	O
,	O
SGT	O
,	O
BRP	O
,	O
JAE	O
,	O
JJG	O
,	O
and	O
DRB	O
contributed	O
reagents	S-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

KGA	O
and	O
DRB	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Ackerman	O
KG	O
,	O
Herron	O
BJ	O
,	O
Vargas	O
SO	O
,	O
Huang	O
H	O
,	O
Tevosian	O
SG	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
Fog2	S-PRGE
is	O
required	O
for	O
normal	O
diaphragm	O
and	O
lung	O
development	O
in	O
mice	S-LIVB
and	O
humans	S-LIVB
.	O

PLoS	O
Genet	O
1	O
(	O
1	O
)	O
:	O
e10	O
.	O

A	O
Hybrid	O
Photoreceptor	S-CL
Expressing	O
Both	O
Rod	S-CL
and	O
Cone	S-CL
Genes	S-SO
in	O
a	O
Mouse	S-LIVB
Model	O
of	O
Enhanced	O
S	O
-	O
Cone	S-CL
Syndrome	O

Abstract	O

Rod	B-CL
and	I-CL
cone	I-CL
photoreceptors	E-CL
subserve	O
vision	O
under	O
dim	O
and	O
bright	O
light	O
conditions	O
,	O
respectively	O
.	O

The	O
differences	O
in	O
their	O
function	O
are	O
thought	O
to	O
stem	O
from	O
their	O
different	O
gene	S-SO
expression	O
patterns	O
,	O
morphologies	O
,	O
and	O
synaptic	S-GO
connectivities	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
examined	O
the	O
photoreceptor	B-CL
cells	E-CL
of	O
the	O
retinal	O
degeneration	O
7	O
(	O
rd7	O
)	O
mutant	S-SO
mouse	S-LIVB
,	O
a	O
model	O
for	O
the	O
human	S-LIVB
enhanced	O
S	O
-	O
cone	S-CL
syndrome	O
(	O
ESCS	O
)	O
.	O

This	O
mutant	S-SO
carries	O
a	O
spontaneous	O
deletion	S-SO
in	O
the	O
mouse	S-LIVB
ortholog	S-SO
of	O
NR2E3	S-PRGE
,	O
an	O
orphan	O
nuclear	S-GO
receptor	O
transcription	O
factor	O
mutated	S-SO
in	O
ESCS	O
.	O

Employing	O
microarray	O
and	O
in	O
situ	O
hybridization	O
analysis	O
we	O
have	O
found	O
that	O
the	O
rd7	O
retina	O
contains	O
a	O
modestly	O
increased	O
number	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
that	O
ultrastructurally	O
appear	O
to	O
be	O
normal	O
cones	S-CL
.	O

Strikingly	O
,	O
the	O
majority	O
of	O
the	O
photoreceptors	B-CL
in	I-CL
the	I-CL
rd7	I-CL
retina	E-CL
represent	O
a	O
morphologically	O
hybrid	O
cell	S-CL
type	O
that	O
expresses	O
both	O
rod	S-CL
-	O
and	O
cone	S-CL
-	O
specific	O
genes	S-SO
.	O

In	O
addition	O
,	O
in	O
situ	O
hybridization	O
screening	O
of	O
genes	S-SO
shown	O
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
by	O
microarray	O
identified	O
ten	O
new	O
cone	S-CL
-	O
specific	O
or	O
cone	S-CL
-	O
enriched	O
genes	S-SO
with	O
a	O
wide	O
range	O
of	O
biochemical	O
functions	O
,	O
including	O
two	O
genes	S-SO
specifically	O
involved	O
in	O
glucose	S-CHEBI
/	O
glycogen	S-CHEBI
metabolism	O
.	O

We	O
suggest	O
that	O
the	O
abnormal	O
electroretinograms	O
,	O
slow	O
retinal	O
degeneration	O
,	O
and	O
retinal	O
dysmorphology	O
seen	O
in	O
humans	S-LIVB
with	O
ESCS	O
may	O
,	O
in	O
part	O
,	O
be	O
attributable	O
to	O
the	O
aberrant	O
function	O
of	O
a	O
hybrid	O
photoreceptor	B-CL
cell	E-CL
type	O
similar	O
to	O
that	O
identified	O
in	O
this	O
study	O
.	O

The	O
functional	O
diversity	O
of	O
the	O
novel	O
cone	S-CL
-	O
specific	O
genes	S-SO
identified	O
here	O
indicates	O
molecular	S-CHEBI
differences	O
between	O
rods	S-CL
and	O
cones	S-CL
extending	O
far	O
beyond	O
those	O
previously	O
discovered	O
.	O

Synopsis	O

Vision	O
begins	O
with	O
light	O
entering	O
the	O
eye	O
.	O

This	O
light	O
is	O
projected	O
onto	O
the	O
retina	O
,	O
a	O
thin	O
neural	O
structure	O
lining	O
the	O
inside	O
of	O
the	O
eye	O
.	O

Photoreceptors	S-CL
,	O
among	O
the	O
most	O
important	O
cell	S-CL
types	O
in	O
the	O
retina	O
,	O
are	O
the	O
first	O
to	O
receive	O
the	O
incoming	O
rays	O
of	O
light	O
.	O

In	O
mammals	S-LIVB
,	O
there	O
are	O
two	O
types	O
of	O
photoreceptors	S-CL
:	O
rods	S-CL
and	O
cones	S-CL
.	O

Rods	S-CL
are	O
specialized	O
for	O
nighttime	O
vision	O
,	O
and	O
cones	S-CL
for	O
daytime	O
and	O
color	O
vision	O
.	O

In	O
this	O
study	O
,	O
the	O
authors	O
examined	O
the	O
photoreceptors	S-CL
of	O
a	O
mouse	S-LIVB
with	O
a	O
gene	S-SO
mutation	S-SO
that	O
causes	O
photoreceptors	S-CL
to	O
develop	O
abnormally	O
.	O

Humans	S-LIVB
with	O
a	O
similar	O
mutation	S-SO
have	O
a	O
form	O
of	O
blindness	O
called	O
enhanced	O
S	O
-	O
cone	S-CL
syndrome	O
(	O
ESCS	O
)	O
.	O

Surprisingly	O
,	O
the	O
majority	O
of	O
photoreceptors	S-CL
in	O
this	O
mutant	S-SO
mouse	S-LIVB
were	O
found	O
to	O
have	O
features	O
of	O
both	O
normal	O
rods	S-CL
and	O
cones	S-CL
.	O

It	O
is	O
possible	O
that	O
the	O
abnormal	O
features	O
of	O
these	O
photoreceptors	S-CL
predispose	O
them	O
to	O
undergo	O
premature	O
death	O
.	O

If	O
this	O
model	O
accurately	O
reflects	O
the	O
situation	O
in	O
human	S-LIVB
patients	O
with	O
ESCS	O
,	O
it	O
may	O
provide	O
an	O
explanation	O
for	O
the	O
loss	O
of	O
vision	O
seen	O
in	O
this	O
disease	O
.	O

This	O
study	O
also	O
elucidated	O
previously	O
unknown	O
molecular	S-CHEBI
differences	O
between	O
normal	O
rods	S-CL
and	O
cones	S-CL
.	O

This	O
new	O
knowledge	O
may	O
contribute	O
to	O
a	O
better	O
overall	O
understanding	O
of	O
the	O
mechanisms	O
underlying	O
night	O
,	O
day	O
,	O
and	O
color	O
vision	O
.	O

Introduction	O

Enhanced	O
S	O
-	O
cone	S-CL
syndrome	O
(	O
ESCS	O
)	O
is	O
an	O
unusual	O
disease	O
of	O
photoreceptors	S-CL
that	O
includes	O
night	O
blindness	O
(	O
suggestive	O
of	O
rod	S-CL
dysfunction	O
)	O
,	O
an	O
abnormal	O
electroretinogram	O
(	O
ERG	O
)	O
with	O
a	O
waveform	O
that	O
is	O
nearly	O
identical	O
under	O
both	O
light	O
and	O
dark	O
adaptation	O
,	O
and	O
an	O
increased	O
sensitivity	O
of	O
the	O
ERG	O
to	O
short	O
-	O
wavelength	O
light	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
disease	O
is	O
caused	O
by	O
mutations	S-SO
in	O
the	O
orphan	O
nuclear	S-GO
receptor	O
transcription	O
factor	O
NR2E3	S-PRGE
(	O
also	O
known	O
as	O
photoreceptor	B-PRGE
nuclear	I-PRGE
receptor	E-PRGE
)	O
,	O
which	O
is	O
expressed	O
exclusively	O
in	O
rods	S-CL
[	O
3	O
,	O
4	O
]	O
.	O

Recent	O
human	S-LIVB
genetic	S-SO
studies	O
have	O
also	O
demonstrated	O
mutations	S-SO
in	O
this	O
gene	S-SO
in	O
Goldmann	O
-	O
Favre	O
syndrome	O
and	O
many	O
cases	O
of	O
clumped	O
pigmentary	O
retinal	O
degeneration	O
[	O
5	O
]	O
.	O

The	O
initial	O
reports	O
of	O
patients	O
with	O
ESCS	O
attributed	O
the	O
unusual	O
ERG	O
to	O
an	O
abnormally	O
functioning	O
rod	B-CL
photoreceptor	E-CL
system	O
with	O
persistent	O
activity	O
under	O
light	O
adaptation	O
[	O
6	O
-	O
8	O
]	O
.	O

Subsequent	O
studies	O
,	O
however	O
,	O
concluded	O
that	O
the	O
ERG	O
was	O
due	O
to	O
supernumerary	O
short	O
-	O
wavelength	O
(	O
"	O
blue	O
"	O
)	O
cone	B-CL
photoreceptors	E-CL
(	O
S	O
-	O
cones	S-CL
)	O
in	O
these	O
patients	O
[	O
1	O
,	O
2	O
,	O
9	O
-	O
11	O
]	O
.	O

Histopathologic	O
analysis	O
of	O
a	O
retina	O
from	O
a	O
human	S-LIVB
patient	O
with	O
ESCS	O
and	O
extensive	O
retinal	O
degeneration	O
demonstrated	O
an	O
absence	O
of	O
rhodopsin	S-PRGE
-	O
positive	O
cells	S-CL
and	O
an	O
increase	O
in	O
the	O
number	O
of	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
.	O

Nevertheless	O
,	O
the	O
overall	O
density	O
of	O
cones	S-CL
was	O
only	O
modestly	O
increased	O
in	O
this	O
patient	O
(	O
approximately	O
2	O
-	O
fold	O
)	O
,	O
suggesting	O
that	O
there	O
might	O
be	O
additional	O
factors	O
that	O
contribute	O
to	O
the	O
very	O
large	O
,	O
light	O
-	O
adapted	O
ERG	O
seen	O
in	O
this	O
disease	O
.	O

In	O
addition	O
to	O
the	O
ERG	O
findings	O
,	O
patients	O
with	O
ESCS	O
have	O
dysmorphic	O
retinas	O
with	O
rosette	O
formation	O
in	O
the	O
outer	O
nuclear	O
layer	O
(	O
ONL	O
)	O
where	O
photoreceptor	B-CL
cell	E-CL
bodies	O
reside	O
,	O
and	O
a	O
slow	O
retinal	O
degeneration	O
that	O
can	O
ultimately	O
lead	O
to	O
complete	O
blindness	O
[	O
12	O
-	O
14	O
]	O
.	O

Mutations	S-SO
in	O
the	O
mouse	S-LIVB
ortholog	S-SO
of	O
NR2E3	S-PRGE
have	O
been	O
identified	O
in	O
the	O
spontaneous	O
mutant	S-SO
retinal	O
degeneration	O
7	O
(	O
rd7	O
)	O
[	O
15	O
]	O
.	O

This	O
mutant	S-SO
demonstrates	O
slow	O
retinal	O
degeneration	O
and	O
abnormal	O
lamination	O
of	O
the	O
ONL	O
with	O
rosette	O
formation	O
[	O
15	O
,	O
16	O
]	O
.	O

Curiously	O
,	O
the	O
ERG	O
of	O
the	O
mouse	S-LIVB
under	O
both	O
light	O
and	O
dark	O
adaptation	O
has	O
been	O
reported	O
to	O
be	O
normal	O
,	O
showing	O
progressive	O
attenuation	O
with	O
time	O
,	O
presumably	O
due	O
to	O
degenerative	O
cell	S-CL
loss	O
[	O
15	O
]	O
.	O

A	O
prior	O
study	O
showed	O
a	O
2	O
-	O
to	O
3	O
-	O
fold	O
increase	O
in	O
the	O
number	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
in	O
the	O
rd7	O
retina	O
compared	O
to	O
wild	B-SO
type	E-SO
[	O
17	O
]	O
.	O

In	O
addition	O
,	O
two	O
groups	O
recently	O
reported	O
derepression	O
of	O
additional	O
cone	S-CL
genes	S-SO
in	O
the	O
rd7	O
mutant	S-SO
[	O
18	O
,	O
19	O
]	O
.	O

In	O
order	O
to	O
better	O
understand	O
the	O
mechanistic	O
basis	O
of	O
ESCS	O
,	O
we	O
undertook	O
a	O
molecular	S-CHEBI
and	O
ultrastructural	O
analysis	O
of	O
the	O
photoreceptors	S-CL
of	O
the	O
rd7	O
mutant	S-SO
mouse	S-LIVB
.	O

Microarray	O
and	O
in	O
situ	O
hybridization	O
analyses	O
revealed	O
a	O
modest	O
increase	O
in	O
the	O
number	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
and	O
widespread	O
derepression	O
of	O
many	O
cone	S-CL
-	O
specific	O
genes	S-SO
within	O
rod	B-CL
photoreceptor	I-CL
cells	E-CL
.	O

Ultrastructural	O
studies	O
demonstrated	O
that	O
the	O
cells	S-CL
that	O
coexpress	O
rod	S-CL
and	O
cone	S-CL
genes	S-SO
in	O
the	O
rd7	O
retina	O
represent	O
a	O
morphologically	O
hybrid	O
cell	S-CL
type	O
,	O
intermediate	O
between	O
normal	O
rods	S-CL
and	O
cones	S-CL
.	O

Results	O

Widespread	O
Up	O
-	O
Regulation	O
of	O
Cone	S-CL
Genes	S-SO
in	O
the	O
rd7	O
Mutant	S-SO
Retina	O

In	O
an	O
initial	O
analysis	O
of	O
the	O
rd7	O
mutant	S-SO
,	O
homozygous	O
mutant	S-SO
retinas	O
were	O
compared	O
with	O
wild	B-SO
-	I-SO
type	E-SO
controls	O
at	O
multiple	O
postnatal	O
time	O
points	O
using	O
both	O
cDNA	S-SO
and	O
Affymetrix	O
microarrays	O
.	O

The	O
cDNA	S-SO
microarray	O
used	O
in	O
this	O
study	O
contains	O
approximately	O
12	O
,	O
000	O
different	O
cDNAs	S-SO
largely	O
derived	O
from	O
the	O
retina	O
and	O
nervous	O
system	O
,	O
and	O
the	O
Affymetrix	O
microarray	O
contains	O
over	O
34	O
,	O
000	O
genes	S-SO
.	O

Experiments	O
at	O
all	O
timepoints	O
were	O
carried	O
out	O
in	O
triplicate	O
,	O
and	O
stringent	O
criteria	O
were	O
applied	O
in	O
deciding	O
whether	O
a	O
given	O
gene	S-SO
was	O
up	O
-	O
or	O
down	O
-	O
regulated	O
in	O
the	O
mutant	S-SO
(	O
see	O
Materials	O
and	O
Methods	O
for	O
details	O
)	O
.	O

These	O
experiments	O
demonstrated	O
widespread	O
up	O
-	O
regulation	O
of	O
cone	S-CL
-	O
specific	O
and	O
cone	S-CL
-	O
enriched	O
genes	S-SO
in	O
the	O
rd7	O
retina	O
,	O
especially	O
by	O
postnatal	O
day	O
14	O
(	O
P14	O
)	O
and	O
P21	O
(	O
Figure	O
1	O
)	O
.	O

Most	O
known	S-SO
cone	S-CL
-	O
specific	O
or	O
cone	S-CL
-	O
enriched	O
genes	S-SO
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
mutant	S-SO
(	O
Figure	O
1	O
,	O
genes	S-SO
G1	O
-	O
G15	O
)	O
.	O

The	O
majority	O
of	O
these	O
genes	S-SO
represent	O
components	O
of	O
the	O
phototransduction	O
cascade	O
(	O
e	O
.	O
g	O
.	O
,	O
opsins	S-PRGE
,	O
transducins	O
,	O
and	O
phosphodiesterase	S-GO
subunits	O
)	O
.	O

In	O
addition	O
to	O
these	O
genes	S-SO
,	O
several	O
novel	O
cone	S-CL
-	O
specific	O
genes	S-SO
of	O
unknown	O
function	O
recently	O
identified	O
in	O
our	O
lab	O
were	O
also	O
up	O
-	O
regulated	O
(	O
Figure	O
1	O
,	O
genes	S-SO
G16	O
,	O
G17	O
,	O
G21	O
,	O
and	O
G24	O
;	O
unpublished	O
data	O
)	O
.	O

Finally	O
,	O
a	O
wide	O
range	O
of	O
other	O
genes	S-SO
,	O
most	O
with	O
no	O
previously	O
recognized	O
role	O
in	O
the	O
retina	O
,	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	S-SO
(	O
Figure	O
1	O
,	O
G26	O
-	O
G53	O
;	O
Tables	O
S1	O
and	O
S2	O
;	O
Figures	O
S1	O
-	O
S7	O
)	O
.	O

Nr2e3	S-PRGE
expression	O
is	O
first	O
detectable	O
by	O
in	O
situ	O
hybridization	O
around	O
embryonic	O
day	O
18	O
(	O
E18	O
)	O
;	O
it	O
then	O
peaks	O
around	O
P6	O
and	O
subsequently	O
decreases	O
to	O
adult	O
levels	O
by	O
P21	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
accordance	O
with	O
this	O
time	O
course	O
of	O
expression	O
,	O
almost	O
no	O
gene	S-SO
expression	O
changes	O
were	O
found	O
at	O
P0	O
,	O
with	O
progressively	O
more	O
changes	O
at	O
later	O
timepoints	O
(	O
Figure	O
1	O
)	O
.	O

One	O
exception	O
to	O
this	O
statement	O
is	O
the	O
gene	S-SO
RIKEN	B-PRGE
cDNA	I-PRGE
4933409K07	E-PRGE
(	O
Figure	O
1	O
,	O
gene	S-SO
G47	O
)	O
,	O
which	O
was	O
the	O
only	O
gene	S-SO
shown	O
to	O
be	O
up	O
-	O
regulated	O
at	O
all	O
timepoints	O
examined	O
.	O

Additional	O
discussion	O
of	O
this	O
gene	S-SO
and	O
its	O
unusual	O
expression	O
pattern	O
will	O
be	O
presented	O
below	O
.	O

Two	O
Distinct	O
Patterns	O
of	O
Cone	S-CL
Gene	S-SO
Derepression	O
in	O
rd7	O

In	O
order	O
to	O
confirm	O
these	O
microarray	O
results	O
,	O
an	O
in	O
situ	O
hybridization	O
analysis	O
of	O
the	O
putative	O
up	O
-	O
regulated	O
cone	S-CL
genes	S-SO
was	O
carried	O
out	O
in	O
which	O
the	O
rd7	O
mutant	S-SO
retina	O
was	O
compared	O
with	O
age	O
-	O
matched	O
,	O
wild	B-SO
-	I-SO
type	E-SO
controls	O
.	O

We	O
found	O
that	O
the	O
majority	O
of	O
the	O
cone	S-CL
-	O
specific	O
genes	S-SO
that	O
were	O
up	O
-	O
regulated	O
in	O
microarray	O
experiments	O
were	O
derepressed	O
when	O
assessed	O
by	O
in	O
situ	O
hybridization	O
(	O
Figure	O
2	O
)	O
.	O

There	O
were	O
two	O
major	O
patterns	O
of	O
cone	S-CL
gene	S-SO
derepression	O
.	O

The	O
more	O
common	O
pattern	O
(	O
type	O
I	O
)	O
manifested	O
itself	O
as	O
ectopic	O
gene	S-SO
expression	O
throughout	O
the	O
ONL	O
,	O
consistent	O
with	O
gene	S-SO
expression	O
in	O
all	O
photoreceptors	S-CL
(	O
Figure	O
2	O
;	O
upper	O
left	O
photomicrographs	O
)	O
.	O

Typical	O
examples	O
of	O
this	O
pattern	O
of	O
derepression	O
are	O
shown	O
in	O
Figure	O
2	O
,	O
and	O
many	O
more	O
are	O
available	O
in	O
Table	O
S1	O
.	O

This	O
pattern	O
of	O
expression	O
contrasts	O
sharply	O
with	O
the	O
usual	O
pattern	O
of	O
cone	S-CL
gene	S-SO
expression	O
,	O
which	O
consists	O
of	O
scattered	O
cells	S-CL
localized	O
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
(	O
Figure	O
2	O
)	O
.	O

The	O
second	O
category	O
of	O
cone	S-CL
gene	S-SO
derepression	O
(	O
type	O
II	O
)	O
consisted	O
of	O
a	O
patchy	O
,	O
salt	O
-	O
and	O
-	O
pepper	O
pattern	O
of	O
ectopic	O
expression	O
in	O
which	O
individual	O
positive	O
cells	S-CL
were	O
scattered	O
throughout	O
the	O
ONL	O
(	O
Figure	O
2	O
,	O
upper	O
right	O
photomicrographs	O
;	O
Table	O
S1	O
)	O
.	O

Although	O
numerous	O
positive	O
cells	S-CL
were	O
present	O
in	O
the	O
rd7	O
retina	O
(	O
particularly	O
in	O
the	O
ventral	O
portion	O
)	O
,	O
there	O
were	O
clearly	O
many	O
interspersed	O
cells	S-CL
that	O
showed	O
a	O
complete	O
absence	O
of	O
expression	O
.	O

In	O
order	O
to	O
rule	O
out	O
the	O
possibility	O
that	O
these	O
scattered	O
positive	O
cells	S-CL
were	O
simply	O
the	O
normal	O
complement	O
of	O
cones	S-CL
that	O
had	O
failed	O
to	O
localize	O
their	O
cell	B-GO
bodies	E-GO
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
,	O
the	O
number	O
of	O
positive	O
cells	S-CL
in	O
the	O
rd7	O
retina	O
was	O
quantitated	O
by	O
dissociated	O
cell	S-CL
in	O
situ	O
hybridization	O
.	O

Dissociated	O
cell	S-CL
in	O
situ	O
hybridization	O
was	O
performed	O
using	O
a	O
probe	S-SO
for	O
the	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
gene	S-SO
(	O
Opn1sw	S-PRGE
)	O
,	O
which	O
shows	O
type	O
II	O
derepression	O
(	O
Figures	O
2	O
and	O
3A	O
-	O
3C	O
)	O
.	O

S	B-PRGE
-	I-PRGE
opsin	E-PRGE
was	O
expressed	O
in	O
3	O
.	O
2	O
%	O
of	O
retinal	O
cells	S-CL
in	O
the	O
rd7	O
mutant	S-SO
(	O
66	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
out	O
of	O
2	O
,	O
056	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	S-CHEBI
[	O
DAPI	O
]	O
-	O
positive	O
cells	S-CL
)	O
.	O

This	O
value	O
is	O
approximately	O
2	O
-	O
fold	O
greater	O
than	O
the	O
percentage	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
identified	O
in	O
wild	B-SO
-	I-SO
type	E-SO
control	O
retinas	O
,	O
1	O
.	O
65	O
%	O
(	O
54	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
out	O
of	O
3	O
,	O
271	O
DAPI	O
-	O
positive	O
cells	S-CL
)	O
,	O
and	O
accords	O
well	O
with	O
the	O
previously	O
reported	O
value	O
of	O
2	O
-	O
to	O
3	O
-	O
fold	O
more	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
in	O
rd7	O
compared	O
to	O
wild	B-SO
type	E-SO
arrived	O
at	O
by	O
antibody	S-GO
staining	O
of	O
tissue	O
sections	O
[	O
17	O
]	O
.	O

Previous	O
studies	O
have	O
estimated	O
that	O
the	O
total	O
number	O
of	O
cones	S-CL
in	O
the	O
mouse	S-LIVB
retina	O
is	O
2	O
%	O
of	O
all	O
retinal	O
cells	S-CL
[	O
20	O
]	O
,	O
and	O
that	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
is	O
largely	O
repressed	O
in	O
cones	S-CL
in	O
the	O
dorsal	O
third	O
of	O
the	O
retina	O
[	O
21	O
]	O
.	O

The	O
estimate	O
of	O
1	O
.	O
65	O
%	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
is	O
in	O
agreement	O
with	O
these	O
data	O
.	O

The	O
fact	O
that	O
only	O
3	O
.	O
2	O
%	O
of	O
all	O
retinal	O
cells	S-CL
are	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
in	O
the	O
rd7	O
mutant	S-SO
also	O
confirms	O
that	O
the	O
majority	O
of	O
the	O
photoreceptors	S-CL
(	O
which	O
make	O
up	O
just	O
over	O
70	O
%	O
of	O
the	O
cells	S-CL
in	O
the	O
adult	O
mouse	S-LIVB
retina	O
)	O
do	O
not	O
express	O
this	O
gene	S-SO
.	O

In	O
order	O
to	O
assess	O
whether	O
these	O
supernumerary	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
coexpressed	O
rod	S-CL
-	O
specific	O
markers	O
,	O
a	O
double	O
antibody	S-GO
staining	O
for	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
and	O
rhodopsin	S-PRGE
was	O
performed	O
.	O

This	O
study	O
showed	O
mutually	O
exclusive	O
domains	O
of	O
expression	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
and	O
rhodopsin	S-PRGE
in	O
the	O
photoreceptor	B-GO
outer	I-GO
segments	E-GO
(	O
Figure	O
3D	O
-	O
3F	O
)	O
.	O

This	O
finding	O
suggests	O
that	O
the	O
supernumerary	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
in	O
the	O
rd7	O
retina	O
may	O
represent	O
normal	O
"	O
blue	O
"	O
cones	S-CL
.	O

Novel	O
Cone	S-CL
-	O
Specific	O
Genes	S-SO
Are	O
Derepressed	O
in	O
rd7	O

Given	O
that	O
the	O
majority	O
of	O
known	S-SO
cone	S-CL
-	O
specific	O
genes	S-SO
showed	O
marked	O
derepression	O
in	O
the	O
rd7	O
mutant	S-SO
,	O
additional	O
candidate	O
genes	S-SO
up	O
-	O
regulated	O
on	O
microarray	O
analysis	O
were	O
evaluated	O
for	O
cone	S-CL
-	O
specific	O
expression	O
.	O

In	O
situ	O
hybridization	O
was	O
performed	O
on	O
an	O
additional	O
45	O
up	O
-	O
regulated	O
genes	S-SO
,	O
confirming	O
that	O
21	O
of	O
them	O
were	O
derepressed	O
.	O

Of	O
these	O
,	O
at	O
least	O
ten	O
showed	O
a	O
definite	O
cone	S-CL
-	O
specific	O
or	O
cone	S-CL
-	O
enriched	O
pattern	O
of	O
expression	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
(	O
Figure	O
1	O
,	O
genes	S-SO
G26	O
-	O
G35	O
)	O
.	O

Several	O
examples	O
are	O
given	O
in	O
Figure	O
4	O
.	O

Note	O
that	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
,	O
there	O
is	O
a	O
relatively	O
weak	O
pattern	O
of	O
scattered	O
positive	O
cells	S-CL
at	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
,	O
consistent	O
with	O
a	O
cone	S-CL
-	O
specific	O
pattern	O
of	O
expression	O
.	O

All	O
of	O
these	O
genes	S-SO
show	O
marked	O
derepression	O
in	O
the	O
rd7	O
retina	O
.	O

A	O
number	O
of	O
these	O
novel	O
cone	S-CL
-	O
specific	O
genes	S-SO
showed	O
a	O
striking	O
localization	O
of	O
their	O
transcripts	S-SO
to	O
the	O
photoreceptor	B-GO
inner	I-GO
segment	E-GO
(	O
e	O
.	O
g	O
.	O
,	O
Bub1b	S-PRGE
and	O
Tcta	S-PRGE
)	O
.	O

This	O
localization	O
manifests	O
in	O
a	O
section	O
in	O
situ	O
hybridization	O
as	O
a	O
dark	O
band	O
of	O
staining	O
just	O
beyond	O
the	O
outer	O
edge	O
of	O
the	O
ONL	O
immediately	O
underlying	O
the	O
outer	B-GO
segment	E-GO
layer	O
.	O

Although	O
such	O
a	O
pattern	O
of	O
transcript	S-SO
localization	O
is	O
commonly	O
seen	O
in	O
many	O
rod	S-CL
-	O
specific	O
genes	S-SO
(	O
e	O
.	O
g	O
.	O
,	O
Rho	S-PRGE
in	O
Figure	O
2	O
;	O
Pcdh21	S-PRGE
,	O
Rbp3	S-PRGE
,	O
and	O
Cnga1	S-PRGE
in	O
Table	O
S2	O
)	O
,	O
it	O
is	O
not	O
easily	O
appreciated	O
in	O
cone	S-CL
-	O
specific	O
genes	S-SO
,	O
possibly	O
due	O
to	O
the	O
relative	O
scarcity	O
of	O
cones	S-CL
in	O
the	O
mouse	S-LIVB
.	O

In	O
the	O
rd7	O
mutant	S-SO
retina	O
in	O
which	O
such	O
genes	S-SO
are	O
widely	O
derepressed	O
,	O
such	O
a	O
pattern	O
of	O
transcript	S-SO
localization	O
often	O
becomes	O
apparent	O
.	O

In	O
addition	O
to	O
the	O
ten	O
genes	S-SO
that	O
showed	O
cone	S-CL
-	O
specific	O
expression	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
,	O
another	O
11	O
novel	O
genes	S-SO
were	O
derepressed	O
in	O
the	O
rd7	O
retina	O
by	O
in	O
situ	O
hybridization	O
(	O
Figure	O
1	O
,	O
genes	S-SO
G36	O
-	O
G46	O
)	O
.	O

Some	O
of	O
these	O
genes	S-SO
showed	O
faint	O
expression	O
in	O
a	O
cone	S-CL
-	O
like	O
distribution	O
(	O
see	O
Table	O
S1	O
,	O
genes	S-SO
G36	O
,	O
G40	O
,	O
and	O
G44	O
)	O
,	O
and	O
one	O
appeared	O
to	O
be	O
expressed	O
throughout	O
the	O
ONL	O
but	O
at	O
greater	O
levels	O
in	O
cones	S-CL
than	O
in	O
rods	S-CL
(	O
Table	O
S1	O
,	O
gene	S-SO
G37	O
)	O
.	O

The	O
remainder	O
of	O
the	O
up	O
-	O
regulated	O
genes	S-SO
did	O
not	O
have	O
detectable	O
cone	S-CL
staining	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
.	O

Despite	O
this	O
apparent	O
absence	O
of	O
cone	S-CL
staining	O
,	O
the	O
pattern	O
of	O
derepression	O
in	O
rd7	O
suggests	O
that	O
these	O
genes	S-SO
may	O
also	O
be	O
novel	O
cone	S-CL
-	O
specific	O
genes	S-SO
,	O
albeit	O
expressed	O
at	O
levels	O
below	O
the	O
sensitivity	O
threshold	O
of	O
our	O
in	O
situ	O
hybridization	O
assay	O
.	O

In	O
most	O
cases	O
,	O
the	O
novel	O
cone	S-CL
genes	S-SO
identified	O
in	O
this	O
study	O
appear	O
to	O
have	O
a	O
type	O
I	O
pattern	O
of	O
derepression	O
.	O

However	O
,	O
due	O
to	O
the	O
weakness	O
of	O
the	O
signal	O
in	O
some	O
cases	O
,	O
or	O
transcript	S-SO
localization	O
to	O
the	O
inner	B-GO
segment	E-GO
in	O
others	O
,	O
it	O
was	O
not	O
always	O
possible	O
to	O
determine	O
with	O
confidence	O
which	O
of	O
the	O
two	O
patterns	O
of	O
derepression	O
(	O
if	O
either	O
)	O
each	O
of	O
these	O
genes	S-SO
displayed	O
.	O

In	O
terms	O
of	O
functional	O
categorization	O
,	O
the	O
novel	O
cone	S-CL
genes	S-SO
cover	O
a	O
broad	O
range	O
including	O
glucose	S-CHEBI
metabolism	O
(	O
Pygm	S-PRGE
and	O
Glo1	S-PRGE
)	O
,	O
fatty	B-CHEBI
acid	E-CHEBI
metabolism	O
(	O
Elovl2	S-PRGE
)	O
,	O
DNA	S-SO
repair	O
(	O
Smug1	S-PRGE
)	O
,	O
cell	S-CL
cycle	O
/	O
chromosome	S-GO
segregation	O
(	O
Bub1b	S-PRGE
)	O
,	O
carcinogenesis	O
(	O
Tcta	S-PRGE
)	O
,	O
endothelial	O
biology	O
(	O
Ece1	S-PRGE
)	O
,	O
cytoskeletal	S-GO
function	O
(	O
Ebp4	O
.	O
1l1	O
)	O
,	O
and	O
even	O
otolith	O
formation	O
(	O
Otop3	S-PRGE
)	O
.	O

A	O
relatively	O
frequent	O
finding	O
among	O
both	O
previously	O
identified	O
cone	S-CL
-	O
specific	O
genes	S-SO
,	O
as	O
well	O
as	O
in	O
some	O
of	O
those	O
identified	O
in	O
the	O
present	O
study	O
,	O
is	O
the	O
occurrence	O
of	O
gene	S-SO
expression	O
in	O
an	O
early	O
photoreceptor	S-CL
precursor	O
pattern	O
(	O
Figure	O
5	O
)	O
.	O

This	O
pattern	O
of	O
expression	O
consists	O
of	O
positive	O
staining	O
by	O
in	O
situ	O
hybridization	O
specifically	O
at	O
the	O
scleral	O
border	O
of	O
the	O
retina	O
during	O
prenatal	O
timepoints	O
(	O
in	O
the	O
range	O
of	O
E13	O
-	O
E18	O
)	O
.	O

Gnb3	S-PRGE
and	O
Thrb2	S-PRGE
are	O
two	O
examples	O
of	O
known	S-SO
cone	S-CL
genes	S-SO
with	O
this	O
early	O
pattern	O
of	O
expression	O
(	O
Figure	O
5	O
)	O
.	O

Two	O
of	O
the	O
11	O
novel	O
cone	S-CL
genes	S-SO
identified	O
in	O
this	O
study	O
also	O
have	O
this	O
early	O
photoreceptor	S-CL
pattern	O
of	O
expression	O
(	O
Ece1	S-PRGE
and	O
Otop3	S-PRGE
)	O
.	O

Intriguingly	O
,	O
three	O
genes	S-SO
shown	O
to	O
be	O
up	O
-	O
regulated	O
in	O
rd7	O
on	O
microarray	O
,	O
but	O
that	O
had	O
either	O
no	O
detectable	O
signal	O
by	O
in	O
situ	O
hybridization	O
at	O
adult	O
stages	O
or	O
no	O
apparent	O
change	O
in	O
expression	O
by	O
in	O
situ	O
hybridization	O
between	O
wild	B-SO
type	E-SO
and	O
rd7	O
,	O
also	O
showed	O
this	O
early	O
photoreceptor	S-CL
pattern	O
(	O
Figure	O
1	O
,	O
genes	S-SO
G48	O
-	O
G50	O
)	O
.	O

The	O
embryonic	O
expression	O
pattern	O
of	O
two	O
of	O
these	O
genes	S-SO
is	O
shown	O
in	O
Figure	O
5	O
(	O
the	O
embryonic	O
in	O
situ	O
hybridization	O
for	O
the	O
third	O
,	O
G50	O
,	O
can	O
be	O
found	O
in	O
Table	O
S1	O
)	O
.	O

Although	O
the	O
significance	O
of	O
such	O
early	O
photoreceptor	S-CL
expression	O
is	O
not	O
known	O
,	O
it	O
is	O
possible	O
that	O
these	O
genes	S-SO
may	O
also	O
be	O
cone	S-CL
-	O
specific	O
but	O
are	O
expressed	O
at	O
undetectably	O
low	O
levels	O
in	O
the	O
adult	O
.	O

M	B-PRGE
-	I-PRGE
Opsin	E-PRGE
and	O
Thyroid	B-PRGE
Hormone	I-PRGE
Receptor	I-PRGE
beta	I-PRGE
2	E-PRGE
Are	O
Unchanged	O
in	O
the	O
rd7	O
Mutant	S-SO

Only	O
two	O
cone	S-CL
-	O
specific	O
genes	S-SO
failed	O
to	O
show	O
any	O
change	O
in	O
expression	O
by	O
either	O
microarray	O
or	O
in	O
situ	O
hybridization	O
in	O
the	O
rd7	O
mutant	S-SO
:	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
(	O
Opn1mw	S-PRGE
)	O
and	O
thyroid	B-PRGE
hormone	I-PRGE
receptor	I-PRGE
beta	I-PRGE
2	E-PRGE
(	O
Thrb2	S-PRGE
)	O
(	O
Figure	O
S8	O
)	O
.	O

This	O
result	O
is	O
particularly	O
notable	O
because	O
Thrb2	S-PRGE
is	O
absolutely	O
required	O
for	O
the	O
expression	O
of	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
[	O
22	O
]	O
.	O

Furthermore	O
,	O
the	O
repression	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
expression	O
in	O
the	O
dorsal	O
third	O
of	O
the	O
mouse	S-LIVB
retina	O
is	O
thought	O
to	O
depend	O
,	O
at	O
least	O
in	O
part	O
,	O
on	O
Thrb2	S-PRGE
since	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
shows	O
dorsal	O
derepression	O
in	O
the	O
Thrb2	S-PRGE
mutant	S-SO
[	O
22	O
]	O
.	O

Despite	O
the	O
derepression	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
seen	O
in	O
the	O
ventral	O
portion	O
of	O
the	O
rd7	O
retina	O
,	O
the	O
normal	O
dorsal	O
repression	O
of	O
this	O
gene	S-SO
is	O
still	O
present	O
in	O
this	O
mutant	S-SO
(	O
unpublished	O
data	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
normal	O
expression	O
pattern	O
and	O
function	O
of	O
Thrb2	S-PRGE
in	O
the	O
rd7	O
mutant	S-SO
.	O

One	O
further	O
finding	O
to	O
note	O
is	O
that	O
the	O
cell	B-GO
bodies	E-GO
of	O
the	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
appear	O
to	O
be	O
scattered	O
throughout	O
the	O
ONL	O
in	O
the	O
rd7	O
mutant	S-SO
at	O
P14	O
(	O
Figure	O
S8	O
)	O
.	O

Despite	O
this	O
fact	O
,	O
their	O
overall	O
number	O
does	O
not	O
appear	O
to	O
be	O
increased	O
relative	O
to	O
wild	B-SO
-	I-SO
type	E-SO
.	O

In	O
addition	O
,	O
by	O
P28	O
,	O
the	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cell	B-GO
bodies	E-GO
in	O
rd7	O
appear	O
to	O
have	O
relocated	O
to	O
their	O
normal	O
position	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
(	O
Figure	O
S8	O
)	O
.	O

It	O
is	O
known	O
that	O
until	O
P11	O
,	O
the	O
cell	B-GO
bodies	E-GO
of	O
cone	B-CL
photoreceptors	E-CL
in	O
the	O
mouse	S-LIVB
are	O
normally	O
dispersed	O
throughout	O
the	O
ONL	O
,	O
only	O
to	O
relocate	O
subsequently	O
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
around	O
P12	O
[	O
23	O
]	O
.	O

It	O
is	O
possible	O
that	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
,	O
there	O
is	O
a	O
short	O
delay	O
in	O
the	O
relocation	O
of	O
the	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cone	O
cell	B-GO
bodies	E-GO
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
.	O

Rod	S-CL
Genes	S-SO
Are	O
Only	O
Modestly	O
and	O
Temporarily	O
Affected	O
in	O
rd7	O

In	O
sharp	O
contrast	O
to	O
changes	O
in	O
cone	S-CL
gene	S-SO
expression	O
,	O
rod	S-CL
-	O
specific	O
genes	S-SO
were	O
much	O
less	O
severely	O
affected	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

Microarray	O
and	O
in	O
situ	O
hybridization	O
analysis	O
of	O
numerous	O
rod	S-CL
genes	S-SO
failed	O
to	O
reveal	O
marked	O
changes	O
in	O
expression	O
levels	O
at	O
P14	O
and	O
P21	O
(	O
see	O
Figure	O
2	O
,	O
lower	O
left	O
photomicrographs	O
;	O
Table	O
S2	O
)	O
.	O

In	O
addition	O
to	O
the	O
three	O
rod	S-CL
genes	S-SO
depicted	O
in	O
Figure	O
2	O
,	O
in	O
situ	O
hybridization	O
analysis	O
on	O
an	O
additional	O
19	O
rod	S-CL
-	O
specific	O
and	O
pan	O
-	O
photoreceptor	S-CL
genes	S-SO
demonstrated	O
only	O
a	O
very	O
mild	O
diminution	O
of	O
expression	O
in	O
two	O
of	O
these	O
genes	S-SO
,	O
gucy2e	S-PRGE
and	O
Rgs9	S-PRGE
,	O
at	O
P14	O
,	O
and	O
an	O
increase	O
in	O
expression	O
in	O
two	O
,	O
Nr2e3	S-PRGE
,	O
and	O
Cnga1	S-PRGE
(	O
Table	O
S2	O
)	O
.	O

Despite	O
the	O
minimal	O
changes	O
in	O
rod	S-CL
gene	S-SO
expression	O
at	O
later	O
postnatal	O
timepoints	O
,	O
there	O
was	O
evidence	O
of	O
a	O
significant	O
delay	O
in	O
the	O
onset	O
of	O
rhodopsin	S-PRGE
(	O
Rho	S-PRGE
)	O
expression	O
in	O
rd7	O
mutants	S-SO
relative	O
to	O
wild	B-SO
-	I-SO
type	E-SO
.	O

Microarray	O
analysis	O
at	O
P6	O
demonstrated	O
five	O
cDNA	S-SO
spots	O
that	O
were	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
experiments	O
.	O

Of	O
these	O
spots	O
,	O
three	O
corresponded	O
to	O
rhodopsin	S-PRGE
(	O
Table	O
S3	O
)	O
.	O

In	O
situ	O
hybridization	O
analysis	O
of	O
several	O
rod	S-CL
-	O
specific	O
genes	S-SO
at	O
P6	O
revealed	O
that	O
rhodopsin	S-PRGE
alone	O
showed	O
a	O
markedly	O
lower	O
level	O
of	O
expression	O
compared	O
to	O
wild	B-SO
type	E-SO
(	O
Figure	O
6	O
;	O
unpublished	O
data	O
)	O
.	O

Despite	O
this	O
modest	O
delay	O
in	O
the	O
onset	O
of	O
rhodopsin	S-PRGE
expression	O
,	O
by	O
P14	O
the	O
gene	S-SO
had	O
attained	O
nearly	O
normal	O
levels	O
in	O
the	O
rd7	O
mutant	S-SO
(	O
see	O
Figure	O
2	O
,	O
lower	O
left	O
photomicrographs	O
)	O
.	O

This	O
latter	O
finding	O
suggests	O
that	O
all	O
the	O
rod	S-CL
-	O
and	O
many	O
cone	S-CL
-	O
specific	O
genes	S-SO
are	O
coexpressed	O
in	O
the	O
majority	O
of	O
photoreceptors	S-CL
in	O
the	O
rd7	O
mutant	S-SO
.	O

Changes	O
in	O
Retinal	O
Transcription	O
Factor	O
and	O
M	O
u	O
ller	O
Glial	O
Gene	S-SO
Expression	O
in	O
rd7	O

Analysis	O
of	O
several	O
photoreceptor	S-CL
transcription	O
factors	O
in	O
the	O
rd7	O
mutant	S-SO
indicated	O
that	O
the	O
levels	O
of	O
Crx	S-PRGE
and	O
Nrl	S-PRGE
are	O
unaffected	O
in	O
the	O
mutant	S-SO
at	O
P14	O
(	O
see	O
Figure	O
2	O
,	O
lower	O
right	O
photomicrographs	O
)	O
.	O

Nrl	S-PRGE
is	O
a	O
rod	S-CL
-	O
specific	O
,	O
basic	S-CHEBI
leucine	S-CHEBI
zipper	O
transcription	O
factor	O
required	O
for	O
the	O
activation	O
of	O
many	O
rod	S-CL
-	O
specific	O
genes	S-SO
and	O
the	O
repression	O
of	O
most	O
cone	S-CL
-	O
specific	O
genes	S-SO
in	O
rods	S-CL
[	O
24	O
]	O
.	O

Nrl	S-PRGE
is	O
known	O
to	O
be	O
genetically	S-SO
upstream	O
of	O
Nr2e3	S-PRGE
and	O
is	O
required	O
for	O
its	O
expression	O
[	O
24	O
]	O
.	O

Crx	S-PRGE
is	O
a	O
homeobox	O
transcription	O
factor	O
expressed	O
in	O
both	O
rods	S-CL
and	O
cones	S-CL
and	O
is	O
required	O
for	O
the	O
expression	O
of	O
a	O
variety	O
of	O
rod	S-CL
-	O
and	O
cone	S-CL
-	O
specific	O
genes	S-SO
[	O
25	O
]	O
.	O

In	O
contrast	O
to	O
what	O
is	O
seen	O
in	O
the	O
Nrl	S-PRGE
mutant	S-SO
,	O
Nr2e3	S-PRGE
expression	O
is	O
unchanged	O
in	O
Crx	S-PRGE
mutant	S-SO
homozygotes	O
(	O
unpublished	O
data	O
)	O
.	O

Strikingly	O
,	O
Nr2e3	S-PRGE
itself	O
was	O
markedly	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	S-SO
both	O
by	O
microarray	O
and	O
in	O
situ	O
hybridization	O
(	O
see	O
Figure	O
2	O
,	O
lower	O
right	O
photomicrographs	O
;	O
Table	O
S2	O
)	O
.	O

The	O
rd7	O
mutant	S-SO
carries	O
a	O
deletion	S-SO
in	O
Nr2e3	S-PRGE
that	O
removes	S-SO
portions	S-SO
of	O
both	O
the	O
DNA	S-SO
-	O
binding	O
and	O
ligand	O
-	O
binding	O
domains	S-SO
[	O
15	O
]	O
.	O

Although	O
this	O
deletion	S-SO
most	O
likely	O
creates	O
a	O
null	O
allele	S-SO
,	O
a	O
residual	O
transcript	S-SO
is	O
clearly	O
present	O
and	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

This	O
finding	O
suggests	O
that	O
Nr2e3	S-PRGE
is	O
required	O
for	O
repression	O
of	O
its	O
own	O
transcription	O
.	O

One	O
gene	S-SO
,	O
RIKEN	B-PRGE
cDNA	I-PRGE
4933409K07	E-PRGE
(	O
Figure	O
1	O
,	O
gene	S-SO
G47	O
)	O
,	O
was	O
found	O
to	O
be	O
up	O
-	O
regulated	O
on	O
microarray	O
at	O
all	O
four	O
timepoints	O
examined	O
.	O

This	O
gene	S-SO
showed	O
a	O
unique	O
pattern	O
of	O
expression	O
in	O
the	O
adult	O
rd7	O
mutant	S-SO
retina	O
.	O

Whereas	O
there	O
was	O
only	O
a	O
barely	O
detectable	O
hint	O
of	O
expression	O
in	O
the	O
inner	O
nuclear	O
layer	O
(	O
INL	O
)	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
,	O
this	O
gene	S-SO
showed	O
strong	O
expression	O
in	O
the	O
middle	O
and	O
vitreal	O
thirds	O
of	O
the	O
INL	O
as	O
well	O
as	O
patchy	O
expression	O
in	O
the	O
ganglion	O
cell	S-CL
layer	O
(	O
GCL	O
)	O
and	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
in	O
rd7	O
(	O
see	O
Table	O
S1	O
)	O
.	O

This	O
in	O
situ	O
hybridization	O
pattern	O
is	O
consistent	O
with	O
staining	O
in	O
M	B-CL
u	I-CL
ller	I-CL
glia	E-CL
,	O
the	O
principal	O
glial	B-CL
cell	E-CL
type	O
of	O
the	O
mouse	S-LIVB
retina	O
.	O

One	O
possible	O
interpretation	O
of	O
this	O
unusual	O
expression	O
pattern	O
is	O
that	O
it	O
represents	O
an	O
early	O
reaction	O
of	O
M	O
u	O
ller	O
glia	O
to	O
injury	O
in	O
this	O
mutant	S-SO
.	O

The	O
Majority	O
of	O
the	O
Photoreceptors	S-CL
in	O
the	O
rd7	O
Retina	O
Represent	O
a	O
Morphologically	O
Hybrid	O
Cell	S-CL
Type	O

In	O
order	O
to	O
assess	O
the	O
morphologic	O
effects	O
of	O
the	O
above	O
gene	S-SO
expression	O
changes	O
,	O
the	O
ultrastructure	O
of	O
the	O
photoreceptor	B-CL
cell	E-CL
bodies	O
in	O
the	O
rd7	O
mutant	S-SO
was	O
examined	O
.	O

The	O
cell	B-GO
bodies	E-GO
were	O
chosen	O
for	O
evaluation	O
rather	O
than	O
the	O
outer	B-GO
segments	E-GO
,	O
since	O
in	O
the	O
mouse	S-LIVB
,	O
the	O
ultrastructural	O
differences	O
between	O
rod	S-CL
and	O
cone	S-CL
somata	O
are	O
much	O
greater	O
than	O
are	O
the	O
differences	O
between	O
the	O
outer	B-GO
segments	E-GO
[	O
26	O
]	O
.	O

In	O
the	O
wild	B-SO
-	I-SO
type	E-SO
mouse	S-LIVB
,	O
cone	O
cell	B-GO
bodies	E-GO
are	O
aligned	O
along	O
the	O
scleral	O
border	O
of	O
the	O
ONL	O
,	O
and	O
they	O
are	O
larger	O
than	O
those	O
of	O
rods	S-CL
.	O

They	O
have	O
a	O
smaller	O
,	O
more	O
irregular	O
mass	O
of	O
nuclear	B-GO
heterochromatin	E-GO
that	O
is	O
often	O
broken	O
up	O
into	O
multiple	O
discrete	O
clumps	O
connected	O
by	O
thin	O
threads	O
.	O

They	O
also	O
have	O
more	O
abundant	O
electron	S-CHEBI
-	O
lucent	O
euchromatin	S-GO
than	O
rods	S-CL
.	O

Lastly	O
,	O
they	O
frequently	O
have	O
a	O
patch	O
of	O
organelle	S-GO
-	O
rich	O
cytoplasm	S-GO
next	O
to	O
their	O
nuclei	S-GO
,	O
usually	O
containing	O
large	O
mitochondria	S-GO
[	O
26	O
]	O
.	O

Analysis	O
of	O
toluidine	O
blue	O
-	O
stained	O
semi	O
-	O
thin	O
sections	O
revealed	O
that	O
such	O
cone	S-CL
-	O
like	O
cells	S-CL
were	O
present	O
in	O
greater	O
abundance	O
in	O
the	O
rd7	O
retina	O
than	O
in	O
wild	B-SO
-	I-SO
type	E-SO
,	O
and	O
that	O
their	O
somata	S-GO
were	O
scattered	O
throughout	O
the	O
ONL	O
(	O
Figure	O
7	O
)	O
.	O

A	O
comparison	O
between	O
the	O
distribution	O
of	O
these	O
cells	S-CL
and	O
those	O
expressing	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
strongly	O
suggests	O
that	O
they	O
represent	O
the	O
same	O
cell	S-CL
population	O
(	O
compare	O
Figure	O
7D	O
and	O
7F	O
)	O
.	O

Analysis	O
of	O
the	O
nuclear	S-GO
morphology	O
of	O
dissociated	O
retinal	O
cells	S-CL
stained	O
for	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
by	O
dissociated	O
cell	S-CL
in	O
situ	O
hybridization	O
confirmed	O
that	O
this	O
is	O
the	O
case	O
(	O
unpublished	O
data	O
)	O
.	O

These	O
findings	O
,	O
along	O
with	O
the	O
absence	O
of	O
rhodopsin	S-PRGE
staining	O
in	O
these	O
cells	S-CL
(	O
see	O
Figure	O
3D	O
-	O
3F	O
)	O
,	O
suggest	O
that	O
these	O
"	O
cone	S-CL
-	O
like	O
"	O
cells	S-CL
in	O
the	O
rd7	O
mutant	S-SO
retina	O
may	O
represent	O
supernumerary	O
normal	O
cones	S-CL
with	O
an	O
abnormal	O
localization	O
of	O
their	O
cell	B-GO
bodies	E-GO
.	O

In	O
contrast	O
to	O
the	O
cone	O
cell	B-GO
body	E-GO
,	O
the	O
wild	B-SO
-	I-SO
type	E-SO
rod	S-CL
soma	S-GO
is	O
small	O
and	O
nearly	O
round	O
.	O

It	O
has	O
a	O
single	O
,	O
large	O
clump	O
of	O
dense	O
heterochromatin	S-GO
,	O
a	O
thin	O
rim	O
of	O
moderately	O
electron	S-CHEBI
-	O
dense	O
euchromatin	S-GO
,	O
and	O
very	O
scant	O
juxtanuclear	B-GO
cytoplasm	E-GO
without	O
organelles	S-GO
[	O
26	O
,	O
27	O
]	O
.	O

The	O
second	O
cell	S-CL
population	O
in	O
the	O
ONL	O
of	O
the	O
rd7	O
retina	O
has	O
some	O
of	O
the	O
nuclear	S-GO
features	O
of	O
normal	O
rods	S-CL
,	O
such	O
as	O
a	O
single	O
,	O
dense	O
mass	O
of	O
heterochromatin	S-GO
and	O
moderately	O
electron	S-CHEBI
-	O
dense	O
euchromatin	S-GO
(	O
Figure	O
7H	O
)	O
;	O
yet	O
these	O
cells	S-CL
also	O
show	O
features	O
of	O
cones	S-CL
.	O

First	O
,	O
the	O
euchromatin	S-GO
is	O
,	O
on	O
average	O
,	O
more	O
abundant	O
in	O
these	O
cells	S-CL
than	O
in	O
wild	B-SO
-	I-SO
type	E-SO
rods	S-CL
(	O
compare	O
Figure	O
7G	O
and	O
7H	O
)	O
.	O

In	O
addition	O
,	O
comparison	O
of	O
the	O
diagrammatic	O
representation	O
of	O
the	O
wild	B-SO
-	I-SO
type	E-SO
and	O
rd7	O
ONLs	O
suggests	O
that	O
the	O
average	O
area	O
of	O
the	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
negative	O
cells	S-CL
in	O
rd7	O
is	O
greater	O
than	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
(	O
Figure	O
7C	O
and	O
7D	O
)	O
.	O

In	O
order	O
to	O
confirm	O
this	O
impression	O
,	O
we	O
quantitated	O
the	O
area	O
of	O
50	O
wild	B-SO
-	I-SO
type	E-SO
and	O
50	O
mutant	S-SO
rod	S-CL
-	O
like	O
cell	B-GO
bodies	E-GO
(	O
see	O
Materials	O
and	O
Methods	O
for	O
details	O
)	O
.	O

This	O
experiment	O
confirmed	O
that	O
the	O
average	O
area	O
of	O
the	O
rod	S-CL
-	O
like	O
somata	S-GO
in	O
rd7	O
is	O
approximately	O
30	O
%	O
larger	O
than	O
that	O
of	O
wild	B-SO
-	I-SO
type	E-SO
rod	S-CL
somata	S-GO
(	O
mean	O
area	O
in	O
rd7	O
was	O
9	O
.	O
75	O
+/-	O
1	O
.	O
36	O
(	O
standard	O
deviation	O
)	O
mu	O
m2	O
,	O
compared	O
to	O
wild	B-SO
-	I-SO
type	E-SO
rods	S-CL
,	O
with	O
7	O
.	O
53	O
+/-	O
0	O
.	O
72	O
mu	O
m2	O
;	O
n	O
=	O
50	O
;	O
p	O
=	O
7	O
.	O
6	O
x	O
10	O
-	O
16	O
,	O
Student	O
'	O
s	O
t	O
-	O
test	O
)	O
.	O

It	O
is	O
also	O
notable	O
that	O
the	O
standard	O
deviation	O
of	O
the	O
somal	S-GO
area	O
is	O
nearly	O
twice	O
as	O
great	O
in	O
rd7	O
than	O
in	O
wild	B-SO
-	I-SO
type	E-SO
,	O
confirming	O
the	O
subjective	O
impression	O
of	O
greater	O
variability	O
in	O
somal	O
size	O
and	O
shape	O
in	O
the	O
mutant	S-SO
compared	O
to	O
the	O
wild	B-SO
-	I-SO
type	E-SO
(	O
compare	O
Figure	O
7C	O
and	O
7D	O
)	O
.	O

Lastly	O
,	O
38	O
%	O
(	O
19	O
/	O
50	O
)	O
of	O
the	O
rd7	O
photoreceptors	S-CL
selected	O
for	O
somal	S-GO
area	O
quantitation	O
had	O
prominent	O
juxtanuclear	S-GO
mitochondria	S-GO
(	O
red	O
arrow	O
in	O
Figure	O
7H	O
;	O
unpublished	O
data	O
)	O
.	O

Such	O
juxtanuclear	S-GO
organelles	S-GO
are	O
only	O
very	O
rarely	O
seen	O
in	O
normal	O
rods	S-CL
(	O
1	O
.	O
5	O
%	O
;	O
six	O
out	O
of	O
399	O
cells	S-CL
counted	O
)	O
,	O
but	O
are	O
common	O
in	O
cones	S-CL
(	O
yellow	O
arrow	O
in	O
Figure	O
7H	O
)	O
.	O

In	O
conclusion	O
,	O
it	O
is	O
clear	O
that	O
this	O
second	O
cell	S-CL
population	O
in	O
the	O
rd7	O
retina	O
has	O
morphological	O
features	O
of	O
both	O
normal	O
rods	S-CL
and	O
cones	S-CL
consistent	O
with	O
the	O
coexpression	O
of	O
many	O
rod	S-CL
-	O
and	O
cone	S-CL
-	O
specific	O
genes	S-SO
in	O
these	O
cells	S-CL
.	O

Discussion	O

In	O
this	O
paper	O
we	O
have	O
determined	O
that	O
the	O
primary	O
role	O
of	O
the	O
rod	S-CL
-	O
specific	O
transcription	O
factor	O
,	O
Nr2e3	S-PRGE
,	O
is	O
to	O
maintain	O
cone	S-CL
genes	S-SO
transcriptionally	O
silent	O
within	O
rods	S-CL
.	O

We	O
have	O
identified	O
two	O
patterns	O
of	O
cone	S-CL
gene	S-SO
derepression	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
,	O
in	O
agreement	O
with	O
a	O
previous	O
report	O
by	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
.	O

The	O
first	O
pattern	O
of	O
derepression	O
identified	O
(	O
type	O
I	O
)	O
consists	O
of	O
ectopic	O
expression	O
of	O
cone	S-CL
genes	S-SO
in	O
the	O
vast	O
majority	O
of	O
cells	S-CL
in	O
the	O
ONL	O
.	O

These	O
cells	S-CL
were	O
also	O
shown	O
to	O
coexpress	O
all	O
rod	S-CL
genes	S-SO
tested	O
.	O

Consistent	O
with	O
the	O
hybrid	O
pattern	O
of	O
gene	S-SO
expression	O
in	O
these	O
cells	S-CL
,	O
electron	S-CHEBI
microscopic	O
analysis	O
revealed	O
them	O
to	O
be	O
morphologically	O
intermediate	O
between	O
normal	O
rods	S-CL
and	O
cones	S-CL
.	O

Although	O
genes	S-SO
showing	O
type	O
I	O
derepression	O
demonstrated	O
staining	O
in	O
the	O
majority	O
of	O
cells	S-CL
in	O
the	O
ONL	O
,	O
two	O
lines	O
of	O
evidence	O
suggest	O
that	O
these	O
genes	S-SO
are	O
not	O
completely	O
derepressed	O
in	O
these	O
cells	S-CL
when	O
compared	O
to	O
their	O
expression	O
in	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cones	S-CL
.	O

First	O
,	O
close	O
evaluation	O
of	O
the	O
staining	O
pattern	O
of	O
a	O
number	O
of	O
type	O
I	O
genes	S-SO
in	O
the	O
rd7	O
mutant	S-SO
retina	O
(	O
e	O
.	O
g	O
.	O
,	O
see	O
Table	O
S1	O
,	O
genes	S-SO
G9	O
,	O
G19	O
,	O
and	O
G24	O
)	O
,	O
reveals	O
that	O
,	O
in	O
addition	O
to	O
the	O
background	O
staining	O
throughout	O
the	O
ONL	O
,	O
there	O
is	O
a	O
more	O
darkly	O
staining	O
subpopulation	O
of	O
cells	S-CL
scattered	O
throughout	O
this	O
layer	O
in	O
a	O
distribution	O
corresponding	O
to	O
that	O
of	O
the	O
supernumerary	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
.	O

This	O
pattern	O
of	O
staining	O
suggests	O
that	O
these	O
genes	S-SO
are	O
more	O
highly	O
expressed	O
in	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
expressing	O
cells	S-CL
than	O
in	O
the	O
hybrid	O
cells	S-CL
of	O
the	O
rd7	O
retina	O
.	O

The	O
second	O
line	O
of	O
evidence	O
derives	O
from	O
a	O
comparison	O
of	O
the	O
expression	O
pattern	O
of	O
many	O
type	O
I	O
genes	S-SO
in	O
rd7	O
and	O
Nrl	S-PRGE
-	O
/	O
-	O
mutant	S-SO
backgrounds	O
.	O

As	O
mentioned	O
above	O
,	O
Nrl	S-PRGE
is	O
a	O
retinal	O
transcription	O
factor	O
that	O
,	O
when	O
mutated	S-SO
,	O
results	O
in	O
en	O
masse	O
conversion	O
of	O
rods	S-CL
into	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cones	S-CL
[	O
24	O
]	O
.	O

It	O
can	O
be	O
inferred	O
from	O
this	O
fact	O
that	O
Nrl	S-PRGE
is	O
absolutely	O
required	O
for	O
the	O
normal	O
silencing	O
of	O
cone	S-CL
-	O
specific	O
genes	S-SO
in	O
rods	S-CL
.	O

In	O
the	O
Nrl	S-PRGE
homozygous	O
mutant	S-SO
,	O
there	O
is	O
a	O
stronger	O
and	O
more	O
uniform	O
derepression	O
of	O
many	O
cone	S-CL
-	O
specific	O
genes	S-SO
throughout	O
the	O
ONL	O
than	O
is	O
seen	O
in	O
the	O
rd7	O
retina	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
finding	O
further	O
suggests	O
that	O
,	O
in	O
addition	O
to	O
its	O
repression	O
of	O
cone	S-CL
gene	S-SO
expression	O
via	O
induction	O
of	O
Nr2e3	S-PRGE
expression	O
,	O
Nrl	S-PRGE
exerts	O
an	O
additional	O
level	O
of	O
negative	O
control	O
over	O
cone	S-CL
genes	S-SO
either	O
directly	O
or	O
via	O
a	O
second	O
,	O
as	O
yet	O
uncharacterized	O
,	O
repressor	O
.	O

The	O
second	O
pattern	O
of	O
derepression	O
seen	O
in	O
the	O
rd7	O
retina	O
(	O
type	O
II	O
)	O
,	O
is	O
represented	O
by	O
a	O
scattered	O
population	O
of	O
cells	S-CL
throughout	O
the	O
ONL	O
that	O
shows	O
derepression	O
of	O
several	O
cone	S-CL
-	O
specific	O
genes	S-SO
,	O
including	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
.	O

By	O
ultrastructural	O
criteria	O
,	O
these	O
cells	S-CL
appear	O
to	O
be	O
normal	O
cones	S-CL
,	O
albeit	O
with	O
displaced	O
cell	B-GO
bodies	E-GO
.	O

Quantitation	O
of	O
these	O
supernumerary	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
indicates	O
that	O
they	O
are	O
approximately	O
2	O
-	O
fold	O
more	O
abundant	O
than	O
in	O
normal	O
retina	O
,	O
consistent	O
with	O
previous	O
antibody	S-GO
studies	O
[	O
17	O
]	O
.	O

Two	O
recent	O
studies	O
have	O
presented	O
data	O
that	O
are	O
consistent	O
with	O
many	O
of	O
the	O
findings	O
in	O
our	O
study	O
[	O
18	O
,	O
19	O
]	O
.	O

Both	O
studies	O
showed	O
that	O
cone	S-CL
genes	S-SO
in	O
addition	O
to	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
are	O
derepressed	O
in	O
the	O
mouse	S-LIVB
rd7	O
mutant	S-SO
.	O

In	O
addition	O
,	O
Peng	O
et	O
al	O
.	O

[	O
19	O
]	O
found	O
by	O
RT	O
-	O
PCR	O
that	O
the	O
levels	O
of	O
several	O
rod	S-CL
-	O
specific	O
genes	S-SO
,	O
including	O
rhodopsin	S-PRGE
,	O
were	O
modestly	O
reduced	O
in	O
rd7	O
at	O
P28	O
.	O

Our	O
in	O
situ	O
hybridization	O
data	O
suggest	O
that	O
rhodopsin	S-PRGE
expression	O
is	O
markedly	O
reduced	O
at	O
P6	O
,	O
but	O
that	O
it	O
attains	O
levels	O
indistinguishable	O
from	O
wild	B-SO
-	I-SO
type	E-SO
by	O
P14	O
.	O

Since	O
the	O
change	O
in	O
rhodopsin	S-PRGE
levels	O
identified	O
by	O
Peng	O
et	O
al	O
.	O
were	O
relatively	O
small	O
(	O
an	O
approximately	O
15	O
%	O
reduction	O
)	O
,	O
it	O
is	O
not	O
surprising	O
that	O
such	O
a	O
difference	O
was	O
not	O
detected	O
by	O
in	O
situ	O
hybridization	O
.	O

The	O
overall	O
finding	O
of	O
modest	O
reductions	O
in	O
rod	S-CL
-	O
specific	O
gene	S-SO
expression	O
is	O
entirely	O
in	O
keeping	O
with	O
the	O
results	O
of	O
the	O
present	O
study	O
.	O

In	O
addition	O
to	O
demonstrating	O
derepression	O
of	O
a	O
range	O
of	O
known	S-SO
cone	S-CL
-	O
specific	O
genes	S-SO
in	O
rd7	O
mutants	S-SO
,	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
showed	O
up	O
-	O
regulation	O
by	O
Northern	O
blot	O
of	O
two	O
additional	O
genes	S-SO
in	O
the	O
rd7	O
mutant	S-SO
,	O
Elovl2	S-PRGE
and	O
Fabp7	S-PRGE
.	O

These	O
two	O
genes	S-SO
were	O
also	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
rd7	O
in	O
the	O
present	O
study	O
(	O
see	O
Figure	O
1	O
;	O
Table	O
S1	O
)	O
.	O

Although	O
we	O
found	O
Elovl2	S-PRGE
to	O
have	O
a	O
cone	S-CL
-	O
enriched	O
pattern	O
of	O
expression	O
(	O
see	O
Figure	O
1	O
)	O
,	O
in	O
situ	O
hybridization	O
analysis	O
of	O
Fabp7	S-PRGE
failed	O
to	O
show	O
a	O
signal	O
in	O
wild	B-SO
-	I-SO
type	E-SO
or	O
mutant	S-SO
retina	O
(	O
unpublished	O
data	O
)	O
.	O

Nevertheless	O
,	O
previous	O
studies	O
have	O
suggested	O
that	O
Fabp7	S-PRGE
is	O
expressed	O
in	O
radial	B-CL
glia	E-CL
and	O
immature	O
astrocytes	S-CL
in	O
the	O
brain	O
[	O
28	O
-	O
30	O
]	O
.	O

Given	O
the	O
expression	O
pattern	O
elsewhere	O
in	O
the	O
nervous	O
system	O
,	O
it	O
is	O
possible	O
that	O
Fabp7	S-PRGE
is	O
up	O
-	O
regulated	O
in	O
M	B-CL
u	I-CL
ller	I-CL
glia	E-CL
in	O
the	O
rd7	O
retina	O
in	O
response	O
to	O
injury	O
in	O
a	O
manner	O
akin	O
to	O
the	O
novel	O
M	B-CL
u	I-CL
ller	I-CL
glial	E-CL
gene	S-SO
identified	O
in	O
this	O
study	O
,	O
RIKEN	B-PRGE
cDNA	I-PRGE
4933409K07	E-PRGE
(	O
Figure	O
1	O
,	O
gene	S-SO
G47	O
)	O
.	O

Indirect	O
support	O
for	O
this	O
idea	O
is	O
provided	O
by	O
the	O
observation	O
that	O
Fabp7	S-PRGE
is	O
up	O
-	O
regulated	O
by	O
microarray	O
analysis	O
in	O
Nrl	S-PRGE
and	O
Crx	S-PRGE
mutant	S-SO
retinas	O
as	O
well	O
(	O
unpublished	O
data	O
)	O
,	O
suggesting	O
that	O
this	O
change	O
may	O
represent	O
a	O
generalized	O
response	O
to	O
injury	O
in	O
the	O
retina	O
rather	O
than	O
derepression	O
of	O
a	O
cone	S-CL
-	O
enriched	O
gene	S-SO
.	O

The	O
study	O
by	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
made	O
two	O
further	O
observations	O
worthy	O
of	O
note	O
.	O

First	O
,	O
they	O
identified	O
a	O
zebrafish	S-LIVB
homolog	S-SO
of	O
Nr2e3	S-PRGE
and	O
showed	O
it	O
to	O
be	O
expressed	O
in	O
photoreceptors	S-CL
.	O

Interestingly	O
,	O
they	O
showed	O
that	O
this	O
homolog	S-SO
appears	O
to	O
have	O
a	O
pan	O
-	O
photoreceptor	S-CL
pattern	O
of	O
expression	O
early	O
in	O
development	O
that	O
later	O
resolves	O
into	O
a	O
rod	S-CL
-	O
specific	O
pattern	O
of	O
expression	O
.	O

This	O
early	O
expression	O
in	O
cones	S-CL
may	O
represent	O
a	O
mechanism	O
whereby	O
the	O
expression	O
of	O
cone	S-CL
-	O
specific	O
gene	S-SO
products	O
is	O
temporarily	O
repressed	O
.	O

It	O
will	O
be	O
important	O
to	O
determine	O
the	O
extent	O
to	O
which	O
the	O
function	O
of	O
Nr2e3	S-PRGE
has	O
been	O
conserved	O
in	O
the	O
retina	O
of	O
such	O
a	O
distantly	O
related	O
organism	S-LIVB
.	O

Secondly	O
,	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
used	O
an	O
in	O
vitro	O
oligonucleotide	S-SO
selection	O
protocol	O
to	O
determine	O
the	O
preferred	O
binding	B-SO
site	E-SO
for	O
Nr2e3	S-PRGE
.	O

This	O
information	O
will	O
be	O
very	O
useful	O
for	O
future	O
bioinformatic	O
analyses	O
of	O
Nr2e3	S-PRGE
target	O
genes	S-SO
.	O

The	O
gene	S-SO
expression	O
changes	O
identified	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
in	O
the	O
present	O
study	O
suggest	O
the	O
scheme	O
of	O
gene	S-SO
regulation	O
in	O
mouse	S-LIVB
rods	S-CL
depicted	O
in	O
Figure	O
8	O
.	O

As	O
this	O
diagram	O
implies	O
,	O
there	O
appear	O
to	O
be	O
at	O
least	O
two	O
different	O
repressors	O
of	O
cone	S-CL
genes	S-SO
within	O
rods	S-CL
,	O
Nr2e3	S-PRGE
and	O
either	O
Nrl	S-PRGE
itself	O
or	O
an	O
additional	O
unknown	O
transcription	O
factor	O
downstream	O
of	O
Nrl	S-PRGE
,	O
here	O
termed	O
"	O
transcription	O
factor	O
X	O
.	O
"	O
In	O
fact	O
,	O
it	O
appears	O
that	O
the	O
differences	O
between	O
type	O
I	O
and	O
type	O
II	O
cone	S-CL
genes	S-SO
may	O
simply	O
depend	O
on	O
which	O
repressor	O
--	O
Nr2e3	S-PRGE
or	O
transcription	O
factor	O
X	O
--	O
is	O
primarily	O
responsible	O
for	O
the	O
regulation	O
of	O
the	O
gene	S-SO
in	O
question	O
.	O

In	O
the	O
case	O
of	O
type	O
I	O
genes	S-SO
,	O
Nr2e3	S-PRGE
is	O
the	O
primary	O
repressor	O
and	O
transcription	O
factor	O
X	O
is	O
of	O
secondary	O
importance	O
.	O

In	O
the	O
case	O
of	O
type	O
II	O
genes	S-SO
,	O
transcription	O
factor	O
X	O
exerts	O
the	O
major	O
repressive	O
effect	O
on	O
transcription	O
,	O
and	O
Nr2e3	S-PRGE
plays	O
a	O
lesser	O
,	O
but	O
still	O
important	O
role	O
.	O

In	O
contrast	O
to	O
the	O
marked	O
derepression	O
of	O
the	O
vast	O
majority	O
of	O
cone	S-CL
-	O
specific	O
genes	S-SO
in	O
the	O
rd7	O
mutant	S-SO
,	O
two	O
genes	S-SO
stand	O
out	O
as	O
being	O
unaffected	O
by	O
the	O
mutation	S-SO
:	O
the	O
gene	S-SO
encoding	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
and	O
Thrb2	S-PRGE
.	O

As	O
Thrb2	S-PRGE
is	O
known	O
to	O
be	O
required	O
for	O
the	O
expression	O
of	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
[	O
22	O
]	O
,	O
the	O
absence	O
of	O
supernumerary	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
may	O
simply	O
be	O
a	O
consequence	O
of	O
the	O
fact	O
that	O
Thrb2	S-PRGE
expression	O
is	O
unchanged	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

Further	O
support	O
for	O
this	O
idea	O
has	O
been	O
provided	O
by	O
recent	O
work	O
in	O
our	O
lab	O
showing	O
widespread	O
derepression	O
of	O
cone	S-CL
genes	S-SO
in	O
the	O
Notch1	S-PRGE
-	O
/	O
-	O
retina	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
to	O
the	O
rd7	O
mutant	S-SO
,	O
Notch1	S-PRGE
-	O
/	O
-	O
retinas	O
show	O
marked	O
derepression	O
of	O
Thrb2	S-PRGE
and	O
a	O
corresponding	O
derepression	O
of	O
the	O
gene	S-SO
that	O
encodes	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
.	O

An	O
additional	O
observation	O
suggesting	O
that	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
and	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
are	O
controlled	O
by	O
different	O
mechanisms	O
comes	O
from	O
in	O
vitro	O
experiments	O
[	O
31	O
,	O
32	O
]	O
.	O

While	O
explanted	O
P3	O
retinas	O
express	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
and	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
with	O
normal	O
kinetics	O
,	O
explanted	O
P0	O
retinas	O
express	O
only	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
[	O
32	O
]	O
.	O

The	O
factor	O
(	O
s	O
)	O
controlling	O
these	O
differences	O
are	O
unknown	O
,	O
but	O
may	O
be	O
intrinsic	O
,	O
as	O
cocultures	O
of	O
older	O
and	O
younger	O
retinas	O
,	O
conditioned	O
media	O
from	O
older	O
retinas	O
,	O
and	O
addition	O
of	O
a	O
variety	O
of	O
small	O
molecules	S-CHEBI
were	O
unable	O
to	O
promote	O
the	O
expression	O
of	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
in	O
the	O
P0	O
-	O
initiated	O
cultures	O
[	O
32	O
]	O
.	O

In	O
contrast	O
to	O
our	O
findings	O
,	O
Peng	O
et	O
al	O
.	O

[	O
19	O
]	O
reported	O
that	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
expression	O
is	O
mildly	O
increased	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
.	O

It	O
is	O
possible	O
that	O
a	O
subtle	O
increase	O
in	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
transcript	S-SO
levels	O
does	O
occur	O
in	O
the	O
rd7	O
retina	O
,	O
and	O
that	O
this	O
difference	O
could	O
not	O
be	O
detected	O
by	O
in	O
situ	O
hybridization	O
.	O

Since	O
virtually	O
all	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
are	O
localized	O
at	O
the	O
outer	O
edge	O
of	O
the	O
ONL	O
by	O
P28	O
in	O
the	O
rd7	O
mutant	S-SO
(	O
Figure	O
S8	O
)	O
,	O
any	O
increase	O
in	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
transcript	S-SO
in	O
the	O
mutant	S-SO
must	O
have	O
occurred	O
in	O
cells	S-CL
in	O
that	O
location	O
.	O

A	O
variety	O
of	O
novel	O
cone	S-CL
-	O
specific	O
or	O
cone	S-CL
-	O
enriched	O
genes	S-SO
were	O
characterized	O
in	O
this	O
study	O
.	O

One	O
of	O
these	O
genes	S-SO
,	O
Pygm	S-PRGE
,	O
is	O
involved	O
in	O
glycogen	S-CHEBI
/	O
glucose	S-CHEBI
metabolism	O
,	O
and	O
a	O
second	O
,	O
Glo1	S-PRGE
,	O
is	O
required	O
for	O
detoxification	O
of	O
methylglyoxal	S-CHEBI
,	O
a	O
byproduct	S-CHEBI
of	O
glycolysis	O
[	O
33	O
]	O
.	O

A	O
third	O
gene	S-SO
involved	O
in	O
glucose	S-CHEBI
metabolism	O
,	O
hexokinase	B-PRGE
2	E-PRGE
(	O
Hk2	S-PRGE
)	O
,	O
is	O
also	O
derepressed	O
in	O
the	O
rd7	O
mutant	S-SO
and	O
shows	O
a	O
pattern	O
of	O
expression	O
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
,	O
suggesting	O
greater	O
expression	O
in	O
cones	S-CL
than	O
in	O
rods	S-CL
(	O
see	O
Figure	O
1	O
;	O
Table	O
S1	O
)	O
.	O

A	O
fourth	O
gene	S-SO
involved	O
in	O
glucose	S-CHEBI
metabolism	O
,	O
glucokinase	B-PRGE
regulatory	I-PRGE
protein	E-PRGE
(	O
Gckr	S-PRGE
)	O
,	O
was	O
found	O
to	O
be	O
increased	O
in	O
three	O
out	O
of	O
three	O
microarrays	O
at	O
P21	O
but	O
was	O
not	O
tested	O
by	O
in	O
situ	O
hybridization	O
(	O
Table	O
S4	O
)	O
.	O

The	O
increased	O
expression	O
of	O
Gckr	S-PRGE
in	O
rd7	O
mutant	S-SO
retina	O
suggests	O
that	O
it	O
too	O
may	O
be	O
a	O
cone	S-CL
-	O
enriched	O
gene	S-SO
.	O

A	O
previous	O
study	O
found	O
that	O
two	O
of	O
these	O
genes	S-SO
,	O
Pygm	S-PRGE
and	O
Hk2	S-PRGE
,	O
have	O
markedly	O
elevated	O
tag	O
levels	O
in	O
an	O
ONL	O
-	O
specific	O
serial	O
analysis	O
of	O
gene	S-SO
expression	O
library	O
consistent	O
with	O
their	O
being	O
highly	O
enriched	O
in	O
wild	B-SO
-	I-SO
type	E-SO
photoreceptors	S-CL
[	O
34	O
]	O
.	O

Furthermore	O
,	O
prior	O
studies	O
have	O
suggested	O
differences	O
in	O
glycogen	S-CHEBI
and	O
glucose	S-CHEBI
metabolism	O
between	O
primate	S-LIVB
rods	S-CL
and	O
cones	S-CL
[	O
35	O
]	O
.	O

Our	O
findings	O
lend	O
further	O
support	O
to	O
this	O
concept	O
.	O

Interestingly	O
,	O
Pygm	S-PRGE
has	O
been	O
implicated	O
in	O
human	S-LIVB
disease	O
.	O

Mutations	S-SO
in	O
this	O
gene	S-SO
underlie	O
McArdle	O
'	O
s	O
disease	O
(	O
glycogen	S-CHEBI
storage	O
disease	O
type	O
V	O
)	O
,	O
the	O
symptoms	O
of	O
which	O
include	O
exercise	O
intolerance	O
,	O
muscle	O
cramps	O
,	O
and	O
myoglobinuria	O
[	O
36	O
]	O
.	O

To	O
our	O
knowledge	O
,	O
no	O
abnormalities	O
of	O
retinal	O
function	O
have	O
been	O
reported	O
.	O

One	O
of	O
the	O
most	O
curious	O
findings	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
was	O
the	O
occurrence	O
of	O
two	O
different	O
types	O
of	O
changes	O
:	O
an	O
increase	O
in	O
the	O
number	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cones	S-CL
and	O
a	O
transformation	O
of	O
rods	S-CL
into	O
hybrid	O
photoreceptors	S-CL
.	O

It	O
is	O
known	O
that	O
Nr2e3	S-PRGE
is	O
expressed	O
only	O
in	O
rods	S-CL
,	O
and	O
the	O
transcript	S-SO
is	O
first	O
detectable	O
in	O
postmitotic	O
cells	S-CL
(	O
J	O
.	O
Trimarchi	O
and	O
CLC	O
,	O
unpublished	O
data	O
)	O
.	O

Assuming	O
that	O
Nr2e3	S-PRGE
acts	O
cell	S-CL
autonomously	O
,	O
we	O
can	O
conclude	O
that	O
the	O
supernumerary	O
S	B-PRGE
-	I-PRGE
cone	E-PRGE
-	O
positive	O
cells	S-CL
and	O
the	O
hybrid	O
photoreceptors	S-CL
identified	O
in	O
the	O
rd7	O
retina	O
were	O
redirected	O
to	O
these	O
fates	O
from	O
postmitotic	O
cells	S-CL
that	O
were	O
destined	O
to	O
become	O
rods	S-CL
.	O

This	O
conclusion	O
raises	O
this	O
question	O
:	O
Why	O
does	O
loss	O
of	O
a	O
single	O
transcription	O
factor	O
within	O
rod	S-CL
precursors	O
lead	O
to	O
two	O
alternative	O
fates	O
--	O
a	O
hybrid	O
cell	S-CL
type	O
on	O
the	O
one	O
hand	O
and	O
apparently	O
normal	O
S	O
-	O
cones	S-CL
on	O
the	O
other	O
?	O

There	O
are	O
at	O
least	O
two	O
possible	O
explanations	O
for	O
these	O
differences	O
.	O

First	O
,	O
it	O
is	O
possible	O
that	O
there	O
are	O
two	O
distinct	O
types	O
of	O
rod	S-CL
precursor	O
;	O
loss	O
of	O
Nr2e3	S-PRGE
in	O
one	O
leads	O
to	O
S	O
-	O
cone	S-CL
fate	O
and	O
in	O
the	O
other	O
results	O
in	O
a	O
hybrid	O
cell	S-CL
type	O
.	O

In	O
fact	O
,	O
there	O
is	O
experimental	O
evidence	O
from	O
the	O
rat	S-LIVB
to	O
support	O
the	O
conclusion	O
that	O
early	O
-	O
born	O
and	O
late	O
-	O
born	O
rods	S-CL
are	O
intrinsically	O
different	O
[	O
37	O
]	O
.	O

One	O
test	O
of	O
the	O
hypothesis	O
that	O
there	O
are	O
two	O
temporally	O
distinct	O
rod	S-CL
precursor	O
populations	O
would	O
be	O
to	O
carry	O
out	O
birthdating	O
experiments	O
to	O
determine	O
whether	O
the	O
supernumerary	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
in	O
the	O
rd7	O
retina	O
derived	O
exclusively	O
from	O
an	O
early	O
-	O
or	O
late	O
-	O
born	O
population	O
.	O

Of	O
course	O
,	O
if	O
this	O
were	O
not	O
the	O
case	O
,	O
this	O
experiment	O
could	O
not	O
rule	O
out	O
the	O
possibility	O
that	O
molecularly	S-CHEBI
distinct	O
populations	O
of	O
rod	S-CL
precursors	O
are	O
present	O
simultaneously	O
in	O
the	O
developing	O
retina	O
.	O

An	O
alternative	O
explanation	O
would	O
be	O
that	O
there	O
is	O
only	O
a	O
single	O
,	O
homogeneous	O
population	O
of	O
postmitotic	O
rod	S-CL
precursors	O
in	O
the	O
mouse	S-LIVB
,	O
and	O
a	O
stochastic	O
event	O
triggers	O
assumption	O
of	O
the	O
S	O
-	O
cone	S-CL
fate	O
in	O
a	O
small	O
subpopulation	O
of	O
these	O
cells	S-CL
in	O
the	O
rd7	O
mutant	S-SO
.	O

Recent	O
studies	O
in	O
a	O
variety	O
of	O
experiment	O
systems	O
suggest	O
that	O
such	O
a	O
stochastic	O
,	O
all	O
-	O
or	O
-	O
none	O
mechanism	O
of	O
gene	S-SO
activation	O
is	O
commonplace	O
[	O
38	O
-	O
44	O
]	O
.	O

In	O
this	O
scenario	O
,	O
the	O
absence	O
of	O
Nr2e3	S-PRGE
would	O
alter	O
the	O
probability	O
that	O
an	O
unknown	O
master	O
control	O
gene	S-SO
is	O
expressed	O
in	O
rod	S-CL
precursors	O
.	O

Once	O
this	O
event	O
takes	O
place	O
,	O
it	O
would	O
initiate	O
an	O
irreversible	O
program	O
of	O
differentiation	O
toward	O
S	O
-	O
cone	S-CL
fate	O
,	O
albeit	O
at	O
a	O
relatively	O
low	O
frequency	O
.	O

In	O
this	O
way	O
,	O
a	O
subset	O
of	O
cells	S-CL
from	O
an	O
initially	O
homogeneous	O
population	O
would	O
select	O
the	O
S	O
-	O
cone	S-CL
fate	O
in	O
an	O
entirely	O
probabilistic	O
manner	O
.	O

Human	S-LIVB
patients	O
with	O
ESCS	O
display	O
three	O
types	O
of	O
abnormality	O
attributable	O
to	O
the	O
retina	O
:	O
(	O
1	O
)	O
an	O
atypical	O
ERG	O
waveform	O
that	O
is	O
preferentially	O
sensitive	O
to	O
short	O
-	O
wavelength	O
light	O
,	O
(	O
2	O
)	O
slowly	O
progressive	O
retinal	O
degeneration	O
,	O
and	O
(	O
3	O
)	O
abnormal	O
retinal	O
lamination	O
with	O
rosette	O
formation	O
[	O
1	O
,	O
12	O
,	O
13	O
]	O
.	O

The	O
rd7	O
mutant	S-SO
mice	S-LIVB
also	O
demonstrate	O
the	O
latter	O
two	O
defects	O
,	O
but	O
have	O
a	O
normal	O
ERG	O
[	O
15	O
,	O
45	O
]	O
.	O

These	O
similarities	O
and	O
differences	O
between	O
the	O
two	O
species	O
help	O
to	O
explain	O
the	O
possible	O
mechanistic	O
basis	O
of	O
the	O
ESCS	O
.	O

The	O
fact	O
that	O
the	O
rd7	O
mouse	S-LIVB
has	O
a	O
normal	O
ERG	O
strongly	O
suggests	O
that	O
the	O
aberrant	O
ERG	O
in	O
ESCS	O
is	O
not	O
attributable	O
to	O
the	O
activity	O
of	O
a	O
hybrid	O
photoreceptor	S-CL
identical	O
to	O
that	O
found	O
in	O
this	O
study	O
.	O

Namely	O
,	O
the	O
signal	O
is	O
unlikely	O
to	O
derive	O
from	O
a	O
population	O
of	O
cells	S-CL
coexpressing	O
both	O
rod	S-CL
and	O
cone	S-CL
genes	S-SO
but	O
whose	O
photopigment	O
is	O
rhodopsin	S-PRGE
and	O
not	O
S	B-PRGE
-	I-PRGE
cone	I-PRGE
opsin	E-PRGE
.	O

This	O
conclusion	O
is	O
consistent	O
with	O
the	O
evidence	O
from	O
human	S-LIVB
ESCS	O
patients	O
indicating	O
a	O
markedly	O
reduced	O
rod	S-CL
system	O
and	O
a	O
lack	O
of	O
measurable	O
rhodopsin	S-PRGE
by	O
reflection	O
densitometry	O
[	O
1	O
,	O
2	O
,	O
10	O
,	O
11	O
]	O
.	O

It	O
is	O
also	O
unlikely	O
that	O
we	O
would	O
fail	O
to	O
detect	O
an	O
ESCS	O
-	O
like	O
ERG	O
signal	O
in	O
mice	S-LIVB
if	O
it	O
were	O
present	O
,	O
as	O
such	O
a	O
signal	O
has	O
been	O
demonstrated	O
in	O
the	O
Nrl	S-PRGE
mutant	S-SO
mouse	S-LIVB
,	O
which	O
has	O
a	O
near	O
total	O
transformation	O
of	O
all	O
its	O
rods	S-CL
into	O
blue	O
cones	S-CL
[	O
24	O
]	O
.	O

These	O
findings	O
,	O
however	O
,	O
do	O
not	O
rule	O
out	O
the	O
possibility	O
that	O
the	O
abnormal	O
human	S-LIVB
ERG	O
derives	O
from	O
a	O
hybrid	O
photoreceptor	B-CL
cell	E-CL
type	O
that	O
also	O
expresses	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
.	O

It	O
is	O
possible	O
that	O
there	O
are	O
gene	S-SO
regulatory	O
differences	O
between	O
mice	S-LIVB
and	O
humans	S-LIVB
such	O
that	O
in	O
human	B-PRGE
NR2E3	E-PRGE
mutants	S-SO
,	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
shows	O
a	O
type	O
I	O
pattern	O
of	O
derepression	O
rather	O
than	O
a	O
type	O
II	O
as	O
in	O
seen	O
in	O
the	O
rd7	O
mouse	S-LIVB
,	O
and	O
is	O
therefore	O
expressed	O
in	O
all	O
of	O
the	O
hybrid	O
photoreceptor	B-CL
cells	E-CL
.	O

Alternatively	O
,	O
the	O
ratio	O
of	O
supernumerary	O
S	O
-	O
cones	S-CL
to	O
hybrid	O
photoreceptors	S-CL
produced	O
in	O
the	O
retina	O
of	O
ESCS	O
patients	O
might	O
be	O
such	O
that	O
a	O
higher	O
percentage	O
of	O
the	O
presumptive	O
rods	S-CL
in	O
ESCS	O
patients	O
become	O
S	O
-	O
cones	S-CL
rather	O
than	O
hybrid	O
photoreceptors	S-CL
.	O

As	O
discussed	O
above	O
,	O
this	O
ratio	O
could	O
depend	O
either	O
on	O
the	O
relative	O
percentages	O
of	O
two	O
distinct	O
rod	S-CL
precursor	O
populations	O
or	O
on	O
stochastic	O
effects	O
on	O
regulatory	O
gene	S-SO
expression	O
.	O

In	O
contrast	O
to	O
the	O
ERG	O
differences	O
between	O
mouse	S-LIVB
rd7	O
and	O
human	B-PRGE
NR2E3	E-PRGE
mutants	S-SO
,	O
both	O
species	O
demonstrate	O
slow	O
retinal	O
degeneration	O
.	O

It	O
is	O
possible	O
that	O
this	O
degeneration	O
is	O
attributable	O
to	O
the	O
abnormal	O
function	O
of	O
the	O
hybrid	O
photoreceptor	B-CL
cell	E-CL
type	O
characterized	O
in	O
the	O
present	O
study	O
.	O

The	O
coexpression	O
of	O
both	O
rod	S-CL
and	O
cone	S-CL
genes	S-SO
in	O
the	O
same	O
cell	S-CL
could	O
predispose	O
the	O
cell	S-CL
to	O
apoptosis	O
.	O

The	O
final	O
common	O
feature	O
between	O
mouse	S-LIVB
rd7	O
and	O
human	B-PRGE
NR2E3	E-PRGE
mutants	S-SO
is	O
the	O
presence	O
of	O
an	O
abnormally	O
laminated	O
retina	O
with	O
waviness	O
and	O
rosette	O
formation	O
in	O
the	O
ONL	O
[	O
12	O
-	O
15	O
]	O
.	O

The	O
cause	O
of	O
this	O
abnormality	O
is	O
not	O
known	O
,	O
but	O
it	O
is	O
possibly	O
related	O
to	O
defects	O
in	O
photoreceptor	B-CL
cell	E-CL
polarity	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

Rosette	O
formation	O
and	O
abnormally	O
wavy	O
epithelia	O
are	O
common	O
sequelae	O
of	O
defects	O
in	O
pathways	O
controlling	O
cell	S-CL
polarity	O
[	O
46	O
,	O
47	O
]	O
.	O

In	O
particular	O
,	O
loss	O
-	O
of	O
-	O
function	O
mutations	S-SO
in	O
the	O
polarity	O
gene	S-SO
crumbs	S-PRGE
(	O
CRB1	S-PRGE
)	O
have	O
been	O
shown	O
to	O
cause	O
morphological	O
abnormalities	O
of	O
the	O
ONL	O
in	O
both	O
humans	S-LIVB
and	O
mice	S-LIVB
,	O
including	O
rosette	O
formation	O
in	O
mice	S-LIVB
very	O
similar	O
to	O
that	O
seen	O
in	O
the	O
rd7	O
mutant	S-SO
[	O
48	O
,	O
49	O
]	O
.	O

Interestingly	O
,	O
Sharon	O
et	O
al	O
.	O

[	O
5	O
]	O
have	O
recently	O
pointed	O
out	O
additional	O
features	O
shared	O
by	O
patients	O
with	O
CRB1	S-PRGE
mutations	S-SO
and	O
mutations	S-SO
in	O
NR2E3	S-PRGE
,	O
including	O
hyperopic	O
refractive	O
errors	O
and	O
a	O
distinctive	O
pattern	O
of	O
clumped	O
pigmentation	O
in	O
the	O
retina	O
.	O

In	O
the	O
present	O
study	O
we	O
found	O
the	O
mouse	S-LIVB
crumbs	S-PRGE
ortholog	S-SO
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
by	O
microarray	O
,	O
consistent	O
with	O
its	O
higher	O
expression	O
level	O
in	O
cones	S-CL
than	O
in	O
rods	S-CL
[	O
50	O
]	O
.	O

Although	O
we	O
were	O
unable	O
to	O
confirm	O
this	O
finding	O
by	O
in	O
situ	O
hybridization	O
due	O
to	O
the	O
weakness	O
of	O
the	O
signal	O
,	O
it	O
is	O
possible	O
that	O
the	O
up	O
-	O
regulation	O
of	O
crumbs	S-PRGE
in	O
the	O
retina	O
is	O
the	O
cause	O
of	O
the	O
lamination	O
defects	O
seen	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

Overexpression	O
of	O
wild	B-SO
-	I-SO
type	E-SO
crumbs	S-PRGE
in	O
Drosophila	S-LIVB
has	O
been	O
shown	O
to	O
cause	O
polarity	O
defects	O
leading	O
to	O
waviness	O
of	O
epithelia	O
and	O
even	O
to	O
misalignment	O
of	O
nuclei	S-GO
within	O
photoreceptors	S-CL
analogous	O
to	O
what	O
is	O
seen	O
in	O
the	O
rd7	O
retina	O
[	O
47	O
,	O
51	O
]	O
.	O

Future	O
experiments	O
will	O
address	O
this	O
question	O
by	O
overexpressing	O
full	O
-	O
length	O
Crb1	S-PRGE
in	O
a	O
wild	B-SO
-	I-SO
type	E-SO
background	O
.	O

One	O
further	O
point	O
worthy	O
of	O
note	O
is	O
the	O
striking	O
similarity	O
between	O
the	O
hybrid	O
photoreceptor	S-CL
identified	O
in	O
this	O
study	O
and	O
a	O
naturally	O
occurring	O
photoreceptor	S-CL
found	O
in	O
ground	B-LIVB
squirrels	E-LIVB
.	O

The	O
"	O
rods	S-CL
"	O
of	O
this	O
species	O
have	O
electrophysiologic	O
,	O
molecular	S-CHEBI
,	O
and	O
ultrastructural	O
features	O
of	O
both	O
rods	S-CL
and	O
cones	S-CL
[	O
52	O
-	O
58	O
]	O
.	O

Although	O
these	O
unusual	O
findings	O
have	O
been	O
difficult	O
to	O
interpret	O
under	O
the	O
usual	O
assumptions	O
of	O
"	O
duplicity	O
theory	O
"	O
[	O
56	O
]	O
,	O
we	O
would	O
like	O
to	O
suggest	O
that	O
ground	B-LIVB
squirrels	E-LIVB
may	O
have	O
experienced	O
a	O
naturally	O
occurring	O
down	O
-	O
regulation	O
or	O
loss	O
of	O
Nr2e3	S-PRGE
expression	O
in	O
their	O
"	O
rods	S-CL
"	O
that	O
transformed	O
them	O
into	O
a	O
hybrid	O
photoreceptor	B-CL
cell	E-CL
type	O
.	O

The	O
adaptive	O
significance	O
of	O
such	O
a	O
change	O
,	O
if	O
any	O
,	O
is	O
unknown	O
,	O
and	O
it	O
may	O
simply	O
be	O
due	O
to	O
relaxation	O
of	O
selective	O
pressure	O
for	O
night	O
vision	O
in	O
this	O
strictly	O
diurnal	O
species	O
.	O

Materials	O
and	O
Methods	O

Mutant	S-SO
mice	S-LIVB
.	O

Nr2e3rd7	O
mutant	S-SO
mice	S-LIVB
were	O
obtained	O
from	O
Jackson	O
Laboratories	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
;	O
stock	O
#	O
004643	O
)	O
and	O
maintained	O
on	O
a	O
C57BL	O
/	O
6	O
background	O
.	O

All	O
control	O
mice	S-LIVB
were	O
C57BL	O
/	O
6	O
.	O

Microarray	O
analysis	O
.	O

Total	O
retinal	O
RNA	S-SO
samples	O
were	O
isolated	O
from	O
P0	O
,	O
P6	O
,	O
P14	O
,	O
and	O
P21	O
Nr2e3	S-PRGE
mutant	S-SO
mice	S-LIVB
using	O
the	O
Trizol	O
reagent	S-CHEBI
(	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
.	O
United	O
States	O
)	O
.	O

Total	O
retinal	O
RNA	S-SO
samples	O
from	O
age	O
-	O
matched	O
wild	B-SO
-	I-SO
type	E-SO
C57BL	O
/	O
6	O
mice	S-LIVB
were	O
used	O
as	O
controls	O
.	O

Individual	O
total	O
RNA	S-SO
samples	O
were	O
derived	O
from	O
four	O
retinas	O
(	O
pooled	O
from	O
two	O
animals	S-LIVB
)	O
.	O

All	O
microarray	O
experiments	O
were	O
performed	O
in	O
triplicate	O
,	O
in	O
each	O
case	O
with	O
separate	O
RNA	S-SO
preparations	O
.	O

Microarray	O
experiments	O
with	O
cDNAs	S-SO
were	O
performed	O
with	O
the	O
P0	O
,	O
P6	O
,	O
and	O
P14	O
derived	O
samples	O
.	O

Probes	S-SO
were	O
labeled	O
with	O
either	O
Cy3	O
or	O
Cy5	O
using	O
the	O
Array	O
900	O
kit	O
from	O
Genisphere	O
(	O
Hatfield	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
starting	O
with	O
5	O
mu	O
g	O
of	O
total	O
RNA	S-SO
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Wild	B-SO
-	I-SO
type	E-SO
control	O
probes	S-SO
were	O
compared	O
to	O
mutant	S-SO
on	O
the	O
same	O
microarray	O
.	O

In	O
two	O
of	O
the	O
three	O
replicates	O
,	O
the	O
mutant	S-SO
probe	S-SO
was	O
labeled	O
with	O
Cy3	O
and	O
the	O
wild	B-SO
type	E-SO
with	O
Cy5	O
,	O
and	O
in	O
the	O
third	O
replicate	O
the	O
dyes	O
were	O
swapped	O
.	O

Labeled	O
probe	S-SO
was	O
hybridized	O
to	O
microarray	O
slides	O
spotted	O
with	O
approximately	O
11	O
,	O
500	O
cDNA	B-SO
clones	E-SO
from	O
the	O
brain	O
molecular	S-CHEBI
anatomy	O
project	O
library	O
(	O
kind	O
gift	O
of	O
B	O
.	O
Soares	O
,	O
University	O
of	O
Iowa	O
;	O
see	O
http	O
:	O
/	O
/	O
trans	O
.	O
nih	O
.	O
gov	O
/	O
bmap	O
/	O
index	O
.	O
htm	O
for	O
details	O
)	O
and	O
500	O
cDNA	B-SO
clones	E-SO
from	O
our	O
lab	O
collection	O
.	O

Slides	O
were	O
printed	O
and	O
hybridized	O
as	O
described	O
[	O
59	O
,	O
60	O
]	O
.	O

After	O
hybridization	O
and	O
washing	O
of	O
slides	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Genisphere	O
)	O
,	O
the	O
slides	O
were	O
scanned	O
on	O
an	O
Axon	O
Instruments	O
(	O
Union	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
GenePix	O
4000	O
scanner	O
and	O
images	O
were	O
analyzed	O
using	O
the	O
accompanying	O
GenePix	O
Pro	O
software	O
package	O
.	O

The	O
complete	O
raw	O
cDNA	S-SO
microarray	O
data	O
set	O
are	O
available	O
in	O
Tables	O
S6	O
-	O
S14	O
.	O

Two	O
types	O
of	O
normalization	O
were	O
performed	O
on	O
the	O
raw	O
intensity	O
scores	O
derived	O
from	O
the	O
GenePix	O
Pro	O
analysis	O
.	O

First	O
,	O
for	O
a	O
given	O
experiment	O
,	O
the	O
average	O
intensity	O
of	O
all	O
the	O
spots	O
in	O
the	O
weaker	O
of	O
the	O
two	O
channels	O
(	O
Cy3	O
or	O
Cy5	O
)	O
was	O
normalized	O
to	O
those	O
in	O
the	O
stronger	O
channel	O
.	O

Second	O
,	O
in	O
a	O
given	O
set	O
of	O
experiments	O
done	O
in	O
triplicate	O
at	O
a	O
particular	O
time	O
point	O
,	O
the	O
two	O
experiments	O
with	O
the	O
weaker	O
average	O
signal	O
intensity	O
over	O
all	O
spots	O
were	O
normalized	O
to	O
those	O
in	O
the	O
third	O
microarray	O
with	O
the	O
strongest	O
average	O
signal	O
intensity	O
.	O

All	O
spots	O
with	O
signal	O
levels	O
equal	O
to	O
or	O
below	O
background	O
were	O
removed	O
from	O
the	O
analysis	O
.	O

The	O
resulting	O
files	O
contained	O
on	O
average	O
about	O
6	O
,	O
000	O
spots	O
.	O

These	O
files	O
were	O
then	O
sorted	O
according	O
to	O
Cy3	O
/	O
Cy5	O
signal	O
intensity	O
,	O
and	O
those	O
spots	O
with	O
the	O
10	O
%	O
highest	O
and	O
10	O
%	O
lowest	O
intensity	O
ratios	O
(	O
approximately	O
600	O
spots	O
/	O
experiment	O
)	O
were	O
compared	O
across	O
the	O
three	O
experiments	O
at	O
a	O
given	O
time	O
point	O
using	O
custom	O
Perl	O
scripts	O
(	O
available	O
upon	O
request	O
from	O
JCC	O
)	O
.	O

All	O
spots	O
which	O
were	O
present	O
in	O
the	O
top	O
10	O
%	O
most	O
up	O
-	O
or	O
down	O
-	O
regulated	O
genes	S-SO
in	O
two	O
out	O
of	O
three	O
or	O
three	O
out	O
of	O
three	O
experiments	O
were	O
recorded	O
(	O
the	O
latter	O
are	O
listed	O
in	O
Table	O
S3	O
)	O
.	O

Microarray	O
analysis	O
of	O
the	O
P21	O
retinas	O
was	O
performed	O
on	O
Affymetrix	O
mouse	S-LIVB
genome	S-SO
430	O
2	O
.	O
0	O
GeneChip	O
array	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

A	O
total	O
of	O
six	O
microarray	O
hybridizations	O
were	O
performed	O
:	O
three	O
with	O
probes	S-SO
derived	O
from	O
mutant	S-SO
RNA	S-SO
and	O
three	O
from	O
wild	B-SO
-	I-SO
type	E-SO
.	O

Probes	S-SO
were	O
synthesized	O
starting	O
with	O
10	O
mu	O
g	O
of	O
total	O
RNA	S-SO
for	O
each	O
sample	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Affymetrix	O
)	O
.	O

Hybridization	O
,	O
washing	O
,	O
and	O
scanning	O
of	O
the	O
microarrays	O
were	O
all	O
performed	O
at	O
the	O
Bauer	O
Center	O
for	O
Genomics	O
Research	O
at	O
Harvard	O
University	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Affymetrix	O
)	O
.	O

Initial	O
data	O
analysis	O
was	O
carried	O
out	O
using	O
the	O
GeneChip	O
Operating	O
System	O
(	O
GCOS	O
)	O
software	O
from	O
Affymetrix	O
.	O

Pairwise	O
comparisons	O
were	O
made	O
between	O
individual	O
mutant	S-SO
microarray	O
results	O
and	O
controls	O
.	O

All	O
genes	S-SO
were	O
removed	O
from	O
the	O
analysis	O
for	O
which	O
"	O
absent	O
"	O
calls	O
were	O
made	O
by	O
the	O
software	O
for	O
both	O
the	O
wild	B-SO
-	I-SO
type	E-SO
and	O
mutant	S-SO
samples	O
being	O
compared	O
.	O

The	O
remaining	O
gene	S-SO
lists	O
contained	O
approximately	O
26	O
,	O
000	O
transcripts	S-SO
.	O

These	O
lists	O
were	O
then	O
sorted	O
according	O
to	O
the	O
mutant	S-SO
-	O
to	O
-	O
wild	B-SO
-	I-SO
type	E-SO
"	O
signal	O
log	O
ratio	O
"	O
in	O
order	O
to	O
identify	O
the	O
most	O
markedly	O
up	O
-	O
and	O
down	O
-	O
regulated	O
genes	S-SO
.	O

The	O
top	O
500	O
most	O
up	O
-	O
and	O
down	O
-	O
regulated	O
transcripts	S-SO
(	O
approximately	O
2	O
%	O
of	O
all	O
genes	S-SO
in	O
each	O
case	O
)	O
from	O
each	O
of	O
the	O
three	O
pairwise	O
comparisons	O
between	O
mutant	S-SO
and	O
wild	B-SO
-	I-SO
type	E-SO
were	O
compared	O
using	O
custom	O
Perl	O
scripts	O
(	O
available	O
upon	O
request	O
from	O
JCC	O
)	O
to	O
identify	O
those	O
genes	S-SO
that	O
were	O
present	O
in	O
two	O
or	O
three	O
out	O
of	O
three	O
lists	O
.	O

Those	O
genes	S-SO
that	O
were	O
up	O
-	O
or	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
experiments	O
were	O
recorded	O
(	O
Tables	O
S4	O
and	O
S5	O
)	O
.	O

The	O
complete	O
pairwise	O
Affymetrix	O
microarray	O
datasets	O
are	O
available	O
in	O
Tables	O
S15	O
-	O
S17	O
.	O

In	O
Situ	O
hybridization	O
.	O

Section	O
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
previously	O
described	O
[	O
61	O
]	O
using	O
20	O
-	O
mu	O
m	O
cryosections	O
from	O
OCT	O
-	O
embedded	O
tissue	O
or	O
4	O
-	O
mu	O
m	O
paraffin	O
sections	O
.	O

All	O
in	O
situ	O
hybridizations	O
were	O
performed	O
with	O
the	O
mutant	S-SO
and	O
wild	B-SO
-	I-SO
type	E-SO
control	O
sections	O
on	O
the	O
same	O
glass	O
slide	O
.	O

Riboprobes	O
labeled	O
with	O
digoxygenin	S-CHEBI
-	O
tagged	O
UTP	S-CHEBI
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
were	O
detected	O
with	O
NBT	O
/	O
BCIP	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

The	O
sources	O
of	O
the	O
individual	O
riboprobes	O
used	O
in	O
this	O
study	O
are	O
described	O
in	O
Tables	O
S1	O
and	O
S2	O
.	O

Dissociated	O
cell	S-CL
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
described	O
previously	O
[	O
62	O
]	O
using	O
the	O
same	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
digoxygenin	S-CHEBI
-	O
labeled	O
probe	S-SO
used	O
for	O
section	O
in	O
situ	O
hybridization	O
.	O

All	O
images	O
were	O
captured	O
on	O
a	O
compound	O
microscope	O
(	O
Eclipse	O
e1000	O
;	O
Nikon	O
,	O
Tokyo	O
,	O
Japan	O
)	O
using	O
a	O
CCD	O
camera	O
(	O
DXM1200F	O
,	O
Nikon	O
)	O
.	O

S	B-PRGE
-	I-PRGE
opsin	E-PRGE
positive	O
cells	S-CL
were	O
quantitated	O
on	O
dissociated	O
cell	S-CL
in	O
situ	O
hybridization	O
as	O
previously	O
described	O
[	O
62	O
]	O
.	O

Twenty	O
fields	O
were	O
quantitated	O
in	O
this	O
manner	O
at	O
200	O
x	O
magnification	O
for	O
both	O
rd7	O
and	O
wild	B-SO
-	I-SO
type	E-SO
retinas	O
.	O

Immunohistochemistry	O
.	O

For	O
antibody	S-GO
staining	O
,	O
cryosections	O
were	O
prepared	O
and	O
stained	O
as	O
described	O
previously	O
[	O
63	O
]	O
.	O

Primary	O
antibodies	S-GO
used	O
were	O
a	O
polyclonal	O
anti	O
-	O
blue	B-PRGE
opsin	E-PRGE
raised	O
in	O
rabbit	S-LIVB
(	O
1	O
:	O
300	O
;	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
;	O
AB5407	O
)	O
and	O
a	O
mouse	S-LIVB
monoclonal	O
anti	O
-	O
rhodopsin	S-PRGE
(	O
1	O
:	O
200	O
;	O
rho4D2	O
)	O
.	O

Secondary	O
antibodies	S-GO
used	O
were	O
Cy2	O
-	O
or	O
Cy3	O
-	O
conjugated	O
goat	S-LIVB
anti	O
-	O
rabbit	S-LIVB
and	O
anti	O
-	O
mouse	S-LIVB
(	O
1	O
:	O
500	O
;	O
Jackson	O
Immunologicals	O
,	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
.	O

Following	O
antibody	S-GO
staining	O
,	O
4	O
'	O
-	O
DAPI	O
was	O
applied	O
to	O
stain	O
nuclei	S-GO
(	O
Sigma	O
)	O
,	O
and	O
the	O
sections	O
were	O
coverslipped	O
and	O
mounted	O
in	O
Gel	O
/	O
Mount	O
(	O
Biomeda	O
,	O
Foster	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Electron	S-CHEBI
microscopy	O
.	O

This	O
protocol	O
was	O
adapted	O
from	O
one	O
used	O
by	O
Raviola	O
[	O
64	O
]	O
with	O
some	O
modifications	O
derived	O
from	O
Carter	O
-	O
Dawson	O
and	O
Lavail	O
[	O
26	O
]	O
.	O

Four	O
adult	O
wild	B-SO
-	I-SO
type	E-SO
and	O
four	O
mutant	S-SO
animals	S-LIVB
were	O
deeply	O
anesthetized	O
by	O
intraperitoneal	O
injection	O
of	O
Avertin	O
and	O
the	O
eyes	O
were	O
then	O
removed	O
.	O

The	O
cornea	O
was	O
gently	O
punctured	O
with	O
sharp	O
forceps	O
and	O
excised	O
with	O
iridectomy	O
scissors	O
.	O

The	O
eye	O
was	O
then	O
transferred	O
to	O
a	O
solution	O
of	O
2	O
%	O
paraformaldehyde	O
/	O
2	O
%	O
glutaraldehyde	O
in	O
cacodylate	S-CHEBI
buffer	O
(	O
0	O
.	O
1	O
M	O
cacodylic	B-CHEBI
acid	E-CHEBI
;	O
0	O
.	O
1	O
%	O
calcium	B-CHEBI
chloride	E-CHEBI
)	O
.	O

The	O
lens	O
was	O
gently	O
removed	O
and	O
the	O
eyecup	O
allowed	O
to	O
fix	O
for	O
2	O
h	O
at	O
room	O
temperature	O
.	O

The	O
fixed	O
eye	O
was	O
then	O
placed	O
on	O
dental	O
wax	O
and	O
sectioned	O
in	O
the	O
midline	O
with	O
a	O
fresh	O
razor	O
blade	O
(	O
half	O
of	O
the	O
retinas	O
were	O
sectioned	O
along	O
the	O
D	O
-	O
V	O
axis	O
and	O
half	O
along	O
the	O
nasal	O
-	O
temporal	O
axis	O
)	O
.	O

The	O
retinas	O
(	O
and	O
attached	O
retinal	O
pigment	S-CHEBI
epithelium	O
)	O
were	O
carefully	O
dissected	O
away	O
from	O
the	O
sclera	O
,	O
which	O
was	O
discarded	O
.	O

The	O
retinas	O
were	O
then	O
rinsed	O
four	O
times	O
for	O
15	O
min	O
each	O
with	O
Sorenson	O
'	O
s	O
buffer	O
(	O
pH	O
7	O
.	O
4	O
)	O
.	O

They	O
were	O
then	O
stained	O
for	O
2	O
h	O
at	O
4	O
degrees	O
C	O
with	O
1	O
%	O
osmium	S-CHEBI
tetroxide	O
in	O
1	O
.	O
5	O
%	O
potassium	B-CHEBI
ferrocyanide	E-CHEBI
.	O

Next	O
,	O
the	O
retinas	O
were	O
rinsed	O
four	O
times	O
for	O
15	O
min	O
in	O
maleate	S-CHEBI
buffer	O
(	O
pH	O
5	O
.	O
1	O
)	O
and	O
then	O
stained	O
for	O
2	O
h	O
at	O
room	O
temperature	O
with	O
1	O
%	O
uranyl	S-CHEBI
acetate	S-CHEBI
in	O
maleate	S-CHEBI
buffer	O
(	O
pH	O
6	O
.	O
2	O
)	O
.	O

They	O
were	O
then	O
washed	O
four	O
times	O
for	O
15	O
min	O
with	O
maleate	S-CHEBI
buffer	O
(	O
pH	O
5	O
.	O
1	O
)	O
;	O
once	O
for	O
10	O
min	O
with	O
70	O
%	O
ethanol	S-CHEBI
;	O
once	O
for	O
10	O
min	O
with	O
95	O
%	O
ethanol	S-CHEBI
;	O
and	O
four	O
times	O
for	O
30	O
min	O
with	O
100	O
%	O
ethanol	S-CHEBI
.	O

Next	O
,	O
the	O
retinas	O
were	O
washed	O
three	O
times	O
over	O
one	O
hour	O
with	O
propylene	B-CHEBI
oxide	E-CHEBI
and	O
then	O
embedded	O
in	O
TAAB	O
812	O
Resin	O
(	O
Marivac	O
,	O
Quebec	O
,	O
Canada	O
)	O
for	O
1	O
-	O
2	O
d	O
in	O
a	O
60	O
degrees	O
C	O
oven	O
.	O

Semi	O
-	O
thin	O
sections	O
were	O
cut	O
at	O
a	O
thickness	O
of	O
0	O
.	O
5	O
mu	O
m	O
and	O
stained	O
with	O
1	O
%	O
toluidine	O
blue	O
in	O
1	O
%	O
sodium	B-CHEBI
borate	E-CHEBI
buffer	O
.	O

Images	O
of	O
semi	O
-	O
thin	O
sections	O
from	O
the	O
mutant	S-SO
retina	O
were	O
taken	O
within	O
the	O
ventral	O
two	O
-	O
thirds	O
of	O
the	O
retina	O
where	O
the	O
majority	O
of	O
the	O
supernumerary	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
expressing	O
cells	S-CL
reside	O
.	O

Wild	B-SO
-	I-SO
type	E-SO
images	O
were	O
taken	O
in	O
comparable	O
regions	O
.	O

Sections	O
for	O
electron	S-CHEBI
microscopy	O
were	O
cut	O
at	O
a	O
thickness	O
of	O
95	O
nm	O
,	O
placed	O
on	O
grids	O
,	O
and	O
poststained	O
with	O
2	O
%	O
uranyl	S-CHEBI
acetate	S-CHEBI
followed	O
by	O
0	O
.	O
2	O
%	O
lead	S-CHEBI
citrate	S-CHEBI
.	O

All	O
sections	O
were	O
cut	O
in	O
a	O
plane	O
perpendicular	O
to	O
the	O
plane	O
of	O
the	O
photoreceptor	S-CL
layer	O
.	O

They	O
were	O
then	O
visualized	O
on	O
a	O
Jeol	O
1200EX	O
electron	S-CHEBI
microscope	O
(	O
Jeol	O
,	O
Tokyo	O
,	O
Japan	O
)	O
.	O

The	O
electron	S-CHEBI
microscopic	O
images	O
in	O
Figure	O
7	O
derive	O
from	O
the	O
ventral	O
two	O
-	O
thirds	O
of	O
the	O
wild	B-SO
-	I-SO
type	E-SO
and	O
mutant	S-SO
retinas	O
.	O

The	O
area	O
of	O
the	O
cell	B-GO
bodies	E-GO
of	O
the	O
rods	S-CL
and	O
"	O
rod	S-CL
-	O
like	O
"	O
cells	S-CL
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
and	O
mutant	S-SO
ONLs	O
,	O
respectively	O
,	O
were	O
quantitated	O
in	O
the	O
following	O
manner	O
.	O

First	O
,	O
ten	O
fields	O
within	O
the	O
ONL	O
were	O
chosen	O
at	O
random	O
at	O
1	O
,	O
000	O
x	O
magnification	O
and	O
then	O
photographed	O
at	O
4	O
,	O
000	O
x	O
magnification	O
for	O
each	O
of	O
the	O
two	O
genotypes	S-SO
.	O

Such	O
images	O
typically	O
contained	O
35	O
-	O
45	O
cell	B-GO
bodies	E-GO
.	O

In	O
order	O
to	O
quantitate	O
only	O
the	O
area	O
of	O
those	O
cell	B-GO
bodies	E-GO
that	O
were	O
cut	O
as	O
near	O
to	O
the	O
midline	O
of	O
the	O
cell	S-CL
as	O
possible	O
(	O
i	O
.	O
e	O
.	O
,	O
in	O
order	O
to	O
obtain	O
the	O
maximal	O
cross	O
-	O
sectional	O
area	O
)	O
the	O
five	O
cells	S-CL
with	O
the	O
largest	O
apparent	O
area	O
in	O
each	O
photograph	O
were	O
chosen	O
by	O
eye	O
and	O
the	O
outline	O
of	O
the	O
cell	B-GO
membranes	E-GO
were	O
traced	O
onto	O
white	O
paper	O
.	O

These	O
tracings	O
were	O
scanned	O
along	O
with	O
the	O
size	O
bar	O
from	O
the	O
electron	S-CHEBI
micrographs	O
,	O
and	O
the	O
areas	O
of	O
the	O
resulting	O
digital	O
images	O
were	O
quantitated	O
using	O
Scion	O
Image	O
software	O
(	O
NIH	O
Image	O
,	O
http	O
:	O
/	O
/	O
rsb	O
.	O
info	O
.	O
nih	O
.	O
gov	O
/	O
nih	O
-	O
image	O
)	O
.	O

A	O
total	O
of	O
50	O
cells	S-CL
of	O
each	O
genotype	S-SO
were	O
quantitated	O
in	O
this	O
manner	O
.	O

In	O
addition	O
,	O
in	O
order	O
to	O
evaluate	O
the	O
percentage	O
of	O
rods	S-CL
in	O
the	O
wild	B-SO
-	I-SO
type	E-SO
retina	O
that	O
had	O
any	O
juxtanuclear	S-GO
mitochondria	S-GO
,	O
all	O
rods	S-CL
within	O
all	O
ten	O
images	O
were	O
counted	O
as	O
were	O
the	O
number	O
of	O
cells	S-CL
showing	O
juxtanuclear	S-GO
organelles	S-GO
.	O

A	O
total	O
of	O
six	O
out	O
of	O
399	O
wild	B-SO
-	I-SO
type	E-SO
rods	S-CL
(	O
1	O
.	O
5	O
%	O
)	O
possessed	O
a	O
juxtanuclear	S-GO
organelle	S-GO
.	O

This	O
analysis	O
permitted	O
us	O
to	O
evaluate	O
the	O
wild	B-SO
-	I-SO
type	E-SO
rods	S-CL
for	O
juxtanuclear	S-GO
mitochondria	S-GO
at	O
multiple	O
planes	O
of	O
section	O
;	O
however	O
,	O
serial	O
sections	O
of	O
individual	O
cell	B-GO
bodies	E-GO
were	O
not	O
performed	O
.	O

Supporting	O
Information	O

Figures	O
S1	O
-	O
S7	O
show	O
the	O
in	O
situ	O
hybridization	O
images	O
of	O
all	O
genes	S-SO
discussed	O
in	O
the	O
paper	O
(	O
see	O
Tables	O
S1	O
and	O
S2	O
)	O
.	O

All	O
paired	O
images	O
(	O
which	O
show	O
the	O
wild	B-SO
-	I-SO
type	E-SO
control	O
on	O
the	O
left	O
and	O
the	O
rd7	O
mutant	S-SO
retina	O
on	O
the	O
right	O
)	O
are	O
labeled	O
in	O
the	O
lower	O
left	O
-	O
hand	O
corner	O
with	O
the	O
gene	S-SO
symbol	O
followed	O
by	O
the	O
age	O
of	O
the	O
retinas	O
in	O
question	O
(	O
P6	O
,	O
P14	O
,	O
P28	O
,	O
or	O
adult	O
)	O
.	O

Unpaired	O
images	O
represent	O
prenatal	O
time	O
points	O
and	O
are	O
labeled	O
with	O
the	O
gene	S-SO
symbol	O
of	O
the	O
gene	S-SO
in	O
question	O
(	O
"	O
wt	S-SO
"	O
indicates	O
that	O
the	O
retina	O
is	O
from	O
a	O
wild	B-SO
-	I-SO
type	E-SO
animal	S-LIVB
)	O
and	O
a	O
designation	O
of	O
the	O
embryonic	O
day	O
from	O
which	O
the	O
retina	O
derives	O
(	O
e	O
.	O
g	O
.	O
,	O
e17	O
.	O
5	O
=	O
embryonic	O
day	O
17	O
.	O
5	O
)	O
.	O

Figure	O
S1	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G1	O
-	O
G13	O
in	O
Table	O
S1	O

(	O
3	O
.	O
1	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G14	O
-	O
G25	O
in	O
Table	O
S1	O

(	O
2	O
.	O
4	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G26	O
-	O
G35	O
in	O
Table	O
S1	O

(	O
2	O
.	O
1	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G36	O
-	O
G46	O
in	O
Table	O
S1	O

(	O
2	O
.	O
0	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S5	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G47	O
-	O
G53	O
in	O
Table	O
S1	O

(	O
1	O
.	O
7	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S6	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
Genes	S-SO
1	O
-	O
11	O
in	O
Table	O
S2	O

(	O
2	O
.	O
9	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S7	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
Genes	S-SO
12	O
-	O
22	O
in	O
Table	O
S2	O

(	O
3	O
.	O
2	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S8	O

In	O
Situ	O
Hybridization	O
Results	O
for	O
M	B-PRGE
-	I-PRGE
Opsin	E-PRGE
and	O
Thrb2	S-PRGE

Note	O
that	O
the	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
are	O
scattered	O
throughout	O
the	O
ONL	O
at	O
P14	O
,	O
but	O
appear	O
to	O
have	O
migrated	O
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
by	O
P28	O
.	O

There	O
is	O
no	O
change	O
in	O
the	O
number	O
of	O
M	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
or	O
Thrb2	S-PRGE
-	O
positive	O
cells	S-CL
in	O
the	O
rd7	O
mutant	S-SO
.	O

(	O
2	O
.	O
1	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Cone	S-CL
-	O
Specific	O
and	O
Cone	S-CL
-	O
Enriched	O
Genes	S-SO
Evaluated	O
in	O
the	O
rd7	O
Mutant	S-SO
by	O
Microarray	O
and	O
In	O
Situ	O
Hybridization	O

This	O
table	O
is	O
a	O
supplemental	O
version	O
of	O
Figure	O
1	O
.	O

"	O
Figure	O
Number	O
"	O
indicates	O
which	O
figure	O
(	O
Figure	O
S1	O
-	O
S5	O
)	O
contains	O
the	O
in	O
situ	O
hybridization	O
images	O
corresponding	O
to	O
the	O
gene	S-SO
in	O
question	O
.	O

"	O
Lab	O
Clone	S-SO
Information	O
"	O
indicates	O
the	O
region	B-SO
of	I-SO
the	I-SO
gene	E-SO
in	O
question	O
from	O
which	O
the	O
probe	S-SO
used	O
for	O
in	O
situ	O
hybridization	O
was	O
derived	O
.	O

All	O
abbreviations	O
are	O
as	O
indicated	O
in	O
Figure	O
1	O
.	O

(	O
26	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S2	O

Rod	S-CL
Genes	S-SO
Evaluated	O
in	O
the	O
rd7	O
Mutant	S-SO
by	O
In	O
Situ	O
Hybridization	O

This	O
table	O
contains	O
details	O
about	O
the	O
in	O
situ	O
hybridization	O
patterns	O
of	O
22	O
genes	S-SO
(	O
many	O
of	O
which	O
are	O
rod	S-CL
-	O
specific	O
)	O
evaluated	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
.	O

"	O
Figure	O
Number	O
"	O
indicates	O
which	O
figure	O
(	O
Figure	O
S6	O
or	O
S7	O
)	O
contains	O
the	O
in	O
situ	O
hybridization	O
images	O
corresponding	O
to	O
the	O
gene	S-SO
in	O
question	O
.	O

"	O
Lab	O
Clone	S-SO
Information	O
"	O
indicates	O
the	O
region	B-SO
of	I-SO
the	I-SO
gene	E-SO
in	O
question	O
from	O
which	O
the	O
probe	S-SO
used	O
for	O
in	O
situ	O
hybridization	O
was	O
derived	O
.	O

The	O
color	O
coding	O
of	O
the	O
in	O
situ	O
hybridization	O
results	O
under	O
"	O
In	O
Situ	O
Pattern	O
"	O
is	O
as	O
follows	O
:	O
dark	O
green	O
,	O
markedly	O
down	O
-	O
regulated	O
;	O
light	O
green	O
,	O
mildly	O
down	O
-	O
regulated	O
;	O
red	O
,	O
markedly	O
up	O
-	O
regulated	O
;	O
orange	O
,	O
mildly	O
up	O
-	O
regulated	O
.	O

(	O
20	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S3	O

Summary	O
of	O
cDNA	S-SO
Microarray	O
Results	O
from	O
P0	O
,	O
P6	O
,	O
and	O
P14	O

The	O
spots	O
listed	O
in	O
this	O
table	O
represent	O
those	O
that	O
were	O
either	O
up	O
-	O
or	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarray	O
experiments	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

The	O
Cy3	O
/	O
Cy5	O
signal	O
ratios	O
are	O
indicated	O
for	O
all	O
three	O
microarray	O
experiments	O
at	O
each	O
time	O
point	O
.	O

Note	O
that	O
the	O
Cy3	O
/	O
Cy5	O
ratios	O
for	O
"	O
Microarray	O
#	O
3	O
"	O
are	O
reversed	O
relative	O
to	O
the	O
other	O
two	O
,	O
since	O
the	O
fluorescent	B-CHEBI
tag	E-CHEBI
used	O
to	O
label	O
wild	B-SO
-	I-SO
type	E-SO
and	O
mutant	S-SO
RNA	S-SO
was	O
swapped	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

(	O
22	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S4	O

Summary	O
of	O
Genes	S-SO
Up	O
-	O
Regulated	O
in	O
rd7	O
Mutant	S-SO
Retina	O
at	O
P21	O
by	O
Affymetrix	O
Microarray	O

Only	O
genes	S-SO
that	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarray	O
experiments	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
are	O
listed	O
.	O

"	O
Nr2e3	S-PRGE
signal	O
"	O
and	O
"	O
C57BL	O
/	O
6	O
signal	O
"	O
represent	O
the	O
average	O
signal	O
for	O
that	O
transcript	S-SO
in	O
all	O
three	O
microarray	O
experiments	O
.	O

(	O
92	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S5	O

Summary	O
of	O
Genes	S-SO
Down	O
-	O
Regulated	O
in	O
rd7	O
Mutant	S-SO
Retina	O
at	O
P21	O
by	O
Affymetrix	O
Microarray	O

Only	O
genes	S-SO
that	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarray	O
experiments	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
are	O
listed	O
.	O

"	O
Nr2e3	S-PRGE
signal	O
"	O
and	O
"	O
C57BL	O
/	O
6	O
signal	O
"	O
represent	O
the	O
average	O
signal	O
for	O
that	O
transcript	S-SO
in	O
all	O
three	O
microarray	O
experiments	O
.	O

(	O
58	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S6	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P0	O
(	O
I	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S7	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P0	O
(	O
II	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S8	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P0	O
(	O
III	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S9	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P6	O
(	O
I	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S10	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P6	O
(	O
II	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S11	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P6	O
(	O
III	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S12	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P14	O
(	O
I	O
)	O

(	O
5	O
.	O
5	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S13	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P14	O
(	O
II	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S14	O

Raw	O
cDNA	S-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P14	O
(	O
III	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S15	O

Raw	O
Affymetrix	O
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P21	O
(	O
I	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S16	O

Raw	O
Affymetrix	O
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P21	O
(	O
II	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S17	O

Raw	O
Affymetrix	O
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	E-SO
Comparison	O
at	O
P21	O
(	O
III	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
E	O
.	O

Raviola	O
and	O
T	O
.	O

Reese	O
for	O
help	O
with	O
electron	S-CHEBI
microscopy	O
and	O
to	O
A	O
.	O

Jadhav	O
and	O
J	O
.	O

Trimarchi	O
for	O
access	O
to	O
unpublished	O
data	O
and	O
reagents	S-CHEBI
.	O

Thanks	O
to	O
A	O
.	O

Jadhav	O
,	O
J	O
.	O

Trimarchi	O
,	O
D	O
.	O

Kim	O
,	O
and	O
T	O
.	O

Cherry	O
for	O
helpful	O
comments	O
on	O
the	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
and	O
grants	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
EY014822	O
to	O
JCC	O
and	O
EY009676	O
to	O
CLC	O
)	O
.	O

Thanks	O
to	O
A	O
.	O

Swaroop	O
for	O
providing	O
us	O
with	O
Nrl	S-PRGE
mutant	S-SO
mice	S-LIVB
.	O

Abbreviations	O

DAPI	O
-	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	S-CHEBI

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

ERG	O
-	O
electroretinogram	O

ESCS	O
-	O
enhanced	O
S	O
-	O
cone	S-CL
syndrome	O

GCL	O
-	O
ganglion	O
cell	S-CL
layer	O

INL	O
-	O
inner	O
nuclear	O
layer	O

ONL	O
-	O
outer	O
nuclear	O
layer	O

P	O
[	O
number	O
]	O
-	O
postnatal	O
day	O
[	O
number	O
]	O

Figures	O

Figure	O
1	O

Cone	S-CL
-	O
Specific	O
and	O
Cone	S-CL
-	O
Enriched	O
Genes	S-SO
Evaluated	O
in	O
the	O
rd7	O
Mutant	S-SO
by	O
Microarray	O
and	O
In	O
Situ	O
Hybridization	O

The	O
color	O
coding	O
of	O
text	O
in	O
the	O
column	O
"	O
Gene	O
Name	O
"	O
is	O
as	O
follows	O
:	O
light	O
blue	O
(	O
G1	O
-	O
G15	O
)	O
,	O
genes	S-SO
previously	O
reported	O
in	O
the	O
literature	O
to	O
have	O
cone	S-CL
-	O
specific	O
or	O
cone	S-CL
-	O
enriched	O
patterns	O
of	O
expression	O
;	O
yellow	O
(	O
G16	O
-	O
G25	O
)	O
,	O
novel	O
cone	S-CL
genes	S-SO
identified	O
in	O
an	O
unrelated	O
study	O
(	O
unpublished	O
data	O
)	O
;	O
dark	O
green	O
(	O
G26	O
-	O
G36	O
)	O
,	O
novel	O
cone	S-CL
genes	S-SO
identified	O
in	O
the	O
present	O
study	O
that	O
were	O
up	O
-	O
regulated	O
in	O
rd7	O
;	O
light	O
green	O
(	O
G37	O
-	O
G46	O
)	O
,	O
additional	O
genes	S-SO
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
rd7	O
by	O
microarray	O
in	O
the	O
present	O
study	O
but	O
that	O
had	O
either	O
weak	O
or	O
inapparent	O
cone	S-CL
-	O
specific	O
signal	O
on	O
in	O
situ	O
hybridization	O
;	O
white	O
(	O
G47	O
-	O
G53	O
)	O
,	O
additional	O
genes	S-SO
up	O
-	O
regulated	O
by	O
microarray	O
at	O
two	O
different	O
timepoints	O
but	O
with	O
either	O
unusual	O
expression	O
patterns	O
or	O
nonconfirmatory	O
in	O
situ	O
hybridizations	O
.	O

The	O
column	O
"	O
ID	O
"	O
contains	O
identifiers	O
used	O
in	O
the	O
present	O
paper	O
to	O
refer	O
to	O
specific	O
genes	S-SO
.	O

"	O
GenBank	O
ID	O
"	O
contains	O
the	O
GenBank	O
accession	O
number	O
of	O
the	O
clone	S-SO
used	O
to	O
make	O
the	O
probe	S-SO
for	O
in	O
situ	O
hybridization	O
.	O

Within	O
this	O
column	O
,	O
"	O
lab	O
clone	S-SO
"	O
indicates	O
that	O
the	O
probe	S-SO
used	O
for	O
in	O
situ	O
hybridization	O
derived	O
from	O
a	O
clone	S-SO
in	O
our	O
laboratory	O
.	O

The	O
region	B-SO
of	I-SO
the	I-SO
gene	E-SO
to	O
which	O
it	O
corresponds	O
is	O
indicated	O
in	O
Table	O
S1	O
.	O

Columns	O
"	O
P0	O
"	O
through	O
"	O
P21	O
"	O
contain	O
the	O
results	O
of	O
microarray	O
experiments	O
at	O
the	O
given	O
postnatal	O
dates	O
.	O

P0	O
,	O
P6	O
,	O
and	O
P14	O
time	O
points	O
represent	O
analyses	O
on	O
cDNA	S-SO
microarrays	O
;	O
the	O
P21	O
time	O
point	O
represents	O
data	O
from	O
an	O
Affymetrix	O
microarray	O
(	O
mouse	S-LIVB
genome	S-SO
432	O
2	O
.	O
0	O
)	O
.	O

A	O
red	O
cell	S-CL
with	O
a	O
single	O
up	O
arrow	O
indicates	O
that	O
the	O
gene	S-SO
in	O
question	O
was	O
up	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarrays	O
at	O
that	O
time	O
point	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
.	O

Those	O
cells	S-CL
labeled	O
orange	O
with	O
a	O
single	O
up	O
arrow	O
and	O
asterisk	O
indicate	O
that	O
the	O
gene	S-SO
in	O
question	O
was	O
up	O
-	O
regulated	O
in	O
two	O
out	O
of	O
three	O
microarrays	O
at	O
that	O
time	O
point	O
.	O

The	O
column	O
"	O
In	O
Situ	O
"	O
lists	O
the	O
type	O
of	O
derepression	O
seen	O
for	O
the	O
gene	S-SO
in	O
question	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
(	O
type	O
I	O
and	O
type	O
II	O
are	O
described	O
in	O
the	O
main	O
text	O
)	O
.	O

Genes	S-SO
designated	O
"	O
unclassified	O
"	O
represent	O
patterns	O
of	O
derepression	O
that	O
were	O
difficult	O
to	O
classify	O
as	O
either	O
type	O
I	O
or	O
type	O
II	O
(	O
see	O
main	O
text	O
for	O
more	O
details	O
)	O
.	O

"	O
Wild	B-SO
type	E-SO
"	O
in	O
this	O
column	O
indicates	O
that	O
the	O
in	O
situ	O
hybridization	O
pattern	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
was	O
not	O
different	O
from	O
the	O
wild	B-SO
-	I-SO
type	E-SO
pattern	O
;	O
and	O
"	O
special	O
"	O
indicates	O
a	O
special	O
pattern	O
of	O
expression	O
discussed	O
more	O
fully	O
in	O
the	O
main	O
text	O
.	O

The	O
column	O
"	O
Expression	O
Pattern	O
"	O
contains	O
a	O
concise	O
description	O
of	O
the	O
wild	B-SO
-	I-SO
type	E-SO
expression	O
pattern	O
of	O
the	O
gene	S-SO
in	O
question	O
.	O

In	O
the	O
case	O
of	O
genes	S-SO
for	O
which	O
no	O
signal	O
was	O
obtained	O
on	O
in	O
situ	O
hybridization	O
in	O
the	O
present	O
study	O
,	O
the	O
specified	O
expression	O
pattern	O
derives	O
from	O
reports	O
in	O
the	O
literature	O
.	O

Within	O
this	O
column	O
,	O
"	O
cone	S-CL
>	O
rod	S-CL
"	O
indicates	O
that	O
the	O
gene	S-SO
is	O
expressed	O
in	O
all	O
photoreceptors	S-CL
,	O
but	O
at	O
higher	O
levels	O
in	O
cones	S-CL
than	O
rods	S-CL
;	O
"	O
cone	S-CL
?	O
"	O
indicates	O
very	O
weak	O
staining	O
in	O
a	O
cone	S-CL
-	O
like	O
distribution	O
.	O

BP	S-CL
,	O
bipolar	B-CL
cells	E-CL
;	O
EP	O
,	O
early	O
photoreceptor	S-CL
expression	O
pattern	O
;	O
IS	S-GO
,	O
inner	B-GO
core	I-GO
segment	E-GO
localization	O
;	O
MG	S-CL
,	O
M	B-CL
u	I-CL
ller	I-CL
glia	E-CL
;	O
N	O
/	O
A	O
,	O
not	O
available	O
on	O
the	O
microarray	O
;	O
NS	O
,	O
no	O
signal	O
detected	O
on	O
in	O
situ	O
hybridization	O
;	O
RPE	O
,	O
retinal	O
pigment	S-CHEBI
epithelium	O
.	O

Figure	O
2	O

Cone	S-CL
and	O
Rod	S-CL
Gene	S-SO
Expression	O
in	O
the	O
rd7	O
Mutant	S-SO
at	O
P14	O

The	O
upper	O
sets	O
of	O
photomicrographs	O
demonstrate	O
examples	O
of	O
type	O
I	O
and	O
type	O
II	O
cone	S-CL
gene	S-SO
derepression	O
in	O
the	O
rd7	O
mutant	S-SO
retina	O
as	O
explained	O
in	O
the	O
main	O
text	O
.	O

The	O
bottom	O
left	O
images	O
show	O
several	O
rod	S-CL
-	O
specific	O
genes	S-SO
that	O
are	O
essentially	O
unchanged	O
in	O
the	O
rd7	O
background	O
at	O
P14	O
.	O

The	O
bottom	O
right	O
images	O
show	O
the	O
expression	O
pattern	O
of	O
three	O
photoreceptor	S-CL
transcription	O
factors	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

Abbreviations	O
in	O
the	O
lower	O
left	O
hand	O
corner	O
of	O
each	O
pair	O
of	O
panels	O
represent	O
the	O
gene	S-SO
symbols	O
summarized	O
in	O
Figure	O
1	O
.	O

Figure	O
3	O

S	B-PRGE
-	I-PRGE
Opsin	E-PRGE
Dissociated	O
Cell	S-CL
In	O
Situ	O
Hybridization	O
and	O
S	B-PRGE
-	I-PRGE
Opsin	E-PRGE
/	O
Rhodopsin	S-PRGE
Antibody	S-GO
Staining	O
on	O
rd7	O
Mutant	S-SO
Retina	O

(	O
A	O
-	O
C	O
)	O
A	O
dissociated	O
cell	S-CL
in	O
situ	O
hybridization	O
with	O
an	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
probe	S-SO
(	O
red	O
)	O
on	O
dissociated	O
rd7	O
mutant	S-SO
retinal	O
cells	S-CL
stained	O
with	O
DAPI	O
(	O
blue	O
)	O
.	O

(	O
C	O
)	O
shows	O
the	O
merged	O
images	O
.	O

(	O
D	O
-	O
F	O
)	O
The	O
outer	O
nuclear	O
layer	O
of	O
an	O
rd7	O
mutant	S-SO
retina	O
stained	O
by	O
antibody	S-GO
for	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
(	O
red	O
)	O
and	O
rhodopsin	S-PRGE
(	O
green	O
)	O
.	O

The	O
scleral	O
edge	O
of	O
the	O
outer	O
nuclear	O
layer	O
is	O
up	O
.	O

DAPI	O
staining	O
is	O
in	O
blue	O
.	O

(	O
F	O
)	O
shows	O
the	O
merged	O
images	O
.	O

Insets	O
are	O
higher	O
-	O
power	O
images	O
of	O
the	O
outer	B-GO
segments	E-GO
showing	O
non	O
-	O
overlap	O
of	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
and	O
rhodopsin	S-PRGE
staining	O
in	O
the	O
mutant	S-SO
.	O

Figure	O
4	O

Expression	O
Patterns	O
of	O
Several	O
Novel	O
Cone	S-CL
Genes	S-SO
Up	O
-	O
Regulated	O
in	O
rd7	O

In	O
the	O
wild	B-SO
-	I-SO
type	E-SO
images	O
(	O
wt	S-SO
)	O
,	O
note	O
the	O
scattered	O
,	O
weakly	O
positive	O
cells	S-CL
at	O
the	O
scleral	O
edge	O
of	O
the	O
outer	O
nuclear	O
layer	O
in	O
a	O
cone	S-CL
distribution	O
.	O

All	O
of	O
the	O
genes	S-SO
show	O
marked	O
up	O
-	O
regulation	O
in	O
the	O
rd7	O
mutant	S-SO
.	O

Bub1b	S-PRGE
and	O
Tcta	S-PRGE
show	O
transcript	S-SO
localization	O
predominantly	O
to	O
the	O
inner	B-GO
segment	I-GO
of	I-GO
the	I-GO
photoreceptors	E-GO
.	O

Retinas	O
are	O
oriented	O
such	O
that	O
the	O
scleral	O
edge	O
is	O
up	O
.	O

Figure	O
5	O

Some	O
of	O
the	O
Genes	S-SO
Up	O
-	O
Regulated	O
in	O
rd7	O
Show	O
an	O
Early	O
Photoreceptor	S-CL
Pattern	O
of	O
Expression	O

Gnb3	S-PRGE
and	O
Thrb2	S-PRGE
are	O
both	O
previously	O
characterized	O
cone	S-CL
genes	S-SO
that	O
show	O
staining	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
embryonic	O
mouse	S-LIVB
retina	O
in	O
cells	S-CL
that	O
will	O
differentiate	O
into	O
photoreceptors	S-CL
.	O

Ece1	S-PRGE
and	O
Otop3	S-PRGE
are	O
two	O
novel	O
cone	S-CL
genes	S-SO
identified	O
in	O
this	O
study	O
that	O
were	O
up	O
-	O
regulated	O
in	O
rd7	O
and	O
also	O
showed	O
an	O
early	O
photoreceptor	S-CL
pattern	O
of	O
expression	O
.	O

Prdm1	S-PRGE
and	O
RIKEN	O
cDNA	S-SO
1300018I05	O
(	O
Figure	O
1	O
,	O
genes	S-SO
G48	O
and	O
G49	O
,	O
respectively	O
)	O
are	O
two	O
other	O
genes	S-SO
that	O
had	O
either	O
undetectable	O
signal	O
(	O
Prdm1	S-PRGE
)	O
or	O
no	O
apparent	O
change	O
in	O
expression	O
pattern	O
in	O
adult	O
rd7	O
mutants	S-SO
(	O
RIKEN	O
cDNA	S-SO
1300018I05	O
)	O
,	O
but	O
which	O
also	O
showed	O
staining	O
in	O
the	O
embryonic	O
retina	O
in	O
a	O
presumptive	O
photoreceptor	S-CL
pattern	O
.	O

All	O
images	O
are	O
from	O
E17	O
.	O
5	O
retina	O
except	O
Gnb3	S-PRGE
,	O
which	O
was	O
from	O
E16	O
.	O

Figure	O
6	O

The	O
Onset	O
of	O
rhodopsin	S-PRGE
Expression	O
Is	O
Delayed	O
in	O
the	O
rd7	O
Mutant	S-SO
Retina	O

Note	O
the	O
nearly	O
undetectable	O
staining	O
for	O
rhodopsin	S-PRGE
in	O
this	O
P6	O
mutant	S-SO
retina	O
(	O
top	O
right	O
)	O
.	O

The	O
majority	O
of	O
rod	S-CL
-	O
specific	O
genes	S-SO
did	O
not	O
show	O
this	O
delay	O
in	O
expression	O
onset	O
,	O
as	O
indicated	O
by	O
the	O
normal	O
amount	O
of	O
staining	O
for	O
Pde6a	S-PRGE
in	O
the	O
mutant	S-SO
at	O
P6	O
(	O
bottom	O
images	O
)	O
.	O

Figure	O
7	O

The	O
rd7	O
Mutant	S-SO
Retina	O
Contains	O
a	O
Morphologically	O
Hybrid	O
Photoreceptor	B-CL
Cell	E-CL
Type	O
in	O
Addition	O
to	O
Supernumerary	O
S	B-PRGE
-	I-PRGE
Opsin	E-PRGE
-	O
Positive	O
Cones	S-CL

(	O
A	O
and	O
B	O
)	O
Toluidine	O
blue	O
-	O
stained	O
semi	O
-	O
thin	O
sections	O
of	O
the	O
outer	O
nuclear	O
layer	O
(	O
scleral	O
edge	O
oriented	O
up	O
)	O
.	O

(	O
C	O
and	O
D	O
)	O
Hand	O
-	O
drawn	O
diagrams	O
of	O
the	O
cells	S-CL
in	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
respectively	O
.	O

Cells	S-CL
with	O
the	O
nuclear	S-GO
features	O
of	O
cones	S-CL
are	O
highlighted	O
in	O
blue	O
.	O

Note	O
that	O
the	O
number	O
of	O
such	O
cells	S-CL
is	O
greater	O
in	O
the	O
mutant	S-SO
,	O
and	O
their	O
cell	B-GO
bodies	E-GO
are	O
scattered	O
throughout	O
the	O
outer	O
nuclear	O
layer	O
.	O

In	O
addition	O
,	O
the	O
overall	O
columnar	O
architecture	O
of	O
the	O
outer	O
nuclear	O
layer	O
seen	O
in	O
the	O
wild	B-SO
type	E-SO
is	O
disrupted	O
in	O
this	O
portion	O
of	O
the	O
mutant	S-SO
retina	O
.	O

Other	O
portions	O
of	O
the	O
mutant	S-SO
retina	O
with	O
fewer	O
supernumerary	O
cone	B-CL
cells	E-CL
,	O
however	O
,	O
retain	O
the	O
normal	O
columnar	O
appearance	O
(	O
unpublished	O
data	O
)	O
.	O

(	O
E	O
and	O
F	O
)	O
Images	O
of	O
the	O
outer	O
nuclear	O
layer	O
(	O
scleral	O
edge	O
up	O
)	O
stained	O
by	O
in	O
situ	O
hybridization	O
for	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
.	O

Note	O
the	O
typical	O
pattern	O
of	O
staining	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
outer	O
nuclear	O
layer	O
in	O
the	O
wild	B-SO
type	E-SO
.	O

The	O
rd7	O
mutant	S-SO
retina	O
shows	O
supernumerary	O
S	B-PRGE
-	I-PRGE
opsin	E-PRGE
-	O
positive	O
cells	S-CL
scattered	O
throughout	O
the	O
outer	O
nuclear	O
layer	O
in	O
a	O
distribution	O
very	O
similar	O
to	O
the	O
supernumerary	O
cone	B-CL
cells	E-CL
seen	O
in	O
(	O
B	O
)	O
.	O

Since	O
images	O
(	O
E	O
)	O
and	O
(	O
F	O
)	O
derive	O
from	O
different	O
retinas	O
than	O
those	O
depicted	O
in	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
the	O
location	O
of	O
the	O
individual	O
cells	S-CL
do	O
not	O
correspond	O
.	O

(	O
G	O
and	O
H	O
)	O
Electron	S-CHEBI
micrographs	O
of	O
the	O
outer	O
nuclear	O
layer	O
(	O
10	O
,	O
000	O
x	O
magnification	O
)	O
.	O

Note	O
the	O
uniform	O
distribution	O
of	O
rod	O
cell	B-GO
bodies	E-GO
in	O
the	O
wild	B-SO
type	E-SO
(	O
G	O
)	O
.	O

The	O
cell	B-GO
bodies	E-GO
are	O
nearly	O
round	O
and	O
consist	O
almost	O
exclusively	O
of	O
a	O
nucleus	S-GO
with	O
a	O
single	O
,	O
dense	O
mass	O
of	O
heterochromatin	S-GO
.	O

In	O
the	O
rd7	O
mutant	S-SO
(	O
H	O
)	O
,	O
two	O
types	O
of	O
cell	S-CL
are	O
shown	O
.	O

The	O
ovoid	O
one	O
with	O
a	O
lesser	O
quantity	O
of	O
heterochromatin	S-GO
,	O
paler	O
euchromatin	S-GO
,	O
and	O
two	O
juxtanuclear	S-GO
mitochondria	S-GO
(	O
yellow	O
arrow	O
)	O
represents	O
a	O
typical	O
cone	O
cell	B-GO
body	E-GO
.	O

The	O
adjacent	O
cell	S-CL
with	O
a	O
more	O
"	O
rod	S-CL
-	O
like	O
"	O
mass	O
of	O
heterochromatin	S-GO
and	O
a	O
single	O
juxtanuclear	S-GO
mitochondrion	S-GO
(	O
red	O
arrow	O
)	O
represents	O
one	O
of	O
the	O
hybrid	O
photoreceptors	S-CL
discussed	O
more	O
fully	O
in	O
the	O
main	O
text	O
.	O

Figure	O
8	O

A	O
Partial	O
View	O
of	O
the	O
Rod	B-CL
Photoreceptor	E-CL
Transcriptional	O
Regulatory	O
Network	O

Note	O
that	O
green	O
lines	O
indicate	O
activation	O
,	O
and	O
yellow	O
and	O
red	O
lines	O
indicate	O
weak	O
and	O
strong	O
repression	O
,	O
respectively	O
.	O

The	O
dotted	O
lines	O
associated	O
with	O
a	O
question	O
mark	O
indicate	O
that	O
it	O
is	O
not	O
known	O
whether	O
Nrl	S-PRGE
directly	O
represses	O
the	O
target	O
genes	S-SO
in	O
question	O
or	O
whether	O
its	O
repression	O
is	O
mediated	O
by	O
a	O
downstream	O
transcription	O
factor	O
(	O
"	O
X	O
"	O
)	O
.	O

Note	O
that	O
Nr2e3	S-PRGE
appears	O
to	O
negatively	O
regulate	O
its	O
own	O
transcription	O
.	O

The	O
regulatory	O
linkages	O
depicted	O
in	O
this	O
diagram	O
are	O
not	O
necessarily	O
direct	O
.	O

The	O
weak	O
activation	O
of	O
some	O
rod	S-CL
-	O
specific	O
genes	S-SO
by	O
Nr2e3	S-PRGE
is	O
omitted	O
from	O
this	O
diagram	O
for	O
clarity	O
.	O

Also	O
not	O
shown	O
is	O
the	O
role	O
of	O
other	O
photoreceptor	S-CL
transcription	O
factors	O
,	O
such	O
as	O
Crx	S-PRGE
.	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

JCC	O
and	O
CLC	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

JCC	O
performed	O
the	O
experiments	O
.	O

JCC	O
and	O
CLC	O
analyzed	O
the	O
data	O
.	O

JCC	O
contributed	O
reagents	S-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

JCC	O
and	O
CLC	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Corbo	O
JC	O
,	O
Cepko	O
CL	O
(	O
2005	O
)	O
A	O
hybrid	O
photoreceptor	S-CL
expressing	O
both	O
rod	S-CL
and	O
cone	S-CL
genes	S-SO
in	O
a	O
mouse	S-LIVB
model	O
of	O
enhanced	O
s	O
-	O
cone	S-CL
syndrome	O
.	O

PLoS	O
Genet	O
1	O
(	O
2	O
)	O
:	O
e11	O
.	O

Production	O
and	O
characterization	O
of	O
murine	S-LIVB
models	O
of	O
classic	O
and	O
intermediate	O
maple	S-LIVB
syrup	O
urine	O
disease	O

Abstract	O

Background	O

Maple	S-LIVB
Syrup	O
Urine	O
Disease	O
(	O
MSUD	O
)	O
is	O
an	O
inborn	O
error	O
of	O
metabolism	O
caused	O
by	O
a	O
deficiency	O
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	E-GO
.	O

MSUD	O
has	O
several	O
clinical	O
phenotypes	O
depending	O
on	O
the	O
degree	O
of	O
enzyme	S-SO
deficiency	O
.	O

Current	O
treatments	O
are	O
not	O
satisfactory	O
and	O
require	O
new	O
approaches	O
to	O
combat	O
this	O
disease	O
.	O

A	O
major	O
hurdle	O
in	O
developing	O
new	O
treatments	O
has	O
been	O
the	O
lack	O
of	O
a	O
suitable	O
animal	S-LIVB
model	O
.	O

Methods	O

To	O
create	O
a	O
murine	S-LIVB
model	O
of	O
classic	O
MSUD	O
,	O
we	O
used	O
gene	S-SO
targeting	O
and	O
embryonic	O
stem	B-CL
cell	E-CL
technologies	O
to	O
create	O
a	O
mouse	S-LIVB
line	O
that	O
lacked	O
a	O
functional	O
E2	B-PRGE
subunit	E-PRGE
gene	S-SO
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	E-GO
.	O

To	O
create	O
a	O
murine	S-LIVB
model	O
of	O
intermediate	O
MSUD	O
,	O
we	O
used	O
transgenic	S-SO
technology	O
to	O
express	O
a	O
human	B-PRGE
E2	E-PRGE
cDNA	S-SO
on	O
the	O
knockout	O
background	O
.	O

Mice	S-LIVB
of	O
both	O
models	O
were	O
characterized	O
at	O
the	O
molecular	S-CHEBI
,	O
biochemical	O
,	O
and	O
whole	O
animal	S-LIVB
levels	O
.	O

Results	O

By	O
disrupting	O
the	O
E2	B-PRGE
subunit	E-PRGE
gene	S-SO
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	E-GO
,	O
we	O
created	O
a	O
gene	S-SO
knockout	O
mouse	S-LIVB
model	O
of	O
classic	O
MSUD	O
.	O

The	O
homozygous	O
knockout	O
mice	S-LIVB
lacked	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	E-GO
activity	O
,	O
E2	S-PRGE
immunoreactivity	O
,	O
and	O
had	O
a	O
3	O
-	O
fold	O
increase	O
in	O
circulating	O
branched	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	E-CHEBI
.	O

These	O
metabolic	O
derangements	O
resulted	O
in	O
neonatal	O
lethality	O
.	O

Transgenic	S-SO
expression	O
of	O
a	O
human	B-PRGE
E2	E-PRGE
cDNA	S-SO
in	O
the	O
liver	O
of	O
the	O
E2	S-PRGE
knockout	O
animals	S-LIVB
produced	O
a	O
model	O
of	O
intermediate	O
MSUD	O
.	O

Branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	E-GO
activity	O
was	O
5	O
-	O
6	O
%	O
of	O
normal	O
and	O
was	O
sufficient	O
to	O
allow	O
survival	O
,	O
but	O
was	O
insufficient	O
to	O
normalize	O
circulating	O
branched	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	E-CHEBI
levels	O
,	O
which	O
were	O
intermediate	O
between	O
wildtype	S-SO
and	O
the	O
classic	O
MSUD	O
mouse	S-LIVB
model	O
.	O

Conclusion	O

These	O
mice	S-LIVB
represent	O
important	O
animal	S-LIVB
models	O
that	O
closely	O
approximate	O
the	O
phenotype	O
of	O
humans	S-LIVB
with	O
the	O
classic	O
and	O
intermediate	O
forms	O
of	O
MSUD	O
.	O

These	O
animals	S-LIVB
provide	O
useful	O
models	O
to	O
further	O
characterize	O
the	O
pathogenesis	O
of	O
MSUD	O
,	O
as	O
well	O
as	O
models	O
to	O
test	O
novel	O
therapeutic	O
strategies	O
,	O
such	O
as	O
gene	S-SO
and	O
cellular	S-CL
therapies	O
,	O
to	O
treat	O
this	O
devastating	O
metabolic	O
disease	O
.	O

Background	O

Maple	S-LIVB
Syrup	O
Urine	O
Disease	O
(	O
MSUD	O
)	O
is	O
a	O
genetic	S-SO
disorder	O
caused	O
by	O
a	O
deficiency	O
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	E-GO
(	O
BCKDH	S-GO
)	O
,	O
a	O
mitochondrial	S-GO
multienzyme	O
complex	S-GO
responsible	O
for	O
the	O
oxidative	O
decarboxylation	O
of	O
branched	O
-	O
chain	O
keto	S-CHEBI
acids	S-CHEBI
derived	O
from	O
branched	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	E-CHEBI
(	O
BCAA	S-CHEBI
)	O
,	O
leucine	S-CHEBI
,	O
isoleucine	S-CHEBI
and	O
valine	S-CHEBI
(	O
for	O
review	O
,	O
see	O
:	O
[	O
1	O
]	O
)	O
.	O

Patients	O
with	O
MSUD	O
,	O
depending	O
on	O
the	O
mutation	S-SO
,	O
show	O
variable	O
degrees	O
of	O
enzyme	S-SO
deficiency	O
leading	O
to	O
several	O
different	O
clinical	O
phenotypes	O
[	O
1	O
]	O
.	O

Approximately	O
75	O
%	O
of	O
MSUD	O
patients	O
have	O
the	O
classic	O
form	O
of	O
the	O
disease	O
with	O
BCKDH	S-GO
activity	O
in	O
the	O
range	O
of	O
0	O
-	O
2	O
%	O
of	O
normal	O
[	O
1	O
]	O
.	O

These	O
patients	O
show	O
markedly	O
elevated	O
levels	O
of	O
BCAA	S-CHEBI
in	O
blood	O
and	O
other	O
body	O
fluids	O
[	O
1	O
]	O
.	O

Besides	O
the	O
classic	O
form	O
,	O
there	O
are	O
other	O
variants	O
of	O
the	O
disease	O
.	O

Patients	O
with	O
the	O
intermediate	O
form	O
of	O
the	O
disease	O
show	O
BCKDH	S-GO
activity	O
in	O
the	O
range	O
of	O
3	O
-	O
30	O
%	O
of	O
normal	O
.	O

In	O
such	O
patients	O
the	O
onset	O
of	O
the	O
disease	O
is	O
delayed	O
,	O
but	O
there	O
are	O
persistently	O
elevated	O
levels	O
of	O
BCAA	S-CHEBI
[	O
1	O
]	O
.	O

Patients	O
with	O
the	O
intermittent	O
form	O
of	O
MSUD	O
show	O
BCKDH	S-GO
activity	O
in	O
the	O
range	O
of	O
5	O
-	O
20	O
%	O
and	O
during	O
the	O
asymptomatic	O
phase	O
the	O
blood	O
BCAA	S-CHEBI
levels	O
are	O
normal	O
[	O
1	O
]	O
.	O

The	O
overall	O
incidence	O
of	O
MSUD	O
in	O
the	O
general	O
population	O
is	O
1	O
:	O
185	O
,	O
000	O
[	O
1	O
]	O
,	O
and	O
in	O
certain	O
population	O
groups	O
,	O
such	O
as	O
Mennonites	O
of	O
Pennsylvania	O
,	O
the	O
incidence	O
is	O
estimated	O
to	O
be	O
as	O
high	O
as	O
1	O
:	O
176	O
[	O
2	O
]	O
.	O

The	O
BCKDH	B-GO
complex	E-GO
,	O
the	O
deficient	O
enzyme	S-SO
in	O
MSUD	O
,	O
consists	O
of	O
three	O
catalytic	O
proteins	S-CHEBI
,	O
a	O
decarboxylase	O
(	O
E1	O
)	O
,	O
a	O
dihydrolipoyl	B-PRGE
transacylase	E-PRGE
(	O
E2	S-PRGE
)	O
,	O
and	O
a	O
dihydrolipoyl	B-PRGE
dehydrogenase	E-PRGE
(	O
E3	S-PRGE
)	O
.	O

The	O
E1	O
component	O
is	O
a	O
heterotetramer	O
composed	O
of	O
two	O
alpha	B-PRGE
and	I-PRGE
two	I-PRGE
beta	I-PRGE
subunits	E-PRGE
[	O
3	O
]	O
.	O

The	O
E1	O
and	O
E2	S-PRGE
components	O
are	O
specific	O
to	O
BCKDH	S-GO
,	O
whereas	O
E3	S-PRGE
is	O
also	O
used	O
by	O
pyruvate	B-GO
and	I-GO
alpha	I-GO
-	I-GO
ketoglutarate	I-GO
dehydrogenase	I-GO
complexes	E-GO
[	O
3	O
]	O
and	O
the	O
glycine	B-GO
cleavage	I-GO
system	E-GO
[	O
4	O
]	O
.	O

BCKDH	S-GO
is	O
also	O
associated	O
with	O
two	O
regulatory	O
proteins	S-CHEBI
,	O
a	O
specific	O
kinase	O
and	O
a	O
phosphatase	O
which	O
regulate	O
the	O
activity	O
of	O
this	O
enzyme	S-SO
through	O
a	O
phosphorylation	O
(	O
inactivation	O
)	O
and	O
dephosphorylation	O
(	O
activation	O
)	O
cycle	O
of	O
the	O
E1	B-PRGE
alpha	I-PRGE
subunit	E-PRGE
[	O
5	O
,	O
6	O
]	O
.	O

Mutations	S-SO
in	O
the	O
genes	S-SO
of	O
the	O
E1	O
and	O
E2	B-PRGE
subunits	I-PRGE
of	I-PRGE
BCKDH	E-PRGE
have	O
been	O
described	O
,	O
however	O
,	O
the	O
majority	O
of	O
MSUD	O
mutations	S-SO
identified	O
thus	O
far	O
are	O
in	O
the	O
E2	B-PRGE
subunit	E-PRGE
[	O
1	O
,	O
7	O
]	O
.	O

To	O
date	O
,	O
cases	O
of	O
MSUD	O
have	O
not	O
been	O
associated	O
with	O
defects	O
in	O
the	O
regulatory	O
kinase	O
and	O
phosphatase	O
[	O
1	O
]	O
.	O

Current	O
management	O
of	O
MSUD	O
patients	O
relies	O
on	O
a	O
strict	O
lifelong	O
dietary	O
restriction	O
of	O
protein	S-CHEBI
or	O
BCAA	S-CHEBI
[	O
1	O
,	O
8	O
]	O
.	O

Such	O
a	O
dietary	O
management	O
of	O
the	O
disease	O
,	O
however	O
,	O
is	O
not	O
entirely	O
satisfactory	O
especially	O
in	O
times	O
of	O
metabolic	O
decompensation	O
due	O
to	O
infection	O
,	O
injuries	O
and	O
other	O
stressors	O
.	O

In	O
spite	O
of	O
dietary	O
intervention	O
,	O
there	O
is	O
significant	O
mortality	O
associated	O
with	O
MSUD	O
and	O
there	O
is	O
a	O
high	O
incidence	O
of	O
mental	O
retardation	O
in	O
survivors	O
[	O
9	O
]	O
.	O

Because	O
of	O
the	O
central	O
role	O
of	O
the	O
liver	O
in	O
amino	B-CHEBI
acid	E-CHEBI
metabolism	O
and	O
moderate	O
/	O
high	O
levels	O
of	O
BCKDH	S-GO
activity	O
in	O
human	S-LIVB
liver	O
[	O
10	O
-	O
12	O
]	O
,	O
a	O
few	O
cases	O
of	O
MSUD	O
have	O
recently	O
been	O
treated	O
by	O
liver	O
transplantation	O
[	O
13	O
-	O
16	O
]	O
.	O

While	O
the	O
short	O
-	O
term	O
outcome	O
of	O
liver	O
transplantation	O
is	O
encouraging	O
,	O
long	O
-	O
term	O
effects	O
of	O
this	O
approach	O
are	O
not	O
known	O
.	O

However	O
,	O
these	O
patients	O
are	O
now	O
required	O
to	O
take	O
immunosuppressant	B-CHEBI
drugs	E-CHEBI
for	O
the	O
rest	O
of	O
their	O
lives	O
,	O
often	O
with	O
undesirable	O
side	O
effects	O
.	O

Moreover	O
,	O
the	O
cost	O
associated	O
with	O
liver	O
transplantation	O
and	O
the	O
availability	O
of	O
donor	O
livers	O
are	O
additional	O
limiting	O
factors	O
for	O
the	O
practicality	O
of	O
treatment	O
of	O
this	O
disease	O
.	O

Because	O
of	O
the	O
current	O
unsatisfactory	O
options	O
for	O
the	O
treatment	O
of	O
MSUD	O
,	O
there	O
is	O
a	O
need	O
for	O
improved	O
therapies	O
to	O
combat	O
this	O
disease	O
.	O

An	O
obstacle	O
to	O
developing	O
novel	O
treatments	O
for	O
MSUD	O
has	O
been	O
the	O
lack	O
of	O
a	O
suitable	O
animal	S-LIVB
model	O
to	O
perform	O
necessary	O
preclinical	O
studies	O
.	O

Although	O
a	O
Hereford	O
calf	O
model	O
with	O
MSUD	O
has	O
been	O
described	O
[	O
17	O
-	O
19	O
]	O
,	O
this	O
model	O
is	O
neither	O
readily	O
available	O
nor	O
practical	O
to	O
perform	O
preclinical	O
studies	O
.	O

Furthermore	O
,	O
comparison	O
of	O
this	O
animal	S-LIVB
model	O
with	O
human	S-LIVB
MSUD	O
has	O
shown	O
some	O
differences	O
in	O
the	O
pathology	O
of	O
the	O
disease	O
[	O
1	O
]	O
,	O
making	O
this	O
animal	S-LIVB
a	O
less	O
desirable	O
model	O
for	O
the	O
human	S-LIVB
disease	O
.	O

Recently	O
,	O
a	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	E-CHEBI
(	O
ENU	S-CHEBI
)	O
-	O
induced	O
mutant	S-SO
mouse	S-LIVB
that	O
phenotypically	O
resembles	O
human	S-LIVB
MSUD	O
has	O
been	O
described	O
[	O
20	O
]	O
.	O

However	O
,	O
the	O
mutation	S-SO
in	O
this	O
model	O
disrupts	O
a	O
splice	B-SO
site	E-SO
in	O
the	O
mitochondrial	B-PRGE
branched	I-PRGE
-	I-PRGE
chain	I-PRGE
aminotransferase	I-PRGE
(	I-PRGE
BCAT	E-PRGE
)	O
gene	S-SO
,	O
not	O
in	O
BCKDH	S-GO
,	O
the	O
deficient	O
enzyme	S-SO
in	O
MSUD	O
.	O

Because	O
the	O
mutation	S-SO
is	O
not	O
in	O
BCKDH	S-GO
,	O
the	O
validity	O
of	O
this	O
mutant	S-SO
mouse	S-LIVB
line	O
for	O
modeling	O
human	S-LIVB
MSUD	O
is	O
questionable	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
create	O
genetically	S-SO
engineered	O
murine	S-LIVB
models	O
of	O
MSUD	O
that	O
mimic	O
the	O
pathology	O
of	O
the	O
classic	O
and	O
intermediate	O
variant	O
forms	O
of	O
the	O
human	S-LIVB
disease	O
.	O

The	O
classic	O
model	O
was	O
created	O
by	O
targeted	O
inactivation	O
of	O
the	O
E2	B-PRGE
subunit	I-PRGE
of	I-PRGE
BCKDH	E-PRGE
by	O
homologous	O
recombination	O
in	O
embryonic	O
stem	B-CL
(	I-CL
ES	I-CL
)	I-CL
cells	E-CL
.	O

The	O
model	O
of	O
intermediate	O
MSUD	O
was	O
created	O
by	O
partial	O
transgenic	S-SO
rescue	O
of	O
the	O
E2	S-PRGE
gene	S-SO
knockout	O
.	O

This	O
report	O
describes	O
the	O
generation	O
and	O
characterization	O
of	O
these	O
murine	S-LIVB
models	O
of	O
MSUD	O
.	O

These	O
models	O
will	O
allow	O
for	O
the	O
development	O
of	O
novel	O
treatment	O
approaches	O
,	O
such	O
as	O
gene	S-SO
or	O
stem	B-CL
cell	E-CL
therapies	O
,	O
to	O
ultimately	O
cure	O
MSUD	O
.	O

Methods	O

All	O
studies	O
involving	O
animals	S-LIVB
were	O
reviewed	O
and	O
approved	O
by	O
the	O
University	O
of	O
Pittsburgh	O
'	O
s	O
Institutional	O
Animal	S-LIVB
Care	O
and	O
Use	O
Committee	O
.	O

Gene	S-SO
knockout	O
production	O

A	O
genomic	B-SO
DNA	E-SO
subclone	O
of	O
Strain	O
129	O
/	O
SvJ	O
DNA	S-SO
that	O
contained	O
a	O
portion	B-SO
of	I-SO
Exons	E-SO
4	O
and	O
5	O
of	O
the	O
E2	S-PRGE
gene	S-SO
and	O
flanking	O
DNA	S-SO
was	O
obtained	O
from	O
a	O
P1	O
phage	O
library	O
from	O
Genome	S-SO
Systems	O
,	O
Inc	O
.	O
,	O
(	O
St	O
.	O
Louis	O
,	O
MO	O
;	O
'	O
3	O
-	O
Hit	O
Mouse	S-LIVB
ES	O
Library	O
'	O
)	O
.	O

A	O
positive	O
/	O
negative	O
replacement	S-SO
type	O
gene	S-SO
targeting	O
vector	S-SO
[	O
21	O
]	O
was	O
created	O
by	O
replacing	S-SO
a	O
1	O
.	O
67	O
kb	O
EcoRV	O
-	O
Smal	O
fragment	S-SO
that	O
included	O
a	O
portion	B-SO
of	I-SO
Exon	E-SO
4	O
and	O
all	O
of	O
Exon	S-SO
5	O
with	O
the	O
PGKneo	O
marker	O
gene	S-SO
(	O
See	O
Fig	O
.	O
1A	O
)	O
from	O
the	O
pPNT	O
vector	S-SO
[	O
22	O
]	O
.	O

The	O
targeting	O
construct	S-SO
was	O
linearized	O
with	O
NotI	O
and	O
electroporated	O
into	O
R1	O
ES	O
cells	S-CL
[	O
23	O
]	O
under	O
conditions	O
described	O
previously	O
[	O
24	O
]	O
.	O

ES	O
cells	S-CL
were	O
selected	O
with	O
G418	O
(	O
300	O
mu	O
g	O
/	O
ml	O
;	O
Life	O
Technologies	O
Inc	O
.	O
,	O
Gaithersburg	O
,	O
MD	O
)	O
and	O
gancyclovir	O
(	O
2	O
mu	O
M	O
;	O
gift	O
of	O
Syntex	O
,	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

Doubly	O
resistant	O
clones	O
were	O
screened	O
for	O
gene	S-SO
targeting	O
by	O
Southern	O
blot	O
analysis	O
of	O
BglI	O
digested	O
genomic	B-SO
DNA	E-SO
.	O

Blots	O
were	O
hybridized	O
with	O
an	O
Exon	S-SO
6	O
specific	O
probe	S-SO
that	O
was	O
external	O
to	O
the	O
gene	S-SO
targeting	O
construct	S-SO
.	O

Correctly	O
targeted	O
ES	O
cells	S-CL
were	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
to	O
produce	O
chimeric	O
mice	S-LIVB
using	O
standard	O
procedures	O
.	O

Heterozygous	O
offspring	O
from	O
germline	O
competent	O
chimeras	O
were	O
intercrossed	O
to	O
produce	O
wild	B-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
,	O
heterozygous	O
(	O
+	S-SO
/	O
-	O
)	O
and	O
homozygous	O
knockout	O
(	O
-	O
/	O
-	O
)	O
mice	S-LIVB
.	O

At	O
all	O
generations	O
,	O
+	S-SO
/	O
-	O
breeding	O
pairs	O
were	O
used	O
.	O

Results	O
presented	O
here	O
are	O
from	O
mice	S-LIVB
derived	O
from	O
the	O
F2	O
+	O
generations	O
.	O

All	O
animals	S-LIVB
were	O
of	O
a	O
mixed	O
C57BL	O
/	O
6J	O
x	O
Strain	O
129Sv	O
/	O
SvJ	O
genetic	S-SO
background	O
.	O

Figure	O
1	O

E2	S-PRGE
gene	S-SO
knockout	O
mouse	S-LIVB
production	O
.	O

A	O
,	O
Gene	S-SO
targeting	O
strategy	O
used	O
for	O
targeting	O
the	O
E2	S-PRGE
locus	S-SO
in	O
mouse	S-LIVB
ES	O
cells	S-CL
.	O

The	O
targeting	O
construct	S-SO
was	O
designed	O
to	O
delete	S-SO
1	O
.	O
67	O
kb	O
of	O
sequence	S-SO
between	O
an	O
EcoRV	O
site	B-SO
in	I-SO
Exon	E-SO
4	O
and	O
a	O
Smal	O
site	S-SO
in	O
intron	S-SO
5	O
.	O

The	O
wild	B-SO
type	E-SO
E2	S-PRGE
gene	S-SO
contains	O
an	O
~	O
16	O
kb	O
BglI	O
restriction	B-SO
fragment	E-SO
that	O
hybridizes	O
to	O
the	O
Exon	S-SO
6	O
specific	O
probe	S-SO
.	O

A	O
correctly	O
targeted	O
E2	S-PRGE
locus	S-SO
harbors	O
an	O
~	O
11	O
kb	O
BglI	O
restriction	B-SO
fragment	E-SO
that	O
hybridizes	O
to	O
the	O
same	O
probe	S-SO
.	O

Note	O
that	O
the	O
probe	S-SO
will	O
not	O
detect	O
random	O
integration	S-SO
of	O
the	O
targeting	O
vector	S-SO
because	O
it	O
is	O
external	O
to	O
the	O
targeting	O
vector	S-SO
.	O

B	O
,	O
Southern	O
blot	O
analysis	O
of	O
Bgll	O
digested	O
genomic	B-SO
DNA	E-SO
derived	O
from	O
the	O
parental	O
wild	B-SO
type	E-SO
ES	O
cell	S-CL
line	O
(	O
R1	O
)	O
,	O
a	O
heterozygous	O
targeted	O
ES	O
cell	S-CL
line	O
(	O
362	O
)	O
,	O
and	O
from	O
wild	B-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
,	O
heterozygous	O
(	O
+	S-SO
/	O
-	O
)	O
and	O
homozygous	O
knockout	O
(	O
-	O
/	O
-	O
)	O
mice	S-LIVB
.	O

The	O
blot	O
was	O
hybridized	O
with	O
an	O
Exon	S-SO
6	O
specific	O
probe	S-SO
.	O

C	O
,	O
Immunohistochemical	O
analysis	O
of	O
fresh	O
frozen	O
liver	O
sections	O
from	O
control	O
(	O
+	S-SO
/	O
+	S-SO
)	O
and	O
E2	S-PRGE
knockout	O
(	O
-	O
/	O
-	O
)	O
postnatal	O
day	O
1	O
mouse	S-LIVB
pups	O
.	O

Sections	O
were	O
stained	O
for	O
E2	S-PRGE
using	O
an	O
E2	S-PRGE
specific	O
antibody	S-GO
(	O
green	O
)	O
and	O
a	O
nuclear	S-GO
stain	O
(	O
blue	O
)	O
.	O

Note	O
the	O
complete	O
absence	O
of	O
E2	S-PRGE
immunoreactivity	O
in	O
the	O
section	O
from	O
the	O
knockout	O
mouse	S-LIVB
.	O

D	O
,	O
Similar	O
results	O
were	O
observed	O
upon	O
immunohistochemical	O
analysis	O
of	O
primary	O
mouse	S-LIVB
embryonic	O
fibroblasts	S-CL
(	O
MEFs	O
)	O
.	O

Note	O
that	O
the	O
readily	O
detectable	O
signal	O
for	O
E2	S-PRGE
in	O
the	O
control	O
cells	S-CL
was	O
present	O
in	O
a	O
pattern	O
characteristic	O
of	O
mitochondria	S-GO
,	O
the	O
subcellular	O
location	O
of	O
BCKDH	S-GO
.	O

Production	O
of	O
transgenic	S-SO
mice	S-LIVB

Standard	O
molecular	S-CHEBI
techniques	O
were	O
used	O
to	O
assemble	O
the	O
transgenic	S-SO
construct	S-SO
,	O
pTRE	O
-	O
E2	S-PRGE
.	O

This	O
transgene	S-SO
contains	O
the	O
tetracycline	S-CHEBI
responsive	O
hCMV	S-LIVB
*	O
-	O
1	O
promoter	S-SO
[	O
consisting	O
of	O
the	O
tetracycline	S-CHEBI
responsive	O
element	S-SO
(	O
TRE	O
)	O
and	O
a	O
minimal	O
hCMV	S-LIVB
promoter	S-SO
]	O
[	O
25	O
]	O
from	O
pTRE2	O
(	O
Clontech	O
Inc	O
.	O
,	O
Mt	O
.	O
View	O
,	O
CA	O
)	O
,	O
a	O
chimeric	O
intron	S-SO
from	O
pCI	O
(	O
Promega	O
)	O
to	O
increase	O
message	S-SO
stability	O
and	O
expression	O
[	O
26	O
,	O
27	O
]	O
,	O
a	O
Kozak	O
consensus	B-SO
sequence	E-SO
at	O
the	O
initiation	B-SO
codon	E-SO
to	O
optimize	O
translation	O
[	O
28	O
]	O
,	O
the	O
human	B-PRGE
E2	E-PRGE
cDNA	S-SO
which	O
has	O
been	O
modified	S-SO
to	O
contain	O
a	O
4	O
x	O
alanine	S-CHEBI
linker	O
followed	O
by	O
a	O
c	B-PRGE
-	I-PRGE
myc	E-PRGE
epitope	S-SO
tag	O
at	O
the	O
carboxy	B-SO
terminus	E-SO
to	O
facilitate	O
detection	O
,	O
and	O
an	O
SV40	S-LIVB
late	O
polyadenylation	B-SO
sequence	E-SO
from	O
pCI	O
for	O
enhanced	O
mRNA	S-CHEBI
stability	O
and	O
translation	O
.	O

The	O
2	O
.	O
48	O
kb	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
was	O
purified	O
from	O
vector	B-SO
sequences	E-SO
following	O
digestion	O
with	O
XhoI	O
and	O
BamHI	O
and	O
injected	O
into	O
C57BL	O
/	O
6J	O
or	O
C57BL	O
/	O
6J	O
x	O
Strain	O
129SvEv	O
mouse	S-LIVB
embryos	O
at	O
the	O
transgenic	S-SO
core	O
facilities	O
of	O
the	O
University	O
of	O
Pittsburgh	O
and	O
the	O
University	O
of	O
Cincinnati	O
,	O
respectively	O
.	O

Genomic	B-SO
DNA	E-SO
from	O
the	O
tail	O
of	O
mice	S-LIVB
was	O
screened	O
by	O
Southern	O
blot	O
analysis	O
following	O
digestion	O
with	O
EcoRI	O
and	O
hybridization	O
to	O
an	O
~	O
400	O
bp	S-SO
probe	S-SO
derived	O
from	O
the	O
SV40	S-LIVB
portion	S-SO
of	O
the	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
.	O

Production	O
of	O
intermediate	O
MSUD	O
murine	S-LIVB
model	O

The	O
various	O
TRE	O
-	O
E2	S-PRGE
transgenic	S-SO
lines	O
produced	O
were	O
mated	O
independently	O
to	O
mice	S-LIVB
that	O
were	O
heterozygous	O
for	O
both	O
the	O
E2	S-PRGE
knockout	O
and	O
the	O
LAP	S-PRGE
-	O
tTA	O
transgene	S-SO
[	O
Tg	S-SO
(	O
tTALap	O
)	O
Bjd	O
/	O
J	O
;	O
Stock	O
3272	O
;	O
The	O
Jackson	O
Laboratory	O
,	O
Bar	O
Harbor	O
,	O
ME	O
;	O
NMRI	O
x	O
FVB	O
x	O
C57BL	O
/	O
6J	O
background	O
]	O
.	O

Interbreeding	O
of	O
animals	S-LIVB
that	O
were	O
heterozygous	O
for	O
both	O
transgenes	S-SO
and	O
the	O
knockout	O
resulted	O
in	O
the	O
production	O
of	O
mice	S-LIVB
with	O
a	O
variety	O
of	O
genotypes	S-SO
including	O
some	O
animals	S-LIVB
that	O
were	O
homozygous	O
for	O
the	O
knockout	O
and	O
were	O
positive	O
for	O
both	O
transgenes	S-SO
(	O
we	O
refer	O
to	O
this	O
genotype	S-SO
as	O
the	O
"	O
rescue	S-SO
"	O
genotype	S-SO
)	O
.	O

If	O
our	O
strategy	O
for	O
rescuing	O
the	O
neonatal	O
lethal	O
phenotype	O
of	O
the	O
knockout	O
were	O
successful	O
,	O
then	O
those	O
homozygous	O
knockout	O
animals	S-LIVB
that	O
had	O
both	O
transgenes	S-SO
would	O
survive	O
beyond	O
the	O
neonatal	O
period	O
.	O

Genotyping	O

All	O
mice	S-LIVB
were	O
genotyped	O
by	O
Southern	O
blot	O
analysis	O
.	O

Genomic	B-SO
DNAs	E-SO
prepared	O
from	O
tail	O
snips	O
were	O
digested	O
with	O
an	O
appropriate	O
restriction	O
enzyme	S-SO
,	O
size	O
fractionated	O
by	O
agarose	S-CHEBI
gel	O
electrophoresis	O
,	O
blotted	O
to	O
nylon	S-CHEBI
,	O
and	O
probed	O
using	O
standard	O
procedures	O
.	O

Immunohistochemistry	O

Primary	O
mouse	S-LIVB
embryonic	O
fibroblasts	S-CL
were	O
prepared	O
from	O
embryonic	O
day	O
~	O
16	O
.	O
5	O
-	O
18	O
.	O
5	O
fetuses	O
as	O
described	O
[	O
29	O
]	O
.	O

Fibroblasts	S-CL
were	O
passed	O
onto	O
glass	O
,	O
fixed	O
in	O
2	O
%	O
paraformaldehyde	O
in	O
PBS	O
for	O
10	O
minutes	O
,	O
permeabilized	O
in	O
2	O
%	O
paraformaldehyde	O
containing	O
0	O
.	O
1	O
%	O
Triton	O
X100	O
for	O
10	O
minutes	O
and	O
washed	O
three	O
times	O
in	O
PBS	O
containing	O
0	O
.	O
5	O
%	O
BSA	S-PRGE
and	O
0	O
.	O
15	O
%	O
glycine	S-CHEBI
,	O
pH	O
7	O
.	O
4	O
(	O
Buffer	O
A	O
)	O
.	O

Following	O
a	O
30	O
min	O
incubation	O
with	O
purified	O
goat	S-LIVB
IgG	O
(	O
50	O
(	O
mu	O
g	O
/	O
ml	O
)	O
at	O
25	O
degrees	O
C	O
and	O
three	O
additional	O
washes	O
with	O
Buffer	O
A	O
,	O
cells	S-CL
were	O
incubated	O
for	O
60	O
min	O
with	O
E2	S-PRGE
-	O
specific	O
antiserum	O
[	O
30	O
]	O
at	O
1	O
mu	O
g	O
/	O
ml	O
followed	O
by	O
three	O
washes	O
in	O
Buffer	O
A	O
and	O
60	O
minute	O
incubation	O
in	O
fluorescently	B-CHEBI
labeled	E-CHEBI
second	O
antibody	S-GO
(	O
1	O
-	O
2	O
mu	O
g	O
/	O
ml	O
)	O
.	O

The	O
cells	S-CL
were	O
then	O
washed	O
six	O
times	O
(	O
5	O
min	O
/	O
wash	O
)	O
in	O
Buffer	O
A	O
and	O
then	O
mounted	O
in	O
gelvatol	S-CHEBI
(	O
Monsanto	O
,	O
St	O
Louis	O
)	O
.	O

When	O
livers	O
from	O
newborn	O
pups	O
were	O
examined	O
,	O
fixation	O
was	O
by	O
immersion	O
in	O
2	O
%	O
paraformaldehyde	O
followed	O
by	O
cryoprotection	O
and	O
shock	O
freezing	O
in	O
liquid	O
nitrogen	S-CHEBI
cooled	O
isopentane	S-CHEBI
and	O
sectioning	O
(	O
5	O
microns	O
)	O
.	O

Otherwise	O
processing	O
was	O
as	O
for	O
the	O
cells	S-CL
above	O
(	O
without	O
the	O
fixation	O
and	O
permabilization	O
steps	O
)	O
.	O

Amino	B-CHEBI
acid	E-CHEBI
analysis	O

Blood	O
was	O
collected	O
from	O
the	O
retroorbital	O
sinus	O
or	O
tail	O
vein	O
of	O
mice	S-LIVB
and	O
spotted	O
on	O
a	O
filter	O
paper	O
routinely	O
used	O
for	O
blood	O
amino	B-CHEBI
acid	E-CHEBI
analysis	O
for	O
prenatal	O
screening	O
.	O

Concentrations	O
of	O
BCAA	S-CHEBI
and	O
other	O
amino	B-CHEBI
acids	E-CHEBI
in	O
blood	O
were	O
determined	O
by	O
tandem	O
mass	O
spectrometry	O
(	O
Pediatrix	O
Screening	O
,	O
Bridgeville	O
,	O
PA	O
)	O
.	O

Assay	O
of	O
BCKDH	S-GO
activity	O

Livers	O
were	O
removed	O
,	O
frozen	O
in	O
liquid	O
nitrogen	S-CHEBI
,	O
and	O
stored	O
at	O
-	O
80	O
degrees	O
C	O
.	O

At	O
the	O
time	O
of	O
enzyme	S-SO
assay	O
,	O
livers	O
were	O
thawed	O
,	O
and	O
homogenized	O
(	O
1	O
:	O
9	O
,	O
w	O
/	O
v	O
)	O
in	O
0	O
.	O
25	O
M	O
sucrose	S-CHEBI
,	O
10	O
mM	O
Tris	S-CHEBI
-	O
HC1	S-CHEBI
,	O
pH	O
7	O
.	O
4	O
.	O

Liver	O
homogenates	O
were	O
centrifuged	O
at	O
600	O
x	O
g	O
for	O
10	O
min	O
at	O
4	O
degrees	O
C	O
and	O
the	O
supernatant	O
fraction	S-GO
was	O
saved	O
to	O
determine	O
the	O
BCKDH	S-GO
activity	O
.	O

The	O
use	O
of	O
tissue	O
homogenates	O
was	O
necessitated	O
by	O
the	O
limited	O
availability	O
of	O
liver	O
tissue	O
,	O
particularly	O
from	O
newborn	O
pups	O
.	O

BCKDH	S-GO
activity	O
was	O
determined	O
by	O
measuring	O
the	O
release	O
of	O
14CO2	O
from	O
alpha	B-CHEBI
-	I-CHEBI
keto	I-CHEBI
[	I-CHEBI
1	I-CHEBI
-	I-CHEBI
14C	I-CHEBI
]	I-CHEBI
isocaproate	E-CHEBI
as	O
described	O
previously	O
[	O
31	O
]	O
.	O

The	O
complete	O
reaction	O
mixture	O
contained	O
(	O
final	O
volume	O
1	O
ml	O
)	O
30	O
mM	O
potassium	S-CHEBI
phosphate	S-CHEBI
buffer	O
,	O
pH	O
7	O
.	O
4	O
,	O
0	O
.	O
20	O
mM	O
alpha	B-CHEBI
-	I-CHEBI
ketoisocaproate	E-CHEBI
,	O
0	O
.	O
40	O
mM	O
CoASH	S-CHEBI
,	O
0	O
.	O
40	O
mM	O
thiamin	B-CHEBI
pyrophosphate	E-CHEBI
,	O
2	O
mM	O
NAD	B-CHEBI
+	E-CHEBI
,	O
2	O
mM	O
dithiothreitol	S-CHEBI
,	O
5	O
mM	O
Mg2	B-CHEBI
+	E-CHEBI
,	O
approximately	O
250	O
,	O
000	O
DPM	O
of	O
alpha	B-CHEBI
-	I-CHEBI
keto	I-CHEBI
[	I-CHEBI
1	I-CHEBI
-	I-CHEBI
14C	I-CHEBI
]	I-CHEBI
isocaproate	E-CHEBI
,	O
and	O
0	O
.	O
10	O
ml	O
of	O
liver	O
homogenate	O
(	O
2	O
-	O
3	O
mg	O
protein	S-CHEBI
)	O
.	O

Assays	O
were	O
carried	O
out	O
for	O
15	O
min	O
at	O
37	O
degrees	O
C	O
,	O
14CO2	O
was	O
trapped	O
in	O
hydroxide	S-CHEBI
of	O
Hyamine	O
,	O
and	O
radioactivity	O
was	O
determined	O
by	O
liquid	O
scintillation	O
spectrometry	O
.	O

Western	O
blot	O
analysis	O

Protein	S-CHEBI
extracts	O
were	O
isolated	O
from	O
homogenized	O
liver	O
(	O
freshly	O
harvested	O
and	O
flash	O
frozen	O
)	O
of	O
wildtype	S-SO
,	O
Line	O
525A	O
,	O
and	O
Line	O
A	O
transgenic	S-SO
mice	S-LIVB
.	O

Protein	S-CHEBI
(	O
25	O
mu	O
g	O
per	O
sample	O
)	O
was	O
analyzed	O
by	O
electrophoresis	O
on	O
a	O
10	O
%	O
SDS	S-CHEBI
-	O
PAGE	O
Ready	O
Gel	O
(	O
Bio	O
-	O
Rad	O
,	O
Hercules	O
,	O
CA	O
)	O
and	O
transferred	O
to	O
PVDF	O
membrane	O
(	O
Sequi	O
-	O
Blot	O
;	O
Bio	O
-	O
Rad	O
)	O
via	O
electroblotting	O
.	O

All	O
blots	O
were	O
probed	O
for	O
E2	S-PRGE
protein	S-CHEBI
using	O
polyclonal	O
rabbit	S-LIVB
E2	S-PRGE
antisera	O
(	O
1	O
:	O
5	O
,	O
000	O
)	O
,	O
which	O
detects	O
both	O
mouse	B-PRGE
(	I-PRGE
~	I-PRGE
47	I-PRGE
kD	I-PRGE
)	I-PRGE
and	I-PRGE
human	I-PRGE
(	I-PRGE
~	I-PRGE
54	I-PRGE
kD	I-PRGE
)	I-PRGE
E2	I-PRGE
subunits	E-PRGE
(	O
[	O
30	O
]	O
;	O
gift	O
from	O
Dr	O
.	O
Susan	O
Hutson	O
,	O
Wake	O
Forest	O
University	O
)	O
.	O

Blots	O
were	O
re	O
-	O
probed	O
with	O
a	O
rabbit	S-LIVB
anti	O
-	O
c	B-PRGE
-	I-PRGE
myc	E-PRGE
tag	O
antibody	S-GO
(	O
1	O
:	O
10	O
,	O
000	O
;	O
abCam	O
,	O
Cambridge	O
,	O
MA	O
;	O
cat	O
.	O
#	O
ab9106	O
-	O
100	O
)	O
.	O

Blots	O
were	O
also	O
re	O
-	O
probed	O
with	O
an	O
antibody	S-GO
for	O
beta	B-PRGE
-	I-PRGE
actin	E-PRGE
(	O
43	O
kD	O
;	O
1	O
:	O
10	O
,	O
000	O
;	O
abCam	O
;	O
cat	O
.	O
#	O
ab8227	O
-	O
50	O
)	O
to	O
allow	O
for	O
loading	O
comparisons	O
.	O

A	O
goat	S-LIVB
anti	O
-	O
rabbit	S-LIVB
secondary	O
antibody	S-GO
conjugated	O
to	O
horseradish	S-LIVB
peroxidase	O
(	O
1	O
:	O
10	O
,	O
000	O
;	O
Novus	O
,	O
Littleton	O
,	O
CO	O
;	O
cat	O
.	O
#	O
NB730	O
-	O
H	O
)	O
was	O
used	O
for	O
detection	O
using	O
the	O
Western	O
Lightning	O
chemiluminescence	O
reagent	S-CHEBI
(	O
Perkin	O
Elmer	O
,	O
Boston	O
,	O
MA	O
)	O
and	O
exposed	O
to	O
X	O
-	O
ray	O
film	O
.	O

Statistical	O
analyses	O

All	O
BCAA	S-CHEBI
and	O
BCKDH	S-GO
enzyme	S-SO
activity	O
data	O
are	O
presented	O
as	O
the	O
mean	O
+	O
/	O
-	O
the	O
standard	O
error	O
of	O
the	O
mean	O
(	O
S	O
.	O
E	O
.	O
M	O
.	O
)	O
.	O

Differences	O
between	O
genotypes	S-SO
were	O
compared	O
by	O
Student	O
'	O
s	O
t	O
test	O
[	O
32	O
]	O
.	O

Results	O

Production	O
of	O
E2	S-PRGE
gene	S-SO
knockout	O
mice	S-LIVB

To	O
create	O
E2	S-PRGE
knockout	O
mice	S-LIVB
,	O
we	O
used	O
gene	S-SO
targeting	O
in	O
mouse	S-LIVB
ES	O
cells	S-CL
to	O
disrupt	O
the	O
E2	S-PRGE
gene	S-SO
.	O

The	O
overall	O
strategy	O
for	O
disrupting	O
the	O
E2	S-PRGE
gene	S-SO
is	O
illustrated	O
in	O
Fig	O
.	O

1A	O
.	O

The	O
gene	S-SO
targeting	O
construct	S-SO
was	O
designed	O
to	O
replace	S-SO
a	O
1	O
.	O
67	O
kb	O
EcoRV	O
/	O
Smal	O
genomic	B-SO
DNA	E-SO
fragment	S-SO
encompassing	O
part	B-SO
of	I-SO
Exon	E-SO
4	O
and	O
all	O
of	O
Exon	S-SO
5	O
with	O
the	O
PGKneo	O
selectable	O
marker	O
cassette	S-SO
.	O

Of	O
522	O
ES	O
cell	S-CL
clones	O
screened	O
for	O
targeting	O
by	O
Southern	O
blot	O
analysis	O
,	O
29	O
(	O
5	O
%	O
)	O
displayed	O
the	O
predicted	S-SO
restriction	B-SO
fragment	I-SO
length	I-SO
polymorphisms	E-SO
indicative	O
of	O
gene	S-SO
targeting	O
at	O
the	O
E2	S-PRGE
locus	S-SO
.	O

As	O
illustrated	O
in	O
Fig	O
.	O

1A	O
and	O
1B	O
,	O
an	O
E2	S-PRGE
Exon	S-SO
6	O
specific	O
probe	S-SO
,	O
which	O
is	O
external	O
to	O
the	O
targeting	O
construct	S-SO
,	O
hybridizes	O
to	O
only	O
a	O
~	O
16	O
kb	O
BglI	O
restriction	B-SO
fragment	E-SO
from	O
the	O
wild	B-SO
type	E-SO
allele	S-SO
in	O
the	O
parental	O
R1	O
ES	O
cell	S-CL
line	O
.	O

In	O
correctly	O
targeted	O
ES	O
cells	S-CL
,	O
this	O
probe	S-SO
also	O
hybridizes	O
to	O
a	O
~	O
11	O
kb	O
BglI	O
restriction	B-SO
fragment	E-SO
.	O

Targeting	O
was	O
confirmed	O
with	O
several	O
additional	O
restriction	O
enzymes	S-SO
and	O
probes	S-SO
(	O
data	O
not	O
shown	O
)	O
.	O

Correctly	O
targeted	O
ES	O
cells	S-CL
were	O
microinjected	O
into	O
blastocysts	O
to	O
produce	O
chimeric	O
mice	S-LIVB
.	O

Chimerics	O
were	O
bred	O
to	O
C57BL	O
/	O
6J	O
mice	S-LIVB
.	O

Following	O
germline	O
transmission	O
of	O
the	O
targeted	O
allele	S-SO
,	O
heterozygous	O
mice	S-LIVB
were	O
interbred	O
to	O
produce	O
wild	B-SO
type	E-SO
(	O
+	S-SO
/	O
+	S-SO
)	O
,	O
heterozygous	O
(	O
+	S-SO
/	O
-	O
)	O
and	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
animals	S-LIVB
.	O

Mice	S-LIVB
were	O
genotyped	O
by	O
Southern	O
blot	O
analysis	O
.	O

The	O
Exon	S-SO
6	O
specific	O
probe	S-SO
hybridized	O
to	O
only	O
a	O
~	O
16	O
kb	O
BglI	O
restriction	B-SO
fragment	E-SO
in	O
+	S-SO
/	O
+	S-SO
mice	S-LIVB
,	O
a	O
~	O
11	O
kb	O
BglI	O
fragment	S-SO
in	O
-	O
/	O
-	O
mice	S-LIVB
,	O
and	O
to	O
both	O
of	O
these	O
fragments	S-SO
in	O
+	S-SO
/	O
-	O
mice	S-LIVB
(	O
Fig	O
.	O
1B	O
)	O
.	O

Mice	S-LIVB
homozygous	O
for	O
the	O
E2	S-PRGE
mutation	S-SO
were	O
born	O
at	O
the	O
expected	O
frequency	O
.	O

Genotype	S-SO
analysis	O
of	O
pups	O
derived	O
from	O
+	S-SO
/	O
-	O
by	O
+	S-SO
/	O
-	O
matings	O
revealed	O
that	O
+	S-SO
/	O
+	S-SO
,	O
+	S-SO
/	O
-	O
,	O
and	O
-	O
/	O
-	O
mice	S-LIVB
were	O
present	O
at	O
nearly	O
the	O
expected	O
1	O
:	O
2	O
:	O
1	O
frequency	O
.	O

Of	O
the	O
initial	O
60	O
animals	S-LIVB
genotyped	O
,	O
19	O
(	O
32	O
%	O
)	O
were	O
+	S-SO
/	O
+	S-SO
,	O
27	O
(	O
45	O
%	O
)	O
were	O
+	S-SO
/	O
-	O
,	O
and	O
14	O
(	O
23	O
%	O
)	O
were	O
-	O
/	O
-	O
.	O

Thus	O
,	O
the	O
E2	S-PRGE
gene	S-SO
was	O
dispensable	O
for	O
normal	O
embryonic	O
development	O
.	O

However	O
,	O
as	O
expected	O
,	O
nearly	O
all	O
homozygous	O
mice	S-LIVB
died	O
in	O
the	O
perinatal	O
period	O
.	O

Immediately	O
following	O
birth	O
,	O
homozygous	O
pups	O
were	O
indistinguishable	O
from	O
their	O
+	S-SO
/	O
+	S-SO
and	O
+	S-SO
/	O
-	O
littermates	O
;	O
they	O
were	O
vigorous	O
,	O
active	O
and	O
able	O
to	O
suckle	O
.	O

By	O
mid	O
to	O
late	O
day	O
on	O
postnatal	O
day	O
one	O
,	O
most	O
-	O
/	O
-	O
pups	O
became	O
moribund	O
and	O
were	O
readily	O
identifiable	O
as	O
they	O
were	O
lethargic	O
,	O
pale	O
,	O
and	O
exhibited	O
gasping	O
respiratory	O
movements	O
.	O

With	O
few	O
exceptions	O
,	O
-	O
/	O
-	O
pups	O
died	O
within	O
72	O
hours	O
of	O
birth	O
.	O

We	O
have	O
observed	O
one	O
rare	O
-	O
/	O
-	O
pup	O
that	O
survived	O
to	O
postnatal	O
day	O
13	O
.	O

The	O
reason	O
for	O
the	O
prolonged	O
survival	O
of	O
this	O
pup	O
is	O
unknown	O
.	O

E2	S-PRGE
deficient	O
mice	S-LIVB
accurately	O
model	O
classic	O
MSUD	O

To	O
demonstrate	O
that	O
the	O
gene	S-SO
targeting	O
event	O
created	O
a	O
true	O
E2	S-PRGE
null	O
allele	S-SO
,	O
we	O
determined	O
BCKDH	S-GO
activity	O
in	O
liver	O
homogenates	O
of	O
postnatal	O
day	O
1	O
mouse	S-LIVB
pups	O
derived	O
from	O
+	S-SO
/	O
-	O
by	O
+	S-SO
/	O
-	O
mating	O
pairs	O
.	O

As	O
shown	O
in	O
Figure	O
2A	O
,	O
the	O
BCKDH	S-GO
activity	O
in	O
+	S-SO
/	O
+	S-SO
mice	S-LIVB
was	O
readily	O
detectable	O
.	O

In	O
marked	O
contrast	O
,	O
BCKDH	S-GO
activity	O
was	O
completely	O
absent	O
in	O
-	O
/	O
-	O
mouse	S-LIVB
livers	O
.	O

As	O
expected	O
,	O
homogenates	O
from	O
+	S-SO
/	O
-	O
mice	S-LIVB
had	O
approximately	O
half	O
the	O
activity	O
of	O
their	O
+	S-SO
/	O
+	S-SO
littermates	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
results	O
from	O
-	O
/	O
-	O
mice	S-LIVB
are	O
similar	O
to	O
that	O
observed	O
in	O
humans	S-LIVB
with	O
classic	O
MSUD	O
[	O
1	O
]	O
.	O

Figure	O
2	O

Biochemical	O
characterization	O
of	O
the	O
classic	O
MSUD	O
murine	S-LIVB
model	O
.	O

A	O
,	O
BCKDH	S-GO
enzyme	S-SO
activity	O
in	O
liver	O
of	O
newborn	O
wild	B-SO
type	E-SO
control	O
(	O
+	S-SO
/	O
+	S-SO
)	O
,	O
heterozygous	O
(	O
+	S-SO
/	O
-	O
)	O
,	O
and	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
knockout	O
mice	S-LIVB
.	O

Enzyme	S-SO
activity	O
was	O
significantly	O
reduced	O
in	O
+	S-SO
/	O
-	O
liver	O
compared	O
to	O
+	S-SO
/	O
+	S-SO
,	O
and	O
was	O
below	O
the	O
level	O
of	O
detection	O
in	O
-	O
/	O
-	O
liver	O
.	O

B	O
,	O
Total	O
BCAA	S-CHEBI
concentrations	O
in	O
blood	O
of	O
mice	S-LIVB
.	O

Total	O
BCAA	S-CHEBI
represent	O
the	O
sum	O
of	O
leucine	S-CHEBI
,	O
isoleucine	S-CHEBI
,	O
and	O
valine	S-CHEBI
.	O

Total	O
BCAA	S-CHEBI
concentrations	O
in	O
blood	O
from	O
-	O
/	O
-	O
mice	S-LIVB
were	O
significantly	O
elevated	O
compared	O
to	O
+	S-SO
/	O
+	S-SO
and	O
+	S-SO
/	O
-	O
.	O

C	O
,	O
Ratio	O
of	O
total	O
BCAA	S-CHEBI
to	O
alanine	S-CHEBI
in	O
blood	O
of	O
mice	S-LIVB
.	O

This	O
ratio	O
was	O
significantly	O
elevated	O
in	O
-	O
/	O
-	O
mice	S-LIVB
compared	O
to	O
+	S-SO
/	O
+	S-SO
and	O
+	S-SO
/	O
-	O
mice	S-LIVB
.	O

The	O
numbers	O
on	O
the	O
bars	O
indicates	O
the	O
number	O
of	O
mice	S-LIVB
analyzed	O
.	O

*	O
,	O
Significantly	O
different	O
from	O
+	S-SO
/	O
+	S-SO
(	O
P	O
<	O
0	O
.	O
001	O
)	O
;	O
*	O
*	O
,	O
significantly	O
different	O
from	O
+	S-SO
/	O
+	S-SO
and	O
+	S-SO
/	O
-	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Immunohistochemistry	O
with	O
an	O
E2	S-PRGE
specific	O
antibody	S-GO
was	O
used	O
to	O
examine	O
E2	S-PRGE
protein	S-CHEBI
in	O
the	O
mice	S-LIVB
.	O

As	O
shown	O
in	O
Figure	O
1C	O
and	O
1D	O
,	O
immunoreactive	O
E2	S-PRGE
protein	S-CHEBI
was	O
abundant	O
in	O
liver	O
and	O
embryonic	O
fibroblasts	S-CL
of	O
+	S-SO
/	O
+	S-SO
mice	S-LIVB
.	O

In	O
marked	O
contrast	O
,	O
immunoreactive	O
E2	S-PRGE
protein	S-CHEBI
was	O
absent	O
in	O
these	O
same	O
tissues	O
of	O
-	O
/	O
-	O
mice	S-LIVB
.	O

Homozygous	O
E2	S-PRGE
knockout	O
mice	S-LIVB
had	O
a	O
nearly	O
3	O
-	O
fold	O
increase	O
in	O
blood	O
(	O
Figure	O
2B	O
)	O
and	O
urine	O
(	O
data	O
not	O
shown	O
)	O
levels	O
of	O
BCAA	S-CHEBI
(	O
sum	O
of	O
leucine	S-CHEBI
,	O
isoleucine	S-CHEBI
,	O
and	O
valine	S-CHEBI
)	O
as	O
compared	O
to	O
their	O
+	S-SO
/	O
+	S-SO
littermates	O
.	O

Because	O
amino	B-CHEBI
acids	E-CHEBI
were	O
analyzed	O
by	O
tandem	O
mass	O
spectrometry	O
,	O
the	O
sum	O
of	O
BCAA	S-CHEBI
shown	O
in	O
Figure	O
2B	O
also	O
may	O
include	O
alloisoleucine	S-CHEBI
that	O
may	O
have	O
been	O
produced	O
in	O
-	O
/	O
-	O
MSUD	O
mice	S-LIVB
.	O

The	O
metabolism	O
of	O
BCAA	S-CHEBI
is	O
linked	O
with	O
the	O
synthesis	O
of	O
alanine	S-CHEBI
,	O
glutamate	S-CHEBI
,	O
and	O
glutamine	S-CHEBI
[	O
33	O
]	O
.	O

Because	O
of	O
impaired	O
metabolism	O
of	O
BCAA	S-CHEBI
in	O
MSUD	O
mice	S-LIVB
,	O
and	O
to	O
further	O
characterize	O
the	O
abnormal	O
biochemistry	O
in	O
this	O
model	O
,	O
we	O
analyzed	O
the	O
blood	O
levels	O
of	O
the	O
alanine	S-CHEBI
,	O
glutamate	S-CHEBI
,	O
and	O
glutamine	S-CHEBI
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
levels	O
of	O
all	O
three	O
amino	B-CHEBI
acids	E-CHEBI
in	O
homozygous	O
mice	S-LIVB
were	O
markedly	O
lower	O
than	O
the	O
levels	O
in	O
+	S-SO
/	O
+	S-SO
or	O
+	S-SO
/	O
-	O
mice	S-LIVB
.	O

The	O
levels	O
of	O
these	O
amino	B-CHEBI
acids	E-CHEBI
in	O
the	O
+	S-SO
/	O
-	O
mice	S-LIVB
were	O
comparable	O
to	O
those	O
in	O
+	S-SO
/	O
+	S-SO
mice	S-LIVB
(	O
Table	O
1	O
)	O
.	O

Because	O
of	O
the	O
abnormal	O
decrease	O
in	O
the	O
blood	O
alanine	S-CHEBI
level	O
and	O
marked	O
rise	O
in	O
blood	O
BCAA	S-CHEBI
levels	O
that	O
are	O
characteristic	O
of	O
MSUD	O
,	O
a	O
recent	O
report	O
on	O
MSUD	O
patients	O
has	O
suggested	O
that	O
the	O
ratio	O
of	O
BCAA	S-CHEBI
/	O
alanine	S-CHEBI
provides	O
a	O
more	O
sensitive	O
measure	O
of	O
the	O
abnormal	O
biochemistry	O
of	O
MSUD	O
than	O
BCAA	S-CHEBI
level	O
alone	O
[	O
8	O
]	O
.	O

Therefore	O
,	O
we	O
also	O
expressed	O
the	O
amino	B-CHEBI
acid	E-CHEBI
results	O
as	O
BCAA	S-CHEBI
/	O
alanine	S-CHEBI
ratio	O
.	O

As	O
shown	O
in	O
Figure	O
2C	O
,	O
this	O
ratio	O
in	O
-	O
/	O
-	O
pups	O
was	O
more	O
than	O
6	O
-	O
fold	O
higher	O
than	O
+	S-SO
/	O
+	S-SO
or	O
+	S-SO
/	O
-	O
littermates	O
.	O

These	O
blood	O
amino	B-CHEBI
acid	E-CHEBI
results	O
are	O
consistent	O
with	O
the	O
concentrations	O
seen	O
in	O
patients	O
with	O
MSUD	O
[	O
1	O
,	O
8	O
,	O
15	O
]	O
.	O

Table	O
1	O

Summary	O
of	O
additional	O
blood	O
amino	B-CHEBI
acid	E-CHEBI
levels	O
in	O
the	O
classic	O
MSUD	O
model	O
and	O
control	O
littermates	O
as	O
determined	O
by	O
tandem	O
mass	O
spectrometry	O
.	O

All	O
samples	O
were	O
collected	O
on	O
the	O
day	O
of	O
birth	O
.	O

All	O
values	O
are	O
mean	O
+	O
/	O
-	O
SEM	O
.	O

*	O
:	O
Significantly	O
different	O
from	O
+	S-SO
/	O
+	S-SO
and	O
+	S-SO
/	O
-	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

In	O
summary	O
,	O
E2	S-PRGE
knockout	O
mice	S-LIVB
lack	O
BCKDH	S-GO
enzymatic	S-SO
activity	O
,	O
E2	S-PRGE
immunoreactivity	O
,	O
and	O
have	O
markedly	O
elevated	O
levels	O
of	O
BCAA	S-CHEBI
in	O
the	O
blood	O
and	O
urine	O
.	O

These	O
metabolic	O
derangements	O
ultimately	O
result	O
in	O
neonatal	O
lethality	O
.	O

These	O
phenotypes	O
are	O
remarkably	O
similar	O
to	O
that	O
observed	O
in	O
humans	S-LIVB
with	O
the	O
classic	O
form	O
of	O
MSUD	O
.	O

Thus	O
,	O
E2	S-PRGE
knockout	O
mice	S-LIVB
closely	O
model	O
classic	O
MSUD	O
.	O

Knockout	O
mice	S-LIVB
expressing	O
a	O
human	B-PRGE
E2	E-PRGE
transgene	S-SO
model	O
a	O
variant	O
form	O
of	O
MSUD	O
that	O
mimics	O
intermediate	O
MSUD	O

To	O
create	O
a	O
murine	S-LIVB
model	O
of	O
the	O
intermediate	O
variant	O
form	O
of	O
MSUD	O
,	O
we	O
used	O
a	O
transgenic	S-SO
strategy	O
to	O
rescue	O
the	O
severe	O
elevation	O
of	O
BCAA	S-CHEBI
and	O
neonatal	O
lethality	O
that	O
occurs	O
in	O
the	O
classic	O
MSUD	O
mouse	S-LIVB
model	O
.	O

Our	O
strategy	O
was	O
composed	O
of	O
a	O
two	O
part	O
transgenic	S-SO
system	O
to	O
express	O
human	B-PRGE
E2	E-PRGE
in	O
liver	O
on	O
the	O
E2	S-PRGE
knockout	O
background	O
.	O

This	O
bi	O
-	O
transgenic	S-SO
system	O
consisted	O
of	O
a	O
LAP	S-PRGE
-	O
tTA	O
transgene	S-SO
and	O
a	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
(	O
Fig	O
.	O
3A	O
)	O
.	O

The	O
LAP	S-PRGE
-	O
tTA	O
transgene	S-SO
[	O
34	O
]	O
directs	O
high	O
levels	O
of	O
liver	O
specific	O
expression	O
of	O
the	O
tetracycline	S-CHEBI
-	O
controlled	O
transactivator	O
(	O
tTA	O
)	O
,	O
a	O
transcription	O
factor	O
that	O
stimulates	O
expression	O
of	O
promoters	S-SO
that	O
harbor	O
a	O
transactivator	O
response	O
element	S-SO
(	O
TRE	O
)	O
.	O

The	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
was	O
designed	O
to	O
express	O
a	O
human	B-PRGE
E2	E-PRGE
cDNA	S-SO
from	O
a	O
TRE	O
containing	O
minimal	O
promoter	S-SO
upon	O
stimulation	O
by	O
tTA	O
.	O

Figure	O
3	O

Transgenic	S-SO
mouse	S-LIVB
production	O
and	O
characterization	O
.	O

A	O
,	O
Transgenic	S-SO
strategy	O
used	O
to	O
produce	O
mice	S-LIVB
that	O
express	O
human	B-PRGE
E2	E-PRGE
.	O

LAP	S-PRGE
-	O
tTA	O
transgenic	S-SO
mice	S-LIVB
have	O
been	O
previously	O
described	O
[	O
34	O
]	O
.	O

These	O
mice	S-LIVB
express	O
the	O
tetracycline	S-CHEBI
-	O
controlled	O
transactivator	O
(	O
tTA	O
)	O
from	O
the	O
liver	O
specific	O
LAP	S-PRGE
promoter	S-SO
.	O

The	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
contains	O
the	O
tetracycline	S-CHEBI
response	O
element	S-SO
(	O
TRE	O
)	O
as	O
part	O
of	O
the	O
promoter	S-SO
,	O
a	O
synthetic	S-SO
intron	S-SO
(	O
thin	O
line	O
)	O
,	O
the	O
human	B-PRGE
E2	E-PRGE
cDNA	S-SO
,	O
an	O
alanine	S-CHEBI
spacer	O
,	O
a	O
c	B-PRGE
-	I-PRGE
myc	E-PRGE
epitope	S-SO
tag	O
,	O
and	O
SV40	S-LIVB
derived	O
polyadenylation	B-SO
sequence	E-SO
.	O

This	O
construct	S-SO
was	O
used	O
to	O
create	O
several	O
lines	O
of	O
transgenic	S-SO
mice	S-LIVB
.	O

B	O
,	O
Western	O
blot	O
analysis	O
of	O
E2	S-PRGE
protein	S-CHEBI
in	O
liver	O
of	O
control	O
and	O
intermediate	O
MSUD	O
mice	S-LIVB
.	O

Note	O
that	O
the	O
amount	O
of	O
human	B-PRGE
E2	E-PRGE
protein	S-CHEBI
(	O
predicted	O
MW	O
~	O
54	O
Kd	O
)	O
in	O
mice	S-LIVB
from	O
Lines	O
A	O
and	O
525	O
A	O
was	O
variable	O
but	O
in	O
many	O
of	O
the	O
animals	S-LIVB
the	O
amount	O
was	O
similar	O
to	O
the	O
amount	O
of	O
mouse	B-PRGE
E2	E-PRGE
(	O
MW	O
=	O
~	O
47	O
Kd	O
)	O
in	O
control	O
animals	S-LIVB
.	O

Re	O
-	O
probing	O
with	O
a	O
c	B-PRGE
-	I-PRGE
myc	E-PRGE
tag	O
antibody	S-GO
confirmed	O
the	O
presence	O
of	O
the	O
transgene	S-SO
derived	O
,	O
c	B-PRGE
-	I-PRGE
myc	E-PRGE
tagged	O
,	O
human	B-PRGE
E2	E-PRGE
in	O
transgenic	S-SO
mice	S-LIVB
but	O
not	O
in	O
controls	O
.	O

Western	O
blot	O
analysis	O
of	O
brain	O
(	O
C	O
)	O
,	O
kidney	O
(	O
D	O
)	O
,	O
and	O
muscle	O
(	O
E	O
)	O
revealed	O
negligible	O
amounts	O
of	O
transgene	S-SO
derived	O
E2	S-PRGE
in	O
those	O
tissues	O
.	O

All	O
blots	O
were	O
re	O
-	O
probed	O
with	O
an	O
actin	S-PRGE
antibody	S-GO
to	O
allow	O
amount	O
of	O
protein	S-CHEBI
loaded	O
in	O
each	O
lane	O
to	O
be	O
compared	O
.	O

LAP	S-PRGE
-	O
tTA	O
mice	S-LIVB
were	O
previously	O
produced	O
and	O
characterized	O
by	O
the	O
Bujard	O
laboratory	O
[	O
34	O
]	O
.	O

Pronuclear	S-GO
microinjection	O
was	O
used	O
to	O
produce	O
transgenic	S-SO
mice	S-LIVB
that	O
harbored	O
the	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
.	O

From	O
injections	O
at	O
the	O
University	O
of	O
Pittsburgh	O
,	O
2	O
transgene	S-SO
positive	O
founders	O
were	O
identified	O
that	O
led	O
to	O
the	O
generation	O
of	O
3	O
different	O
transgenic	S-SO
lines	O
(	O
Lines	O
A	O
,	O
B	O
,	O
&	O
D	O
)	O
.	O

From	O
the	O
injections	O
at	O
the	O
University	O
of	O
Cincinnati	O
,	O
we	O
obtained	O
8	O
transgene	S-SO
positive	O
founders	O
.	O

Subsequent	O
breeding	O
of	O
these	O
founders	O
revealed	O
that	O
many	O
of	O
the	O
animals	S-LIVB
had	O
multiple	O
transgene	S-SO
insertion	B-SO
sites	E-SO
that	O
segregated	O
.	O

We	O
established	O
a	O
total	O
of	O
15	O
different	O
transgenic	S-SO
lines	O
from	O
these	O
founders	O
.	O

Limited	O
resources	O
allowed	O
us	O
to	O
only	O
focus	O
on	O
a	O
total	O
of	O
9	O
of	O
these	O
lines	O
.	O

These	O
lines	O
differed	O
substantially	O
in	O
transgene	S-SO
copy	O
number	O
as	O
compared	O
by	O
Southern	O
blot	O
analysis	O
of	O
tail	O
DNA	S-SO
(	O
data	O
not	O
shown	O
)	O
.	O

Transgenic	S-SO
TRE	O
-	O
E2	S-PRGE
mice	S-LIVB
from	O
each	O
line	O
(	O
either	O
founders	O
or	O
F1	O
offspring	O
)	O
were	O
crossed	O
to	O
mice	S-LIVB
that	O
were	O
positive	O
for	O
the	O
LAP	S-PRGE
-	O
tTA	O
transgene	S-SO
and	O
were	O
heterozygous	O
for	O
the	O
E2	S-PRGE
knockout	O
.	O

Ultimately	O
,	O
breeding	O
pairs	O
were	O
used	O
in	O
which	O
the	O
mice	S-LIVB
were	O
heterozygous	O
for	O
the	O
LAP	S-PRGE
-	O
tTA	O
transgene	S-SO
,	O
the	O
TRE	O
-	O
E2	S-PRGE
transgene	S-SO
,	O
and	O
the	O
E2	S-PRGE
knockout	O
.	O

To	O
efficiently	O
screen	O
for	O
the	O
ability	O
of	O
the	O
transgenes	S-SO
to	O
rescue	O
the	O
knockout	O
from	O
neonatal	O
lethality	O
,	O
we	O
genotyped	O
litters	O
at	O
weaning	O
.	O

This	O
breeding	O
strategy	O
is	O
expected	O
to	O
result	O
in	O
a	O
theoretical	O
maximum	O
of	O
animals	S-LIVB
with	O
the	O
rescue	S-SO
genotype	S-SO
(	O
i	O
.	O
e	O
.	O
,	O
homozygous	O
E2	S-PRGE
knockout	O
and	O
positive	O
for	O
both	O
transgenes	S-SO
)	O
of	O
14	O
%	O
.	O

Fig	O
.	O

4A	O
shows	O
the	O
percentage	O
of	O
mice	S-LIVB
alive	O
at	O
weaning	O
with	O
the	O
rescue	S-SO
genotype	S-SO
from	O
each	O
transgenic	S-SO
line	O
tested	O
.	O

Considerable	O
variability	O
was	O
observed	O
between	O
lines	O
.	O

The	O
line	O
with	O
the	O
highest	O
percentage	O
of	O
rescue	O
mice	S-LIVB
at	O
weaning	O
was	O
line	O
525	O
A	O
.	O

Approximately	O
10	O
%	O
of	O
weaned	O
,	O
surviving	O
pups	O
from	O
this	O
line	O
had	O
the	O
rescue	S-SO
genotype	S-SO
.	O

Thus	O
,	O
the	O
525A	O
transgene	S-SO
appears	O
to	O
be	O
highly	O
effective	O
at	O
rescuing	O
the	O
neonatal	O
lethal	O
phenotype	O
of	O
the	O
E2	S-PRGE
knockout	O
.	O

In	O
contrast	O
,	O
line	O
520B	O
completely	O
failed	O
to	O
rescue	O
the	O
neonatal	O
lethal	O
phenotype	O
.	O

All	O
other	O
lines	O
tested	O
produced	O
surviving	O
rescue	O
animals	S-LIVB
at	O
a	O
frequency	O
between	O
1	O
and	O
5	O
%	O
of	O
weaned	O
pups	O
.	O

Figure	O
4	O

Characterization	O
of	O
the	O
intermediate	O
MSUD	O
murine	S-LIVB
model	O
.	O

A	O
,	O
Survival	O
analysis	O
of	O
transgenic	S-SO
rescue	O
lines	O
.	O

Presented	O
are	O
percentages	O
of	O
mice	S-LIVB
alive	O
at	O
weaning	O
from	O
each	O
transgenic	S-SO
line	O
tested	O
that	O
had	O
the	O
rescue	S-SO
genotype	S-SO
(	O
i	O
.	O
e	O
.	O
,	O
homozygous	O
for	O
knockout	O
of	O
endogenous	O
E2	S-PRGE
and	O
positive	O
for	O
both	O
the	O
LAP	S-PRGE
-	O
tTA	O
and	O
TRE	O
-	O
E2	S-PRGE
transgenes	S-SO
)	O
.	O

Also	O
plotted	O
is	O
the	O
theoretical	O
maximum	O
frequency	O
at	O
which	O
this	O
genotype	S-SO
is	O
expected	O
in	O
this	O
population	O
of	O
animals	S-LIVB
.	O

The	O
numbers	O
on	O
the	O
bars	O
indicates	O
the	O
numbers	O
of	O
observations	O
for	O
each	O
line	O
.	O

B	O
,	O
Ratio	O
of	O
total	O
BCAA	S-CHEBI
to	O
alanine	S-CHEBI
in	O
blood	O
of	O
mice	S-LIVB
from	O
controls	O
and	O
Lines	O
A	O
and	O
525A	O
.	O

Total	O
BCAA	S-CHEBI
represent	O
the	O
sum	O
of	O
leucine	S-CHEBI
,	O
isoleucine	S-CHEBI
,	O
and	O
valine	S-CHEBI
.	O

BCAA	S-CHEBI
/	O
alanine	S-CHEBI
values	O
were	O
significantly	O
greater	O
for	O
Lines	O
A	O
and	O
525A	O
compared	O
to	O
controls	O
at	O
all	O
ages	O
tested	O
.	O

The	O
numbers	O
on	O
the	O
bars	O
indicates	O
the	O
numbers	O
of	O
samples	O
analyzed	O
.	O

*	O
,	O
P	O
<=	O
0	O
.	O
01	O
;	O
*	O
*	O
,	O
P	O
<	O
0	O
.	O
005	O
.	O

C	O
,	O
BCKDH	S-GO
enzyme	S-SO
activity	O
in	O
liver	O
of	O
control	O
and	O
Lines	O
A	O
and	O
525A	O
mice	S-LIVB
.	O

*	O
,	O
P	O
<=	O
0	O
.	O
001	O
;	O
*	O
*	O
,	O
P	O
<=	O
0	O
.	O
0001	O
.	O

D	O
,	O
Survival	O
curves	O
for	O
mice	S-LIVB
from	O
Lines	O
A	O
and	O
525A	O
.	O

Rescue	S-SO
mice	S-LIVB
alive	O
at	O
weaning	O
were	O
monitored	O
until	O
they	O
were	O
moribund	O
and	O
subsequently	O
sacrificed	O
or	O
were	O
found	O
dead	O
in	O
their	O
cages	O
.	O

Lines	O
A	O
and	O
525A	O
were	O
selected	O
for	O
detailed	O
characterization	O
.	O

Fig	O
.	O

4B	O
shows	O
the	O
results	O
of	O
blood	O
amino	B-CHEBI
acid	E-CHEBI
analysis	O
presented	O
as	O
a	O
ratio	O
of	O
total	O
BCAA	S-CHEBI
to	O
alanine	S-CHEBI
.	O

The	O
BCAA	S-CHEBI
/	O
alanine	S-CHEBI
values	O
for	O
mice	S-LIVB
from	O
both	O
lines	O
were	O
significantly	O
elevated	O
compared	O
to	O
controls	O
for	O
all	O
of	O
the	O
time	O
points	O
analyzed	O
.	O

Note	O
that	O
the	O
BCAA	S-CHEBI
/	O
alanine	S-CHEBI
values	O
for	O
the	O
transgenic	S-SO
mice	S-LIVB
are	O
intermediate	O
between	O
controls	O
and	O
knockouts	O
(	O
see	O
Figure	O
2C	O
)	O
.	O

Blood	O
levels	O
of	O
alanine	S-CHEBI
,	O
glutamate	S-CHEBI
,	O
and	O
glutamine	S-CHEBI
were	O
reduced	O
in	O
Line	O
A	O
mice	S-LIVB
,	O
as	O
was	O
glutamate	S-CHEBI
in	O
Line	O
525A	O
mice	S-LIVB
,	O
compared	O
to	O
controls	O
(	O
Table	O
2	O
)	O
.	O

Table	O
2	O

Summary	O
of	O
additional	O
blood	O
amino	B-CHEBI
acid	E-CHEBI
levels	O
in	O
the	O
intermediate	O
MSUD	O
model	O
and	O
littermate	O
controls	O
as	O
determined	O
by	O
tandem	O
mass	O
spectrometry	O
.	O

Samples	O
were	O
collected	O
from	O
mice	S-LIVB
that	O
were	O
4	O
-	O
6	O
weeks	O
of	O
age	O
.	O

All	O
values	O
are	O
mean	O
+	O
/	O
-	O
SEM	O
.	O

*	O
:	O
Significantly	O
different	O
from	O
control	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

*	O
*	O
:	O
Significantly	O
different	O
from	O
control	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

*	O
*	O
*	O
:	O
Significantly	O
different	O
from	O
Line	O
525A	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Because	O
the	O
LAP	S-PRGE
-	O
tTA	O
mice	S-LIVB
that	O
were	O
used	O
to	O
drive	O
expression	O
of	O
transgenic	S-SO
human	B-PRGE
E2	E-PRGE
have	O
been	O
demonstrated	O
to	O
produce	O
liver	O
specific	O
expression	O
[	O
34	O
]	O
,	O
BCKDH	S-GO
enzyme	S-SO
activity	O
and	O
production	O
of	O
human	B-PRGE
E2	E-PRGE
protein	S-CHEBI
in	O
liver	O
of	O
Lines	O
A	O
and	O
525A	O
was	O
examined	O
.	O

BCKDH	S-GO
enzymatic	S-SO
activity	O
in	O
liver	O
from	O
Lines	O
A	O
and	O
525A	O
was	O
~	O
6	O
and	O
5	O
%	O
,	O
respectively	O
,	O
of	O
the	O
enzymatic	S-SO
activity	O
present	O
in	O
control	O
liver	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

3B	O
,	O
the	O
amount	O
of	O
human	B-PRGE
E2	E-PRGE
(	O
predicted	O
MW	O
~	O
54	O
Kd	O
)	O
in	O
these	O
transgenic	S-SO
mice	S-LIVB
was	O
quite	O
variable	O
between	O
mice	S-LIVB
.	O

In	O
some	O
of	O
these	O
transgenic	S-SO
mice	S-LIVB
,	O
the	O
level	O
of	O
human	B-PRGE
E2	E-PRGE
was	O
approximately	O
equal	O
to	O
the	O
amount	O
of	O
mouse	B-PRGE
E2	E-PRGE
(	O
~	O
47	O
Kd	O
)	O
produced	O
in	O
liver	O
of	O
nontransgenic	O
control	O
mice	S-LIVB
.	O

The	O
observations	O
that	O
these	O
near	O
normal	O
amounts	O
of	O
E2	S-PRGE
protein	S-CHEBI
result	O
in	O
only	O
~	O
5	O
-	O
6	O
%	O
of	O
normal	O
BCKDH	S-GO
enzyme	S-SO
activity	O
suggest	O
that	O
transgene	S-SO
derived	O
E2	S-PRGE
is	O
functioning	O
at	O
a	O
suboptimal	O
level	O
.	O

It	O
is	O
probable	O
that	O
the	O
c	B-PRGE
-	I-PRGE
myc	E-PRGE
tag	O
at	O
the	O
carboxy	B-SO
terminus	E-SO
of	O
the	O
transgene	S-SO
derived	O
human	B-PRGE
E2	E-PRGE
interfered	O
with	O
enzymatic	S-SO
activity	O
.	O

This	O
interpretation	O
is	O
consistent	O
with	O
previous	O
studies	O
which	O
have	O
revealed	O
that	O
the	O
carboxy	B-SO
terminus	E-SO
of	O
an	O
analogous	O
subunit	O
of	O
the	O
pyruvate	B-GO
dehydrogenase	I-GO
complex	E-GO
is	O
essential	O
for	O
subunit	O
interactions	O
[	O
35	O
]	O
and	O
insertion	S-SO
of	O
a	O
Hisx6	O
tag	O
on	O
the	O
carboxy	B-SO
terminus	E-SO
of	O
an	O
analogous	O
E	B-LIVB
.	I-LIVB
coli	E-LIVB
subunit	O
interfered	O
with	O
normal	O
subunit	O
assembly	O
[	O
36	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
human	B-PRGE
E2	E-PRGE
was	O
not	O
fully	O
functional	O
when	O
complexed	O
with	O
mouse	B-PRGE
E1	I-PRGE
and	I-PRGE
E3	I-PRGE
subunits	E-PRGE
.	O

Human	B-PRGE
E2	E-PRGE
shares	O
~	O
88	O
%	O
identity	O
to	O
mouse	B-PRGE
E2	E-PRGE
at	O
the	O
amino	B-CHEBI
acid	E-CHEBI
level	O
.	O

We	O
also	O
used	O
western	O
blot	O
analysis	O
to	O
analyze	O
expression	O
of	O
the	O
E2	S-PRGE
transgene	S-SO
in	O
brain	O
,	O
kidney	O
and	O
muscle	O
.	O

As	O
shown	O
in	O
Figure	O
3C	O
,	O
D	O
and	O
3E	O
respectively	O
,	O
expression	O
of	O
E2	S-PRGE
is	O
negligible	O
in	O
those	O
tissues	O
.	O

Long	O
-	O
term	O
survival	O
of	O
the	O
mice	S-LIVB
from	O
these	O
two	O
transgenic	S-SO
lines	O
that	O
survived	O
beyond	O
weaning	O
is	O
plotted	O
in	O
Fig	O
.	O

4D	O
.	O

Although	O
survival	O
data	O
for	O
control	O
animals	S-LIVB
was	O
not	O
collected	O
,	O
it	O
is	O
readily	O
apparent	O
that	O
survival	O
of	O
the	O
rescue	O
mice	S-LIVB
was	O
compromised	O
.	O

By	O
16	O
weeks	O
,	O
all	O
mice	S-LIVB
of	O
Line	O
A	O
were	O
moribund	O
and	O
humanely	O
sacrificed	O
,	O
or	O
were	O
found	O
dead	O
in	O
their	O
cage	O
.	O

Survival	O
of	O
Line	O
525A	O
appeared	O
to	O
be	O
somewhat	O
better	O
.	O

At	O
20	O
weeks	O
of	O
age	O
,	O
~	O
12	O
%	O
of	O
mice	S-LIVB
(	O
2	O
of	O
16	O
)	O
were	O
still	O
alive	O
.	O

These	O
two	O
rare	O
survivors	O
died	O
at	O
40	O
and	O
60	O
weeks	O
of	O
age	O
.	O

In	O
summary	O
,	O
these	O
surviving	O
mice	S-LIVB
had	O
BCAA	S-CHEBI
/	O
alanine	S-CHEBI
ratios	O
that	O
were	O
intermediate	O
between	O
controls	O
and	O
knockouts	O
and	O
they	O
expressed	O
~	O
5	O
-	O
6	O
%	O
of	O
normal	O
BCKDH	S-GO
enzyme	S-SO
activity	O
in	O
the	O
liver	O
.	O

These	O
phenotypic	O
observations	O
are	O
remarkably	O
similar	O
to	O
the	O
clinical	O
phenotype	O
observed	O
in	O
MSUD	O
patients	O
with	O
the	O
intermediate	O
form	O
of	O
the	O
disease	O
[	O
1	O
]	O
.	O

Thus	O
,	O
these	O
rescue	O
mice	S-LIVB
represent	O
a	O
very	O
useful	O
model	O
of	O
the	O
intermediate	O
MSUD	O
phenotype	O
.	O

Discussion	O

A	O
major	O
hurdle	O
in	O
developing	O
new	O
treatments	O
for	O
MSUD	O
has	O
been	O
the	O
lack	O
of	O
a	O
practical	O
,	O
accurate	O
animal	S-LIVB
model	O
of	O
the	O
disease	O
.	O

This	O
hurdle	O
has	O
now	O
been	O
overcome	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
development	O
and	O
characterization	O
of	O
two	O
genetically	S-SO
engineered	O
mouse	S-LIVB
models	O
that	O
are	O
phenotypically	O
very	O
similar	O
to	O
MSUD	O
patients	O
with	O
the	O
classic	O
and	O
intermediate	O
forms	O
of	O
the	O
disease	O
.	O

Our	O
model	O
of	O
classic	O
MSUD	O
was	O
created	O
by	O
gene	S-SO
knockout	O
of	O
the	O
E2	B-PRGE
subunit	I-PRGE
of	I-PRGE
BCKDH	E-PRGE
.	O

The	O
phenotype	O
of	O
these	O
knockout	O
animals	S-LIVB
is	O
strikingly	O
similar	O
to	O
humans	S-LIVB
with	O
classic	O
MSUD	O
.	O

Knockout	O
mice	S-LIVB
were	O
born	O
at	O
the	O
expected	O
frequency	O
and	O
appeared	O
normal	O
at	O
birth	O
.	O

Within	O
a	O
day	O
of	O
birth	O
and	O
following	O
suckling	O
,	O
blood	O
levels	O
of	O
BCAA	S-CHEBI
were	O
markedly	O
elevated	O
.	O

Concomitantly	O
,	O
levels	O
of	O
the	O
amino	B-CHEBI
acids	E-CHEBI
alanine	S-CHEBI
,	O
glutamate	S-CHEBI
,	O
and	O
glutamine	S-CHEBI
,	O
whose	O
synthesis	O
is	O
linked	O
with	O
normal	O
metabolism	O
of	O
BCAA	S-CHEBI
,	O
were	O
decreased	O
(	O
Table	O
1	O
)	O
.	O

The	O
activity	O
of	O
BCKDH	S-GO
in	O
livers	O
of	O
homozygous	O
knockout	O
mouse	S-LIVB
pups	O
was	O
undetectable	O
,	O
accounting	O
for	O
the	O
accumulation	O
of	O
unmetabolized	O
BCAA	S-CHEBI
.	O

Immunoreactive	O
E2	S-PRGE
protein	S-CHEBI
was	O
absent	O
in	O
liver	O
and	O
fibroblasts	S-CL
of	O
homozygous	O
pups	O
.	O

The	O
phenotypic	O
behavior	O
of	O
homozygous	O
mouse	S-LIVB
pups	O
resembles	O
symptoms	O
seen	O
in	O
newborn	O
classic	O
MSUD	O
patients	O
.	O

These	O
include	O
signs	O
of	O
neurologic	O
dysfunction	O
such	O
as	O
seizures	O
,	O
stupor	O
,	O
lethargy	O
,	O
loss	O
of	O
motor	O
activity	O
,	O
and	O
respiratory	O
difficulties	O
[	O
1	O
]	O
.	O

These	O
neurologic	O
symptoms	O
may	O
result	O
from	O
reduced	O
levels	O
of	O
glutamate	S-CHEBI
,	O
glutamine	S-CHEBI
,	O
alanine	S-CHEBI
,	O
and	O
other	O
similar	O
neuroactive	O
amino	B-CHEBI
acids	E-CHEBI
,	O
which	O
are	O
considered	O
the	O
culprit	O
for	O
MSUD	O
encephalopathies	O
in	O
patients	O
[	O
1	O
,	O
37	O
]	O
.	O

Finally	O
,	O
nearly	O
all	O
of	O
the	O
homozygous	O
pups	O
died	O
within	O
72	O
hours	O
of	O
birth	O
.	O

This	O
neonatal	O
lethality	O
is	O
likely	O
due	O
to	O
the	O
accumulation	O
of	O
BCAA	S-CHEBI
to	O
neurotoxic	O
levels	O
,	O
ketoacidosis	O
,	O
brain	O
edema	O
,	O
dehydration	O
,	O
and	O
malnutrition	O
as	O
observed	O
in	O
the	O
MSUD	O
calf	O
[	O
17	O
]	O
and	O
in	O
classic	O
MSUD	O
patients	O
[	O
1	O
]	O
.	O

Heterozygous	O
knockouts	O
were	O
normal	O
and	O
had	O
normal	O
levels	O
of	O
BCAA	S-CHEBI
despite	O
having	O
approximately	O
half	O
of	O
BCKDH	S-GO
enzymatic	S-SO
activity	O
.	O

From	O
the	O
characterization	O
studies	O
completed	O
thus	O
far	O
,	O
the	O
null	O
mutation	S-SO
mouse	S-LIVB
accurately	O
represents	O
a	O
model	O
of	O
classic	O
MSUD	O
and	O
appears	O
to	O
be	O
a	O
faithful	O
model	O
of	O
the	O
human	S-LIVB
disease	O
with	O
respect	O
to	O
several	O
biochemical	O
phenotypes	O
[	O
1	O
]	O
.	O

To	O
create	O
a	O
model	O
of	O
intermediate	O
MSUD	O
,	O
we	O
used	O
a	O
transgenic	S-SO
strategy	O
to	O
express	O
human	B-PRGE
E2	E-PRGE
in	O
the	O
liver	O
of	O
E2	S-PRGE
knockout	O
mice	S-LIVB
.	O

As	O
mentioned	O
above	O
,	O
E2	S-PRGE
knockouts	O
without	O
transgene	S-SO
derived	O
E2	S-PRGE
die	O
during	O
the	O
early	O
neonatal	O
period	O
.	O

We	O
show	O
that	O
expression	O
of	O
a	O
human	B-PRGE
E2	E-PRGE
transgene	S-SO
in	O
the	O
liver	O
of	O
these	O
knockout	O
mice	S-LIVB
is	O
able	O
to	O
rescue	O
the	O
neonatal	O
lethality	O
.	O

Many	O
of	O
the	O
rescue	O
mice	S-LIVB
survived	O
to	O
adulthood	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
these	O
mouse	S-LIVB
lines	O
only	O
~	O
5	O
-	O
6	O
%	O
of	O
normal	O
BCKDH	S-GO
activity	O
in	O
the	O
liver	O
was	O
sufficient	O
to	O
allow	O
survival	O
.	O

We	O
also	O
demonstrated	O
that	O
BCAA	S-CHEBI
levels	O
in	O
blood	O
of	O
these	O
rescue	O
mice	S-LIVB
were	O
intermediate	O
between	O
controls	O
and	O
knockouts	O
.	O

The	O
hallmarks	O
of	O
intermediate	O
MSUD	O
human	S-LIVB
patients	O
are	O
persistently	O
increased	O
levels	O
of	O
BCAA	S-CHEBI
and	O
BCKDH	S-GO
activity	O
in	O
the	O
range	O
of	O
3	O
-	O
30	O
%	O
of	O
normal	O
[	O
1	O
]	O
.	O

Because	O
of	O
the	O
phenotypic	O
similarities	O
of	O
the	O
rescue	O
mice	S-LIVB
to	O
the	O
human	S-LIVB
patients	O
,	O
these	O
genetically	S-SO
engineered	O
mice	S-LIVB
represent	O
a	O
useful	O
small	O
animal	S-LIVB
model	O
of	O
the	O
intermediate	O
form	O
of	O
MSUD	O
.	O

The	O
transgenic	S-SO
approach	O
that	O
was	O
used	O
to	O
create	O
the	O
intermediate	O
MSUD	O
model	O
was	O
based	O
on	O
the	O
tetracycline	S-CHEBI
regulated	O
gene	S-SO
switch	O
system	O
that	O
has	O
been	O
used	O
with	O
great	O
success	O
in	O
other	O
studies	O
,	O
for	O
example	O
[	O
34	O
]	O
.	O

The	O
strategy	O
behind	O
our	O
approach	O
was	O
to	O
create	O
mice	S-LIVB
with	O
an	O
intermediate	O
MSUD	O
phenotype	O
that	O
could	O
be	O
converted	O
to	O
the	O
classic	O
phenotype	O
at	O
the	O
investigator	O
'	O
s	O
discretion	O
by	O
turning	O
off	O
the	O
rescuing	S-SO
transgene	S-SO
.	O

However	O
,	O
we	O
were	O
unable	O
to	O
consistently	O
turn	O
off	O
the	O
human	B-PRGE
E2	E-PRGE
expression	O
cassette	S-SO
by	O
the	O
potent	O
tetracycline	S-CHEBI
analogue	O
,	O
doxycycline	O
in	O
either	O
of	O
the	O
two	O
transgenic	S-SO
lines	O
tested	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
reason	O
these	O
two	O
lines	O
were	O
unresponsive	O
to	O
doxycycline	O
is	O
unknown	O
.	O

It	O
is	O
conceivable	O
that	O
the	O
integration	B-SO
site	E-SO
of	O
the	O
transgenes	S-SO
was	O
not	O
permissive	O
for	O
regulated	O
expression	O
.	O

Screening	O
of	O
additional	O
lines	O
may	O
be	O
needed	O
to	O
find	O
lines	O
that	O
allow	O
for	O
survival	O
and	O
can	O
also	O
be	O
regulated	O
.	O

The	O
models	O
described	O
in	O
this	O
communication	O
are	O
important	O
advances	O
over	O
the	O
previously	O
described	O
models	O
.	O

An	O
ENU	S-CHEBI
mouse	S-LIVB
resembling	O
human	S-LIVB
MSUD	O
was	O
previously	O
created	O
by	O
disrupting	O
the	O
mitochondrial	B-PRGE
BCAT	E-PRGE
gene	S-SO
[	O
20	O
]	O
.	O

The	O
BCKDH	S-GO
activity	O
in	O
the	O
liver	O
and	O
muscle	O
of	O
this	O
mouse	S-LIVB
was	O
normal	O
even	O
though	O
the	O
blood	O
BCAA	S-CHEBI
levels	O
were	O
markedly	O
elevated	O
.	O

While	O
this	O
is	O
an	O
interesting	O
model	O
,	O
it	O
is	O
not	O
a	O
true	O
model	O
of	O
MSUD	O
because	O
the	O
mutation	S-SO
is	O
not	O
in	O
BCKDH	S-GO
and	O
the	O
levels	O
of	O
BCKDH	S-GO
are	O
normal	O
.	O

Furthermore	O
,	O
no	O
case	O
of	O
MSUD	O
has	O
been	O
described	O
attributing	O
this	O
disease	O
to	O
BCAT	S-PRGE
deficiency	O
.	O

In	O
addition	O
to	O
this	O
mouse	S-LIVB
model	O
,	O
a	O
cow	S-LIVB
model	O
of	O
MSUD	O
has	O
also	O
been	O
previously	O
described	O
[	O
17	O
-	O
19	O
]	O
.	O

However	O
,	O
due	O
to	O
practical	O
constraints	O
imposed	O
by	O
such	O
a	O
large	O
animal	S-LIVB
model	O
and	O
due	O
to	O
the	O
observation	O
of	O
differences	O
between	O
the	O
MSUD	O
cow	S-LIVB
model	O
and	O
MSUD	O
humans	S-LIVB
[	O
1	O
]	O
,	O
this	O
model	O
is	O
also	O
of	O
limited	O
utility	O
.	O

In	O
contrast	O
,	O
the	O
murine	S-LIVB
models	O
described	O
in	O
this	O
report	O
are	O
more	O
valid	O
and	O
appropriate	O
for	O
modeling	O
human	S-LIVB
MSUD	O
.	O

The	O
most	O
significant	O
opportunity	O
presented	O
by	O
the	O
MSUD	O
mouse	S-LIVB
models	O
is	O
to	O
test	O
novel	O
treatments	O
such	O
as	O
gene	S-SO
[	O
38	O
-	O
41	O
]	O
and	O
cell	S-CL
based	O
therapies	O
(	O
e	O
.	O
g	O
.	O
,	O
hepatocytes	S-CL
[	O
42	O
,	O
43	O
]	O
or	O
embryonic	O
stem	B-CL
cells	E-CL
[	O
44	O
]	O
)	O
.	O

Relevant	O
to	O
gene	S-SO
therapy	O
,	O
recent	O
problems	O
with	O
gene	S-SO
therapy	O
in	O
humans	S-LIVB
highlight	O
the	O
importance	O
and	O
critical	O
need	O
of	O
animal	S-LIVB
models	O
of	O
genetic	S-SO
diseases	O
for	O
preclinical	O
studies	O
.	O

The	O
testing	O
of	O
gene	S-SO
and	O
cell	S-CL
based	O
therapies	O
on	O
appropriate	O
animal	S-LIVB
model	O
systems	O
provides	O
a	O
preliminary	O
method	O
of	O
establishing	O
not	O
only	O
the	O
efficacy	O
,	O
but	O
also	O
short	O
-	O
and	O
long	O
-	O
term	O
safety	O
.	O

Success	O
with	O
animal	S-LIVB
studies	O
is	O
expected	O
to	O
advance	O
such	O
therapeutic	O
approaches	O
and	O
could	O
pave	O
the	O
way	O
for	O
studies	O
in	O
humans	S-LIVB
.	O

In	O
addition	O
to	O
testing	O
various	O
treatments	O
,	O
these	O
models	O
should	O
also	O
be	O
very	O
useful	O
for	O
investigating	O
the	O
underlying	O
pathophysiologic	O
consequences	O
of	O
the	O
disease	O
.	O

Such	O
studies	O
are	O
very	O
difficult	O
/	O
impossible	O
to	O
do	O
in	O
human	S-LIVB
patients	O
for	O
obvious	O
ethical	O
reasons	O
,	O
and	O
often	O
must	O
rely	O
on	O
autopsy	O
tissue	O
.	O

Additionally	O
,	O
the	O
intermediate	O
MSUD	O
model	O
may	O
also	O
be	O
useful	O
for	O
studies	O
to	O
test	O
the	O
effect	O
of	O
thiamin	S-CHEBI
.	O

A	O
thiamin	S-CHEBI
-	O
responsive	O
form	O
of	O
MSUD	O
has	O
been	O
described	O
[	O
1	O
]	O
.	O

The	O
phenotype	O
of	O
these	O
patients	O
is	O
heterogeneous	O
and	O
treatment	O
with	O
a	O
wide	O
range	O
of	O
thiamin	O
doses	O
has	O
produced	O
limited	O
success	O
[	O
1	O
]	O
.	O

Recent	O
cell	S-CL
culture	O
studies	O
with	O
MSUD	O
cells	S-CL
have	O
suggested	O
that	O
the	O
thiamin	S-CHEBI
-	O
responsive	O
phenotype	O
is	O
dependent	O
upon	O
the	O
presence	O
of	O
at	O
least	O
one	O
E2	S-PRGE
expressing	O
allele	S-SO
[	O
45	O
,	O
46	O
]	O
.	O

In	O
light	O
of	O
these	O
newer	O
findings	O
,	O
our	O
intermediate	O
MSUD	O
mouse	S-LIVB
provides	O
a	O
model	O
to	O
test	O
the	O
effect	O
of	O
thiamin	S-CHEBI
with	O
respect	O
to	O
BCKDH	S-GO
activity	O
and	O
blood	O
amino	B-CHEBI
acid	E-CHEBI
levels	O
at	O
the	O
level	O
of	O
the	O
whole	O
animal	S-LIVB
.	O

Because	O
of	O
recent	O
interest	O
in	O
structural	O
analysis	O
of	O
multienzyme	O
complexes	S-GO
[	O
35	O
,	O
36	O
,	O
45	O
,	O
46	O
]	O
,	O
the	O
intermediate	O
MSUD	O
model	O
may	O
provide	O
a	O
valuable	O
resource	O
for	O
studies	O
of	O
structural	O
biology	O
.	O

Lastly	O
,	O
the	O
information	O
and	O
knowledge	O
gained	O
from	O
studies	O
with	O
the	O
MSUD	O
models	O
described	O
here	O
will	O
also	O
be	O
applicable	O
and	O
transferable	O
to	O
other	O
mitochondrial	S-GO
disorders	O
due	O
to	O
defects	O
in	O
multisubunit	O
enzymes	S-SO
.	O

Conclusion	O

In	O
summary	O
,	O
this	O
report	O
describes	O
the	O
development	O
and	O
characterization	O
of	O
genetically	S-SO
engineered	O
mouse	S-LIVB
models	O
of	O
classic	O
as	O
well	O
as	O
intermediate	O
MSUD	O
.	O

These	O
animals	S-LIVB
provide	O
useful	O
models	O
to	O
further	O
characterize	O
the	O
pathogenesis	O
of	O
MSUD	O
,	O
as	O
well	O
as	O
models	O
to	O
test	O
novel	O
therapeutic	O
strategies	O
,	O
such	O
as	O
gene	S-SO
and	O
cellular	S-CL
therapies	O
,	O
to	O
treat	O
this	O
devastating	O
metabolic	O
disease	O
.	O

Abbreviations	O

The	O
abbreviations	O
used	O
are	O
:	O
MSUD	O
,	O
Maple	S-LIVB
Syrup	O
Urine	O
Disease	O
;	O
BCKDH	S-GO
,	O
branched	B-GO
chain	I-GO
ketoacid	I-GO
dehydrogenase	E-GO
;	O
BCAA	S-CHEBI
,	O
branched	B-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	E-CHEBI
;	O
ENU	S-CHEBI
,	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	E-CHEBI
;	O
BCAT	S-PRGE
,	O
branched	B-PRGE
chain	I-PRGE
aminotransferase	E-PRGE
;	O
ES	O
cell	S-CL
,	O
embryonic	O
stem	B-CL
cell	E-CL
;	O
TRE	O
,	O
tetracycline	S-CHEBI
responsive	O
element	S-SO
;	O
MEF	O
,	O
mouse	S-LIVB
embryonic	O
fibroblast	S-CL
.	O

Competing	O
interests	O

The	O
author	O
(	O
s	O
)	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
'	O
contributions	O

GEH	O
designed	O
and	O
produced	O
the	O
mouse	S-LIVB
models	O
,	O
coordinated	O
experiments	O
,	O
interpreted	O
data	O
,	O
and	O
helped	O
draft	O
the	O
manuscript	O
.	O

KS	O
conducted	O
much	O
of	O
the	O
characterization	O
of	O
the	O
intermediate	O
MSUD	O
model	O
.	O

CF	O
assisted	O
with	O
production	O
of	O
the	O
mouse	S-LIVB
models	O
,	O
data	O
collection	O
,	O
analysis	O
,	O
and	O
interpretation	O
.	O

SW	O
directed	O
the	O
immunohistochemistry	O
experiments	O
.	O

HSP	O
conceived	O
of	O
the	O
knockout	O
model	O
,	O
interpreted	O
data	O
and	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
contributed	O
to	O
composing	O
and	O
editing	O
the	O
manuscript	O
and	O
have	O
read	O
and	O
approved	O
the	O
final	O
version	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

The	O
authors	O
would	O
like	O
to	O
thank	O
Frank	O
Kist	O
,	O
Jodi	O
Dagget	O
,	O
Edward	O
Mallick	O
,	O
Brian	O
Sloat	O
,	O
and	O
Judith	O
Rodda	O
for	O
expert	O
technical	O
assistance	O
,	O
and	O
Dr	O
.	O
Susan	O
Hutson	O
for	O
the	O
gift	O
of	O
E2	S-PRGE
antiserum	O
.	O

This	O
work	O
was	O
supported	O
by	O
National	O
Institutes	O
of	O
Health	O
Grants	O
DK51960	O
,	O
DK57386	O
,	O
DK57956	O
,	O
AA10422	O
,	O
the	O
Scott	O
C	O
.	O
Foster	O
Metabolic	O
Disease	O
Fund	O
,	O
and	O
the	O
MSUD	O
Family	O
Support	O
Group	O
.	O

Loss	O
of	O
Atrx	S-PRGE
Affects	O
Trophoblast	O
Development	O
and	O
the	O
Pattern	O
of	O
X	S-GO
-	O
Inactivation	O
in	O
Extraembryonic	O
Tissues	O

Abstract	O

ATRX	S-PRGE
is	O
an	O
X	S-GO
-	O
encoded	O
member	O
of	O
the	O
SNF2	O
family	O
of	O
ATPase	O
/	O
helicase	O
proteins	S-CHEBI
thought	O
to	O
regulate	O
gene	S-SO
expression	O
by	O
modifying	O
chromatin	S-GO
at	O
target	O
loci	S-SO
.	O

Mutations	S-SO
in	O
ATRX	S-PRGE
provided	O
the	O
first	O
example	O
of	O
a	O
human	S-LIVB
genetic	S-SO
disease	O
associated	O
with	O
defects	O
in	O
such	O
proteins	S-CHEBI
.	O

To	O
better	O
understand	O
the	O
role	O
of	O
ATRX	S-PRGE
in	O
development	O
and	O
the	O
associated	O
abnormalities	O
in	O
the	O
ATR	O
-	O
X	S-GO
(	O
alpha	O
thalassemia	O
mental	O
retardation	O
,	O
X	S-GO
-	O
linked	O
)	O
syndrome	O
,	O
we	O
conditionally	O
inactivated	O
the	O
homolog	S-SO
in	O
mice	S-LIVB
,	O
Atrx	S-PRGE
,	O
at	O
the	O
8	O
-	O
to	O
16	O
-	O
cell	S-CL
stage	O
of	O
development	O
.	O

The	O
protein	S-CHEBI
,	O
Atrx	S-PRGE
,	O
was	O
ubiquitously	O
expressed	O
,	O
and	O
male	O
embryos	O
null	O
for	O
Atrx	S-PRGE
implanted	O
and	O
gastrulated	O
normally	O
but	O
did	O
not	O
survive	O
beyond	O
9	O
.	O
5	O
days	O
postcoitus	O
due	O
to	O
a	O
defect	O
in	O
formation	O
of	O
the	O
extraembryonic	O
trophoblast	O
,	O
one	O
of	O
the	O
first	O
terminally	O
differentiated	O
lineages	O
in	O
the	O
developing	O
embryo	O
.	O

Carrier	O
female	O
mice	S-LIVB
that	O
inherit	O
a	O
maternal	O
null	O
allele	S-SO
should	O
be	O
affected	O
,	O
since	O
the	O
paternal	O
X	B-GO
chromosome	E-GO
is	O
normally	O
inactivated	O
in	O
extraembryonic	O
tissues	O
.	O

Surprisingly	O
,	O
however	O
,	O
some	O
carrier	O
females	O
established	O
a	O
normal	O
placenta	O
and	O
appeared	O
to	O
escape	O
the	O
usual	O
pattern	O
of	O
imprinted	O
X	S-GO
-	O
inactivation	O
in	O
these	O
tissues	O
.	O

Together	O
these	O
findings	O
demonstrate	O
an	O
unexpected	O
,	O
specific	O
,	O
and	O
essential	O
role	O
for	O
Atrx	S-PRGE
in	O
the	O
development	O
of	O
the	O
murine	S-LIVB
trophoblast	O
and	O
present	O
an	O
example	O
of	O
escape	O
from	O
imprinted	O
X	B-GO
chromosome	E-GO
inactivation	O
.	O

Synopsis	O

ATRX	S-PRGE
belongs	O
to	O
a	O
class	O
of	O
proteins	S-CHEBI
that	O
may	O
modify	O
how	O
DNA	S-SO
is	O
packaged	O
into	O
chromatin	S-GO
,	O
altering	O
the	O
accessibility	O
of	O
other	O
proteins	S-CHEBI
in	O
the	O
nucleus	S-GO
to	O
DNA	S-SO
.	O

In	O
this	O
way	O
,	O
ATRX	S-PRGE
is	O
thought	O
to	O
influence	O
gene	S-SO
expression	O
.	O

Mutations	S-SO
in	O
the	O
ATRX	S-PRGE
gene	S-SO
,	O
which	O
is	O
located	O
on	O
the	O
female	B-GO
sex	I-GO
chromosome	E-GO
(	O
X	S-GO
)	O
,	O
provided	O
the	O
first	O
example	O
of	O
a	O
human	S-LIVB
disease	O
(	O
ATR	O
-	O
X	S-GO
syndrome	O
)	O
associated	O
with	O
defects	O
in	O
such	O
proteins	S-CHEBI
.	O

Affected	O
males	O
(	O
XMUTY	O
)	O
have	O
multiple	O
developmental	O
abnormalities	O
in	O
a	O
wide	O
variety	O
of	O
systems	O
.	O

Currently	O
,	O
it	O
is	O
not	O
understood	O
how	O
proteins	S-CHEBI
like	O
ATRX	S-PRGE
influence	O
cell	S-CL
biology	O
.	O

To	O
address	O
this	O
question	O
,	O
the	O
authors	O
deleted	S-SO
the	O
version	S-SO
of	O
the	O
gene	S-SO
in	O
mice	S-LIVB
,	O
Atrx	S-PRGE
.	O

Although	O
affected	O
male	O
mice	S-LIVB
(	O
XMUTY	O
)	O
started	O
to	O
develop	O
normally	O
,	O
they	O
died	O
early	O
in	O
development	O
because	O
they	O
failed	O
to	O
form	O
a	O
normal	O
placenta	O
.	O

In	O
the	O
placenta	O
,	O
female	O
mice	S-LIVB
normally	O
inactivate	O
the	O
X	B-GO
chromosome	E-GO
that	O
they	O
inherit	O
from	O
their	O
fathers	O
(	O
Xp	O
)	O
,	O
so	O
if	O
females	O
inherit	O
from	O
their	O
mother	O
an	O
X	B-GO
chromosome	E-GO
(	O
Xm	O
)	O
that	O
bears	O
the	O
abnormal	O
copy	O
of	O
Atrx	S-PRGE
(	O
XmMUTXp	O
)	O
,	O
one	O
would	O
predict	O
that	O
,	O
like	O
affected	O
males	O
,	O
they	O
would	O
fail	O
to	O
form	O
a	O
normal	O
placenta	O
.	O

The	O
authors	O
unexpectedly	O
found	O
this	O
not	O
to	O
be	O
so	O
.	O

They	O
showed	O
,	O
instead	O
,	O
that	O
in	O
such	O
females	O
the	O
normal	O
,	O
paternally	O
derived	O
Atrx	S-PRGE
gene	S-SO
is	O
active	O
.	O

This	O
study	O
has	O
therefore	O
demonstrated	O
an	O
important	O
facet	O
of	O
X	B-GO
-	I-GO
chromosome	E-GO
imprinting	O
.	O

Introduction	O

ATR	O
-	O
X	S-GO
syndrome	O
is	O
a	O
severe	O
,	O
nonprogressive	O
form	O
of	O
X	S-GO
-	O
linked	O
mental	O
retardation	O
that	O
is	O
frequently	O
associated	O
with	O
multiple	O
congenital	O
abnormalities	O
[	O
1	O
]	O
.	O

It	O
is	O
usually	O
associated	O
with	O
a	O
mild	O
form	O
of	O
alpha	O
-	O
thalassaemia	O
,	O
caused	O
by	O
reduced	O
expression	O
of	O
structurally	O
intact	O
alpha	O
-	O
globin	S-CHEBI
genes	S-SO
,	O
and	O
characterised	O
by	O
the	O
presence	O
of	O
beta	B-PRGE
-	I-PRGE
globin	E-PRGE
tetramers	O
(	O
haemoglobin	S-GO
H	O
inclusion	B-GO
bodies	E-GO
)	O
in	O
peripheral	O
red	B-CL
blood	I-CL
cells	E-CL
.	O

Carrier	O
females	O
occasionally	O
manifest	O
haemoglobin	S-GO
H	O
inclusions	S-GO
,	O
but	O
are	O
otherwise	O
intellectually	O
and	O
physically	O
normal	O
.	O

Studies	O
of	O
X	B-GO
-	I-GO
chromosome	E-GO
inactivation	O
in	O
carrier	O
females	O
have	O
demonstrated	O
preferential	O
inactivation	O
of	O
the	O
chromosome	S-GO
bearing	O
the	O
abnormal	O
allele	S-SO
in	O
a	O
variety	O
of	O
tissues	O
[	O
2	O
]	O
,	O
and	O
this	O
skewing	O
of	O
X	S-GO
-	O
inactivation	O
is	O
thought	O
to	O
explain	O
the	O
mild	O
phenotype	O
observed	O
in	O
carriers	O
.	O

The	O
ATR	O
-	O
X	S-GO
syndrome	O
is	O
caused	O
by	O
mutations	S-SO
in	O
a	O
gene	S-SO
(	O
ATRX	S-PRGE
)	O
that	O
comprises	O
36	O
exons	S-SO
spanning	O
300	O
kb	O
of	O
genomic	B-SO
DNA	E-SO
at	O
Chromosome	S-GO
Xq13	O
.	O
3	O
[	O
3	O
]	O
.	O

This	O
gene	S-SO
encodes	O
two	O
dominant	O
protein	S-CHEBI
isoforms	S-SO
(	O
Figure	O
1	O
)	O
.	O

As	O
well	O
as	O
the	O
full	O
-	O
length	O
ATRX	S-PRGE
protein	S-CHEBI
of	O
~	O
280	O
kDa	O
,	O
which	O
is	O
encoded	O
by	O
a	O
transcript	S-SO
of	O
~	O
10	O
kb	O
,	O
we	O
recently	O
demonstrated	O
that	O
a	O
truncated	O
isoform	S-SO
called	O
ATRXt	O
(	O
~	O
200	O
kDa	O
)	O
is	O
produced	O
from	O
a	O
transcript	S-SO
of	O
around	O
7	O
kb	O
,	O
which	O
arises	O
when	O
intron	S-SO
11	O
fails	O
to	O
be	O
spliced	O
from	O
the	O
primary	B-SO
transcript	E-SO
and	O
an	O
alternative	O
intronic	S-SO
poly	B-SO
(	I-SO
A	I-SO
)	I-SO
signal	E-SO
is	O
used	O
[	O
4	O
]	O
.	O

The	O
mouse	S-LIVB
homolog	S-SO
of	O
the	O
ATRX	S-PRGE
gene	S-SO
,	O
Atrx	S-PRGE
,	O
is	O
also	O
situated	O
on	O
the	O
X	B-GO
chromosome	E-GO
,	O
and	O
also	O
gives	O
rise	O
to	O
full	O
-	O
length	O
(	O
Atrx	S-PRGE
,	O
~	O
280	O
kDa	O
)	O
and	O
truncated	O
(	O
Atrxt	O
,	O
~	O
200	O
kDa	O
)	O
isoforms	S-SO
[	O
4	O
,	O
5	O
]	O
.	O

Disease	O
-	O
causing	O
missense	O
mutations	S-SO
are	O
clustered	O
in	O
two	O
regions	B-SO
of	I-SO
the	I-SO
gene	E-SO
:	O
a	O
PHD	O
-	O
like	O
zinc	S-CHEBI
finger	O
domain	S-SO
and	O
a	O
SNF2	O
-	O
like	O
ATPase	O
domain	S-SO
(	O
Figure	O
1	O
)	O
[	O
6	O
]	O
.	O

The	O
former	O
motif	O
is	O
thought	O
to	O
be	O
involved	O
in	O
protein	S-CHEBI
-	O
protein	S-CHEBI
interactions	O
in	O
chromatin	S-GO
[	O
7	O
]	O
,	O
and	O
the	O
latter	O
is	O
a	O
feature	S-SO
of	O
chromatin	S-GO
-	O
remodelling	O
proteins	S-CHEBI
,	O
and	O
the	O
presence	O
of	O
disease	O
-	O
causing	O
mutations	S-SO
indicates	O
the	O
functional	O
importance	O
of	O
these	O
domains	S-SO
.	O

ATRX	S-PRGE
has	O
been	O
shown	O
to	O
remodel	O
chromatin	S-GO
[	O
8	O
]	O
.	O

It	O
also	O
interacts	O
with	O
HP1	O
at	O
heterochromatin	S-GO
[	O
9	O
]	O
and	O
is	O
recruited	O
to	O
promyelocytic	B-GO
leukemia	I-GO
nuclear	I-GO
bodies	E-GO
via	O
an	O
interaction	O
with	O
Daxx	S-PRGE
[	O
10	O
]	O
.	O

Furthermore	O
,	O
disruption	O
of	O
ATRX	S-PRGE
leads	O
to	O
diverse	O
changes	O
in	O
DNA	S-SO
methylation	O
[	O
11	O
]	O
.	O

Nevertheless	O
,	O
the	O
role	O
ATRX	S-PRGE
plays	O
in	O
gene	S-SO
expression	O
remains	O
unclear	O
.	O

The	O
consistent	O
core	O
of	O
clinical	O
and	O
haematological	O
features	O
observed	O
in	O
ATR	O
-	O
X	S-GO
patients	O
suggests	O
that	O
,	O
like	O
the	O
SWI2	O
/	O
SNF2	O
chromatin	S-GO
-	O
remodelling	O
protein	S-CHEBI
,	O
ATRX	S-PRGE
probably	O
regulates	O
transcription	O
of	O
a	O
discrete	O
set	O
of	O
target	O
genes	S-SO
.	O

However	O
,	O
although	O
there	O
are	O
clearly	O
others	O
to	O
be	O
found	O
,	O
at	O
present	O
the	O
alpha	O
-	O
globin	S-CHEBI
genes	S-SO
remain	O
the	O
only	O
confirmed	O
targets	O
for	O
transcriptional	O
regulation	O
by	O
ATRX	S-PRGE
.	O

Little	O
is	O
currently	O
known	O
about	O
the	O
precise	O
role	O
of	O
the	O
ATRX	S-PRGE
protein	S-CHEBI
during	O
mammalian	S-LIVB
development	O
.	O

To	O
investigate	O
the	O
role	O
of	O
this	O
protein	S-CHEBI
during	O
mouse	S-LIVB
development	O
,	O
we	O
generated	O
a	O
conditionally	O
deleted	S-SO
allele	S-SO
of	O
the	O
Atrx	S-PRGE
gene	S-SO
in	O
mouse	S-LIVB
embryonic	O
stem	B-CL
(	I-CL
ES	I-CL
)	I-CL
cells	E-CL
,	O
and	O
used	O
these	O
cells	S-CL
to	O
examine	O
the	O
effect	O
of	O
ablating	O
expression	O
of	O
the	O
full	O
-	O
length	O
Atrx	S-PRGE
protein	S-CHEBI
in	O
ES	O
cells	S-CL
and	O
in	O
mouse	S-LIVB
embryos	O
.	O

Results	O

Generation	O
of	O
ES	O
Cells	S-CL
Lacking	O
Full	O
-	O
Length	O
Atrx	S-PRGE

Like	O
the	O
human	S-LIVB
gene	S-SO
,	O
the	O
mouse	B-PRGE
Atrx	E-PRGE
gene	S-SO
is	O
also	O
X	S-GO
-	O
linked	O
,	O
such	O
that	O
a	O
direct	O
disruption	O
of	O
the	O
single	O
Atrx	S-PRGE
allele	S-SO
in	O
male	O
ES	O
cells	S-CL
would	O
immediately	O
give	O
rise	O
to	O
the	O
null	O
state	O
.	O

No	O
targeted	O
clones	S-SO
were	O
recovered	O
after	O
attempted	O
homologous	O
recombination	O
in	O
male	O
E14TG2a	O
ES	O
cells	S-CL
using	O
two	O
different	O
vectors	S-SO
that	O
removed	S-SO
exon	S-SO
18	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
.	O

Exon	S-SO
18	O
encodes	O
the	O
first	O
of	O
the	O
seven	O
motifs	O
composing	O
the	O
conserved	S-SO
SNF2	O
-	O
like	O
domain	S-SO
of	O
Atrx	S-PRGE
(	O
Figure	O
1	O
)	O
;	O
mutation	S-SO
of	O
the	O
corresponding	O
motif	O
of	O
the	O
yeast	B-PRGE
SNF2	E-PRGE
protein	S-CHEBI
has	O
been	O
shown	O
to	O
severely	O
impair	O
SWI	B-GO
/	I-GO
SNF	E-GO
-	O
dependent	O
gene	S-SO
expression	O
[	O
12	O
]	O
.	O

The	O
failure	O
to	O
recover	O
targeted	O
clones	S-SO
with	O
these	O
vectors	S-SO
suggested	O
that	O
Atrx	S-PRGE
may	O
be	O
important	O
for	O
normal	O
ES	O
cell	S-CL
growth	O
and	O
expansion	O
and	O
that	O
direct	O
targeting	O
of	O
the	O
single	O
locus	S-SO
may	O
not	O
be	O
possible	O
.	O

We	O
therefore	O
adopted	O
a	O
conditional	O
strategy	O
for	O
targeting	O
exon	S-SO
18	O
(	O
Figure	O
2	O
)	O
and	O
recovered	O
two	O
clones	S-SO
in	O
which	O
exon	S-SO
18	O
has	O
been	O
flanked	S-SO
by	O
loxP	B-SO
recognition	I-SO
sites	E-SO
for	O
the	O
Cre	O
recombinase	O
(	O
Atrxflox	O
allele	S-SO
in	O
Figure	O
2A	O
)	O
(	O
Figure	O
2B	O
)	O
.	O

This	O
allele	S-SO
also	O
contains	O
a	O
loxP	B-SO
-	I-SO
flanked	E-SO
MC1	O
-	O
neor	O
cassette	S-SO
in	O
intron	S-SO
17	O
(	O
Figure	O
2A	O
)	O
.	O

Northern	O
and	O
Western	O
blot	O
analyses	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
confirmed	O
that	O
the	O
Atrxflox	O
clones	S-SO
continued	O
to	O
express	O
both	O
full	O
-	O
length	O
Atrx	S-PRGE
protein	S-CHEBI
and	O
the	O
truncated	O
Atrxt	O
isoform	S-SO
.	O

To	O
generate	O
the	O
full	O
deletion	S-SO
in	O
ES	O
cells	S-CL
,	O
the	O
Atrxflox	O
clones	S-SO
(	O
1	O
/	O
F12	O
and	O
1	O
/	O
G11	O
)	O
were	O
transiently	O
transfected	O
with	O
a	O
Cre	O
-	O
recombinase	O
expression	O
plasmid	S-SO
(	O
pCAGGS	O
-	O
Cre	O
-	O
IRESpuro	O
)	O
,	O
and	O
subclones	O
were	O
recovered	O
bearing	O
an	O
allele	S-SO
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
in	O
Figure	O
2A	O
)	O
in	O
which	O
both	O
exon	S-SO
18	O
and	O
the	O
neor	O
cassette	S-SO
had	O
been	O
deleted	S-SO
by	O
the	O
Cre	O
recombinase	O
(	O
resulting	O
from	O
the	O
recombination	O
event	O
labelled	O
"	O
C	O
"	O
in	O
the	O
Atrxflox	O
allele	S-SO
shown	O
in	O
Figure	O
2A	O
)	O
(	O
Figure	O
2C	O
)	O
.	O

Northern	O
and	O
Western	O
blot	O
analyses	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
revealed	O
that	O
the	O
full	O
-	O
length	O
Atrx	S-PRGE
transcript	S-SO
and	O
protein	S-CHEBI
is	O
completely	O
abolished	S-SO
in	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
recombinant	O
clones	S-SO
,	O
suggesting	O
that	O
deletion	S-SO
of	O
this	O
region	S-SO
has	O
a	O
highly	O
destabilising	O
effect	O
on	O
the	O
full	O
-	O
length	O
transcript	S-SO
.	O

As	O
expected	O
,	O
the	O
truncated	O
Atrxt	O
isoform	S-SO
,	O
the	O
transcript	S-SO
of	O
which	O
is	O
terminated	O
within	O
intron	S-SO
11	O
[	O
4	O
]	O
,	O
is	O
unaffected	O
by	O
the	O
deletion	S-SO
of	O
exon	S-SO
18	O
(	O
Figure	O
2E	O
)	O
.	O

While	O
the	O
function	O
of	O
Atrxt	O
is	O
not	O
yet	O
clear	O
,	O
this	O
isoform	S-SO
,	O
which	O
contains	O
the	O
PHD	O
-	O
like	O
domain	S-SO
but	O
not	O
the	O
SWI	O
/	O
SNF	O
motifs	O
(	O
Figure	O
1	O
)	O
,	O
is	O
unlikely	O
to	O
be	O
functionally	O
equivalent	O
to	O
the	O
full	O
-	O
length	O
protein	S-CHEBI
.	O

Thus	O
,	O
a	O
conditional	O
knockout	O
strategy	O
allowed	O
the	O
isolation	O
of	O
ES	O
cells	S-CL
that	O
are	O
null	O
for	O
full	O
-	O
length	O
Atrx	S-PRGE
.	O

Perturbed	O
Growth	O
and	O
Methylation	O
Defects	O
in	O
Atrxnull	O
ES	O
Cells	S-CL

Atrxnull	O
ES	O
cells	S-CL
could	O
be	O
maintained	O
in	O
culture	O
but	O
were	O
generally	O
slower	O
growing	O
than	O
Atrx	S-PRGE
+	O
ES	O
clones	O
,	O
and	O
appeared	O
to	O
undergo	O
higher	O
rates	O
of	O
spontaneous	O
differentiation	O
.	O

We	O
investigated	O
directly	O
the	O
effect	O
of	O
Atrx	S-PRGE
on	O
ES	O
cell	S-CL
growth	O
by	O
comparing	O
Atrx	S-PRGE
+	O
and	O
Atrxnull	O
ES	O
cell	S-CL
clones	O
in	O
competition	O
cultures	O
.	O

Equal	O
numbers	O
of	O
Atrx	S-PRGE
+	O
(	O
bearing	O
either	O
an	O
AtrxWT	O
or	O
an	O
Atrxflox	O
allele	S-SO
)	O
and	O
Atrxnull	O
(	O
bearing	O
an	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	S-SO
)	O
ES	O
cells	S-CL
were	O
inoculated	O
into	O
cultures	O
and	O
the	O
mixed	O
cultures	O
were	O
passaged	O
(	O
1	O
:	O
3	O
split	O
)	O
every	O
2	O
d	O
for	O
8	O
-	O
10	O
d	O
.	O

The	O
relative	O
abundance	O
of	O
the	O
different	O
alleles	S-SO
in	O
the	O
culture	O
at	O
each	O
time	O
point	O
was	O
analysed	O
by	O
Southern	O
blotting	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
clone	O
containing	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	S-SO
was	O
rapidly	O
outgrown	O
by	O
both	O
AtrxWT	O
ES	O
cells	S-CL
and	O
cells	S-CL
bearing	O
the	O
Atrxflox	O
allele	S-SO
.	O

In	O
a	O
control	O
competition	O
experiment	O
between	O
different	O
clones	O
bearing	O
functional	O
Atrx	S-PRGE
alleles	S-SO
(	O
AtrxWT	O
and	O
Atrxflox	O
)	O
,	O
both	O
clones	O
continued	O
to	O
be	O
equally	O
represented	O
after	O
8	O
d	O
of	O
cocultivation	O
.	O

Thus	O
,	O
although	O
Atrxnull	O
ES	O
cells	S-CL
could	O
be	O
recovered	O
and	O
maintained	O
in	O
culture	O
by	O
a	O
conditional	O
targeting	O
approach	O
,	O
these	O
cocultivation	O
experiments	O
suggested	O
that	O
the	O
absence	O
of	O
Atrx	S-PRGE
does	O
negatively	O
impact	O
upon	O
normal	O
ES	O
cell	S-CL
growth	O
.	O

To	O
investigate	O
a	O
possible	O
cell	S-CL
-	O
cycle	O
defect	O
in	O
the	O
absence	O
of	O
Atrx	S-PRGE
,	O
we	O
analysed	O
the	O
cell	S-CL
cycle	O
distribution	O
of	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
-	O
pulsed	O
ES	O
cells	S-CL
by	O
flow	O
cytometry	O
(	O
Figure	O
S1A	O
)	O
.	O

Surprisingly	O
,	O
both	O
Atrxnull	O
ES	O
cell	S-CL
clones	O
exhibited	O
a	O
cell	S-CL
cycle	O
profile	O
that	O
was	O
indistinguishable	O
from	O
ES	O
cells	S-CL
bearing	O
a	O
functional	O
Atrx	S-PRGE
allele	S-SO
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
.	O

We	O
also	O
specifically	O
quantitated	O
the	O
mitotic	O
index	O
within	O
each	O
population	O
by	O
flow	O
cytometry	O
after	O
staining	O
ES	O
cells	S-CL
for	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	S-CHEBI
H3	O
,	O
a	O
specific	O
marker	O
of	O
mitosis	O
(	O
Figure	O
S1B	O
)	O
[	O
13	O
]	O
.	O

Consistent	O
with	O
the	O
normal	O
cell	S-CL
-	O
cycle	O
profile	O
observed	O
above	O
,	O
there	O
was	O
no	O
depletion	O
in	O
the	O
size	O
of	O
the	O
mitotic	O
population	O
in	O
the	O
Atrxnull	O
ES	O
clones	O
,	O
despite	O
their	O
slow	O
growth	O
.	O

Finally	O
,	O
we	O
investigated	O
whether	O
the	O
growth	O
defect	O
in	O
the	O
Atrxnull	O
ES	O
cells	S-CL
was	O
due	O
to	O
an	O
up	O
-	O
regulation	O
of	O
apoptosis	O
by	O
staining	O
cells	S-CL
with	O
Annexin	B-PRGE
V	E-PRGE
(	O
Figure	O
S2	O
)	O
and	O
found	O
that	O
the	O
proportion	O
of	O
apoptotic	B-CL
cells	E-CL
was	O
not	O
significantly	O
affected	O
by	O
the	O
absence	O
of	O
full	O
-	O
length	O
Atrx	S-PRGE
.	O

Thus	O
,	O
the	O
growth	O
defect	O
observed	O
in	O
ES	O
cells	S-CL
lacking	O
Atrx	S-PRGE
is	O
not	O
due	O
to	O
a	O
specific	O
cell	S-CL
cycle	O
block	O
or	O
significant	O
induction	O
of	O
cell	S-CL
death	O
.	O

While	O
the	O
cause	O
of	O
the	O
proliferative	O
delay	O
is	O
not	O
yet	O
clear	O
,	O
since	O
Atrxnull	O
ES	O
cells	S-CL
appear	O
to	O
undergo	O
higher	O
rates	O
of	O
spontaneous	O
differentiation	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
seems	O
likely	O
that	O
the	O
observed	O
growth	O
defect	O
reflects	O
the	O
spontaneous	O
transition	O
from	O
fast	O
-	O
cycling	O
,	O
undifferentiated	O
ES	O
cells	S-CL
into	O
more	O
slowly	O
cycling	O
,	O
differentiated	O
cell	S-CL
types	O
in	O
these	O
cultures	O
.	O

It	O
has	O
been	O
shown	O
that	O
disease	O
-	O
causing	O
mutations	S-SO
in	O
the	O
human	B-PRGE
ATRX	E-PRGE
gene	S-SO
give	O
rise	O
to	O
changes	O
in	O
the	O
normal	O
pattern	O
of	O
DNA	S-SO
methylation	O
at	O
several	O
repetitive	B-SO
sequences	E-SO
within	O
the	O
human	S-LIVB
genome	S-SO
[	O
11	O
]	O
.	O

Notably	O
,	O
the	O
transcribed	O
region	O
of	O
the	O
ribosomal	S-GO
DNA	S-SO
(	O
rDNA	O
)	O
repeat	S-SO
was	O
found	O
to	O
be	O
significantly	O
hypomethylated	O
in	O
ATR	B-PRGE
-	I-PRGE
X	E-PRGE
patients	O
relative	O
to	O
normal	O
individuals	S-LIVB
.	O

Using	O
methylation	O
-	O
sensitive	O
restriction	O
enzymes	S-SO
,	O
we	O
also	O
observed	O
significant	O
hypomethylation	O
at	O
several	O
sites	S-SO
tested	O
within	O
the	O
mouse	S-LIVB
rDNA	O
repeats	S-SO
in	O
Atrxnull	O
ES	O
cells	S-CL
and	O
12	O
-	O
d	O
embryoid	O
bodies	O
relative	O
to	O
ES	O
cells	S-CL
and	O
embryoid	O
bodies	O
bearing	O
a	O
functional	O
Atrx	S-PRGE
allele	S-SO
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

The	O
observation	O
that	O
rDNA	O
is	O
hypomethylated	O
in	O
the	O
absence	O
of	O
Atrx	S-PRGE
,	O
even	O
in	O
ES	O
cells	S-CL
,	O
is	O
consistent	O
with	O
the	O
finding	O
that	O
hypomethylation	O
of	O
the	O
human	S-LIVB
rDNA	O
repeats	S-SO
is	O
detectable	O
from	O
an	O
early	O
developmental	O
stage	O
in	O
ATR	O
-	O
X	S-GO
patients	O
.	O

Other	O
mouse	S-LIVB
repetitive	B-SO
sequence	I-SO
elements	E-SO
surveyed	O
in	O
ES	O
cell	S-CL
DNA	S-SO
include	O
the	O
heterochromatic	S-GO
major	O
satellite	B-SO
(	I-SO
assayed	I-SO
with	I-SO
MaeII	I-SO
)	I-SO
and	I-SO
minor	I-SO
satellite	I-SO
(	I-SO
assayed	I-SO
with	I-SO
HpaII	I-SO
)	I-SO
repeats	E-SO
,	O
as	O
well	O
as	O
interspersed	O
retroviral	S-LIVB
repeats	S-SO
of	O
the	O
intracisternal	O
A	O
particle	O
(	O
IAP	O
)	O
type	O
and	O
the	O
Line	O
1	O
and	O
Sine	O
B1	O
families	O
(	O
all	O
assayed	O
with	O
HpaII	O
)	O
.	O

These	O
repeats	S-SO
were	O
found	O
to	O
be	O
moderately	O
(	O
Line	O
1	O
and	O
Sine	O
B1	O
)	O
or	O
highly	O
(	O
IAP	O
,	O
major	O
satellite	S-SO
,	O
minor	O
satellite	S-SO
)	O
methylated	O
in	O
wild	B-SO
-	I-SO
type	E-SO
ES	O
cells	S-CL
,	O
and	O
this	O
methylation	O
was	O
not	O
detectably	O
perturbed	O
by	O
the	O
absence	O
of	O
Atrx	S-PRGE
(	O
Figure	O
S3	O
and	O
unpublished	O
data	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
the	O
subtle	O
interplay	O
between	O
the	O
ATRX	S-PRGE
protein	S-CHEBI
and	O
DNA	S-SO
methylation	O
observed	O
in	O
human	S-LIVB
patients	O
is	O
also	O
present	O
in	O
mouse	S-LIVB
cells	S-CL
.	O

Early	O
Embryonic	O
Lethality	O
in	O
Atrxnull	O
Male	O
Mice	S-LIVB

To	O
investigate	O
the	O
role	O
of	O
the	O
Atrx	S-PRGE
protein	S-CHEBI
during	O
mouse	S-LIVB
development	O
,	O
we	O
initially	O
established	O
lines	O
of	O
mice	S-LIVB
bearing	O
the	O
Atrxflox	O
allele	S-SO
.	O

Two	O
independently	O
targeted	O
Atrxflox	O
ES	O
cell	S-CL
clones	O
with	O
normal	O
male	O
karyotype	O
were	O
injected	O
into	O
C57BL	O
/	O
6	O
blastocysts	O
to	O
produce	O
chimaeric	O
mice	S-LIVB
,	O
which	O
were	O
then	O
used	O
to	O
obtain	O
germline	O
transmission	O
.	O

Intercrosses	O
between	O
males	O
hemizygous	O
(	O
Atrxflox	O
/	O
Y	O
)	O
and	O
females	O
heterozygous	O
(	O
AtrxWT	O
/	O
flox	S-SO
)	O
for	O
the	O
floxed	S-SO
allele	S-SO
were	O
also	O
carried	O
out	O
to	O
generate	O
homozygous	O
females	O
(	O
Atrxflox	O
/	O
flox	S-SO
)	O
.	O

Males	O
hemizygous	O
and	O
females	O
heterozygous	O
or	O
homozygous	O
for	O
the	O
Atrxflox	O
allele	S-SO
were	O
viable	O
,	O
appeared	O
healthy	O
,	O
and	O
bred	O
normally	O
,	O
suggesting	O
that	O
,	O
as	O
expected	O
,	O
the	O
Atrxflox	O
allele	S-SO
was	O
functionally	O
normal	O
.	O

To	O
generate	O
Atrxnull	O
mice	S-LIVB
by	O
Cre	O
-	O
mediated	O
recombination	O
,	O
the	O
Atrxflox	O
mice	S-LIVB
were	O
crossed	O
with	O
mice	S-LIVB
harboring	O
a	O
transgene	S-SO
in	O
which	O
the	O
Cre	O
recombinase	O
is	O
expressed	O
under	O
the	O
control	O
of	O
the	O
regulatory	B-SO
elements	E-SO
of	O
the	O
mouse	B-PRGE
GATA	I-PRGE
-	I-PRGE
1	E-PRGE
gene	S-SO
(	O
GATA1	S-PRGE
-	O
cre	O
)	O
[	O
14	O
]	O
.	O

Widespread	O
expression	O
of	O
the	O
GATA1	S-PRGE
-	O
cre	O
transgene	S-SO
has	O
been	O
demonstrated	O
during	O
early	O
embryogenesis	O
[	O
14	O
]	O
.	O

We	O
more	O
accurately	O
defined	O
the	O
onset	O
of	O
GATA1	S-PRGE
-	O
cre	O
expression	O
using	O
a	O
ROSA26	S-PRGE
reporter	O
strain	O
,	O
in	O
which	O
a	O
beta	O
-	O
galactosidase	O
/	O
neor	O
fusion	B-SO
reporter	I-SO
gene	E-SO
is	O
expressed	O
only	O
after	O
Cre	O
-	O
mediated	O
excision	S-SO
of	O
loxP	B-SO
-	I-SO
flanked	E-SO
transcription	O
and	O
translation	B-SO
termination	I-SO
signals	E-SO
[	O
14	O
]	O
.	O

We	O
found	O
that	O
the	O
GATA1	S-PRGE
-	O
cre	O
transgene	S-SO
was	O
already	O
active	O
at	O
the	O
16	O
-	O
cell	S-CL
morula	O
stage	O
of	O
development	O
(	O
0	O
.	O
5	O
days	O
postcoitus	O
[	O
dpc	O
]	O
)	O
(	O
Figure	O
4A	O
)	O
.	O

To	O
generate	O
Atrxnull	O
mice	S-LIVB
,	O
heterozygous	O
floxed	S-SO
females	O
(	O
AtrxWT	O
/	O
flox	S-SO
)	O
were	O
mated	O
with	O
homozygous	O
GATA1	S-PRGE
-	O
cre	O
transgenic	S-SO
males	O
(	O
AtrxWT	O
/	O
Y	O
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
+	S-SO
)	O
.	O

No	O
Atrxnull	O
males	O
(	O
Atrxnull	O
/	O
Y	O
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
-	O
)	O
were	O
recovered	O
at	O
birth	O
,	O
indicating	O
that	O
the	O
absence	O
of	O
Atrx	S-PRGE
results	O
in	O
embryonic	O
lethality	O
.	O

This	O
finding	O
was	O
unexpected	O
,	O
since	O
human	S-LIVB
ATR	O
-	O
X	S-GO
patients	O
clearly	O
survive	O
to	O
adulthood	O
(	O
see	O
Discussion	O
)	O
.	O

Embryos	O
were	O
dissected	O
at	O
7	O
.	O
5	O
,	O
8	O
.	O
5	O
,	O
and	O
9	O
.	O
5	O
dpc	O
and	O
genotyped	O
by	O
PCR	O
analysis	O
of	O
DNA	S-SO
extracted	O
from	O
yolk	O
sac	O
or	O
total	O
embryo	O
(	O
Figure	O
4B	O
and	O
Protocol	O
S1	O
)	O
.	O

Atrxnull	O
males	O
were	O
present	O
at	O
expected	O
mendelian	O
ratios	O
(	O
~	O
25	O
%	O
)	O
at	O
both	O
7	O
.	O
5	O
dpc	O
and	O
8	O
.	O
5	O
dpc	O
(	O
Table	O
1	O
)	O
.	O

However	O
,	O
by	O
9	O
.	O
5	O
dpc	O
,	O
depletion	O
was	O
observed	O
both	O
in	O
the	O
number	O
of	O
Atrxnull	O
males	O
(	O
7	O
%	O
)	O
and	O
in	O
the	O
total	O
number	O
of	O
males	O
recovered	O
(	O
31	O
%	O
)	O
.	O

No	O
Atrxnull	O
males	O
were	O
recovered	O
after	O
9	O
.	O
5	O
dpc	O
.	O

Thus	O
the	O
absence	O
of	O
Atrx	S-PRGE
gives	O
rise	O
to	O
embryonic	O
lethality	O
in	O
mice	S-LIVB
before	O
9	O
.	O
5	O
dpc	O
.	O

To	O
investigate	O
the	O
morphology	O
of	O
Atrxnull	O
embryos	O
prior	O
to	O
death	O
,	O
embryos	O
from	O
the	O
above	O
crosses	O
were	O
initially	O
dissected	O
in	O
their	O
deciduas	O
at	O
7	O
.	O
5	O
dpc	O
,	O
and	O
paraffin	O
sections	O
were	O
stained	O
with	O
haematoxylin	O
(	O
Figure	O
5A	O
)	O
or	O
with	O
an	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
(	O
Figure	O
5B	O
-	O
5E	O
)	O
.	O

Immunohistochemical	O
staining	O
revealed	O
that	O
Atrx	S-PRGE
was	O
widely	O
expressed	O
in	O
wild	B-SO
-	I-SO
type	E-SO
7	O
.	O
5	O
dpc	O
embryos	O
(	O
Figure	O
5B	O
)	O
.	O

Expression	O
was	O
highest	O
in	O
the	O
embryonic	O
region	O
(	O
Figure	O
5C	O
)	O
and	O
the	O
chorion	O
(	O
Figure	O
5D	O
)	O
.	O

Detectable	O
but	O
lower	O
levels	O
of	O
expression	O
were	O
observed	O
in	O
the	O
ectoplacental	O
cone	O
(	O
Figure	O
5D	O
)	O
and	O
surrounding	O
decidual	O
tissue	O
.	O

We	O
also	O
observed	O
very	O
high	O
levels	O
of	O
Atrx	S-PRGE
expression	O
in	O
trophoblast	B-CL
giant	I-CL
cells	E-CL
(	O
TGCs	O
)	O
surrounding	O
the	O
Reichert	O
'	O
s	O
membrane	S-GO
(	O
Figure	O
5E	O
)	O
.	O

Within	O
the	O
large	O
nuclei	S-GO
of	O
these	O
TGCs	O
,	O
the	O
typical	O
nuclear	S-GO
association	O
of	O
Atrx	S-PRGE
with	O
blocks	O
of	O
pericentromeric	B-GO
heterochromatin	E-GO
[	O
15	O
]	O
was	O
clearly	O
observable	O
.	O

Only	O
background	O
staining	O
was	O
seen	O
in	O
the	O
corresponding	O
Atrxnull	O
embryonic	O
tissues	O
(	O
Figure	O
5B	O
-	O
5D	O
)	O
,	O
while	O
expression	O
in	O
the	O
surrounding	O
decidual	O
tissue	O
(	O
of	O
maternal	O
origin	O
)	O
was	O
normal	O
and	O
served	O
as	O
an	O
antibody	S-GO
staining	O
control	O
(	O
unpublished	O
data	O
)	O
.	O

Morphologically	O
,	O
7	O
.	O
5	O
dpc	O
Atrxnull	O
embryos	O
were	O
dramatically	O
reduced	O
in	O
size	O
and	O
appeared	O
developmentally	O
retarded	O
relative	O
to	O
stage	O
-	O
matched	O
wild	B-SO
-	I-SO
type	E-SO
embryos	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

However	O
,	O
despite	O
their	O
reduced	O
size	O
,	O
the	O
general	O
morphology	O
and	O
organisation	O
of	O
embryonic	O
structures	O
in	O
Atrxnull	O
conceptuses	O
appeared	O
grossly	O
normal	O
.	O

The	O
amnion	O
and	O
chorion	O
were	O
clearly	O
present	O
and	O
the	O
amniotic	O
,	O
exocoelomic	O
,	O
and	O
ectoplacental	O
cavities	O
were	O
distinguishable	O
,	O
as	O
were	O
all	O
three	O
embryonic	O
germ	O
layers	O
(	O
Figure	O
5A	O
-	O
5C	O
)	O
.	O

At	O
8	O
.	O
5	O
dpc	O
,	O
embryos	O
were	O
dissected	O
free	O
of	O
deciduas	O
,	O
and	O
observed	O
in	O
whole	O
mount	O
.	O

Individual	O
conceptuses	O
were	O
genotyped	O
by	O
PCR	O
using	O
DNA	S-SO
isolated	O
from	O
yolk	O
sac	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

Consistent	O
with	O
observations	O
at	O
7	O
.	O
5	O
dpc	O
,	O
the	O
general	O
morphology	O
of	O
the	O
embryo	O
proper	O
of	O
Atrxnull	O
conceptuses	O
also	O
appeared	O
grossly	O
normal	O
at	O
8	O
.	O
5	O
dpc	O
.	O

The	O
head	O
fold	O
had	O
clearly	O
formed	O
,	O
and	O
expression	O
of	O
the	O
early	O
mesoderm	O
marker	O
brachyury	S-PRGE
(	O
T	S-PRGE
)	O
[	O
16	O
]	O
was	O
detected	O
in	O
the	O
primitive	O
streak	O
and	O
emerging	O
notochord	O
by	O
whole	O
-	O
mount	O
in	O
situ	O
hybridisation	O
(	O
WMISH	O
)	O
(	O
Figure	O
5F	O
)	O
,	O
indicating	O
that	O
Atrxnull	O
embryos	O
had	O
gastrulated	O
.	O

To	O
investigate	O
whether	O
the	O
reduced	O
size	O
of	O
the	O
Atrxnull	O
embryos	O
was	O
due	O
to	O
an	O
increase	O
in	O
apoptosis	O
,	O
we	O
analysed	O
sections	O
of	O
paraffin	O
-	O
embedded	O
7	O
.	O
5	O
dpc	O
embryos	O
by	O
TdT	S-PRGE
-	O
mediated	O
dUTP	S-CHEBI
nick	O
end	O
labeling	O
(	O
TUNEL	O
)	O
assay	O
(	O
Figure	O
6A	O
)	O
.	O

Very	O
few	O
apoptotic	B-CL
cells	E-CL
were	O
detected	O
in	O
wild	B-SO
-	I-SO
type	E-SO
7	O
.	O
5	O
dpc	O
embryos	O
.	O

In	O
Atrxnull	O
embryos	O
,	O
a	O
slight	O
increase	O
in	O
the	O
apoptotic	O
population	O
was	O
evident	O
.	O

However	O
,	O
consistent	O
with	O
our	O
observation	O
of	O
a	O
grossly	O
normal	O
apoptotic	O
index	O
in	O
Atrxnull	O
ES	O
cells	S-CL
(	O
Figure	O
S2	O
)	O
,	O
the	O
apoptotic	O
response	O
observed	O
in	O
Atrxnull	O
embryos	O
was	O
also	O
not	O
uniform	O
,	O
but	O
was	O
restricted	O
to	O
a	O
low	O
number	O
of	O
scattered	O
TUNEL	O
-	O
positive	O
cells	S-CL
.	O

Since	O
this	O
small	O
apoptotic	O
response	O
is	O
unlikely	O
to	O
account	O
fully	O
for	O
the	O
dramatic	O
size	O
deficit	O
observed	O
in	O
Atrxnull	O
embryos	O
,	O
a	O
possible	O
proliferation	O
defect	O
was	O
also	O
investigated	O
by	O
immunohistochemical	O
staining	O
of	O
7	O
.	O
5	O
dpc	O
embryo	O
sections	O
for	O
the	O
mitosis	O
marker	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	S-CHEBI
H3	O
[	O
13	O
]	O
.	O

Relative	O
to	O
the	O
very	O
high	O
mitotic	O
index	O
observed	O
in	O
wild	B-SO
-	I-SO
type	E-SO
embryos	O
,	O
the	O
proportion	O
of	O
mitotic	O
cells	S-CL
observed	O
in	O
Atrxnull	O
embryos	O
at	O
7	O
.	O
5	O
dpc	O
was	O
dramatically	O
reduced	O
(	O
Figure	O
6B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
size	O
deficit	O
observed	O
in	O
Atrxnull	O
embryos	O
prior	O
to	O
lethality	O
largely	O
reflects	O
a	O
proliferative	O
defect	O
,	O
with	O
a	O
minor	O
but	O
indirect	O
contribution	O
from	O
increased	O
apoptosis	O
.	O

Although	O
a	O
growth	O
defect	O
was	O
also	O
observed	O
in	O
Atrxnull	O
ES	O
cells	S-CL
(	O
Figure	O
3A	O
)	O
,	O
in	O
contrast	O
to	O
the	O
Atrxnull	O
embryos	O
,	O
the	O
mitotic	O
index	O
of	O
the	O
ES	O
cell	S-CL
population	O
(	O
as	O
measured	O
with	O
the	O
same	O
antibody	S-GO
)	O
was	O
not	O
depleted	O
(	O
Figure	O
S1B	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
mitotic	O
defect	O
observed	O
in	O
embryos	O
is	O
unlikely	O
to	O
be	O
a	O
direct	O
,	O
cell	S-CL
-	O
autonomous	O
effect	O
of	O
the	O
absence	O
of	O
Atrx	S-PRGE
,	O
and	O
is	O
more	O
likely	O
to	O
be	O
a	O
secondary	O
effect	O
resulting	O
from	O
the	O
failure	O
to	O
develop	O
a	O
normal	O
trophoblast	O
(	O
see	O
below	O
)	O
.	O

Trophectoderm	O
Failure	O
in	O
Atrxnull	O
Embryos	O

Whole	O
-	O
mount	O
observation	O
of	O
8	O
.	O
5	O
dpc	O
embryos	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
the	O
basically	O
normal	O
although	O
delayed	O
morphology	O
of	O
the	O
embryo	O
itself	O
,	O
the	O
extraembryonic	O
tissues	O
of	O
Atrxnull	O
conceptuses	O
appeared	O
highly	O
disorganised	O
.	O

When	O
embryos	O
were	O
removed	O
from	O
deciduas	O
,	O
the	O
surrounding	O
trophectoderm	O
layer	O
appeared	O
dramatically	O
reduced	O
in	O
Atrxnull	O
embryos	O
relative	O
to	O
wild	B-SO
-	I-SO
type	E-SO
littermates	O
,	O
and	O
the	O
underlying	O
ectoplacental	O
cone	O
appeared	O
reduced	O
and	O
abnormally	O
shaped	O
(	O
Figure	O
7A	O
)	O
.	O

Vacated	O
deciduas	O
surrounding	O
8	O
.	O
5	O
dpc	O
wild	B-SO
-	I-SO
type	E-SO
and	O
Atrxnull	O
embryos	O
were	O
bisected	O
and	O
analysed	O
by	O
WMISH	O
for	O
expression	O
of	O
placental	B-PRGE
lactogen	I-PRGE
-	I-PRGE
1	E-PRGE
(	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
)	O
,	O
a	O
marker	O
of	O
terminally	O
differentiated	O
TGCs	O
.	O

The	O
number	O
of	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
-	O
expressing	O
cells	S-CL
attached	O
to	O
the	O
decidual	O
wall	O
after	O
removal	O
of	O
the	O
embryo	O
is	O
an	O
indication	O
of	O
the	O
density	O
of	O
trophoblast	B-CL
cells	E-CL
surrounding	O
each	O
implantation	O
site	O
[	O
17	O
]	O
.	O

We	O
found	O
that	O
the	O
population	O
of	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
-	O
expressing	O
cells	S-CL
was	O
depleted	O
in	O
the	O
decidual	O
implantation	O
sites	O
containing	O
Atrxnull	O
embryos	O
relative	O
to	O
those	O
containing	O
wild	B-SO
-	I-SO
type	E-SO
littermates	O
(	O
Figure	O
7B	O
)	O
;	O
this	O
was	O
also	O
apparent	O
at	O
7	O
.	O
5	O
dpc	O
,	O
as	O
determined	O
by	O
immunohistochemical	O
staining	O
of	O
paraffin	O
sections	O
of	O
embryos	O
in	O
deciduas	O
with	O
an	O
anti	O
-	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
antibody	S-GO
(	O
Figure	O
7C	O
)	O
.	O

A	O
TGC	O
deficiency	O
in	O
the	O
absence	O
of	O
Atrx	S-PRGE
is	O
consistent	O
with	O
the	O
observation	O
that	O
Atrx	S-PRGE
is	O
highly	O
expressed	O
in	O
giant	O
cells	S-CL
surrounding	O
wild	B-SO
-	I-SO
type	E-SO
7	O
.	O
5	O
dpc	O
embryos	O
(	O
Figure	O
5E	O
)	O
.	O

To	O
investigate	O
whether	O
the	O
trophoblast	O
defect	O
was	O
restricted	O
to	O
the	O
production	O
of	O
secondary	O
TGCs	O
(	O
produced	O
by	O
diploid	O
precursors	O
in	O
the	O
ectoplacental	O
cone	O
and	O
derived	O
originally	O
from	O
the	O
polar	O
trophectoderm	O
overlying	O
the	O
inner	O
cell	S-CL
mass	O
of	O
the	O
blastocyst	O
)	O
or	O
also	O
affected	O
the	O
production	O
of	O
primary	O
TGCs	O
(	O
resulting	O
from	O
differentiation	O
of	O
the	O
mural	O
trophectoderm	O
of	O
the	O
blastocyst	O
)	O
,	O
blastocysts	O
(	O
3	O
.	O
5	O
dpc	O
)	O
from	O
crosses	O
between	O
AtrxWT	O
/	O
flox	S-SO
females	O
and	O
GATA1	S-PRGE
-	O
Cre	O
homozygous	O
transgenic	S-SO
males	O
(	O
AtrxWT	O
/	O
Y	O
;	O
GATA1	S-PRGE
-	O
Cre	O
+	S-SO
/	O
+	S-SO
)	O
were	O
cultured	O
in	O
vitro	O
for	O
5	O
d	O
to	O
monitor	O
outgrowth	O
of	O
the	O
primary	O
trophoblast	O
.	O

After	O
5	O
d	O
,	O
individual	O
blastocyst	O
cultures	O
were	O
scored	O
for	O
the	O
extent	O
of	O
primary	O
trophoblast	O
outgrowth	O
,	O
and	O
the	O
Atrx	S-PRGE
genotype	S-SO
and	O
sex	O
of	O
the	O
blastocyst	O
were	O
determined	O
by	O
PCR	O
.	O

Most	O
blastocysts	O
hatched	O
from	O
the	O
zona	O
pellucida	O
within	O
24	O
h	O
,	O
and	O
trophoblast	B-CL
cells	E-CL
spreading	O
out	O
from	O
the	O
inner	O
cell	S-CL
mass	O
could	O
usually	O
be	O
detected	O
within	O
48	O
h	O
of	O
culture	O
.	O

No	O
difference	O
was	O
observed	O
in	O
the	O
rate	O
or	O
extent	O
of	O
trophoblast	O
outgrowth	O
over	O
5	O
d	O
of	O
culture	O
between	O
Atrxnull	O
blastocysts	O
(	O
Atrxnull	O
/	O
Y	O
,	O
n	O
=	O
6	O
)	O
and	O
blastocysts	O
bearing	O
an	O
AtrxWT	O
allele	S-SO
(	O
AtrxWT	O
/	O
WT	S-SO
,	O
n	O
=	O
6	O
;	O
AtrxWT	O
/	O
null	O
,	O
n	O
=	O
6	O
;	O
AtrxWT	O
/	O
Y	O
,	O
n	O
=	O
6	O
)	O
(	O
examples	O
shown	O
in	O
Figure	O
7D	O
)	O
,	O
suggesting	O
that	O
the	O
defect	O
specifically	O
involves	O
the	O
secondary	O
giant	O
cell	S-CL
compartment	O
.	O

This	O
is	O
consistent	O
with	O
the	O
observation	O
that	O
Atrxnull	O
conceptuses	O
implant	O
successfully	O
and	O
survive	O
to	O
gastrulation	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
loss	O
of	O
Atrx	S-PRGE
results	O
in	O
a	O
defect	O
in	O
formation	O
of	O
the	O
secondary	O
trophoblast	O
that	O
is	O
apparent	O
from	O
7	O
.	O
5	O
dpc	O
.	O

Despite	O
initiating	O
normal	O
organisation	O
in	O
the	O
embryo	O
proper	O
,	O
Atrxnull	O
conceptuses	O
exhibit	O
a	O
proliferative	O
defect	O
by	O
7	O
.	O
5	O
dpc	O
and	O
die	O
by	O
around	O
9	O
.	O
5	O
dpc	O
,	O
probably	O
due	O
to	O
a	O
nutritional	O
deficit	O
resulting	O
from	O
failure	O
to	O
develop	O
a	O
normal	O
trophoblast	O
.	O

Escape	O
from	O
Imprinted	O
Inactivation	O
of	O
the	O
Paternally	O
Inherited	O
AtrxWT	O
Allele	S-SO
in	O
Extraembryonic	O
Tissues	O
of	O
Carrier	O
Female	O
Mice	S-LIVB

Female	O
mice	S-LIVB
carrying	O
an	O
Atrxnull	O
allele	S-SO
(	O
AtrxWT	O
/	O
null	O
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
-	O
)	O
were	O
detected	O
at	O
9	O
.	O
5	O
dpc	O
(	O
Table	O
1	O
)	O
and	O
recovered	O
at	O
birth	O
(	O
unpublished	O
data	O
)	O
,	O
although	O
at	O
both	O
time	O
points	O
the	O
number	O
of	O
carrier	O
females	O
was	O
lower	O
than	O
that	O
of	O
wild	B-SO
-	I-SO
type	E-SO
(	O
AtrxWT	O
/	O
WT	S-SO
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
-	O
)	O
females	O
,	O
suggesting	O
that	O
a	O
proportion	O
of	O
carrier	O
female	O
embryos	O
died	O
in	O
utero	O
.	O

Surviving	O
adult	O
carrier	O
female	O
mice	S-LIVB
were	O
not	O
phenotypically	O
normal	O
and	O
exhibited	O
mild	O
behavioural	O
abnormalities	O
,	O
although	O
some	O
could	O
reproduce	O
.	O

For	O
all	O
AtrxWT	O
/	O
null	O
carrier	O
female	O
embryos	O
presented	O
in	O
Table	O
1	O
,	O
the	O
AtrxWT	O
allele	S-SO
was	O
paternally	O
derived	O
,	O
while	O
the	O
Atrxnull	O
allele	S-SO
was	O
maternally	O
derived	O
.	O

In	O
the	O
mouse	S-LIVB
,	O
X	B-GO
chromosome	E-GO
inactivation	O
is	O
subject	O
to	O
parental	O
imprinting	O
in	O
the	O
trophectoderm	O
and	O
primitive	O
endoderm	O
lineages	O
that	O
give	O
rise	O
to	O
the	O
extraembryonic	O
tissues	O
,	O
resulting	O
in	O
inactivation	O
of	O
the	O
paternal	O
X	B-GO
chromosome	E-GO
(	O
Xp	O
)	O
[	O
18	O
]	O
.	O

In	O
contrast	O
,	O
in	O
tissues	O
of	O
the	O
embryo	O
proper	O
(	O
derived	O
from	O
the	O
inner	O
cell	S-CL
mass	O
of	O
the	O
blastocyst	O
)	O
X	S-GO
-	O
inactivation	O
is	O
random	O
[	O
19	O
]	O
.	O

Thus	O
,	O
in	O
the	O
extraembryonic	O
compartment	O
of	O
AtrxWT	O
/	O
null	O
carrier	O
females	O
,	O
normal	O
imprinted	O
X	S-GO
-	O
inactivation	O
would	O
be	O
expected	O
to	O
result	O
in	O
silencing	O
of	O
the	O
paternally	O
derived	O
AtrxWT	O
allele	S-SO
,	O
leaving	O
only	O
the	O
Atrxnull	O
allele	S-SO
on	O
the	O
active	O
maternal	O
X	S-GO
(	O
Xm	O
)	O
and	O
thereby	O
render	O
the	O
extraembryonic	O
tissues	O
null	O
for	O
full	O
-	O
length	O
Atrx	S-PRGE
protein	S-CHEBI
.	O

However	O
,	O
the	O
absence	O
of	O
Atrx	S-PRGE
in	O
the	O
extraembryonic	O
compartment	O
is	O
lethal	O
in	O
Atrxnull	O
/	O
Y	O
males	O
.	O

This	O
suggested	O
the	O
possibility	O
of	O
an	O
escape	O
from	O
imprinted	O
inactivation	O
of	O
the	O
paternally	O
derived	O
AtrxWT	O
allele	S-SO
in	O
the	O
extraembryonic	O
compartment	O
of	O
a	O
proportion	O
of	O
carrier	O
female	O
embryos	O
.	O

To	O
investigate	O
further	O
,	O
we	O
crossed	O
homozygous	O
Atrxflox	O
/	O
flox	S-SO
females	O
and	O
homozygous	O
GATA1	S-PRGE
-	O
cre	O
transgenic	S-SO
males	O
(	O
AtrxWT	O
/	O
Y	O
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
+	S-SO
)	O
,	O
which	O
would	O
be	O
expected	O
to	O
yield	O
only	O
Atrxnull	O
males	O
(	O
Atrxnull	O
/	O
Y	O
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
-	O
)	O
and	O
carrier	O
females	O
(	O
AtrxWT	O
/	O
null	O
;	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
-	O
)	O
.	O

In	O
these	O
carrier	O
females	O
,	O
the	O
AtrxWT	O
allele	S-SO
is	O
paternally	O
inherited	O
.	O

Embryos	O
were	O
dissected	O
in	O
their	O
deciduas	O
at	O
7	O
.	O
5	O
dpc	O
,	O
and	O
paraffin	O
sections	O
were	O
stained	O
with	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
,	O
along	O
with	O
sections	O
from	O
a	O
wild	B-SO
-	I-SO
type	E-SO
7	O
.	O
5	O
dpc	O
embryo	O
for	O
comparison	O
(	O
Figure	O
8	O
)	O
.	O

As	O
described	O
above	O
,	O
Atrx	S-PRGE
expression	O
was	O
detected	O
in	O
every	O
cell	B-CL
in	I-CL
the	I-CL
epiblast	I-CL
(	I-CL
embryo	I-CL
proper	I-CL
)	I-CL
region	E-CL
of	O
wild	B-SO
-	I-SO
type	E-SO
7	O
.	O
5	O
dpc	O
embryos	O
(	O
Figure	O
8B	O
)	O
.	O

In	O
contrast	O
,	O
the	O
epiblast	O
region	O
of	O
carrier	O
female	O
embryos	O
was	O
composed	O
of	O
a	O
mosaic	O
of	O
small	O
clusters	O
of	O
Atrx	S-PRGE
-	O
positive	O
cells	S-CL
(	O
in	O
which	O
the	O
Atrxnull	O
allele	S-SO
on	O
Xm	O
had	O
been	O
inactivated	O
)	O
and	O
Atrx	S-PRGE
-	O
negative	O
cells	S-CL
(	O
in	O
which	O
the	O
AtrxWT	O
allele	S-SO
on	O
Xp	O
had	O
been	O
inactivated	O
)	O
,	O
indicating	O
that	O
the	O
Atrx	S-PRGE
gene	S-SO
was	O
subject	O
to	O
normal	O
random	O
X	S-GO
-	O
inactivation	O
in	O
the	O
epiblast	O
.	O

Remarkably	O
,	O
clear	O
Atrx	S-PRGE
expression	O
could	O
also	O
be	O
detected	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
carrier	O
females	O
,	O
as	O
shown	O
in	O
the	O
extraembryonic	O
-	O
derived	O
chorionic	O
ectoderm	O
(	O
Figure	O
8C	O
)	O
.	O

Atrx	S-PRGE
expression	O
could	O
be	O
detected	O
in	O
almost	O
all	O
cells	B-CL
of	I-CL
the	I-CL
chorionic	I-CL
ectoderm	E-CL
.	O

Atrx	S-PRGE
expression	O
was	O
also	O
clearly	O
detected	O
in	O
other	O
extraembryonic	O
structures	O
,	O
including	O
TGCs	O
(	O
unpublished	O
data	O
)	O
.	O

Escape	O
from	O
silencing	O
of	O
an	O
Xp	O
-	O
inherited	O
AtrxWT	O
allele	S-SO
was	O
also	O
observed	O
in	O
the	O
chorionic	O
ectoderm	O
of	O
carrier	O
females	O
at	O
8	O
.	O
5	O
dpc	O
(	O
Figure	O
S4	O
)	O
.	O

Thus	O
,	O
although	O
random	O
X	S-GO
-	O
inactivation	O
occurs	O
normally	O
within	O
the	O
epiblast	O
,	O
the	O
AtrxWT	O
allele	S-SO
(	O
inherited	O
on	O
the	O
Xp	O
chromosome	S-GO
)	O
escaped	O
the	O
normal	O
imprinted	O
X	S-GO
-	O
inactivation	O
in	O
the	O
extraembryonic	O
compartment	O
of	O
some	O
carrier	O
females	O
.	O

Discussion	O

We	O
investigated	O
the	O
role	O
of	O
the	O
Atrx	S-PRGE
protein	S-CHEBI
in	O
mouse	S-LIVB
development	O
.	O

By	O
using	O
a	O
conditional	O
knockout	O
approach	O
,	O
we	O
ablated	O
the	O
full	O
-	O
length	O
Atrx	S-PRGE
protein	S-CHEBI
first	O
in	O
ES	O
cells	S-CL
and	O
embryoid	O
bodies	O
,	O
and	O
then	O
in	O
developing	O
mouse	S-LIVB
embryos	O
.	O

Atrx	S-PRGE
in	O
ES	O
Cells	S-CL

Atrxnull	O
ES	O
cells	S-CL
could	O
not	O
be	O
recovered	O
by	O
direct	O
targeting	O
and	O
were	O
eventually	O
generated	O
by	O
adopting	O
a	O
conditional	O
targeting	O
approach	O
.	O

This	O
is	O
consistent	O
with	O
our	O
observation	O
that	O
Atrx	S-PRGE
is	O
highly	O
expressed	O
in	O
ES	O
cells	S-CL
,	O
and	O
that	O
the	O
absence	O
of	O
full	O
-	O
length	O
Atrx	S-PRGE
imparts	O
a	O
growth	O
disadvantage	O
relative	O
to	O
cells	S-CL
bearing	O
a	O
functional	O
Atrx	S-PRGE
allele	S-SO
.	O

At	O
present	O
,	O
the	O
cause	O
of	O
the	O
proliferative	O
delay	O
in	O
Atrxnull	O
ES	O
cells	S-CL
is	O
not	O
known	O
.	O

Interestingly	O
,	O
we	O
demonstrated	O
that	O
apoptosis	O
is	O
not	O
significantly	O
up	O
-	O
regulated	O
in	O
ES	O
cells	S-CL
lacking	O
Atrx	S-PRGE
and	O
is	O
only	O
mildly	O
elevated	O
in	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
mouse	S-LIVB
embryos	O
.	O

In	O
contrast	O
,	O
it	O
was	O
recently	O
shown	O
that	O
the	O
loss	O
of	O
Atrx	S-PRGE
markedly	O
increased	O
the	O
apoptotic	O
population	O
in	O
the	O
differentiating	O
cells	S-CL
of	O
the	O
embryonic	O
cortex	O
and	O
postnatal	O
hippocampus	O
,	O
when	O
Atrx	S-PRGE
expression	O
was	O
ablated	O
in	O
the	O
developing	O
mouse	S-LIVB
forebrain	O
using	O
the	O
Atrxflox	O
allele	S-SO
described	O
here	O
[	O
20	O
]	O
.	O

The	O
human	B-PRGE
ATRX	E-PRGE
protein	S-CHEBI
has	O
been	O
shown	O
to	O
associate	O
in	O
a	O
complex	S-GO
with	O
Daxx	S-PRGE
[	O
8	O
]	O
,	O
a	O
protein	S-CHEBI
that	O
has	O
been	O
implicated	O
in	O
multiple	O
pathways	O
for	O
the	O
regulation	O
of	O
apoptosis	O
[	O
21	O
]	O
.	O

It	O
is	O
possible	O
that	O
disruption	O
of	O
the	O
mouse	B-PRGE
Atrx	I-PRGE
-	I-PRGE
Daxx	E-PRGE
complex	S-GO
(	O
by	O
ablation	O
of	O
the	O
Atrx	S-PRGE
protein	S-CHEBI
)	O
could	O
have	O
triggered	O
a	O
universal	O
proapoptotic	O
response	O
.	O

However	O
,	O
our	O
observations	O
in	O
ES	O
cells	S-CL
demonstrate	O
that	O
the	O
induction	O
of	O
apoptosis	O
is	O
not	O
an	O
automatic	O
response	O
triggered	O
by	O
the	O
removal	O
of	O
Atrx	S-PRGE
in	O
all	O
cell	S-CL
types	O
,	O
and	O
suggest	O
that	O
the	O
inappropriate	O
apoptosis	O
observed	O
in	O
the	O
Atrx	S-PRGE
-	O
mutant	S-SO
forebrain	O
may	O
reflect	O
a	O
requirement	O
for	O
Atrx	S-PRGE
during	O
terminal	O
differentiation	O
.	O

An	O
Unexpected	O
Role	O
for	O
Atrx	S-PRGE
in	O
Development	O
of	O
the	O
Mouse	S-LIVB
Trophoblast	O

We	O
show	O
that	O
Atrxnull	O
male	O
mice	S-LIVB
are	O
not	O
viable	O
and	O
embryos	O
die	O
by	O
around	O
9	O
.	O
5	O
dpc	O
.	O

Before	O
death	O
,	O
Atrxnull	O
embryos	O
exhibit	O
a	O
markedly	O
reduced	O
mitotic	O
index	O
,	O
suggesting	O
a	O
proliferative	O
defect	O
.	O

Although	O
the	O
embryonic	O
compartment	O
of	O
the	O
conceptus	O
appears	O
initially	O
normal	O
,	O
by	O
7	O
.	O
5	O
dpc	O
Atrxnull	O
embryos	O
display	O
abnormalities	O
in	O
development	O
of	O
the	O
trophoblast	O
,	O
including	O
a	O
depletion	O
in	O
the	O
population	O
of	O
TGCs	O
surrounding	O
the	O
conceptus	O
and	O
a	O
reduction	O
in	O
the	O
size	O
of	O
the	O
ectoplacental	O
cone	O
,	O
which	O
contains	O
the	O
diploid	B-CL
giant	I-CL
cell	E-CL
precursors	O
[	O
22	O
]	O
.	O

TGCs	O
are	O
highly	O
differentiated	O
,	O
postmitotic	O
cells	S-CL
that	O
ultimately	O
form	O
an	O
epithelial	O
layer	O
at	O
the	O
periphery	O
of	O
the	O
placenta	O
,	O
which	O
interfaces	O
with	O
the	O
maternal	O
cells	S-CL
of	O
the	O
decidua	O
[	O
23	O
]	O
.	O

These	O
highly	O
invasive	O
cells	S-CL
are	O
important	O
for	O
mediating	O
initial	O
invasion	O
of	O
the	O
uterine	O
tissue	O
,	O
but	O
are	O
also	O
involved	O
in	O
remodelling	O
the	O
maternal	O
decidua	O
after	O
implantation	O
and	O
in	O
secreting	O
hormones	O
that	O
regulate	O
fetal	O
and	O
maternal	O
growth	O
[	O
24	O
]	O
.	O

Since	O
Atrxnull	O
embryos	O
appear	O
to	O
implant	O
normally	O
,	O
lethality	O
is	O
likely	O
to	O
arise	O
due	O
to	O
a	O
failure	O
of	O
TGC	O
function	O
later	O
during	O
development	O
.	O

Embryonic	O
lethality	O
in	O
mice	S-LIVB
in	O
the	O
absence	O
of	O
Atrx	S-PRGE
was	O
a	O
surprising	O
finding	O
,	O
as	O
there	O
had	O
been	O
no	O
suggestion	O
of	O
foetal	O
loss	O
in	O
the	O
human	S-LIVB
ATR	B-PRGE
-	I-PRGE
X	E-PRGE
syndrome	O
.	O

It	O
is	O
possible	O
that	O
the	O
role	O
of	O
Atrx	S-PRGE
in	O
the	O
trophoblast	O
is	O
specific	O
to	O
mice	S-LIVB
and	O
that	O
ATRX	S-PRGE
has	O
no	O
role	O
or	O
is	O
redundant	O
in	O
the	O
human	S-LIVB
trophoblast	O
.	O

Indeed	O
,	O
the	O
birth	O
weight	O
of	O
babies	O
with	O
ATR	B-PRGE
-	I-PRGE
X	E-PRGE
syndrome	O
is	O
usually	O
normal	O
.	O

An	O
alternative	O
explanation	O
for	O
the	O
unexpectedly	O
severe	O
phenotype	O
we	O
observed	O
in	O
mice	S-LIVB
is	O
that	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
deletion	S-SO
generated	O
by	O
Cre	O
recombination	O
completely	O
ablates	O
full	O
-	O
length	O
Atrx	S-PRGE
protein	S-CHEBI
(	O
Figure	O
2E	O
)	O
.	O

In	O
contrast	O
,	O
all	O
disease	O
-	O
causing	O
mutations	S-SO
characterised	O
in	O
human	S-LIVB
ATR	O
-	O
X	S-GO
pedigrees	O
appear	O
to	O
give	O
rise	O
to	O
hypomorphic	O
alleles	S-SO
.	O

Some	O
full	O
-	O
length	O
ATRX	S-PRGE
protein	S-CHEBI
is	O
detected	O
in	O
cases	O
predicted	O
to	O
have	O
truncating	O
mutations	S-SO
(	O
RJG	O
,	O
unpublished	O
data	O
)	O
,	O
and	O
residual	O
ATPase	O
activity	O
in	O
ATRX	S-PRGE
immunoprecipitates	O
can	O
be	O
detected	O
in	O
Epstein	B-LIVB
-	I-LIVB
Barr	I-LIVB
virus	E-LIVB
-	O
transformed	O
lymphocytes	S-CL
of	O
all	O
human	S-LIVB
patients	O
analysed	O
to	O
date	O
(	O
A	O
.	O
Argentaro	O
and	O
M	O
.	O
Mitson	O
,	O
unpublished	O
data	O
)	O
.	O

The	O
failure	O
to	O
observe	O
a	O
truly	O
null	O
ATRX	S-PRGE
allele	S-SO
among	O
human	S-LIVB
patients	O
strongly	O
suggests	O
that	O
,	O
as	O
in	O
the	O
mouse	S-LIVB
,	O
the	O
complete	O
absence	O
of	O
ATRX	S-PRGE
protein	S-CHEBI
is	O
incompatible	O
with	O
human	S-LIVB
fetal	O
survival	O
.	O

While	O
this	O
study	O
has	O
revealed	O
an	O
unexpected	O
role	O
for	O
Atrx	S-PRGE
in	O
the	O
murine	S-LIVB
trophectoderm	O
,	O
as	O
a	O
result	O
of	O
the	O
early	O
lethality	O
observed	O
in	O
Atrxnull	O
embryos	O
it	O
is	O
not	O
possible	O
to	O
rule	O
out	O
other	O
roles	O
for	O
Atrx	S-PRGE
at	O
later	O
developmental	O
stages	O
in	O
tissues	O
of	O
the	O
embryo	O
proper	O
.	O

Indeed	O
,	O
we	O
show	O
that	O
Atrx	S-PRGE
is	O
highly	O
expressed	O
throughout	O
the	O
entire	O
developing	O
embryo	O
at	O
7	O
.	O
5	O
dpc	O
(	O
Figure	O
5B	O
)	O
,	O
and	O
it	O
is	O
likely	O
that	O
Atrx	S-PRGE
function	O
will	O
turn	O
out	O
to	O
be	O
important	O
for	O
other	O
differentiating	O
tissues	O
.	O

Tetraploid	O
aggregation	O
experiments	O
(	O
in	O
which	O
mutant	S-SO
embryos	O
are	O
rescued	O
with	O
wild	B-SO
-	I-SO
type	E-SO
extraembryonic	O
tissues	O
)	O
might	O
shed	O
more	O
light	O
on	O
the	O
role	O
of	O
Atrx	S-PRGE
during	O
later	O
mouse	S-LIVB
development	O
,	O
but	O
these	O
issues	O
can	O
be	O
more	O
subtly	O
dissected	O
by	O
combining	O
the	O
conditional	O
Atrxflox	O
allele	S-SO
that	O
we	O
have	O
generated	O
with	O
different	O
tissue	O
-	O
specific	O
Cre	O
transgenes	S-SO
.	O

As	O
mentioned	O
above	O
,	O
this	O
approach	O
has	O
already	O
revealed	O
a	O
critical	O
role	O
for	O
Atrx	S-PRGE
during	O
neuronal	S-CL
differentiation	O
in	O
adult	O
mice	S-LIVB
[	O
20	O
]	O
.	O

Further	O
evidence	O
that	O
Atrx	S-PRGE
is	O
also	O
required	O
at	O
later	O
stages	O
of	O
mouse	S-LIVB
development	O
is	O
provided	O
by	O
the	O
observed	O
dramatic	O
skewing	O
against	O
Atrx	S-PRGE
-	O
negative	O
cells	S-CL
in	O
some	O
somatic	O
tissues	O
of	O
carrier	O
female	O
mice	S-LIVB
,	O
whose	O
tissues	O
initially	O
comprise	O
a	O
mosaic	O
of	O
Atrx	S-PRGE
-	O
positive	O
and	O
Atrx	S-PRGE
-	O
negative	O
cells	S-CL
as	O
a	O
result	O
of	O
random	O
X	S-GO
-	O
inactivation	O
(	O
M	O
.	O
Muers	O
,	O
personal	O
communication	O
)	O
.	O

Atrx	S-PRGE
joins	O
an	O
expanding	O
list	O
of	O
mouse	S-LIVB
genes	S-SO
for	O
which	O
targeted	O
disruption	O
results	O
in	O
peri	O
-	O
implantation	O
lethality	O
as	O
a	O
result	O
of	O
trophoblast	O
or	O
placental	O
abnormalities	O
(	O
reviewed	O
in	O
[	O
25	O
]	O
)	O
.	O

Comparison	O
with	O
other	O
phenotypes	O
might	O
provide	O
some	O
insight	O
into	O
the	O
role	O
of	O
Atrx	S-PRGE
in	O
trophoblast	O
development	O
.	O

Atrx	S-PRGE
-	O
mutant	S-SO
embryos	O
progress	O
further	O
than	O
embryos	O
nullizygous	O
for	O
factors	O
involved	O
in	O
the	O
initial	O
specification	O
of	O
trophoblast	B-CL
stem	I-CL
cells	E-CL
(	O
such	O
as	O
Cdx2	S-PRGE
)	O
or	O
in	O
stem	B-CL
cell	E-CL
maintenance	O
and	O
proliferation	O
(	O
such	O
as	O
Eomes	S-PRGE
)	O
.	O

Cdx2	S-PRGE
-	O
mutant	S-SO
embryos	O
fail	O
to	O
implant	O
and	O
die	O
between	O
3	O
.	O
5	O
and	O
5	O
.	O
5	O
dpc	O
[	O
26	O
]	O
,	O
while	O
Eomes	S-PRGE
-	O
mutant	S-SO
blastocysts	O
implant	O
into	O
the	O
uterus	O
,	O
but	O
arrest	O
soon	O
after	O
implantation	O
without	O
forming	O
organised	O
embryonic	O
or	O
extraembryonic	O
structures	O
[	O
27	O
]	O
.	O

In	O
contrast	O
,	O
Atrx	S-PRGE
-	O
mutant	S-SO
embryos	O
implant	O
successfully	O
and	O
establish	O
organised	O
embryonic	O
structures	O
by	O
7	O
.	O
5	O
dpc	O
.	O

The	O
Atrx	S-PRGE
-	O
mutant	S-SO
phenotype	O
closely	O
resembles	O
that	O
observed	O
in	O
mice	S-LIVB
nullizygous	O
for	O
the	O
basic	S-CHEBI
helix	S-SO
-	O
loop	O
-	O
helix	S-SO
transcription	O
factor	O
Hand1	S-PRGE
.	O

Hand1	S-PRGE
-	O
mutant	S-SO
conceptuses	O
arrest	O
at	O
around	O
7	O
.	O
5	O
dpc	O
and	O
display	O
a	O
normal	O
embryonic	O
compartment	O
,	O
but	O
,	O
like	O
Atrx	S-PRGE
-	O
mutant	S-SO
embryos	O
,	O
ablation	O
of	O
Hand1	S-PRGE
causes	O
a	O
reduction	O
in	O
the	O
size	O
of	O
the	O
ectoplacental	O
cone	O
and	O
density	O
of	O
TGCs	O
[	O
28	O
]	O
.	O

As	O
with	O
Atrx	S-PRGE
mutants	S-SO
,	O
only	O
arrested	O
or	O
resorbed	O
Hand1	S-PRGE
-	O
mutant	S-SO
conceptuses	O
were	O
recovered	O
after	O
8	O
.	O
5	O
dpc	O
.	O

Also	O
like	O
Atrx	S-PRGE
,	O
disruption	O
of	O
Hand1	S-PRGE
specifically	O
affects	O
secondary	O
giant	O
cell	S-CL
formation	O
,	O
and	O
primary	O
trophoblast	O
outgrowths	O
from	O
blastocysts	O
appeared	O
normal	O
.	O

Hand1	S-PRGE
is	O
required	O
for	O
terminal	O
differentiation	O
of	O
secondary	O
TGCs	O
,	O
and	O
in	O
its	O
absence	O
trophoblast	B-CL
cells	E-CL
arrest	O
at	O
a	O
precursor	O
stage	O
in	O
the	O
ectoplacental	O
cone	O
[	O
17	O
,	O
28	O
]	O
.	O

Given	O
the	O
similarity	O
of	O
the	O
Atrx	S-PRGE
-	O
and	O
Hand1	S-PRGE
-	O
mutant	S-SO
phenotypes	O
and	O
the	O
likelihood	O
that	O
Atrx	S-PRGE
acts	O
as	O
a	O
transcriptional	O
regulator	O
by	O
modifying	O
chromatin	S-GO
structure	O
,	O
it	O
will	O
be	O
of	O
interest	O
to	O
determine	O
whether	O
Atrx	S-PRGE
is	O
itself	O
a	O
regulator	O
of	O
Hand1	S-PRGE
expression	O
,	O
or	O
alternatively	O
whether	O
it	O
acts	O
as	O
a	O
co	O
-	O
regulator	O
of	O
one	O
or	O
more	O
of	O
the	O
downstream	O
transcriptional	O
targets	O
of	O
Hand1	S-PRGE
.	O

It	O
is	O
noteworthy	O
that	O
,	O
in	O
the	O
brain	O
-	O
specific	O
Atrx	S-PRGE
knockout	O
mice	S-LIVB
,	O
the	O
defect	O
was	O
observed	O
in	O
terminally	O
differentiating	O
neurons	S-CL
[	O
20	O
]	O
.	O

The	O
secondary	O
TGCs	O
affected	O
in	O
the	O
universal	O
Atrx	S-PRGE
knockout	O
reported	O
here	O
represent	O
one	O
of	O
the	O
first	O
terminally	O
differentiated	O
tissues	O
in	O
the	O
developing	O
mouse	S-LIVB
,	O
and	O
this	O
may	O
point	O
to	O
the	O
requirement	O
for	O
Atrx	S-PRGE
in	O
the	O
high	O
-	O
level	O
expression	O
of	O
some	O
tissue	O
-	O
specific	O
genes	S-SO
during	O
the	O
final	O
stages	O
of	O
differentiation	O
.	O

Interestingly	O
,	O
the	O
alpha	O
-	O
globin	S-CHEBI
genes	S-SO
,	O
the	O
only	O
confirmed	O
transcriptional	O
targets	O
of	O
regulation	O
by	O
human	B-PRGE
ATRX	E-PRGE
,	O
are	O
also	O
highly	O
expressed	O
specifically	O
during	O
terminal	O
differentiation	O
within	O
the	O
erythroid	O
lineage	O
.	O

Atrx	S-PRGE
Escapes	O
Imprinted	O
X	S-GO
-	O
Inactivation	O
in	O
Extraembryonic	O
Tissues	O
of	O
Carrier	O
Female	O
Mice	S-LIVB

Another	O
surprising	O
finding	O
of	O
this	O
study	O
is	O
that	O
,	O
in	O
carrier	O
female	O
embryos	O
,	O
a	O
paternally	O
inherited	O
AtrxWT	O
allele	S-SO
appears	O
to	O
escape	O
the	O
process	O
of	O
imprinted	O
X	S-GO
-	O
inactivation	O
,	O
which	O
ordinarily	O
silences	O
the	O
Xp	O
chromosome	S-GO
in	O
the	O
extraembryonic	O
compartment	O
of	O
female	O
murine	S-LIVB
tissues	O
[	O
18	O
]	O
.	O

Silencing	O
of	O
the	O
AtrxWT	O
allele	S-SO
on	O
Xp	O
should	O
render	O
these	O
females	O
null	O
for	O
Atrx	S-PRGE
in	O
the	O
extraembryonic	O
tissues	O
,	O
since	O
the	O
normally	O
active	O
Xm	O
chromosome	S-GO
carries	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	S-SO
.	O

Although	O
not	O
phenotypically	O
normal	O
,	O
some	O
Atrx	S-PRGE
carrier	O
females	O
developed	O
to	O
term	O
and	O
went	O
on	O
to	O
reproduce	O
.	O

Thus	O
,	O
the	O
failure	O
to	O
correctly	O
silence	O
the	O
paternally	O
derived	O
AtrxWT	O
allele	S-SO
in	O
the	O
extraembryonic	O
tissues	O
of	O
carrier	O
females	O
is	O
consistent	O
with	O
our	O
observations	O
that	O
in	O
Atrxnull	O
males	O
,	O
the	O
Atrx	S-PRGE
protein	S-CHEBI
plays	O
an	O
essential	O
role	O
in	O
the	O
development	O
of	O
the	O
trophoblast	O
and	O
is	O
necessary	O
for	O
survival	O
in	O
utero	O
in	O
the	O
mouse	S-LIVB
.	O

The	O
survival	O
of	O
Atrx	S-PRGE
carrier	O
females	O
contrasts	O
with	O
the	O
phenotypes	O
seen	O
in	O
carriers	O
of	O
mutations	S-SO
of	O
other	O
murine	S-LIVB
X	S-GO
-	O
linked	O
genes	S-SO
known	O
to	O
be	O
essential	O
in	O
the	O
extraembryonic	O
compartment	O
.	O

For	O
example	O
,	O
targeted	O
disruption	O
of	O
the	O
dyskerin	S-PRGE
(	O
Dkc1	S-PRGE
)	O
,	O
glucose	B-PRGE
6	I-PRGE
-	I-PRGE
phosphate	I-PRGE
dehydrogenase	E-PRGE
(	O
G6PD	S-PRGE
)	O
,	O
and	O
choroideremia	S-PRGE
(	O
Chm	S-PRGE
)	O
genes	S-SO
cause	O
embryonic	O
lethality	O
in	O
null	O
male	O
embryos	O
through	O
defects	O
of	O
the	O
extraembryonic	O
-	O
derived	O
tissues	O
[	O
29	O
-	O
31	O
]	O
.	O

Female	O
mice	S-LIVB
carrying	O
mutations	S-SO
of	O
these	O
genes	S-SO
on	O
the	O
maternally	O
inherited	O
X	B-GO
chromosome	E-GO
also	O
die	O
in	O
utero	O
,	O
whereas	O
females	O
that	O
inherit	O
the	O
mutation	S-SO
on	O
the	O
Xp	O
chromosome	S-GO
survive	O
.	O

Thus	O
,	O
unlike	O
Atrx	S-PRGE
,	O
these	O
genes	S-SO
and	O
/	O
or	O
their	O
effects	O
on	O
cell	S-CL
growth	O
are	O
unable	O
to	O
circumvent	O
the	O
processes	O
that	O
ultimately	O
cause	O
all	O
cells	B-CL
in	I-CL
the	I-CL
extraembryonic	I-CL
tissues	E-CL
to	O
express	O
only	O
the	O
maternally	O
derived	O
X	B-GO
chromosome	E-GO
.	O

How	O
might	O
expression	O
of	O
the	O
paternal	O
AtrxWT	O
allele	S-SO
be	O
maintained	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
the	O
Atrx	S-PRGE
carrier	O
females	O
?	O

One	O
possibility	O
is	O
that	O
,	O
like	O
some	O
other	O
X	S-GO
-	O
linked	O
genes	S-SO
,	O
silencing	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
on	O
Xp	O
is	O
incomplete	O
,	O
such	O
that	O
there	O
is	O
always	O
a	O
low	O
-	O
level	O
,	O
leaky	O
output	O
of	O
Atrx	S-PRGE
from	O
a	O
normally	O
inactivated	O
Xp	O
chromosome	S-GO
in	O
extraembryonic	O
tissues	O
.	O

However	O
,	O
it	O
was	O
recently	O
demonstrated	O
that	O
the	O
paternal	O
Atrx	S-PRGE
(	O
called	O
Xnp	O
)	O
allele	S-SO
is	O
completely	O
silenced	O
in	O
a	O
normal	O
mouse	S-LIVB
trophoblast	B-CL
stem	I-CL
cell	E-CL
line	O
[	O
32	O
]	O
,	O
suggesting	O
that	O
Atrx	S-PRGE
does	O
not	O
normally	O
escape	O
imprinted	O
X	S-GO
-	O
inactivation	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
wild	B-SO
-	I-SO
type	E-SO
females	O
.	O

Thus	O
,	O
the	O
expression	O
of	O
the	O
Xp	O
-	O
linked	O
AtrxWT	O
allele	S-SO
that	O
we	O
observed	O
is	O
unique	O
to	O
female	O
carriers	O
of	O
the	O
Atrxnull	O
allele	S-SO
.	O

Perhaps	O
a	O
more	O
likely	O
explanation	O
for	O
this	O
phenomenon	O
stems	O
from	O
experimental	O
observations	O
suggesting	O
that	O
imprinted	O
X	S-GO
-	O
inactivation	O
is	O
not	O
imposed	O
on	O
all	O
precursors	O
of	O
the	O
mouse	S-LIVB
extraembryonic	O
tissues	O
:	O
A	O
subpopulation	O
of	O
cells	S-CL
may	O
escape	O
this	O
process	O
and	O
make	O
a	O
random	O
"	O
choice	O
"	O
of	O
which	O
X	B-GO
chromosome	E-GO
will	O
be	O
inactivated	O
.	O

On	O
average	O
,	O
50	O
%	O
of	O
the	O
cells	S-CL
in	O
this	O
randomly	O
inactivating	O
subpopulation	O
would	O
be	O
expected	O
to	O
maintain	O
an	O
active	O
Xp	O
chromosome	S-GO
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
expression	O
of	O
paternally	O
transmitted	O
X	S-GO
-	O
linked	O
lacZ	O
[	O
33	O
,	O
34	O
]	O
and	O
GFP	O
[	O
35	O
]	O
transgenes	S-SO
failed	O
to	O
be	O
silenced	O
in	O
a	O
small	O
subpopulation	O
of	O
extraembryonic	B-CL
cells	E-CL
.	O

Further	O
,	O
it	O
has	O
been	O
shown	O
that	O
in	O
a	O
subpopulation	O
of	O
extraembryonic	B-CL
cells	E-CL
,	O
it	O
is	O
the	O
Xm	O
rather	O
than	O
the	O
Xp	O
that	O
undergoes	O
late	O
replication	O
,	O
a	O
molecular	S-CHEBI
correlate	O
of	O
the	O
inactive	O
state	O
[	O
18	O
,	O
36	O
]	O
.	O

Although	O
initially	O
small	O
and	O
quickly	O
diluted	O
in	O
normal	O
embryos	O
,	O
the	O
cellular	S-CL
subpopulation	O
that	O
inactivates	O
the	O
Xm	O
chromosome	S-GO
could	O
rapidly	O
expand	O
to	O
replace	O
the	O
normally	O
imprinted	O
cells	S-CL
in	O
extraembryonic	O
lineages	O
if	O
the	O
normal	O
silencing	O
of	O
Xp	O
compromises	O
cell	S-CL
growth	O
or	O
differentiation	O
.	O

Interestingly	O
,	O
it	O
has	O
been	O
suggested	O
that	O
the	O
size	O
of	O
the	O
population	O
that	O
initially	O
escapes	O
imprinting	O
may	O
range	O
widely	O
(	O
from	O
0	O
%	O
to	O
30	O
%	O
)	O
,	O
even	O
between	O
genetically	S-SO
identical	O
embryos	O
[	O
37	O
]	O
,	O
and	O
this	O
may	O
account	O
for	O
the	O
variable	O
phenotype	O
observed	O
among	O
females	O
bearing	O
Xm	O
-	O
linked	O
mutant	S-SO
alleles	S-SO
of	O
genes	S-SO
essential	O
for	O
normal	O
extraembryonic	O
development	O
[	O
38	O
]	O
.	O

Put	O
simply	O
,	O
carrier	O
females	O
bearing	O
a	O
small	O
initial	O
population	O
of	O
escaping	O
cells	S-CL
would	O
be	O
more	O
severely	O
affected	O
than	O
those	O
bearing	O
a	O
larger	O
population	O
.	O

This	O
could	O
explain	O
why	O
we	O
have	O
observed	O
significant	O
phenotypic	O
variation	O
among	O
Atrx	S-PRGE
carrier	O
females	O
,	O
with	O
some	O
carriers	O
dying	O
in	O
utero	O
by	O
9	O
.	O
5	O
dpc	O
(	O
Table	O
1	O
)	O
and	O
others	O
developing	O
to	O
term	O
.	O

Another	O
possible	O
mechanism	O
is	O
that	O
inactivation	O
of	O
the	O
paternal	O
X	S-GO
proceeds	O
normally	O
in	O
all	O
cells	S-CL
,	O
but	O
subsequently	O
the	O
Atrx	S-PRGE
gene	S-SO
within	O
individual	O
cells	S-CL
is	O
reactivated	O
.	O

Alternatively	O
,	O
in	O
the	O
absence	O
of	O
Atrx	S-PRGE
,	O
the	O
paternal	O
allele	S-SO
may	O
partially	O
escape	O
the	O
normal	O
process	O
of	O
silencing	O
.	O

In	O
both	O
of	O
these	O
cases	O
,	O
other	O
genes	S-SO
on	O
the	O
paternal	O
X	B-GO
chromosome	E-GO
must	O
be	O
inactivated	O
and	O
remain	O
so	O
,	O
since	O
blocking	O
inactivation	O
of	O
the	O
entire	O
Xp	O
chromosome	S-GO
causes	O
embryonic	O
lethality	O
due	O
to	O
biallelic	O
expression	O
of	O
X	S-GO
-	O
linked	O
genes	S-SO
in	O
the	O
trophoblast	O
[	O
39	O
]	O
.	O

Summary	O

ATR	O
-	O
X	S-GO
syndrome	O
is	O
the	O
first	O
human	S-LIVB
genetic	S-SO
disease	O
known	O
to	O
be	O
caused	O
by	O
mutations	S-SO
in	O
a	O
chromatin	S-GO
remodelling	O
factor	O
.	O

At	O
present	O
we	O
do	O
not	O
know	O
how	O
ATRX	S-PRGE
influences	O
gene	S-SO
expression	O
or	O
what	O
effect	O
it	O
has	O
on	O
cell	S-CL
behaviour	O
.	O

Nevertheless	O
,	O
we	O
have	O
previously	O
noted	O
that	O
none	O
of	O
the	O
natural	S-SO
mutations	S-SO
causing	O
ATR	O
-	O
X	S-GO
syndrome	O
are	O
nulls	O
,	O
which	O
suggests	O
that	O
it	O
plays	O
a	O
critical	O
role	O
in	O
normal	O
development	O
.	O

Results	O
of	O
conditional	O
inactivation	O
of	O
Atrx	S-PRGE
in	O
the	O
developing	O
mouse	S-LIVB
forebrain	O
,	O
based	O
on	O
the	O
Atrxflox	O
allele	S-SO
described	O
here	O
,	O
shows	O
that	O
Atrx	S-PRGE
exerts	O
a	O
major	O
effect	O
on	O
terminally	O
differentiating	O
neurons	S-CL
.	O

Conditional	O
inactivation	O
of	O
Atrx	S-PRGE
in	O
other	O
tissues	O
is	O
underway	O
.	O

Here	O
we	O
have	O
shown	O
that	O
animal	S-LIVB
-	O
wide	O
disruption	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
causes	O
a	O
severe	O
embryonic	O
-	O
lethal	O
phenotype	O
,	O
revealing	O
an	O
essential	O
role	O
for	O
Atrx	S-PRGE
in	O
the	O
formation	O
of	O
the	O
murine	S-LIVB
trophoblast	O
.	O

In	O
addition	O
,	O
Atrx	S-PRGE
appears	O
to	O
escape	O
imprinted	O
X	B-GO
-	I-GO
chromosome	E-GO
inactivation	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
some	O
carrier	O
female	O
mice	S-LIVB
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
ES	O
cells	S-CL
bearing	O
the	O
Atrxflox	O
allele	S-SO
.	O

Briefly	O
,	O
the	O
targeting	O
vector	S-SO
(	O
shown	O
in	O
Figure	O
2A	O
)	O
places	O
a	O
loxP	B-SO
site	E-SO
within	O
intron	S-SO
18	O
and	O
a	O
loxP	B-SO
-	I-SO
flanked	E-SO
MC1neopA	O
selection	O
cassette	S-SO
in	O
intron	S-SO
17	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
.	O

A	O
detailed	O
description	O
of	O
the	O
targeting	O
construct	S-SO
is	O
provided	O
in	O
[	O
20	O
]	O
.	O

Linearised	O
plasmid	S-SO
(	O
150	O
mu	O
g	O
)	O
was	O
electroporated	O
into	O
1	O
x	O
108	O
E14Tg2a	O
ES	O
cells	S-CL
,	O
and	O
colonies	O
resistant	O
to	O
G418	O
and	O
ganciclovir	O
were	O
isolated	O
.	O

Homologous	O
targeting	O
events	O
were	O
identified	O
by	O
Southern	O
blot	O
of	O
EcoRI	O
-	O
digested	O
DNA	S-SO
and	O
hybridisation	O
with	O
a	O
5	O
'	O
probe	S-SO
(	O
generated	O
with	O
primers	S-SO
PPS1	O
.	O
20	O
and	O
PPS1	O
.	O
27	O
)	O
and	O
a	O
3	O
'	O
probe	S-SO
(	O
a	O
0	O
.	O
9	O
-	O
kb	O
HaeIII	O
fragment	S-SO
)	O
as	O
shown	O
in	O
Figure	O
2A	O
and	O
2B	O
.	O

DNA	S-SO
from	O
correctly	O
targeted	O
clones	O
was	O
also	O
digested	O
with	O
SacI	O
and	O
analysed	O
by	O
Southern	O
blot	O
and	O
hybridisation	O
with	O
a	O
probe	S-SO
from	O
within	O
intron	S-SO
17	O
(	O
a	O
PCR	B-SO
product	E-SO
generated	O
with	O
primers	S-SO
PPS1	O
.	O
15	O
and	O
Xnp46	O
)	O
to	O
confirm	O
that	O
the	O
loxP	B-SO
site	E-SO
within	O
intron	S-SO
18	O
had	O
been	O
included	O
within	O
the	O
crossed	O
-	O
over	O
region	S-SO
(	O
Figure	O
2A	O
and	O
2C	O
)	O
.	O

Sequences	S-SO
of	O
primers	S-SO
are	O
shown	O
in	O
Table	O
S1	O
.	O

Cre	O
-	O
recombination	O
and	O
characterisation	O
of	O
Atrxnull	O
ES	O
cells	S-CL
and	O
embryoid	O
bodies	O
.	O

ES	O
cell	S-CL
clones	O
bearing	O
the	O
Atrxflox	O
allele	S-SO
(	O
1	O
x	O
107	O
cells	S-CL
)	O
were	O
transiently	O
transfected	O
with	O
50	O
mu	O
g	O
of	O
uncut	O
Cre	O
expression	O
plasmid	S-SO
(	O
pCAGGS	O
-	O
Cre	O
-	O
IRESpuro	O
)	O
[	O
40	O
]	O
.	O

Following	O
transfection	O
,	O
cells	S-CL
were	O
plated	O
at	O
a	O
range	O
of	O
clonal	O
densities	O
in	O
complete	O
medium	O
without	O
G418	O
,	O
and	O
isolated	O
subclones	O
were	O
picked	O
after	O
7	O
d	O
.	O

Subclones	O
were	O
expanded	O
and	O
analysed	O
for	O
the	O
presence	O
of	O
a	O
recombinant	O
locus	S-SO
initially	O
by	O
PCR	O
,	O
to	O
detect	O
deletion	S-SO
of	O
the	O
MC1neopA	O
cassette	S-SO
,	O
and	O
then	O
by	O
Southern	O
blot	O
and	O
hybridisation	O
with	O
the	O
intron	S-SO
17	O
probe	S-SO
described	O
above	O
(	O
Figure	O
2A	O
and	O
2C	O
)	O
.	O

Northern	O
blots	O
were	O
carried	O
out	O
according	O
to	O
standard	O
techniques	O
using	O
20	O
mu	O
g	O
of	O
total	O
RNA	S-SO
isolated	O
using	O
TRI	O
Reagent	S-CHEBI
(	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

The	O
blot	O
was	O
hybridised	O
with	O
a	O
probe	S-SO
from	O
within	O
exon	S-SO
10	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
(	O
generated	O
with	O
primers	S-SO
Mxnp4	O
and	O
Mxnp28	O
[	O
Table	O
S1	O
]	O
)	O
.	O

After	O
it	O
was	O
stripped	O
,	O
the	O
membrane	O
was	O
hybridised	O
with	O
a	O
beta	B-PRGE
-	I-PRGE
actin	E-PRGE
cDNA	S-SO
probe	S-SO
(	O
Clontech	O
,	O
Palo	O
Alto	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Protein	S-CHEBI
extraction	O
and	O
detection	O
of	O
Atrx	S-PRGE
by	O
Western	O
blotting	O
was	O
performed	O
as	O
described	O
previously	O
[	O
4	O
]	O
,	O
using	O
the	O
mouse	S-LIVB
monoclonal	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
23C	O
[	O
15	O
]	O
.	O

Analyses	O
of	O
cell	S-CL
cycle	O
and	O
apoptosis	O
are	O
described	O
in	O
Protocol	O
S1	O
.	O

Methylation	O
of	O
rDNA	O
was	O
analysed	O
in	O
DNA	S-SO
from	O
ES	O
cell	S-CL
clones	O
or	O
from	O
embryoid	O
bodies	O
recovered	O
after	O
7	O
d	O
of	O
in	O
vitro	O
differentiation	O
as	O
described	O
previously	O
[	O
41	O
]	O
.	O

Genomic	B-SO
DNA	E-SO
was	O
digested	O
with	O
methylation	O
-	O
sensitive	O
restriction	O
enzymes	S-SO
as	O
described	O
and	O
analysed	O
by	O
Southern	O
blotting	O
.	O

The	O
RIB3	O
and	O
RIB4	O
probes	S-SO
(	O
which	O
were	O
amplified	O
from	O
human	S-LIVB
DNA	S-SO
,	O
but	O
cross	O
-	O
react	O
with	O
the	O
mouse	S-LIVB
rDNA	O
repeat	S-SO
)	O
have	O
been	O
described	O
previously	O
[	O
11	O
]	O
.	O

Oligonucleotide	S-SO
probes	S-SO
to	O
detect	O
Line	O
1	O
and	O
Sine	O
B1	O
repeats	S-SO
have	O
been	O
described	O
previously	O
[	O
42	O
]	O
.	O

The	O
minor	O
satellite	S-SO
probe	S-SO
was	O
a	O
27	O
-	O
mer	O
oligonucleotide	S-SO
(	O
mCENT2	O
)	O
.	O

The	O
major	O
satellite	S-SO
probe	S-SO
was	O
a	O
27	O
-	O
mer	O
oligonucleotide	S-SO
(	O
DG27	O
)	O
.	O

The	O
IAP	O
probe	S-SO
was	O
an	O
~	O
400	O
bp	S-SO
PCR	B-SO
product	E-SO
(	O
primers	S-SO
14A	O
and	O
13K	O
)	O
amplified	O
from	O
an	O
IAP	O
inserted	S-SO
into	O
the	O
mouse	B-PRGE
agouti	E-PRGE
gene	S-SO
[	O
43	O
]	O
and	O
was	O
a	O
gift	O
from	O
Peter	O
Warnecke	O
and	O
Tim	O
Bestor	O
.	O

The	O
PCR	B-SO
product	E-SO
included	O
the	O
entire	O
5	B-SO
'	I-SO
LTR	E-SO
of	O
the	O
IAP	O
.	O

All	O
oligonucleotide	B-SO
sequences	E-SO
are	O
shown	O
in	O
Table	O
S1	O
.	O

Generation	O
of	O
chimeras	O
,	O
floxed	S-SO
mice	S-LIVB
,	O
and	O
mutant	S-SO
mice	S-LIVB
.	O

Targeted	O
Atrxflox	O
ES	O
cell	S-CL
clones	O
were	O
injected	O
into	O
C57BL	O
/	O
6	O
blastocysts	O
and	O
transferred	O
into	O
2	O
.	O
5	O
dpc	O
pseudopregnant	O
recipients	O
by	O
standard	O
techniques	O
.	O

Resulting	O
chimeras	O
were	O
mated	O
with	O
C57BL	O
/	O
6	O
to	O
establish	O
germline	O
transmission	O
.	O

Offspring	O
with	O
the	O
Atrxflox	O
allele	S-SO
were	O
identified	O
by	O
Southern	O
blotting	O
of	O
SacI	O
-	O
digested	O
tail	O
DNA	S-SO
using	O
the	O
intron	S-SO
17	O
probe	S-SO
as	O
shown	O
in	O
Figure	O
2A	O
and	O
2C	O
.	O

For	O
Cre	O
-	O
recombination	O
,	O
Atrxflox	O
mice	S-LIVB
were	O
crossed	O
with	O
GATA1	S-PRGE
-	O
Cre	O
transgenic	S-SO
mice	S-LIVB
as	O
described	O
in	O
the	O
text	O
.	O

Recombinant	O
alleles	S-SO
were	O
detected	O
by	O
Southern	O
blotting	O
as	O
described	O
above	O
or	O
by	O
PCR	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

Immunohistochemistry	O
,	O
in	O
situ	O
hybridisation	O
,	O
and	O
TUNEL	O
assay	O
.	O

7	O
.	O
5	O
dpc	O
decidual	O
swellings	O
were	O
dissected	O
away	O
from	O
maternal	O
tissue	O
and	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
/	O
PBS	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

After	O
embryos	O
were	O
washed	O
thoroughly	O
in	O
PBS	O
,	O
they	O
were	O
dehydrated	O
through	O
an	O
ethanol	S-CHEBI
series	O
and	O
xylene	S-CHEBI
,	O
embedded	O
in	O
paraffin	O
,	O
and	O
sectioned	O
at	O
5	O
mu	O
m	O
.	O

Sections	O
were	O
processed	O
for	O
immunohistochemistry	O
using	O
the	O
ABC	O
Staining	O
System	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
California	O
,	O
United	O
States	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Sections	O
were	O
stained	O
with	O
rabbit	S-LIVB
polyclonal	O
antibodies	S-GO
against	O
ATRX	S-PRGE
(	O
H	O
-	O
300	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
,	O
Placental	B-PRGE
lactogen	I-PRGE
-	I-PRGE
I	E-PRGE
(	O
AB1288	O
,	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
phospho	S-CHEBI
(	O
Ser10	O
)	O
-	O
histone	S-CHEBI
H3	O
(	O
06	O
-	O
570	O
,	O
Upstate	O
Biotechnology	O
,	O
Waltham	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Where	O
appropriate	O
,	O
adjacent	O
sections	O
were	O
stained	O
with	O
haematoxylin	O
.	O

In	O
some	O
cases	O
,	O
adjacent	O
sections	O
were	O
also	O
analysed	O
to	O
detect	O
apoptotic	B-CL
cells	E-CL
by	O
TUNEL	O
using	O
the	O
in	O
situ	O
cell	S-CL
death	O
detection	O
kit	O
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
.	O

After	O
labelling	O
,	O
these	O
slides	O
were	O
mounted	O
in	O
Vectashield	O
containing	O
DAPI	O
(	O
Vector	S-SO
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
visualised	O
by	O
fluorescence	O
microscopy	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridisations	O
were	O
performed	O
on	O
8	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
away	O
from	O
maternal	O
and	O
extraembryonic	O
tissues	O
)	O
using	O
a	O
brachyury	S-PRGE
(	O
T	S-PRGE
)	O
riboprobe	O
[	O
16	O
]	O
and	O
on	O
bisected	O
decidual	O
implantation	O
sites	O
from	O
which	O
embryos	O
(	O
8	O
.	O
5	O
dpc	O
)	O
had	O
been	O
removed	O
using	O
a	O
placental	B-PRGE
lactogen	I-PRGE
-	I-PRGE
1	E-PRGE
(	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
)	O
riboprobe	O
(	O
see	O
Protocol	O
S1	O
for	O
details	O
)	O
.	O

Blastocyst	O
outgrowth	O
cultures	O
.	O

Superovulated	O
heterozygous	O
female	O
mice	S-LIVB
(	O
AtrxWT	O
/	O
flox	S-SO
)	O
were	O
mated	O
to	O
homozygous	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
+	S-SO
transgenic	S-SO
males	O
,	O
and	O
blastocysts	O
were	O
flushed	O
from	O
uterine	O
horns	O
with	O
M2	O
medium	O
(	O
Sigma	O
)	O
at	O
3	O
.	O
5	O
dpc	O
.	O

Individual	O
blastocysts	O
were	O
cultured	O
in	O
multiwell	O
tissue	O
cultures	O
plates	O
as	O
described	O
previously	O
[	O
44	O
]	O
.	O

Cultures	O
were	O
inspected	O
and	O
photographed	O
daily	O
and	O
the	O
extent	O
of	O
outgrowth	O
scored	O
.	O

After	O
7	O
d	O
,	O
cultures	O
were	O
harvested	O
and	O
DNA	S-SO
extracted	O
.	O

The	O
Atrx	S-PRGE
genotype	S-SO
and	O
sex	O
of	O
each	O
culture	O
was	O
determined	O
by	O
PCR	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Cell	S-CL
Cycle	O
Analysis	O
of	O
Atrx	S-PRGE
-	O
Positive	O
and	O
Atrxnull	O
ES	O
Cells	S-CL

(	O
A	O
)	O
Representative	O
FACS	O
profiles	O
of	O
BrdU	O
-	O
pulsed	O
ES	O
cells	S-CL
bearing	O
either	O
functional	O
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
or	O
null	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
Atrx	S-PRGE
alleles	S-SO
showing	O
BrdU	O
-	O
FITC	S-CHEBI
(	O
y	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
against	O
propidium	O
iodide	S-CHEBI
(	O
x	O
-	O
axis	O
,	O
linear	O
scale	O
)	O
.	O

The	O
gated	O
populations	O
show	O
cells	S-CL
in	O
G1	O
(	O
PIlow	O
,	O
BrdU	O
-	O
negative	O
)	O
(	O
R1	O
)	O
,	O
S	O
(	O
BrdU	O
-	O
positive	O
)	O
(	O
R2	O
)	O
,	O
and	O
G2	O
/	O
M	O
(	O
PIhi	O
,	O
BrdU	O
-	O
negative	O
)	O
(	O
R3	O
)	O
phases	O
of	O
the	O
cell	S-CL
cycle	O
.	O

Below	O
is	O
shown	O
the	O
quantitation	O
of	O
gated	O
populations	O
,	O
indicating	O
the	O
percentage	O
of	O
cells	S-CL
in	O
G1	O
,	O
S	O
,	O
and	O
G2	O
/	O
M	O
cell	S-CL
-	O
cycle	O
phases	O
in	O
each	O
culture	O
.	O

(	O
B	O
)	O
FACS	O
profiles	O
of	O
ES	O
cells	S-CL
bearing	O
either	O
functional	O
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
or	O
null	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
Atrx	S-PRGE
alleles	S-SO
stained	O
for	O
the	O
mitosis	O
marker	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	S-CHEBI
H3	O
(	O
FITC	S-CHEBI
,	O
y	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
against	O
propidium	O
iodide	S-CHEBI
(	O
x	O
-	O
axis	O
,	O
linear	O
scale	O
)	O
.	O

The	O
size	O
of	O
the	O
mitotic	O
population	O
(	O
phosphoH3S10	O
-	O
positive	O
,	O
PIhi	O
)	O
(	O
gate	O
R3	O
)	O
is	O
indicated	O
for	O
each	O
profile	O
.	O

The	O
ES	O
cell	S-CL
clone	O
analysed	O
in	O
each	O
trace	O
is	O
indicated	O
.	O

(	O
3	O
.	O
2	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Analysis	O
of	O
Apoptosis	O
in	O
Atrx	S-PRGE
-	O
Positive	O
and	O
Atrxnull	O
ES	O
Cells	S-CL

FACS	O
analysis	O
of	O
ES	O
cells	S-CL
bearing	O
different	O
Atrx	S-PRGE
alleles	S-SO
as	O
shown	O
,	O
after	O
costaining	O
for	O
Annexin	B-PRGE
V	E-PRGE
(	O
FITC	O
,	O
x	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
and	O
propidium	O
iodide	S-CHEBI
(	O
y	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
.	O

The	O
size	O
of	O
the	O
early	O
apoptotic	O
(	O
Annexin	S-PRGE
-	O
positive	O
,	O
PIlow	O
)	O
and	O
late	O
apoptotic	O
or	O
necrotic	O
(	O
Annexin	S-PRGE
-	O
positive	O
,	O
PIhi	O
)	O
populations	O
is	O
indicated	O
for	O
each	O
genotype	S-SO
.	O

(	O
223	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Normal	O
DNA	S-SO
Methylation	O
at	O
Mouse	S-LIVB
Repetitive	B-SO
Elements	E-SO
in	O
Atrxnull	O
ES	O
Cells	S-CL

DNA	S-SO
from	O
Atrx	S-PRGE
-	O
positive	O
(	O
bearing	O
either	O
an	O
AtrxWT	O
or	O
Atrxflox	O
allele	S-SO
)	O
or	O
Atrxnull	O
(	O
bearing	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	S-SO
)	O
ES	O
cells	S-CL
was	O
digested	O
with	O
either	O
a	O
CpG	O
-	O
methylation	O
-	O
sensitive	O
enzyme	S-SO
HpaII	O
(	O
H	O
)	O
or	O
its	O
methylation	O
-	O
insensitive	O
isoschizomer	O
MspI	O
(	O
M	O
)	O
as	O
indicated	O
,	O
and	O
digested	O
DNA	S-SO
was	O
analysed	O
by	O
Southern	O
blotting	O
.	O

Membranes	O
were	O
hybridised	O
with	O
probes	S-SO
specific	O
for	O
the	O
mouse	S-LIVB
Line	O
1	O
(	O
A	O
)	O
,	O
Sine	O
B1	O
(	O
B	O
)	O
,	O
minor	O
satellite	S-SO
(	O
C	O
)	O
,	O
and	O
IAP	O
(	O
D	O
)	O
repeat	B-SO
elements	E-SO
.	O

No	O
significant	O
loss	O
of	O
CpG	O
-	O
methylation	O
was	O
observed	O
at	O
any	O
of	O
these	O
repetitive	B-SO
elements	E-SO
in	O
Atrxnull	O
ES	O
cells	S-CL
.	O

As	O
a	O
positive	O
control	O
for	O
loss	O
of	O
methylation	O
,	O
DNA	S-SO
from	O
ES	O
cells	S-CL
lacking	O
either	O
the	O
Dnmt1	B-PRGE
(	I-PRGE
Dnmt1	I-PRGE
-	I-PRGE
/	I-PRGE
-	I-PRGE
)	I-PRGE
or	I-PRGE
both	I-PRGE
the	I-PRGE
Dnmt3a	I-PRGE
and	I-PRGE
Dnmt3b	I-PRGE
(	I-PRGE
Dnmt3a3b	I-PRGE
-	I-PRGE
/	I-PRGE
-	I-PRGE
)	I-PRGE
DNA	I-PRGE
methyltransferases	E-PRGE
was	O
included	O
in	O
the	O
analysis	O
of	O
Line	O
1	O
and	O
Sine	O
B1	O
repeats	S-SO
.	O

Loss	O
of	O
CpG	O
-	O
methylation	O
was	O
clearly	O
observed	O
at	O
these	O
repetitive	B-SO
elements	E-SO
in	O
these	O
cell	S-CL
lines	O
.	O

(	O
1	O
.	O
8	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Escape	O
from	O
Imprinted	O
Inactivation	O
in	O
8	O
.	O
5	O
dpc	O
Carrier	O
Female	O
Embryo	O

A	O
cross	O
was	O
carried	O
out	O
between	O
a	O
carrier	O
female	O
(	O
AtrxWT	O
/	O
null	O
)	O
and	O
wild	B-SO
-	I-SO
type	E-SO
male	O
(	O
AtrxWT	O
/	O
Y	O
)	O
,	O
and	O
embryos	O
were	O
dissected	O
in	O
their	O
deciduas	O
at	O
8	O
.	O
5	O
dpc	O
.	O

Any	O
carrier	O
female	O
progeny	O
of	O
this	O
cross	O
will	O
carry	O
an	O
AtrxWT	O
allele	S-SO
on	O
the	O
Xp	O
chromosome	S-GO
and	O
an	O
Atrxnull	O
allele	S-SO
on	O
the	O
Xm	O
chromosome	S-GO
.	O

Transverse	O
paraffin	O
sections	O
were	O
stained	O
with	O
the	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
(	O
H	O
-	O
300	O
)	O
.	O

(	O
A	O
)	O
High	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
of	O
the	O
neural	O
fold	O
region	O
(	O
nf	O
)	O
(	O
embryo	O
proper	O
)	O
of	O
a	O
carrier	O
female	O
(	O
AtrxWT	O
/	O
null	O
)	O
embryo	O
.	O

This	O
tissue	O
is	O
clearly	O
comprised	O
of	O
a	O
mosaic	O
of	O
Atrx	S-PRGE
-	O
positive	O
and	O
Atrx	S-PRGE
-	O
negative	O
cells	S-CL
due	O
to	O
random	O
X	S-GO
-	O
inactivation	O
.	O

This	O
section	O
was	O
counterstained	O
with	O
haematoxylin	O
.	O

(	O
B	O
)	O
High	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
of	O
the	O
same	O
embryo	O
depicted	O
in	O
(	O
A	O
)	O
,	O
showing	O
the	O
extraembryonic	O
derived	O
-	O
chorionic	O
ectoderm	O
(	O
ce	O
)	O
and	O
visceral	O
endoderm	O
(	O
ve	O
)	O
,	O
two	O
tissues	O
that	O
undergo	O
imprinted	O
X	S-GO
-	O
inactivation	O
.	O

Although	O
Atrx	S-PRGE
is	O
poorly	O
expressed	O
in	O
the	O
visceral	O
endoderm	O
(	O
even	O
in	O
wild	B-SO
-	I-SO
type	E-SO
females	O
[	O
unpublished	O
data	O
]	O
)	O
,	O
strong	O
expression	O
of	O
Atrx	S-PRGE
can	O
be	O
seen	O
in	O
the	O
chorionic	O
ectoderm	O
,	O
indicating	O
that	O
the	O
paternally	O
-	O
derived	O
AtrxWT	O
allele	S-SO
had	O
escaped	O
inactivation	O
in	O
this	O
tissue	O
.	O

(	O
1	O
.	O
7	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Protocol	O
S1	O

Supplementary	O
Methods	O

(	O
42	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Primers	S-SO
Used	O
in	O
This	O
Study	O

(	O
20	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
Online	O
Mendelian	O
Inheritance	O
in	O
Man	S-LIVB
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
OMIM	O
)	O
accession	O
number	O
for	O
ATR	O
-	O
X	S-GO
syndrome	O
is	O
301040	O
.	O

The	O
GeneID	O
(	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
gene	O
)	O
for	O
human	B-PRGE
ATRX	E-PRGE
is	O
546	O
and	O
for	O
mouse	B-PRGE
Atrx	E-PRGE
is	O
22589	O
.	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
)	O
accession	O
number	O
for	O
the	O
minor	O
satellite	S-SO
probe	S-SO
mCENT2	O
is	O
X14470	O
(	O
nucleotides	S-CHEBI
75	O
-	O
101	O
)	O
,	O
for	O
the	O
major	O
satellite	S-SO
probe	S-SO
DG27	O
is	O
M25032	O
(	O
nucleotides	S-SO
146	O
-	O
172	O
)	O
,	O
and	O
for	O
the	O
IAP	O
probe	S-SO
is	O
L33247	O
.	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
Stu	O
Orkin	O
for	O
providing	O
access	O
to	O
the	O
GATA1	S-PRGE
-	O
Cre	O
transgenic	S-SO
mice	S-LIVB
,	O
Gillian	O
Morriss	O
-	O
Kay	O
for	O
advice	O
,	O
Peter	O
Warnecke	O
and	O
Tim	O
Bestor	O
for	O
the	O
IAP	O
probe	S-SO
,	O
En	O
Li	O
for	O
the	O
Dnmt	O
knockout	O
ES	O
cells	S-CL
,	O
Frank	O
Talamantes	O
for	O
the	O
pRSV	O
-	O
mPL	B-PRGE
-	I-PRGE
1	E-PRGE
plasmid	S-SO
,	O
Ann	O
Atzberger	O
for	O
assistance	O
with	O
flow	O
cytometry	O
,	O
and	O
Deb	O
Bogani	O
and	O
Terry	O
Hacker	O
for	O
assistance	O
with	O
whole	O
-	O
mount	O
in	O
situ	O
hybridisation	O
analyses	O
and	O
embryo	O
sectioning	O
.	O

Abbreviations	O

BrdU	O
-	O
bromodeoxyuridine	O

dpc	O
-	O
days	O
postcoitus	O

ES	O
cells	S-CL
-	O
embryonic	O
stem	B-CL
cells	E-CL

IAP	O
-	O
intracisternal	O
A	O
particle	O

rDNA	O
-	O
ribosomal	S-GO
DNA	S-SO

TGC	O
-	O
trophoblast	B-CL
giant	I-CL
cell	E-CL

TUNEL	O
-	O
TdT	S-PRGE
-	O
mediated	O
dUTP	S-CHEBI
nick	O
end	O
labeling	O

WMISH	O
-	O
whole	O
-	O
mount	O
in	O
situ	O
hybridisation	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Schematic	O
Representation	O
of	O
the	O
ATRX	S-PRGE
Isoforms	S-SO

Shown	O
at	O
the	O
top	O
is	O
the	O
human	B-PRGE
ATRX	E-PRGE
cDNA	S-SO
.	O

The	O
boxes	O
represent	O
the	O
36	O
exons	S-SO
.	O

The	O
introns	S-SO
are	O
not	O
to	O
scale	O
.	O

The	O
alternative	O
splicing	O
of	O
exons	S-SO
6	O
and	O
7	O
is	O
indicated	O
.	O

Shown	O
underneath	O
are	O
the	O
two	O
ATRX	S-PRGE
protein	O
isoforms	S-SO
.	O

Full	O
-	O
length	O
ATRX	S-PRGE
(	O
~	O
280	O
kDa	O
)	O
is	O
encoded	O
by	O
the	O
largest	O
open	B-SO
reading	I-SO
frame	E-SO
.	O

The	O
positions	S-SO
of	O
the	O
principal	O
features	S-SO
(	O
the	O
PHD	O
-	O
like	O
domain	S-SO
and	O
the	O
seven	O
SWI	O
/	O
SNF	O
-	O
like	O
motifs	O
)	O
are	O
indicated	O
.	O

Above	O
full	O
-	O
length	O
ATRX	S-PRGE
is	O
shown	O
the	O
truncated	O
ATRXt	O
isoform	S-SO
(	O
apparent	O
molecular	S-CHEBI
weight	O
of	O
~	O
200	O
kDa	O
)	O
that	O
arises	O
through	O
the	O
failure	O
to	O
splice	O
intron	S-SO
11	O
and	O
the	O
use	O
of	O
an	O
intronic	S-SO
poly	B-SO
(	I-SO
A	I-SO
)	I-SO
signal	E-SO
.	O

The	O
intron	S-SO
-	O
encoded	O
region	S-SO
of	O
ATRXt	O
is	O
indicated	O
as	O
a	O
filled	O
grey	O
box	O
.	O

Locations	S-SO
of	O
recombinant	O
proteins	S-CHEBI
(	O
A2	O
,	O
FXNP5	O
,	O
and	O
H	O
-	O
300	O
)	O
used	O
to	O
generate	O
antibodies	S-GO
are	O
shown	O
.	O

The	O
scale	O
bar	O
represents	O
200	O
amino	B-CHEBI
acids	E-CHEBI
.	O

Figure	O
2	O

Cre	O
-	O
Mediated	O
Ablation	O
of	O
Full	O
-	O
Length	O
Atrx	S-PRGE
Protein	S-CHEBI
in	O
ES	O
Cells	S-CL

(	O
A	O
)	O
Strategy	O
for	O
targeted	O
deletion	S-SO
of	O
exon	S-SO
18	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
.	O

The	O
top	O
line	O
shows	O
the	O
wild	B-SO
-	I-SO
type	E-SO
allele	S-SO
(	O
AtrxWT	O
)	O
at	O
the	O
region	S-SO
surrounding	O
exon	S-SO
18	O
.	O

Below	O
is	O
shown	O
the	O
targeting	O
vector	S-SO
and	O
the	O
targeted	O
allele	S-SO
(	O
Atrxflox	O
)	O
resulting	O
from	O
homologous	O
recombination	O
.	O

The	O
loxP	B-SO
target	I-SO
sites	E-SO
of	O
the	O
Cre	O
recombinase	O
are	O
shown	O
as	O
black	O
triangles	O
,	O
and	O
the	O
three	O
possible	O
recombination	O
events	O
that	O
can	O
be	O
mediated	O
by	O
the	O
Cre	O
recombinase	O
are	O
indicated	O
(	O
labelled	O
A	O
,	O
B	O
,	O
and	O
C	O
in	O
the	O
Atrxflox	O
allele	S-SO
)	O
.	O

At	O
bottom	O
is	O
shown	O
the	O
Cre	O
-	O
recombined	O
allele	S-SO
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
(	O
resulting	O
from	O
recombination	O
event	O
C	O
)	O
in	O
which	O
both	O
exon	S-SO
18	O
and	O
the	O
MC1neopA	O
selection	O
cassette	S-SO
have	O
been	O
deleted	S-SO
.	O

EcoRI	O
(	O
labelled	O
E	O
)	O
and	O
SacI	O
(	O
labelled	O
S	O
)	O
sites	S-SO
present	O
on	O
the	O
targeted	O
129	O
strain	O
X	B-GO
chromosome	E-GO
are	O
indicated	O
.	O

Black	O
bars	O
indicate	O
the	O
positions	S-SO
of	O
the	O
probes	S-SO
used	O
in	O
Southern	O
blots	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
EcoRI	O
-	O
digested	O
DNA	S-SO
from	O
either	O
wild	B-SO
-	I-SO
type	E-SO
ES	O
cells	S-CL
(	O
E14	O
)	O
or	O
targeted	O
ES	O
cell	S-CL
clones	O
bearing	O
the	O
Atrxflox	O
allele	S-SO
(	O
1	O
/	O
F12	O
and	O
1	O
/	O
G11	O
)	O
hybridised	O
with	O
either	O
the	O
20	O
/	O
27	O
(	O
left	O
blot	O
)	O
or	O
Hae0	O
.	O
9	O
(	O
right	O
blot	O
)	O
probes	S-SO
.	O

The	O
EcoRI	O
fragment	S-SO
of	O
the	O
AtrxWT	O
allele	S-SO
(	O
18	O
.	O
5	O
kb	O
)	O
has	O
been	O
replaced	S-SO
with	O
the	O
expected	S-SO
fragments	S-SO
of	O
11	O
.	O
2	O
kb	O
(	O
20	O
/	O
27	O
probe	S-SO
)	O
or	O
8	O
.	O
5	O
kb	O
(	O
Hae0	O
.	O
9	O
probe	S-SO
)	O

(	O
C	O
)	O
Southern	O
blot	O
analysis	O
of	O
SacI	O
-	O
digested	O
DNA	S-SO
from	O
either	O
wild	B-SO
-	I-SO
type	E-SO
ES	O
cells	S-CL
(	O
E14	O
)	O
or	O
targeted	O
ES	O
cell	S-CL
clones	O
bearing	O
the	O
Atrxflox	O
allele	S-SO
(	O
1	O
/	O
F12	O
and	O
1	O
/	O
G11	O
)	O
or	O
Cre	O
-	O
recombinant	O
clones	S-SO
derived	O
from	O
these	O
(	O
1	O
/	O
F12B1F12	O
and	O
1	O
/	O
G11D5	O
)	O
.	O

The	O
membrane	O
was	O
hybridised	O
with	O
the	O
intron	S-SO
17	O
probe	S-SO
indicated	O
in	O
(	O
A	O
)	O
.	O

The	O
expected	O
bands	O
of	O
6	O
.	O
2	O
(	O
AtrxWT	O
)	O
,	O
5	O
.	O
0	O
(	O
Atrxflox	O
)	O
,	O
and	O
2	O
.	O
8	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
kb	O
were	O
observed	O
.	O

(	O
D	O
)	O
Northern	O
blot	O
analysis	O
of	O
RNA	S-SO
from	O
ES	O
cells	S-CL
shown	O
in	O
(	O
C	O
)	O
.	O

The	O
membrane	O
was	O
hybridised	O
first	O
to	O
a	O
probe	S-SO
from	O
exon	S-SO
10	O
of	O
the	O
Atrx	S-PRGE
gene	S-SO
(	O
top	O
blot	O
)	O
and	O
subsequently	O
to	O
a	O
beta	B-PRGE
-	I-PRGE
actin	E-PRGE
cDNA	S-SO
probe	S-SO
as	O
loading	O
control	O
(	O
bottom	O
blot	O
)	O
.	O

The	O
transcripts	S-SO
responsible	O
for	O
full	O
-	O
length	O
Atrx	S-PRGE
(	O
~	O
10	O
kb	O
)	O
and	O
the	O
truncated	O
Atrxt	O
isoforms	S-SO
(	O
~	O
7	O
kb	O
)	O
are	O
indicated	O
.	O

(	O
E	O
)	O
Western	O
blot	O
analysis	O
of	O
whole	O
-	O
cell	S-CL
extracts	O
from	O
the	O
clones	S-SO
shown	O
in	O
(	O
C	O
)	O
using	O
an	O
anti	O
-	O
ATRX	S-PRGE
monoclonal	O
antibody	S-GO
(	O
23C	O
,	O
raised	O
against	O
peptide	S-SO
A2	O
of	O
the	O
human	B-PRGE
ATRX	E-PRGE
protein	S-CHEBI
shown	O
in	O
Figure	O
1	O
)	O
.	O

The	O
full	O
-	O
length	O
and	O
truncated	O
Atrx	S-PRGE
isoforms	S-SO
are	O
indicated	O
.	O

Figure	O
3	O

Growth	O
and	O
Methylation	O
Defects	O
in	O
Atrxnull	O
ES	O
Cells	S-CL

(	O
A	O
)	O
Cultures	O
were	O
inoculated	O
with	O
equivalent	O
numbers	O
of	O
ES	O
cells	S-CL
bearing	O
different	O
Atrx	S-PRGE
alleles	S-SO
as	O
indicated	O
,	O
and	O
were	O
serially	O
passaged	O
.	O

After	O
the	O
indicated	O
days	O
of	O
coculture	O
,	O
DNA	S-SO
extracted	O
from	O
a	O
sample	O
of	O
cells	S-CL
was	O
analysed	O
by	O
Southern	O
blot	O
to	O
detect	O
the	O
Atrx	S-PRGE
alleles	S-SO
.	O

DNA	S-SO
was	O
digested	O
with	O
SpeI	O
,	O
and	O
the	O
membrane	O
was	O
hybridised	O
with	O
the	O
20	O
/	O
27	O
probe	S-SO
shown	O
in	O
Figure	O
2A	O
.	O

The	O
expected	O
sizes	O
of	O
the	O
different	O
alleles	S-SO
are	O
indicated	O
.	O

(	O
B	O
)	O
Schematic	O
diagram	O
of	O
the	O
transcribed	O
portion	O
of	O
the	O
mouse	S-LIVB
rDNA	O
repeat	S-SO
with	O
the	O
18S	S-PRGE
,	O
5	B-PRGE
.	I-PRGE
8S	E-PRGE
,	O
and	O
28S	S-PRGE
genes	S-SO
indicated	O
.	O

The	O
positions	B-SO
of	I-SO
the	I-SO
limit	I-SO
-	I-SO
digesting	I-SO
enzymes	E-SO
BamH	O
(	O
labelled	O
B	O
)	O
and	O
EcoRI	O
(	O
labelled	O
E	O
)	O
and	O
the	O
probes	S-SO
(	O
RIB3	O
and	O
RIB4	O
)	O
used	O
in	O
the	O
Southern	O
blots	O
shown	O
in	O
(	O
C	O
)	O
are	O
indicated	O
.	O

Below	O
are	O
shown	O
the	O
locations	S-SO
of	O
the	O
methylation	O
-	O
sensitive	O
enzymes	S-SO
(	O
SmaI	O
,	O
PvuI	O
,	O
and	O
MluI	O
)	O
whose	O
methylation	O
status	O
has	O
been	O
analysed	O
in	O
the	O
Southern	O
blots	O
shown	O
in	O
(	O
C	O
)	O
.	O

(	O
C	O
)	O
DNA	S-SO
from	O
Atrx	S-PRGE
-	O
positive	O
(	O
Atrx	S-PRGE
+	O
,	O
bearing	O
either	O
an	O
AtrxWT	O
or	O
Atrxflox	O
allele	S-SO
)	O
or	O
Atrxnull	O
(	O
bearing	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	S-SO
)	O
ES	O
cells	S-CL
and	O
7	O
-	O
d	O
embryoid	O
bodies	O
were	O
digested	O
with	O
the	O
enzymes	S-SO
shown	O
and	O
analysed	O
by	O
Southern	O
blotting	O
using	O
the	O
probes	S-SO
indicated	O
.	O

Arrows	O
indicate	O
the	O
fully	O
methylated	O
copies	O
(	O
cut	O
by	O
only	O
the	O
limit	O
-	O
digesting	O
enzyme	S-SO
)	O
.	O

Phosphorimager	O
quantitation	O
of	O
the	O
blots	O
are	O
shown	O
below	O
.	O

The	O
y	O
-	O
axis	O
shows	O
the	O
percentage	O
of	O
copies	O
that	O
are	O
undigested	O
by	O
the	O
methylation	O
-	O
sensitive	O
enzyme	S-SO
as	O
a	O
percentage	O
of	O
the	O
total	O
signal	O
from	O
cut	O
and	O
uncut	O
rDNA	O
.	O

Mean	O
values	O
are	O
indicated	O
by	O
horizontal	O
lines	O
,	O
and	O
the	O
significance	O
of	O
the	O
differences	O
between	O
the	O
Atrx	S-PRGE
-	O
positive	O
and	O
Atrxnull	O
populations	O
are	O
shown	O
for	O
each	O
enzyme	S-SO
.	O

Figure	O
4	O

Timing	O
of	O
Onset	O
of	O
GATA1	S-PRGE
-	O
Cre	O
Expression	O
and	O
PCR	O
Genotyping	O
of	O
Atrx	S-PRGE
Alleles	S-SO

(	O
A	O
)	O
GATA1	S-PRGE
-	O
cre	O
+	S-SO
/	O
+	S-SO
transgenic	S-SO
males	O
were	O
crossed	O
to	O
females	O
of	O
the	O
ROSA26	S-PRGE
reporter	O
strain	O
(	O
ROSA26	S-PRGE
+	S-SO
/	O
-	O
)	O
,	O
and	O
embryos	O
were	O
recovered	O
at	O
0	O
.	O
5	O
dpc	O
(	O
~	O
16	O
-	O
cell	S-CL
morula	O
stage	O
)	O
and	O
stained	O
with	O
X	O
-	O
gal	O
.	O

Cre	O
-	O
mediated	O
activation	O
of	O
the	O
ROSA26	S-PRGE
beta	O
-	O
galactosidase	O
reporter	O
allele	S-SO
was	O
detected	O
in	O
all	O
cells	S-CL
in	O
embryos	O
in	O
which	O
both	O
alleles	S-SO
are	O
coinherited	O
.	O

(	O
B	O
)	O
Top	O
gel	O
:	O
PCR	O
genotyping	O
of	O
Atrx	S-PRGE
alleles	S-SO
in	O
embryos	O
using	O
primers	S-SO
PPS1	O
.	O
15	O
(	O
exon	S-SO
17	O
)	O
and	O
Mxnp30	O
(	O
exon	S-SO
20	O
)	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

The	O
sizes	O
of	O
PCR	B-SO
products	E-SO
from	O
the	O
different	O
alleles	S-SO
are	O
indicated	O
.	O

Both	O
the	O
Atrx	O
Delta	O
18	O
(	O
resulting	O
from	O
recombination	O
event	O
B	O
in	O
Figure	O
2A	O
)	O
and	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	S-SO
(	O
resulting	O
from	O
recombination	O
event	O
C	O
in	O
Figure	O
2A	O
)	O
are	O
null	O
for	O
full	O
-	O
length	O
Atrx	S-PRGE
protein	S-CHEBI
.	O

The	O
bottom	O
gel	O
shows	O
products	B-SO
from	I-SO
a	I-SO
PCR	I-SO
reaction	E-SO
(	O
primers	S-SO
DG52	O
/	O
DG53	O
)	O
used	O
to	O
sex	O
embryos	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

A	O
450	O
-	O
bp	S-SO
PCR	B-SO
product	E-SO
is	O
amplified	O
from	O
a	O
mouse	S-LIVB
Y	B-GO
chromosome	E-GO
-	O
specific	O
satellite	B-SO
repeat	E-SO
.	O

Figure	O
5	O

Morphology	O
of	O
Atrxnull	O
Embryos	O
at	O
7	O
.	O
5	O
dpc	O
and	O
8	O
.	O
5	O
dpc	O

Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	E-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
stained	O
with	O
haematoxylin	O
(	O
A	O
)	O
or	O
with	O
an	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
(	O
H	O
-	O
300	O
,	O
Figure	O
1	O
)	O
(	O
B	O
-	O
E	O
)	O
.	O

Photomicrographs	O
C	O
-	O
E	O
show	O
higher	O
magnification	O
images	O
(	O
200	O
x	O
)	O
of	O
the	O
stained	O
sections	O
shown	O
in	O
(	O
B	O
)	O
(	O
40	O
x	O
)	O
.	O

Scale	O
bars	O
represent	O
200	O
mu	O
m	O
(	O
40	O
x	O
magnification	O
)	O
or	O
40	O
mu	O
m	O
(	O
200	O
x	O
magnification	O
)	O
.	O

a	O
,	O
amnion	O
;	O
ac	O
,	O
amniotic	O
cavity	O
;	O
c	O
,	O
chorion	O
;	O
e	O
,	O
epiblast	O
;	O
ec	O
,	O
ectoplacental	O
cavity	O
;	O
ecc	O
,	O
exocoelomic	O
cavity	O
;	O
ep	O
,	O
ectoplacental	O
cone	O
;	O
ne	O
,	O
neural	O
ectoderm	O
;	O
rm	O
,	O
Reichert	O
'	O
s	O
membrane	S-GO
;	O
tgc	O
,	O
trophoblast	B-CL
giant	I-CL
cell	E-CL
.	O

(	O
F	O
)	O
Detection	O
of	O
brachyury	S-PRGE
(	O
T	S-PRGE
)	O
expression	O
in	O
Atrxnull	O
8	O
.	O
5	O
dpc	O
embryo	O
(	O
head	O
fold	O
stage	O
)	O
by	O
WMISH	O
.	O

The	O
genotype	S-SO
was	O
determined	O
by	O
PCR	O
(	O
as	O
shown	O
in	O
Protocol	O
S1	O
)	O
using	O
DNA	S-SO
extracted	O
from	O
yolk	O
sac	O
.	O

hf	O
,	O
head	O
fold	O
;	O
n	O
,	O
emerging	O
notochord	O
;	O
ps	O
,	O
primitive	O
streak	O
.	O

Figure	O
6	O

Analysis	O
of	O
Apoptosis	O
and	O
Mitosis	O
in	O
Atrxnull	O
Embryos	O

(	O
A	O
)	O
Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	E-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
analysed	O
by	O
TUNEL	O
assay	O
and	O
apoptotic	B-CL
cells	E-CL
labelled	O
with	O
fluorescein	S-CHEBI
-	O
dUTP	S-CHEBI
.	O

Sections	O
were	O
counterstained	O
with	O
DAPI	O
.	O

(	O
B	O
)	O
Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	E-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
were	O
stained	O
with	O
an	O
antibody	S-GO
against	O
the	O
mitosis	O
marker	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	S-CHEBI
H3	O
.	O

Sections	O
were	O
counterstained	O
with	O
haematoxylin	O
.	O

For	O
both	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
the	O
presence	O
or	O
absence	O
of	O
Atrx	S-PRGE
in	O
each	O
embryo	O
was	O
determined	O
by	O
staining	O
adjacent	O
sections	O
with	O
the	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
(	O
H	O
-	O
300	O
)	O
as	O
in	O
Figure	O
5	O
(	O
unpublished	O
data	O
)	O
.	O

Figure	O
7	O

Trophectoderm	O
Defect	O
in	O
Atrxnull	O
Embryos	O

(	O
A	O
)	O
8	O
.	O
5	O
dpc	O
embryos	O
were	O
dissected	O
from	O
surrounding	O
decidual	O
tissue	O
and	O
observed	O
in	O
whole	O
mount	O
.	O

The	O
genotype	S-SO
of	O
each	O
(	O
indicated	O
above	O
)	O
was	O
determined	O
by	O
PCR	O
using	O
DNA	S-SO
extracted	O
from	O
whole	O
embryos	O
after	O
photography	O
.	O

In	O
the	O
left	O
image	O
,	O
the	O
wild	B-SO
-	I-SO
type	E-SO
female	O
(	O
three	O
-	O
somite	O
stage	O
,	O
left	O
)	O
is	O
surrounded	O
by	O
trophoblast	O
(	O
t	O
)	O
while	O
the	O
trophoblast	O
component	O
surrounding	O
the	O
Atrxnull	O
males	O
(	O
at	O
headfold	O
/	O
presomite	O
[	O
middle	O
]	O
and	O
two	O
-	O
somite	O
stages	O
[	O
right	O
]	O
,	O
respectively	O
)	O
is	O
severely	O
depleted	O
.	O

In	O
the	O
right	O
image	O
,	O
the	O
trophoblast	O
has	O
been	O
dissected	O
away	O
from	O
the	O
embryonic	O
region	O
of	O
the	O
wild	B-SO
-	I-SO
type	E-SO
embryo	O
,	O
to	O
reveal	O
the	O
small	O
,	O
abnormally	O
shaped	O
ectoplacental	O
cone	O
(	O
epc	O
)	O
of	O
the	O
mutant	S-SO
littermates	O
.	O

(	O
B	O
)	O
WMISH	O
to	O
detect	O
expression	O
of	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
(	O
a	O
marker	O
of	O
TGCs	O
)	O
at	O
the	O
implantation	O
sites	O
in	O
vacated	O
deciduas	O
that	O
had	O
contained	O
8	O
.	O
5	O
dpc	O
wild	B-SO
-	I-SO
type	E-SO
(	O
AtrxWT	O
/	O
WT	S-SO
)	O
or	O
Atrxnull	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
/	O
Y	O
)	O
embryos	O
.	O

The	O
genotype	S-SO
was	O
determined	O
by	O
PCR	O
using	O
DNA	S-SO
extracted	O
from	O
whole	O
embryos	O
.	O

TGCs	O
are	O
stained	O
with	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
.	O

(	O
C	O
)	O
Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	E-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
stained	O
with	O
an	O
anti	O
-	O
Pl	B-PRGE
-	I-PRGE
1	E-PRGE
antibody	S-GO
.	O

The	O
presence	O
or	O
absence	O
of	O
Atrx	S-PRGE
in	O
each	O
embryo	O
was	O
determined	O
by	O
staining	O
adjacent	O
sections	O
with	O
the	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
(	O
H	O
-	O
300	O
)	O
as	O
in	O
Figure	O
5	O
(	O
unpublished	O
data	O
)	O
.	O

(	O
D	O
)	O
Examples	O
of	O
5	O
-	O
d	O
blastocyst	O
outgrowth	O
cultures	O
.	O

Extensive	O
trophoblast	O
outgrowing	O
from	O
the	O
inner	O
cell	S-CL
mass	O
(	O
icm	O
)	O
was	O
observed	O
in	O
all	O
genotypes	S-SO
.	O

The	O
Atrx	S-PRGE
genotype	S-SO
and	O
sex	O
of	O
the	O
blastocyst	O
indicated	O
were	O
determined	O
by	O
PCR	O
.	O

Figure	O
8	O

Escape	O
from	O
Imprinted	O
Inactivation	O
of	O
the	O
Paternally	O
Inherited	O
AtrxWT	O
Allele	S-SO
in	O
Carrier	O
Females	O

Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	E-SO
(	O
AtrxWT	O
/	O
Y	O
)	O
and	O
carrier	O
female	O
(	O
AtrxWT	O
/	O
null	O
)	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
stained	O
with	O
the	O
anti	O
-	O
ATRX	S-PRGE
antibody	S-GO
(	O
H	O
-	O
300	O
)	O
.	O

Scale	O
bars	O
represent	O
200	O
mu	O
m	O
(	O
40	O
x	O
magnification	O
)	O
or	O
20	O
mu	O
m	O
(	O
400	O
x	O
magnification	O
)	O
.	O

(	O
A	O
)	O
Stained	O
sections	O
showing	O
whole	O
embryos	O
at	O
40	O
x	O
magnification	O
.	O

a	O
,	O
amnion	O
;	O
c	O
,	O
chorion	O
;	O
e	O
,	O
epiblast	O
;	O
ep	O
,	O
ectoplacental	O
cone	O
.	O

(	O
B	O
)	O
Higher	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
of	O
the	O
epiblast	O
regions	O
of	O
the	O
stained	O
sections	O
shown	O
in	O
(	O
A	O
)	O
.	O

(	O
C	O
)	O
Higher	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
showing	O
the	O
extraembryonic	O
derived	O
-	O
chorionic	O
ectoderm	O
of	O
the	O
stained	O
sections	O
shown	O
in	O
(	O
A	O
)	O
.	O

ce	O
,	O
chorionic	O
ectoderm	O
;	O
cm	O
,	O
chorionic	O
mesoderm	O
.	O

Table	O
1	O

Distribution	O
of	O
Atrx	S-PRGE
Genotypes	S-SO
in	O
Timed	O
Matings	O

Footnotes	O

Author	O
contributions	O
.	O

DG	O
,	O
AJHS	O
,	O
WGW	O
,	O
DRH	O
,	O
and	O
RJG	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

DG	O
,	O
JAS	O
,	O
RA	O
,	O
and	O
RJG	O
performed	O
the	O
experiments	O
.	O

DG	O
,	O
RA	O
,	O
WGW	O
,	O
DRH	O
,	O
and	O
RJG	O
analysed	O
the	O
data	O
.	O

LD	O
contributed	O
reagents	S-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

LD	O
provided	O
technical	O
assistance	O
.	O

DG	O
wrote	O
the	O
paper	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Medical	O
Research	O
Council	O
of	O
the	O
United	O
Kingdom	O
.	O

Citation	O
:	O
Garrick	O
D	O
,	O
Sharpe	O
JA	O
,	O
Arkell	O
R	O
,	O
Dobbie	O
L	O
,	O
Smith	O
AJH	O
,	O
et	O
al	O
.	O

(	O
2006	O
)	O
Loss	O
of	O
Atrx	S-PRGE
affects	O
trophoblast	O
development	O
and	O
the	O
pattern	O
of	O
X	S-GO
-	O
inactivation	O
in	O
extraembryonic	O
tissues	O
.	O

PLoS	O
Genet	O
2	O
(	O
4	O
)	O
:	O
e58	O
.	O

DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020058	O

Adenomatous	B-PRGE
Polyposis	I-PRGE
Coli	E-PRGE
(	O
APC	S-PRGE
)	O
Is	O
Required	O
for	O
Normal	O
Development	O
of	O
Skin	O
and	O
Thymus	O

Abstract	O

The	O
tumor	O
suppressor	O
gene	S-SO
Apc	S-PRGE
(	O
adenomatous	B-PRGE
polyposis	I-PRGE
coli	E-PRGE
)	O
is	O
a	O
member	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
that	O
is	O
involved	O
in	O
development	O
and	O
tumorigenesis	O
.	O

Heterozygous	O
knockout	O
mice	S-LIVB
for	O
Apc	S-PRGE
have	O
a	O
tumor	O
predisposition	O
phenotype	O
and	O
homozygosity	O
leads	O
to	O
embryonic	O
lethality	O
.	O

To	O
understand	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
development	O
we	O
generated	O
a	O
floxed	S-SO
allele	S-SO
.	O

These	O
mice	S-LIVB
were	O
mated	O
with	O
a	O
strain	O
carrying	O
Cre	O
recombinase	O
under	O
the	O
control	O
of	O
the	O
human	B-PRGE
Keratin	I-PRGE
14	I-PRGE
(	I-PRGE
K14	E-PRGE
)	O
promoter	S-SO
,	O
which	O
is	O
active	O
in	O
basal	O
cells	B-CL
of	I-CL
epidermis	I-CL
and	I-CL
other	I-CL
stratified	I-CL
epithelia	E-CL
.	O

Mice	S-LIVB
homozygous	O
for	O
the	O
floxed	S-SO
allele	S-SO
that	O
also	O
carry	O
the	O
K14	S-PRGE
-	O
cre	O
transgene	S-SO
were	O
viable	O
but	O
had	O
stunted	O
growth	O
and	O
died	O
before	O
weaning	O
.	O

Histological	O
and	O
immunochemical	O
examinations	O
revealed	O
that	O
K14	S-PRGE
-	O
cre	O
-	O
mediated	O
Apc	S-PRGE
loss	O
resulted	O
in	O
aberrant	O
growth	O
in	O
many	O
ectodermally	O
derived	O
squamous	O
epithelia	O
,	O
including	O
hair	O
follicles	O
,	O
teeth	O
,	O
and	O
oral	O
and	O
corneal	O
epithelia	O
.	O

In	O
addition	O
,	O
squamous	O
metaplasia	O
was	O
observed	O
in	O
various	O
epithelial	O
-	O
derived	O
tissues	O
,	O
including	O
the	O
thymus	O
.	O

The	O
aberrant	O
growth	O
of	O
hair	O
follicles	O
and	O
other	O
appendages	O
as	O
well	O
as	O
the	O
thymic	O
abnormalities	O
in	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
mice	S-LIVB
suggest	O
the	O
Apc	S-PRGE
gene	S-SO
is	O
crucial	O
in	O
embryonic	O
cells	S-CL
to	O
specify	O
epithelial	B-CL
cell	E-CL
fates	O
in	O
organs	O
that	O
require	O
epithelial	O
-	O
mesenchymal	O
interactions	O
for	O
their	O
development	O
.	O

Synopsis	O

Patients	O
with	O
familial	O
adenomatous	O
polyposis	O
(	O
FAP	O
)	O
and	O
its	O
variant	O
,	O
Gardner	O
'	O
s	O
syndrome	O
,	O
will	O
develop	O
hundreds	O
of	O
colorectal	O
polyps	O
.	O

It	O
is	O
a	O
heritable	O
disease	O
that	O
is	O
linked	O
to	O
a	O
genetic	S-SO
mutation	S-SO
in	O
the	O
tumor	O
suppressor	O
gene	S-SO
APC	S-PRGE
(	O
adenomatous	B-PRGE
polyposis	I-PRGE
coli	E-PRGE
)	O
.	O

These	O
individuals	S-LIVB
also	O
develop	O
extracolonic	O
symptoms	O
,	O
among	O
which	O
are	O
congenital	O
hypertrophy	O
of	O
the	O
retinal	O
pigment	O
epithelium	O
,	O
desmoid	O
tumors	O
,	O
epidermoid	O
cysts	O
,	O
disorders	O
of	O
the	O
maxillary	O
and	O
skeletal	O
bones	O
,	O
and	O
dental	O
abnormalities	O
,	O
suggesting	O
the	O
importance	O
of	O
APC	S-PRGE
functions	O
in	O
these	O
organs	O
.	O

To	O
understand	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
development	O
and	O
in	O
organs	O
other	O
than	O
intestine	O
,	O
we	O
generated	O
Apc	S-PRGE
mutant	S-SO
mice	S-LIVB
that	O
can	O
conditionally	O
delete	S-SO
the	O
gene	S-SO
when	O
exposed	O
to	O
Cre	O
recombinase	O
.	O

These	O
mice	S-LIVB
were	O
mated	O
with	O
K14	S-PRGE
(	O
Keratin	B-PRGE
14	E-PRGE
)	O
-	O
cre	O
mice	S-LIVB
that	O
express	O
Cre	O
recombinase	O
in	O
skin	O
and	O
its	O
appendages	O
.	O

The	O
authors	O
found	O
that	O
the	O
mutant	S-SO
mice	S-LIVB
that	O
have	O
lost	O
Apc	S-PRGE
in	O
K14	S-PRGE
-	O
cre	O
transgene	S-SO
-	O
expressing	O
tissues	O
were	O
viable	O
,	O
but	O
had	O
stunted	O
growth	O
and	O
died	O
before	O
weaning	O
.	O

These	O
mutant	S-SO
mice	S-LIVB
showed	O
developmental	O
abnormalities	O
not	O
only	O
in	O
skin	O
but	O
also	O
in	O
many	O
epithelial	O
-	O
derived	O
tissues	O
,	O
including	O
teeth	O
and	O
thymus	O
.	O

This	O
work	O
demonstrates	O
the	O
importance	O
of	O
Apc	S-PRGE
in	O
development	O
of	O
many	O
organs	O
,	O
and	O
provides	O
new	O
insights	O
into	O
diagnosis	O
and	O
management	O
of	O
patients	O
with	O
APC	S-PRGE
mutations	S-SO
.	O

Introduction	O

Adenomatous	B-PRGE
polyposis	I-PRGE
coli	E-PRGE
(	O
APC	S-PRGE
)	O
is	O
a	O
member	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
and	O
one	O
of	O
its	O
known	O
functions	O
is	O
to	O
regulate	O
the	O
levels	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
.	O

Alterations	O
in	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
regulation	O
are	O
very	O
common	O
in	O
human	S-LIVB
tumors	O
[	O
1	O
]	O
.	O

Loss	O
of	O
APC	S-PRGE
is	O
associated	O
with	O
stabilization	O
of	O
the	O
cytosolic	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
that	O
ultimately	O
results	O
in	O
its	O
migration	O
to	O
the	O
nucleus	S-GO
and	O
activating	O
a	O
cascade	O
of	O
events	O
leading	O
to	O
tumorigenesis	O
.	O

APC	S-PRGE
also	O
interacts	O
with	O
a	O
multitude	O
of	O
other	O
cellular	S-CL
proteins	S-CHEBI
,	O
including	O
axin	B-PRGE
-	I-PRGE
2	E-PRGE
(	O
AXIN2	S-PRGE
)	O
,	O
plakoglobin	S-PRGE
(	O
JUP	S-PRGE
)	O
,	O
Asef	S-PRGE
(	O
ARHGEF4	S-PRGE
)	O
,	O
kinesin	B-PRGE
superfamily	I-PRGE
-	I-PRGE
associated	I-PRGE
protein	I-PRGE
3	E-PRGE
(	O
KIFAP3	S-PRGE
)	O
,	O
EB1	S-PRGE
(	O
MAPRE1	S-PRGE
)	O
,	O
microtubules	S-GO
,	O
and	O
the	O
human	B-PRGE
homolog	I-PRGE
of	I-PRGE
Drosophila	I-PRGE
discs	I-PRGE
large	E-PRGE
(	O
DLG1	S-PRGE
)	O
.	O

These	O
interactions	O
suggest	O
that	O
APC	S-PRGE
can	O
potentially	O
regulate	O
many	O
cellular	S-CL
functions	O
,	O
including	O
intercellular	O
adhesion	O
,	O
cytoskeletal	S-GO
organization	O
,	O
regulation	O
of	O
plakoglobin	S-PRGE
levels	O
,	O
regulation	O
of	O
the	O
cell	S-CL
cycle	O
and	O
apoptosis	O
,	O
orientation	O
of	O
asymmetric	O
stem	B-CL
cell	E-CL
division	O
,	O
and	O
control	O
of	O
cell	S-CL
polarization	O
[	O
2	O
,	O
3	O
]	O
.	O

APC	S-PRGE
is	O
a	O
tumor	O
suppressor	O
gene	S-SO
.	O

Somatic	O
mutations	S-SO
in	O
APC	S-PRGE
are	O
frequently	O
found	O
in	O
many	O
sporadic	O
tumors	O
of	O
the	O
colon	O
and	O
rectum	O
.	O

Autosomal	S-GO
dominant	O
germline	O
mutations	S-SO
in	O
APC	S-PRGE
cause	O
familial	O
adenomatous	O
polypois	O
(	O
FAP	O
)	O
and	O
its	O
variant	O
,	O
Gardner	O
syndrome	O
.	O

FAP	O
patients	O
are	O
characterized	O
by	O
hundreds	O
of	O
adenomatous	O
colorectal	O
polyps	O
,	O
with	O
an	O
almost	O
inevitable	O
progression	O
to	O
colorectal	O
cancer	O
in	O
the	O
third	O
and	O
fourth	O
decades	O
of	O
life	O
[	O
4	O
,	O
5	O
]	O
.	O

In	O
addition	O
to	O
colorectal	O
neoplams	O
,	O
these	O
individuals	S-LIVB
can	O
develop	O
extracolonic	O
symptoms	O
,	O
among	O
which	O
are	O
upper	O
gastrointestinal	O
tract	O
polyps	O
,	O
congenital	O
hypertrophy	O
of	O
the	O
retinal	O
pigment	O
epithelium	O
,	O
desmoid	O
tumors	O
,	O
disorders	O
of	O
the	O
maxillary	O
and	O
skeletal	O
bones	O
,	O
and	O
dental	O
abnormalities	O
[	O
6	O
]	O
,	O
suggesting	O
the	O
importance	O
of	O
APC	S-PRGE
gene	S-SO
functions	O
in	O
these	O
organ	O
systems	O
.	O

Although	O
the	O
role	O
of	O
APC	S-PRGE
in	O
the	O
initiation	O
of	O
human	S-LIVB
colorectal	O
cancer	O
is	O
well	O
established	O
,	O
its	O
role	O
in	O
other	O
tissue	O
and	O
developmental	O
processes	O
are	O
not	O
well	O
understood	O
.	O

Given	O
the	O
importance	O
of	O
regulation	O
of	O
Wnt	O
signaling	O
in	O
embryonic	O
pattern	O
formation	O
and	O
morphogenesis	O
of	O
many	O
organs	O
,	O
mechanistic	O
understanding	O
of	O
APC	S-PRGE
in	O
development	O
and	O
in	O
extracolonic	O
tissues	O
becomes	O
critical	O
to	O
better	O
assess	O
potential	O
adverse	O
events	O
in	O
humans	S-LIVB
.	O

One	O
approach	O
to	O
understand	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
development	O
is	O
to	O
develop	O
mice	S-LIVB
with	O
an	O
inactivating	O
Apc	S-PRGE
mutation	S-SO
.	O

Several	O
genetically	S-SO
modified	S-SO
mouse	S-LIVB
strains	O
for	O
Apc	S-PRGE
have	O
been	O
described	O
[	O
7	O
-	O
10	O
]	O
.	O

Most	O
of	O
these	O
models	O
,	O
in	O
the	O
heterozygous	O
state	O
,	O
show	O
a	O
gastrointestinal	O
and	O
other	O
tumor	O
predisposition	O
phenotype	O
[	O
7	O
-	O
10	O
]	O
.	O

Mouse	S-LIVB
embryos	O
that	O
are	O
homozygous	O
for	O
the	O
genetic	S-SO
modification	S-SO
die	O
during	O
embryogenesis	O
,	O
and	O
some	O
of	O
the	O
models	O
do	O
not	O
survive	O
beyond	O
gastrulation	O
[	O
8	O
,	O
11	O
]	O
.	O

An	O
alternate	O
approach	O
to	O
understand	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
development	O
and	O
/	O
or	O
in	O
specific	O
tissues	O
is	O
to	O
generate	O
a	O
mouse	S-LIVB
strain	O
that	O
carries	O
a	O
conditionally	O
modified	S-SO
allele	S-SO
and	O
mate	O
it	O
with	O
a	O
mouse	S-LIVB
strain	O
that	O
facilitates	O
the	O
modification	S-SO
of	O
the	O
conditional	O
allele	S-SO
in	O
specific	O
cell	S-CL
lineages	O
.	O

To	O
assess	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
different	O
stages	O
of	O
life	O
systematically	O
,	O
we	O
generated	O
mice	S-LIVB
containing	O
a	O
conditional	O
knockout	O
(	O
CKO	O
)	O
mutant	S-SO
allele	S-SO
of	O
Apc	S-PRGE
(	O
ApcCKO	O
)	O
.	O

These	O
mice	S-LIVB
were	O
mated	O
with	O
a	O
strain	O
carrying	O
Cre	O
recombinase	O
under	O
the	O
control	O
of	O
the	O
human	B-PRGE
Keratin	I-PRGE
14	I-PRGE
(	I-PRGE
K14	E-PRGE
)	O
promoter	S-SO
,	O
which	O
is	O
active	O
in	O
basal	O
cells	B-CL
of	I-CL
epidermis	I-CL
and	I-CL
other	I-CL
stratified	I-CL
epithelia	E-CL
.	O

We	O
report	O
here	O
that	O
K14	S-PRGE
promoter	S-SO
-	O
driven	O
loss	O
of	O
Apc	S-PRGE
resulted	O
in	O
aberrant	O
development	O
of	O
several	O
organs	O
that	O
require	O
inductive	O
epithelial	O
-	O
mesenchymal	O
interactions	O
,	O
including	O
hair	O
follicle	O
,	O
teeth	O
,	O
and	O
thymus	O
,	O
and	O
resulted	O
in	O
neonatal	O
death	O
in	O
mice	S-LIVB
.	O

We	O
found	O
that	O
Apc	S-PRGE
plays	O
a	O
crucial	O
role	O
in	O
determinations	O
of	O
cell	S-CL
fates	O
during	O
the	O
embryonic	O
development	O
,	O
possibly	O
via	O
temporal	O
and	O
tissue	O
-	O
specific	O
regulation	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
levels	O
in	O
the	O
skin	O
,	O
its	O
appendages	O
,	O
and	O
in	O
the	O
thymus	O
.	O

Results	O

Generation	O
of	O
the	O
ApcCKO	O
and	O
Apc	O
Delta	O
580	O
Mice	S-LIVB

To	O
investigate	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
development	O
of	O
skin	O
and	O
its	O
appendages	O
,	O
we	O
used	O
the	O
Cre	O
/	O
loxP	S-SO
technology	O
to	O
introduce	O
a	O
conditional	O
mutation	S-SO
of	O
the	O
Apc	S-PRGE
gene	S-SO
in	O
mice	S-LIVB
.	O

We	O
constructed	O
embryonic	O
stem	B-CL
(	I-CL
ES	I-CL
)	I-CL
cells	E-CL
and	O
mice	S-LIVB
carrying	O
an	O
Apc	S-PRGE
allele	S-SO
harboring	O
both	O
a	O
pair	O
of	O
loxP	B-SO
sites	E-SO
flanking	O
Apc	S-PRGE
exon	S-SO
14	O
and	O
a	O
pair	O
of	O
FLP	B-SO
recognition	I-SO
target	I-SO
(	I-SO
FRT	I-SO
)	I-SO
sites	E-SO
flanking	O
PGK	O
-	O
neomycin	S-CHEBI
selection	O
cassette	S-SO
by	O
recombineering	O
[	O
12	O
,	O
13	O
]	O
(	O
Figure	O
1A	O
,	O
ApcCKON	O
allele	S-SO
,	O
N	O
for	O
neomycin	O
cassette	S-SO
)	O
.	O

A	O
PGK	O
-	O
neomycin	O
cassette	S-SO
was	O
inserted	S-SO
in	O
the	O
same	O
transcriptional	O
orientation	O
as	O
Apc	S-PRGE
in	O
intron	S-SO
14	O
of	O
the	O
endogenous	O
gene	S-SO
.	O

The	O
loxP	B-SO
and	I-SO
FRT	I-SO
sites	E-SO
were	O
used	O
to	O
aid	O
unidirectional	O
recombination	O
[	O
12	O
,	O
13	O
]	O
.	O

Two	O
mouse	S-LIVB
lines	O
containing	O
the	O
same	O
modification	S-SO
were	O
generated	O
from	O
two	O
independent	O
ES	O
clones	O
to	O
ensure	O
that	O
these	O
two	O
lines	O
behave	O
in	O
the	O
same	O
way	O
.	O

These	O
ApcCKON	O
/	O
+	S-SO
mice	S-LIVB
were	O
crossed	O
with	O
FLPe	O
-	O
deleter	O
to	O
generate	O
ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
that	O
were	O
heterozygous	O
for	O
the	O
final	O
Apc	S-PRGE
conditional	O
(	O
ApcCKO	O
)	O
allele	S-SO
that	O
removed	S-SO
the	O
PGK	O
-	O
neomycin	O
cassette	S-SO
and	O
contains	O
only	O
the	O
loxP	B-SO
sites	E-SO
in	O
the	O
introns	S-SO
flanking	O
exon	S-SO
14	O
.	O

To	O
assess	O
the	O
effect	O
of	O
deleting	S-SO
exon	S-SO
14	O
in	O
mice	S-LIVB
,	O
both	O
lines	O
of	O
ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
were	O
crossed	O
with	O
the	O
Cre	O
-	O
deleter	O
to	O
generate	O
the	O
germline	O
knockout	O
line	O
of	O
Apc	S-PRGE
,	O
designated	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
.	O

The	O
mutant	S-SO
allele	S-SO
(	O
Apc	O
Delta	O
580	O
)	O
lacks	O
exon	S-SO
14	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
transcript	S-SO
from	O
loss	S-SO
of	O
exon	S-SO
14	O
results	O
in	O
a	O
shift	B-SO
in	I-SO
the	I-SO
normal	I-SO
reading	I-SO
frame	E-SO
,	O
resulting	O
in	O
a	O
premature	O
chain	S-SO
termination	B-SO
codon	E-SO
which	O
,	O
if	O
utilized	O
,	O
would	O
result	O
in	O
a	O
truncated	O
polypeptide	S-SO
that	O
is	O
605	O
aa	S-CHEBI
in	O
length	O
,	O
of	O
which	O
the	O
first	O
580	O
aa	S-CHEBI
correspond	O
to	O
the	O
normal	O
Apc	S-PRGE
protein	S-CHEBI
.	O

Southern	O
blot	O
analysis	O
of	O
tail	O
DNA	S-SO
from	O
F1	O
offspring	O
of	O
both	O
ApcCKON	O
and	O
Apc	O
Delta	O
580	O
lines	O
confirmed	O
the	O
germline	O
transmission	O
of	O
modified	S-SO
Apc	S-PRGE
allele	S-SO
(	O
Figure	O
1B	O
)	O
.	O

Mice	S-LIVB
that	O
are	O
heterozygous	O
for	O
Apc	O
Delta	O
580	O
mutation	S-SO
are	O
viable	O
but	O
have	O
a	O
significantly	O
reduced	O
lifespan	O
(	O
Figure	O
1C	O
)	O
.	O

These	O
results	O
suggested	O
that	O
deletion	S-SO
of	O
exon	S-SO
14	O
indeed	O
results	O
in	O
either	O
loss	O
or	O
abnormal	O
function	O
of	O
the	O
Apc	S-PRGE
gene	S-SO
product	O
.	O

Apc	O
Delta	O
580	O
/	O
+	S-SO
mice	S-LIVB
have	O
median	O
survival	O
of	O
5	O
mo	O
of	O
age	O
(	O
Figure	O
1C	O
)	O
,	O
with	O
progressive	O
signs	O
of	O
rectal	O
bleeding	O
and	O
anemia	O
.	O

Similar	O
to	O
the	O
results	O
reported	O
with	O
an	O
independently	O
generated	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
conditional	O
mouse	S-LIVB
strain	O
[	O
14	O
]	O
,	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
mice	S-LIVB
had	O
more	O
than	O
100	O
(	O
120	O
+/-	O
37	O
,	O
n	O
=	O
11	O
)	O
intestinal	O
tumors	O
at	O
the	O
time	O
of	O
their	O
death	O
(	O
Figure	O
S1	O
)	O
.	O

Inactivation	O
of	O
wild	B-SO
-	I-SO
type	E-SO
Apc	S-PRGE
is	O
an	O
important	O
prerequisite	O
for	O
tumor	O
development	O
.	O

We	O
analyzed	O
30	O
intestinal	O
tumors	O
from	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
mice	S-LIVB
by	O
in	O
vitro	O
transcription	O
and	O
translation	O
assay	O
,	O
but	O
none	O
of	O
them	O
showed	O
truncated	O
Apc	S-PRGE
products	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
the	O
most	O
likely	O
mechanism	O
of	O
wild	B-SO
-	I-SO
type	E-SO
Apc	S-PRGE
inactivation	O
is	O
by	O
allelic	S-SO
loss	S-SO
.	O

The	O
mutant	S-SO
allele	S-SO
had	O
to	O
be	O
maintained	O
and	O
transmitted	O
through	O
male	O
mice	S-LIVB
,	O
as	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
females	O
were	O
frequently	O
not	O
healthy	O
enough	O
to	O
successfully	O
nurse	O
their	O
own	O
pups	O
because	O
of	O
their	O
tumor	O
burden	O
.	O

ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
were	O
intercrossed	O
to	O
generate	O
ApcCKO	O
/	O
CKO	O
offspring	O
.	O

Approximately	O
one	O
-	O
quarter	O
of	O
the	O
offspring	O
(	O
17	O
of	O
81	O
)	O
were	O
homozygous	O
for	O
the	O
ApcCKO	O
allele	S-SO
.	O

These	O
mice	S-LIVB
as	O
well	O
as	O
heterozygous	O
mice	S-LIVB
for	O
ApcCKO	O
allele	S-SO
are	O
normal	O
,	O
showing	O
no	O
differences	O
in	O
their	O
survival	O
to	O
the	O
wild	B-SO
-	I-SO
type	E-SO
littermates	O
(	O
Figure	O
1C	O
)	O
.	O

We	O
tested	O
whether	O
our	O
ApcCKO	O
allele	S-SO
can	O
compliment	O
the	O
wild	B-SO
-	I-SO
type	E-SO
allele	S-SO
by	O
crossing	O
the	O
ApcCKO	O
/	O
CKO	O
female	O
with	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
male	O
mouse	S-LIVB
.	O

The	O
resultant	O
ApcCKO	O
/	O
Delta	O
580	O
offspring	O
were	O
viable	O
and	O
born	O
in	O
the	O
Mendelian	O
ratio	O
,	O
suggesting	O
that	O
the	O
presence	O
of	O
loxP	B-SO
sites	E-SO
in	O
introns	S-SO
flanking	O
exon	S-SO
14	O
have	O
no	O
adverse	O
effect	O
on	O
the	O
function	O
of	O
the	O
Apc	S-PRGE
gene	S-SO
.	O

K14	S-PRGE
-	O
Driven	O
Loss	O
of	O
Apc	S-PRGE
Results	O
in	O
Severe	O
Growth	O
Retardation	O
and	O
Early	O
Lethality	O

To	O
introduce	O
the	O
mutation	S-SO
of	O
Apc	S-PRGE
into	O
cells	S-CL
expressing	O
K14	S-PRGE
,	O
we	O
crossed	O
WW6	O
ES	O
cell	S-CL
-	O
derived	O
[	O
15	O
]	O
ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
with	O
K14	S-PRGE
-	O
cre	O
recombinase	O
mice	S-LIVB
in	O
FVB	O
background	O
[	O
16	O
]	O
.	O

The	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
were	O
normal	O
in	O
appearance	O
and	O
were	O
fertile	O
.	O

K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
+	S-SO
males	O
were	O
crossed	O
to	O
ApcCKO	O
/	O
CKO	O
females	O
to	O
avoid	O
the	O
potential	O
deleter	O
effect	O
in	O
oocytes	S-CL
of	O
K14	S-PRGE
-	O
cre	O
-	O
positive	O
females	O
[	O
17	O
]	O
.	O

The	O
mice	S-LIVB
were	O
intercrossed	O
thereafter	O
for	O
maintenance	O
;	O
hence	O
,	O
the	O
mice	S-LIVB
used	O
for	O
analysis	O
were	O
in	O
a	O
mixed	O
background	O
of	O
FVB	O
,	O
129	O
/	O
S	O
,	O
and	O
C57BL	O
/	O
6	O
in	O
similar	O
proportions	O
,	O
with	O
minimal	O
contribution	O
of	O
SJ	O
.	O

The	O
K14	S-PRGE
promoter	S-SO
is	O
a	O
commonly	O
used	O
epidermal	B-CL
cell	E-CL
promoter	S-SO
because	O
of	O
its	O
expression	O
by	O
the	O
mitotically	O
active	O
cells	B-CL
of	I-CL
the	I-CL
epidermis	E-CL
and	O
its	O
appendages	O
in	O
mature	O
skin	O
[	O
18	O
]	O
,	O
but	O
most	O
notably	O
it	O
is	O
active	O
in	O
embryonic	O
ectoderm	O
as	O
early	O
as	O
the	O
single	O
layered	O
ectodermal	O
stage	O
of	O
embryonic	O
day	O
(	O
E	O
)	O
9	O
.	O
5	O
[	O
19	O
]	O
.	O

A	O
restricted	O
expression	O
of	O
K14	S-PRGE
is	O
also	O
found	O
in	O
thymic	O
epithelial	B-CL
cells	E-CL
(	O
TECs	O
)	O
in	O
the	O
medulla	O
of	O
normal	O
thymus	O
[	O
20	O
]	O
.	O

We	O
genotyped	O
a	O
total	O
of	O
458	O
pups	O
(	O
8	O
-	O
10	O
d	O
old	O
)	O
from	O
67	O
litters	O
resulting	O
from	O
crosses	O
between	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
+	S-SO
and	O
ApcCKO	O
/	O
CKO	O
mice	S-LIVB
.	O

The	O
mutant	S-SO
mice	S-LIVB
of	O
the	O
genotype	S-SO
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
(	O
hereafter	O
,	O
KA	O
mutant	S-SO
)	O
were	O
born	O
,	O
but	O
the	O
observed	O
frequency	O
of	O
KA	O
mutants	S-SO
was	O
much	O
less	O
than	O
expected	O
(	O
78	O
of	O
458	O
[	O
17	O
.	O
0	O
%	O
]	O
;	O
p	O
<	O
0	O
.	O
0005	O
Chi	O
-	O
square	O
analysis	O
,	O
Table	O
1	O
)	O
.	O

To	O
assess	O
the	O
basis	O
for	O
the	O
neonatal	O
lethality	O
of	O
KA	O
mutants	S-SO
,	O
we	O
monitored	O
three	O
litters	O
from	O
birth	O
to	O
weaning	O
by	O
measuring	O
the	O
body	O
weight	O
of	O
each	O
pup	O
every	O
day	O
.	O

A	O
total	O
of	O
25	O
pups	O
were	O
born	O
from	O
three	O
litters	O
,	O
of	O
which	O
7	O
(	O
28	O
%	O
)	O
were	O
confirmed	O
to	O
be	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
by	O
genotyping	O
,	O
indicating	O
that	O
KA	O
mutants	S-SO
were	O
born	O
in	O
the	O
expected	O
Mendelian	O
ratio	O
.	O

The	O
KA	O
mutant	S-SO
pups	O
were	O
nursed	O
normally	O
,	O
and	O
there	O
was	O
milk	O
in	O
their	O
stomachs	O
during	O
the	O
first	O
2	O
or	O
3	O
d	O
after	O
birth	O
,	O
but	O
they	O
failed	O
to	O
thrive	O
(	O
Figure	O
2	O
)	O
.	O

By	O
postnatal	O
day	O
(	O
P	O
)	O
8	O
-	O
10	O
,	O
at	O
the	O
time	O
of	O
genotyping	O
,	O
many	O
KA	O
mutant	S-SO
pups	O
were	O
considerably	O
smaller	O
than	O
their	O
littermates	O
(	O
Figure	O
2B	O
-	O
2F	O
)	O
and	O
some	O
have	O
died	O
at	O
or	O
prior	O
to	O
this	O
age	O
.	O

None	O
of	O
KA	O
mutants	S-SO
survived	O
to	O
weaning	O
age	O
.	O

The	O
ability	O
of	O
whole	O
embryos	O
to	O
exclude	O
blue	O
dye	S-CHEBI
was	O
used	O
to	O
examine	O
the	O
epidermal	O
barrier	O
,	O
normally	O
acquired	O
beginning	O
at	O
E16	O
and	O
complete	O
by	O
E18	O
.	O
5	O
[	O
21	O
]	O
.	O

Analyses	O
of	O
E17	O
.	O
5	O
-	O
E18	O
.	O
5	O
KA	O
mutants	S-SO
showed	O
that	O
they	O
were	O
able	O
to	O
exclude	O
blue	O
dye	S-CHEBI
,	O
indicating	O
that	O
the	O
epidermal	O
barrier	O
was	O
intact	O
(	O
Figure	O
S2	O
)	O
.	O

At	O
these	O
embryonic	O
ages	O
,	O
there	O
were	O
no	O
differences	O
in	O
size	O
between	O
the	O
mutants	S-SO
and	O
their	O
littermates	O
,	O
but	O
the	O
mutants	S-SO
showed	O
a	O
patch	O
of	O
"	O
birthmark	O
"	O
or	O
dark	O
pigmentation	O
on	O
their	O
foreheads	O
and	O
a	O
dark	O
median	O
line	O
that	O
ran	O
caudally	O
from	O
head	O
to	O
tail	O
.	O

Their	O
external	O
ears	O
or	O
pinnae	O
were	O
shriveled	O
in	O
appearance	O
and	O
pigmented	O
compared	O
to	O
those	O
of	O
littermates	O
.	O

External	O
characteristics	O
of	O
KA	O
mutants	S-SO
that	O
were	O
evident	O
at	O
E18	O
.	O
5	O
persisted	O
after	O
birth	O
and	O
became	O
more	O
prominent	O
as	O
they	O
grew	O
(	O
Figure	O
2A	O
-	O
2F	O
)	O
.	O

Growth	O
of	O
pelage	O
hair	O
was	O
generally	O
delayed	O
in	O
the	O
mutants	S-SO
.	O

At	O
around	O
P8	O
,	O
the	O
KA	O
mutants	S-SO
were	O
hairless	O
and	O
had	O
wrinkled	O
skin	O
while	O
their	O
phenotypically	O
normal	O
littermates	O
had	O
a	O
smooth	O
thin	O
coat	O
of	O
hair	O
(	O
Figure	O
2B	O
)	O
.	O

At	O
this	O
age	O
,	O
two	O
lower	O
incisors	O
start	O
to	O
erupt	O
in	O
normal	O
littermates	O
and	O
these	O
were	O
absent	O
in	O
the	O
KA	O
mutants	S-SO
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

Animals	S-LIVB
also	O
tended	O
to	O
be	O
smaller	O
and	O
around	O
P10	O
-	O
P12	O
displayed	O
abnormally	O
short	O
and	O
misshapen	O
vibrissae	O
and	O
short	O
,	O
shaggy	O
pelage	O
hairs	O
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

Development	O
of	O
thick	O
ridges	O
in	O
their	O
skin	O
,	O
particularly	O
around	O
the	O
ears	O
,	O
eyelids	O
,	O
forehead	O
,	O
nose	O
,	O
and	O
paws	O
,	O
became	O
noticeable	O
(	O
Figure	O
2E	O
)	O
.	O

These	O
regions	O
looked	O
scaly	O
,	O
and	O
these	O
animals	S-LIVB
hardly	O
kept	O
their	O
eyes	O
open	O
.	O

In	O
contrast	O
to	O
the	O
normal	O
littermates	O
that	O
consistently	O
increased	O
their	O
body	O
weight	O
with	O
age	O
,	O
surviving	O
KA	O
mutants	S-SO
started	O
to	O
lose	O
weight	O
from	O
P10	O
onwards	O
;	O
by	O
P16	O
-	O
P17	O
they	O
were	O
all	O
lethargic	O
,	O
and	O
none	O
of	O
them	O
survived	O
to	O
weaning	O
(	O
Figure	O
2E	O
and	O
2F	O
)	O
.	O

At	O
the	O
time	O
of	O
autopsy	O
all	O
the	O
mutants	S-SO
were	O
toothless	O
,	O
without	O
incisors	O
or	O
molars	O
,	O
and	O
their	O
stomachs	O
were	O
consistently	O
small	O
and	O
had	O
no	O
solid	O
food	S-CHEBI
,	O
unlike	O
their	O
age	O
-	O
matched	O
littermates	O
,	O
suggesting	O
that	O
the	O
observed	O
weight	O
loss	O
could	O
be	O
the	O
result	O
of	O
failure	O
to	O
ingest	O
solid	O
food	S-CHEBI
(	O
Figure	O
2F	O
)	O
.	O

Interestingly	O
,	O
changes	O
in	O
body	O
weights	O
and	O
timing	O
of	O
hair	O
growth	O
varied	O
considerably	O
among	O
mutant	S-SO
pups	O
even	O
if	O
they	O
were	O
from	O
the	O
same	O
litter	O
,	O
whereas	O
those	O
of	O
phenotypically	O
normal	O
littermates	O
tended	O
to	O
be	O
similar	O
.	O

This	O
difference	O
was	O
also	O
reflected	O
in	O
the	O
variation	O
in	O
timing	O
of	O
death	O
in	O
mutants	S-SO
:	O
some	O
mutant	S-SO
pups	O
were	O
born	O
alive	O
but	O
died	O
within	O
a	O
day	O
or	O
two	O
,	O
some	O
survived	O
close	O
to	O
the	O
weaning	O
age	O
.	O

This	O
variability	O
of	O
the	O
mutant	S-SO
phenotypes	O
suggests	O
possible	O
variation	O
in	O
the	O
timing	O
and	O
efficiency	O
of	O
cre	O
-	O
mediated	O
Apc	S-PRGE
deletion	S-SO
.	O

It	O
is	O
possible	O
that	O
the	O
genetic	S-SO
background	O
has	O
a	O
role	O
to	O
play	O
in	O
this	O
variability	O
.	O

Gross	O
examination	O
of	O
internal	O
organs	O
also	O
showed	O
that	O
the	O
mutants	S-SO
'	O
thymi	O
were	O
consistently	O
inconspicuous	O
and	O
were	O
very	O
small	O
for	O
their	O
age	O
,	O
whereas	O
those	O
of	O
their	O
littermates	O
were	O
very	O
prominent	O
in	O
size	O
(	O
Figure	O
2G	O
)	O
.	O

This	O
difference	O
was	O
evident	O
as	O
early	O
as	O
P3	O
.	O

Quite	O
frequently	O
mutant	S-SO
thymi	O
in	O
P12	O
-	O
P17	O
mutant	S-SO
mice	S-LIVB
also	O
contained	O
black	O
deposits	O
within	O
the	O
tissue	O
(	O
unpublished	O
data	O
)	O
.	O

Mutant	S-SO
mice	S-LIVB
were	O
also	O
examined	O
for	O
any	O
skeletal	O
abnormalities	O
by	O
preparing	O
skeletal	O
specimens	O
of	O
P16	O
-	O
P17	O
mice	S-LIVB
stained	O
with	O
Alizarin	B-CHEBI
red	E-CHEBI
.	O

No	O
differences	O
between	O
the	O
normal	O
and	O
KA	O
mutant	S-SO
mice	S-LIVB
in	O
the	O
mandibular	O
bone	O
can	O
be	O
detected	O
,	O
but	O
the	O
mutant	S-SO
mice	S-LIVB
lacked	O
or	O
had	O
underdeveloped	O
set	O
of	O
maxillary	O
incisors	O
and	O
molars	O
(	O
Figure	O
2H	O
)	O
.	O

We	O
detected	O
no	O
other	O
major	O
skeletal	O
abnormalities	O
.	O

Genotype	S-SO
-	O
and	O
Tissue	O
-	O
Specific	O
Expression	O
of	O
the	O
Truncated	O
Apc	S-PRGE
Transcripts	S-SO

To	O
assess	O
the	O
molecular	S-CHEBI
effects	O
of	O
the	O
K14	S-PRGE
-	O
cre	O
-	O
mediated	O
recombination	O
,	O
we	O
screened	O
for	O
the	O
presence	O
of	O
deleted	S-SO
Apc	S-PRGE
(	O
Apc	O
Delta	O
580	O
)	O
alleles	S-SO
.	O

Genomic	B-SO
DNA	E-SO
was	O
extracted	O
from	O
liver	O
,	O
thymus	O
,	O
and	O
skin	O
from	O
all	O
4	O
possible	O
genotypes	S-SO
:	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
,	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
+	S-SO
,	O
ApcCKO	O
/	O
CKO	O
,	O
and	O
ApcCKO	O
/	O
+	S-SO
.	O

Genotyping	O
on	O
genomic	B-SO
DNA	E-SO
from	O
these	O
tissues	O
showed	O
that	O
the	O
Apc	O
Delta	O
580	O
allele	S-SO
(	O
500	O
-	O
bp	S-SO
product	O
)	O
was	O
detected	O
only	O
from	O
the	O
skin	O
and	O
thymus	O
of	O
the	O
K14	S-PRGE
-	O
cre	O
-	O
positive	O
mice	S-LIVB
.	O

The	O
presence	O
of	O
mutant	S-SO
Apc	S-PRGE
allele	S-SO
in	O
the	O
thymus	O
of	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
was	O
consistently	O
much	O
less	O
than	O
the	O
DNA	S-SO
from	O
the	O
skin	O
of	O
the	O
same	O
animal	S-LIVB
or	O
other	O
tissues	O
from	O
the	O
KA	O
mutants	S-SO
.	O

In	O
addition	O
,	O
this	O
product	O
was	O
not	O
detected	O
at	O
all	O
in	O
either	O
the	O
liver	O
of	O
K14	S-PRGE
-	O
cre	O
-	O
positive	O
or	O
in	O
any	O
of	O
the	O
K14	S-PRGE
-	O
cre	O
-	O
negative	O
mouse	S-LIVB
tissues	O
samples	O
,	O
establishing	O
that	O
Cre	O
-	O
mediated	O
recombination	O
has	O
taken	O
place	O
in	O
the	O
tissue	O
-	O
specific	O
manner	O
in	O
the	O
mice	S-LIVB
that	O
inherited	O
K14	S-PRGE
-	O
cre	O
(	O
Figure	O
3A	O
)	O
.	O

Apc	S-PRGE
transcripts	S-SO
were	O
also	O
analyzed	O
by	O
RT	O
-	O
PCR	O
with	O
primers	S-SO
spanning	O
exon	S-SO
14	O
(	O
Figure	O
1A	O
)	O
using	O
total	O
RNA	S-SO
isolated	O
from	O
the	O
corresponding	O
tissue	O
samples	O
.	O

We	O
detected	O
the	O
expected	S-SO
RT	O
-	O
PCR	B-SO
product	E-SO
(	O
313	O
bp	S-SO
)	O
from	O
the	O
truncated	O
Apc	S-PRGE
(	O
Apc	O
Delta	O
580	O
)	O
allele	S-SO
only	O
in	O
the	O
tissues	O
where	O
Cre	O
recombinase	O
is	O
known	O
to	O
be	O
expressed	O
in	O
the	O
K14	S-PRGE
-	O
cre	O
-	O
positive	O
mice	S-LIVB
.	O

However	O
,	O
this	O
product	S-SO
was	O
not	O
detected	O
in	O
either	O
the	O
K14	S-PRGE
-	O
cre	O
-	O
negative	O
mouse	S-LIVB
tissues	O
samples	O
or	O
the	O
liver	O
of	O
K14	S-PRGE
-	O
cre	O
-	O
positive	O
mice	S-LIVB
,	O
and	O
only	O
the	O
product	S-SO
from	O
the	O
wild	B-SO
-	I-SO
type	E-SO
allele	S-SO
(	O
528	O
bp	S-SO
)	O
was	O
detected	O
from	O
these	O
RNA	S-SO
samples	O
,	O
further	O
confirming	O
that	O
Cre	O
-	O
mediated	O
recombination	O
has	O
taken	O
place	O
in	O
the	O
tissue	O
-	O
and	O
genotype	S-SO
-	O
specific	O
manner	O
(	O
Figure	O
3B	O
)	O
.	O

K14	S-PRGE
-	O
cre	O
-	O
Driven	O
Apc	S-PRGE
Loss	O
Induced	O
Aberrant	O
Hair	O
Follicles	O
throughout	O
the	O
Epidermis	O

To	O
understand	O
the	O
basis	O
for	O
delayed	O
and	O
abnormal	O
hair	O
development	O
in	O
the	O
KA	O
mutants	S-SO
,	O
we	O
conducted	O
a	O
histological	O
and	O
immunohistochemical	O
examination	O
(	O
Figure	O
4	O
)	O
.	O

The	O
hair	O
follicle	O
is	O
an	O
epidermal	O
appendage	O
that	O
consists	O
of	O
an	O
upper	O
permanent	O
portion	O
,	O
and	O
a	O
lower	O
cycling	O
portion	O
that	O
produces	O
the	O
hair	O
[	O
22	O
,	O
23	O
]	O
.	O

The	O
outer	O
root	O
sheath	O
(	O
ORS	O
)	O
is	O
contiguous	O
with	O
and	O
biochemically	O
similar	O
to	O
the	O
basal	O
layer	O
of	O
the	O
epidermis	O
.	O

The	O
inner	O
layers	O
of	O
the	O
hair	O
follicle	O
include	O
three	O
concentric	O
layers	O
of	O
inner	O
root	O
sheath	O
and	O
three	O
concentric	O
layers	O
of	O
hair	O
-	O
producing	O
cells	S-CL
.	O

At	O
the	O
base	O
of	O
the	O
hair	O
follicle	O
is	O
the	O
germinative	O
hair	O
follicle	O
bulb	O
,	O
which	O
contains	O
rapidly	O
proliferating	O
"	O
matrix	O
"	O
cells	S-CL
that	O
differentiate	O
to	O
populate	O
all	O
of	O
the	O
layers	O
of	O
the	O
inner	O
root	O
sheath	O
and	O
the	O
hair	O
shaft	O
itself	O
[	O
22	O
]	O
.	O

During	O
the	O
anagen	O
phase	O
of	O
the	O
hair	O
cycle	O
(	O
until	O
P15	O
)	O
,	O
hair	O
follicles	O
of	O
phenotypically	O
normal	O
mice	S-LIVB
grew	O
deeply	O
into	O
the	O
subcutaneous	O
fat	O
and	O
were	O
uniformly	O
spaced	O
and	O
aligned	O
in	O
parallel	O
arrays	O
at	O
a	O
specific	O
angle	O
relative	O
to	O
the	O
skin	O
surface	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
contrast	O
,	O
KA	O
mutant	S-SO
follicles	O
were	O
irregularly	O
spaced	O
and	O
often	O
seen	O
as	O
disoriented	O
and	O
clamped	O
invaginations	O
at	O
P3	O
that	O
became	O
even	O
more	O
remarkable	O
at	O
P12	O
when	O
the	O
mutant	S-SO
mice	S-LIVB
were	O
covered	O
by	O
fur	O
coat	O
(	O
Figure	O
4F	O
)	O
.	O

Bulbs	O
were	O
often	O
bent	O
in	O
addition	O
to	O
being	O
irregularly	O
angled	O
to	O
one	O
another	O
and	O
their	O
sizes	O
and	O
locations	O
were	O
often	O
variable	O
.	O

Clusters	O
of	O
multiple	O
invaginations	O
or	O
dysplastic	O
follicular	O
structures	O
were	O
frequently	O
observed	O
throughout	O
the	O
epidermis	O
,	O
whereas	O
other	O
regions	O
showed	O
gaps	O
with	O
no	O
follicles	O
.	O

Serial	O
sectioning	O
indicated	O
that	O
some	O
of	O
the	O
hair	O
follicles	O
in	O
the	O
P12	O
mutant	S-SO
skin	O
were	O
not	O
properly	O
formed	O
or	O
shorter	O
than	O
normal	O
.	O

Taken	O
together	O
,	O
these	O
features	O
could	O
account	O
for	O
the	O
apparently	O
delayed	O
,	O
followed	O
by	O
outgrowth	O
,	O
of	O
the	O
short	O
and	O
shaggy	O
-	O
looking	O
fur	O
coat	O
of	O
these	O
mutant	S-SO
mice	S-LIVB
.	O

Apc	S-PRGE
is	O
a	O
regulator	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
that	O
is	O
important	O
for	O
Wnt	O
signaling	O
.	O

We	O
examined	O
the	O
patterns	O
of	O
expression	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
the	O
affected	O
tissues	O
.	O

In	O
the	O
normal	O
skin	O
,	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
,	O
a	O
member	O
of	O
the	O
adherens	B-GO
junction	I-GO
complex	E-GO
,	O
was	O
found	O
in	O
the	O
ORS	O
of	O
hair	O
follicles	O
and	O
basal	O
layer	O
of	O
epidermis	O
,	O
where	O
K14	S-PRGE
expression	O
is	O
also	O
observed	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
,	O
whereas	O
the	O
expression	O
of	O
K1	S-PRGE
,	O
involucrin	S-PRGE
,	O
and	O
loricrin	S-PRGE
(	O
markers	O
for	O
spinous	O
and	O
granular	O
layers	O
of	O
epidermis	O
)	O
was	O
only	O
observed	O
in	O
the	O
nonbasal	O
epidermis	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
patterns	O
of	O
expression	O
of	O
K14	S-PRGE
,	O
K1	S-PRGE
,	O
involucrin	S-PRGE
,	O
and	O
loricrin	S-PRGE
,	O
in	O
skin	O
from	O
mutant	S-SO
and	O
normal	O
littermate	O
mice	S-LIVB
at	O
P3	O
-	O
P17	O
,	O
showed	O
no	O
significant	O
differences	O
in	O
the	O
terminal	O
differentiation	O
(	O
Figure	O
4A	O
-	O
4D	O
,	O
4F	O
-	O
4I	O
)	O
.	O

Similarly	O
,	O
the	O
pattern	O
of	O
expression	O
of	O
K6	S-PRGE
,	O
which	O
is	O
normally	O
only	O
expressed	O
in	O
the	O
suprabasal	O
or	O
inner	O
layer	O
of	O
the	O
ORS	O
of	O
the	O
hair	O
follicle	O
but	O
not	O
in	O
the	O
epidermis	O
(	O
Figure	O
4E	O
)	O
,	O
did	O
not	O
change	O
.	O

Due	O
to	O
the	O
abnormal	O
and	O
disorganized	O
structure	O
of	O
hair	O
follicles	O
themselves	O
,	O
K6	S-PRGE
localization	O
highlighted	O
the	O
histological	O
abnormality	O
(	O
Figure	O
4J	O
)	O
.	O

Yet	O
as	O
in	O
the	O
normal	O
skin	O
,	O
K6	S-PRGE
was	O
principally	O
seen	O
only	O
in	O
the	O
suprabasal	O
layer	O
of	O
the	O
ORS	O
that	O
did	O
not	O
colocalize	O
with	O
the	O
basal	O
markers	O
,	O
K14	S-PRGE
or	O
K5	S-PRGE
(	O
Figure	O
4I	O
and	O
4J	O
)	O
.	O

In	O
normal	O
skin	O
,	O
proliferating	O
cells	S-CL
were	O
detected	O
in	O
either	O
the	O
basal	O
layer	O
of	O
epidermis	O
or	O
in	O
germinative	O
hair	O
follicle	O
bulbs	O
at	O
the	O
base	O
(	O
Figure	O
4B	O
)	O
.	O

In	O
the	O
mutant	S-SO
skin	O
,	O
either	O
BrdU	O
incorporation	S-SO
or	O
Ki67	S-PRGE
expression	O
was	O
observed	O
not	O
only	O
in	O
cells	S-CL
in	O
bulbs	O
at	O
the	O
base	O
of	O
the	O
hair	O
follicle	O
but	O
also	O
in	O
bulb	O
-	O
like	O
structures	O
that	O
were	O
budding	O
out	O
from	O
the	O
ORS	O
of	O
the	O
existing	O
hair	O
follicles	O
(	O
Figure	O
4G	O
and	O
4G	O
'	O
)	O
.	O

Each	O
budding	O
tip	O
was	O
becoming	O
like	O
a	O
hair	O
follicle	O
bulb	O
containing	O
proliferating	O
cells	S-CL
.	O

Hence	O
,	O
despite	O
the	O
abnormal	O
histology	O
in	O
the	O
mutant	S-SO
skin	O
,	O
proliferation	O
seems	O
to	O
be	O
confined	O
to	O
bulb	O
-	O
like	O
structures	O
as	O
in	O
the	O
normal	O
skin	O
(	O
Figure	O
4G	O
and	O
4G	O
'	O
)	O
.	O

The	O
exact	O
locations	O
of	O
hair	O
follicle	O
bulbs	O
were	O
not	O
as	O
easy	O
to	O
define	O
for	O
some	O
mutant	S-SO
follicles	O
due	O
to	O
their	O
disorganized	O
structures	O
.	O

Interestingly	O
,	O
in	O
the	O
mutant	S-SO
skin	O
,	O
in	O
addition	O
to	O
diffuse	O
membrane	S-GO
-	O
bound	O
localization	O
as	O
in	O
the	O
normal	O
skin	O
,	O
cells	S-CL
with	O
strong	O
cytosolic	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
localization	O
were	O
also	O
observed	O
frequently	O
(	O
Figure	O
4H	O
and	O
4H	O
'	O
)	O
.	O

These	O
elevated	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
-	O
expressing	O
cells	S-CL
were	O
usually	O
surrounded	O
by	O
proliferating	O
cells	S-CL
,	O
forming	O
bulb	O
-	O
like	O
structures	O
.	O

Comparison	O
of	O
immunochemically	O
stained	O
serial	O
sections	O
showed	O
that	O
these	O
intense	O
cytosolic	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
stainings	O
were	O
usually	O
found	O
in	O
either	O
K14	S-PRGE
-	O
positive	O
K1	S-PRGE
-	O
negative	O
basal	O
epidermis	O
or	O
K14	S-PRGE
-	O
positive	O
K6	S-PRGE
-	O
negative	O
basal	O
ORS	O
cells	S-CL
,	O
and	O
are	O
surrounded	O
by	O
proliferating	O
cells	S-CL
.	O

To	O
determine	O
the	O
initiation	O
of	O
hair	O
follicle	O
morphogenesis	O
in	O
these	O
mutants	S-SO
,	O
we	O
examined	O
the	O
expression	O
pattern	O
of	O
Sonic	B-PRGE
hedgehog	E-PRGE
(	O
Shh	S-PRGE
)	O
,	O
a	O
factor	O
expressed	O
in	O
hair	O
bulbs	O
in	O
embryonic	O
skin	O
(	O
Figure	O
5	O
)	O
.	O

The	O
aberrant	O
hair	O
follicle	O
morphogenesis	O
is	O
evident	O
as	O
early	O
as	O
E14	O
.	O
5	O
in	O
mutant	S-SO
embryonic	O
skin	O
,	O
by	O
multiple	O
apolarized	O
expression	O
of	O
Shh	S-PRGE
throughout	O
the	O
epidermis	O
(	O
Figure	O
5B	O
)	O
,	O
whereas	O
that	O
of	O
control	O
embryos	O
was	O
well	O
polarized	O
and	O
regularly	O
spaced	O
(	O
Figure	O
5A	O
)	O
.	O

With	O
development	O
,	O
control	O
mouse	S-LIVB
hair	O
follicles	O
invaginate	O
downward	O
in	O
a	O
polarized	O
manner	O
(	O
Figure	O
5C	O
)	O
,	O
whereas	O
those	O
of	O
mutant	S-SO
embryos	O
were	O
completely	O
irregular	O
and	O
apolarized	O
(	O
Figure	O
5D	O
)	O
.	O

It	O
was	O
also	O
noted	O
that	O
the	O
size	O
of	O
each	O
"	O
budding	O
"	O
follicle	O
,	O
as	O
detected	O
by	O
Shh	S-PRGE
expression	O
,	O
was	O
variable	O
(	O
Figure	O
5D	O
)	O
.	O

The	O
intensity	O
of	O
Shh	S-PRGE
staining	O
was	O
generally	O
stronger	O
in	O
mutant	S-SO
skin	O
than	O
in	O
the	O
normal	O
skin	O
.	O

The	O
aberrant	O
initiation	O
of	O
multiple	O
hair	O
placodes	O
during	O
early	O
hair	O
follicle	O
morphogenesis	O
was	O
also	O
evident	O
by	O
the	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
(	O
ISH	O
)	O
of	O
E15	O
.	O
5	O
mutant	S-SO
embryos	O
for	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
(	O
Figure	O
5F	O
and	O
5F	O
'	O
)	O
.	O

The	O
expression	O
pattern	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
embryos	O
clearly	O
demonstrated	O
the	O
formation	O
of	O
regular	O
arrays	O
of	O
hair	O
placodes	O
in	O
the	O
normal	O
embryonic	O
skin	O
(	O
Figure	O
5E	O
and	O
5E	O
'	O
)	O
,	O
but	O
such	O
regular	O
patterning	O
was	O
lost	O
,	O
and	O
often	O
tightly	O
clustered	O
abnormal	O
hair	O
placodes	O
were	O
initiated	O
in	O
mutant	S-SO
embryonic	O
skin	O
(	O
Figure	O
5F	O
'	O
)	O
.	O

Aberrant	O
hair	O
placodes	O
were	O
also	O
evident	O
throughout	O
the	O
skin	O
surface	O
of	O
limbs	O
in	O
E15	O
.	O
5	O
mutants	S-SO
(	O
Figure	O
5F	O
)	O
,	O
whereas	O
those	O
of	O
the	O
control	O
embryos	O
had	O
not	O
yet	O
formed	O
(	O
Figure	O
5E	O
)	O
.	O

Most	O
interestingly	O
,	O
in	O
the	O
mutant	S-SO
footpads	O
,	O
where	O
hair	O
placodes	O
do	O
not	O
normally	O
form	O
(	O
Figure	O
5G	O
)	O
,	O
we	O
also	O
found	O
ectopic	O
irregularly	O
sized	O
and	O
spaced	O
hair	O
placodes	O
,	O
indicating	O
that	O
the	O
footpads	O
still	O
have	O
the	O
potential	O
to	O
form	O
hair	O
placodes	O
in	O
the	O
absence	O
of	O
the	O
Apc	S-PRGE
gene	S-SO
(	O
Figure	O
5H	O
)	O
.	O

These	O
results	O
collectively	O
suggest	O
that	O
the	O
terminal	O
differentiation	O
does	O
take	O
place	O
normally	O
in	O
the	O
mutant	S-SO
skin	O
,	O
but	O
initiation	O
of	O
embryonic	O
hair	O
follicle	O
morphogenesis	O
is	O
severely	O
disrupted	O
,	O
accompanied	O
by	O
a	O
continuous	O
ectopic	O
hair	O
follicle	O
morphogenesis	O
in	O
postnatal	O
mutant	S-SO
skin	O
.	O

Effects	O
of	O
K14	S-PRGE
-	O
cre	O
-	O
Driven	O
Loss	O
of	O
Apc	S-PRGE
in	O
Other	O
Epidermal	O
Appendages	O

Similar	O
to	O
the	O
biology	O
of	O
hair	O
follicles	O
,	O
K14	S-PRGE
-	O
cre	O
-	O
driven	O
loss	O
of	O
Apc	S-PRGE
also	O
affected	O
the	O
development	O
of	O
other	O
epidermal	O
appendages	O
that	O
depend	O
on	O
epithelial	O
-	O
mesenchymal	O
interactions	O
for	O
their	O
formation	O
.	O

The	O
most	O
striking	O
of	O
these	O
was	O
dental	O
dysplasia	O
(	O
Figure	O
4K	O
-	O
4R	O
)	O
.	O

Tooth	O
development	O
is	O
normally	O
initiated	O
between	O
E11	O
and	O
E12	O
by	O
invagination	O
of	O
ectodermally	O
derived	O
oral	O
epithelium	O
into	O
the	O
underlying	O
cranial	O
neural	O
crest	O
-	O
derived	O
mesenchyme	O
,	O
generating	O
a	O
tooth	O
germ	O
.	O

Despite	O
the	O
grossly	O
toothless	O
phenotype	O
of	O
KA	O
mutants	S-SO
,	O
histological	O
analysis	O
of	O
their	O
oral	O
cavities	O
revealed	O
the	O
formation	O
of	O
multiple	O
tooth	O
buds	O
at	O
each	O
location	O
.	O

These	O
aberrant	O
teeth	O
obviously	O
failed	O
to	O
grow	O
out	O
during	O
the	O
dietary	O
transition	O
from	O
milk	O
to	O
solid	O
food	S-CHEBI
.	O

Analogous	O
to	O
the	O
expression	O
patterns	O
of	O
K14	S-PRGE
and	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
the	O
normal	O
skin	O
,	O
diffuse	O
membrane	S-GO
-	O
bound	O
expression	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
was	O
detected	O
in	O
K14	S-PRGE
-	O
expressing	O
oral	O
epithelium	O
and	O
ameloblasts	S-CL
of	O
normal	O
mice	S-LIVB
.	O

In	O
mutants	S-SO
,	O
some	O
of	O
the	O
K14	S-PRGE
-	O
expressing	O
cells	S-CL
also	O
showed	O
strong	O
cytosolic	S-GO
/	O
nuclear	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
,	O
as	O
observed	O
in	O
the	O
mutant	S-SO
skin	O
(	O
Figure	O
4Q	O
,	O
4Q	O
'	O
,	O
and	O
4R	O
)	O
.	O

Initiation	O
of	O
ectopic	O
tooth	O
buds	O
in	O
the	O
mutant	S-SO
mice	S-LIVB
was	O
evident	O
at	O
E15	O
.	O
5	O
by	O
extra	O
dots	O
of	O
Shh	S-PRGE
expression	O
adjacent	O
to	O
the	O
primary	O
teeth	O
(	O
data	O
not	O
shown	O
)	O
.	O

Loss	O
of	O
Apc	S-PRGE
also	O
leads	O
to	O
hyperplasia	O
in	O
squamous	O
epithelia	O
of	O
cornea	O
,	O
oral	O
,	O
salivary	O
,	O
and	O
Hardarian	O
glands	O
(	O
unpublished	O
data	O
)	O
.	O

Squamous	O
metaplasia	O
to	O
hair	O
follicle	O
-	O
like	O
structures	O
,	O
ectopic	O
hair	O
follicle	O
morphogenesis	O
was	O
also	O
observed	O
in	O
these	O
epithelia	O
.	O

K14	S-PRGE
-	O
cre	O
-	O
Driven	O
Apc	S-PRGE
Loss	O
Results	O
in	O
Hypoplastic	O
/	O
Athymic	O
Mice	S-LIVB

Thymus	O
is	O
an	O
organ	O
that	O
is	O
also	O
known	O
to	O
have	O
K14	S-PRGE
expression	O
[	O
16	O
]	O
.	O

It	O
represents	O
the	O
primary	O
lymphoid	O
organ	O
for	O
thymocyte	O
development	O
and	O
selection	O
.	O

Distinct	O
population	O
of	O
TECs	O
of	O
cortex	O
and	O
medulla	O
mediates	O
both	O
of	O
these	O
critical	O
functions	O
.	O

Cortical	O
and	O
medullary	O
TEC	O
subsets	O
are	O
characterized	O
by	O
differential	O
expression	O
of	O
four	O
keratin	O
species	O
:	O
K8	S-PRGE
,	O
K18	S-PRGE
,	O
K5	S-PRGE
,	O
and	O
K14	S-PRGE
.	O

The	O
normal	O
thymus	O
is	O
a	O
lobulated	O
lymphoid	O
organ	O
,	O
each	O
lobule	O
clearly	O
showing	O
the	O
two	O
distinct	O
TEC	O
compartments	O
,	O
an	O
outer	O
cortex	O
and	O
an	O
inner	O
medulla	O
(	O
Figure	O
6	O
)	O
.	O

There	O
were	O
no	O
major	O
differences	O
in	O
the	O
histology	O
of	O
thymus	O
between	O
the	O
ages	O
P3	O
to	O
P17	O
in	O
phenotypically	O
normal	O
littermates	O
.	O

As	O
shown	O
in	O
the	O
H	O
&	O
E	O
staining	O
of	O
thymus	O
,	O
the	O
cortex	O
was	O
formed	O
of	O
dense	O
lymphoid	O
tissue	O
that	O
lacks	O
nodules	O
(	O
Figure	O
6A	O
)	O
.	O

Since	O
the	O
stroma	O
of	O
the	O
medulla	O
is	O
less	O
heavily	O
infiltrated	O
with	O
lymphocytes	S-CL
than	O
the	O
cortex	O
,	O
the	O
medulla	O
stained	O
more	O
lightly	O
than	O
the	O
cortex	O
.	O

In	O
normal	O
mice	S-LIVB
,	O
the	O
thymus	O
retains	O
its	O
size	O
until	O
the	O
young	O
adult	O
age	O
and	O
regresses	O
thereafter	O
by	O
atrophy	O
.	O

In	O
the	O
normal	O
young	O
mice	S-LIVB
we	O
examined	O
(	O
P3	O
-	O
P17	O
)	O
,	O
it	O
is	O
evident	O
that	O
thymocytes	O
were	O
mitotically	O
active	O
in	O
the	O
cortex	O
as	O
determined	O
by	O
BrdU	O
immunostaining	O
(	O
Figure	O
6B	O
)	O
.	O

Immunohistochemistry	O
of	O
normal	O
thymus	O
from	O
P3	O
to	O
P17	O
mice	S-LIVB
showed	O
a	O
similar	O
staining	O
pattern	O
for	O
K14	S-PRGE
in	O
that	O
its	O
expression	O
was	O
restricted	O
to	O
a	O
small	O
population	O
of	O
TECs	O
in	O
the	O
inner	O
medullary	O
region	O
and	O
in	O
the	O
keratinocytes	S-CL
in	O
Hassall	O
'	O
s	O
corpuscles	O
(	O
Figure	O
6D	O
)	O
.	O

Diffuse	O
cytoplasmic	S-GO
staining	O
for	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
was	O
also	O
detected	O
in	O
the	O
medullary	O
epithelial	B-CL
cells	E-CL
(	O
Figure	O
6C	O
)	O
.	O

In	O
contrast	O
to	O
K14	S-PRGE
expression	O
,	O
diffuse	O
staining	O
for	O
K8	S-PRGE
was	O
observed	O
in	O
epithelial	B-CL
cells	E-CL
both	O
in	O
the	O
medulla	O
and	O
cortex	O
(	O
Figure	O
S3	O
)	O
.	O

K1	S-PRGE
staining	O
was	O
not	O
detected	O
in	O
young	O
mice	S-LIVB
at	O
P3	O
but	O
in	O
older	O
mice	S-LIVB
it	O
was	O
detected	O
in	O
differentiated	O
keratinocytes	S-CL
in	O
some	O
of	O
Hassall	O
'	O
s	O
corpuscles	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
histological	O
abnormalities	O
of	O
thymus	O
were	O
evident	O
as	O
early	O
as	O
P3	O
in	O
KA	O
mutants	S-SO
(	O
Figure	O
6E	O
and	O
6H	O
)	O
.	O

The	O
thymus	O
was	O
made	O
of	O
two	O
lobules	O
as	O
in	O
the	O
normal	O
mice	S-LIVB
but	O
the	O
mutant	S-SO
thymus	O
was	O
significantly	O
smaller	O
in	O
size	O
than	O
that	O
of	O
the	O
age	O
-	O
matched	O
controls	O
(	O
Figure	O
2G	O
)	O
.	O

Interestingly	O
,	O
variations	O
in	O
the	O
phenotypic	O
severity	O
of	O
the	O
mutant	S-SO
pups	O
at	O
P3	O
were	O
prominently	O
reflected	O
in	O
the	O
extent	O
of	O
histological	O
abnormalities	O
of	O
thymus	O
.	O

A	O
P3	O
KA	O
mutant	S-SO
pup	O
that	O
showed	O
milder	O
phenotype	O
with	O
a	O
comparable	O
body	O
weight	O
to	O
its	O
normal	O
littermates	O
(	O
Figure	O
2A	O
,	O
M2	O
)	O
showed	O
milder	O
thymus	O
abnormalities	O
(	O
Figure	O
6E	O
)	O
compared	O
to	O
its	O
more	O
severe	O
mutant	S-SO
littermate	O
(	O
Figure	O
2A	O
,	O
M1	O
;	O
Figure	O
6H	O
)	O
.	O

The	O
milder	O
P3	O
mutant	S-SO
thymus	O
was	O
already	O
much	O
smaller	O
in	O
size	O
compared	O
to	O
those	O
of	O
normal	O
littermates	O
(	O
data	O
not	O
shown	O
)	O
but	O
two	O
epithelial	O
compartments	O
of	O
thymus	O
were	O
histologically	O
still	O
distinguishable	O
,	O
with	O
colonization	O
of	O
thymocytes	O
evident	O
in	O
the	O
cortex	O
.	O

However	O
,	O
there	O
were	O
small	O
populations	O
of	O
lightly	O
stained	O
cells	S-CL
by	O
H	O
&	O
E	O
extending	O
from	O
the	O
edge	O
of	O
the	O
outer	O
cortex	O
towards	O
inner	O
medulla	O
(	O
Figure	O
6E	O
)	O
,	O
and	O
these	O
cells	S-CL
showed	O
intense	O
nuclear	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
whereas	O
the	O
rest	O
of	O
the	O
medullary	O
cells	S-CL
showed	O
diffuse	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
pattern	O
similar	O
to	O
that	O
of	O
the	O
control	O
(	O
Figure	O
6F	O
)	O
.	O

Localization	O
of	O
K14	S-PRGE
was	O
limited	O
to	O
a	O
few	O
cells	S-CL
in	O
the	O
medulla	O
and	O
some	O
overlapped	O
with	O
K8	S-PRGE
localization	O
(	O
Figure	O
6G	O
)	O
.	O

In	O
the	O
other	O
P3	O
mutant	S-SO
thymus	O
the	O
distinct	O
thymic	O
epithelial	O
compartments	O
have	O
been	O
lost	O
completely	O
,	O
and	O
only	O
a	O
few	O
lymphocytes	S-CL
were	O
remaining	O
at	O
the	O
edges	O
and	O
some	O
in	O
the	O
middle	O
(	O
Figure	O
6H	O
)	O
.	O

Proliferative	O
activities	O
were	O
no	O
longer	O
observed	O
in	O
thymocytes	O
as	O
prominently	O
as	O
in	O
the	O
normal	O
thymus	O
,	O
but	O
the	O
epithelial	B-CL
cells	E-CL
seemed	O
to	O
be	O
forming	O
concentric	O
structures	O
(	O
Figure	O
6I	O
)	O
.	O

Unlike	O
in	O
the	O
normal	O
or	O
mild	O
mutant	S-SO
thymi	O
,	O
the	O
severe	O
P3	O
mutant	S-SO
thymus	O
showed	O
extensive	O
K14	S-PRGE
expression	O
that	O
overlapped	O
with	O
K8	S-PRGE
expression	O
(	O
Figure	O
6K	O
)	O
.	O

These	O
cells	S-CL
were	O
more	O
like	O
basal	B-CL
cells	E-CL
of	O
the	O
skin	O
than	O
TECs	O
and	O
were	O
adjacent	O
to	O
the	O
most	O
immature	O
looking	O
cells	S-CL
that	O
were	O
showing	O
strong	O
nuclear	S-GO
and	O
cytoplasmic	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
(	O
Figure	O
6J	O
)	O
.	O

The	O
nuclear	S-GO
staining	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
was	O
not	O
observed	O
in	O
the	O
normal	O
age	O
-	O
matched	O
thymus	O
(	O
Figure	O
6C	O
)	O
.	O

Most	O
notably	O
,	O
the	O
K14	S-PRGE
and	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
patterns	O
were	O
mutually	O
exclusive	O
(	O
Figure	O
6J	O
and	O
6K	O
)	O
.	O

At	O
P10	O
-	O
P13	O
,	O
the	O
mutant	S-SO
thymus	O
consisted	O
of	O
numerous	O
enlarged	O
Hassall	O
'	O
s	O
corpuscle	O
-	O
like	O
structures	O
,	O
made	O
of	O
arrays	O
of	O
K14	S-PRGE
-	O
and	O
K8	S-PRGE
-	O
expressing	O
keratinizing	O
epithelial	B-CL
cells	E-CL
surrounding	O
large	O
keratin	O
deposits	O
(	O
Figure	O
6L	O
and	O
6O	O
)	O
.	O

There	O
were	O
numerous	O
neutrophils	S-CL
and	O
macrophages	S-CL
infiltrating	O
the	O
thymus	O
in	O
response	O
to	O
these	O
keratins	O
;	O
hence	O
,	O
these	O
structures	O
could	O
be	O
called	O
pyogranuloma	O
.	O

Varying	O
degrees	O
of	O
differentiation	O
-	O
specific	O
markers	O
depending	O
on	O
the	O
age	O
of	O
mice	S-LIVB
,	O
in	O
this	O
case	O
K1	S-PRGE
and	O
involucrin	S-PRGE
that	O
are	O
normally	O
present	O
only	O
in	O
Hassall	O
'	O
s	O
corpuscles	O
,	O
were	O
also	O
detected	O
in	O
mutant	S-SO
thymi	O
(	O
Figure	O
S3	O
)	O
.	O

In	O
these	O
mice	S-LIVB
no	O
thymocytes	O
were	O
detectable	O
.	O

BrdU	O
incorporation	S-SO
was	O
only	O
observed	O
in	O
very	O
few	O
keratinizing	O
epithelial	B-CL
cells	E-CL
,	O
looking	O
somewhat	O
similar	O
to	O
the	O
pattern	O
of	O
mature	O
skin	O
(	O
Figure	O
6M	O
)	O
.	O

The	O
diffuse	O
expression	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
was	O
also	O
present	O
in	O
these	O
epithelial	B-CL
cells	E-CL
,	O
and	O
at	O
this	O
age	O
fewer	O
cells	S-CL
were	O
positive	O
for	O
nuclear	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
(	O
Figure	O
6N	O
)	O
.	O

As	O
in	O
the	O
younger	O
mutant	S-SO
mice	S-LIVB
,	O
however	O
,	O
nuclear	S-GO
localization	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
was	O
only	O
observed	O
in	O
K14	S-PRGE
-	O
negative	O
cells	S-CL
that	O
looked	O
like	O
undifferentiated	O
basal	B-CL
cells	E-CL
.	O

In	O
older	O
P17	O
mice	S-LIVB
,	O
the	O
histopathology	O
and	O
keratin	O
expression	O
pattern	O
of	O
the	O
mutant	S-SO
thymus	O
was	O
similar	O
to	O
that	O
of	O
P13	O
except	O
for	O
the	O
fact	O
that	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
expression	O
became	O
increasingly	O
diffuse	O
and	O
appeared	O
to	O
colocalize	O
with	O
K8	S-PRGE
/	O
K14	S-PRGE
expression	O
(	O
data	O
not	O
shown	O
)	O
.	O

This	O
coincided	O
with	O
fewer	O
immature	O
cells	S-CL
in	O
the	O
older	O
mutant	S-SO
thymus	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
loss	O
of	O
Apc	S-PRGE
and	O
consequent	O
stabilization	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
K14	S-PRGE
-	O
expressing	O
TECs	O
lead	O
to	O
their	O
aberrant	O
proliferation	O
and	O
differentiation	O
to	O
keratinocytes	S-CL
,	O
causing	O
massive	O
squamous	O
metaplasia	O
,	O
rather	O
than	O
to	O
form	O
either	O
medullary	O
or	O
cortical	O
TECs	O
.	O

Loss	O
of	O
proper	O
TEC	O
compartments	O
consequently	O
resulted	O
in	O
loss	O
of	O
thymocytes	O
for	O
maturation	O
and	O
the	O
mice	S-LIVB
to	O
be	O
"	O
athymic	O
.	O
"	O

Discussion	O

Apc	S-PRGE
is	O
implicated	O
in	O
the	O
Wnt	O
signaling	O
pathway	O
that	O
is	O
involved	O
both	O
in	O
development	O
and	O
tumorigenesis	O
.	O

Human	S-LIVB
germline	O
mutations	S-SO
in	O
APC	S-PRGE
cause	O
FAP	O
[	O
4	O
,	O
5	O
]	O
,	O
which	O
is	O
characterized	O
by	O
hundreds	O
of	O
adenomatous	O
colorectal	O
polyps	O
,	O
with	O
an	O
almost	O
inevitable	O
progression	O
to	O
colorectal	O
cancer	O
in	O
the	O
third	O
and	O
fourth	O
decades	O
of	O
life	O
.	O

The	O
phenotypical	O
features	O
of	O
FAP	O
and	O
its	O
variant	O
,	O
Gardner	O
'	O
s	O
syndrome	O
,	O
can	O
be	O
very	O
variable	O
.	O

As	O
well	O
as	O
colorectal	O
polyps	O
,	O
these	O
individuals	S-LIVB
can	O
develop	O
extracolonic	O
symptoms	O
,	O
among	O
which	O
are	O
upper	O
gastrointestinal	O
tract	O
polyps	O
,	O
congenital	O
hypertrophy	O
of	O
the	O
retinal	O
pigment	S-CHEBI
epithelium	O
,	O
desmoid	O
tumors	O
,	O
disorders	O
of	O
the	O
maxillary	O
and	O
skeletal	O
bones	O
,	O
and	O
dental	O
abnormalities	O
[	O
6	O
]	O
.	O

While	O
the	O
heterozygous	O
knockout	O
mice	S-LIVB
for	O
Apc	S-PRGE
develop	O
adenomatous	O
polyps	O
predominantly	O
in	O
small	O
intestine	O
,	O
the	O
homozygous	O
embryos	O
die	O
before	O
gastrulation	O
.	O

To	O
gain	O
more	O
insights	O
into	O
the	O
effects	O
of	O
Apc	S-PRGE
loss	O
in	O
tissues	O
other	O
than	O
gastrointestinal	O
tract	O
during	O
life	O
of	O
animals	S-LIVB
and	O
to	O
circumvent	O
the	O
embryonic	O
lethality	O
associated	O
with	O
Apc	S-PRGE
nullizygosity	O
,	O
we	O
created	O
a	O
mouse	S-LIVB
strain	O
carrying	O
a	O
conditional	O
allele	S-SO
of	O
Apc	S-PRGE
(	O
ApcCKO	O
)	O
in	O
which	O
exon	S-SO
14	O
of	O
the	O
Apc	S-PRGE
is	O
flanked	S-SO
by	O
loxP	B-SO
sequences	E-SO
.	O

The	O
homozygous	O
mice	S-LIVB
for	O
the	O
conditional	O
allele	S-SO
are	O
viable	O
and	O
indistinguishable	O
to	O
the	O
normal	O
mice	S-LIVB
,	O
allowing	O
us	O
to	O
study	O
the	O
roles	O
of	O
Apc	S-PRGE
in	O
a	O
tissue	O
-	O
and	O
temporal	O
-	O
specific	O
manner	O
.	O

To	O
assess	O
the	O
phenotypic	O
consequences	O
of	O
inactivation	O
of	O
the	O
Apc	S-PRGE
gene	S-SO
in	O
cells	S-CL
that	O
express	O
K14	S-PRGE
,	O
we	O
created	O
mice	S-LIVB
that	O
are	O
homozygous	O
for	O
the	O
ApcCKO	O
allele	S-SO
and	O
contain	O
a	O
K14	S-PRGE
-	O
cre	O
transgene	S-SO
.	O

These	O
mice	S-LIVB
failed	O
to	O
thrive	O
and	O
died	O
before	O
weaning	O
.	O

They	O
also	O
exhibited	O
hair	O
,	O
tooth	O
,	O
and	O
thymus	O
phenotypes	O
.	O

Apc	S-PRGE
and	O
Hair	O
Follicle	O
Morphogenesis	O

Current	O
models	O
of	O
hair	O
follicle	O
development	O
suggest	O
that	O
the	O
establishment	O
of	O
a	O
regular	O
array	O
of	O
placodes	O
in	O
the	O
surface	O
epithelium	O
in	O
response	O
to	O
the	O
first	O
dermal	O
message	O
is	O
achieved	O
through	O
the	O
competing	O
activities	O
of	O
molecules	S-CHEBI
that	O
promote	O
or	O
repress	O
placode	O
fate	O
[	O
24	O
]	O
.	O

There	O
is	O
accumulating	O
evidence	O
that	O
activation	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
in	O
the	O
dermis	O
may	O
be	O
involved	O
in	O
establishing	O
the	O
first	O
dermal	O
signal	O
.	O

Experimental	O
activation	O
of	O
epithelial	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
signaling	O
(	O
by	O
expression	O
of	O
N	B-SO
-	I-SO
terminal	E-SO
-	O
truncated	O
,	O
constitutively	O
stabilized	O
forms	S-SO
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
or	O
ectopic	O
expression	O
of	O
Lef1	S-PRGE
)	O
induces	O
ectopic	O
follicles	O
in	O
both	O
mouse	S-LIVB
and	O
chick	O
skin	O
[	O
25	O
-	O
27	O
]	O
.	O

Conversely	O
,	O
down	O
-	O
regulation	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
signaling	O
(	O
through	O
Lef1	S-PRGE
knock	O
-	O
out	O
,	O
ectopic	O
expression	O
of	O
Wnt	O
inhibitor	O
Dkk1	S-PRGE
or	O
conditional	O
deletion	S-SO
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
epidermis	O
)	O
results	O
in	O
loss	O
of	O
vibrissae	O
and	O
some	O
pelage	O
follicles	O
in	O
mice	S-LIVB
[	O
28	O
-	O
30	O
]	O
.	O

Our	O
finding	O
that	O
K14	S-PRGE
-	O
driven	O
Apc	S-PRGE
loss	O
in	O
embryonic	O
ectoderm	O
resulted	O
in	O
irregularly	O
spaced	O
and	O
often	O
tightly	O
clustered	O
abnormal	O
hair	O
placode	O
initiation	O
and	O
follicle	O
morphogenesis	O
(	O
Figures	O
4F	O
,	O
5B	O
,	O
5D	O
,	O
and	O
5F	O
)	O
as	O
well	O
as	O
in	O
the	O
development	O
of	O
multiple	O
tooth	O
buds	O
(	O
Figure	O
4O	O
and	O
4P	O
)	O
,	O
is	O
in	O
line	O
with	O
the	O
effects	O
seen	O
in	O
activation	O
of	O
epithelial	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
signaling	O
during	O
placode	O
formation	O
,	O
indicating	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
specification	O
of	O
embryonic	O
ectodermal	B-CL
stem	I-CL
cells	E-CL
to	O
produce	O
a	O
hair	O
follicle	O
.	O

Given	O
the	O
role	O
of	O
Apc	S-PRGE
in	O
down	O
-	O
regulation	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
,	O
loss	O
of	O
Apc	S-PRGE
would	O
inevitably	O
lead	O
to	O
altered	O
expression	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
ectodermal	B-CL
cells	E-CL
during	O
the	O
hair	O
placode	O
formation	O
,	O
giving	O
rise	O
to	O
aberrant	O
follicular	O
growth	O
throughout	O
the	O
embryonic	O
epidermis	O
,	O
including	O
the	O
footpads	O
,	O
where	O
normally	O
hairless	O
(	O
Figure	O
5B	O
,	O
5D	O
,	O
5F	O
,	O
and	O
5H	O
)	O
.	O

Of	O
interest	O
are	O
the	O
phenotypic	O
similarities	O
and	O
differences	O
between	O
our	O
KA	O
mutant	S-SO
mice	S-LIVB
and	O
the	O
previously	O
described	O
K14	S-PRGE
-	O
Delta	O
N87	O
beta	O
cat	O
transgenic	S-SO
mice	S-LIVB
expressing	O
stable	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
under	O
the	O
control	O
of	O
K14	S-PRGE
promoter	S-SO
[	O
25	O
]	O
and	O
K14	S-PRGE
-	O
Lef1	S-PRGE
transgenic	S-SO
mice	S-LIVB
[	O
27	O
]	O
.	O

Surprisingly	O
,	O
our	O
mutant	S-SO
mice	S-LIVB
shared	O
more	O
similarities	O
with	O
the	O
K14	S-PRGE
-	O
Lef1	S-PRGE
mice	S-LIVB
than	O
the	O
K14	S-PRGE
-	O
Delta	O
N87	O
beta	O
cat	O
transgenic	S-SO
mice	S-LIVB
.	O

For	O
example	O
,	O
the	O
KA	O
mutant	S-SO
mice	S-LIVB
displayed	O
the	O
disoriented	O
and	O
short	O
,	O
curly	O
whiskers	O
seen	O
in	O
K14	S-PRGE
-	O
Lef1but	O
not	O
in	O
K14	S-PRGE
-	O
Delta	O
N87	O
beta	O
cat	O
transgenic	S-SO
mice	S-LIVB
.	O

In	O
addition	O
,	O
KA	O
mutant	S-SO
mice	S-LIVB
displayed	O
a	O
disorganized	O
hair	O
coat	O
beginning	O
with	O
the	O
emergence	O
of	O
neonatal	O
hairs	O
,	O
similar	O
to	O
that	O
observed	O
in	O
K14	S-PRGE
-	O
Lef1	S-PRGE
mice	S-LIVB
,	O
whereas	O
in	O
K14	S-PRGE
-	O
Delta	O
N87	O
beta	O
cat	O
mice	S-LIVB
,	O
embryonic	O
hair	O
follicle	O
morphogenesis	O
was	O
unaffected	O
and	O
other	O
skin	O
changes	O
only	O
emerged	O
postnatally	O
.	O

The	O
reason	O
for	O
this	O
difference	O
could	O
be	O
attributed	O
to	O
one	O
or	O
all	O
of	O
three	O
possible	O
contributing	O
factors	O
.	O

(	O
1	O
)	O
Although	O
the	O
K14	S-PRGE
promoter	S-SO
itself	O
is	O
known	O
to	O
initiate	O
the	O
expression	O
at	O
E9	O
.	O
5	O
and	O
elevated	O
dramatically	O
by	O
E13	O
.	O
5	O
-	O
E14	O
.	O
5	O
[	O
19	O
,	O
31	O
]	O
,	O
many	O
factors	O
could	O
influence	O
the	O
expression	O
of	O
promoter	S-SO
/	O
transgene	S-SO
construct	S-SO
in	O
transgenic	S-SO
mice	S-LIVB
.	O

One	O
of	O
the	O
most	O
important	O
considerations	O
has	O
to	O
do	O
with	O
the	O
integration	B-SO
site	E-SO
of	O
the	O
transgene	S-SO
in	O
the	O
mouse	S-LIVB
genome	S-SO
.	O

Depending	O
on	O
the	O
location	B-SO
of	I-SO
integration	E-SO
,	O
the	O
transcriptional	O
activity	O
of	O
even	O
the	O
same	O
transgene	S-SO
could	O
vary	O
considerably	O
.	O

It	O
is	O
possible	O
that	O
the	O
apparent	O
lack	O
of	O
Delta	O
N87	O
beta	O
cat	O
function	O
in	O
embryogenesis	O
could	O
be	O
due	O
to	O
the	O
delayed	O
or	O
weak	O
expression	O
of	O
the	O
K14	S-PRGE
-	O
Delta	O
N87	O
beta	O
cat	O
transgene	S-SO
compared	O
to	O
the	O
intrinsic	O
promoter	S-SO
.	O

In	O
contrast	O
,	O
Cre	O
-	O
mediated	O
recombination	O
is	O
seen	O
in	O
E13	O
.	O
5	O
skin	O
of	O
K14	S-PRGE
-	O
cre	O
transgenic	S-SO
mice	S-LIVB
used	O
in	O
this	O
study	O
[	O
16	O
]	O
and	O
K14	S-PRGE
-	O
cre	O
-	O
mediated	O
truncation	O
of	O
the	O
Apc	S-PRGE
gene	S-SO
is	O
likely	O
to	O
have	O
occurred	O
by	O
then	O
,	O
in	O
time	O
for	O
the	O
second	O
wave	O
of	O
hair	O
follicle	O
morphgenesis	O
.	O

(	O
2	O
)	O
Another	O
important	O
fact	O
is	O
that	O
in	O
the	O
aforementioned	O
transgenic	S-SO
model	O
the	O
overexpression	O
of	O
transgene	S-SO
is	O
confined	O
to	O
the	O
basal	O
cells	B-CL
of	I-CL
the	I-CL
epidermis	E-CL
and	O
the	O
ORS	O
of	O
hair	O
follicles	O
,	O
where	O
the	O
K14	S-PRGE
promoter	S-SO
is	O
active	O
.	O

The	O
expression	O
of	O
transgene	S-SO
is	O
hence	O
transient	O
and	O
stops	O
once	O
K14	S-PRGE
-	O
expressing	O
cells	S-CL
terminally	O
differentiate	O
.	O

In	O
contrast	O
,	O
in	O
our	O
model	O
,	O
K14	S-PRGE
-	O
cre	O
-	O
mediated	O
deletion	S-SO
of	O
Apc	S-PRGE
would	O
result	O
in	O
Apc	S-PRGE
mutation	S-SO
not	O
only	O
in	O
K14	S-PRGE
promoter	S-SO
active	O
cells	S-CL
,	O
but	O
remain	O
so	O
in	O
all	O
cell	S-CL
layers	O
that	O
derived	O
from	O
the	O
K14	S-PRGE
promoter	S-SO
active	O
progenitors	O
.	O

These	O
derivatives	O
include	O
the	O
suprabasal	O
epidermis	O
and	O
the	O
entire	O
epithelium	O
of	O
the	O
hair	O
follicle	O
.	O

Stabilization	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
a	O
broader	O
population	O
of	O
cells	S-CL
could	O
account	O
for	O
some	O
of	O
the	O
phenotypic	O
differences	O
.	O

However	O
,	O
we	O
did	O
not	O
detect	O
any	O
elevated	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
expression	O
in	O
either	O
K1	S-PRGE
-	O
or	O
K6	S-PRGE
-	O
positive	O
differentiated	O
cells	S-CL
in	O
postnatal	O
mutant	S-SO
skin	O
.	O

This	O
indicates	O
that	O
despite	O
the	O
absence	O
of	O
Apc	S-PRGE
and	O
potential	O
stabilization	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
derivatives	O
of	O
K14	S-PRGE
-	O
expressing	O
progenitors	O
,	O
elevated	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
expression	O
,	O
and	O
subsequent	O
cell	S-CL
fate	O
determination	O
may	O
only	O
take	O
place	O
in	O
basal	B-CL
cells	E-CL
.	O

(	O
3	O
)	O
We	O
cannot	O
exclude	O
the	O
possibility	O
that	O
given	O
the	O
multifunctional	O
properties	O
of	O
Apc	S-PRGE
,	O
disruption	O
of	O
its	O
functions	O
other	O
than	O
down	O
-	O
regulation	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
may	O
also	O
have	O
contributed	O
to	O
the	O
observed	O
overt	O
phenotype	O
.	O

While	O
some	O
features	O
of	O
our	O
mutant	S-SO
mice	S-LIVB
were	O
similar	O
to	O
these	O
transgenic	S-SO
mice	S-LIVB
,	O
other	O
phenotypic	O
aspects	O
were	O
largely	O
distinct	O
.	O

In	O
addition	O
to	O
aberrant	O
hair	O
follicle	O
morphogenesis	O
,	O
K14	S-PRGE
-	O
driven	O
loss	O
of	O
Apc	S-PRGE
caused	O
formation	O
of	O
multiple	O
tooth	O
buds	O
that	O
,	O
like	O
hair	O
follicles	O
,	O
were	O
known	O
to	O
develop	O
through	O
inductive	O
interactions	O
between	O
the	O
epithelium	O
and	O
mesenchyme	O
.	O

This	O
observation	O
was	O
similar	O
to	O
the	O
ectopic	O
tooth	O
buds	O
found	O
in	O
animals	S-LIVB
misexpressing	O
Lef1	S-PRGE
[	O
27	O
]	O
,	O
but	O
more	O
severe	O
and	O
was	O
also	O
present	O
at	O
birth	O
,	O
indicating	O
the	O
effect	O
of	O
Apc	S-PRGE
loss	O
during	O
the	O
initiation	O
of	O
embryonic	O
tooth	O
development	O
,	O
which	O
was	O
evident	O
by	O
aberrant	O
Shh	S-PRGE
expression	O
in	O
E15	O
.	O
5	O
embryonic	O
oral	O
epithelium	O
(	O
unpublished	O
data	O
)	O
.	O

It	O
should	O
be	O
noted	O
that	O
although	O
multiple	O
tooth	O
buds	O
were	O
histologically	O
visible	O
(	O
Figure	O
4O	O
and	O
4P	O
)	O
,	O
these	O
teeth	O
never	O
broke	O
out	O
and	O
the	O
KA	O
mutant	S-SO
mice	S-LIVB
appeared	O
toothless	O
.	O

This	O
unusual	O
severe	O
tooth	O
defect	O
is	O
unique	O
to	O
these	O
mutant	S-SO
mice	S-LIVB
.	O

In	O
addition	O
,	O
neither	O
of	O
the	O
two	O
transgenic	S-SO
mice	S-LIVB
was	O
postnatally	O
lethal	O
as	O
in	O
the	O
KA	O
mutant	S-SO
mice	S-LIVB
.	O

We	O
did	O
not	O
find	O
any	O
obvious	O
histopathological	O
abnormalities	O
in	O
the	O
internal	O
organs	O
of	O
KA	O
mice	S-LIVB
that	O
could	O
contribute	O
to	O
the	O
lethality	O
.	O

However	O
,	O
the	O
fact	O
that	O
all	O
the	O
mutants	S-SO
had	O
lower	O
weight	O
(	O
Figure	O
2F	O
)	O
with	O
hardly	O
any	O
evidence	O
of	O
solid	O
food	S-CHEBI
in	O
their	O
stomach	O
indicates	O
that	O
the	O
mutants	S-SO
might	O
have	O
died	O
of	O
starvation	O
.	O

Dermal	O
fat	O
was	O
reduced	O
in	O
the	O
mutant	S-SO
skin	O
,	O
possibly	O
as	O
a	O
consequence	O
of	O
poor	O
nutrition	O
caused	O
by	O
the	O
absence	O
of	O
teeth	O
.	O

Since	O
the	O
weight	O
loss	O
in	O
KA	O
mutants	S-SO
started	O
from	O
P8	O
-	O
P10	O
while	O
pups	O
were	O
still	O
nursed	O
by	O
their	O
mothers	O
,	O
starvation	O
due	O
to	O
lack	O
of	O
teeth	O
cannot	O
be	O
the	O
sole	O
cause	O
of	O
death	O
,	O
but	O
is	O
likely	O
to	O
be	O
a	O
contributing	O
factor	O
.	O

Absence	O
of	O
teeth	O
and	O
mammary	O
glands	O
have	O
been	O
observed	O
in	O
mice	S-LIVB
deficient	O
in	O
Lef1	S-PRGE
and	O
ectopically	O
expressing	O
Dkk1	S-PRGE
[	O
29	O
,	O
30	O
]	O
but	O
their	O
absence	O
was	O
due	O
to	O
the	O
block	O
in	O
development	O
before	O
the	O
bud	O
stage	O
.	O

Hence	O
,	O
neither	O
loss	O
nor	O
excess	O
of	O
tooth	O
bud	O
formation	O
allows	O
proper	O
development	O
of	O
teeth	O
for	O
mice	S-LIVB
to	O
have	O
a	O
healthy	O
diet	O
and	O
normal	O
life	O
.	O

Mechanistic	O
studies	O
to	O
understand	O
how	O
increased	O
levels	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
leads	O
to	O
altered	O
skin	O
and	O
tooth	O
phenotypes	O
are	O
under	O
way	O
.	O

Apc	S-PRGE
and	O
Thymus	O
Organogenesis	O

In	O
this	O
study	O
,	O
we	O
observed	O
that	O
K14	S-PRGE
-	O
driven	O
loss	O
of	O
Apc	S-PRGE
resulted	O
in	O
a	O
small	O
thymus	O
with	O
severe	O
squamous	O
metaplasia	O
leading	O
to	O
the	O
formation	O
of	O
numerous	O
pyogranuloma	O
and	O
loss	O
of	O
proper	O
meshwork	O
structure	O
for	O
thymocyte	O
maturation	O
,	O
rendering	O
the	O
mice	S-LIVB
athymic	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
in	O
normal	O
adult	O
thymus	O
K14	S-PRGE
expression	O
is	O
found	O
together	O
with	O
K5	S-PRGE
in	O
the	O
stellate	O
medullary	O
TECs	O
,	O
but	O
not	O
in	O
association	O
with	O
K5	S-PRGE
+	O
TECs	O
in	O
the	O
cortex	O
or	O
at	O
the	O
cortico	O
-	O
medullary	O
junction	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
K14	S-PRGE
+	O
TECs	O
do	O
not	O
coexpress	O
K8	S-PRGE
;	O
hence	O
,	O
there	O
are	O
two	O
distinct	O
medullary	O
subsets	O
,	O
namely	O
a	O
K8	S-PRGE
-	O
K14	S-PRGE
+	O
stellate	O
subset	O
and	O
a	O
K8	S-PRGE
+	O
K14	S-PRGE
-	O
globular	O
subset	O
[	O
32	O
]	O
.	O

In	O
agreement	O
with	O
the	O
previous	O
results	O
,	O
in	O
P3	O
normal	O
thymus	O
K14	S-PRGE
expression	O
was	O
restricted	O
to	O
stellate	O
medullary	O
TECs	O
(	O
Figure	O
6D	O
)	O
,	O
whereas	O
K8	S-PRGE
expression	O
was	O
found	O
throughout	O
the	O
TECs	O
(	O
unpublished	O
data	O
)	O
.	O

We	O
could	O
not	O
clarify	O
whether	O
these	O
two	O
keratins	O
were	O
coexpressed	O
in	O
the	O
same	O
TECs	O
without	O
double	O
-	O
staining	O
.	O

There	O
were	O
individual	O
differences	O
among	O
mutants	S-SO
and	O
these	O
were	O
prominently	O
reflected	O
in	O
the	O
histological	O
abnormalities	O
of	O
the	O
thymus	O
at	O
P3	O
,	O
but	O
as	O
the	O
older	O
surviving	O
mutants	S-SO
all	O
showed	O
the	O
same	O
histopathologies	O
of	O
the	O
thymus	O
,	O
the	O
mutant	S-SO
thymi	O
eventually	O
seem	O
to	O
result	O
in	O
the	O
same	O
fate	O
.	O

It	O
is	O
unclear	O
when	O
K14	S-PRGE
-	O
cre	O
induction	O
actually	O
takes	O
place	O
in	O
the	O
mutant	S-SO
thymus	O
,	O
but	O
as	O
the	O
population	O
of	O
cells	S-CL
showing	O
a	O
strong	O
nuclear	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
staining	O
as	O
well	O
as	O
the	O
cells	S-CL
expressing	O
K14	S-PRGE
were	O
small	O
and	O
thymic	O
epithelial	O
compartments	O
still	O
existed	O
in	O
a	O
mild	O
P3	O
mutant	S-SO
thymus	O
(	O
Figure	O
6E	O
and	O
6F	O
)	O
,	O
it	O
seems	O
that	O
initial	O
differentiation	O
to	O
medullary	O
and	O
cortical	O
TECs	O
and	O
thymocyte	O
colonization	O
have	O
already	O
taken	O
place	O
prior	O
to	O
the	O
major	O
effects	O
of	O
K14	S-PRGE
-	O
driven	O
Apc	S-PRGE
loss	O
.	O

However	O
,	O
cells	S-CL
with	O
nuclear	S-GO
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
and	O
K8	S-PRGE
+	O
K14	S-PRGE
+	O
double	O
-	O
positive	O
epithelial	B-CL
cells	E-CL
increased	O
subsequently	O
,	O
associated	O
with	O
active	O
proliferation	O
in	O
the	O
latter	O
group	O
of	O
cells	S-CL
and	O
loss	O
of	O
TEC	O
compartments	O
.	O

With	O
age	O
,	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
expression	O
pattern	O
became	O
more	O
diffuse	O
and	O
fewer	O
epithelial	B-CL
cells	E-CL
showed	O
nuclear	S-GO
localization	O
but	O
K8	S-PRGE
+	O
K14	S-PRGE
+	O
cells	S-CL
remained	O
,	O
forming	O
concentric	O
structures	O
of	O
epithelial	B-CL
cells	E-CL
filled	O
with	O
hard	O
keratin	O
deposits	O
and	O
infiltrated	O
with	O
vast	O
number	O
of	O
neutrophils	S-CL
and	O
macrophages	S-CL
.	O

Only	O
a	O
few	O
epithelial	B-CL
cells	E-CL
were	O
dividing	O
and	O
hardly	O
any	O
thymocytes	O
were	O
present	O
by	O
this	O
time	O
.	O

These	O
results	O
suggest	O
that	O
with	O
the	O
deletion	S-SO
of	O
Apc	S-PRGE
in	O
TECs	O
,	O
stabililization	O
and	O
nuclear	S-GO
localization	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
took	O
place	O
and	O
subsequently	O
these	O
cells	S-CL
differentiated	O
into	O
keratinocytes	S-CL
that	O
expressed	O
both	O
K14	S-PRGE
and	O
K8	S-PRGE
,	O
similar	O
to	O
the	O
basal	B-CL
cells	E-CL
of	O
the	O
skin	O
,	O
instead	O
of	O
TEC	O
subsets	O
.	O

The	O
expansion	O
and	O
differentiation	O
of	O
these	O
keratinocytes	S-CL
lead	O
to	O
loss	O
of	O
proper	O
thymic	O
epithelial	O
compartments	O
and	O
in	O
turn	O
produced	O
and	O
deposited	O
the	O
hard	O
keratins	O
that	O
consequently	O
caused	O
vast	O
amount	O
of	O
neutrophils	S-CL
and	O
macrophages	S-CL
to	O
infiltrate	O
the	O
thymus	O
.	O

These	O
aberrant	O
epithelial	O
structures	O
eventually	O
have	O
overtaken	O
the	O
whole	O
of	O
the	O
thymus	O
and	O
driven	O
out	O
the	O
colonized	O
thymocytes	O
.	O

K14	S-PRGE
-	O
driven	O
loss	O
of	O
Apc	S-PRGE
and	O
subsequent	O
constitutive	O
expression	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
TECs	O
have	O
therefore	O
misdirected	O
them	O
to	O
wrong	O
epithelial	B-CL
cell	E-CL
fate	O
,	O
not	O
allowing	O
proper	O
differentiation	O
to	O
either	O
cortical	O
or	O
medullary	O
TECs	O
,	O
which	O
is	O
essential	O
for	O
normal	O
thymocyte	O
development	O
.	O

This	O
is	O
not	O
only	O
evident	O
from	O
the	O
lack	O
of	O
dividing	O
thymocytes	O
in	O
the	O
mutant	S-SO
thymus	O
by	O
P13	O
,	O
but	O
also	O
by	O
the	O
differential	O
expression	O
pattern	O
of	O
keratins	O
,	O
which	O
were	O
more	O
skin	O
-	O
like	O
than	O
TEC	O
-	O
like	O
.	O

The	O
importance	O
of	O
Apc	S-PRGE
function	O
in	O
thymic	O
development	O
has	O
been	O
demonstrated	O
by	O
thymocyte	O
-	O
specific	O
loss	O
of	O
Apc	S-PRGE
by	O
crossing	O
a	O
different	O
strain	O
of	O
Apc	S-PRGE
conditional	O
mice	S-LIVB
and	O
LckCre	O
transgenic	S-SO
mice	S-LIVB
[	O
33	O
]	O
.	O

Here	O
,	O
by	O
K14	S-PRGE
-	O
driven	O
TEC	O
-	O
specific	O
loss	O
of	O
Apc	S-PRGE
,	O
we	O
have	O
demonstrated	O
its	O
importance	O
in	O
thymus	O
development	O
not	O
only	O
in	O
thymocytes	O
but	O
also	O
in	O
TECs	O
.	O

It	O
is	O
of	O
interest	O
that	O
dental	O
abnormalities	O
,	O
such	O
as	O
supernumerary	O
and	O
impacted	O
teeth	O
similar	O
to	O
those	O
observed	O
in	O
our	O
mutant	S-SO
mice	S-LIVB
,	O
are	O
frequently	O
seen	O
in	O
patients	O
with	O
Gardner	O
'	O
s	O
syndrome	O
,	O
carriers	O
of	O
APC	S-PRGE
germline	O
mutation	S-SO
[	O
6	O
]	O
.	O

The	O
importance	O
of	O
odonto	O
-	O
stomatological	O
examinations	O
should	O
hence	O
be	O
pointed	O
out	O
as	O
a	O
means	O
of	O
reaching	O
a	O
presumptive	O
diagnosis	O
,	O
whose	O
confirmation	O
is	O
vital	O
to	O
the	O
patient	O
.	O

Further	O
characterization	O
of	O
the	O
mechanism	O
of	O
such	O
developmental	O
defects	O
using	O
our	O
mouse	S-LIVB
model	O
should	O
provide	O
important	O
insights	O
into	O
Apc	S-PRGE
function	O
in	O
multiple	O
organ	O
systems	O
and	O
to	O
give	O
better	O
insights	O
into	O
potential	O
adverse	O
events	O
in	O
human	S-LIVB
subjects	O
.	O

In	O
conclusion	O
,	O
we	O
have	O
shown	O
that	O
loss	O
of	O
Apc	S-PRGE
in	O
K14	S-PRGE
-	O
expressing	O
embryonic	O
cells	S-CL
causes	O
aberrant	O
morphogenesis	O
in	O
various	O
skin	O
appendages	O
,	O
including	O
hair	O
follicles	O
and	O
teeth	O
,	O
and	O
abnormal	O
thymus	O
organogensis	O
.	O

Our	O
results	O
provide	O
genetic	S-SO
evidence	O
that	O
expression	O
of	O
Apc	S-PRGE
is	O
essential	O
for	O
regulation	O
of	O
proper	O
cell	S-CL
fates	O
in	O
these	O
organs	O
that	O
require	O
epithelial	O
-	O
mesenchymal	O
interactions	O
.	O

Materials	O
and	O
Methods	O

Construction	O
of	O
targeting	O
vectors	S-SO
.	O

To	O
target	O
the	O
Apc	S-PRGE
locus	S-SO
,	O
we	O
obtained	O
BAC	S-SO
clone	S-SO
RP23	O
-	O
233F17	O
that	O
contains	O
all	O
the	O
sequence	S-SO
of	O
Apc	S-PRGE
except	O
for	O
the	O
5	B-SO
'	I-SO
UTR	E-SO
and	O
exon	S-SO
1	O
.	O

Using	O
a	O
recombineering	O
-	O
based	O
method	O
for	O
generating	O
conditional	O
mutations	S-SO
[	O
12	O
,	O
13	O
]	O
,	O
subcloning	O
of	O
BAC	S-SO
and	O
further	O
modifications	S-SO
were	O
conducted	O
.	O

The	O
genomic	B-SO
sequence	E-SO
encompassing	O
Apc	S-PRGE
exons	S-SO
11	O
to	O
15	O
was	O
first	O
subcloned	O
into	O
pBR322	O
vector	S-SO
,	O
and	O
then	O
a	O
loxP	B-SO
site	E-SO
was	O
introduced	S-SO
into	O
intron	S-SO
13	O
followed	O
by	O
loxP	S-SO
-	O
FRT	S-SO
-	O
PGKneor	O
-	O
FRT	S-SO
selection	O
cassette	S-SO
into	O
intron14	O
of	O
the	O
Apc	S-PRGE
gene	S-SO
(	O
Figure	O
1A	O
)	O
.	O

Generation	O
of	O
ApcCKO	O
ES	O
cells	S-CL
and	O
mice	S-LIVB
.	O

The	O
linearized	O
targeting	O
vectors	S-SO
were	O
electroporated	O
into	O
129	O
/	O
S	O
-	O
derived	O
ES	O
cells	S-CL
,	O
WW6	O
cells	S-CL
[	O
15	O
]	O
.	O

All	O
candidate	O
G418	O
-	O
resistant	O
ES	O
clones	O
were	O
screened	O
by	O
long	O
-	O
range	O
gene	S-SO
-	O
specific	O
PCR	O
using	O
Expand	O
Long	O
Template	O
PCR	O
System	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
,	O
followed	O
by	O
sequencing	O
to	O
validate	O
the	O
correct	O
insertion	S-SO
of	O
the	O
single	O
loxP	B-SO
site	E-SO
and	O
the	O
selection	O
cassette	S-SO
.	O

Two	O
ES	O
clones	O
with	O
correct	O
ApcCKON	O
/	O
+	S-SO
modification	S-SO
were	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
,	O
after	O
which	O
chimeric	O
mice	S-LIVB
with	O
high	O
levels	O
of	O
ES	O
cell	S-CL
contribution	O
were	O
backcrossed	O
to	O
C57BL	O
/	O
6J	O
females	O
to	O
produce	O
heterozygous	O
F1	O
offspring	O
.	O

The	O
genomic	B-SO
DNA	E-SO
samples	O
obtained	O
from	O
the	O
tail	O
of	O
F1	O
offspring	O
were	O
subsequently	O
analyzed	O
by	O
Southern	O
blot	O
analysis	O
to	O
further	O
confirm	O
the	O
correct	O
homologous	O
recombination	O
.	O

By	O
crossing	O
the	O
heterozygous	O
mice	S-LIVB
to	O
FLPe	O
deleter	O
mice	S-LIVB
[	O
34	O
]	O
,	O
PGKneor	O
cassette	S-SO
was	O
deleted	S-SO
in	O
the	O
germline	O
by	O
FRT	S-SO
-	O
mediated	O
recombination	O
to	O
generate	O
mice	S-LIVB
with	O
the	O
final	O
ApcCKO	O
allele	S-SO
.	O

ApcCKO	O
heterozygous	O
mice	S-LIVB
were	O
crossed	O
together	O
to	O
generate	O
homozygous	O
mice	S-LIVB
,	O
and	O
the	O
homozygous	O
offspring	O
were	O
interbred	O
for	O
maintenance	O
.	O

Generation	O
of	O
Apc	O
Delta	O
580	O
mice	S-LIVB
.	O

ApcCKO	O
heterozygote	O
mice	S-LIVB
were	O
crossed	O
with	O
Cre	O
deleter	O
mice	S-LIVB
,	O
EIIA	O
-	O
cre	O
transgenic	S-SO
mice	S-LIVB
that	O
express	O
Cre	O
in	O
early	O
embryo	O
[	O
35	O
]	O
,	O
to	O
knockout	O
the	O
Apc	S-PRGE
allele	S-SO
in	O
the	O
germline	O
,	O
consequently	O
creating	O
a	O
knockout	O
strain	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
resultant	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
mice	S-LIVB
were	O
maintained	O
by	O
backcrossing	O
to	O
C57BL	O
/	O
6J	O
females	O
.	O

Generation	O
of	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
mice	S-LIVB
.	O

The	O
mice	S-LIVB
analyzed	O
in	O
this	O
study	O
were	O
generated	O
by	O
crossing	O
ApcCKO	O
heterozygote	O
mice	S-LIVB
of	O
the	O
F1	O
generation	O
(	O
C57BL	O
/	O
6J	O
x	O
129	O
/	O
S	O
background	O
)	O
with	O
K14	S-PRGE
-	O
cre	O
transgenic	S-SO
mice	S-LIVB
(	O
FVB	O
background	O
)	O
.	O

K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
+	S-SO
male	O
mice	S-LIVB
thus	O
generated	O
were	O
then	O
crossed	O
with	O
ApcCKO	O
/	O
CKO	O
females	O
to	O
generate	O
homozygous	O
and	O
heterozygous	O
ApcCKO	O
offspring	O
either	O
with	O
or	O
without	O
K14	S-PRGE
-	O
cre	O
.	O

The	O
mice	S-LIVB
were	O
intercrossed	O
thereafter	O
for	O
maintenance	O
.	O

Genotyping	O
of	O
mice	S-LIVB
.	O

Genomic	B-SO
DNA	E-SO
from	O
tips	O
of	O
mouse	S-LIVB
tails	O
obtained	O
at	O
~	O
10	O
d	O
of	O
age	O
was	O
genotyped	O
in	O
a	O
single	O
PCR	O
reaction	O
with	O
the	O
following	O
primers	S-SO
:	O
Apc	S-PRGE
-	O
Int13F2	O
(	O
GAGAAACCCTGTCTCGAAAAAA	O
)	O
and	O
Apc	S-PRGE
-	O
Int13R2	O
(	O
AGTGCTGTTTCTATGAGTCAAC	O
)	O
,	O
resulting	O
in	O
320	O
-	O
bp	S-SO
and	O
430	O
-	O
bp	S-SO
products	S-SO
from	O
the	O
wild	B-SO
-	I-SO
type	E-SO
and	O
conditional	O
ApcCKO	O
allele	S-SO
,	O
respectively	O
.	O

For	O
the	O
detection	O
of	O
Cre	O
-	O
mediated	O
deleted	S-SO
Apc	S-PRGE
allele	S-SO
,	O
Apc	O
Delta	O
580	O
,	O
the	O
primer	S-SO
Apc	S-PRGE
-	O
Int14R4	O
(	O
TTGGCAGACTGTGTATATAAGC	O
)	O
in	O
combination	O
with	O
Apc	S-PRGE
-	O
Int13F2	O
resulted	O
in	O
500	O
-	O
bp	S-SO
product	S-SO
.	O

Primers	S-SO
Cre	O
-	O
F1	O
(	O
TCCAATTTACTGACCGTACACC	O
)	O
and	O
Cre	O
-	O
R1	O
(	O
CCGACGATGAAGCATGTTTAG	O
)	O
were	O
used	O
for	O
detection	O
of	O
cre	O
transgene	S-SO
in	O
the	O
germline	O
,	O
resulting	O
in	O
300	O
-	O
bp	S-SO
products	S-SO
.	O

Amplification	O
was	O
performed	O
in	O
a	O
25	O
-	O
mu	O
l	O
volume	O
containing	O
15	O
mM	O
Tris	S-CHEBI
-	O
HCl	S-CHEBI
(	O
pH	O
8	O
.	O
3	O
)	O
,	O
50	O
mM	O
KCl	S-CHEBI
,	O
2	O
.	O
5	O
mM	O
MgCl2	S-CHEBI
,	O
0	O
.	O
2	O
mM	O
dNTP	S-CHEBI
,	O
0	O
.	O
2	O
mu	O
M	O
of	O
each	O
primer	S-SO
,	O
and	O
1	O
.	O
25	O
U	O
of	O
AmpliTaq	O
Gold	S-CHEBI
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
reactions	O
were	O
heated	O
for	O
10	O
min	O
at	O
94	O
degrees	O
C	O
to	O
heat	O
-	O
activate	O
the	O
enzyme	S-SO
followed	O
by	O
30	O
PCR	O
cycles	O
at	O
94	O
degrees	O
C	O
for	O
30	O
s	O
,	O
58	O
degrees	O
C	O
for	O
30	O
s	O
,	O
and	O
72	O
degrees	O
C	O
for	O
45	O
s	O
,	O
followed	O
by	O
the	O
final	O
extension	O
for	O
5	O
min	O
at	O
72	O
degrees	O
C	O
.	O

Skin	O
permeability	O
assay	O
.	O

Unfixed	O
and	O
freshly	O
isolated	O
E18	O
.	O
5	O
embryos	O
were	O
rinsed	O
in	O
PBS	O
and	O
then	O
submerged	O
in	O
X	O
-	O
gal	O
reaction	O
mix	O
at	O
pH	O
4	O
.	O
5	O
(	O
100	O
mM	O
NaPO4	S-CHEBI
,	O
1	O
.	O
3	O
mM	O
MgCl2	S-CHEBI
,	O
3	O
mM	O
K3Fe	B-CHEBI
(	I-CHEBI
CN	I-CHEBI
)	I-CHEBI
6	E-CHEBI
,	O
3	O
mM	O
K4Fe	B-CHEBI
(	I-CHEBI
CN	I-CHEBI
)	I-CHEBI
6	E-CHEBI
,	O
and	O
1	O
mg	O
/	O
ml	O
X	O
-	O
gal	O
)	O
at	O
room	O
temperature	O
overnight	O
[	O
36	O
]	O
.	O

At	O
this	O
pH	O
in	O
the	O
absence	O
of	O
epidermal	O
barrier	O
,	O
the	O
solution	O
penetrates	O
epidermis	O
and	O
an	O
endogenous	O
beta	O
-	O
galactosidase	O
-	O
like	O
activity	O
catalyzes	O
production	O
of	O
a	O
blue	O
precipitate	O
.	O

After	O
staining	O
,	O
embryos	O
were	O
washed	O
twice	O
in	O
PBS	O
,	O
fixed	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
and	O
were	O
photographed	O
using	O
a	O
35	O
mm	O
Nikon	O
digital	O
camera	O
.	O

Skeletal	O
preparations	O
.	O

The	O
skinned	O
and	O
eviscerated	O
bodies	O
of	O
the	O
oldest	O
surviving	O
KA	O
mutants	S-SO
(	O
P16	O
-	O
P17	O
)	O
and	O
their	O
age	O
-	O
matched	O
littermates	O
were	O
placed	O
into	O
1	O
%	O
potassium	B-CHEBI
hydroxide	E-CHEBI
(	O
KOH	S-CHEBI
)	O
for	O
5	O
d	O
.	O

The	O
bodies	O
were	O
transferred	O
into	O
a	O
fresh	O
solution	O
of	O
1	O
%	O
KOH	S-CHEBI
containing	O
a	O
few	O
drops	O
of	O
0	O
.	O
5	O
%	O
alizarin	B-CHEBI
red	E-CHEBI
S	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
and	O
left	O
for	O
another	O
5	O
d	O
.	O

The	O
stained	O
bodies	O
were	O
stored	O
in	O
glycerin	O
and	O
viewed	O
under	O
a	O
dissection	O
microscope	O
.	O

Analysis	O
for	O
tissue	O
-	O
specific	O
recombination	O
.	O

Genotype	S-SO
/	O
tissue	O
-	O
specific	O
recombination	O
of	O
the	O
conditional	O
allele	S-SO
was	O
examined	O
by	O
both	O
PCR	O
and	O
RT	O
-	O
PCR	O
.	O

DNA	S-SO
samples	O
extracted	O
from	O
various	O
tissues	O
collected	O
at	O
the	O
time	O
of	O
autopsy	O
were	O
examined	O
by	O
genotyping	O
PCR	O
as	O
described	O
.	O

RNA	S-SO
extracted	O
from	O
various	O
tissue	O
homogenates	O
in	O
Trizol	O
reagent	S-CHEBI
were	O
examined	O
for	O
expression	O
of	O
wild	B-SO
-	I-SO
type	E-SO
and	O
truncated	O
Apc	S-PRGE
alleles	S-SO
by	O
SuperScript	O
One	O
-	O
Step	O
RT	O
-	O
PCR	O
with	O
Platinum	S-CHEBI
Taq	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
following	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Approximately	O
200	O
ng	O
of	O
total	O
RNA	S-SO
from	O
either	O
skin	O
,	O
liver	O
,	O
or	O
thymus	O
from	O
each	O
genotype	S-SO
was	O
reverse	O
-	O
transcribed	O
using	O
primers	S-SO
Apc	S-PRGE
-	O
F546	O
(	O
TGAGGAATTTGTCTTGGCGAG	O
)	O
and	O
Apc	S-PRGE
-	O
R721	O
(	O
GCACTTCCCATGGCAATCATT	O
)	O
,	O
resulting	O
in	O
528	O
-	O
bp	S-SO
and	O
313	O
-	O
bp	S-SO
products	S-SO
from	O
the	O
wild	B-SO
-	I-SO
type	E-SO
/	O
ApcCKO	O
alleles	S-SO
and	O
Apc	O
Delta	O
580	O
allele	S-SO
,	O
respectively	O
.	O

BrdU	O
labeling	O
.	O

Mice	S-LIVB
were	O
injected	O
intraperitoneally	O
with	O
approximately	O
50	O
mu	O
g	O
/	O
g	O
body	O
weight	O
of	O
BrdU	O
(	O
Sigma	O
)	O
dissolved	O
in	O
PBS	O
2	O
h	O
before	O
their	O
death	O
.	O

Tissue	O
samples	O
were	O
fixed	O
in	O
Bouin	O
'	O
s	O
and	O
processed	O
as	O
described	O
below	O
.	O

Histological	O
and	O
immunochemical	O
analysis	O
.	O

Mutant	S-SO
mice	S-LIVB
and	O
age	O
-	O
matching	O
littermates	O
were	O
humanely	O
killed	O
at	O
various	O
ages	O
by	O
CO2	S-CHEBI
inhalation	O
.	O

Mice	S-LIVB
were	O
skinned	O
and	O
pieces	O
of	O
skin	O
were	O
either	O
snap	O
-	O
frozen	O
in	O
liquid	O
nitrogen	S-CHEBI
or	O
immediately	O
homogenized	O
in	O
Trizol	O
reagent	S-CHEBI
and	O
stored	O
at	O
-	O
80	O
degrees	O
C	O
until	O
molecular	S-CHEBI
analysis	O
,	O
or	O
fixed	O
flat	O
on	O
a	O
piece	O
of	O
paper	O
towel	O
in	O
Bouin	O
'	O
s	O
solution	O
for	O
histological	O
and	O
immunohistochemical	O
examinations	O
.	O

The	O
mice	S-LIVB
were	O
then	O
dissected	O
for	O
gross	O
examination	O
,	O
various	O
tissues	O
were	O
similarly	O
collected	O
for	O
future	O
molecular	S-CHEBI
analyses	O
,	O
and	O
then	O
the	O
whole	O
body	O
was	O
fixed	O
in	O
Bouin	O
'	O
s	O
solution	O
.	O

The	O
samples	O
were	O
then	O
submitted	O
to	O
Rodent	S-LIVB
Histopathological	O
Core	O
for	O
processing	O
and	O
histopathological	O
examinations	O
.	O

For	O
immunohistochemistry	O
,	O
5	O
-	O
mu	O
m	O
paraffin	O
-	O
embedded	O
tissue	O
sections	O
were	O
deparafinized	O
in	O
xylene	S-CHEBI
,	O
followed	O
by	O
alcohol	S-CHEBI
rehydration	O
.	O

After	O
quenching	O
endogenous	O
peroxidases	O
in	O
3	O
%	O
H2O2	S-CHEBI
in	O
methanol	S-CHEBI
,	O
the	O
slides	O
were	O
rinsed	O
in	O
distilled	O
water	S-CHEBI
,	O
and	O
an	O
antigen	O
retrieval	O
step	O
was	O
carried	O
out	O
in	O
a	O
microwave	O
oven	O
for	O
a	O
total	O
of	O
10	O
min	O
in	O
preheated	O
citrate	S-CHEBI
buffer	O
(	O
pH	O
6	O
.	O
0	O
)	O
.	O

The	O
slides	O
were	O
then	O
incubated	O
with	O
primary	O
antibodies	S-GO
at	O
room	O
temperature	O
overnight	O
.	O

Antibodies	S-GO
used	O
were	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
(	O
BD	O
Transduction	O
Lab	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
keratins	B-PRGE
1	I-PRGE
,	I-PRGE
5	I-PRGE
,	I-PRGE
6	I-PRGE
,	I-PRGE
14	E-PRGE
,	O
involucrin	S-PRGE
,	O
loricrin	S-PRGE
(	O
Covance	O
,	O
Berkeley	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
keratin	B-PRGE
8	E-PRGE
(	O
Abcam	O
,	O
Cambridge	O
,	O
United	O
Kingdom	O
)	O
,	O
Ki67	S-PRGE
(	O
Vector	O
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
BrdU	O
(	O
Roche	O
)	O
.	O

Biotinylated	O
secondary	O
antibodies	S-GO
(	O
donkey	S-LIVB
anti	O
-	O
rabbit	S-LIVB
and	O
goat	S-LIVB
anti	O
-	O
mouse	S-LIVB
IgG	O
,	O
1	O
:	O
250	O
;	O
Jackson	O
ImmunoResearch	O
,	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
,	O
followed	O
by	O
the	O
Vectastain	O
Elite	O
ABC	O
kit	O
(	O
Vector	O
Laboratories	O
)	O
were	O
used	O
for	O
detection	O
.	O

The	O
slides	O
were	O
stained	O
with	O
DAB	O
and	O
counterstained	O
with	O
Mayer	O
'	O
s	O
hematoxylin	O
.	O

In	O
situ	O
hybridization	O
.	O

Section	O
ISH	O
using	O
rat	B-PRGE
Shh	E-PRGE
probe	S-SO
[	O
37	O
]	O
and	O
whole	O
-	O
mount	O
ISH	O
using	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
probe	S-SO
[	O
38	O
]	O
were	O
performed	O
as	O
previously	O
described	O
[	O
39	O
,	O
40	O
]	O
.	O

Riboprobes	O
labeled	O
with	O
DIG	O
were	O
detected	O
with	O
BM	O
purple	O
AP	O
substrate	O
precipitation	O
solution	O
(	O
Roche	O
)	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Multiple	O
Intestinal	O
Neoplasia	O
in	O
Apc	O
Delta	O
580	O
Mice	S-LIVB

(	O
A	O
)	O
A	O
representative	O
appearance	O
of	O
small	O
intestine	O
of	O
4	O
-	O
month	O
-	O
old	O
mouse	S-LIVB
.	O

Scale	O
bar	O
,	O
1	O
.	O
5	O
mm	O
.	O

(	O
B	O
)	O
Histological	O
analysis	O
of	O
longitudinal	O
section	O
of	O
small	O
intestine	O
shown	O
in	O
(	O
A	O
)	O
by	O
H	O
&	O
E	O
staining	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
.	O

(	O
C	O
)	O
The	O
typical	O
histopathological	O
appearance	O
of	O
an	O
adenoma	O
shown	O
in	O
(	O
B	O
)	O
.	O

Scale	O
bar	O
,	O
20	O
mu	O
m	O
.	O

(	O
621	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Skin	O
Permeability	O
Assay	O
and	O
Neonatal	O
Mice	S-LIVB

(	O
A	O
)	O
Skin	O
permeability	O
assay	O
of	O
E18	O
.	O
5	O
embryos	O
.	O

Both	O
normal	O
(	O
N	O
)	O
and	O
KA	O
mutant	S-SO
(	O
M	S-SO
)	O
embryos	O
can	O
exclude	O
the	O
blue	O
dye	S-CHEBI
at	O
this	O
age	O
,	O
showing	O
no	O
defects	O
in	O
skin	O
barrier	O
function	O
.	O

Note	O
slight	O
pigmentations	O
in	O
pinnnae	O
and	O
"	O
birthmark	O
"	O
in	O
the	O
forehead	O
of	O
mutant	S-SO
embryo	O
(	O
B	O
)	O
,	O
which	O
are	O
present	O
at	O
P1	O
(	O
C	O
)	O
,	O
and	O
become	O
prominent	O
as	O
they	O
grow	O
.	O

(	O
749	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Immunochemical	O
Examination	O
of	O
P13	O
Normal	O
and	O
Mutant	S-SO
Thymi	O

(	O
A	O
-	O
E	O
)	O
P13	O
normal	O
thymus	O
.	O

(	O
F	O
-	O
K	O
)	O
P13	O
mutant	S-SO
thymus	O
.	O

Stained	O
with	O
K8	S-PRGE
(	O
A	O
)	O
,	O
(	O
D	O
)	O
,	O
(	O
F	O
)	O
,	O
(	O
I	O
)	O
,	O
K1	S-PRGE
(	O
B	O
)	O
,	O
(	O
E	O
)	O
,	O
(	O
G	O
)	O
,	O
(	O
J	O
)	O
,	O
and	O
involucrin	S-PRGE
(	O
C	O
)	O
,	O
(	O
H	O
)	O
,	O
(	O
K	O
)	O
.	O

Scale	O
bars	O
,	O
100	O
mu	O
m	O
for	O
(	O
A	O
-	O
C	O
)	O
,	O
(	O
F	O
-	O
H	O
)	O
,	O
(	O
J	O
-	O
K	O
)	O
and	O
20	O
mu	O
m	O
for	O
(	O
D	O
-	O
E	O
)	O
,	O
(	O
I	O
)	O
.	O

Note	O
the	O
lack	O
of	O
involucrin	S-PRGE
staining	O
in	O
normal	O
thymus	O
but	O
varying	O
degree	O
of	O
positive	O
cells	S-CL
in	O
mutant	S-SO
thymus	O
.	O

(	O
6	O
.	O
4	O
MB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
GenBank	O
(	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
)	O
accession	O
numbers	O
for	O
the	O
genes	S-SO
and	O
gene	S-SO
products	O
discussed	O
in	O
this	O
paper	O
are	O
Apc	S-PRGE
(	O
NM	O
_	O
007462	O
)	O
,	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
(	O
NM	O
_	O
007614	O
)	O
,	O
AXIN	B-PRGE
2	E-PRGE
(	O
NM	O
_	O
004655	O
)	O
,	O
plakoglobin	S-PRGE
(	O
NM	O
_	O
002230	O
)	O
,	O
Asef	S-PRGE
(	O
NM	O
_	O
015320	O
)	O
,	O
kinesin	B-PRGE
superfamily	I-PRGE
-	I-PRGE
associated	I-PRGE
protein	I-PRGE
3	E-PRGE
(	O
NM	O
_	O
014970	O
)	O
,	O
EB1	S-PRGE
(	O
NM	O
_	O
012325	O
)	O
,	O
human	B-PRGE
homolog	I-PRGE
of	I-PRGE
Drosophila	I-PRGE
Discs	I-PRGE
large	E-PRGE
(	O
U13897	O
)	O
,	O
Lef1	S-PRGE
(	O
NM	O
_	O
010703	O
)	O
,	O
Dkk1	S-PRGE
(	O
NM	O
_	O
010051	O
)	O
,	O
K1	S-PRGE
(	O
NM	O
_	O
008473	O
)	O
,	O
K5	S-PRGE
(	O
NM	O
_	O
027011	O
)	O
,	O
K6	S-PRGE
(	O
NM	O
_	O
008476	O
)	O
,	O
K8	S-PRGE
(	O
NM	O
_	O
031170	O
)	O
,	O
K14	S-PRGE
(	O
NM	O
_	O
016958	O
)	O
,	O
involucrin	S-PRGE
(	O
NM	O
_	O
008412	O
)	O
,	O
loricrin	S-PRGE
(	O
NM	O
_	O
008508	O
)	O
,	O
and	O
Shh	S-PRGE
(	O
NM	O
_	O
009170	O
)	O
.	O

Abbreviations	O

APC	S-PRGE
-	O
adenomatous	B-PRGE
polyposis	I-PRGE
coli	E-PRGE

CKO	O
-	O
conditional	O
knockout	O

E	O
-	O
embryonic	O
day	O

ES	O
-	O
embryonic	O
stem	O

FAP	O
-	O
familial	O
adenomatous	O
polyposis	O

FRT	S-SO
-	O
FLP	B-SO
recognition	I-SO
target	E-SO

ISH	O
-	O
in	O
situ	O
hybridization	O

K14	S-PRGE
-	O
keratin	B-PRGE
14	E-PRGE

ORS	O
-	O
outer	O
root	O
sheath	O

P	O
-	O
postnatal	O
day	O

TEC	O
-	O
thymic	O
epithelial	B-CL
cell	E-CL

Figures	O
and	O
Tables	O

Figure	O
1	O

Generation	O
of	O
the	O
Conditional	O
Apc	S-PRGE
Allele	S-SO

(	O
A	O
)	O
Schematic	O
diagram	O
of	O
exons	S-SO
14	O
and	O
15	O
of	O
the	O
mouse	B-PRGE
Apc	E-PRGE
gene	S-SO
,	O
the	O
targeting	O
vector	S-SO
,	O
and	O
the	O
resulting	O
conditional	O
allele	S-SO
with	O
2	O
LoxP	B-SO
sites	E-SO
sandwiching	O
the	O
exon	S-SO
14	O
.	O

The	O
PGK	O
-	O
neomycin	O
cassette	S-SO
was	O
inserted	S-SO
within	O
intron	S-SO
14	O
by	O
recombineering	O
technique	O
.	O

This	O
cassette	S-SO
is	O
sandwiched	S-SO
by	O
2	O
FRT	B-SO
sites	E-SO
that	O
could	O
be	O
removed	S-SO
by	O
crossing	O
to	O
FLPe	O
-	O
expressing	O
mice	S-LIVB
.	O

Positions	S-SO
of	O
PCR	O
primers	S-SO
used	O
for	O
genotyping	O
PCR	O
(	O
F2	O
,	O
R2	O
,	O
R4	O
)	O
and	O
RT	O
-	O
PCR	O
(	O
F546	O
and	O
R721	O
)	O
are	O
indicated	O
.	O

Positions	S-SO
of	O
probe	S-SO
used	O
for	O
Southern	O
blot	O
analysis	O
with	O
NdeI	O
sites	S-SO
are	O
also	O
shown	O
.	O

Upon	O
Cre	O
-	O
mediated	O
recombination	O
,	O
exon	S-SO
14	O
is	O
removed	S-SO
and	O
leads	O
to	O
truncated	O
Apc	S-PRGE
protein	S-CHEBI
,	O
of	O
which	O
the	O
first	O
580	O
aa	S-CHEBI
correspond	O
to	O
the	O
normal	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
NdeI	O
-	O
digested	O
genomic	B-SO
tail	I-SO
DNA	E-SO
isolated	O
from	O
F1	O
mice	S-LIVB
of	O
various	O
Apc	S-PRGE
mouse	S-LIVB
lines	O
(	O
ApcCKON	O
,	O
Apc	O
Delta	O
580	O
)	O
,	O
hybridized	O
to	O
a	O
600	O
-	O
bp	S-SO
probe	S-SO
.	O

Tail	O
genomic	B-SO
DNA	E-SO
from	O
ApcCKON	O
F1	O
mice	S-LIVB
derived	O
from	O
a	O
modified	S-SO
ES	O
clone	O
showed	O
a	O
12	O
-	O
kb	O
band	O
for	O
the	O
ApcCKON	O
allele	S-SO
and	O
a	O
10	O
-	O
kb	O
band	O
for	O
the	O
wild	B-SO
-	I-SO
type	E-SO
allele	S-SO
,	O
whereas	O
genomic	B-SO
DNA	E-SO
from	O
the	O
Apc	O
Delta	O
580	O
mouse	S-LIVB
was	O
heterozygous	O
for	O
the	O
Apc	O
Delta	O
580	O
allele	S-SO
(	O
9	O
.	O
2	O
-	O
kb	O
band	O
)	O
.	O

(	O
C	O
)	O
Kaplan	O
-	O
Meier	O
survival	O
plot	O
of	O
ApcCKO	O
/	O
+	S-SO
mice	S-LIVB
(	O
thin	O
solid	O
line	O
,	O
n	O
=	O
39	O
)	O
,	O
ApcCKO	O
/	O
CKO	O
mice	S-LIVB
(	O
thin	O
dotted	O
line	O
,	O
n	O
=	O
57	O
)	O
,	O
Apc	O
Delta	O
580	O
/	O
+	S-SO
mice	S-LIVB
(	O
solid	O
line	O
,	O
n	O
=	O
51	O
)	O
,	O
and	O
wild	B-SO
-	I-SO
type	E-SO
littermates	O
(	O
broken	O
line	O
,	O
n	O
=	O
21	O
)	O
.	O

Heterozygosity	O
of	O
the	O
Apc	O
Delta	O
580	O
allele	S-SO
led	O
to	O
a	O
significantly	O
shortened	O
survival	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
whereas	O
those	O
of	O
heterozygous	O
and	O
homozygous	O
ApcCKO	O
mice	S-LIVB
had	O
no	O
significant	O
difference	O
to	O
that	O
of	O
wild	B-SO
-	I-SO
type	E-SO
littermates	O
.	O

Figure	O
2	O

Postnatal	O
Mortality	O
and	O
Stunted	O
Growth	O
in	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
Mutant	S-SO
Mice	S-LIVB

Animals	S-LIVB
whose	O
genotype	S-SO
is	O
either	O
heterozygous	O
or	O
homozygous	O
for	O
the	O
wild	B-SO
-	I-SO
type	E-SO
Apc	S-PRGE
allele	S-SO
are	O
referred	O
to	O
as	O
normal	O
(	O
N	O
)	O
;	O
those	O
whose	O
genotype	S-SO
are	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
and	O
show	O
the	O
presence	O
of	O
K14	S-PRGE
-	O
cre	O
-	O
recombined	O
mutant	S-SO
Apc	S-PRGE
allele	S-SO
are	O
called	O
mutant	S-SO
(	O
M	S-SO
)	O
.	O

(	O
A	O
)	O
Two	O
P3	O
mutant	S-SO
mice	S-LIVB
,	O
M1	O
and	O
M2	O
,	O
and	O
their	O
normal	O
littermates	O
,	O
showing	O
size	O
variation	O
among	O
mutants	S-SO
.	O

(	O
B	O
)	O
P8	O
mutant	S-SO
mouse	S-LIVB
(	O
right	O
)	O
and	O
a	O
normal	O
littermate	O
.	O

Note	O
sparseness	O
of	O
hair	O
coat	O
and	O
abnormal	O
ears	O
.	O

(	O
C	O
-	O
D	O
)	O
Vibrissae	O
of	O
whisker	O
pads	O
are	O
short	O
and	O
oddly	O
angled	O
in	O
a	O
P12	O
mutant	S-SO
mouse	S-LIVB
(	O
C	O
)	O
,	O
relative	O
to	O
control	O
(	O
D	O
)	O
.	O

Note	O
the	O
lack	O
of	O
incisors	O
in	O
the	O
mutant	S-SO
.	O

(	O
E	O
)	O
A	O
P17	O
mutant	S-SO
mouse	S-LIVB
(	O
right	O
)	O
with	O
its	O
littermate	O
.	O

Its	O
bare	O
forehead	O
,	O
dorsal	O
median	O
line	O
,	O
and	O
abnormal	O
ears	O
are	O
evident	O
.	O

(	O
F	O
)	O
Growth	O
curve	O
of	O
mutants	S-SO
and	O
normal	O
littermates	O
.	O

Mutants	S-SO
exhibit	O
stunted	O
growth	O
,	O
which	O
became	O
more	O
prominent	O
as	O
they	O
aged	O
,	O
and	O
weigh	O
significantly	O
less	O
than	O
littermates	O
from	O
P8	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

(	O
G	O
)	O
Comparison	O
of	O
mutant	S-SO
and	O
normal	O
thymus	O
from	O
P3	O
mice	S-LIVB
.	O

The	O
mutant	S-SO
thymus	O
(	O
left	O
)	O
is	O
dramatically	O
smaller	O
for	O
its	O
age	O
compared	O
to	O
the	O
normal	O
littermate	O
(	O
right	O
)	O
.	O

The	O
scale	O
bar	O
equals	O
1	O
mm	O
.	O

(	O
H	O
)	O
Skeletal	O
preparations	O
of	O
normal	O
(	O
left	O
)	O
and	O
mutant	S-SO
(	O
right	O
)	O
,	O
showing	O
differences	O
in	O
development	O
of	O
both	O
incisor	O
(	O
I	O
)	O
and	O
molar	O
(	O
M	O
)	O
teeth	O
.	O

Figure	O
3	O

Tissue	O
-	O
Specific	O
Detection	O
and	O
Expression	O
of	O
Deleted	S-SO
Apc	S-PRGE
Alleles	S-SO

(	O
A	O
)	O
Tissue	O
-	O
specific	O
genotyping	O
PCR	O
.	O

Only	O
genomic	B-SO
DNA	E-SO
samples	O
from	O
the	O
skin	O
(	O
S	O
)	O
and	O
thymus	O
(	O
T	O
)	O
,	O
but	O
not	O
liver	O
(	O
L	O
)	O
of	O
mice	S-LIVB
positive	O
for	O
K14	S-PRGE
-	O
cre	O
show	O
the	O
presence	O
of	O
deleted	S-SO
Apc	O
Delta	O
580	O
allele	S-SO
.	O

(	O
B	O
)	O
Genotype	S-SO
-	O
and	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
truncated	O
Apc	S-PRGE
transcripts	S-SO
.	O

A	O
representative	O
gel	O
of	O
RT	O
-	O
PCR	O
using	O
primers	S-SO
F546	O
and	O
R721	O
,	O
showing	O
that	O
only	O
RNA	S-SO
from	O
the	O
skin	O
and	O
thymus	O
but	O
not	O
liver	O
of	O
mice	S-LIVB
positive	O
for	O
K14	S-PRGE
-	O
cre	O
have	O
transcripts	S-SO
from	O
both	O
wild	B-SO
-	I-SO
type	E-SO
(	O
528	O
bp	S-SO
)	O
and	O
deleted	S-SO
(	O
313	O
bp	S-SO
)	O
Apc	S-PRGE
alleles	S-SO
.	O

Figure	O
4	O

Histological	O
and	O
Immunochemical	O
Examination	O
of	O
P12	O
Skin	O
and	O
Teeth	O

(	O
A	O
-	O
E	O
)	O
P12	O
normal	O
skin	O
.	O

(	O
F	O
-	O
J	O
)	O
P12	O
mutant	S-SO
skin	O
.	O

(	O
K	O
-	O
N	O
)	O
P12	O
normal	O
oral	O
cavity	O
.	O

(	O
O	O
-	O
R	O
)	O
P12	O
mutant	S-SO
oral	O
cavity	O
.	O

Stained	O
with	O
H	O
&	O
E	O
for	O
histology	O
(	O
A	O
,	O
F	O
,	O
K	O
-	O
L	O
,	O
O	O
-	O
P	O
)	O
,	O
Ki67	S-PRGE
(	O
B	O
,	O
G	O
)	O
,	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
(	O
C	O
,	O
H	O
,	O
M	O
,	O
Q	O
)	O
,	O
K14	S-PRGE
(	O
D	O
,	O
I	O
,	O
N	O
,	O
R	O
)	O
,	O
and	O
K6	S-PRGE
(	O
E	O
,	O
J	O
)	O
.	O

Aberrant	O
follicular	O
morphogenesis	O
,	O
characterized	O
by	O
formation	O
of	O
irregularly	O
spaced	O
,	O
nonpolarized	O
hair	O
follicles	O
,	O
in	O
mutant	S-SO
skin	O
is	O
evident	O
.	O

Despite	O
the	O
abnormal	O
histology	O
,	O
proliferation	O
seems	O
to	O
be	O
confined	O
to	O
hair	O
bulb	O
-	O
like	O
structures	O
(	O
arrows	O
in	O
[	O
G	O
]	O
,	O
inset	O
[	O
G	O
'	O
]	O
at	O
higher	O
magnification	O
)	O
,	O
but	O
in	O
mutant	S-SO
skin	O
(	O
arrows	O
in	O
[	O
H	O
]	O
,	O
inset	O
[	O
H	O
'	O
]	O
at	O
higher	O
magnification	O
)	O
and	O
oral	O
cavity	O
(	O
arrows	O
in	O
insets	O
[	O
Q	O
'	O
]	O
at	O
higher	O
magnification	O
)	O
elevated	O
cytosolic	S-GO
localization	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
is	O
detected	O
in	O
some	O
cells	S-CL
.	O

Scale	O
bars	O
:	O
50	O
mu	O
m	O
for	O
(	O
A	O
-	O
F	O
)	O
,	O
(	O
H	O
-	O
J	O
)	O
;	O
250	O
mu	O
m	O
for	O
(	O
K	O
)	O
and	O
(	O
O	O
)	O
;	O
100	O
mu	O
m	O
for	O
(	O
G	O
)	O
,	O
(	O
L	O
-	O
N	O
)	O
,	O
(	O
P	O
-	O
R	O
)	O
;	O
20	O
mu	O
m	O
for	O
(	O
Q	O
'	O
)	O
.	O

Figure	O
5	O

Expression	O
of	O
Shh	S-PRGE
and	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
Transcripts	S-SO
in	O
Normal	O
(	O
ApcCKO	O
/	O
CKO	O
)	O
and	O
Mutant	S-SO
(	O
K14	S-PRGE
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
)	O
Embryonic	O
Skin	O

(	O
A	O
-	O
D	O
)	O
Section	O
ISH	O
with	O
Shh	S-PRGE
probe	S-SO
in	O
E14	O
.	O
5	O
normal	O
(	O
A	O
)	O
,	O
E14	O
.	O
5	O
mutant	S-SO
(	O
B	O
)	O
,	O
E16	O
.	O
5	O
normal	O
(	O
C	O
)	O
,	O
and	O
E16	O
.	O
5	O
mutant	S-SO
(	O
D	O
)	O
skin	O
.	O

Broken	O
lines	O
indicate	O
the	O
interface	O
between	O
epithelium	O
and	O
mesenchyme	O
.	O

Scale	O
bars	O
:	O
50	O
mu	O
m	O
.	O

Whole	O
mount	O
in	O
situ	O
detection	O
of	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
in	O
E15	O
.	O
5	O
normal	O
(	O
E	O
,	O
G	O
)	O
,	O
mutant	S-SO
(	O
F	O
,	O
H	O
)	O
embryos	O
.	O

Aberrant	O
initiation	O
of	O
multiple	O
hair	O
placodes	O
is	O
evident	O
at	O
E14	O
.	O
5	O
.	O

Loss	O
of	O
K14	S-PRGE
-	O
driven	O
Apc	S-PRGE
loss	O
caused	O
aberrant	O
pattern	O
formation	O
(	O
F	O
'	O
)	O
and	O
formed	O
ectopic	O
hair	O
placodes	O
in	O
normally	O
hairless	O
foot	O
pads	O
(	O
H	O
,	O
arrows	O
)	O
which	O
are	O
absent	O
in	O
normal	O
(	O
G	O
)	O
.	O

Figure	O
6	O

Histological	O
and	O
Immunochemical	O
Examination	O
of	O
Thymus	O

(	O
A	O
-	O
D	O
)	O
P3	O
normal	O
thymus	O
.	O

(	O
E	O
-	O
G	O
)	O
Mild	O
P3	O
mutant	S-SO
thymus	O
.	O

(	O
H	O
-	O
K	O
)	O
Severe	O
P3	O
mutant	S-SO
thymus	O
.	O

(	O
L	O
-	O
O	O
)	O
P13	O
mutant	S-SO
thymus	O
.	O

Stained	O
with	O
H	O
&	O
E	O
for	O
histology	O
(	O
A	O
,	O
E	O
,	O
H	O
,	O
L	O
)	O
,	O
BrdU	O
(	O
B	O
,	O
I	O
,	O
M	O
)	O
,	O
beta	B-PRGE
-	I-PRGE
catenin	E-PRGE
(	O
C	O
,	O
F	O
,	O
J	O
,	O
N	O
)	O
,	O
and	O
K14	S-PRGE
(	O
D	O
,	O
G	O
,	O
K	O
,	O
O	O
)	O
.	O

(	O
B	O
)	O
Actively	O
dividing	O
thymocytes	O
are	O
visible	O
at	O
the	O
superficial	O
edge	O
of	O
cortex	O
of	O
normal	O
P3	O
thymus	O
.	O

Note	O
the	O
progression	O
of	O
histological	O
abnormalities	O
in	O
the	O
mutant	S-SO
thymus	O
from	O
mild	O
P3	O
,	O
severe	O
P3	O
to	O
P13	O
(	O
A	O
,	O
E	O
,	O
H	O
,	O
L	O
)	O
.	O

Scale	O
bars	O
,	O
20	O
mu	O
m	O
.	O

Table	O
1	O

Genotype	S-SO
Distribution	O
of	O
Progeny	O
from	O
the	O
Matings	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
July	O
28	O
,	O
2006	O
(	O
DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020146	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

M	O
.	O

Kuraguchi	O
and	O
R	O
.	O

Kucherlapati	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

M	O
.	O

Kuraguchi	O
,	O
X	O
.	O

Wang	O
,	O
R	O
.	O

Bronson	O
,	O
R	O
.	O

Rothenberg	O
,	O
N	O
.	O

Ohene	O
-	O
Baah	O
,	O
J	O
.	O

Lund	O
,	O
and	O
M	O
.	O

Kucherlapati	O
performed	O
the	O
experiments	O
.	O

M	O
.	O

Kuraguchi	O
analyzed	O
the	O
data	O
.	O

R	O
.	O

Maas	O
contributed	O
reagents	S-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

M	O
.	O

Kuraguchi	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
National	O
Cancer	O
Institute	O
(	O
CA	O
-	O
084301	O
)	O
,	O
the	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
(	O
ES	O
-	O
11040	O
)	O
,	O
and	O
the	O
National	O
Institute	O
of	O
Dental	O
and	O
Craniofacial	O
Research	O
(	O
DE	O
-	O
11697	O
,	O
DE	O
-	O
16140	O
)	O
.	O

Deletion	S-SO
at	O
ITPR1	S-PRGE
Underlies	O
Ataxia	O
in	O
Mice	S-LIVB
and	O
Spinocerebellar	O
Ataxia	O
15	O
in	O
Humans	S-LIVB

Abstract	O

We	O
observed	O
a	O
severe	O
autosomal	S-GO
recessive	O
movement	O
disorder	O
in	O
mice	S-LIVB
used	O
within	O
our	O
laboratory	O
.	O

We	O
pursued	O
a	O
series	O
of	O
experiments	O
to	O
define	O
the	O
genetic	S-SO
lesion	O
underlying	O
this	O
disorder	O
and	O
to	O
identify	O
a	O
cognate	O
disease	O
in	O
humans	S-LIVB
with	O
mutation	S-SO
at	O
the	O
same	O
locus	S-SO
.	O

Through	O
linkage	O
and	O
sequence	S-SO
analysis	O
we	O
show	O
here	O
that	O
this	O
disorder	O
is	O
caused	O
by	O
a	O
homozygous	O
in	O
-	O
frame	S-SO
18	O
-	O
bp	S-SO
deletion	S-SO
in	O
Itpr1	S-PRGE
(	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
)	O
,	O
encoding	O
inositol	B-PRGE
1	I-PRGE
,	I-PRGE
4	I-PRGE
,	I-PRGE
5	I-PRGE
-	I-PRGE
triphosphate	I-PRGE
receptor	I-PRGE
1	E-PRGE
.	O

A	O
previously	O
reported	O
spontaneous	O
Itpr1	S-PRGE
mutation	S-SO
in	O
mice	S-LIVB
causes	O
a	O
phenotype	O
identical	O
to	O
that	O
observed	O
here	O
.	O

In	O
both	O
models	O
in	O
-	O
frame	S-SO
deletion	S-SO
within	O
Itpr1	S-PRGE
leads	O
to	O
a	O
decrease	O
in	O
the	O
normally	O
high	O
level	O
of	O
Itpr1	S-PRGE
expression	O
in	O
cerebellar	O
Purkinje	B-CL
cells	E-CL
.	O

Spinocerebellar	O
ataxia	O
15	O
(	O
SCA15	O
)	O
,	O
a	O
human	S-LIVB
autosomal	S-GO
dominant	O
disorder	O
,	O
maps	O
to	O
the	O
genomic	B-SO
region	E-SO
containing	O
ITPR1	S-PRGE
;	O
however	O
,	O
to	O
date	O
no	O
causal	O
mutations	S-SO
had	O
been	O
identified	O
.	O

Because	O
ataxia	O
is	O
a	O
prominent	O
feature	O
in	O
Itpr1	S-PRGE
mutant	S-SO
mice	S-LIVB
,	O
we	O
performed	O
a	O
series	O
of	O
experiments	O
to	O
test	O
the	O
hypothesis	O
that	O
mutation	S-SO
at	O
ITPR1	S-PRGE
may	O
be	O
the	O
cause	O
of	O
SCA15	O
.	O

We	O
show	O
here	O
that	O
heterozygous	O
deletion	S-SO
of	O
the	O
5	O
'	O
part	B-SO
of	I-SO
the	I-SO
ITPR1	I-SO
gene	E-SO
,	O
encompassing	O
exons	S-SO
1	O
-	O
10	O
,	O
1	O
-	O
40	O
,	O
and	O
1	O
-	O
44	O
in	O
three	O
studied	O
families	O
,	O
underlies	O
SCA15	O
in	O
humans	S-LIVB
.	O

Author	O
Summary	O

We	O
have	O
identified	O
a	O
spontaneous	O
in	O
-	O
frame	S-SO
deletion	B-SO
mutation	E-SO
in	O
the	O
gene	S-SO
Itpr1	S-PRGE
that	O
causes	O
a	O
recessive	O
movement	O
disorder	O
in	O
mice	S-LIVB
.	O

In	O
an	O
attempt	O
to	O
define	O
whether	O
any	O
similar	O
disease	O
occurs	O
in	O
humans	S-LIVB
we	O
performed	O
a	O
literature	O
search	O
for	O
diseases	O
linked	O
to	O
the	O
human	S-LIVB
chromosomal	B-SO
region	E-SO
containing	O
ITPR1	S-PRGE
.	O

We	O
identified	O
the	O
disease	O
spinocerebellar	O
ataxia	O
15	O
as	O
linked	O
to	O
this	O
region	S-SO
.	O

High	O
-	O
density	O
genomic	S-SO
analysis	O
of	O
affected	O
members	O
from	O
three	O
families	O
revealed	O
that	O
disease	O
in	O
these	O
patients	O
was	O
caused	O
by	O
deletion	S-SO
of	O
a	O
large	O
portion	S-SO
of	O
the	O
region	S-SO
containing	O
ITPR1	S-PRGE
.	O

We	O
show	O
here	O
that	O
this	O
mutation	S-SO
results	O
in	O
a	O
dramatic	O
reduction	O
in	O
ITPR1	S-PRGE
in	O
cells	S-CL
from	O
these	O
patients	O
.	O

These	O
data	O
show	O
convincingly	O
that	O
ITPR1	S-PRGE
deletion	S-SO
underlies	O
spinocerebellar	O
ataxia	O
15	O
in	O
humans	S-LIVB
.	O

Introduction	O

The	O
use	O
of	O
forward	O
genetics	O
to	O
define	O
novel	O
loci	S-SO
of	O
interest	O
in	O
human	S-LIVB
disease	O
has	O
become	O
increasingly	O
viable	O
with	O
the	O
implementation	O
of	O
large	O
-	O
scale	O
mutagenesis	S-SO
programs	O
.	O

Prior	O
to	O
these	O
initiatives	O
this	O
work	O
was	O
carried	O
out	O
in	O
part	O
by	O
the	O
investigation	O
of	O
spontaneous	O
mutations	S-SO
that	O
cause	O
disorders	O
in	O
mouse	S-LIVB
breeding	O
colonies	O
.	O

Careful	O
observation	O
of	O
these	O
serendipitous	O
events	O
has	O
led	O
to	O
the	O
establishment	O
and	O
study	O
of	O
many	O
in	O
vivo	O
disease	O
models	O
[	O
3	O
]	O
.	O

During	O
the	O
generation	O
of	O
a	O
knockout	O
line	O
of	O
mice	S-LIVB
we	O
noted	O
an	O
early	O
movement	O
disorder	O
that	O
was	O
inherited	O
independently	O
of	O
targeting	O
vector	S-SO
transmission	O
.	O

We	O
embarked	O
on	O
a	O
series	O
of	O
experiments	O
to	O
identify	O
the	O
genetic	S-SO
lesion	O
underlying	O
this	O
movement	O
disorder	O
and	O
to	O
identify	O
a	O
cognate	O
disease	O
and	O
corresponding	O
mutation	S-SO
in	O
humans	S-LIVB
.	O

Here	O
we	O
describe	O
this	O
effort	O
and	O
the	O
discovery	O
of	O
deletion	S-SO
at	O
the	O
ITPR1	S-PRGE
locus	S-SO
as	O
a	O
cause	O
of	O
this	O
disorder	O
in	O
mice	S-LIVB
and	O
of	O
spinocerebellar	O
ataxia	O
15	O
(	O
SCA15	O
)	O
in	O
humans	S-LIVB
.	O

Results	O
/	O
Discussion	O

During	O
the	O
generation	O
of	O
a	O
line	O
of	O
mice	S-LIVB
with	O
knockout	O
of	O
the	O
gene	S-SO
Park7	S-PRGE
we	O
noted	O
an	O
early	O
movement	O
disorder	O
that	O
was	O
inherited	O
independently	O
of	O
targeting	O
vector	S-SO
transmission	O
.	O

Our	O
initial	O
observations	O
suggested	O
the	O
affected	O
mice	S-LIVB
suffered	O
from	O
an	O
apparently	O
paroxysmal	O
movement	O
disorder	O
,	O
often	O
induced	O
by	O
touch	O
.	O

The	O
abnormal	O
movements	O
occurred	O
predominantly	O
below	O
the	O
cervical	O
level	O
,	O
and	O
the	O
disorder	O
appeared	O
progressive	O
.	O

At	O
initial	O
examination	O
,	O
a	O
human	S-LIVB
movement	O
disorder	O
specialist	O
(	O
K	O
.	O
G	O
.	O
-	O
H	O
.	O
)	O
likened	O
the	O
disorder	O
to	O
episodic	O
intermittent	O
ataxia	O
or	O
kinesiogenic	O
paroxysmal	O
dystonia	O
and	O
predicted	O
the	O
involvement	O
of	O
an	O
ion	S-CHEBI
channel	O
mutation	S-SO
in	O
the	O
etiology	O
.	O

Affected	O
mice	S-LIVB
presented	O
at	O
approximately	O
postnatal	O
day	O
14	O
,	O
and	O
survival	O
time	O
without	O
weaning	O
was	O
on	O
average	O
4	O
wk	O
after	O
onset	O
.	O

Breeding	O
experiments	O
suggested	O
that	O
the	O
observed	O
disorder	O
was	O
inherited	O
in	O
an	O
autosomal	S-GO
recessive	O
manner	O
.	O

To	O
map	O
the	O
location	S-SO
of	O
the	O
disease	O
-	O
causing	O
lesion	O
,	O
we	O
performed	O
genome	S-SO
-	O
wide	O
linkage	O
analysis	O
using	O
strain	O
-	O
specific	O
single	B-SO
nucleotide	I-SO
polymorphisms	E-SO
(	O
SNPs	S-SO
)	O
at	O
120	O
loci	S-SO
across	O
the	O
mouse	S-LIVB
genome	S-SO
.	O

Analysis	O
of	O
these	O
data	O
showed	O
a	O
single	O
genomic	B-SO
region	E-SO
with	O
significant	O
linkage	O
to	O
disease	O
,	O
providing	O
a	O
two	O
-	O
point	O
LOD	O
score	O
of	O
5	O
.	O
13	O
at	O
marker	O
20	O
.	O
MMHAP85FLG2	O
on	O
Chromosome	S-GO
6qE1	O
.	O

The	O
linked	O
haplotype	S-SO
suggested	O
the	O
mutation	S-SO
had	O
occurred	O
on	O
the	O
129x1	O
/	O
SvJ	O
background	O
(	O
Figure	O
S1	O
)	O
.	O

Literature	O
searches	O
revealed	O
that	O
among	O
disease	O
lines	O
mapped	O
to	O
6qE1	O
,	O
the	O
spontaneous	O
mutant	S-SO
opt	O
mouse	S-LIVB
displays	O
a	O
strikingly	O
similar	O
presentation	O
to	O
that	O
described	O
here	O
[	O
1	O
]	O
.	O

The	O
underlying	O
genetic	S-SO
lesion	O
causing	O
the	O
opt	O
phenotype	O
is	O
a	O
homozygous	O
in	O
-	O
frame	S-SO
deletion	S-SO
of	O
exons	S-SO
43	O
and	O
44	O
of	O
the	O
gene	S-SO
Itpr1	S-PRGE
(	O
Itpr1opt	O
/	O
opt	O
)	O
,	O
encoding	O
inositol	B-PRGE
1	I-PRGE
,	I-PRGE
4	I-PRGE
,	I-PRGE
5	I-PRGE
-	I-PRGE
triphosphate	I-PRGE
receptor	I-PRGE
1	E-PRGE
(	O
Itpr1	S-PRGE
)	O
.	O

Sequencing	O
of	O
all	O
exons	S-SO
and	O
intron	B-SO
-	I-SO
exon	I-SO
boundaries	E-SO
of	O
Itpr1	S-PRGE
in	O
affected	O
mice	S-LIVB
from	O
the	O
current	O
study	O
revealed	O
a	O
single	O
mutation	S-SO
within	O
Itpr1	S-PRGE
:	O
a	O
novel	O
in	O
-	O
frame	S-SO
deletion	S-SO
of	O
18	O
bp	S-SO
within	O
exon	S-SO
36	O
(	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
)	O
.	O

To	O
confirm	O
the	O
pathogenicity	O
of	O
this	O
mutation	S-SO
we	O
crossed	O
heterozygous	O
mice	S-LIVB
from	O
the	O
current	O
study	O
(	O
Itpr1wt	O
/	O
Delta	O
18	O
)	O
with	O
mice	S-LIVB
heterozygous	O
for	O
the	O
opt	O
mutation	S-SO
(	O
Itpr1wt	O
/	O
opt	O
)	O
.	O

This	O
resulted	O
in	O
two	O
litters	O
of	O
mice	S-LIVB
with	O
a	O
total	O
of	O
four	O
affected	O
Itpr1opt	O
/	O
Delta	O
18	O
pups	O
(	O
from	O
a	O
total	O
of	O
15	O
)	O
with	O
a	O
phenotype	O
indistinguishable	O
from	O
that	O
of	O
the	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
and	O
Itpr1opt	O
/	O
opt	O
mice	S-LIVB
[	O
1	O
]	O
.	O

Furthermore	O
,	O
this	O
phenotype	O
was	O
similar	O
,	O
although	O
less	O
severe	O
,	O
to	O
that	O
described	O
in	O
a	O
mouse	S-LIVB
line	O
with	O
targeted	O
deletion	S-SO
of	O
Itpr1	S-PRGE
,	O
where	O
ataxia	O
was	O
described	O
as	O
a	O
prominent	O
feature	O
[	O
4	O
]	O
.	O

As	O
with	O
the	O
Itpr1opt	O
/	O
opt	O
mice	S-LIVB
,	O
where	O
the	O
deletion	S-SO
of	O
exons	S-SO
43	O
and	O
44	O
is	O
also	O
predicted	O
to	O
leave	O
the	O
translational	O
reading	B-SO
frame	E-SO
unaffected	O
,	O
the	O
in	O
-	O
frame	S-SO
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
deletion	B-SO
mutation	E-SO
results	O
in	O
markedly	O
decreased	O
levels	O
of	O
Itpr1	S-PRGE
in	O
cerebellar	O
Purkinje	B-CL
cells	E-CL
.	O

In	O
these	O
two	O
spontaneous	O
mutants	S-SO
[	O
1	O
]	O
and	O
in	O
the	O
Itpr1	S-PRGE
-	O
deficient	O
mouse	S-LIVB
[	O
4	O
]	O
generated	O
by	O
gene	S-SO
targeting	O
,	O
decreased	O
Itpr1	S-PRGE
expression	O
is	O
associated	O
with	O
the	O
same	O
autosomal	S-GO
recessive	O
movement	O
disorder	O
(	O
Figure	O
1	O
)	O
.	O

Given	O
our	O
interest	O
in	O
human	S-LIVB
neurological	O
disease	O
we	O
sought	O
to	O
identify	O
any	O
cognate	O
human	S-LIVB
disorders	O
where	O
linkage	O
had	O
been	O
established	O
to	O
the	O
syntenic	B-SO
region	E-SO
of	O
the	O
human	S-LIVB
genome	S-SO
,	O
but	O
where	O
no	O
causal	O
mutation	S-SO
had	O
been	O
identified	O
.	O

SCA15	O
,	O
an	O
adult	O
-	O
onset	O
autosomal	S-GO
dominant	O
progressive	O
ataxia	O
is	O
linked	O
to	O
this	O
locus	S-SO
[	O
5	O
]	O
.	O

Although	O
missense	O
mutation	S-SO
of	O
ITPR1	S-PRGE
had	O
previously	O
been	O
ruled	O
out	O
[	O
2	O
]	O
and	O
the	O
mode	O
of	O
inheritance	O
was	O
inconsistent	O
with	O
that	O
seen	O
in	O
the	O
Itpr1	O
Delta	O
18	O
and	O
Itpr1opt	O
mice	S-LIVB
,	O
the	O
phenotypic	O
presence	O
of	O
ataxia	O
in	O
the	O
mice	S-LIVB
led	O
us	O
to	O
reexamine	O
this	O
candidate	O
gene	S-SO
as	O
a	O
possible	O
cause	O
of	O
SCA15	O
.	O

We	O
obtained	O
genomic	B-SO
DNA	E-SO
from	O
three	O
affected	O
family	O
members	O
and	O
one	O
family	O
member	O
with	O
unknown	O
disease	O
status	O
from	O
the	O
kindred	O
originally	O
used	O
to	O
define	O
and	O
map	O
SCA15	O
(	O
family	O
AUS1	O
,	O
of	O
Australian	O
Anglo	O
-	O
Celtic	O
origin	O
)	O
[	O
2	O
]	O
.	O

We	O
performed	O
two	O
experiments	O
concurrently	O
in	O
three	O
affected	O
members	O
of	O
this	O
family	O
:	O
sequence	S-SO
analysis	O
of	O
the	O
coding	B-SO
exons	E-SO
of	O
ITPR1	S-PRGE
and	O
high	O
-	O
density	O
genome	S-SO
-	O
wide	O
SNP	S-SO
genotyping	O
.	O

Sequence	S-SO
analysis	O
failed	O
to	O
show	O
any	O
coding	S-SO
alterations	S-SO
segregating	O
with	O
disease	O
or	O
any	O
alterations	S-SO
that	O
were	O
inconsistent	O
with	O
Mendelian	O
patterns	O
of	O
inheritance	O
within	O
the	O
family	O
.	O

However	O
,	O
visualization	O
of	O
log	O
R	O
ratio	O
and	O
B	O
allele	S-SO
frequency	O
metrics	O
from	O
the	O
genome	S-SO
-	O
wide	O
SNP	S-SO
genotyping	O
experiments	O
clearly	O
showed	O
data	O
consistent	O
with	O
a	O
heterozygous	O
genomic	S-SO
deletion	S-SO
across	O
the	O
first	O
one	O
-	O
third	O
of	O
ITPR1	S-PRGE
and	O
across	O
the	O
first	O
half	O
of	O
a	O
neighboring	O
gene	S-SO
,	O
SUMF1	S-PRGE
(	O
Figure	O
2	O
)	O
.	O

This	O
deletion	S-SO
was	O
apparent	O
in	O
all	O
three	O
affected	O
family	O
members	O
studied	O
and	O
absent	O
from	O
the	O
family	O
member	O
with	O
unknown	O
affection	O
status	O
(	O
Figure	O
3	O
)	O
.	O

The	O
SNP	S-SO
data	O
showed	O
a	O
deletion	S-SO
of	O
between	O
188	O
kb	O
and	O
210	O
kb	O
in	O
size	O
;	O
examination	O
of	O
SNPs	S-SO
at	O
the	O
flanking	B-SO
unknown	I-SO
regions	E-SO
of	O
this	O
deletion	S-SO
allowed	O
us	O
to	O
delimit	O
the	O
borders	B-SO
of	I-SO
the	I-SO
deletion	E-SO
to	O
7	O
.	O
5	O
kb	O
on	O
the	O
telomeric	S-SO
side	O
of	O
the	O
deletion	S-SO
(	O
between	O
rs12634249	O
and	O
rs793396	O
)	O
and	O
~	O
14	O
.	O
4	O
kb	O
on	O
the	O
centromeric	S-SO
side	O
of	O
the	O
deletion	S-SO
(	O
between	O
rs4073665	O
and	O
rs17709863	O
)	O
.	O

In	O
an	O
attempt	O
to	O
define	O
whether	O
this	O
variation	S-SO
was	O
a	O
benign	O
polymorphism	S-SO
we	O
analyzed	O
genome	S-SO
-	O
wide	O
SNP	S-SO
data	O
at	O
this	O
locus	S-SO
,	O
produced	O
using	O
the	O
same	O
genotyping	O
chip	O
,	O
from	O
577	O
individuals	S-LIVB
of	O
European	O
descent	O
who	O
were	O
either	O
controls	O
or	O
individuals	S-LIVB
with	O
an	O
unrelated	O
neurological	O
disorder	O
.	O

We	O
failed	O
to	O
find	O
any	O
deletions	S-SO
affecting	O
the	O
coding	B-SO
sequence	E-SO
of	O
either	O
gene	S-SO
,	O
ITPR1	S-PRGE
or	O
SUMF1	S-PRGE
;	O
we	O
did	O
,	O
however	O
,	O
identify	O
a	O
single	O
individual	S-LIVB
with	O
a	O
possible	O
heterozygous	O
deletion	S-SO
approximately	O
6	O
kb	O
in	O
size	O
within	O
intron	S-SO
40	O
-	O
41	O
of	O
ITPR1	S-PRGE
,	O
at	O
least	O
5	O
kb	O
away	O
from	O
exon	S-SO
40	O
.	O

Given	O
the	O
location	S-SO
of	O
this	O
alteration	S-SO
it	O
is	O
unlikely	O
to	O
effect	O
the	O
expression	O
or	O
splicing	O
of	O
ITPR1	S-PRGE
.	O

In	O
an	O
attempt	O
to	O
fine	O
-	O
map	O
the	O
breakpoints	B-SO
of	I-SO
the	I-SO
disease	I-SO
-	I-SO
causing	I-SO
deletion	E-SO
we	O
performed	O
a	O
series	O
of	O
experiments	O
designed	O
to	O
refine	O
the	O
unknown	O
intervals	S-SO
at	O
the	O
edges	S-SO
between	O
definite	O
deleted	S-SO
and	O
definite	O
diploid	O
sequences	S-SO
.	O

These	O
data	O
narrowed	O
the	O
unknown	O
borders	S-SO
to	O
~	O
4	O
kb	O
on	O
the	O
telomeric	S-SO
side	O
and	O
~	O
7	O
kb	O
on	O
the	O
centromeric	S-SO
side	O
.	O

We	O
used	O
all	O
possible	O
combinations	O
of	O
forward	B-SO
orientation	I-SO
primers	E-SO
designed	S-SO
within	O
the	O
newly	O
defined	O
telomeric	S-SO
boundary	S-SO
and	O
of	O
reverse	B-SO
orientation	I-SO
primers	E-SO
designed	S-SO
within	O
the	O
newly	O
defined	O
centromeric	S-SO
boundary	S-SO
in	O
PCR	O
assays	O
in	O
an	O
attempt	O
to	O
amplify	O
across	O
the	O
deletion	S-SO
in	O
affected	O
family	O
members	O
.	O

Using	O
PCR	O
primers	S-SO
T3F	O
and	O
C11R	O
,	O
which	O
should	O
be	O
more	O
than	O
200	O
kb	O
apart	O
,	O
we	O
were	O
able	O
to	O
amplify	O
a	O
fragment	S-SO
953	O
bp	S-SO
in	O
size	O
using	O
DNA	S-SO
from	O
each	O
of	O
the	O
three	O
affected	O
family	O
members	O
as	O
template	O
.	O

Sequencing	O
of	O
this	O
fragment	S-SO
revealed	O
a	O
deletion	S-SO
of	O
201	O
,	O
509	O
bp	S-SO
(	O
Figure	O
S3	O
)	O
,	O
removing	S-SO
the	O
first	O
three	O
of	O
the	O
nine	O
exons	S-SO
of	O
SUMF1	S-PRGE
and	O
the	O
first	O
ten	O
of	O
the	O
58	O
exons	S-SO
of	O
ITPR1	S-PRGE
.	O

We	O
were	O
unable	O
to	O
amplify	O
the	O
deletion	S-SO
-	O
specific	O
fragment	S-SO
in	O
the	O
family	O
member	O
of	O
unknown	O
affection	O
status	O
,	O
or	O
in	O
275	O
neurologically	O
normal	O
controls	O
.	O

To	O
further	O
establish	O
genetic	S-SO
deletion	S-SO
at	O
ITPR1	S-PRGE
as	O
the	O
cause	O
of	O
SCA15	O
we	O
analyzed	O
two	O
additional	O
families	O
with	O
an	O
inherited	O
cerebellar	O
ataxia	O
similar	O
to	O
that	O
described	O
in	O
the	O
AUS1	O
family	O
,	O
ascertained	O
through	O
neurology	O
clinics	O
in	O
London	O
,	O
United	O
Kingdom	O
.	O

DNA	S-SO
extracted	O
from	O
probands	O
from	O
these	O
two	O
families	O
(	O
family	O
H33	O
and	O
family	O
H27	O
)	O
were	O
also	O
analyzed	O
using	O
Illumina	O
Infinium	O
HumanHap550	O
genotyping	O
chips	O
.	O

These	O
experiments	O
showed	O
deletion	S-SO
at	O
the	O
SCA15	O
locus	S-SO
in	O
all	O
affected	O
members	O
assayed	O
,	O
from	O
SUMF1	S-PRGE
through	O
ITPR1	S-PRGE
.	O

These	O
mutations	S-SO
segregated	O
with	O
disease	O
in	O
these	O
two	O
families	O
(	O
Figure	O
S3	O
)	O
.	O

A	O
strategy	O
similar	O
to	O
the	O
one	O
outlined	O
above	O
enabled	O
us	O
to	O
sequence	O
over	O
the	O
breakpoint	S-SO
in	O
family	O
H27	O
but	O
not	O
family	O
H33	O
.	O

In	O
the	O
former	O
,	O
the	O
deletion	S-SO
spans	O
344	O
,	O
408	O
bp	S-SO
,	O
removing	S-SO
exons	S-SO
1	O
-	O
3	O
of	O
SUMF1	S-PRGE
and	O
1	O
-	O
44	O
of	O
ITPR1	S-PRGE
;	O
in	O
the	O
latter	O
,	O
we	O
estimate	O
that	O
the	O
deletion	S-SO
is	O
310	O
kb	O
in	O
length	O
and	O
that	O
it	O
removes	S-SO
exons	S-SO
1	O
-	O
3	O
of	O
SUMF1	S-PRGE
and	O
exons	S-SO
1	O
-	O
40	O
of	O
ITPR1	S-PRGE
.	O

The	O
site	S-SO
of	O
mutation	S-SO
is	O
of	O
interest	O
,	O
particularly	O
the	O
fact	O
that	O
in	O
each	O
of	O
the	O
three	O
families	O
the	O
telomeric	S-SO
end	O
of	O
the	O
deletion	S-SO
is	O
anchored	O
between	O
exons	S-SO
3	O
and	O
4	O
of	O
SUMF1	S-PRGE
;	O
sequence	S-SO
searches	O
failed	O
to	O
identify	O
any	O
repeat	B-SO
sequences	E-SO
that	O
might	O
explain	O
this	O
phenomenon	O
.	O

With	O
three	O
cerebellar	O
ataxia	O
families	O
segregating	O
a	O
SUMF1	S-PRGE
-	O
ITPR1	S-PRGE
deletion	S-SO
,	O
and	O
this	O
deletion	S-SO
not	O
observed	O
in	O
a	O
control	O
population	O
,	O
we	O
may	O
reasonably	O
conclude	O
that	O
the	O
association	O
is	O
causal	O
,	O
and	O
that	O
the	O
deletion	S-SO
is	O
indeed	O
the	O
genetic	S-SO
basis	O
of	O
the	O
disease	O
,	O
with	O
SCA15	O
the	O
diagnosis	O
in	O
the	O
two	O
British	O
families	O
as	O
well	O
as	O
the	O
original	O
Australian	O
family	O
.	O

It	O
is	O
improbable	O
that	O
heterozygosity	O
for	O
the	O
deletion	S-SO
of	O
SUMF1	S-PRGE
,	O
encoding	O
sulfatase	B-PRGE
modifying	I-PRGE
factor	I-PRGE
1	E-PRGE
,	O
of	O
itself	O
causes	O
or	O
contributes	O
to	O
SCA15	O
.	O

Homozygous	O
mutation	S-SO
of	O
SUMF1	S-PRGE
results	O
in	O
autosomal	S-GO
recessive	O
multiple	O
sulfatase	O
deficiency	O
,	O
a	O
metabolic	O
disorder	O
characterized	O
by	O
hepatosplenomegaly	O
,	O
deafness	O
,	O
and	O
developmental	O
delay	O
[	O
6	O
,	O
7	O
]	O
.	O

No	O
co	O
-	O
occurrence	O
of	O
ataxia	O
has	O
been	O
described	O
in	O
(	O
heterozygous	O
)	O
parents	O
of	O
patients	O
with	O
multiple	O
sulfatase	O
deficiency	O
.	O

Conversely	O
,	O
mutation	S-SO
of	O
ITPR1	S-PRGE
is	O
biologically	O
plausible	O
as	O
a	O
cause	O
of	O
ataxia	O
:	O
the	O
protein	S-CHEBI
is	O
highly	O
expressed	O
in	O
Purkinje	B-CL
cells	E-CL
;	O
as	O
we	O
have	O
shown	O
here	O
,	O
mice	S-LIVB
with	O
mutation	S-SO
at	O
this	O
locus	S-SO
present	O
with	O
ataxia	O
;	O
and	O
perturbed	O
Ca2	B-CHEBI
+	E-CHEBI
signaling	O
has	O
previously	O
been	O
implicated	O
in	O
the	O
etiology	O
of	O
ataxia	O
,	O
notably	O
in	O
episodic	O
ataxia	O
type	O
2	O
and	O
SCA6	O
[	O
8	O
]	O
.	O

In	O
further	O
support	O
of	O
this	O
conclusion	O
,	O
analysis	O
of	O
protein	S-CHEBI
levels	O
of	O
ITPR1	S-PRGE
in	O
Epstein	B-LIVB
-	I-LIVB
Barr	I-LIVB
virus	E-LIVB
(	O
EBV	S-LIVB
)	O
immortalized	O
lymphocytes	S-CL
from	O
affected	O
and	O
unaffected	O
AUS1	O
family	O
members	O
revealed	O
that	O
all	O
affected	O
members	O
showed	O
a	O
dramatic	O
decrease	O
in	O
ITPR1	S-PRGE
levels	O
when	O
compared	O
with	O
the	O
family	O
member	O
without	O
the	O
deletion	S-SO
(	O
Figure	O
4	O
)	O
.	O

Itpr1	S-PRGE
contains	O
three	O
domains	S-SO
,	O
an	O
N	B-SO
-	I-SO
terminal	I-SO
inositol	I-SO
triphosphate	I-SO
binding	I-SO
domain	E-SO
,	O
a	O
coupling	O
domain	S-SO
,	O
and	O
a	O
C	B-SO
-	I-SO
terminal	I-SO
transmembrane	I-SO
domain	E-SO
;	O
it	O
also	O
contains	O
two	O
protein	S-CHEBI
kinase	O
A	O
phosphorylation	O
sites	S-SO
and	O
an	O
ATP	S-CHEBI
-	O
binding	B-SO
site	E-SO
.	O

Itpr1	S-PRGE
is	O
coupled	O
to	O
Ca2	B-CHEBI
+	E-CHEBI
channels	O
and	O
facilitates	O
Ca2	B-CHEBI
+	E-CHEBI
release	O
from	O
the	O
endoplasmic	B-GO
reticulum	E-GO
after	O
binding	O
by	O
the	O
intracellular	S-GO
second	O
messenger	O
inositol	S-CHEBI
1	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
[	O
9	O
]	O
.	O

Itpr1	S-PRGE
is	O
enriched	O
in	O
the	O
Purkinje	B-CL
cells	E-CL
of	O
the	O
cerebellum	O
[	O
4	O
]	O
.	O

ITPR1	S-PRGE
mutations	S-SO
have	O
more	O
than	O
one	O
potential	O
pathogenic	O
mechanism	O
.	O

First	O
,	O
the	O
disease	O
may	O
be	O
a	O
result	O
of	O
haploinsufficiency	O
at	O
ITPR1	S-PRGE
;	O
this	O
concept	O
is	O
consistent	O
with	O
the	O
observation	O
that	O
heterozygous	O
deletion	S-SO
leads	O
to	O
a	O
later	O
onset	O
disorder	O
in	O
humans	S-LIVB
,	O
whereas	O
homozygous	O
deletion	S-SO
in	O
mice	S-LIVB
leads	O
to	O
an	O
early	O
onset	O
disorder	O
,	O
able	O
to	O
be	O
expressed	O
within	O
the	O
much	O
shorter	O
life	O
span	O
of	O
the	O
mouse	S-LIVB
.	O

Second	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
existence	O
of	O
an	O
alternate	O
start	B-SO
site	E-SO
for	O
ITPR1	S-PRGE
that	O
may	O
result	O
in	O
a	O
product	O
that	O
confers	O
a	O
pathogenic	O
gain	O
of	O
function	O
to	O
the	O
protein	S-CHEBI
;	O
however	O
,	O
Western	O
blot	O
analysis	O
of	O
cells	S-CL
derived	O
from	O
affected	O
AUS1	O
family	O
members	O
,	O
which	O
was	O
performed	O
using	O
an	O
antibody	S-GO
raised	O
against	O
the	O
C	B-SO
-	I-SO
terminal	I-SO
portion	E-SO
of	O
ITPR1	S-PRGE
,	O
failed	O
to	O
identify	O
any	O
disease	O
-	O
specific	O
truncated	O
protein	B-CHEBI
products	E-CHEBI
.	O

Clearly	O
,	O
the	O
identification	O
of	O
distinct	O
ITPR1	S-PRGE
mutations	S-SO
underlying	O
SCA15	O
will	O
help	O
elucidate	O
the	O
pathogenic	O
mechanism	O
of	O
this	O
disorder	O
.	O

We	O
show	O
here	O
the	O
utility	O
of	O
investigating	O
spontaneous	O
mouse	S-LIVB
mutations	S-SO
in	O
understanding	O
human	S-LIVB
disease	O
.	O

Currently	O
,	O
the	O
small	O
number	O
of	O
aged	O
Itpr1wt	O
/	O
Delta	O
18	O
animals	S-LIVB
precludes	O
us	O
from	O
examining	O
these	O
mice	S-LIVB
for	O
subtle	O
signs	O
and	O
symptoms	O
similar	O
to	O
those	O
seen	O
in	O
SCA15	O
patients	O
;	O
however	O
,	O
these	O
mice	S-LIVB
are	O
clearly	O
of	O
interest	O
to	O
us	O
as	O
a	O
potential	O
model	O
of	O
SCA15	O
.	O

These	O
data	O
also	O
demonstrate	O
that	O
genome	S-SO
-	O
wide	O
SNP	S-SO
assay	O
can	O
facilitate	O
rapid	O
detection	O
of	O
structural	O
genomic	S-SO
mutations	S-SO
that	O
may	O
underlie	O
disease	O
.	O

The	O
data	O
provided	O
by	O
these	O
approaches	O
provide	O
compelling	O
evidence	O
that	O
heterozygous	O
deletion	S-SO
of	O
ITPR1	S-PRGE
causes	O
SCA15	O
.	O

Clearly	O
,	O
sequence	S-SO
analysis	O
of	O
ITPR1	S-PRGE
in	O
potential	O
SCA15	O
cases	O
may	O
provide	O
additional	O
insight	O
into	O
the	O
disease	O
,	O
particularly	O
if	O
a	O
stop	O
mutation	S-SO
were	O
to	O
be	O
identified	O
;	O
however	O
,	O
the	O
mutational	S-SO
mechanism	O
noted	O
here	O
means	O
that	O
standard	O
sequencing	O
approaches	O
alone	O
are	O
insufficient	O
to	O
confidently	O
rule	O
out	O
ITPR1	S-PRGE
mutation	S-SO
as	O
a	O
cause	O
of	O
disease	O
:	O
a	O
comprehensive	O
gene	S-SO
dosage	O
approach	O
is	O
also	O
required	O
.	O

Given	O
that	O
SCA16	O
and	O
autosomal	S-GO
dominant	O
congenital	O
nonprogressive	O
ataxia	O
have	O
both	O
recently	O
been	O
mapped	O
to	O
regions	S-SO
overlapping	S-SO
with	O
the	O
SCA15	O
locus	S-SO
[	O
10	O
,	O
11	O
]	O
,	O
ITPR1	S-PRGE
is	O
a	O
gene	S-SO
of	O
importance	O
for	O
screening	O
in	O
these	O
families	O
.	O

These	O
data	O
add	O
weight	O
to	O
a	O
role	O
for	O
aberrant	O
intracellular	S-GO
Ca2	B-CHEBI
+	E-CHEBI
signaling	O
in	O
Purkinje	B-CL
cells	E-CL
in	O
the	O
pathogenesis	O
of	O
spinocerebellar	O
ataxia	O
.	O

Materials	O
and	O
Methods	O

Genome	S-SO
-	O
wide	O
linkage	O
in	O
mice	S-LIVB
.	O

One	O
hundred	O
and	O
twenty	O
DNA	S-SO
fragments	S-SO
were	O
amplified	O
across	O
the	O
genome	S-SO
,	O
each	O
selected	O
to	O
contain	O
one	O
or	O
more	O
strain	O
-	O
specific	O
SNPs	S-SO
that	O
would	O
differentiate	O
between	O
C57BL	O
/	O
6J	O
and	O
129x1	O
/	O
SvJ	O
inbred	O
strains	O
[	O
12	O
]	O
.	O

Each	O
fragment	S-SO
was	O
initially	O
amplified	O
in	O
11	O
affected	O
mice	S-LIVB
and	O
nine	O
unaffected	O
mice	S-LIVB
;	O
genotype	S-SO
calling	O
was	O
performed	O
by	O
dye	S-CHEBI
-	O
terminator	S-SO
sequencing	O
of	O
these	O
fragments	S-SO
.	O

Linkage	O
analysis	O
using	O
these	O
data	O
was	O
performed	O
using	O
mlink	O
[	O
13	O
]	O
,	O
which	O
revealed	O
a	O
positive	O
linkage	O
at	O
Chromosome	S-GO
6qE1	O
,	O
on	O
the	O
129x1	O
/	O
SvJ	O
background	O
(	O
two	O
-	O
point	O
LOD	O
score	O
5	O
.	O
13	O
at	O
marker	O
20	O
.	O
MMHAP85FLG2	O
)	O
.	O

In	O
an	O
attempt	O
to	O
narrow	O
the	O
disease	O
interval	S-SO
we	O
performed	O
backcross	O
experiments	O
that	O
resulted	O
in	O
the	O
generation	O
of	O
three	O
additional	O
affected	O
mice	S-LIVB
.	O

Genotyping	O
of	O
all	O
affected	O
mice	S-LIVB
across	O
the	O
disease	O
-	O
segregating	O
interval	S-SO
revealed	O
flanking	O
recombinants	O
and	O
a	O
candidate	O
region	S-SO
of	O
~	O
5	O
Mb	O
,	O
between	O
markers	O
D6Mit37	O
and	O
44	O
.	O
MMHAP85FLG5	O
(	O
Figure	O
S1	O
)	O
.	O

This	O
region	S-SO
contains	O
16	O
genes	S-SO
and	O
predicted	S-SO
transcripts	S-SO
.	O

Identification	O
of	O
the	O
underlying	O
genetic	S-SO
lesion	O
in	O
mice	S-LIVB
.	O

Identification	O
of	O
similar	O
phenotypes	O
in	O
mice	S-LIVB
linked	O
to	O
the	O
6qE1	O
interval	S-SO
was	O
performed	O
by	O
literature	O
searches	O
.	O

This	O
revealed	O
the	O
Itpr1opt	O
/	O
opt	O
mouse	S-LIVB
,	O
in	O
which	O
disease	O
is	O
caused	O
by	O
homozygous	O
deletion	B-SO
mutation	E-SO
of	O
exons	S-SO
43	O
and	O
44	O
of	O
Itpr1	S-PRGE
.	O

Primer	S-SO
pairs	O
were	O
designed	O
to	O
sequence	O
each	O
of	O
the	O
coding	B-SO
exons	E-SO
and	O
at	O
least	O
50	O
bp	S-SO
of	O
each	O
flanking	B-SO
intronic	I-SO
sequence	E-SO
of	O
Itpr1	S-PRGE
.	O

PCR	O
amplification	O
of	O
each	O
exon	S-SO
was	O
performed	O
using	O
DNA	S-SO
from	O
two	O
affected	O
mice	S-LIVB
as	O
templates	O
.	O

The	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mutation	S-SO
was	O
confirmed	O
by	O
sequencing	O
in	O
all	O
affected	O
mice	S-LIVB
(	O
Figure	O
S2	O
)	O
.	O

Breeding	O
experiments	O
were	O
performed	O
between	O
two	O
female	O
mice	S-LIVB
heterozygous	O
for	O
the	O
current	O
mutation	S-SO
(	O
Itpr1wt	O
/	O
Delta	O
18	O
)	O
and	O
a	O
male	O
mouse	S-LIVB
heterozygous	O
for	O
the	O
Itpr1opt	O
mutation	S-SO
(	O
Itpr1wt	O
/	O
opt	O
)	O
.	O

This	O
resulted	O
in	O
two	O
litters	O
of	O
mice	S-LIVB
with	O
a	O
total	O
of	O
four	O
affected	O
Itpr1opt	O
/	O
Delta	O
18	O
pups	O
(	O
from	O
a	O
total	O
of	O
15	O
;	O
two	O
of	O
seven	O
from	O
first	O
mating	O
;	O
two	O
of	O
eight	O
from	O
the	O
second	O
mating	O
)	O
with	O
a	O
phenotype	O
indistinguishable	O
from	O
that	O
of	O
the	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
and	O
Itpr1opt	O
/	O
opt	O
mice	S-LIVB
.	O

Analysis	O
of	O
Itpr1	S-PRGE
protein	S-CHEBI
in	O
mice	S-LIVB
.	O

We	O
performed	O
Western	O
blot	O
analyses	O
using	O
standard	O
techniques	O
with	O
ECL	O
detection	O
kits	O
(	O
Amersham	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
amersham	O
.	O
com	O
)	O
.	O

Briefly	O
,	O
dissected	O
whole	O
brains	O
from	O
postnatal	O
day	O
21	O
littermates	O
were	O
homogenized	O
in	O
a	O
buffer	O
containing	O
50	O
mM	O
Tris	S-CHEBI
-	O
HCl	S-CHEBI
,	O
150	O
mM	O
NaCl	S-CHEBI
,	O
1	O
mM	O
EDTA	S-CHEBI
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
1	O
%	O
sodium	B-CHEBI
deoxycholate	E-CHEBI
,	O
0	O
.	O
1	O
%	O
SDS	S-CHEBI
,	O
and	O
a	O
cocktail	O
of	O
protease	B-CHEBI
inhibitors	E-CHEBI
(	O
Roche	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
roche	O
.	O
com	O
)	O
.	O

Homogenates	O
were	O
diluted	O
appropriately	O
,	O
mixed	O
with	O
4	O
x	O
reducing	O
sample	O
buffer	O
,	O
and	O
loaded	O
onto	O
4	O
%	O
-	O
12	O
%	O
precast	O
gradient	O
gels	O
(	O
Novex	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
invitrogen	O
.	O
com	O
)	O
for	O
SDS	S-CHEBI
-	O
PAGE	O
and	O
immunoblotting	O
.	O

The	O
antibodies	S-GO
to	O
Itpr1	S-PRGE
(	O
1	O
:	O
2	O
,	O
000	O
)	O
and	O
Actb	S-PRGE
(	O
1	O
:	O
5	O
,	O
000	O
)	O
were	O
used	O
as	O
recommended	O
by	O
manufacturers	O
.	O

Immunohistochemistry	O
.	O

Brains	O
were	O
isolated	O
from	O
21	O
-	O
d	O
-	O
old	O
mice	S-LIVB
,	O
perfused	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
,	O
and	O
post	O
-	O
fixed	O
overnight	O
in	O
the	O
same	O
fixative	O
.	O

Brains	O
were	O
embedded	O
in	O
gelatin	O
,	O
and	O
35	O
-	O
mu	O
m	O
sagittal	O
sections	O
were	O
cut	O
using	O
a	O
sliding	O
microtome	O
(	O
NeuroScience	O
Associates	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
neuroscienceassociates	O
.	O
com	O
)	O
.	O

Sections	O
from	O
wild	B-SO
-	I-SO
type	E-SO
,	O
heterozygote	O
,	O
and	O
homozygous	O
brains	O
were	O
placed	O
in	O
the	O
MultiBrain	O
template	O
.	O

Sections	O
were	O
washed	O
in	O
1	O
x	O
PBS	O
prior	O
to	O
1	O
h	O
of	O
incubation	O
in	O
block	O
solution	O
containing	O
1	O
x	O
PBS	O
with	O
20	O
%	O
normal	O
goat	S-LIVB
serum	O
and	O
0	O
.	O
3	O
%	O
Triton	O
X	O
-	O
100	O
(	O
pH	O
7	O
.	O
4	O
)	O
.	O

Sections	O
were	O
incubated	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
primary	O
antibodies	S-GO
:	O
affinity	O
purified	O
polyclonal	O
Itpr1	S-PRGE
antibody	S-GO
(	O
1	O
:	O
2	O
,	O
000	O
,	O
Chemicon	O
International	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
chemicon	O
.	O
com	O
)	O
and	O
monoclonal	O
anti	O
-	O
Calb1	S-PRGE
antibody	S-GO
(	O
1	O
:	O
6	O
,	O
000	O
,	O
Sigma	O
-	O
Aldrich	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
)	O
diluted	O
in	O
carrier	O
solution	O
.	O

Following	O
extensive	O
washes	O
(	O
in	O
6	O
.	O
0	O
ml	O
of	O
PBS	O
,	O
three	O
times	O
)	O
,	O
sections	O
were	O
incubated	O
with	O
appropriate	O
secondary	O
antibodies	S-GO
(	O
Alexa	O
Fluor	O
555	O
goat	S-LIVB
anti	O
-	O
rabbit	S-LIVB
IgG	O
and	O
Alexa	O
Fluor	O
488	O
goat	S-LIVB
anti	O
-	O
mouse	S-LIVB
IgG	O
[	O
Invitrogen	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
invitrogen	O
.	O
com	O
]	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Sections	O
were	O
washed	O
and	O
mounted	O
on	O
glass	O
slides	O
in	O
a	O
buffered	S-CHEBI
medium	O
containing	O
Mowiol	O
(	O
Calbiochem	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
emdbiosciences	O
.	O
com	O
)	O
as	O
described	O
earlier	O
[	O
14	O
]	O
.	O

Sections	O
were	O
imaged	O
using	O
a	O
laser	O
scanning	O
confocal	O
microscope	O
(	O
LSM	O
510	O
;	O
Zeiss	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
zeiss	O
.	O
com	O
)	O
.	O

Imaging	O
parameters	O
(	O
pinhole	O
,	O
detector	O
gain	O
,	O
laser	O
power	O
)	O
were	O
optimized	O
,	O
and	O
were	O
kept	O
constant	O
for	O
the	O
wild	B-SO
-	I-SO
type	E-SO
,	O
heterozygous	O
,	O
and	O
homozygous	O
mutant	S-SO
brains	O
.	O

Specificity	O
of	O
the	O
Itpr1	S-PRGE
antibodies	S-GO
was	O
verified	O
by	O
preabsorption	O
control	O
experiments	O
.	O

Antibody	S-GO
dilutions	O
were	O
incubated	O
for	O
24	O
h	O
at	O
4	O
degrees	O
C	O
with	O
the	O
immunizing	O
peptide	S-SO
.	O

Tissue	O
sections	O
were	O
incubated	O
with	O
the	O
preabsorbed	O
antibodies	S-GO
and	O
processed	O
as	O
described	O
above	O
.	O

Under	O
these	O
conditions	O
,	O
no	O
staining	O
above	O
autofluorescence	O
was	O
detected	O
.	O

Analysis	O
of	O
ITPR1	S-PRGE
in	O
SCA15	O
patients	O
.	O

DNA	S-SO
was	O
extracted	O
from	O
EBV	S-LIVB
immortalized	O
lymphocytes	S-CL
,	O
derived	O
from	O
family	O
members	O
.	O

The	O
coding	B-SO
exons	E-SO
and	O
at	O
least	O
50	O
bp	S-SO
of	O
flanking	O
introns	S-SO
of	O
ITPR1	S-PRGE
were	O
PCR	O
amplified	O
and	O
sequenced	O
using	O
dye	S-CHEBI
-	O
terminator	S-SO
sequencing	O
(	O
BigDye	O
version	O
3	O
.	O
1	O
;	O
Applied	O
Biosystems	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
appliedbiosystems	O
.	O
com	O
)	O
.	O

Sequence	S-SO
reactions	O
were	O
run	O
on	O
an	O
ABI3730XP	O
automated	O
sequencer	O
as	O
per	O
the	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Applied	O
Biosystems	O
)	O
.	O

This	O
analysis	O
was	O
performed	O
in	O
all	O
three	O
affected	O
family	O
members	O
for	O
whom	O
genomic	B-SO
DNA	E-SO
was	O
available	O
(	O
members	O
6	O
,	O
7	O
,	O
and	O
19	O
)	O
.	O

Primer	B-SO
sequences	E-SO
and	O
conditions	O
are	O
available	O
upon	O
request	O
.	O

Sequence	S-SO
data	O
were	O
analyzed	O
using	O
Sequencher	O
(	O
Gene	S-SO
Codes	O
Corporation	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
genecodes	O
.	O
com	O
)	O
.	O

Genome	S-SO
-	O
wide	O
SNP	S-SO
genotyping	O
was	O
performed	O
using	O
Infinium	O
HumanHap550	O
SNP	S-SO
genotyping	O
chips	O
as	O
per	O
the	O
manufacturer	O
'	O
s	O
protocol	O
(	O
Illumina	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
illumina	O
.	O
com	O
)	O
.	O

This	O
product	O
assays	O
555	O
,	O
352	O
unique	O
SNPs	S-SO
.	O

Data	O
were	O
collected	O
using	O
the	O
Illumina	O
BeadStation	O
scanner	O
and	O
data	O
collection	O
software	O
.	O

Genotypes	S-SO
were	O
produced	O
using	O
the	O
genotyping	O
module	O
of	O
BeadStudio	O
(	O
version	O
2	O
.	O
3	O
.	O
25	O
;	O
Illumina	O
)	O
,	O
and	O
log	O
R	O
ratio	O
and	O
B	O
allele	S-SO
frequency	O
were	O
visualized	O
using	O
the	O
genome	S-SO
viewer	O
tool	O
within	O
this	O
package	O
.	O

In	O
order	O
to	O
rule	O
out	O
the	O
possibility	O
that	O
the	O
observed	O
deletion	S-SO
within	O
ITPR1	S-PRGE
was	O
a	O
benign	O
copy	O
number	O
variant	O
we	O
examined	O
log	O
R	O
ratio	O
and	O
B	O
allele	S-SO
frequency	O
metrics	O
of	O
HumanHap550	O
genotyping	O
data	O
at	O
this	O
locus	S-SO
from	O
577	O
individuals	S-LIVB
of	O
Northern	O
European	O
descent	O
from	O
North	O
America	O
and	O
Europe	O
,	O
produced	O
by	O
us	O
as	O
a	O
part	O
of	O
an	O
ongoing	O
study	O
.	O

In	O
an	O
attempt	O
to	O
narrow	O
the	O
unknown	O
intervals	S-SO
flanking	O
the	O
deletion	S-SO
observed	O
in	O
family	O
AUS1	O
,	O
we	O
designed	O
primers	S-SO
for	O
30	O
PCR	O
amplifications	O
that	O
would	O
generate	O
overlapping	S-SO
fragments	S-SO
across	O
the	O
two	O
bordering	B-SO
regions	E-SO
(	O
primer	B-SO
sequence	E-SO
and	O
conditions	O
available	O
upon	O
request	O
)	O
.	O

There	O
were	O
ten	O
primer	S-SO
pairs	O
in	O
the	O
telomeric	S-SO
flanking	B-SO
region	E-SO
and	O
20	O
pairs	O
in	O
the	O
centromeric	S-SO
flanking	B-SO
region	E-SO
(	O
Figure	O
S3	O
)	O
.	O

On	O
average	O
each	O
product	O
was	O
~	O
750	O
bp	S-SO
in	O
size	O
,	O
and	O
amplifications	O
were	O
performed	O
using	O
genomic	B-SO
DNA	E-SO
from	O
each	O
of	O
the	O
three	O
affected	O
individuals	S-LIVB
(	O
family	O
members	O
6	O
,	O
7	O
,	O
and	O
19	O
)	O
.	O

Dye	S-CHEBI
-	O
terminator	S-SO
sequencing	O
of	O
each	O
product	O
was	O
performed	O
using	O
the	O
forward	B-SO
and	I-SO
reverse	I-SO
primers	E-SO
designed	S-SO
for	O
amplification	O
;	O
running	O
and	O
analysis	O
of	O
each	O
fragment	S-SO
was	O
performed	O
as	O
described	O
above	O
.	O

Amplification	O
of	O
a	O
fragment	S-SO
from	O
a	O
normal	O
diploid	O
genome	S-SO
was	O
denoted	O
by	O
the	O
presence	O
of	O
a	O
heterozygous	O
polymorphism	S-SO
;	O
amplification	O
of	O
a	O
fragment	S-SO
from	O
a	O
region	S-SO
of	O
the	O
genome	S-SO
harboring	O
a	O
heterozygous	O
genomic	S-SO
deletion	S-SO
was	O
inferred	O
when	O
homozygosity	O
for	O
the	O
major	O
allele	S-SO
and	O
the	O
minor	O
allele	S-SO
were	O
noted	O
among	O
the	O
three	O
affected	O
family	O
members	O
(	O
i	O
.	O
e	O
.	O
,	O
this	O
is	O
inconsistent	O
with	O
Mendelian	O
inheritance	O
in	O
related	O
individuals	S-LIVB
known	O
to	O
share	O
a	O
common	O
haplotype	S-SO
)	O
.	O

Using	O
the	O
data	O
from	O
the	O
experiments	O
described	O
above	O
we	O
were	O
able	O
to	O
limit	O
the	O
size	O
of	O
unknown	O
regions	S-SO
flanking	O
the	O
deletion	S-SO
to	O
~	O
4	O
kb	O
on	O
the	O
telomeric	S-SO
side	O
and	O
7	O
kb	O
on	O
the	O
centromeric	S-SO
side	O
.	O

All	O
combinations	O
of	O
forward	B-SO
primers	E-SO
from	O
the	O
newly	O
defined	O
region	S-SO
flanking	O
the	O
deletion	S-SO
on	O
the	O
telomeric	S-SO
side	O
with	O
reverse	B-SO
primers	E-SO
from	O
the	O
newly	O
defined	O
region	S-SO
flanking	O
the	O
deletion	S-SO
on	O
the	O
centromeric	S-SO
side	O
were	O
used	O
in	O
PCR	O
amplification	O
reactions	O
performed	O
with	O
DNA	S-SO
from	O
the	O
three	O
affected	O
family	O
members	O
and	O
single	O
unaffected	O
family	O
members	O
.	O

This	O
experiment	O
was	O
performed	O
in	O
an	O
attempt	O
to	O
amplify	O
across	O
the	O
deleted	S-SO
fragment	S-SO
and	O
define	O
the	O
exact	O
breakpoint	S-SO
.	O

A	O
single	O
fragment	S-SO
was	O
obtained	O
from	O
the	O
third	O
forward	B-SO
primer	E-SO
from	O
the	O
telomeric	S-SO
side	O
(	O
T3f	O
5	O
'	O
-	O
TGAATGCTCAATTTTCCAGC	O
-	O
3	O
'	O
)	O
with	O
the	O
11th	O
reverse	B-SO
primer	E-SO
from	O
the	O
centromeric	S-SO
side	O
(	O
C11r	O
5	O
'	O
-	O
GGGAAAATGGATAGAGGGTG	O
-	O
3	O
'	O
)	O
.	O

The	O
fragment	S-SO
,	O
which	O
is	O
953	O
bp	S-SO
in	O
size	O
,	O
was	O
sequenced	O
as	O
described	O
above	O
and	O
compared	O
to	O
the	O
current	O
build	S-SO
of	O
the	O
human	S-LIVB
genome	S-SO
.	O

A	O
similar	O
series	O
of	O
experiments	O
was	O
performed	O
to	O
identify	O
the	O
deletion	B-SO
breakpoints	E-SO
in	O
families	O
H27	O
and	O
H33	O
;	O
we	O
were	O
able	O
to	O
amplify	O
a	O
369	O
-	O
bp	S-SO
PCR	B-SO
product	E-SO
across	O
the	O
breakpoint	S-SO
found	O
in	O
affected	O
members	O
of	O
family	O
H27	O
using	O
primer	S-SO
pair	O
H27	O
-	O
11F	O
5	O
'	O
-	O
GACCTCAAGAAGGCATGAATAC	O
-	O
3	O
'	O
and	O
H27	O
-	O
3R	O
5	O
'	O
-	O
ATGGTGGCCAGGTACACAAG	O
-	O
3	O
'	O
(	O
Figure	O
S4	O
)	O
,	O
but	O
to	O
date	O
we	O
have	O
been	O
unable	O
to	O
identify	O
the	O
breakpoint	S-SO
in	O
family	O
H33	O
.	O

Western	O
blot	O
analysis	O
in	O
SCA15	O
patients	O
.	O

EBV	S-LIVB
immortalized	O
lymphoblasts	O
from	O
three	O
affected	O
family	O
members	O
who	O
carry	O
the	O
deletion	S-SO
and	O
one	O
family	O
member	O
without	O
the	O
mutation	S-SO
were	O
used	O
as	O
a	O
readily	O
accessible	O
source	O
of	O
protein	S-CHEBI
;	O
all	O
samples	O
came	O
from	O
members	O
of	O
family	O
AUS1	O
.	O

Protein	S-CHEBI
extraction	O
was	O
performed	O
using	O
lysis	O
buffer	O
containing	O
1	O
x	O
TBS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
and	O
a	O
cocktail	O
of	O
protease	B-CHEBI
inhibitors	E-CHEBI
(	O
Roche	O
)	O
with	O
overnight	O
lysis	O
at	O
-	O
80	O
degrees	O
C	O
.	O

Homogenates	O
were	O
diluted	O
appropriately	O
,	O
mixed	O
with	O
4	O
x	O
reducing	O
sample	O
buffer	O
,	O
and	O
loaded	O
onto	O
4	O
%	O
-	O
12	O
%	O
precast	O
gradient	O
gels	O
(	O
NuPAGE	O
,	O
Invitrogen	O
)	O
for	O
SDS	S-CHEBI
-	O
PAGE	O
and	O
immunoblotting	O
.	O

The	O
antibodies	S-GO
to	O
ITPR1	S-PRGE
(	O
1	O
:	O
1	O
,	O
000	O
)	O
and	O
ACTB	S-PRGE
(	O
1	O
:	O
5	O
,	O
000	O
)	O
were	O
used	O
as	O
recommended	O
by	O
manufacturers	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Schematic	O
of	O
Genotyping	O
Results	O
across	O
Mouse	S-LIVB
Chromosome	S-GO
6	O
in	O
Affected	O
Mice	S-LIVB

Black	O
squares	O
are	O
indicative	O
of	O
a	O
C57BL	O
/	O
6J	O
homozygous	O
genotype	S-SO
;	O
light	O
grey	O
squares	O
,	O
a	O
129x1	O
/	O
SvJ	O
homozygous	O
genotype	S-SO
;	O
grey	O
squares	O
,	O
a	O
C57BL	O
/	O
6J	O
129x1	O
/	O
SvJ	O
heterozygous	O
genotype	S-SO
;	O
white	O
squares	O
,	O
undetermined	O
genotype	S-SO
.	O

The	O
black	O
box	O
bounds	O
a	O
region	S-SO
of	O
homozygous	O
129x1	O
/	O
SvJ	O
genotypes	S-SO
that	O
segregate	O
with	O
disease	O
;	O
thus	O
,	O
the	O
critical	O
region	S-SO
was	O
determined	O
to	O
be	O
between	O
markers	O
D6Mit37	O
and	O
44	O
.	O
MMHAP85FLG5	O
.	O

(	O
10	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Sequence	S-SO
of	O
Exon	S-SO
36	O
of	O
Itpr1	S-PRGE
from	O
Four	O
Mice	S-LIVB

A	O
wild	B-SO
-	I-SO
type	E-SO
homozygous	O
C57BL	O
/	O
6J	O
mouse	S-LIVB
(	O
A	O
)	O
,	O
a	O
wild	B-SO
-	I-SO
type	E-SO
homozygous	O
129x1	O
/	O
SvJ	O
mouse	S-LIVB
(	O
B	O
)	O
,	O
an	O
affected	O
129x1B6	O
mice	S-LIVB
homozygous	O
for	O
the	O
18	O
-	O
bp	S-SO
deletion	B-SO
mutation	E-SO
(	O
C	O
)	O
,	O
and	O
an	O
unaffected	O
mouse	S-LIVB
heterozygous	O
for	O
the	O
18	O
-	O
bp	S-SO
deletion	B-SO
mutation	E-SO
(	O
D	O
)	O
.	O

The	O
deleted	S-SO
nucleotides	S-CHEBI
are	O
bounded	O
by	O
a	O
green	O
box	O
.	O

(	O
5	O
.	O
1	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Additional	O
Families	O
Harboring	O
Deletion	S-SO
at	O
the	O
SCA15	O
Locus	S-SO

(	O
A	O
)	O
Family	O
H33	O
;	O
(	O
B	O
)	O
family	O
H27	O
.	O

Upper	O
panel	O
shows	O
log	O
R	O
ratio	O
and	O
B	O
allele	S-SO
frequency	O
metrics	O
generated	O
from	O
Infinium	O
HumanHap550	O
arrays	O
for	O
an	O
affected	O
family	O
member	O
from	O
each	O
family	O
.	O

Log	O
R	O
ratio	O
is	O
the	O
ratio	O
of	O
normalized	O
,	O
observed	O
R	O
to	O
expected	O
R	O
for	O
each	O
SNP	S-SO
(	O
each	O
SNP	S-SO
is	O
a	O
blue	O
dot	O
)	O
and	O
thus	O
serves	O
as	O
a	O
surrogate	O
of	O
copy	O
number	O
at	O
each	O
locus	S-SO
.	O

B	O
allele	S-SO
frequency	O
is	O
a	O
measure	O
of	O
the	O
number	O
of	O
times	O
the	O
A	O
or	O
B	O
alleles	S-SO
are	O
detected	O
at	O
each	O
locus	S-SO
(	O
each	O
SNP	S-SO
is	O
denoted	O
by	O
a	O
blue	O
dot	O
)	O
.	O

Thus	O
,	O
SNPs	S-SO
with	O
a	O
B	O
allele	S-SO
frequency	O
of	O
one	O
are	O
apparent	O
B	O
/	O
B	O
homozygotes	O
,	O
SNPs	S-SO
with	O
a	O
B	O
allele	S-SO
frequency	O
of	O
0	O
.	O
5	O
are	O
apparent	O
A	O
/	O
B	O
heterozygotes	O
,	O
and	O
those	O
with	O
a	O
B	O
allele	S-SO
frequency	O
of	O
zero	O
are	O
apparent	O
A	O
/	O
A	O
homozygotes	O
.	O

These	O
plots	O
show	O
a	O
contiguous	O
region	S-SO
~	O
310	O
kb	O
long	O
(	O
family	O
H33	O
)	O
and	O
~	O
350	O
kb	O
long	O
(	O
family	O
H27	O
)	O
with	O
decreased	O
copy	O
number	O
and	O
apparent	O
homozygosity	O
indicative	O
of	O
a	O
genomic	S-SO
deletion	S-SO
(	O
shaded	O
grey	O
)	O
.	O

The	O
pedigrees	O
below	O
show	O
the	O
available	O
family	O
members	O
assayed	O
for	O
these	O
deletions	S-SO
,	O
all	O
of	O
whom	O
were	O
affected	O
and	O
all	O
of	O
whom	O
carried	O
a	O
deletion	S-SO
at	O
this	O
locus	S-SO
.	O

(	O
6	O
.	O
8	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Deleted	S-SO
Regions	S-SO
Identified	O
in	O
Families	O
AUS1	O
and	O
H27	O

(	O
Top	O
)	O
Family	O
AUS1	O
;	O
sequence	S-SO
from	O
the	O
PCR	B-SO
product	E-SO
generated	O
using	O
primers	S-SO
T3f	O
and	O
C11r	O
from	O
genomic	B-SO
DNA	E-SO
from	O
an	O
affected	O
family	O
member	O
.	O

Red	O
arrowhead	O
denotes	O
the	O
deletion	B-SO
breakpoint	E-SO
;	O
the	O
deletion	S-SO
is	O
201	O
,	O
510	O
bp	S-SO
in	O
length	O
.	O

(	O
Bottom	O
)	O
Family	O
H27	O
;	O
sequence	S-SO
flanking	O
deleted	S-SO
region	S-SO
.	O

Green	O
font	O
indicates	O
nucleotides	S-CHEBI
telomeric	S-SO
to	O
the	O
deletion	S-SO
;	O
blue	O
font	O
indicates	O
nucleotides	S-CHEBI
centromeric	S-SO
to	O
the	O
deletion	S-SO
.	O

The	O
deletion	S-SO
is	O
344	O
,	O
408	O
bp	S-SO
in	O
length	O
.	O

Basepair	B-SO
positions	E-SO
are	O
based	O
on	O
NCBI	O
genome	S-SO
build	S-SO
36	O
reference	O
assembly	S-SO
.	O

(	O
876	O
KB	O
MB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
OMIM	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
OMIM	O
)	O
accession	O
number	O
for	O
SUMF1	S-PRGE
is	O
607939	S-PRGE
.	O

Acknowledgements	O

We	O
thank	O
the	O
SCA15	O
family	O
members	O
for	O
participating	O
in	O
this	O
study	O
.	O

Abbreviations	O

EBV	S-LIVB
-	O
Epstein	B-LIVB
-	I-LIVB
Barr	I-LIVB
virus	E-LIVB

SCA	O
[	O
number	O
]	O
-	O
spinocerebellar	O
ataxia	O
[	O
number	O
]	O

SNP	S-SO
-	O
single	B-SO
nucleotide	I-SO
polymorphism	E-SO

Figures	O
and	O
Tables	O

Figure	O
1	O

Immunohistochemistry	O
and	O
Western	O
Blot	O
Analysis	O
of	O
ITPR1	S-PRGE
Protein	S-CHEBI
Levels	O
in	O
Mouse	S-LIVB
Cerebellum	O

(	O
A	O
-	O
F	O
)	O
Immunohistochemistry	O
of	O
cerebellum	O
from	O
a	O
wild	B-SO
-	I-SO
type	E-SO
mouse	S-LIVB
(	O
A	O
and	O
D	O
)	O
,	O
a	O
mouse	S-LIVB
heterozygous	O
for	O
the	O
Itpr1	S-PRGE
18	O
-	O
bp	S-SO
deletion	S-SO
(	O
B	O
and	O
E	O
)	O
,	O
and	O
a	O
mouse	S-LIVB
homozygous	O
for	O
the	O
18	O
-	O
bp	S-SO
Itpr1	S-PRGE
deletion	S-SO
(	O
C	O
and	O
F	O
)	O
.	O

(	O
A	O
-	O
C	O
)	O
Immunohistochemistry	O
using	O
polyclonal	O
Itpr1	S-PRGE
anti	O
-	O
rabbit	S-LIVB
antibody	S-GO
(	O
1	O
:	O
2	O
,	O
000	O
;	O
Alexa	O
Fluor	O
555	O
)	O
;	O
(	O
D	O
-	O
F	O
)	O
immunohistochemistry	O
using	O
monoclonal	O
Calb1	S-PRGE
anti	O
-	O
mouse	S-LIVB
antibody	S-GO
(	O
1	O
:	O
6	O
,	O
000	O
;	O
Alexa	O
Fluor	O
488	O
)	O
.	O

Scale	O
bars	O
denote	O
100	O
mu	O
m	O
.	O

As	O
previously	O
described	O
,	O
Iptr1	S-PRGE
is	O
highly	O
expressed	O
in	O
the	O
Purkinje	B-CL
cells	E-CL
.	O

Notably	O
,	O
there	O
appears	O
to	O
be	O
decreased	O
immunoreactivity	O
to	O
Itpr1	S-PRGE
in	O
the	O
heterozygous	O
and	O
homozygous	O
mutant	S-SO
mice	S-LIVB
.	O

(	O
G	O
)	O
Western	O
blot	O
performed	O
to	O
examine	O
Itpr1	S-PRGE
levels	O
in	O
whole	O
brain	O
from	O
wild	B-SO
-	I-SO
type	E-SO
,	O
Itpr1wt	O
/	O
Delta	O
18	O
,	O
and	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mice	S-LIVB
;	O
this	O
clearly	O
shows	O
a	O
reduction	O
of	O
Itpr1	S-PRGE
in	O
brain	O
tissue	O
from	O
Itpr1wt	O
/	O
Delta	O
18	O
mice	S-LIVB
and	O
a	O
greater	O
reduction	O
of	O
Itpr1	S-PRGE
in	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mice	S-LIVB
.	O

Figure	O
2	O

Metrics	O
Derived	O
from	O
Analysis	O
of	O
DNA	S-SO
from	O
Affected	O
Family	O
Member	O
7	O
Using	O
Illumina	O
Infinium	O
HumanHap550	O
Genotyping	O
Chips	O

The	O
upper	O
and	O
lower	O
plots	O
are	O
log	O
R	O
ratio	O
and	O
B	O
allele	S-SO
frequency	O
,	O
respectively	O
,	O
at	O
an	O
~	O
800	O
-	O
kb	O
segment	S-SO
on	O
the	O
p	O
arm	B-SO
of	I-SO
Chromosome	E-SO
3	O
.	O

Log	O
R	O
ratio	O
is	O
the	O
ratio	O
of	O
normalized	O
,	O
observed	O
R	O
to	O
expected	O
R	O
for	O
each	O
SNP	S-SO
(	O
each	O
SNP	S-SO
is	O
a	O
blue	O
dot	O
)	O
and	O
thus	O
serves	O
as	O
a	O
surrogate	O
of	O
copy	O
number	O
at	O
each	O
locus	S-SO
.	O

B	O
allele	S-SO
frequency	O
is	O
a	O
measure	O
of	O
the	O
number	O
of	O
times	O
the	O
A	O
or	O
B	O
alleles	S-SO
are	O
detected	O
at	O
each	O
locus	S-SO
(	O
each	O
SNP	S-SO
is	O
denoted	O
by	O
a	O
blue	O
dot	O
)	O
.	O

Thus	O
,	O
SNPs	S-SO
with	O
a	O
B	O
allele	S-SO
frequency	O
of	O
one	O
are	O
apparent	O
B	O
/	O
B	O
homozygotes	O
,	O
SNPs	S-SO
with	O
a	O
B	O
allele	S-SO
frequency	O
of	O
0	O
.	O
5	O
are	O
apparent	O
A	O
/	O
B	O
heterozygotes	O
,	O
and	O
those	O
with	O
a	O
B	O
allele	S-SO
frequency	O
of	O
zero	O
are	O
apparent	O
A	O
/	O
A	O
homozygotes	O
.	O

Clearly	O
,	O
these	O
plots	O
show	O
a	O
contiguous	O
region	S-SO
~	O
200	O
kb	O
long	O
with	O
decreased	O
copy	O
number	O
and	O
apparent	O
homozygosity	O
(	O
bounded	O
by	O
a	O
red	O
box	O
)	O
.	O

As	O
we	O
have	O
demonstrated	O
previously	O
,	O
this	O
is	O
indicative	O
of	O
a	O
heterozygous	O
genomic	S-SO
deletion	S-SO
[	O
15	O
]	O
.	O

Below	O
these	O
plots	O
is	O
a	O
schematic	O
of	O
the	O
two	O
known	S-SO
genes	S-SO
affected	O
by	O
this	O
deletion	S-SO
,	O
ITPR1	S-PRGE
and	O
SUMF1	S-PRGE
.	O

Figure	O
3	O

Mutation	S-SO
Analysis	O
in	O
the	O
Australian	O
SCA15	O
Family	O

(	O
Top	O
)	O
Pedigree	O
of	O
kindred	O
.	O

Filled	O
symbols	O
denote	O
affected	O
individuals	S-LIVB
;	O
open	O
symbols	O
,	O
unaffected	O
individuals	S-LIVB
;	O
grey	O
symbol	O
denotes	O
unknown	O
disease	O
status	O
;	O
bulls	O
-	O
eye	O
symbol	O
denotes	O
obligate	O
carrier	O
.	O

w	S-SO
/	O
w	S-SO
,	O
wild	B-SO
-	I-SO
type	E-SO
at	O
ITPR1	S-PRGE
;	O
w	S-SO
/	O
m	S-SO
,	O
heterozygous	O
carrier	O
of	O
the	O
ITPR1	S-PRGE
deletion	S-SO
.	O

(	O
Middle	O
)	O
Schematic	O
of	O
primer	S-SO
pairs	O
used	O
to	O
narrow	O
the	O
unknown	O
regions	S-SO
between	O
known	S-SO
deleted	S-SO
sequence	S-SO
and	O
known	S-SO
diploid	O
sequence	S-SO
at	O
the	O
SCA15	O
locus	S-SO
.	O

Nine	O
primer	S-SO
pairs	O
(	O
T1	O
-	O
T9	O
)	O
were	O
used	O
to	O
amplify	O
across	O
the	O
unknown	O
region	S-SO
telomeric	S-SO
to	O
the	O
known	S-SO
deleted	S-SO
region	S-SO
;	O
19	O
primer	S-SO
pairs	O
(	O
C1	O
-	O
C19	O
)	O
were	O
used	O
to	O
amplify	O
across	O
the	O
unknown	O
region	S-SO
centromeric	S-SO
to	O
the	O
known	S-SO
deleted	S-SO
region	S-SO
.	O

All	O
PCRs	O
were	O
carried	O
out	O
in	O
the	O
three	O
affected	O
family	O
members	O
.	O

Analysis	O
of	O
these	O
data	O
narrowed	O
the	O
unknown	O
region	S-SO
,	O
and	O
ultimately	O
we	O
were	O
able	O
to	O
use	O
primer	S-SO
T3f	O
and	O
C11r	O
to	O
amplify	O
across	O
the	O
deletion	B-SO
breakpoint	E-SO
in	O
the	O
three	O
affected	O
family	O
members	O
,	O
producing	O
a	O
fragment	S-SO
of	O
953	O
bp	S-SO
in	O
affected	O
individuals	S-LIVB
.	O

(	O
Bottom	O
)	O
Gel	O
showing	O
amplification	O
product	S-SO
using	O
primer	S-SO
pair	O
T3f	O
and	O
C11r	O
from	O
affected	O
pedigree	O
members	O
6	O
,	O
7	O
,	O
and	O
19	O
;	O
in	O
pedigree	O
member	O
23	O
,	O
with	O
unknown	O
disease	O
affection	O
status	O
;	O
in	O
a	O
neurologically	O
normal	O
control	O
(	O
C	O
)	O
;	O
and	O
in	O
a	O
no	O
template	O
control	O
(	O
NC	O
)	O
.	O

Figure	O
4	O

Western	O
Blot	O
Analysis	O
of	O
ITPR1	S-PRGE
Protein	S-CHEBI
Levels	O
in	O
EBV	S-LIVB
Immortalized	O
Lymphoblasts	O
from	O
AUS1	O
Family	O
Members	O

Western	O
blot	O
performed	O
to	O
examine	O
ITPR1	S-PRGE
levels	O
in	O
EBV	S-LIVB
immortalized	O
lymphocytes	S-CL
from	O
AUS1	O
affected	O
family	O
members	O
carrying	O
the	O
ITPR1	S-PRGE
deletion	S-SO
and	O
from	O
an	O
AUS1	O
family	O
member	O
of	O
unknown	O
disease	O
status	O
who	O
does	O
not	O
carry	O
the	O
deletion	S-SO
.	O

Notably	O
the	O
samples	O
from	O
patients	O
with	O
ITPR1	S-PRGE
deletion	S-SO
show	O
a	O
dramatic	O
decrease	O
in	O
ITPR1	S-PRGE
levels	O
.	O

To	O
demonstrate	O
equal	O
loading	O
,	O
these	O
samples	O
were	O
diluted	O
one	O
in	O
five	O
,	O
and	O
the	O
Western	O
blot	O
was	O
repeated	O
using	O
an	O
antibody	S-GO
against	O
ACTB	S-PRGE
.	O

Footnotes	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
May	O
16	O
,	O
2007	O
(	O
doi	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0030108	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

EMCF	O
,	O
JTR	O
,	O
and	O
ABS	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

JvdL	O
,	O
JC	O
,	O
MAK	O
,	O
LAH	O
,	O
SS	O
,	O
MRC	O
,	O
HCF	O
,	O
XL	O
,	O
DH	O
,	O
JSS	O
,	O
IR	O
,	O
and	O
HC	O
performed	O
the	O
experiments	O
.	O

JvdL	O
,	O
JC	O
,	O
MAK	O
,	O
SS	O
,	O
MRC	O
,	O
KGH	O
,	O
HCF	O
,	O
JSS	O
,	O
JTR	O
,	O
and	O
ABS	O
analyzed	O
the	O
data	O
.	O

HH	O
,	O
NWW	O
,	O
PG	O
,	O
JH	O
,	O
ES	O
,	O
RJMG	O
,	O
SMF	O
,	O
HC	O
,	O
and	O
ABS	O
contributed	O
reagents	S-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

RJMG	O
,	O
EMCF	O
,	O
and	O
ABS	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
research	O
was	O
funded	O
in	O
part	O
by	O
the	O
intramural	O
programs	O
of	O
the	O
National	O
Institute	O
on	O
Aging	O
and	O
the	O
National	O
Institute	O
on	O
Neurological	O
Disorders	O
and	O
Stroke	O
(	O
NINDS	O
)	O
,	O
both	O
of	O
the	O
National	O
Institutes	O
of	O
Health	O
,	O
Department	O
of	O
Health	O
and	O
Human	S-LIVB
Services	O
,	O
United	O
States	O
of	O
America	O
.	O

MAK	O
was	O
supported	O
by	O
a	O
NINDS	O
Competitive	O
Postdoctoral	O
Fellowship	O
.	O

HH	O
is	O
supported	O
by	O
the	O
Medical	O
Research	O
Council	O
,	O
United	O
Kingdom	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O
